Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,cytoplasmic translation (GO:0002181),-0.6280471560522493,-2.1995523481778156,0.0,0.0,0.0,63/91,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;EIF4A1;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;EIF4A2;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RPL36A;DRG2;FTSJ1;RPS26;RPL35A;RPS29;RPL8;RPL36;TMA7;RPS3;RPL13A
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),-0.6132635534485527,-2.1811667269769277,0.0,0.0005593969932199614,0.001,60/87,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;SEC61B;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,cotranslational protein targeting to membrane (GO:0006613),-0.6018357972665559,-2.1330287721899603,0.0,0.0014917253152532306,0.004,68/91,31.89%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;TRAM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;RPS21
prerank,transition metal ion transport (GO:0000041),0.8010610700985817,2.1162702964698425,0.0,0.05635472767604138,0.05,7/35,3.70%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1;ATP7A
prerank,bone development (GO:0060348),-0.6820469166318193,-2.109277450769511,0.0,0.0022375879728798458,0.008,16/39,11.93%,RANBP3L;SULF1;AKAP13;CYP26B1;TGM2;FGFR2;GJA1;LRP6;SKI;SULF2;SFRP4;RPL13;GNAS;NOTUM;MYOC;DYM
prerank,response to ATP (GO:0033198),0.8932818059498302,2.09732453011469,0.0,0.050093091267592336,0.086,2/18,0.02%,ABCC9;TRPC3
prerank,muscle contraction (GO:0006936),0.6666989127751068,2.0698223557873514,0.0,0.06231819092218333,0.142,20/126,3.93%,SNTB1;ITGA1;GJC1;EDNRA;CALD1;CASQ2;UTRN;DMD;DYSF;KCNJ12;UTS2;MYLK;CACNA1H;VCL;MYH11;ROCK1;TACR2;MYL9;ITGB5;TMOD1
prerank,manganese ion transport (GO:0006828),0.9276228081077166,2.06114005561117,0.0,0.05590746793258073,0.164,6/14,2.39%,TRPC3;TRPC4;TRPC6;SLC30A10;TRPC1;ATP2C1
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.6400335454251079,2.057175450498634,0.0,0.04955637957543957,0.181,16/142,4.04%,TRPC3;TRPC4;TRPC6;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;ATP1A2;TRPC1;GPER1;CCRL2;ADCY8;ACKR3;ATP2B3;TACR1
prerank,positive regulation of calcium ion transport (GO:0051928),0.7887679188566774,2.0551974635291286,0.0018281535648994515,0.043086021953375554,0.19,5/36,1.47%,TRPC3;TRPC6;PDGFRB;CACNB2;MYLK
prerank,protein targeting to ER (GO:0045047),-0.565375097490874,-2.040118471606653,0.0,0.006489005121351553,0.029,73/99,32.07%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RPL18;RPS9;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;CHMP4B;CHMP4A;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;SPCS1;RPS7;RPL38;RPLP0;RPL27;SEC61A1;RPL36A;RPS26;RPL35A;RPS29;RPL8;RPL36;RPS3;RPL13A;EDEM1;RPS2;RPL21;RPL29;SRP14;SEC63;RPL19;RPL23A;GET3;RPS21;SPCS2
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",-0.5488967145268205,-2.0366524849009777,0.0,0.005780435596606268,0.031,66/110,25.74%,RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;SMG5;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;PNRC2;UPF2;RPL36A;RPS26;RPL35A;DHX34;HELZ2;RPS29;RPL8;RPL36;RPS3;RPL13A
prerank,embryonic skeletal system development (GO:0048706),-0.6859179638877589,-2.0359916844645762,0.0,0.005114486795153934,0.032,13/35,6.26%,SULF1;COL1A1;PDGFRA;PCSK5;OSR1;KIAA1217;HOXB3;RBP4;WNT9A;HOXA3;SULF2;SIX1;WNT5A
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",0.7451368437372042,2.0305177864525867,0.0,0.05980501712559493,0.284,11/46,5.56%,GRM3;GRM7;MEF2C;CDH2;ATP1A2;NRXN1;CACNG7;GRIK1;GRM5;ATAD1;GRM1
prerank,response to purine-containing compound (GO:0014074),0.8813202007986471,2.0203427054467764,0.0,0.06395814331487236,0.324,2/17,0.02%,ABCC9;TRPC3
prerank,response to organophosphorus (GO:0046683),0.8905527364697172,2.0113309416900913,0.002074688796680498,0.06738713468140398,0.367,2/16,0.02%,ABCC9;TRPC3
prerank,modulation of chemical synaptic transmission (GO:0050804),0.6539115033604511,2.0042344046234746,0.0,0.07156155895370335,0.422,25/107,6.61%,GRM3;GRM7;PTEN;MEF2C;SLC12A2;CEL;CLSTN1;CDH2;ATP1A2;BEGAIN;LRRC4C;EIF4EBP2;IL1B;GRIK1;NMU;GRM5;RIMS1;CLSTN3;NRG3;RIMS2;ITGB1;GRM1;GRID1;SYN1;CHRNA7
prerank,regulation of heart contraction (GO:0008016),0.662211669569298,1.9972298882874633,0.0016051364365971107,0.07538359676145796,0.467,15/90,3.94%,ABCC9;ACE2;PDE4D;TBX2;CASQ2;ATP2A3;KCNJ12;ATP1A2;TRPC1;CACNA1H;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1
prerank,sprouting angiogenesis (GO:0002040),-0.6215777546890162,-1.996069586504206,0.0,0.011048090616094238,0.078,26/51,14.62%,ROBO1;EFNB2;NRP1;TEK;CCBE1;RECK;SLIT2;RSPO3;RNF213;THBS1;BMP4;EPHB4;ANGPT1;RAMP2;VEGFD;VEGFC;BMPER;ACVRL1;PTK2B;SEMA3E;AKT1;CDH13;KDR;FLT4;PARVA;ESM1
prerank,regulation of cardiac conduction (GO:1903779),0.7228515646230836,1.9952575105588293,0.0,0.07238153515004787,0.486,15/54,7.48%,ABCC9;ACE2;CASQ2;ATP2A3;ATP1A2;TRPC1;ITPR2;ATP1A4;FXYD2;ATP2B3;ITPR1;ATP1B2;RYR2;ATP2A2;STIM1
prerank,cellular calcium ion homeostasis (GO:0006874),0.6166583257377816,1.9817357363074082,0.0,0.08938313950082755,0.575,21/133,7.48%,TRPC3;ATP13A5;TRPC4;TRPC6;PTH1R;ATP2A3;TRPC1;GPER1;ATP2C1;STIM2;ADCY8;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,potassium ion import across plasma membrane (GO:1990573),0.7329420426632797,1.9649013024401736,0.0,0.11398734033339888,0.692,9/41,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;ATP1A4;FXYD2;SLC12A6;ATP1B2
prerank,metal ion transport (GO:0030001),0.6479131038171182,1.953911943614547,0.0,0.12976496023604872,0.749,10/86,3.94%,TRPC3;TRPC4;CACNA1C;ATP2A3;TRPC1;ATP2C1;NDFIP2;CACNG7;CACNA2D1;ITPR1
prerank,inorganic ion transmembrane transport (GO:0098660),0.9023615495757842,1.9337957927199692,0.004338394793926247,0.17280998337960704,0.847,3/12,1.67%,ABCC9;KCNJ8;CACNA1H
prerank,eye morphogenesis (GO:0048592),-0.729366393014096,-1.9264096897181398,0.0,0.04462744901465914,0.271,11/19,7.33%,FBN1;COL5A2;EFEMP1;COL5A1;SHROOM2;MFAP5;NKD1;SKI;RARG;FBN2;STAT3
prerank,androgen receptor signaling pathway (GO:0030521),-0.8345291250870466,-1.9258585392749012,0.0,0.040724101106413196,0.274,6/11,12.24%,ZMIZ1;DDX5;AR;TMF1;KDM3A;PLPP1
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.8134530548478754,1.9139757501505357,0.006521739130434782,0.23194364107935614,0.934,7/21,6.40%,PDE4D;CACNA1C;CASQ2;DMD;ATP1A2;AKAP6;RYR2
prerank,skin development (GO:0043588),-0.5625946877396941,-1.9136281711659846,0.0,0.04759959869580763,0.327,21/65,14.82%,COL1A2;COL3A1;COL5A2;COL1A1;ERRFI1;CLIC4;COL5A1;ITGA6;ANXA1;ADAM9;ITGA3;LSR;WNT5A;TXNIP;ITGB4;GATA6;WNT16;MET;UGCG;CLDN1;PKD1
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.8229052140969773,1.9129669489053898,0.0020408163265306124,0.22362987173032295,0.935,6/17,6.40%,GJD3;GJC1;CACNA1C;ATP1A2;ATP1B2;RYR2
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),0.7300630868188149,1.9053215266155992,0.003484320557491289,0.24006078230587724,0.952,12/35,7.26%,GUCY1B1;PDE4D;CAP2;PDE3A;RAPGEF2;IRAG1;PDE7B;PDE9A;AKAP6;RIMS2;HTR2C;CAP1
prerank,chordate embryonic development (GO:0043009),-0.5769427374073064,-1.902787495745586,0.0,0.050718660718609844,0.374,22/55,11.87%,SULF1;ALDH1A2;COL1A1;CHD7;BMP7;PCSK5;KIAA1217;RBP4;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;SULF2;WNT5A;HINFP;TBX1;FUT8;FLCN;TGFB1;PTCH1
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.7796431937895388,1.8980451283393218,0.004048582995951417,0.25632455897729617,0.964,11/24,10.18%,PDE4D;PDE3A;RAPGEF2;GPR61;PRKAR1B;PEX5L;PRKAR2B;PRKAR2A;GPR62;CGAS;PRKAR1A
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),-0.8400160132601143,-1.8894717375679664,0.0,0.05903789805367594,0.445,7/11,11.59%,TGFBR3;TGFBR2;TGFBR1;SMAD7;ACVR1;USP15;TGFB1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.8236702103396402,1.8855972308874802,0.012903225806451613,0.2973638351522637,0.977,4/16,1.22%,CACNA1C;CASQ2;DMD;ATP1A2
prerank,platelet degranulation (GO:0002576),-0.5041111199792508,-1.8838528817709026,0.0,0.060494789123930116,0.475,42/118,18.45%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;SRGN;TMSB4X;ECM1;PSAP;LGALS3BP;ITGB3;TGFB1;ACTN1;F5;APOOL;SCG3;SERPINE1;APLP2;SYTL4;CD109;CALM1;QSOX1;CYRIB;BRPF3;MAGED2
prerank,amino acid import (GO:0043090),-0.7189092629139271,-1.8819280522055999,0.0,0.05817728729487599,0.487,15/21,22.10%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SFXN2;SLC22A4;SLC7A5;SLC6A1;SLC25A38;SLC7A1;SLC22A2;SH3BP4;SLC36A1;SLC1A1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.852964801239656,1.8775387481177979,0.00425531914893617,0.3162532986033549,0.986,4/15,5.56%,GRM3;GRM7;GRM5;GRM1
prerank,regulation of adenylate cyclase activity (GO:0045761),0.7822173576115323,1.8720034851779548,0.005836575875486381,0.3250217109652711,0.991,4/22,2.17%,GRM3;CACNA1C;CAP2;NF1
prerank,mesenchymal cell development (GO:0014031),0.8007364430475347,1.8713902828249425,0.018255578093306288,0.31419996978110376,0.991,6/18,2.80%,HEY2;CDH2;HEYL;NOTCH1;TBX20;NRG1
prerank,cGMP metabolic process (GO:0046068),0.8665854163823764,1.8609195344481029,0.002105263157894737,0.34764605339709087,0.993,4/12,3.73%,GUCY1B1;GUCY1A1;PDE9A;GUCY2D
prerank,positive regulation of positive chemotaxis (GO:0050927),-0.7514511529995659,-1.8596809045032767,0.0036363636363636364,0.07845542829909959,0.59,8/15,10.62%,NTRK3;F3;VEGFD;VEGFC;IL16;CXCL12;CDH13;KDR
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.7796983284325474,1.8524690483291566,0.014705882352941176,0.3717416560070984,0.998,6/20,6.59%,CACNA1C;CASQ2;DMD;ATP1A2;RYR2;ATP2A2
prerank,calcium ion transport (GO:0006816),0.5888106610163008,1.849820861781874,0.0,0.3696684605580657,0.998,21/113,7.48%,TRPC3;TRPC4;TRPC6;CACNA1C;CACNB2;ATP2A3;TRPC1;CACNA1H;TRPV2;ATP2C1;CACNG7;CACNA2D1;STIM2;ITPR1;SLC24A4;SLC24A2;RYR2;ATP2A2;CHRNA7;CACNA1D;STIM1
prerank,respiratory tube development (GO:0030323),-0.6406429901792003,-1.8473599723755378,0.0,0.0881214792848857,0.641,10/28,8.16%,GLI2;PDPN;PCSK5;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6
prerank,proteoglycan metabolic process (GO:0006029),-0.6671454095195971,-1.84431271755092,0.004008016032064128,0.08714162049937622,0.656,8/26,8.96%,SULF1;IGF1;CHST11;ADAMTS12;BMPR2;CSGALNACT1;SULF2;FOXL1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.6339295078025422,1.8381856343775036,0.0,0.4098177135080832,0.999,13/75,4.90%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;TRPV2;ATP1A4;SLC5A1;FXYD2;CACNA2D1;SLC24A2;SLC12A6;ATP1B2
prerank,skeletal system morphogenesis (GO:0048705),-0.595658698029652,-1.8374977277237574,0.0,0.09221217804025891,0.691,12/42,6.61%,PDGFRA;WWOX;CYP26B1;HOXB3;FGFR2;TGFBR1;LRP6;SKI;HOXA3;SFRP4;SIX1;FBN2
prerank,chemical synaptic transmission (GO:0007268),0.5336953582468329,1.8371672855034291,0.0,0.4006830391416408,0.999,66/284,12.33%,GRM3;GRM7;LIN7A;PTEN;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;SLC1A4;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;RIMS1;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;GRID1;ASIC2;HTR1B;GRIA2;CDH8;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;SLC32A1;OPRK1;CHRNA7;CHRFAM7A;ERC2;RIMBP2;PRKAR2A;KCNQ3;SYT1;SLC5A7;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;STXBP2;PRKAR1A;APBA2;DLG2;GAD1;BRSK1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;DLGAP2;GRIK5;GRIK2
prerank,cation transport (GO:0006812),0.5652059903233887,1.8364521824265805,0.0,0.390040313613914,0.999,19/167,5.52%,ABCC9;ANO1;TRPC6;KCNJ8;SLC12A2;NEDD4L;KCNJ12;ATP1A2;KCNG1;KCNMB1;ATP1A4;SLC5A1;KCNQ4;NDFIP2;FGF13;SCN2A;KCNH4;KCNAB3;SCN5A
prerank,ATP transport (GO:0015867),-0.8373244707179315,-1.8355554247799442,0.0,0.09118170989485372,0.708,5/10,10.65%,CD47;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,respiratory system development (GO:0060541),-0.6156022583904305,-1.8199345335666912,0.0021321961620469083,0.11065405284932,0.786,13/32,13.41%,GLI2;PDPN;CHD7;RBP4;FGFR2;BMP4;ITGA3;FGF1;ABCA3;STRA6;DISP1;ZIC3;SPEF2
prerank,inorganic cation transmembrane transport (GO:0098662),0.5299314231640699,1.8148215170924584,0.0,0.4832713666760579,1.0,42/268,9.02%,ABCC9;TRPC3;TRPC4;TRPC6;CACNA1C;KCNJ8;SLC30A10;SLC12A2;ATP2A3;KCNJ12;ATP1A2;TRPC1;KCNG1;CACNA1H;TRPV2;ATP2C1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;SCN2A;KCNH8;KCNH4;KCNAB3;SCN5A;ASIC2;KCNQ5;ATP6V0E2;HCN2;SCN8A;ATP2A2;CACNA1D;KCNA4;KCNQ3;SLC9A7;RYR3;HCN3;SLC6A15;SCN9A;PKD2
prerank,bone morphogenesis (GO:0060349),-0.7661233969673437,-1.813791077802356,0.0019047619047619048,0.1155409062359775,0.827,6/14,5.90%,CYP26B1;FGFR2;BMPR2;LRP6;SKI;SFRP4
prerank,digestive tract development (GO:0048565),-0.6180649714490847,-1.8137038514040704,0.0,0.1108092478743541,0.827,15/32,16.39%,CLMP;GLI2;PCSK5;RARB;FGFR2;SMO;STRA6;BBS7;KIT;GLI3;ZIC3;GATA6;PKD1;PKDCC;EPHB3
prerank,extracellular matrix organization (GO:0030198),-0.4323871770118859,-1.812973593802528,0.0,0.10707790778552097,0.827,110/276,12.53%,FLRT2;ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;GSN;COL12A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL25A1;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;TLL1;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;PLEC;COL11A1;CAPN2;TIMP2;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HTRA1;HSPG2;ADAM10;PLOD2;COL13A1;GAS6;BGN;ST7;SERPINH1;ADAMTS1;ITGA11;SPOCK2;NDNF;P4HB;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CYP1B1;CD47;GFOD2;KLK2;CAPNS1;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;CAPN1;DPT;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;TGFB1;CTSS;ADAMTS3;F11R;COL20A1;SMOC2;COL9A2
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),-0.6339789419087338,-1.8127187104578129,0.002079002079002079,0.10328706082813369,0.827,12/30,12.55%,TGFBR3;SMAD3;FSTL1;DKK3;SMURF2;SMAD7;ITGA3;LTBP4;SFRP4;FKBP1A;TGFB1;TWSG1
prerank,negative regulation of cell aging (GO:0090344),0.7780035444492855,1.8115413237459166,0.017543859649122806,0.4848854693792727,1.0,4/16,2.56%,SLC30A10;CDK6;AKT3;FOXM1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),-0.5852825208279383,-1.8044392844402557,0.002232142857142857,0.1116642459542923,0.861,17/38,16.55%,SMAD3;ROCK2;PTGIS;CAV1;KLF4;KLF2;CD34;DDAH1;P2RX4;CD47;NOS1AP;AKT1;ZC3H12A;PTGS2;HSP90AB1;SIRPA;TLR4
prerank,peptide cross-linking (GO:0018149),-0.6343193770698587,-1.8007195979083634,0.0020408163265306124,0.11403411298824696,0.875,6/25,6.07%,FN1;COL3A1;TGM2;THBS1;ANXA1;NDNF
prerank,visual perception (GO:0007601),-0.5057529684240083,-1.7958106041834738,0.0,0.11779302400088904,0.896,17/84,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,renal system development (GO:0072001),-0.5606211123164679,-1.7956624819669167,0.0,0.11388551199898801,0.896,15/52,9.11%,SULF1;WNT4;GLI2;PCSK5;GREB1L;RBP4;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STAT1;STRA6;ARL3
prerank,mesonephros development (GO:0001823),-0.7901243041099821,-1.7940731435409143,0.0018656716417910447,0.11262526130161891,0.9,5/11,5.36%,ZBTB16;BMP7;OSR1;BMP4;FGF1
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),-0.4570297266069899,-1.7924846407326254,0.0,0.11076060465755237,0.907,88/168,24.60%,SAMD4A;RPLP1;RPS14;DDX5;CNOT7;RPL9;TUT4;RPS12;THRAP3;TUT7;RPL41;RPS20;CTIF;RPL18A;RPS13;RPS19;RPS23;RPS4X;RPS11;RPL13;RC3H2;SMG6;RPL18;RPS9;UPF3A;RPL34;RPL32;RPL27A;RPS8;RPL12;RPL37;ZC3H12A;MTPAP;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;CNOT8;RPL10;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;NBDY;RPL31;CNOT3;SMG5;RPS25;RPL15;RPSA;PNLDC1;RPS7;RPL38;RPLP0;RPL27;AGO1;CNOT11;PNRC2;UPF2;TENT4B;RPL36A;PAN3;RPS26;RPL35A;DHX34;CSDE1;HELZ2;EXOSC7;SAMD4B;RPS29;RPL8;RPL36;POLR2G
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.7968589522534647,1.791723286150201,0.012219959266802444,0.5738478041855681,1.0,4/17,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,diacylglycerol metabolic process (GO:0046339),0.7469245728415007,1.7905792068592266,0.011881188118811881,0.5627843042568633,1.0,4/23,1.88%,DGKB;PLCE1;DGKH;DGKG
prerank,chloride transmembrane transport (GO:1902476),0.6544772000667253,1.7875763944736849,0.005272407732864675,0.5628316611708768,1.0,7/48,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;GABRG2;GABRA2
prerank,cGMP biosynthetic process (GO:0006182),0.8613222281584981,1.7863576023047416,0.006578947368421052,0.5540554310936379,1.0,3/10,3.73%,GUCY1B1;GUCY1A1;GUCY2D
prerank,regulation of bone mineralization (GO:0030500),-0.5498172040001444,-1.7858375661356638,0.0,0.11726359470373442,0.922,25/55,12.78%,BMP6;WNT4;BMP7;OSR1;ENPP1;SGMS2;ANKH;BMPR2;BMP4;ADGRV1;ACVR1;SRGN;BMP2K;FBN2;ANO6;PTK2B;KL;ATRAID;ECM1;NOTUM;P2RX7;TGFB1;TMEM119;S1PR1;CCN1
prerank,membrane lipid biosynthetic process (GO:0046467),-0.5327453273367787,-1.7834952510696205,0.002347417840375587,0.11750727142426584,0.927,19/58,14.58%,ST3GAL4;PLPP3;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA
prerank,anterograde trans-synaptic signaling (GO:0098916),0.527704151849252,1.7816971232127652,0.0,0.5639824484027,1.0,66/224,16.41%,GRM3;GRM7;CEL;CACNB2;UTS2;PRKAR1B;RAPSN;PDE7B;PCDHB11;KCNMB1;NRXN1;CHRNA3;GRIK1;SNAP25;GRM5;KCND2;MINK1;RPS6KA2;SLC12A6;RIT2;SYN2;GABRG2;GRM1;ASIC2;HTR1B;GRIA2;GABRA2;SYN1;PRKAR2B;SNCA;HTR2C;OPRK1;CHRNA7;CHRFAM7A;PRKAR2A;KCNQ3;SYT1;GRM4;PLP1;GRIN2B;CACNA1A;SLC12A5;PRKAR1A;APBA2;DLG2;GAD1;NTSR1;SCN2B;GABRA5;KCNC4;GABRA4;GRIK2;SLC12A4;NLGN3;DLGAP1;CHRNB2;CAMKK2;PCDHB16;GABRB3;CDK5;GRIN2A;HTR4;GRIA1;GRIA4;MAPK1;APBA1
prerank,collagen fibril organization (GO:0030199),-0.505235689928752,-1.779895779651572,0.0,0.12023744783680819,0.936,39/88,12.53%,COL1A2;COL3A1;COL5A2;COL1A1;ADAMTS2;COL22A1;COL12A1;COL5A1;LOXL1;COL6A3;COL25A1;COL6A1;COL8A2;ITGA6;TLL1;COL4A5;COL6A2;TGFBR1;PLEC;COL11A1;COL23A1;COL4A6;PLOD2;COL13A1;SERPINH1;P4HB;COL18A1;CYP1B1;ITGB4;COL14A1;DPT;COL15A1;COL16A1;LUM;ADAMTS14;LAMA3;ADAMTS3;COL20A1;COL9A2
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.5554467404941824,1.7778056498814945,0.004273504273504274,0.5699266131013525,1.0,16/140,6.40%,TRPC3;EDNRA;CACNA1C;PLCE1;S1PR3;TBXA2R;GPER1;CCRL2;CACNA2D1;ADCY8;ACKR3;TACR1;GRM1;CXCR2;HTR2C;RYR2
prerank,secondary palate development (GO:0062009),-0.7439805802228362,-1.7775674974997968,0.003703703703703704,0.12073385390810253,0.942,5/14,6.26%,TGFBR3;CHD7;TGFBR2;LEF1;WNT5A
prerank,prostaglandin metabolic process (GO:0006693),-0.6366506879690303,-1.7767361533947466,0.0,0.11890293866997625,0.944,9/26,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;ACOX1;TBXAS1;GSTM1;PTGS2
prerank,negative regulation of nuclear division (GO:0051784),-0.7746276818288629,-1.7761766692282426,0.0,0.11677790204408062,0.945,4/11,6.19%,BMP7;TOM1L2;BMP4;TOM1L1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),0.7937617676494834,1.7750234097560889,0.014084507042253521,0.5687538389022377,1.0,6/18,2.51%,IL34;DAAM2;TNFRSF21;NOTCH1;NF1;PTN
prerank,regulation of multicellular organism growth (GO:0040014),-0.7223286683129596,-1.7715428303728484,0.001984126984126984,0.12085919248252326,0.954,5/15,13.16%,IGF1;APP;GHR;PTCH1;MFSD2A
prerank,positive regulation of behavior (GO:0048520),0.8554973588242353,1.771389496685176,0.012958963282937365,0.5742367846291233,1.0,2/10,0.63%,SGIP1;MEF2C
prerank,positive regulation of phosphatase activity (GO:0010922),0.7436859481949277,1.76976222460781,0.024793388429752067,0.5685216778096347,1.0,3/21,0.63%,ITGA1;PDGFRB;MEF2C
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.7779739045368871,1.7694743096857335,0.026785714285714284,0.5566466978613067,1.0,4/17,1.62%,NOTCH3;HEYL;NOTCH1;MAML2
prerank,positive regulation of transporter activity (GO:0032411),0.8080155207860802,1.767310980000851,0.015283842794759825,0.5544980679973729,1.0,4/13,7.40%,TRPC6;NR1H3;STK39;PDZK1
prerank,calcium ion transmembrane transport (GO:0070588),0.5847642268746381,1.7648731026170368,0.009389671361502348,0.5552323115297136,1.0,12/86,4.63%,TRPC3;TRPC4;TRPC6;CACNA1C;ATP2A3;TRPC1;TRPV2;ATP2C1;CACNA2D1;ATP2B3;SLC24A4;SLC24A2
prerank,cGMP-mediated signaling (GO:0019934),0.8232568756248075,1.764492377096795,0.02434077079107505,0.5446629764809643,1.0,4/13,2.42%,GUCY1B1;PDE3A;IRAG1;PDE9A
prerank,skeletal system development (GO:0001501),-0.45763376523639504,-1.7630925101191233,0.0,0.1311857666664043,0.966,40/148,8.80%,BMP6;SULF1;IGF1;FBN1;COL1A2;EXT1;ZBTB16;COL1A1;WWOX;GLI2;AKAP13;CHD7;BMP7;PCSK5;KIAA1217;ITGB8;RBP4;TLL1;SUFU;ANKH;TGM2;NPR3;FGFR2;GJA1;TGFBR1;CREB3L2;TNFRSF11B;COL13A1;PAPSS2;IGF2;TEAD4;SULF2;WNT5A;PRELP;ALPL;EVC;RPL13;GNAS;MMP14;CMKLR1
prerank,cellular response to BMP stimulus (GO:0071773),-0.5249979933700138,-1.7617680543730314,0.002544529262086514,0.13008777077330202,0.97,19/66,9.08%,BMP6;TGFBR3;SMAD3;ADAMTS12;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,negative regulation of cyclase activity (GO:0031280),0.7760038957211217,1.760616321653947,0.013972055888223553,0.5507128667306735,1.0,1/14,0.04%,GRM3
prerank,tight junction assembly (GO:0120192),-0.539344915885066,-1.7596823504165602,0.0,0.12972552711061935,0.972,15/49,12.08%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;LSR;PDCD6IP;PARD6G;CLDN11;ACTG1;PARD3;PATJ;F11R
prerank,negative regulation of programmed necrotic cell death (GO:0062099),-0.7697988366504199,-1.7591110747106498,0.0018484288354898336,0.12751587650209312,0.973,8/11,17.18%,NUPR1;ARHGEF2;BIRC3;SLC25A4;CASP8;YBX3;PELI1;RIPK1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),-0.6545487658915691,-1.7583111936476417,0.0064516129032258064,0.1258773327068918,0.975,7/23,4.34%,TGFBR3;SMAD3;DKK3;SMURF2;SMAD7;ITGA3;LTBP4
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),-0.6307885251536731,-1.7570628133079185,0.007561436672967864,0.12510150939282774,0.976,15/24,19.58%,SEC23A;SEC24D;B2M;SEC31A;TAPBP;ACE;SEC24A;ERAP1;IDE;CALR;PDIA3;HFE;BCAP31;SAR1B;CANX
prerank,diol metabolic process (GO:0034311),-0.6501394610586404,-1.749651396634905,0.012195121951219513,0.13430500254996586,0.983,10/19,16.18%,PLPP3;NOS3;NAAA;AKT1;DEGS2;GCH1;PLPP1;SPHK1;PTS;CALM1
prerank,negative regulation of lyase activity (GO:0051350),0.7582504363111714,1.749614633015959,0.015655577299412915,0.5951219114157845,1.0,1/16,0.04%,GRM3
prerank,negative regulation of cellular senescence (GO:2000773),0.7727071609541402,1.7482882364198158,0.03260869565217391,0.5891901687188242,1.0,3/13,2.36%,SLC30A10;CDK6;AKT3
prerank,central nervous system neuron development (GO:0021954),0.7868215332079462,1.7478505282936372,0.010141987829614604,0.5795938610257978,1.0,7/15,9.18%,PTEN;RAPGEF2;MAP2;ATP7A;NTRK2;B4GALT6;ARHGAP35
prerank,lung development (GO:0030324),-0.5939387710774823,-1.7468824861515262,0.0,0.13586050452724804,0.985,11/33,8.16%,ERRFI1;GLI2;PDPN;RBP4;FGFR2;BMP4;ITGA3;RCN3;FGF1;ABCA3;STRA6
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.8052925119030245,1.7467956471871962,0.023965141612200435,0.5729934025423027,1.0,2/12,0.33%,GJD3;PDE4D
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.8338016815214762,1.746372890636213,0.01694915254237288,0.5638805291182865,1.0,2/10,0.99%,PDE4D;PDE3A
prerank,positive regulation of blood coagulation (GO:0030194),-0.687373901053055,-1.7458221042942876,0.005917159763313609,0.134731360920212,0.987,7/17,15.73%,ST3GAL4;F3;THBS1;THBD;ANO6;USF1;SERPINE1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),0.8086779274418668,1.7430357494939301,0.01735357917570499,0.56884558449064,1.0,2/12,3.74%,ANO1;ADCY8
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.6998717040041594,1.7417237457692487,0.01303538175046555,0.5640367308192953,1.0,7/32,6.29%,TRPC3;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,prostanoid biosynthetic process (GO:0046457),-0.7101710770446711,-1.7413399771169615,0.0,0.13945300876812622,0.99,7/15,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,sensory perception of light stimulus (GO:0050953),-0.49024949472872414,-1.741321154665648,0.0,0.13665269405801914,0.99,17/87,12.34%,COL1A1;EFEMP1;ABLIM1;ZIC2;DHRS3;EYA4;SLC4A10;COL11A1;ADGRV1;PITPNA;CRYBG3;MYO9A;COL18A1;ATF6;EML2;CRYBB3;OAT
prerank,neurotransmitter secretion (GO:0007269),0.6615467184885429,1.7401512010082594,0.01060070671378092,0.5609962397051197,1.0,14/44,10.73%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;RIMS2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,glutamate receptor signaling pathway (GO:0007215),0.6694968663676348,1.7347053784904356,0.018018018018018018,0.5758103257265713,1.0,6/37,5.80%,GRM3;GRM7;GRIK1;GRM5;GRM1;GRIA2
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.6839527823912419,1.7320584868444429,0.015779092702169626,0.577667905803957,1.0,3/32,0.19%,DLC1;ITGA1;PDGFRB
prerank,lipid phosphorylation (GO:0046834),0.8099386572517322,1.7319852161073768,0.03418803418803419,0.5679571008976926,1.0,3/10,1.88%,DGKB;DGKH;DGKG
prerank,neuron cell-cell adhesion (GO:0007158),0.7553549491457223,1.7298914489887618,0.022821576763485476,0.5679736059456968,1.0,7/14,7.51%,CEL;NRXN1;ASTN1;ASTN2;CNTN4;NINJ2;NRXN3
prerank,positive regulation of Rho protein signal transduction (GO:0035025),-0.6031267337100575,-1.7276284665176291,0.004329004329004329,0.1587121149163675,0.996,11/30,16.36%,ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;F11R;LPAR6;PRAG1;LPAR4;NET1
prerank,BMP signaling pathway (GO:0030509),-0.5164215570333875,-1.7264827979888717,0.0024630541871921183,0.15801319773189734,0.996,18/62,9.08%,BMP6;TGFBR3;SMAD3;SMAD6;BMP7;BMPR2;BMP4;DDX5;SMAD9;SMAD7;ACVR1;PDCD4;RGMB;ACVRL1;SMURF1;HIVEP1;USP15;TMEM100
prerank,negative regulation of adenylate cyclase activity (GO:0007194),0.7787460989972784,1.7199608562896105,0.020202020202020204,0.6036338788522765,1.0,1/13,0.04%,GRM3
prerank,negative regulation of wound healing (GO:0061045),0.6871984633737785,1.719261269596574,0.027833001988071572,0.5969426709388088,1.0,7/28,5.26%,PTEN;SLC12A2;VTN;AJAP1;PHLDB2;FGF2;CLASP2
prerank,cAMP-mediated signaling (GO:0019933),0.7081656580306206,1.7189415069743552,0.01338432122370937,0.5887844576947014,1.0,8/24,7.26%,PDE4D;CAP2;PDE3A;RAPGEF2;PDE7B;AKAP6;RIMS2;CAP1
prerank,cardiac ventricle development (GO:0003231),0.7218670077437738,1.7156434400078906,0.03333333333333333,0.5942639217225981,1.0,4/20,5.52%,HEY2;HEYL;NOTCH1;SCN5A
prerank,placenta development (GO:0001890),0.7843605845507459,1.7133164908819327,0.03632478632478633,0.5951678306869808,1.0,3/12,2.53%,PTK2;NODAL;ADAM19
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.7418194425021112,-1.7131892284470935,0.0038535645472061657,0.18221281290691743,0.998,3/12,1.10%,NFIB;EPHA4;GLI2
prerank,positive regulation of embryonic development (GO:0040019),-0.6557847357535677,-1.7124808493922912,0.003898635477582846,0.18042136230381173,0.998,5/19,7.38%,PLCB1;WNT4;OSR1;NIBAN2;NR2C2
prerank,retinoic acid metabolic process (GO:0042573),-0.7110902868034503,-1.7110265078269355,0.0018975332068311196,0.18012583181682756,0.998,4/14,13.44%,ALDH1A2;CYP26B1;SCPEP1;ADH1A
prerank,integrin-mediated signaling pathway (GO:0007229),-0.4938571992630717,-1.7105676606576836,0.0024691358024691358,0.17784756042625904,0.998,27/73,11.50%,ITGBL1;DAB2;FN1;COL3A1;NRP1;FBLN1;PLPP3;NEDD9;ITGB8;FYB1;ITGA5;SEMA7A;ADAM9;ADAM10;ADAMTS1;ITGA11;ITGA10;PTK2B;PTPRA;CD47;ZYX;ITGB4;ADAM15;LAMA5;COL16A1;ITGB3;LAMA3
prerank,negative regulation of cell junction assembly (GO:1901889),0.7153483645197898,1.7097401894355129,0.021696252465483234,0.6022212677027765,1.0,7/25,2.62%,DLC1;PTEN;ARHGAP6;PHLDB2;SLIT1;ROCK1;IL1B
prerank,calcium ion import (GO:0070509),0.7102528927447898,1.7096262474467574,0.023346303501945526,0.5934792749766263,1.0,4/28,1.67%,TRPC4;CACNA1C;CACNB2;CACNA1H
prerank,kidney development (GO:0001822),-0.512952146997329,-1.7095595127963903,0.0,0.1767894283215514,0.998,17/65,9.11%,SULF1;ZBTB16;WNT4;GLI2;CTSH;BMP7;PCSK5;OSR1;GREB1L;BMP4;TGFBR1;SULF2;ACE;SIX1;FOXC1;STRA6;ARL3
prerank,positive regulation of epithelial cell migration (GO:0010634),-0.47910899970735593,-1.7079553287317297,0.0,0.17686758968087973,0.998,36/92,13.39%,DOCK5;ANXA3;NRP2;ROCK2;FOXP1;NRP1;CTSH;TEK;SPARC;PLCG1;SASH1;BMPR2;THBS1;BMP4;ANGPT1;RAB11A;FOXC2;ADAM9;FGF1;PRKCE;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;RREB1;HIF1A;ZC3H12A;KDR;ITGB3;PFN1;SMOC2;FLT4;CALR;ATOH8;PLCG2
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.705134549279609,-1.7075863423201845,0.007858546168958742,0.17470546784804106,0.998,4/14,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,substrate-dependent cell migration (GO:0006929),-0.7158288432181779,-1.7071549145181653,0.007380073800738007,0.17267352611054135,0.998,10/14,19.66%,NRP1;CD2AP;ANKS1A;SDCBP;VEGFC;ITGA11;EPHA8;OPHN1;NTN1;ITGA2
prerank,signal release from synapse (GO:0099643),0.6538413634068996,1.7065649632214244,0.017889087656529516,0.5983115568203096,1.0,13/43,10.73%,LIN7A;NRXN1;SNAP25;RIMS1;SYN2;SYN1;SNCA;SLC32A1;SYT1;GRM4;STXBP2;GAD1;BRSK1
prerank,prostaglandin biosynthetic process (GO:0001516),-0.6717310564152351,-1.706091358342417,0.003816793893129771,0.17190269601649416,0.998,7/18,11.61%,PTGDS;PLA2G4A;PTGIS;PTGS1;DAGLB;TBXAS1;PTGS2
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.7004812765879024,-1.7057175962828204,0.006012024048096192,0.16974489089346698,0.998,6/15,8.00%,PDGFRA;TGFBR2;FGFR2;TGFBR1;SIX1;TBX1
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5557063841988301,-1.70259148198987,0.0,0.1735754734768648,0.998,15/43,13.07%,NFIB;SMAD3;FOXO3;NR3C1;BMP4;KLF4;DDX5;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;PPARA;ATOH8
prerank,regulation of epithelial cell migration (GO:0010632),-0.5209078689369188,-1.7020903706757784,0.004728132387706856,0.1716372044276485,0.998,23/51,15.89%,MCC;DOCK5;GLUL;CTSH;PLCG1;MACF1;SASH1;BMPR2;ARSB;RAB11A;PTPRG;BMPER;PRKCE;RREB1;HIF1A;DAB2IP;RHOJ;PFN1;EVL;PLCG2;CORO1C;DUSP10;CEACAM1
prerank,in utero embryonic development (GO:0001701),-0.6054971334844808,-1.700643347399853,0.004056795131845842,0.17129784801757506,0.998,12/25,14.82%,CHD7;MBNL1;FGFR2;TGFBR1;ADAM10;IGF2;ARNT2;HINFP;FUT8;FLCN;ZNF568;PKD1
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.7799490061330443,1.6991954940141107,0.028629856850715747,0.6242277404627612,1.0,3/13,0.73%,GJC1;CACNA1C;CACNB2
prerank,inositol lipid-mediated signaling (GO:0048017),0.6217933529705197,1.6967955700976023,0.015410958904109588,0.6268739945551065,1.0,11/50,7.19%,ADAP2;PDGFRB;PLCL1;PLCE1;PIK3CD;PIK3R1;PIK3CA;PITPNM2;OGT;PIK3C2A;IRS1
prerank,regulation of BMP signaling pathway (GO:0030510),-0.49576967983051595,-1.696154112028298,0.0024509803921568627,0.17757842397077975,0.999,21/73,7.15%,SULF1;ZNF423;FSTL1;SMAD6;CDH5;SKIL;HTRA3;BMPR2;SMURF2;BMP4;FOXD1;SMAD9;SMAD7;ITGA3;SKI;BMPER;SFRP4;ACVRL1;SMURF1;NBL1;VWC2
prerank,phospholipid translocation (GO:0045332),-0.5919136266089793,-1.6954243078456082,0.008368200836820083,0.17659993561713816,0.999,14/28,17.16%,ABCA1;ATP10A;PLSCR2;ANO6;ABCA4;PLSCR4;P2RX7;ATP9A;ATP8A1;MFSD2A;TMEM30A;PLSCR3;ATP11A;ATP11B
prerank,regulation of DNA binding (GO:0051101),-0.5404468547821236,-1.6932401695923875,0.006772009029345372,0.17828900586894117,0.999,18/44,21.26%,IGF1;SP100;LEF1;SKI;SMO;FOXC1;MDFI;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;NFKBIA;E2F1;PLAUR;RSF1;HJURP
prerank,negative regulation of cell-substrate junction organization (GO:0150118),0.7740463397900499,1.6928365808819354,0.04040404040404041,0.627096496881265,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,negative regulation of focal adhesion assembly (GO:0051895),0.7740463397900499,1.6928365808819354,0.04040404040404041,0.627096496881265,1.0,4/16,1.69%,DLC1;PTEN;ARHGAP6;PHLDB2
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),0.7446189562729935,1.6925419291661044,0.043052837573385516,0.619473642992014,1.0,7/17,7.38%,CACNA1C;CACNB2;ATP1A2;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,embryonic appendage morphogenesis (GO:0035113),-0.7418408950886015,-1.692500128028552,0.01282051282051282,0.1770491483541178,0.999,5/12,11.87%,CYP26B1;MBNL1;LRP6;SKI;PTCH1
prerank,sodium ion homeostasis (GO:0055078),0.7194322191696886,1.692493056937695,0.038314176245210725,0.6111431677936842,1.0,6/21,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.7367246365008542,-1.6923074158373184,0.00929368029739777,0.17477507796863664,0.999,7/11,16.28%,DAB2;RSPO3;NKD1;MLLT3;WNT5B;SFRP1;PLEKHA4
prerank,T cell migration (GO:0072678),0.7771123555319388,1.6917118850681356,0.033126293995859216,0.606300406758611,1.0,3/13,5.81%,SLC12A2;PIK3CD;CXCL10
prerank,arachidonic acid metabolic process (GO:0019369),-0.5741708652601288,-1.6914911865600308,0.002136752136752137,0.17370075778041547,0.999,11/35,12.26%,PTGDS;PLA2G4A;PTGIS;PTGS1;CYP1B1;DAGLB;GPX4;TBXAS1;MGLL;PTGS2;EPHX2
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.7076224620569646,-1.6914519042973688,0.005671077504725898,0.17136457186667833,0.999,4/13,2.27%,PLXNA2;NRP2;NRP1;PLXNA4
prerank,cellular response to zinc ion (GO:0071294),-0.6732380435607095,-1.6893872129704077,0.017208413001912046,0.17344414550892248,1.0,13/15,31.15%,P2RX4;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;ATP13A2;HVCN1;MT2A
prerank,potassium ion transmembrane transport (GO:0071805),0.5300107790321749,1.688634932475979,0.0014104372355430183,0.6113557169060045,1.0,30/135,10.26%,ABCC9;KCNJ8;SLC12A2;KCNJ12;ATP1A2;KCNG1;KCNV2;ATP1A4;KCNQ4;FXYD2;KCNE4;KCND2;SLC24A4;SLC24A2;SLC12A6;ATP1B2;KCNH8;KCNH4;KCNAB3;KCNQ5;HCN2;KCNE5;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3;SLC12A5;KCNJ6
prerank,aorta morphogenesis (GO:0035909),0.7554559702091936,1.6880834952458397,0.03024193548387097,0.6057685965430988,1.0,4/17,1.47%,PDGFRB;TBX2;HEY2;MYLK
prerank,mesonephric tubule development (GO:0072164),-0.6858194738560025,-1.6878939263210642,0.008,0.17422534298423345,1.0,7/15,6.84%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,eye development (GO:0001654),-0.5159527599807598,-1.687697280829878,0.0,0.17230939274940274,1.0,15/54,8.16%,PBX1;FBN1;SMOC1;COL5A2;EFEMP1;LAMA1;COL5A1;SHROOM2;PBX3;RBP4;SKI;RAB3GAP1;FBN2;FOXC1;STRA6
prerank,positive regulation of protein secretion (GO:0050714),-0.4986487457855854,-1.6873400527527098,0.0026041666666666665,0.17075779683703732,1.0,22/69,17.60%,BMP6;IGF1;UNC13B;CD2AP;MCU;MYRIP;RBP4;MYO18A;EZR;TCF7L2;ADAM9;NNAT;GOLPH3;C1QTNF3;MYH10;NLGN2;TGFB1;PPID;PPIA;SYTL4;TLR4;ACSL4
prerank,ventricular cardiac muscle tissue development (GO:0003229),-0.6179165133922568,-1.683158485585178,0.01037344398340249,0.1769313805660715,1.0,7/23,12.56%,TGFBR3;ADAMTS9;FGFR2;SMAD7;FKBP1A;TGFB1;ID2
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.7720305723066198,1.6829084441005888,0.053418803418803416,0.6208671438828703,1.0,3/14,3.07%,ACE2;ENPEP;ECE1
prerank,positive regulation of DNA binding (GO:0043388),-0.5670998018669634,-1.6822220978600555,0.008438818565400843,0.17672586048141276,1.0,16/31,26.38%,IGF1;SKI;NIBAN2;FOXC1;PINX1;CEBPG;TGFB1;NME1;TXN;HMGB2;SIRT2;PARK7;PLAUR;TRIM6;PRKN;TWIST1
prerank,type I interferon signaling pathway (GO:0060337),-0.5442082899672183,-1.6808967091311862,0.0,0.17526828324279098,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,cellular response to type I interferon (GO:0071357),-0.5442082899672183,-1.6808967091311862,0.0,0.17526828324279098,1.0,19/41,17.63%,SP100;IFITM3;STAT2;IRF1;IRF2;STAT1;IFI27;IFIT2;IRF9;OAS2;IFI35;IFIT3;IFIT1;SAMHD1;IP6K2;IFITM2;GBP2;RNASEL;RSAD2
prerank,regulation of execution phase of apoptosis (GO:1900117),0.7993720624236909,1.680195867375924,0.03076923076923077,0.6248625215912006,1.0,2/11,0.68%,DLC1;FAP
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.7055366060079257,1.679904897864783,0.04296875,0.6178491968959564,1.0,4/21,1.44%,PDE4D;PTEN;DMD;NCK2
prerank,cellular metal ion homeostasis (GO:0006875),0.5396345229628061,1.6798612693370802,0.003125,0.6101415513006812,1.0,22/102,8.66%,ATP13A5;PTH1R;SLC12A2;ATP2A3;NEDD4L;ATP1A2;ATP2C1;ATP1A4;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;ATP1B2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2;LETM1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.7084019530653123,1.6774401676440454,0.024096385542168676,0.6123656777591434,1.0,6/21,3.95%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6
prerank,response to muscle stretch (GO:0035994),0.7423724518228458,1.6760849020910216,0.03966597077244259,0.6107690709094934,1.0,5/15,6.40%,DMD;CDH2;PTK2;PIK3CA;RYR2
prerank,cardiac muscle cell action potential (GO:0086001),0.6672768411888449,1.6756999097927014,0.044036697247706424,0.604967892514562,1.0,8/30,7.38%,CACNA1C;DMD;ATP1A2;FGF12;CACNA2D1;SCN5A;HCN2;CACNA1D
prerank,response to laminar fluid shear stress (GO:0034616),-0.7603756989804079,-1.6751578498217197,0.007858546168958742,0.18402762584453683,1.0,6/10,7.48%,ABCA1;SMAD6;KLF4;SMAD7;KLF2;MAP2K5
prerank,cellular response to interferon-gamma (GO:0071346),-0.4706512292819651,-1.6742211305309997,0.0,0.1836479610333977,1.0,28/88,16.89%,DAPK1;SP100;B2M;VCAM1;LGALS9;IRF1;WNT5A;CCL15;ICAM1;IRF2;STAT1;CCL14;CD47;GBP4;PRKCD;IRF9;OAS2;PML;GBP6;CAMK2A;GBP5;CCL25;GBP7;GBP2;CCL13;SIRPA;TLR4;TRIM8
prerank,ganglion development (GO:0061548),-0.7136734169496106,-1.674197219897102,0.012727272727272728,0.18146292706891431,1.0,2/11,1.02%,NRP2;NRP1
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),-0.569050758524469,-1.6737607962015524,0.0,0.18003147569748928,1.0,12/35,12.08%,NOTCH2;PDGFRA;NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2;PTK2B;SEMA3E;IQGAP2;ARHGDIA;F11R
prerank,intraciliary transport involved in cilium assembly (GO:0035735),0.6340704706800997,1.673496422845671,0.013084112149532711,0.607130852725591,1.0,11/37,16.99%,DYNLL1;IFT43;IFT81;IFT20;KIF3A;IFT57;KIF3C;TRIP11;IFT80;TNPO1;TRAF3IP1
prerank,regulation of biosynthetic process (GO:0009889),0.7767140127941083,1.6733910902587024,0.0511727078891258,0.6002864699732526,1.0,4/11,7.50%,SLC25A33;CCN6;SNCA;PIKFYVE
prerank,bicellular tight junction assembly (GO:0070830),-0.5227987380328598,-1.6731708517013755,0.0070921985815602835,0.17902035680641673,1.0,13/46,12.08%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;CLDN11;PARD3;PATJ;F11R
prerank,response to cholesterol (GO:0070723),-0.6679090602846591,-1.6730986554090326,0.009505703422053232,0.17701953321918265,1.0,8/17,11.87%,TGFBR2;TGFBR1;LRP6;SMO;GRAMD1C;GRAMD1A;TGFB1;PTCH1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5767032455595066,-1.6727632519213982,0.006329113924050633,0.17571570203307021,1.0,10/31,10.27%,PDGFRA;OSR1;HOXB3;TGFBR2;FGFR2;TGFBR1;HOXA3;SIX1;TBX1;HOXB9
prerank,negative regulation of chemokine production (GO:0032682),-0.6854226695612923,-1.6725140596886465,0.006,0.17414607085482112,1.0,7/14,21.75%,APOD;KLF4;LGALS9;MAP2K5;C1QTNF3;SIRPA;SIGIRR
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.6745369960443628,1.6718884228427555,0.020560747663551402,0.59919124737456,1.0,5/32,1.69%,DLC1;PTEN;ARHGAP6;AJAP1;PHLDB2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.5114623801974162,1.6716163930881434,0.0054869684499314125,0.5933992642890662,1.0,28/172,9.40%,INPP4B;PIP5K1B;DGKB;PTEN;PIK3CD;PLD1;DGKH;PIK3R1;DGKG;CDS2;PLD6;PIP4K2A;PIK3CA;SLC44A2;FGF2;PITPNM2;CPNE7;INPP5J;PIP4K2C;LIPH;PIK3C2A;ABHD3;PIKFYVE;ACHE;MTMR12;MTMR14;STARD7;MTMR7
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.6076304357072709,-1.6707397956617926,0.014675052410901468,0.17568879657515107,1.0,10/23,14.98%,UACA;BMP7;HDAC7;CCN3;TMSB4X;C1QTNF3;IFI35;ZC3H12A;RELA;PPM1B
prerank,icosanoid secretion (GO:0032309),-0.7084380717158736,-1.6706807074595882,0.011428571428571429,0.17385304306139474,1.0,4/12,6.54%,ABCC4;ANXA1;ACE;BDKRB2
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.673933756707598,-1.6703887551574423,0.009523809523809525,0.17246830853186101,1.0,11/15,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SPHK1;SIRT3;ORMDL3;ORMDL2;RACK1;SPHK2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),-0.6643621407999165,-1.667992598112858,0.0038314176245210726,0.1748515173093251,1.0,5/17,3.70%,NRP1;NTRK3;BAIAP2L1;TEK;BAIAP2
prerank,response to interferon-gamma (GO:0034341),-0.4950337635583816,-1.6673035239137612,0.0,0.1743980930384232,1.0,21/67,16.55%,DAPK1;SP100;IFITM3;LGALS9;WNT5A;CCL15;STAT1;CCL14;CD47;GBP4;GBP6;GBP5;GCH1;CCL25;GBP7;IFITM2;GBP2;CXCL16;CCL13;SIRPA;TLR4
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.6666802817627663,1.666539395627075,0.04807692307692308,0.6080470507764524,1.0,9/27,7.08%,PDE4D;CACNA1C;CTNNA3;FGF13;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,Notch signaling pathway (GO:0007219),0.5887931245066029,1.666517025605713,0.014035087719298246,0.6012390751411428,1.0,6/59,1.62%,NOTCH3;HEY2;HEYL;NOTCH1;DTX3;MAML2
prerank,pteridine-containing compound metabolic process (GO:0042558),-0.7034379695054584,-1.6630262388548285,0.014344262295081968,0.18070327387434498,1.0,6/13,16.85%,NOS3;AKT1;GCH1;PTS;CALM1;FPGS
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.716199397256146,-1.6626199895698401,0.011428571428571429,0.17964974926940636,1.0,5/11,17.18%,EGFR;BMP4;DDX5;TGFB1;RIPK1
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7347515828394149,1.6623290383773268,0.049891540130151846,0.6116804657813809,1.0,6/14,10.18%,RAPGEF2;PRKAR1B;PKIA;PRKAR2B;PRKAR2A;PRKAR1A
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),-0.4881520015821814,-1.6622900620732481,0.0024330900243309003,0.17826510076569593,1.0,28/75,11.35%,SULF1;DCN;ROCK2;WNT4;TEK;SEMA6A;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7241143642017082,1.6617934029006356,0.035940803382663845,0.6068817763490454,1.0,2/17,0.19%,ITGA1;PDGFRB
prerank,negative regulation of cartilage development (GO:0061037),-0.6923978606170618,-1.6616740669720584,0.022813688212927757,0.17749200430708362,1.0,4/13,4.28%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of interleukin-1 production (GO:0032652),-0.6736853529016977,-1.661527826426759,0.013513513513513514,0.17590440296077592,1.0,6/15,16.55%,FOXP1;ANXA1;GAS6;CEACAM1;SIRPA;TLR4
prerank,negative regulation of neurogenesis (GO:0050768),0.6531770941092954,1.6612616236812785,0.04085257548845471,0.602375320423481,1.0,7/34,2.62%,PTEN;RAPGEF2;NOTCH1;LINGO1;NF1;PTN;IL1B
prerank,heart morphogenesis (GO:0003007),0.6122967455758126,1.6608281581808337,0.03298611111111111,0.5977820932109559,1.0,8/50,1.88%,DLC1;TBX2;HEY2;HEYL;NOTCH1;TBX20;PTK2;TBX3
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.6398176013250525,-1.6590804822039127,0.013888888888888888,0.17898420530005216,1.0,6/18,11.59%,EGFR;ESR1;BMP4;DDX5;ZC3H12A;TGFB1
prerank,carnitine shuttle (GO:0006853),-0.7154970631273465,-1.65825170342277,0.01855287569573284,0.17896183403295574,1.0,7/11,18.87%,PRKAG2;CPT1A;SLC25A20;CPT2;ACACA;PRKAA2;ACACB
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.5732463885692715,1.6563068864788633,0.017488076311605722,0.6096583135378405,1.0,10/75,4.08%,RGS5;RGS4;RGS6;PLCE1;METAP2;GPER1;ROCK1;RGS3;GUCY2D;RGS11
prerank,cellular response to increased oxygen levels (GO:0036295),-0.7162520948923485,-1.656281089712746,0.015625,0.18058453735126798,1.0,10/11,27.55%,FOXO1;CAV1;ATP6V1G1;ATP6V0A2;CCDC115;ATG7;TMEM199;FAS;ATP6AP1;ATP6V0D1
prerank,inorganic anion transmembrane transport (GO:0098661),0.5846486873054004,1.6557636435329839,0.015050167224080268,0.6051900137260263,1.0,8/63,5.87%,ANO1;ANO4;SLC12A2;SLC5A1;XPR1;SLC12A6;GABRG2;GABRA2
prerank,macrophage differentiation (GO:0030225),-0.6995952780526293,-1.655458788845274,0.005780346820809248,0.18057999571231312,1.0,5/13,10.09%,IL31RA;IL15;BMP4;CSF1;CASP8
prerank,keratan sulfate biosynthetic process (GO:0018146),-0.6002623497026488,-1.6549526067637452,0.012875536480686695,0.17987355474145386,1.0,11/26,10.88%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;ST3GAL3;PRELP;LUM;OMD
prerank,dendrite morphogenesis (GO:0048813),0.639204240850381,1.653732705351666,0.032432432432432434,0.6068890999004003,1.0,9/35,4.29%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;PTN;WASL;MINK1
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),-0.7414894296241665,-1.6532020934755212,0.009345794392523364,0.18125548788080578,1.0,4/10,6.89%,PODXL;DPP4;PIEZO1;WNK1
prerank,protein O-linked mannosylation (GO:0035269),-0.6434786915753061,-1.651354630091398,0.007547169811320755,0.1828582709760174,1.0,5/18,7.53%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,extracellular structure organization (GO:0043062),-0.41578835974604145,-1.650336196996905,0.0,0.1830986272665108,1.0,88/204,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;TGFBR1;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.5755774605873247,1.6501503898854097,0.025041736227045076,0.6141994427073321,1.0,14/69,7.19%,PDGFRB;PLCL1;PTEN;PLCE1;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;PITPNM2;OGT;NYAP2;PIK3C2A;IRS1
prerank,mesenchyme morphogenesis (GO:0072132),0.7331735313558503,1.650034566113435,0.056795131845841784,0.6083285822087622,1.0,4/17,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,positive regulation of ossification (GO:0045778),-0.5372755745038775,-1.6482612421335892,0.006772009029345372,0.18538205262104532,1.0,20/39,15.76%,BMP6;ZBTB16;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;WNT5A;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.6512806543744002,1.6476601905675186,0.0546448087431694,0.6115866243080338,1.0,3/28,2.83%,NOTCH3;CHAC1;TSPAN15
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.6934547330241423,1.6458647714064378,0.05327868852459016,0.612113360014979,1.0,4/24,4.10%,PDE4D;CASQ2;DMD;AKAP6
prerank,pore complex assembly (GO:0046931),-0.624131199766511,-1.6455774573955746,0.00423728813559322,0.1889925355598281,1.0,8/19,17.49%,AFDN;ADAM10;ANO6;PLEKHA7;GSDMD;P2RX7;NUP98;TPR
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.7618329101095844,1.6451586875757778,0.05183585313174946,0.6090246474754923,1.0,2/11,3.42%,SLC30A10;ABCD2
prerank,leukotriene biosynthetic process (GO:0019370),0.7585691174354529,1.644412349101006,0.03805496828752643,0.6058642481317993,1.0,3/14,1.42%,GGT5;GGT1;GGTA1
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.6621736763092003,1.6443036111504787,0.038461538461538464,0.6002751945175351,1.0,10/30,7.70%,GJC1;CACNA1C;NEDD4L;FGF12;KCNE4;CACNA2D1;SCN5A;RYR2;CACNA1D;KCNE5
prerank,external encapsulating structure organization (GO:0045229),-0.4124499191906813,-1.6439836657216262,0.0,0.19040216176634983,1.0,87/205,12.53%,ADAMTS10;FBN1;COL1A2;SMOC1;FN1;ADAMTSL3;COL3A1;ADAMTS12;COL5A2;COL1A1;ADAMTS6;DCN;ADAMTS2;THSD4;ITGA9;ELN;COL22A1;LAMA1;COL5A1;VWF;LOXL1;COL6A3;JAM2;PECAM1;APP;ADAMTS9;SPARC;RECK;SH3PXD2A;COL6A1;COL8A2;ITGA6;ADAMTS5;ITGB8;VIT;MFAP5;BSG;COL4A5;COL6A2;THBS1;ITGA5;COL11A1;NID2;CDH1;FBLN5;VCAM1;COL23A1;ITGA3;COL4A6;HSPG2;COL13A1;BGN;ST7;ADAMTS1;ITGA11;SPOCK2;NDNF;ITGA10;TNC;DDR1;ADAMTS15;ICAM1;FBN2;COL18A1;ADAMTSL1;CD47;GFOD2;ADAMTSL4;ITGB4;TGFBI;MMP14;COL14A1;ADAM15;LAMA5;COL15A1;SLC39A8;KDR;COL16A1;LUM;MMP19;ITGB3;ADAMTS14;LAMA3;ADAMTS3;F11R;SMOC2;COL9A2
prerank,actin filament depolymerization (GO:0030042),-0.730820329179233,-1.6434328081726224,0.0019801980198019802,0.1896201844540471,1.0,5/11,13.17%,MICAL3;GSN;MICAL2;DSTN;TWF1
prerank,focal adhesion assembly (GO:0048041),0.6867433097599165,1.6417262713847693,0.06679764243614932,0.6046430652275163,1.0,4/21,2.10%,DLC1;PTPRK;PEAK1;FERMT2
prerank,vascular transport (GO:0010232),0.5595451905002323,1.6399850072091566,0.024883359253499222,0.6055036811565875,1.0,15/81,5.04%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),-0.6205455272696722,-1.639731525330118,0.013888888888888888,0.19441588227999207,1.0,12/20,17.68%,ENTPD1;APP;TXNIP;ANO6;P2RX4;IL18;NT5E;P2RX7;ENTPD5;TXN;HSP90AB1;SUGT1
prerank,transport across blood-brain barrier (GO:0150104),0.5553615489617069,1.638456709230981,0.02476780185758514,0.605649327278176,1.0,15/83,5.04%,ABCC9;KCNJ8;SLC16A12;SLC12A2;SLCO3A1;ATP2A3;ATP1A2;SLC1A5;SLC1A4;ATP1A4;SLC5A1;SLC19A1;SLC27A4;ATP1B2;SLC22A8
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.6246266492807973,-1.6364688328870391,0.012605042016806723,0.19924612183733692,1.0,7/20,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,odontogenesis (GO:0042476),-0.5506304761861549,-1.6361594478613137,0.012684989429175475,0.197996567903801,1.0,9/35,8.00%,COL1A2;GLI2;OSR1;WNT6;FGFR2;BMP4;LRP6;FOXC1;TBX1
prerank,positive regulation of fat cell differentiation (GO:0045600),-0.5262608216558431,-1.6344111918900244,0.004694835680751174,0.19973937949061066,1.0,18/47,13.91%,ZBTB16;MEDAG;BMP7;TMEM64;SOX13;SIX1;SYAP1;NOCT;WDFY2;AKT1;CMKLR1;RREB1;CARM1;ZC3H12A;METRNL;PTGS2;ID2;SFRP1
prerank,B cell homeostasis (GO:0001782),0.7796092921480928,1.6342383754262182,0.056133056133056136,0.6163154876256859,1.0,2/10,0.75%,MEF2C;DOCK10
prerank,peptidyl-arginine modification (GO:0018195),0.7411306583602592,1.6340651088811033,0.04142011834319527,0.6112159694185934,1.0,1/15,0.14%,ART3
prerank,positive regulation of stem cell differentiation (GO:2000738),0.7231782017021691,1.6322080910892858,0.04040404040404041,0.6124145450274103,1.0,4/16,3.00%,SOX5;TCF15;PTN;RBM24
prerank,cation transmembrane transport (GO:0098655),0.6102567181177183,1.630662971943405,0.021621621621621623,0.6130659059721851,1.0,4/44,1.67%,ABCC9;KCNJ8;ATP1A2;CACNA1H
prerank,positive regulation of endothelial cell migration (GO:0010595),-0.46941329280731636,-1.6305933821413885,0.0,0.20615251297506157,1.0,36/84,13.47%,ANXA3;NRP2;ROCK2;FOXP1;NRP1;PLPP3;TEK;SPARC;PLCG1;SASH1;NOS3;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;WNT5A;MAPK14;PTK2B;RHOB;P2RX4;TMSB4X;PIK3CB;AKT1;HIF1A;ZC3H12A;KDR;GATA2;ITGB3;TGFB1;SMOC2;FLT4;CALR;ATOH8;MET
prerank,carbohydrate biosynthetic process (GO:0016051),-0.614103296838304,-1.627998831772731,0.010438413361169102,0.2100705960799761,1.0,7/21,11.77%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST3GAL3;FUT8;ST6GALNAC6
prerank,ureteric bud development (GO:0001657),-0.6456042858457922,-1.6257135386478685,0.013916500994035786,0.21290842457466636,1.0,7/17,6.84%,BMP7;OSR1;SLIT2;FGFR2;BMP4;SIX1;FOXC1
prerank,inositol phosphate metabolic process (GO:0043647),0.6069042287626476,1.6255094894511797,0.03880070546737213,0.6272939881965593,1.0,8/46,5.65%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;FGF2;ITPKB;INPP5J
prerank,keratan sulfate metabolic process (GO:0042339),-0.5694312814589233,-1.6251822311927826,0.0066815144766146995,0.21211186501889204,1.0,13/31,10.88%,ST3GAL4;B4GALT1;ST3GAL6;OGN;FMOD;ST3GAL1;ST3GAL2;HEXA;ST3GAL3;PRELP;HEXB;LUM;OMD
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),0.584784939267143,1.6238613255198258,0.027874564459930314,0.627936562350514,1.0,6/55,2.56%,PDGFRB;ACE2;PID1;SLC25A33;CCN6;FOXM1
prerank,cellular sodium ion homeostasis (GO:0006883),0.7473030356923321,1.6238194944458846,0.03822937625754527,0.6224897215236204,1.0,5/15,4.90%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2
prerank,regulation of endothelial cell migration (GO:0010594),-0.4666559254001402,-1.623523366068351,0.002680965147453083,0.2139172027293012,1.0,38/85,13.07%,ANXA3;NRP2;DCN;ROCK2;FOXP1;GLUL;NRP1;TEK;SP100;APOE;ADAMTS9;SPARC;SLIT2;SASH1;PTPRM;BMPR2;THBS1;BMP4;ANGPT1;FOXC2;FGF1;BMPER;ACVRL1;WNT5A;PTK2B;RHOB;PIK3CB;AKT1;PRCP;DAB2IP;ZC3H12A;KDR;ITGB3;RHOJ;SMOC2;FLT4;CALR;ATOH8
prerank,cardiac muscle contraction (GO:0060048),0.6236617049990116,1.6235009492361523,0.04634581105169341,0.6182633713940419,1.0,8/34,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;MYL3;KCNE5
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.6378604268211584,-1.6228044941798436,0.009433962264150943,0.21357683184836748,1.0,7/17,10.62%,ROBO1;EFNB2;NRP1;SLIT2;EPHB4;AKT1;KDR
prerank,nucleotide catabolic process (GO:0009166),-0.6516298261055925,-1.621987828059092,0.015841584158415842,0.21347521589595764,1.0,12/16,25.02%,XDH;SAMHD1;NT5E;DERA;NUDT3;GDA;GPX1;NT5C1A;PNP;VCP;NT5C2;NT5C
prerank,negative regulation of biosynthetic process (GO:0009890),0.7052187519995934,1.6217225238572277,0.04132231404958678,0.6194233580443307,1.0,3/16,3.42%,SLC30A10;GPER1;ABCD2
prerank,monocyte chemotaxis (GO:0002548),-0.5583609352992742,-1.621701755332299,0.012320328542094456,0.21235819410384885,1.0,9/32,15.69%,FLT1;IL6R;ANXA1;CCL15;CCL14;RPS19;CCL25;TNFRSF11A;CCL13
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.7340187884388245,1.6216949215588463,0.0611353711790393,0.6141304091382327,1.0,2/13,0.50%,PDE4D;CASQ2
prerank,blood vessel diameter maintenance (GO:0097746),0.626479517296516,1.6216552756337512,0.04553734061930783,0.6090135430956547,1.0,7/34,3.95%,ACE2;EDNRA;PER2;GPER1;ROCK1;ECE1;ADCY6
prerank,primary alcohol metabolic process (GO:0034308),-0.592905979528012,-1.6206350602988349,0.004484304932735426,0.21280011848638042,1.0,8/25,13.44%,IGF1;DHRS3;RBP4;GPD2;NAAA;CYP1B1;ALDH3A2;ADH1A
prerank,heart contraction (GO:0060047),0.5999965186993467,1.6203103802187284,0.03942652329749104,0.6086402334600871,1.0,9/41,7.70%,CASQ2;DMD;ATP1A2;PIK3CA;SCN5A;RYR2;SGCZ;MYL3;KCNE5
prerank,lipid catabolic process (GO:0016042),0.6991343962845551,1.619859882739754,0.0486815415821501,0.6053319497427033,1.0,5/18,7.39%,CEL;PLA1A;LIPH;LIPC;PPT1
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.5586359909799038,1.619393530886369,0.018151815181518153,0.6020867844028127,1.0,10/76,6.60%,ANO1;PLCE1;PTH1R;GRM5;TACR1;GRM1;CXCR2;HTR2C;TRHR;OPRK1
prerank,positive regulation of response to biotic stimulus (GO:0002833),-0.5340612264019103,-1.617797172676898,0.0022222222222222222,0.21746444412850144,1.0,9/38,14.61%,BMP6;SASH1;DDX60;USP15;IFI35;PUM1;GBP5;CYBA;CD180
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.4988832733112083,1.6174798487749849,0.005738880918220947,0.6040764638470061,1.0,18/140,3.88%,DLC1;STARD8;CHN1;PLCE1;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;ARHGAP6;ARHGAP32;ARHGEF6;ARHGAP1;FOXM1;STARD13;ARAP2;SH3BP1;RAC3
prerank,pinocytosis (GO:0006907),0.7584089800069075,1.6161353646725525,0.06866952789699571,0.6042368243307841,1.0,2/10,7.39%,CARMIL1;PPT1
prerank,heart looping (GO:0001947),0.6096152350719664,1.6158777981884624,0.04316546762589928,0.6003105612474906,1.0,6/39,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,striated muscle contraction (GO:0006941),0.5896209563110458,1.6142820053929452,0.04310344827586207,0.6011680028241849,1.0,10/53,8.91%,CASQ2;DMD;ATP1A2;RCSD1;PIK3CA;SCN5A;RYR2;MYL3;KCNE5;STAC
prerank,cyclooxygenase pathway (GO:0019371),-0.7223617602847785,-1.6133276220621682,0.02531645569620253,0.2253918756069009,1.0,5/10,11.61%,PTGDS;PTGIS;PTGS1;TBXAS1;PTGS2
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6208598007945314,-1.6132443019996052,0.021032504780114723,0.22373194623231002,1.0,10/19,12.42%,ROBO1;DCN;SEMA6A;CCBE1;JCAD;XDH;PIK3CB;DAB2IP;ADAMTS3;SMOC2
prerank,hematopoietic progenitor cell differentiation (GO:0002244),-0.5592000583175595,-1.611776328515476,0.02186878727634195,0.22517060874706352,1.0,14/30,21.77%,FLT1;BMP4;MLLT3;ACE;KIT;KDR;TGFB1;FLT4;SFRP1;LMBR1L;CSF1R;PLEK;FSTL3;SP7
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7609471554783696,1.6076644527192703,0.0706401766004415,0.6156727163022914,1.0,4/11,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7609471554783696,1.6076644527192703,0.0706401766004415,0.6156727163022914,1.0,4/11,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),-0.4812691726654261,-1.607574856759693,0.0024937655860349127,0.2325505799530794,1.0,15/63,5.30%,IGF1;WWOX;SP100;SH3RF1;CAV1;ITGA6;THBS1;BMP4;TGFBR1;DEPTOR;TCF7L2;ACVR1;CFLAR;AR;TNFSF10
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.7002188353550075,1.607549864742635,0.053830227743271224,0.6111626910364544,1.0,4/16,4.10%,TRPC3;ROCK1;PDE9A;AKAP6
prerank,vasoconstriction (GO:0042310),0.764791570662571,1.607494967995235,0.056962025316455694,0.6065194294352706,1.0,2/11,7.14%,EDNRA;PIK3C2A
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),-0.6579185980966318,-1.6072336298070136,0.026365348399246705,0.23146798710079716,1.0,7/15,14.53%,EGFR;IGF1R;DDR1;PTK2B;BMX;KDR;MAPK3
prerank,lymphocyte chemotaxis (GO:0048247),0.625219767269879,1.6063370179666219,0.04448398576512456,0.605729461315546,1.0,3/34,0.77%,CYP7B1;SLC12A2;PIK3CD
prerank,potassium ion transport (GO:0006813),0.5169022928470212,1.6061076120729074,0.008982035928143712,0.6017619813528421,1.0,23/120,9.41%,ABCC9;KCNJ8;KCNJ12;ATP1A2;KCNG1;KCNMB1;KCNV2;ATP1A4;KCNQ4;KCND2;SLC24A4;SLC24A2;KCNH8;KCNH4;KCNAB3;KCNQ5;HCN2;KCNA4;KCNQ3;SLC9A7;HCN3;PKD2;KCNJ3
prerank,regulation of vasoconstriction (GO:0019229),0.6606541692674046,1.6059284208835702,0.048,0.5977798494329787,1.0,5/27,3.07%,ACE2;TBXA2R;SMTNL2;PER2;ECE1
prerank,neuron projection extension (GO:1990138),-0.5521461199392315,-1.6056813134792536,0.01072961373390558,0.2328479143251089,1.0,5/32,1.93%,AUTS2;ALCAM;NRP2;NRP1;IQGAP1
prerank,neuron projection regeneration (GO:0031102),0.7532219104378853,1.6054583038946943,0.06623931623931624,0.5948144884444795,1.0,4/10,8.93%,RTN4RL1;PTN;DHFR;GAP43
prerank,regulation of Ras protein signal transduction (GO:0046578),0.537576109761798,1.604817539280698,0.021922428330522766,0.592639490073695,1.0,20/85,9.11%,DLC1;STARD8;EPS8;PLCE1;NOTCH1;SPRY4;FOXM1;CADM4;STARD13;SH3BP1;RALGPS1;PDCD10;EPS8L1;SPRY2;OGT;LZTR1;FGF10;ARHGDIB;LRRD1;LYN
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.44167202630157887,-1.6046940251587056,0.0,0.2331910912044319,1.0,26/108,11.01%,NXN;SULF1;TRABD2B;WWOX;VGLL4;APP;MDFIC;MACF1;RSPO3;ESR1;FGFR2;NKD1;LRRK2;NFATC1;ITGA3;RNF43;SKI;SULF2;SFRP4;RSPO2;TIAM1;FOXL1;TLE1;FZD7;NOTUM;MDFI
prerank,regulation of blood circulation (GO:1903522),0.6248849045784216,1.60270491405279,0.03275529865125241,0.5955952869497368,1.0,6/34,3.07%,ACE2;TBX2;KCNJ12;PER2;CACNA1H;ECE1
prerank,response to interleukin-1 (GO:0070555),-0.4651742738116726,-1.6017429433738968,0.012658227848101266,0.23804690674839676,1.0,22/73,16.32%,ADAMTS12;HDAC4;PTGIS;APP;IL1R1;ANXA1;IRAK2;LGALS9;CCL15;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;CCL25;RELA;TNFRSF11A;SFRP1;GBP2;CCL13;SIRPA
prerank,sensory perception of smell (GO:0007608),0.7602393979447508,1.6015169465918648,0.06396588486140725,0.5954095268430656,1.0,3/11,6.84%,ADCY3;SLC24A4;UBR3
prerank,lipid oxidation (GO:0034440),-0.6888047486421712,-1.6014332084442735,0.0248565965583174,0.23681139379645036,1.0,5/12,20.35%,ADIPOR2;ACOX1;ALOX12;PPARGC1A;ADIPOR1
prerank,polyol metabolic process (GO:0019751),0.5973326274195654,1.601178749887803,0.042105263157894736,0.5922116567635362,1.0,7/46,5.65%,INPP4B;PTEN;PLCE1;IMPA2;INPP5A;ITPKB;INPP5J
prerank,glycolipid metabolic process (GO:0006664),-0.5134089456033389,-1.6000022723909233,0.01098901098901099,0.23834517903600586,1.0,16/47,15.36%,ST3GAL4;ST3GAL6;ESYT2;ST3GAL2;ST6GALNAC3;SMPD3;HEXA;HEXB;FUCA1;B3GALNT1;PSAP;NAGA;ST6GALNAC6;ESYT3;UGCG;SUMF2
prerank,negative regulation of heart contraction (GO:0045822),0.7463602702839036,1.5999534140340435,0.08,0.5917509499951087,1.0,2/11,1.22%,PDE4D;ATP1A2
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),-0.6675065891229784,-1.5995770335561719,0.0260707635009311,0.2374014045554684,1.0,7/13,16.12%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NNMT;PARP16
prerank,cellular protein metabolic process (GO:0044267),-0.3685297702408376,-1.5985899620140986,0.0,0.23788046360571516,1.0,138/396,18.99%,IGF1;FBN1;FN1;FSTL1;IGFBP2;ST3GAL6;CTSH;IGFBP5;PCSK5;APOE;PAPPA;APP;CP;ST3GAL1;CPE;RPLP1;BMP4;RPS14;IGFBP6;YES1;ITIH2;CSF1;IGFBP4;PHKA2;ADAM10;IGFBP3;PLOD2;DENND3;IGF2;GAS6;WWP2;RPL9;VWA1;RPS12;P4HB;SERPIND1;RPL41;RPS20;TNC;CALU;RPL18A;RPS13;RPS19;ABCA3;RPS23;SRBD1;RPS4X;SEPHS1;DUSP12;CST3;MSLN;RPS11;RPL13;RPL18;RPS9;EEF1A1;GOLM1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;SFTPA2;SFTPA1;NOTUM;IDE;DAB2IP;PRSS23;ST8SIA2;MXRA8;RPL11;RPS18;CKAP4;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;GATA6;CCN1;RPS24;LMCD1;RPS27;RPL14;SPG7;RPL26;SPP1;MRPS7;MRPS6;F5;UBE2G2;LTBP1;SARS1;MSRB3;RPL10;MRPS18A;RPL7;NEDD8;SCG3;MRPL52;RCN1;RPL10A;MRPL24;HARS1;RPL22;UBA3;RPS15;RPS6;MMP2;FBXL2;DNAJC3;RPL23;RPL17;APLP2;AFG3L2;PDIA6;RPL31;MANBA;RIPK1;RPS25;UBA7;PSEN2;RPL15;RPSA;SPCS1;RPN2;QSOX1;RPS7;RPL38;UBE2M;RPLP0;HSP90B1;RPL27;CSF2RA
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),-0.6567019718279226,-1.596300658974492,0.019230769230769232,0.2417253124819904,1.0,7/13,19.04%,SP100;MDFIC;APOD;SUFU;TPR;PARK7;CHP1
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.511084250325127,1.5945249346257837,0.009259259259259259,0.6067257976874978,1.0,24/119,11.03%,INPP4B;PIP5K1B;PTEN;PIK3CD;PIGU;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;ITPKB;SOCS5;PIGO;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;PIGZ;SOCS6;FIG4;DPM3
prerank,response to nitric oxide (GO:0071731),0.7289531890435409,1.594046702113962,0.07415730337078652,0.6039562222782932,1.0,1/13,0.12%,GUCY1B1
prerank,determination of heart left/right asymmetry (GO:0061371),0.596746842623027,1.5923387266573215,0.044563279857397504,0.6050684258943431,1.0,6/42,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,smooth muscle contraction (GO:0006939),0.7284754255314171,1.5923340382782976,0.04878048780487805,0.6007592874163395,1.0,6/14,7.14%,EDNRA;MYLK;MYH11;ROCK1;SMTN;PIK3C2A
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.4183756310877785,-1.5917648328302498,0.005571030640668524,0.25063435210093193,1.0,36/128,9.08%,BMP6;TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;BMP7;CLDN5;TGFBR2;BMPR2;SMURF2;BMP4;TGFBR1;DDX5;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;PDCD4;RGMB;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;HIVEP1;FKBP1A;ZYX;USP15;PARD3;TMEM100
prerank,myelin maintenance (GO:0043217),0.7688433725066994,1.591485177133296,0.05793991416309013,0.5994359061044829,1.0,2/10,3.42%,PTEN;ABCD2
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5035640164263065,-1.5913203637561912,0.006756756756756757,0.2498964191161173,1.0,21/48,13.39%,PLCG1;JCAD;HDAC7;NOS3;THBS1;ANGPT1;FOXC2;ANXA1;HDAC9;MAPK14;P2RX4;TMSB4X;AKT1;HIF1A;FGFBP1;KDR;GATA2;TGFB1;PTGS2;RHOJ;SRPX2
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7186675670290937,1.5911298887941259,0.058823529411764705,0.5962980289611448,1.0,2/16,0.30%,GUCY1B1;GUCY1A1
prerank,negative regulation of BMP signaling pathway (GO:0030514),-0.49902889839306075,-1.5906108837933044,0.017167381974248927,0.249917649488918,1.0,15/51,7.15%,FBN1;FSTL1;SMAD6;SKIL;HTRA3;BMPR2;SMURF2;SMAD9;SMAD7;SKI;BMPER;GREM2;SMURF1;NBL1;VWC2
prerank,protein mannosylation (GO:0035268),-0.5908168383675702,-1.588234808313004,0.01364522417153996,0.25349474317043424,1.0,5/22,7.53%,TMTC1;LARGE1;TMTC4;TMTC2;RXYLT1
prerank,positive regulation of calcium ion import (GO:0090280),0.7337428411666125,1.5870486227701808,0.052752293577981654,0.6061902092243471,1.0,3/12,9.15%,PDGFRB;STC1;PDGFB
prerank,cellular macromolecule biosynthetic process (GO:0034645),-0.369856957964945,-1.5844901610981972,0.0,0.2605123699489046,1.0,123/306,27.15%,EXT1;ST3GAL4;LARGE1;APOE;RPLP1;ST3GAL2;RPS14;REV1;THRB;RPL9;RPS12;RPL41;RPS20;PTMS;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;GOLPH3;RPS11;POLR2A;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;RPL11;RPS18;EEF1B2;ALAS1;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;MEF2A;RPL28;ATM;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;RPA1;DTX1;MRPL52;GCNT1;RAD50;DBF4;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;POLR2E;RPL15;RPSA;RPS7;RPL38;GAL3ST2;TYMS;RPLP0;RPL27;RFC3;E2F1;RRBP1;RPL36A;THAP1;TOP3A;POLE2;RPS26;MCM8;RPL35A;RMI2;CDC45;FARSB;RPS29;BRCA1;RPL8;RPL36;RPA3;POLR2G;MRPL35;GTPBP2;ING4;PPP5C;RPS3;RRAGC;RPL13A;EPC1;POLA1;ABCF1;B4GALT5;HUS1;ASMT;MRPL34;EXT2;POLD1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5149134671184589,1.584348785961457,0.022590361445783132,0.6109195379219539,1.0,20/109,10.75%,INPP4B;PDGFRB;PIP5K1B;PTEN;PIK3CD;PIK3R1;PIP4K2A;PIK3CA;FGF2;PITPNM2;INPP5J;PIP4K2C;PIK3C2A;PIKFYVE;MTMR12;MTMR14;MTMR7;INPP5B;FIG4;PLA2G4E
prerank,protein localization to cell surface (GO:0034394),0.6544311146364659,1.5837058808405249,0.04132231404958678,0.6088654846978194,1.0,7/26,7.63%,PTPRK;PIGU;JAM3;VCL;GGA3;EMP2;FGF10
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.6231685202733757,-1.5825449081144212,0.017786561264822136,0.26305052693851905,1.0,5/17,5.90%,SULF1;FSTL1;SLIT2;ITGA3;SFRP4
prerank,regulation of necroptotic process (GO:0060544),-0.5840856024299208,-1.5816352463476524,0.027559055118110236,0.26344077700283275,1.0,11/23,17.18%,ARHGEF2;CFLAR;SDCBP;PDCD6IP;BIRC3;SLC25A4;FLOT2;CASP8;YBX3;PELI1;RIPK1
prerank,positive regulation of glucose import (GO:0046326),-0.5964680192840918,-1.5812324595975742,0.02286902286902287,0.2624659614577325,1.0,5/21,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.46011220768160255,-1.5811996655607004,0.0026246719160104987,0.2607407254052711,1.0,21/74,10.09%,EYA2;IGF1;EYA1;SH3RF1;ITGA6;EYA4;NOS3;THBS1;BMP4;TGFBR1;TCF7L2;ARHGEF2;ACVR1;CFLAR;AR;TNFSF10;ICAM1;MAP2K5;AKT1;MCL1;CASP8
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.6868583011526563,1.5810483258748205,0.07056451612903226,0.6141305156920726,1.0,5/18,4.24%,ITGA4;MEF2C;COL4A3;AKT3;FGF2
prerank,negative regulation of stem cell differentiation (GO:2000737),0.7334197890310896,1.579916799082315,0.06134969325153374,0.6140054780226679,1.0,6/12,13.28%,NOTCH1;TCF15;N4BP2L2;JAG1;YTHDF2;HNRNPU
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),-0.5377582070662432,-1.5798575461529558,0.025210084033613446,0.262127300644866,1.0,14/33,12.45%,CDH5;TEK;NUPR1;CAST;ANGPT1;TCF7L2;RAMP2;GAS6;YAP1;NDNF;ICAM1;KDR;GATA2;PPARA
prerank,vasculogenesis (GO:0001570),0.6171314504870342,1.579744949575561,0.05714285714285714,0.6103644926096864,1.0,6/32,2.21%,PDGFRB;GLMN;HEY2;NOTCH1;TBX20;SPRED1
prerank,regulation of angiogenesis (GO:0045765),-0.393658500492434,-1.5795277229475255,0.0,0.2612650337857801,1.0,60/192,11.80%,SULF1;ANXA3;FLT1;CDH5;DCN;ROCK2;GLUL;PTGIS;CTSH;TEK;SEMA6A;SP100;SPARC;F3;PLCG1;CLDN5;ITGB8;SASH1;THBS2;PTPRM;NOS3;THBS1;KLF4;RAMP2;HSPG2;CD34;HOXA5;VEGFD;VEGFC;NIBAN2;FGF1;NPR1;GTF2I;BMPER;ADAMTS1;WNT5A;PRKCB;FOXC1;CYP1B1;STAT1;RHOB;SERPINF1;SEMA3E;HK2;PIK3R6;PLXND1;TIE1;HGS;PPP1R16B;HIF1A;STAB1;ECM1;EMILIN1;DAB2IP;ZC3H12A;KDR;PML;GATA2;ECSCR;RHOJ
prerank,positive regulation of Ras protein signal transduction (GO:0046579),-0.4745585035210201,-1.5788961300709703,0.009900990099009901,0.2611174451324853,1.0,12/61,8.37%,AUTS2;NOTCH2;IGF1;ROBO1;COL3A1;AKAP13;LPAR1;ARHGEF3;ARRB1;ALS2;RAPGEF1;PIK3CB
prerank,amyloid fibril formation (GO:1990000),-0.4834995727563078,-1.5784949540614224,0.007389162561576354,0.26031107330133724,1.0,13/51,8.57%,TSPAN5;SNCAIP;GSN;APP;B2M;HSPG2;ADAM10;IAPP;GGA2;FKBP1A;H3-3A;CST3;TGFBI
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.48050244854405905,-1.578294853999002,0.009615384615384616,0.2591201458860624,1.0,13/56,6.10%,BMP6;DAB2;LDLRAD4;SMAD6;BMP7;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;SDCBP;BMPER;ACVRL1
prerank,regulation of tissue remodeling (GO:0034103),-0.6043659423460531,-1.5780182970573073,0.03508771929824561,0.2580561308193118,1.0,7/18,15.89%,LEPR;IL15;CST3;IL18;TGFB1;FLT4;CEACAM1
prerank,cellular modified amino acid catabolic process (GO:0042219),0.6988559719290807,1.577391306828641,0.05578512396694215,0.6143607864067347,1.0,3/15,2.70%,GGT5;GGT1;CHAC1
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.7016142070708605,-1.577384245700978,0.023809523809523808,0.2578893743611551,1.0,5/11,7.78%,SLIT2;RIN3;CCN3;NBL1;DUSP1
prerank,membrane depolarization during action potential (GO:0086010),0.6506712327274947,1.5770056430921333,0.09023941068139964,0.6116366443773025,1.0,10/26,11.06%,CACNA1C;ATP1A2;CACNA1H;SCN2A;SCN5A;HCN2;SCN8A;CACNA1D;SCN9A;SCN2B
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.5042447655972238,1.5768714234008374,0.014792899408284023,0.6080836840628924,1.0,17/116,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,regulation of transmembrane transport (GO:0034762),0.6278042526865563,1.5767425722811603,0.04896421845574388,0.6045480482431812,1.0,4/31,1.12%,ACE2;KCNJ8;NEDD4L;KCNJ12
prerank,cellular response to inorganic substance (GO:0071241),0.6525974203378936,1.5760503736355664,0.05928853754940711,0.6030581440324014,1.0,1/21,0.12%,GUCY1B1
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.5146886971212014,-1.5747996238203659,0.015873015873015872,0.2625509678635649,1.0,19/40,15.76%,BMP6;WNT4;BMP7;OSR1;WNT6;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6206789075537615,-1.5744997238515506,0.0299625468164794,0.26154352146638743,1.0,6/16,4.69%,IGF1;IGFBP2;IGFBP5;IGFBP6;IGFBP4;IGFBP3
prerank,base conversion or substitution editing (GO:0016553),0.7378552779831073,1.5740134123160603,0.07708333333333334,0.6058452696419778,1.0,2/11,6.19%,APOBEC1;ADARB2
prerank,ERBB signaling pathway (GO:0038127),0.5523948579093125,1.5738474018914868,0.024509803921568627,0.602484844362078,1.0,10/64,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;ERBB4;NRG1;PIK3CA
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.6339719748002488,1.5737604225463362,0.05905511811023622,0.5988807964938049,1.0,2/26,3.74%,ANO1;ADCY8
prerank,regulation of systemic arterial blood pressure (GO:0003073),-0.6369147746011704,-1.5734338377030135,0.01972386587771203,0.26227418252439383,1.0,6/16,9.43%,BMPR2;ACE;DDAH1;PLCB3;KLK2;PRCP
prerank,positive regulation of interleukin-2 production (GO:0032743),0.646029136042899,1.5733241489767849,0.05511811023622047,0.5964963607914063,1.0,5/25,6.03%,PDE4D;GLMN;IL1B;SPTBN1;PDE4B
prerank,calcium ion homeostasis (GO:0055074),0.5135828609101412,1.5732690504169076,0.025889967637540454,0.5928626052621763,1.0,18/95,8.35%,ATP13A5;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;TFAP2B;SNCA;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1;STC2
prerank,negative regulation of stress fiber assembly (GO:0051497),0.6481702130898322,1.573168410300083,0.06538461538461539,0.5894939677898541,1.0,5/24,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,organonitrogen compound biosynthetic process (GO:1901566),-0.4038177822251536,-1.5717917211168706,0.0,0.2641931594389351,1.0,39/151,15.58%,ST3GAL4;LARGE1;PLA2G4A;PLPP3;PAM;PCSK5;APOE;SGMS1;CERT1;SGMS2;ST3GAL2;ELOVL7;ACER2;HACD4;LPCAT3;HACD3;ACER3;CSNK1G2;GSTA4;GOLPH3;GSTM1;SPNS2;MGST1;DEGS2;ALAS1;GCH1;PLPP1;GSTT1;ALDH3A2;MFSD2A;SPHK1;ASL;LPIN3;SPTLC2;GSTM2;VAPA;GCNT1;AKR1A1;TYW5
prerank,positive regulation of exosomal secretion (GO:1903543),-0.6449480506496872,-1.571026230135161,0.02490421455938697,0.2643132977773451,1.0,7/15,15.66%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;SDC1
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.6034849986043153,-1.570486248703704,0.028225806451612902,0.26385127546028103,1.0,4/18,10.32%,IGF1;IGFBP2;IGF2;IL18
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.6367080354173364,1.570320604898432,0.056179775280898875,0.5950902701679759,1.0,6/26,7.50%,SLC30A10;SLC25A33;CCN6;ABCD2;SNCA;PIKFYVE
prerank,regulation of melanin biosynthetic process (GO:0048021),0.741522493033668,1.5686794048001345,0.06553911205073996,0.5969834150976333,1.0,5/10,12.24%,RAPGEF2;ZEB2;ATP7A;APPL1;OPN3
prerank,sulfur compound transport (GO:0072348),-0.5528625066890387,-1.5661097298974653,0.018292682926829267,0.2728661132085143,1.0,9/27,13.54%,SLC13A4;SLC6A13;SLC6A6;SLC26A7;ABCG2;SLC5A6;MGST1;SLC35F3;SLC25A19
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.7648452390718683,1.566000967740514,0.06471816283924843,0.6018128325898247,1.0,3/11,1.01%,MEF2C;PIK3CD;RAPGEF2
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),0.7251192911338071,1.5655845510480122,0.058315334773218146,0.599498179575269,1.0,3/11,3.38%,NR1H3;SCARB1;LDLR
prerank,regulation of transforming growth factor beta production (GO:0071634),-0.6150712133530646,-1.5644491887739456,0.0196078431372549,0.27503452417900925,1.0,9/18,16.21%,FN1;SMAD3;ITGB8;CD34;LGALS9;HIF1A;PTGS2;LTBP1;CD200
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.6465894155637187,-1.5641205687981132,0.03333333333333333,0.2741323228016678,1.0,4/13,8.76%,IGF1;SORBS1;IGF2;AKT1
prerank,chloride transport (GO:0006821),0.5341510648582374,1.5640547448163316,0.02689075630252101,0.6009207372749547,1.0,9/74,6.37%,ANO1;ANO4;SLC12A2;SLC5A1;SLC12A6;SLC26A1;GABRG2;GABRA2;TTYH1
prerank,dendritic spine morphogenesis (GO:0060997),0.698689494787787,1.5639147371165365,0.07520325203252033,0.5976853931794646,1.0,3/15,3.93%,PTEN;DOCK10;WASL
prerank,apical junction assembly (GO:0043297),-0.4765622971319126,-1.5630630614204597,0.019559902200488997,0.27485038933540773,1.0,14/53,10.01%,AFDN;CDH5;OCLN;PECAM1;DLG1;CLDN5;RAMP2;PDCD6IP;PARD6G;RHOA;CLDN11;PARD3;CTNNA1;PATJ
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.6584541771782937,-1.5619821309784991,0.03564356435643564,0.2757998770744109,1.0,4/12,8.76%,IGF1;SORBS1;IGF2;AKT1
prerank,response to iron ion (GO:0010039),-0.6651028319338665,-1.5614132663034945,0.028419182948490232,0.27550301916083103,1.0,4/12,9.24%,BMP6;B2M;ACO1;HIF1A
prerank,regulation of aerobic respiration (GO:1903715),0.7094064459376853,1.5606443487266406,0.057971014492753624,0.604722116516833,1.0,3/15,3.70%,CBFA2T3;SLC25A33;ATP7A
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.4670270372287342,-1.5594497518688974,0.00954653937947494,0.27860004433238517,1.0,23/63,16.89%,TIMP3;LEPR;PTPN3;NUPR1;TIMP2;DAP;RASIP1;STAT3;CST3;ATRAID;AKT1;MCL1;FOXK1;DAPL1;DAB2IP;ZKSCAN3;EIF4G3;MFSD2A;MET;RGP1;WASHC1;TIMP4;SIRT2
prerank,inositol phosphate catabolic process (GO:0071545),0.7337011476206541,1.5582450370513388,0.07777777777777778,0.6093606011414785,1.0,4/12,5.65%,PTEN;IMPA2;INPP5A;INPP5J
prerank,regulation of mesenchymal cell proliferation (GO:0010464),-0.6729236895431283,-1.556817606080106,0.03364485981308411,0.2830953169061598,1.0,7/11,19.48%,TGFBR2;FGFR2;WNT5A;STAT1;TBX1;CHRD;CTNNBIP1
prerank,myotube cell development (GO:0014904),-0.7032179043898128,-1.556560141291091,0.027829313543599257,0.2820164769651198,1.0,4/10,14.31%,IGF1;SKI;SIX1;CAV2
prerank,stabilization of membrane potential (GO:0030322),-0.6295524980867597,-1.5563487013291866,0.01949317738791423,0.28090386394060946,1.0,2/16,2.80%,KCNK2;KCNK5
prerank,positive regulation of axonogenesis (GO:0050772),-0.4954333172341578,-1.5546431819256543,0.013303769401330377,0.2833925027900605,1.0,10/43,8.75%,PLXNA2;ROBO1;TIAM2;PLXNA4;SLIT2;MACF1;SEMA7A;RHOA;TIAM1;PLXND1
prerank,presynapse assembly (GO:0099054),0.7020829068709832,1.5540539093928247,0.07581967213114754,0.6197103216892579,1.0,3/16,2.44%,PTEN;CEL;LRRTM3
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.4967973210548534,1.5527252851309394,0.02040816326530612,0.6205848033347562,1.0,17/117,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;NPSR1;PRKAR2B;GPR45;ADCY9
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.6793334435689041,1.552522962574398,0.06490872210953347,0.6176446582018127,1.0,6/17,7.70%,KCNJ8;NEDD4L;KCNE4;SCN5A;RYR2;KCNE5
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.5628827744275604,-1.5521475692582802,0.026584867075664622,0.2877472321712515,1.0,9/23,16.18%,PRKAG2;CEMIP;BMP7;APP;CALM2;IRGM;TGFB1;SPHK1;CALM1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.494949014359842,-1.5521412806292185,0.02097902097902098,0.28607104247426424,1.0,16/43,12.78%,BMP6;IGF1;WNT4;BMP7;IL6R;BMPR2;BMP4;IL6ST;ACVR1;ZHX3;YAP1;FBN2;ATRAID;CCN4;TMEM119;CCN1
prerank,hemopoiesis (GO:0030097),-0.4268476807739865,-1.5518915685247976,0.007594936708860759,0.28508431882377294,1.0,23/87,13.91%,TGFBR3;NOTCH2;ZBTB16;FLT1;MECOM;TEK;MFAP5;TGFBR2;FGFR2;BMP4;ETV6;CD34;WNT5A;KIT;FLCN;KDR;CD164;MKNK2;TGFB1;FLT4;FLT3LG;TAL1;SFRP1
prerank,clathrin coat assembly (GO:0048268),0.6781507115392448,1.5509381353454006,0.07099391480730223,0.6193213514361731,1.0,4/15,10.21%,SGIP1;PIK3C2A;AP2S1;HIP1
prerank,extracellular matrix disassembly (GO:0022617),-0.4758229044857939,-1.5508568541564567,0.007228915662650603,0.28569988862972784,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),-0.4333679346687481,-1.5499040652731908,0.012755102040816327,0.28652056798706554,1.0,27/87,9.05%,TGFBR3;ZMIZ1;COL1A2;COL3A1;SMAD3;SMAD6;CDH5;FMOD;CLDN5;TGFBR2;TGFBR1;SMAD9;ADAM9;SMAD7;ACVR1;PXN;ID1;SKI;APPL2;ACVRL1;SMURF1;PRKCZ;RHOA;FKBP1A;ZYX;USP15;PARD3
prerank,leukotriene metabolic process (GO:0006691),0.6693922893130227,1.5495560644237174,0.09183673469387756,0.6202764544542362,1.0,2/19,0.87%,GGT5;GGT1
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),0.5719580417894825,1.5479334461857268,0.05536912751677853,0.6221305472044498,1.0,8/45,3.05%,SLC30A10;PLCE1;GAB1;PTK2;PIK3R1;NCK2;BCAR1;PIK3CA
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.5819269099009576,1.5476941636206225,0.0564373897707231,0.6194547446929946,1.0,9/48,6.29%,PDE4D;CASQ2;DMD;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,regulation of focal adhesion assembly (GO:0051893),0.5696491115432819,1.5476424853784716,0.03292894280762565,0.6160632379525816,1.0,10/54,2.15%,DLC1;PTEN;LIMS1;ARHGAP6;PTK2;VCL;PHLDB2;PEAK1;FERMT2;ROCK1
prerank,positive regulation of cell communication (GO:0010647),0.62180523101042,1.5476170881886187,0.06909090909090909,0.6126492810964741,1.0,10/28,12.33%,CLSTN1;NMU;RIMS1;CLSTN3;RIMS2;ANK3;SYT1;KCTD13;WLS;GRIK2
prerank,amino acid import across plasma membrane (GO:0089718),-0.5569776970577358,-1.5462779667879467,0.029473684210526315,0.29368661799472673,1.0,9/24,6.94%,SLC6A13;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC7A2;SLC6A9;SLC22A4;SLC7A5
prerank,heterochromatin organization (GO:0070828),-0.6323108743772958,-1.5457716315959724,0.02702702702702703,0.2933655822397866,1.0,7/14,20.13%,MECOM;SETD7;PRDM16;EZH1;SNAI1;SETDB1;HP1BP3
prerank,regulation of keratinocyte migration (GO:0051547),0.7132369126278303,1.5448926465355257,0.08602150537634409,0.6178350074299535,1.0,6/12,12.35%,PTEN;MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.6673547157813609,-1.5446692825495414,0.043233082706766915,0.2942554601736595,1.0,6/12,17.44%,WEE1;PLK2;CHFR;NABP1;ZW10;PRCC
prerank,cellular response to leucine (GO:0071233),0.7313328809692533,1.5445229588910916,0.09255079006772009,0.6120462243613699,1.0,4/10,12.03%,UBR1;SESN3;MTOR;UBR2
prerank,response to leucine (GO:0043201),0.7313328809692533,1.5445229588910916,0.09255079006772009,0.6120462243613699,1.0,4/10,12.03%,UBR1;SESN3;MTOR;UBR2
prerank,regulation of cell killing (GO:0031341),-0.597516238149036,-1.5444026073075867,0.039603960396039604,0.29343200706150446,1.0,6/16,13.32%,CD55;CFH;WNT5A;ICAM1;FZD7;CYBA
prerank,positive regulation of organelle organization (GO:0010638),-0.5341740356489498,-1.5424343204195248,0.027896995708154508,0.2967929186932946,1.0,17/32,20.14%,ANXA2;ANXA1;SORBS3;RAB3GAP1;IRGM;C2CD5;P2RX7;LMAN1;UVRAG;SURF4;PFDN2;SYNJ1;RAB3GAP2;STX18;ADRB2;PPARGC1A;TMED9
prerank,response to calcium ion (GO:0051592),0.5084317612943232,1.5422923672848825,0.013740458015267175,0.6151660207084775,1.0,22/102,11.38%,TRPC3;CASQ2;MEF2C;TRPC1;RASGRP2;KCNMB1;ADCY8;PPP3CA;ITPKB;CPNE7;SLC25A13;SCN5A;RYR2;STIM1;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,cellular component disassembly (GO:0022411),-0.4752755147543532,-1.5415064126496592,0.009592326139088728,0.29731328637426263,1.0,18/53,15.44%,GSN;ADAMTS5;TLL1;BSG;CAPN2;TIMP2;HTRA1;ADAM10;ADAMTS15;KLK2;CAPNS1;MMP14;ADAM15;CAPN1;MMP19;CTSS;WASHC1;MMP2
prerank,ethanol metabolic process (GO:0006067),-0.6717765498220876,-1.5411967838452798,0.038181818181818185,0.29650513113556165,1.0,3/12,13.44%,ALDH1A1;SULT1A1;ADH1A
prerank,regulation of endothelial cell proliferation (GO:0001936),-0.4313881870097316,-1.5393690840559375,0.007957559681697613,0.2994802496229679,1.0,30/88,13.07%,SULF1;NRP2;NRP1;TEK;APOE;SPARC;F3;CAV1;XDH;PTPRM;BMPR2;THBS1;BMP4;TGFBR1;ANGPT1;VEGFD;VEGFC;ACVRL1;WNT5A;STAT1;AKT1;TIE1;PPP1R16B;HIF1A;ECM1;CDH13;KDR;ITGB3;FLT4;ATOH8
prerank,axon development (GO:0061564),0.516647847493702,1.5391902832693907,0.046948356807511735,0.621656448734008,1.0,21/78,12.82%,GRM7;RTN4RL1;SEMA5A;SVBP;DHFR;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;MARK2;GAP43;ARHGAP35;PLP1;CTNNA2;BRSK1;PAK3;ZDHHC17;SLITRK2
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.6547865876132527,1.5391143142950066,0.09725158562367865,0.61854056543713,1.0,5/18,7.70%,NEDD4L;ATP1A2;STK39;BIN1;KCNE5
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.55952255001033,-1.537458677308935,0.026584867075664622,0.3026307165178286,1.0,12/25,17.93%,EPHA4;TAF1;PML;PRKCG;RPL11;TRIM39;HSP90AB1;OPHN1;HIPK2;RPL23;HFE;RPS7
prerank,vesicle transport along actin filament (GO:0030050),0.6761882474336175,1.5370948661939676,0.08299595141700405,0.6218767906261613,1.0,4/19,8.18%,MYO1B;WASL;ACTN4;MYO6
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.4394587255107276,-1.5367239374108137,0.008547008547008548,0.3029195522307094,1.0,29/95,13.00%,TGFBR3;DAB2;LDLRAD4;SMAD3;SMAD6;DKK3;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;THBS1;TGFBR1;SNX6;SMAD7;ITGA3;LTBP4;SKI;SDCBP;SMURF1;PRDM16;FKBP1A;FLCN;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB
prerank,muscle cell differentiation (GO:0042692),0.6294082409643095,1.5360780378788024,0.060546875,0.6219195348009787,1.0,6/32,1.29%,MEF2C;DMD;GLMN;HEY2;SYNE1;RORA
prerank,positive regulation of bone mineralization (GO:0030501),-0.5153001536899052,-1.5359438738598492,0.026726057906458798,0.3033201685615177,1.0,18/35,15.76%,BMP6;WNT4;BMP7;OSR1;BMPR2;BMP4;ADGRV1;ACVR1;FBN2;ANO6;KL;ATRAID;P2RX7;TGFB1;TMEM119;CCN1;PKDCC;BMPR1A
prerank,negative regulation of epithelial cell proliferation (GO:0050680),-0.46394005055070286,-1.5355971561080042,0.007832898172323759,0.30259768320340436,1.0,15/66,3.56%,NFIB;TGFBR3;MCC;SULF1;ROBO1;MTSS1;APOE;SPARC;CAV1;NUPR1;XDH;FGFR2;PTPRM;THBS1;B2M
prerank,regulation of interleukin-12 production (GO:0032655),-0.4909165901964936,-1.5351382343769078,0.0215311004784689,0.3019786506500999,1.0,15/47,22.31%,PLCB1;FOXP1;THBS1;IL16;LGALS9;MAPK14;CD47;CMKLR1;IRAK3;MAST2;PLCG2;TLR4;SYK;MDK;CCL19
prerank,regulation of calcium ion transport (GO:0051924),0.5601244699806694,1.5349070835819962,0.04634581105169341,0.6224888580878223,1.0,13/54,12.17%,TRPC6;CACNB2;MYLK;EPB41;CACNA2D1;STIM2;STC1;CACNA1D;STIM1;PKD2;CASQ1;PACSIN3;SLC8B1
prerank,mesenchyme development (GO:0060485),-0.6254539897133686,-1.534836550835764,0.04408817635270541,0.3011460153713078,1.0,5/15,3.45%,BMP7;FGFR2;BMPR2;BMP4;TGFBR1
prerank,fatty acid transmembrane transport (GO:1902001),-0.5878226922127336,-1.534559979623023,0.03206412825651302,0.30025707605392704,1.0,6/19,9.91%,PRKAG2;SLC2A1;CPT1A;SLC25A20;CPT2;ACACA
prerank,positive regulation of biosynthetic process (GO:0009891),-0.49121206682882995,-1.5335897440791766,0.02027027027027027,0.30110868047679945,1.0,12/40,14.16%,SORBS1;WNT4;APOE;VIM;BMP4;RAB27A;AKT1;TGFB1;PPARA;CYBA;PLCG2;CREB3L1
prerank,negative regulation of proteolysis (GO:0045861),-0.5152016631616378,-1.5333089357205931,0.022587268993839837,0.3003112507371121,1.0,9/34,9.39%,TIMP3;EPHA4;PTPN3;GAS1;TIMP2;LRRK2;CST3;AKT1;ECM1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.4884333668206497,-1.5327927217727668,0.011737089201877934,0.3001689303306237,1.0,12/49,10.32%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,positive regulation of signal transduction (GO:0009967),-0.36694952244581003,-1.5325341516549458,0.0038022813688212928,0.2992744929426627,1.0,55/238,11.85%,TSPAN5;BMP6;SULF1;IGF1;SORBS1;ROBO1;ZMIZ1;NRP1;NTRK3;PTGIS;VWF;TEK;CCBE1;F3;LIMS2;MACF1;RSPO3;JCAD;SASH1;SHANK3;FGFR2;NOS3;IL6ST;ITGA5;TGFBR1;KAT2B;LRRK2;KLF2;SKI;SMO;IGF2;SLC39A14;GAS6;MN1;FGF1;CCN3;SULF2;YAP1;BMP2K;PRKCZ;RSPO2;PRKCB;PTK2B;STAT3;EVC;TTC23;HIF1A;TRIM16;NLGN2;DAB2IP;VPS35;ITGB3;POGLUT1;ERN1;ADAMTS3
prerank,carboxylic acid metabolic process (GO:0019752),-0.5089166803272936,-1.5324306142957396,0.022821576763485476,0.2980028889448277,1.0,12/33,19.67%,PLA2G4A;PTGIS;DDO;ST3GAL1;SLC2A1;CSGALNACT1;CARNMT1;TBXAS1;PON3;AGXT;CYB5R3;GNE
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.6381400397846195,1.531897412981073,0.07610993657505286,0.6286259740562145,1.0,5/22,7.81%,DYNLL1;ROCK1;TESK1;ANKLE2;CDKN1A
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.5841332381096174,1.5318428001698636,0.04371584699453552,0.625431761264696,1.0,14/41,14.03%,ACE2;GNG2;KCNJ12;KCNMB1;AKAP6;ANK3;PDZK1;KCNE5;STAC;KCNJ3;KCNJ6;PIRT;KCNMA1;ANK2
prerank,detection of calcium ion (GO:0005513),0.7137167569564965,1.531293480070055,0.07399103139013453,0.6239368582923555,1.0,5/13,8.40%,CASQ2;KCNMB1;RYR2;STIM1;SYT1
prerank,negative regulation of mitochondrion organization (GO:0010823),-0.5207614252678057,-1.5308556246146388,0.02027027027027027,0.30054822659317393,1.0,14/33,25.65%,IGF1;IAPP;TFRC;AKT1;FLCN;BNIP3;ADCK1;GPX1;VAT1;PRELID1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,response to metal ion (GO:0010038),0.5328852660927235,1.5301767950772869,0.04208754208754209,0.6240953603381074,1.0,6/67,6.29%,TRPC3;NEDD4L;TRPC1;PPP3CA;SLC25A13;SNCA
prerank,regulation of dendrite morphogenesis (GO:0048814),0.5948771144926064,1.5296418398868732,0.06324110671936758,0.6223737030187377,1.0,17/32,18.45%,NEDD4L;RAPGEF2;SDC2;HECW2;CHRNA3;CAPRIN2;IL1RAPL1;ADGRB3;HECW1;SARM1;CUX2;LZTS1;CHRNB2;NSMF;GORASP1;GSK3B;KNDC1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.7131648756719156,1.529152942366895,0.08733624454148471,0.6206232400437112,1.0,5/11,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,cell-matrix adhesion (GO:0007160),0.504601018902047,1.5283630201522667,0.03827751196172249,0.6198134842788954,1.0,12/95,3.62%,DLC1;PTPRK;ITGA1;ITGA4;ITGA7;ECM2;VTN;VCL;PEAK1;FERMT2;CD96;ITGB5
prerank,translation (GO:0006412),-0.37911977958239396,-1.5283529774068096,0.0,0.3054250501655151,1.0,93/208,26.69%,RPLP1;RPS14;LARS2;RPL9;RPS12;RPL41;RPS20;RPL18A;RARS2;RPS13;RPS19;RPS23;SRBD1;RPS4X;EEF1D;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;KARS1;RPL11;RPS18;EEF1B2;CARS1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RWDD1;RPL26;MRPS7;MRPS6;QARS1;SARS1;RPL10;MRPS18A;RPL7;MRPS24;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;RPL31;EEFSEC;RPS25;MARS2;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;RRBP1;RPL36A;DRG2;FARSA;FTSJ1;RPS26;PPA1;RPL35A;APEH;FARSB;RPS29;TRMT112;RPL8;RPL36;MRPL35;GTPBP2;TMA7;RPS3;RPL13A;ABCF1;ASMT;MRPL34
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.6780676865757453,-1.5280164701602987,0.04788213627992634,0.30310276273035525,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.6780676865757453,-1.5280164701602987,0.04788213627992634,0.30310276273035525,1.0,8/10,28.35%,SMPD3;NSMAF;PRKCD;PLA2G6;TNFRSF1A;SIRT3;RACK1;SPHK2
prerank,epithelial cell differentiation (GO:0030855),-0.42690516448158267,-1.5278153798416163,0.007832898172323759,0.3021418413027856,1.0,21/88,16.16%,DAB2;MAF;FSTL1;ANXA4;FGFR2;BMP4;ANXA1;CPT1A;CNN3;SIX1;TBX1;AKT1;CTSB;FZD7;KDR;ANXA7;HDAC1;GATA6;BDH2;CASP6;KDM6B
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.5134175993743294,-1.5268810340708245,0.018140589569160998,0.30279599846003297,1.0,13/35,12.24%,ZMIZ1;RBFOX2;NR3C1;ESR1;DDX5;NR3C2;AR;YAP1;TMF1;EGLN2;PGR;KDM3A;PLPP1
prerank,regulation of glucose import (GO:0046324),-0.5281935807618091,-1.5263537382623686,0.0423728813559322,0.3025975934269651,1.0,7/30,2.24%,PRKAG2;IGF1;SORBS1;OSBPL8;OCLN;RHOQ;ENPP1
prerank,acidic amino acid transport (GO:0015800),-0.5969642964499844,-1.5263107047330562,0.04081632653061224,0.30121589580462976,1.0,7/17,16.03%,SLC6A13;SLC1A3;SLC6A6;GJA1;SLC6A1;SLC25A22;ARL6IP5
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.5593496498576731,-1.5252334864557504,0.03711340206185567,0.30203579723579854,1.0,6/24,10.77%,IGF1;SORBS1;ENPP1;IGF2;AKT1;PPP1R3B
prerank,blood vessel endothelial cell migration (GO:0043534),-0.5648410830390631,-1.5250252046213253,0.02895752895752896,0.30112011087975693,1.0,9/22,10.62%,ROBO1;EFNB2;CDH5;NRP1;SLIT2;EPHB4;ID1;AKT1;KDR
prerank,negative regulation of sprouting angiogenesis (GO:1903671),-0.6611037787167067,-1.5249200409369799,0.051923076923076926,0.29992410887215804,1.0,6/11,14.16%,SEMA6A;ADAMTS9;THBS1;KLF2;PIK3CB;CREB3L1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),0.6925353892342426,1.5248772591924145,0.07252747252747253,0.6275726249072051,1.0,6/13,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.7166050508238979,1.524738966277915,0.10697674418604651,0.6247342540359062,1.0,4/10,3.66%,NEDD4L;ATP1A2;HECW2;STK39
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),-0.3943878438304404,-1.5240726839606293,0.0060790273556231,0.3006242889874226,1.0,34/136,12.56%,HDAC4;PTGIS;BMP7;SP100;ANXA4;NUPR1;SUFU;ESR1;KLF4;TCF7L2;SMAD7;TAF1;ID1;IRAK2;GAS6;ARRB1;WWP2;DAP;GLIS2;SFRP4;BHLHE40;ID3;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A;MDFI;CEBPG;PTCH1;ID2
prerank,regulation of nucleocytoplasmic transport (GO:0046822),-0.6645490908425756,-1.5240270113620467,0.03954802259887006,0.29928549857547965,1.0,7/12,20.51%,PTPN14;BMP4;IFI27;TGFB1;SIRT7;TPR;NUP214
prerank,tube closure (GO:0060606),0.5998637628490436,1.5233163673968944,0.0780399274047187,0.6262003390802652,1.0,3/31,2.42%,DLC1;VASP;GRHL3
prerank,negative regulation of mitotic cell cycle (GO:0045930),-0.4950525754325396,-1.5230689495298977,0.026726057906458798,0.3001702750349343,1.0,16/45,13.44%,SMAD3;BMP7;PTPN3;TOM1L2;BMP4;GAS1;WEE1;TOM1L1;FOXC1;PLK2;CHFR;BTG3;NABP1;TGFB1;TRIM35;ZW10
prerank,activin receptor signaling pathway (GO:0032924),-0.6229412554576982,-1.5228845579071955,0.04477611940298507,0.29937642337626375,1.0,3/15,4.09%,SMAD3;TGFBR1;ACVR1
prerank,primary neural tube formation (GO:0014020),0.602982737244054,1.5225273937851265,0.07608695652173914,0.6257574559758431,1.0,3/30,2.42%,DLC1;VASP;GRHL3
prerank,defense response to tumor cell (GO:0002357),0.7200449852901905,1.5224128743846908,0.10762331838565023,0.6229579009577652,1.0,2/10,1.51%,DLEC1;RBMS3
prerank,embryonic digit morphogenesis (GO:0042733),0.6712594099240226,1.5220748170376892,0.08835341365461848,0.6207513461715118,1.0,4/18,3.07%,TBX2;MAP3K20;TBX3;ECE1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.5361138456402201,-1.5213166283991706,0.049689440993788817,0.30191454862643063,1.0,5/26,1.64%,IGF1;SORBS1;OSBPL8;OCLN;RHOQ
prerank,negative regulation of actin filament bundle assembly (GO:0032232),0.6160194047784753,1.520662628121941,0.08097928436911488,0.6223203536021017,1.0,5/27,2.30%,DLC1;ARHGAP6;PIK3R1;PHLDB2;WAS
prerank,regulation of platelet activation (GO:0010543),-0.5853525789094405,-1.5194932892421253,0.03571428571428571,0.305006571004662,1.0,5/21,3.29%,PDGFRA;PLA2G4A;APOE;NOS3;THBD
prerank,aggrephagy (GO:0035973),0.6037902767147241,1.5175247926131097,0.08221797323135756,0.6291558085286559,1.0,1/27,0.06%,DYNLL1
prerank,endocardial cushion morphogenesis (GO:0003203),0.663120428345602,1.5174565931595514,0.09898989898989899,0.6262971512160865,1.0,4/18,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,dendritic cell migration (GO:0036336),0.6771463960617841,1.5172515678925576,0.07835051546391752,0.6238166342703089,1.0,2/16,5.78%,EPS8;CXCR2
prerank,ERK1 and ERK2 cascade (GO:0070371),-0.5710434923526925,-1.515921378250467,0.029354207436399216,0.3124179433832237,1.0,8/21,19.09%,IGF1;CTSH;LGALS9;KARS1;KDR;MAPK3;ZFP36L2;MT3
prerank,nucleoside phosphate catabolic process (GO:1901292),-0.6347996570407572,-1.5156061925684026,0.04081632653061224,0.3117653383339982,1.0,6/13,19.02%,ENTPD1;ENPP1;ENPP3;ENTPD5;SMPDL3A;ENTPD2
prerank,nitric oxide biosynthetic process (GO:0006809),-0.6366489549905272,-1.5150188669363536,0.041501976284584984,0.3116886854091671,1.0,6/13,18.75%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,nitric oxide metabolic process (GO:0046209),-0.6242972723878799,-1.5148435128152966,0.03777335984095427,0.31061884017940405,1.0,6/14,18.75%,NOS3;CYP1B1;AKT1;GCH1;NOS1;CYB5R3
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),0.5978029866845036,1.5148070424704376,0.066543438077634,0.6281906308152678,1.0,4/33,1.63%,PTEN;MEF2C;PRKG1;GPER1
prerank,regulation of T cell migration (GO:2000404),-0.5901974799709757,-1.5134647541394464,0.043052837573385516,0.312459477925872,1.0,5/18,6.59%,APP;APOD;LRCH1;CXCL12;RHOA
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.5811631088767035,1.5134317104254205,0.06593406593406594,0.6294084664347167,1.0,15/39,11.62%,UTRN;DMD;NEDD4L;HECW2;FGF12;FXYD2;STK39;FGF13;ANK3;HECW1;NETO1;SCN2B;RANGRF;FGF11;FGF14
prerank,blood circulation (GO:0008015),0.5461815370162855,1.5128459888521024,0.07414104882459313,0.6282843065553616,1.0,7/49,3.95%,GUCY1B1;ACE2;GUCY1A1;COL4A3;ADORA2A;ROCK1;ADCY6
prerank,glutathione biosynthetic process (GO:0006750),0.7085314233226596,1.5127714143003264,0.1079913606911447,0.6254384721346331,1.0,2/11,2.70%,GGT1;CHAC1
prerank,regulation of actin filament-based movement (GO:1903115),0.6921552792509915,1.5120043756567305,0.10191082802547771,0.6248715571415735,1.0,4/10,7.08%,PDE4D;SCN5A;PDE4B;STC1
prerank,sphingolipid metabolic process (GO:0006665),-0.41511006498966097,-1.5103222504104343,0.01084010840108401,0.3187325485516243,1.0,43/108,24.73%,PLPP3;SGMS1;ESYT2;CERT1;SGMS2;ELOVL7;ST6GALNAC3;ACER2;SMPD3;HACD4;HACD3;HEXA;HEXB;ACER3;CSNK1G2;NSMAF;B3GALNT1;PSAP;SPNS2;DEGS2;ST6GALNAC6;PLPP1;ALDH3A2;ESYT3;PLA2G15;SPHK1;UGCG;SPTLC2;VAPA;SUMF2;SERINC1;ELOVL1;CLN8;NEU3;ORMDL3;GLB1;ENPP2;SUMF1;SGPL1;PPM1L;SPTSSA;ORMDL2;PDXDC1
prerank,regulation of muscle contraction (GO:0006937),0.6198687079735672,1.510217184108146,0.08713692946058091,0.6273419982459448,1.0,4/26,3.41%,PLCE1;ATP1A2;MYL9;CHRNA3
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.6070881862739905,-1.5099515787119102,0.04133858267716536,0.3181223983369335,1.0,6/15,28.10%,MOXD1;DDC;SAT1;ASMT;SRM;SMOX
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),0.7102842149538482,1.5098596473372772,0.10492505353319058,0.625598681168954,1.0,2/12,1.87%,PTEN;BTRC
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5854690004319734,1.5094502517208945,0.08203125,0.6239997556098756,1.0,8/33,4.24%,MEF2C;TBXA2R;NOTCH1;RGCC;STARD13;MECP2;PDCD10;FGF2
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.44505667465899257,-1.5092759891803882,0.012531328320802004,0.3182534656312689,1.0,24/65,13.93%,FBN1;LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;SMURF2;TGFBR1;SNX6;SMAD7;SKI;SMURF1;FBN2;PRDM16;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;LTBP1
prerank,actin filament network formation (GO:0051639),0.7171971089784723,1.5092598496252685,0.09978308026030369,0.6215935365467945,1.0,3/11,7.02%,CARMIL1;SPIRE1;PLS3
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5654946405016403,1.5069220514613595,0.07092198581560284,0.6261425436871939,1.0,6/43,3.37%,TBX2;MEF2C;NOTCH1;TBX20;TBX3;TBX6
prerank,negative regulation of T cell activation (GO:0050868),0.5850806196941949,1.5066606631106632,0.06818181818181818,0.624017634000694,1.0,4/35,3.86%,GLMN;TNFRSF21;PTPN22;PAG1
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.5567728702235653,1.5065570095846703,0.07809847198641766,0.6214193435661395,1.0,3/47,0.80%,PDGFRB;ACE2;PID1
prerank,peptide catabolic process (GO:0043171),0.6140315819161097,1.5064152191357592,0.09486166007905138,0.6189825216150151,1.0,6/23,3.20%,ENPEP;GGT5;GGT1;CHAC1;ECE1;ANPEP
prerank,regulation of ion transmembrane transport (GO:0034765),0.5928423345645408,1.5056380881074292,0.08812949640287769,0.6182082152227941,1.0,5/33,4.10%,KCNJ8;CASQ2;NEDD4L;KCNJ12;AKAP6
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.6296523202297675,1.5051867073190954,0.08898305084745763,0.6166289700004391,1.0,7/22,11.85%,PTEN;HEXIM1;CDKN1A;INCA1;NR2F2;LATS2;APC
prerank,action potential (GO:0001508),0.5577326470705675,1.504260352695615,0.07557117750439367,0.616590641014687,1.0,12/44,8.85%,DMD;GPER1;CACNA1H;KCNE4;KCND2;AKAP6;SCN2A;SCN5A;ANK3;SCN8A;KCNE5;SCN9A
prerank,regulation of autophagy (GO:0010506),-0.37017980654587956,-1.503642536141742,0.0,0.3307460149549078,1.0,68/216,19.58%,PRKAG2;DAPK1;LEPR;DCN;FOXO1;FOXO3;NUPR1;SNX6;LRRK2;WDR41;ACER2;TPCN1;DAP;RASIP1;SNX32;PLK2;EXOC4;STAT3;CAPNS1;ATP6V1G1;PIK3CB;AKT1;MCL1;EEF1A1;IRGM;CAPN1;FOXK1;DAPL1;FLCN;ATF6;PSAP;GFAP;ATP6V0B;ZC3H12A;ZKSCAN3;PIP4K2B;TRIM27;OPTN;VPS35;ERN1;SH3GLB1;EIF4G3;RAB8A;ATP6V0A1;PRKAG3;ATM;PRKAB1;MET;TICAM1;BNIP3;WASHC1;ATP6V0A2;FBXL2;SREBF1;PRKAA2;GPR137;MTMR3;TRIM8;SIRT2;RRAGB;TRIM14;LAMTOR5;SH3BP4;TMEM59;MT3;PIM2;ATG101;ORMDL3
prerank,protein ADP-ribosylation (GO:0006471),0.5891303076582445,1.5030535095870272,0.10223048327137546,0.6174553506799901,1.0,2/28,0.90%,ART3;PARP8
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.5511055060257848,1.5029351325391174,0.06761565836298933,0.6150594012140768,1.0,9/48,7.33%,GUCY1B1;GUCY1A1;GUCY2D;ADCY8;ADCY3;ADCY6;SLC26A1;ADCY9;ADSL
prerank,xenobiotic transport (GO:0042908),-0.5971978555868221,-1.5029183069801164,0.05078125,0.3310060850831419,1.0,8/17,16.74%,SLC47A1;GJA1;ABCG2;SLC22A4;SLC7A5;ABCA3;SLC22A18;SLC22A2
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),-0.6695086461061157,-1.5012425238076255,0.03308823529411765,0.33371306393729194,1.0,5/10,13.24%,TGFBR2;FGFR2;STAT1;TBX1;CHRD
prerank,actin filament bundle assembly (GO:0051017),0.5955061453909706,1.5009303964253644,0.09090909090909091,0.6184286782227025,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5955516836727662,1.5006229478820834,0.08592321755027423,0.6165294242087385,1.0,5/35,7.39%,SGIP1;VTN;LDLRAP1;IL4;PPT1
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.47511616556045017,1.500460498635836,0.03767660910518053,0.6141859045760837,1.0,16/107,7.48%,ATP13A5;SLC30A10;PTH1R;ATP2A3;ATP2C1;STIM2;ATP2B3;ATP13A4;SLC24A4;SLC24A2;HTR2C;RYR2;ATP2A2;CHRNA7;STC1;STIM1
prerank,cellular response to heat (GO:0034605),0.5907915923406843,1.4995850322006905,0.056640625,0.614115581505433,1.0,1/35,0.04%,ANO1
prerank,actin filament bundle organization (GO:0061572),0.5991581456173904,1.498828137468365,0.07114624505928854,0.613636392385842,1.0,4/33,1.13%,MYO1B;EPS8;CALD1;AIF1L
prerank,glycerolipid metabolic process (GO:0046486),0.7056069898381545,1.4988261196610266,0.11555555555555555,0.6109251451606256,1.0,2/11,1.88%,DGKB;DGKG
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.5800694674273636,1.4985047824067452,0.06629834254143646,0.6092189985816375,1.0,2/35,0.19%,ITGA1;PDGFRB
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.6408305535042929,-1.4976067814449072,0.041970802919708027,0.34151311861413447,1.0,6/12,18.66%,CYP26B1;DHRS3;KLF2;TRIM16;CALR;EZH2
prerank,B cell receptor signaling pathway (GO:0050853),0.602211628641675,1.497221665480225,0.07372400756143667,0.610360463242628,1.0,4/32,2.48%,MEF2C;PIK3CD;BCAR1;RFTN1
prerank,embryonic organ morphogenesis (GO:0048562),-0.4806221179463415,-1.496418066489159,0.03811659192825112,0.34321003380448994,1.0,17/42,14.68%,FBN1;EFEMP1;PDGFRA;HOXB3;RBP4;MFAP5;FGFR2;ACVR1;HOXA3;RARG;SIX1;FBN2;TBX1;HOXB9;ID2;SOX17;HOXC4
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.6373938368011021,1.4961380676286329,0.0967741935483871,0.6109685281631408,1.0,4/20,3.66%,CASQ2;NEDD4L;HECW2;STK39
prerank,regulation of autophagosome maturation (GO:1901096),-0.6207937517700786,-1.4954927133370661,0.050724637681159424,0.34412114055805026,1.0,6/13,18.06%,CLEC16A;IRGM;PHF23;UVRAG;TBC1D25;ADRB2
prerank,central nervous system myelination (GO:0022010),0.71753285240863,1.4942301416161068,0.09221311475409837,0.6139787297469721,1.0,4/11,9.76%,PTEN;B4GALT6;TENM4;PLP1
prerank,positive regulation of leukocyte proliferation (GO:0070665),0.6853778168461023,1.492708334482289,0.08597285067873303,0.6156423878320681,1.0,2/12,1.34%,IL34;PTK2
prerank,glutamine family amino acid catabolic process (GO:0009065),-0.6205658260970105,-1.4926656108946144,0.049429657794676805,0.3497765836544212,1.0,6/13,8.48%,GLUL;NOS3;DDAH1;ALDH4A1;PRODH;GLS
prerank,regulation of programmed necrotic cell death (GO:0062098),-0.5755639520006668,-1.492390561549812,0.031007751937984496,0.34898486604333945,1.0,9/20,17.18%,NUPR1;CFLAR;SDCBP;PDCD6IP;BIRC3;FLOT2;CASP8;PELI1;RIPK1
prerank,epithelial structure maintenance (GO:0010669),-0.6616978710591659,-1.4922004189146947,0.06998158379373849,0.34794492978281605,1.0,3/11,12.20%,CXADR;RBP4;STRAP
prerank,cell-substrate junction assembly (GO:0007044),0.5829567076572334,1.4920504119527902,0.08801498127340825,0.6146814036377853,1.0,5/33,2.10%,DLC1;PTPRK;LAMC1;PEAK1;FERMT2
prerank,ruffle organization (GO:0031529),0.6533212218697557,1.491527918953112,0.08577405857740586,0.6135405504028563,1.0,2/16,1.13%,CARMIL1;AIF1L
prerank,sensory organ development (GO:0007423),-0.4670667801871367,-1.4913886271328696,0.02320185614849188,0.3486191375126357,1.0,13/51,16.97%,PBX1;SMOC1;CHD7;SHROOM2;PBX3;RBP4;FOXC1;STRA6;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,regulated exocytosis (GO:0045055),-0.3732013268323253,-1.490860391288583,0.007220216606498195,0.3484410905941937,1.0,42/173,16.18%,IGF1;TIMP3;FN1;ABCC4;LHFPL2;LAMP2;SERPING1;VWF;PECAM1;ACTN2;APP;SPARC;PCDH7;ANXA5;THBS1;CLEC3B;ISLR;CD9;VEGFD;VEGFC;IGF2;GAS6;ARHGAP17;SRGN;TMSB4X;ECM1;PSAP;STX1A;LGALS3BP;ITGB3;TGFB1;ACTN1;RAB11FIP1;F5;APOOL;SCG3;RAB11FIP5;SERPINE1;APLP2;SYTL4;CD109;CALM1
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.5503193786584936,1.489366822960825,0.06205673758865248,0.6170311320660368,1.0,5/46,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,regulation of feeding behavior (GO:0060259),0.7072650686583457,1.4892592000512272,0.08869179600886919,0.6147366302077224,1.0,1/11,0.11%,SGIP1
prerank,sphingolipid biosynthetic process (GO:0030148),-0.4341875890398754,-1.488963170657625,0.014778325123152709,0.3519842119676251,1.0,22/71,16.94%,LARGE1;PLPP3;SGMS1;CERT1;SGMS2;ELOVL7;A4GALT;ACER2;HACD4;HACD3;ACER3;CSNK1G2;SPNS2;DEGS2;PLPP1;ALDH3A2;SPHK1;SPTLC2;VAPA;ST3GAL5;ELOVL1;CLN8
prerank,positive regulation of epithelial cell proliferation (GO:0050679),-0.4008976519177439,-1.488962066233721,0.008875739644970414,0.3504766834159236,1.0,33/113,12.65%,BMP6;NOTCH2;IGF1;EGFR;NRP2;NRP1;TEK;TGFA;OSR1;F3;FGFR2;BMPR2;BMP4;TGFBR1;TCF7L2;VEGFD;VEGFC;FGF1;YAP1;WNT5A;STXBP4;TBX1;AKT1;PPP1R16B;RREB1;HIF1A;ECM1;CDH13;FZD7;KDR;ITGB3;NME1;FLT4
prerank,activation of protein kinase B activity (GO:0032148),-0.5201405973686606,-1.4885407796647738,0.02795698924731183,0.35012969915547765,1.0,13/29,19.09%,IGF1;NTRK3;OSBPL8;GAS6;FGF1;WNT5A;AKT1;IL18;TXN;PPIA;PDPK1;PARK7;MT3
prerank,actin filament-based transport (GO:0099515),0.637437854054256,1.4884499614037567,0.0825147347740668,0.6142998866327701,1.0,4/21,8.18%,MYO1B;WASL;ACTN4;MYO6
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6236986896846749,-1.4883644645831409,0.05575539568345324,0.3490780672819026,1.0,5/13,6.61%,FBN1;FSTL1;GREM2;NBL1;FBN2
prerank,endocardial cushion development (GO:0003197),0.6364750967178373,1.488144067018488,0.11788617886178862,0.6125382596306178,1.0,4/21,1.22%,TBX2;HEYL;NOTCH1;TBX20
prerank,regulation of calcium ion import (GO:0090279),0.6097987300517399,1.488022072006298,0.0859538784067086,0.6103404179880193,1.0,4/21,9.15%,PDGFRB;STC1;PKD2;PDGFB
prerank,cellular response to thyroid hormone stimulus (GO:0097067),-0.6293647302326572,-1.4873730572487258,0.0547945205479452,0.35013967032642795,1.0,5/12,11.79%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,negative regulation of cellular component movement (GO:0051271),-0.6014182624077326,-1.4867431912186433,0.04914933837429111,0.3504053284224869,1.0,7/15,15.09%,TGFBR3;FBLN1;SP100;CD9;CCDC125;ACTN1;FRMD5
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.6091638976175975,1.4866100963773783,0.08867924528301886,0.6119710973536677,1.0,3/27,0.73%,PDE4D;DMD;CACNB2
prerank,lipid modification (GO:0030258),0.5796118412031342,1.4864962661699632,0.08045977011494253,0.6096746649693218,1.0,5/37,3.81%,DGKB;MBOAT2;DGKH;DGKG;PLPPR5
prerank,negative regulation of protein autophosphorylation (GO:0031953),-0.6644466317467906,-1.4863787000788493,0.052123552123552123,0.3498662342236643,1.0,3/10,2.43%,ERRFI1;ENPP1;CAV1
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),-0.6337437707582921,-1.4863185963911179,0.055855855855855854,0.3485278308513814,1.0,6/12,10.24%,ADAMTS12;DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,positive regulation of cellular catabolic process (GO:0031331),-0.3906406473005438,-1.4861360487488324,0.003401360544217687,0.34760320609658124,1.0,37/132,13.84%,IGF1;DAPK1;DCN;VGLL4;FOXO1;APOE;FOXO3;APP;EZR;SNX9;LRRK2;ADAM9;CNOT7;TPCN1;MOV10;TNFRSF1B;PLK2;PRKCD;DAGLB;PIK3CB;DTX3L;IRGM;HIF1A;FLCN;ATF6;ZC3H12A;TRIM27;P2RX7;OPTN;VPS35;SH3GLB1;PPARA;GRSF1;ENTPD5;TICAM1;BNIP3;CNOT8
prerank,anion transport (GO:0006820),-0.514884020953499,-1.4852075891847527,0.04439746300211417,0.34845771035993434,1.0,6/33,4.69%,SLC13A4;SLC13A3;SLCO2B1;SLC26A7;ABCG2;SLC22A6
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5726133711373024,1.485128615544921,0.0996309963099631,0.6113316911779437,1.0,8/42,4.29%,LIMS1;ECM2;GCNT2;NOTCH1;PTK2;NF1;CORO2B;MINK1
prerank,positive regulation of endocytosis (GO:0045807),0.555989337901154,1.4849184158914903,0.08170515097690942,0.6093304105001127,1.0,10/45,7.39%,SGIP1;NEDD4L;VTN;LDLRAP1;AXL;GPC3;IL4;CBLL1;SNCA;PPT1
prerank,neural crest cell differentiation (GO:0014033),0.6609032046227028,1.4848705508621078,0.10940919037199125,0.6069958920037555,1.0,3/18,2.80%,MEF2C;CDH2;NRG1
prerank,neural tube closure (GO:0001843),0.5766850058306305,1.4846484469332053,0.08828828828828829,0.6052744111872096,1.0,3/34,2.42%,DLC1;VASP;GRHL3
prerank,purine nucleotide catabolic process (GO:0006195),-0.6233918538577795,-1.4845086380539643,0.04142011834319527,0.34896623549657857,1.0,9/13,25.02%,XDH;NT5E;HINT1;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.5818769359643862,1.4844645006689092,0.0865561694290976,0.6033844282779576,1.0,9/33,7.19%,PTEN;PIK3CD;PIK3R1;NF1;PIK3CA;MYO16;NYAP2;PIK3C2A;IRS1
prerank,purine-containing compound catabolic process (GO:0072523),-0.6284032495104293,-1.483473672715006,0.050682261208576995,0.3501547790618172,1.0,9/13,25.02%,XDH;DPYD;NT5E;GDA;GPX1;NT5C1A;PNP;NT5C2;NT5C
prerank,negative regulation of angiogenesis (GO:0016525),-0.4259714930554697,-1.4826688793153635,0.015789473684210527,0.3508316945132598,1.0,30/84,11.35%,SULF1;DCN;ROCK2;TEK;SEMA6A;ADAMTS9;SPARC;CLDN5;THBS2;PTPRM;THBS1;KLF4;KLF2;HSPG2;HOXA5;NIBAN2;NPR1;GTF2I;ADAMTS1;FOXC1;STAT1;SERPINF1;SEMA3E;PIK3CB;HGS;STAB1;EMILIN1;DAB2IP;PML;ECSCR
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",-0.6598130381389891,-1.482331674752298,0.05952380952380952,0.350223784746999,1.0,3/10,5.51%,CD55;TGFBR2;LGALS9
prerank,regulation of protein localization to nucleus (GO:1900180),-0.4728151315022411,-1.4822949224048863,0.03167420814479638,0.34885366449016925,1.0,21/43,21.84%,GLUL;BMP4;LIMK2;PARP9;YAP1;MFHAS1;TFRC;AKT1;DTX3L;CTNNA1;CARD10;FLCN;TGFB1;BYSL;TPR;PARK7;LAMTOR5;ORMDL3;CDK5RAP3;SIN3A;EIF2AK3
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.5700074765599672,1.4819263537079401,0.08849557522123894,0.6077714474918641,1.0,11/38,11.06%,CACNA1C;CACNB2;KCNE4;CACNA2D1;CTNNA3;SCN5A;BIN1;CACNA1D;KCNE5;KCNJ3;SCN2B
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.5805727555094412,1.4813513359390658,0.0935672514619883,0.6070201995175117,1.0,9/35,10.51%,DLC1;TNFAIP1;SPRY4;CUL3;SPRY2;LZTR1;KCTD13;ARHGAP35;ABL2
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),-0.41567118743452186,-1.4801627056163356,0.005390835579514825,0.3528294206016635,1.0,20/86,6.79%,BMP6;IGF1;EGFR;EPHA7;NRP1;PECAM1;APP;IL15;IL6R;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;CNOT7;IGF2;EFNA5;PRKCZ;PTK2B
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.65533478121773,1.480137555621749,0.09859154929577464,0.6079341993654679,1.0,10/17,21.13%,KCNG1;KCNE4;AKAP6;ANK3;KCNE5;RNF207;SUMO1;VAMP2;KCNS2;KCNAB1
prerank,positive regulation of binding (GO:0051099),-0.4165581029117939,-1.4800910149892275,0.01020408163265306,0.3515504359091568,1.0,30/84,16.89%,IGF1;APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;SKI;PARP9;FOXC1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;CEBPG;RPL11;ADD1;NME1;RAN;MET;TXN;PKD1;HIPK2;HFE;HMGB2;SIRT2
prerank,artery development (GO:0060840),-0.5509548588629456,-1.4800066133316634,0.06047516198704104,0.35035394586652135,1.0,8/23,8.16%,ROBO1;NRP1;BMPR2;TGFBR1;SMAD7;ACVRL1;TBX1;STRA6
prerank,inorganic anion transport (GO:0015698),0.5311513391692262,1.4798525165993395,0.06434782608695652,0.6062614803728402,1.0,2/53,0.25%,ANO1;ANO4
prerank,epithelial cell-cell adhesion (GO:0090136),0.6878375477139604,1.4796994921401052,0.11416490486257928,0.6042872722727571,1.0,3/11,3.62%,SERPINB8;VCL;ITGB5
prerank,regulation of triglyceride biosynthetic process (GO:0010866),0.6588519525219977,1.4791583507015071,0.0989247311827957,0.6033551758397399,1.0,4/15,6.68%,NR1H3;SCARB1;LDLR;SIK1
prerank,negative regulation of intracellular protein transport (GO:0090317),-0.5426642516619165,-1.4790830870204732,0.04384133611691023,0.3514900239808124,1.0,5/22,3.94%,SP100;MDFIC;APOD;SUFU;LRRK2
prerank,positive regulation of cell differentiation (GO:0045597),-0.36438826963486354,-1.4789131452717255,0.0,0.3505360566554109,1.0,64/237,12.78%,BMP6;RANBP3L;IGF1;DAB2;PLCB1;SMAD3;ZBTB16;COL1A1;WNT4;BOC;PDPN;MEDAG;PRKCH;BMP7;CCN2;TMEM64;SLC6A6;CDON;IL6R;TGFBR2;BMPR2;BMP4;IL6ST;GJA1;TGFBR1;TCF4;CSF1;ARHGEF2;LEF1;ACVR1;CD34;HOXA5;ZHX3;IGFBP3;SDCBP;AR;YAP1;ACVRL1;NBL1;RHOA;FBN2;MAPK14;FOXC1;SYAP1;VWC2;NOCT;WDFY2;ATRAID;TIAM1;AKT1;CMKLR1;TMEM100;CTNNA1;CCN4;CARM1;IL18;ZC3H12A;KDR;TGFB1;BCL9L;TMEM119;ID2;MEF2A;CCN1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.6599669535470061,1.4782689998702345,0.10851063829787234,0.6033746920114333,1.0,4/13,16.10%,PIGU;PTPRT;JAK2;MGAT5
prerank,glutathione metabolic process (GO:0006749),0.565746742291907,1.4774291292712283,0.09906542056074766,0.60337637565436,1.0,4/38,4.11%,GGT5;GGT1;CHAC1;GSTT2
prerank,hematopoietic stem cell proliferation (GO:0071425),-0.6272698345468368,-1.4770628137610293,0.061511423550087874,0.3538152552017059,1.0,4/11,6.26%,MECOM;ETV6;CD34;WNT5A
prerank,positive regulation of coagulation (GO:0050820),-0.6618881112587233,-1.4770463043492272,0.07692307692307693,0.3510625177687454,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,positive regulation of hemostasis (GO:1900048),-0.6618881112587233,-1.4770463043492272,0.07692307692307693,0.3510625177687454,1.0,2/10,3.21%,ST3GAL4;THBS1
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.6520234659274309,-1.4768799500645582,0.053003533568904596,0.3487653787062053,1.0,3/10,7.48%,KLF4;WNK1;MAP2K5
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.6520234659274309,-1.4768799500645582,0.053003533568904596,0.3487653787062053,1.0,3/10,7.48%,KLF4;WNK1;MAP2K5
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),-0.42426355516741826,-1.4759518030167864,0.0160857908847185,0.3496843048086093,1.0,23/76,13.40%,EGFR;NFAT5;UACA;BMP7;APP;DLG1;HDAC7;SASH1;EZR;RASSF2;NR3C2;NOD1;PDCD4;CCN3;LGALS9;RHOA;TMSB4X;C1QTNF3;IFI35;ZC3H12A;TRIP6;RELA;SPHK1
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5036555924016778,-1.475150586582122,0.04330708661417323,0.35030440970752585,1.0,11/33,13.07%,SMAD3;FOXO3;NR3C1;KLF4;TEAD1;STAT3;HIF1A;GATA2;TGFB1;RELA;ATOH8
prerank,endothelial cell differentiation (GO:0045446),-0.6197797739980634,-1.4746511408707503,0.06019417475728155,0.35017384493409554,1.0,7/12,16.16%,FSTL1;BMPR2;ACVRL1;TIE1;KDR;SOX18;KDM6B
prerank,positive regulation of neurogenesis (GO:0050769),-0.43125438066225663,-1.4740640610987499,0.018823529411764704,0.3503077881248339,1.0,13/68,8.75%,PLXNA2;ROBO1;CUX1;TIAM2;PLXNA4;SLIT2;SHANK3;TGM2;RHOA;SERPINF1;OBSL1;TIAM1;PLXND1
prerank,positive regulation of inflammatory response (GO:0050729),-0.42118633743747186,-1.4739318171003242,0.0111731843575419,0.3492917856203379,1.0,28/86,22.25%,APP;IL15;NUPR1;LBP;IL6ST;PDCD4;IL16;WNT5A;RPS19;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;KARS1;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1;CD81;MDK;VAMP8;LPL
prerank,lung epithelium development (GO:0060428),-0.6665604178422525,-1.473801388651019,0.06529850746268656,0.3482792820086487,1.0,5/10,14.82%,ERRFI1;BMP4;RCN3;STRA6;PKD1
prerank,cellular response to growth factor stimulus (GO:0071363),-0.3802970483275495,-1.4735302384249285,0.006756756756756757,0.34763320474079273,1.0,41/151,9.08%,BMP6;SMAD3;ADAMTS12;EGFR;FLT1;NRP1;WNT4;NTRK3;WWOX;BMP7;SEMA6A;IQGAP1;NR3C1;PLCG1;TGFBR2;BMPR2;BMP4;GAS1;TGFBR1;CLEC3B;MAGI2;KLF4;SMAD9;ANXA1;SMAD7;ACVR1;RAMP2;APPL2;NDNF;ACVRL1;WNT5A;MAPK14;FOXC1;SYAP1;MAP2K5;TBX1;RAPGEF1;EHD1;AKT1;EEF1A1;TMEM100
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.6404200589102005,1.4734836943657328,0.10095238095238095,0.6121154588239238,1.0,6/20,5.65%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;ATP1B2;TFAP2B
prerank,amino sugar metabolic process (GO:0006040),-0.6662267197177131,-1.4732949260053843,0.05128205128205128,0.3469154691565101,1.0,6/10,19.67%,ST3GAL1;CSGALNACT1;EXTL2;GFPT2;GFPT1;GNE
prerank,osteoclast differentiation (GO:0030316),-0.5452287529848413,-1.4731672612827684,0.04770992366412214,0.34593194817842604,1.0,10/22,21.20%,FOXP1;ANXA2;CSF1;SBNO2;MAPK14;TNFRSF11A;SNX10;GLO1;CSF1R;TYROBP
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.7109344938949957,1.4720392787735008,0.0894854586129754,0.6136824630626849,1.0,2/10,1.47%,CARMIL1;SEMA5A
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),-0.5180601247074549,-1.4719187298810474,0.05660377358490566,0.34762406811123325,1.0,7/26,10.24%,EGFR;IQGAP1;PLCG1;FOXC1;SYAP1;EEF1A1;DAB2IP
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),0.6364799747711696,1.469732312447405,0.08847736625514403,0.6177530611377966,1.0,4/20,1.63%,ITGA4;PLA2R1;RGCC;GPER1
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),-0.5675922603271999,-1.469473858802801,0.06201550387596899,0.35272293718355197,1.0,5/19,7.48%,APP;KLF4;SLCO1C1;KLF2;MAP2K5
prerank,carboxylic acid transmembrane transport (GO:1905039),0.5450653584734183,1.468985123231896,0.08193668528864059,0.6174412056922787,1.0,2/40,3.11%,SLC38A11;SLC19A1
prerank,regulation of peptide hormone secretion (GO:0090276),0.5203935189050988,1.4686990947624199,0.07345575959933222,0.6159217394326348,1.0,18/67,12.83%,CACNA1C;RAPGEF4;PER2;ITPR2;IL1B;FFAR2;GIPR;SNAP25;ITPR1;TFAP2B;HTR2C;RAP1A;CACNA1D;GCK;CACNA1A;SLC8B1;KCNG2;RASL10B
prerank,aorta development (GO:0035904),0.6635407478921937,1.4681971024324372,0.1078838174273859,0.6151289313440799,1.0,7/14,9.82%,PDGFRB;TBX2;TFAP2B;ROBO2;PKD2;JAG1;EFEMP2
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.5777040263090566,1.4680451788656879,0.07652173913043478,0.6131965487441106,1.0,9/39,7.70%,TRPC6;UTRN;NEDD4L;FGF12;FXYD2;STK39;CACNA1D;PDZK1;KCNE5
prerank,regulation of brown fat cell differentiation (GO:0090335),-0.5955259662198139,-1.4674599151760936,0.061567164179104475,0.35660615513851385,1.0,8/16,14.26%,BMP7;SOX13;SIX1;RREB1;FLCN;METRNL;PTGS2;FTO
prerank,artery morphogenesis (GO:0048844),0.6045810292900375,1.4669831989610822,0.09961685823754789,0.6139968049116836,1.0,5/30,2.17%,PDGFRB;TBX2;HEY2;NOTCH1;NF1
prerank,second-messenger-mediated signaling (GO:0019932),0.503504027943892,1.466497192214122,0.06351791530944625,0.612950700331983,1.0,12/82,8.64%,GUCY1B1;GUCY1A1;PLCE1;INPP5A;CCRL2;ACKR3;CXCR2;RYR2;MAFA;ACKR2;CCR9;GPR62
prerank,homotypic cell-cell adhesion (GO:0034109),-0.47849175309032893,-1.4663241235637787,0.03263403263403263,0.3580683455183265,1.0,14/39,14.14%,FN1;PDGFRA;TJP2;PLPP3;MEGF11;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;MEGF10;ACTB;PPIA
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.6467185453980403,1.46624040107748,0.12552301255230125,0.6112969310451591,1.0,3/18,2.79%,DLC1;TNFAIP1;CUL3
prerank,sulfur compound catabolic process (GO:0044273),0.5601598641822335,1.4656469876510532,0.08901515151515152,0.6107026847130034,1.0,8/38,6.34%,CSPG4;GGT5;GGT1;CHAC1;CTH;ACAN;TXN2;GNS
prerank,positive regulation of lymphocyte migration (GO:2000403),-0.6320737038445172,-1.4653576901309655,0.05389221556886228,0.3592285286125986,1.0,4/12,6.59%,JAM2;APP;CXCL12;RHOA
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.627670752663489,-1.4653390327573714,0.07635009310986965,0.3579394893950127,1.0,3/12,6.46%,SORBS1;IGF2;PRKCZ
prerank,regulation of cell morphogenesis (GO:0022604),-0.5116704103673225,-1.4642071637509206,0.04904051172707889,0.35987598004411264,1.0,8/30,6.66%,FMNL2;PDPN;SPARC;CAPZB;MACF1;MOV10;EFNA5;MYO9A
prerank,regulation of activated T cell proliferation (GO:0046006),-0.4918690197174124,-1.4610620055884571,0.046610169491525424,0.366771106532579,1.0,5/30,10.32%,IGF1;IGFBP2;IGF2;LGALS9;IL18
prerank,UV protection (GO:0009650),-0.655921465866674,-1.4607493151318898,0.0694980694980695,0.3661857797229043,1.0,5/10,23.71%,SCARA3;ERCC5;MFAP4;GPX1;ERCC2
prerank,phosphatidic acid metabolic process (GO:0046473),0.533772928703427,1.4607206051771702,0.0721830985915493,0.6219880913908604,1.0,5/48,2.73%,DGKB;PLD1;DGKH;DGKG;PLD6
prerank,positive regulation of angiogenesis (GO:0045766),-0.39590741481301034,-1.4605886347810957,0.005970149253731343,0.3653189020904871,1.0,33/108,11.02%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;ITGA5;KLF4;FOXC2;RAMP2;CD34;VEGFD;VEGFC;FGF1;BMPER;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2
prerank,positive regulation of lipid transport (GO:0032370),-0.6276884611032058,-1.4603468234816734,0.06809338521400778,0.36464140440226855,1.0,5/12,21.92%,APOE;ABCA3;SPP1;PRELID1;DBI
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.5389868449205235,-1.460121257247429,0.06326530612244897,0.36387152968398434,1.0,7/22,6.32%,TIMP3;PTPN3;APOE;SNX9;TIMP2;ADAM9;TNFRSF1B
prerank,visual system development (GO:0150063),-0.48763310095238876,-1.4599495935356746,0.032679738562091505,0.3628931483525422,1.0,10/37,16.97%,PBX1;SMOC1;PBX3;RBP4;FOXC1;ATF6;MEIS2;HIPK2;MEIS1;RAB18
prerank,regulation of fatty acid metabolic process (GO:0019217),-0.5699530163491716,-1.4596206838780132,0.07875457875457875,0.3624208361469326,1.0,3/17,2.43%,PRKAG2;ADIPOR2;CAV1
prerank,regulation of adaptive immune response (GO:0002819),-0.5692438061748734,-1.4592904612889062,0.06557377049180328,0.36201205990622554,1.0,5/18,12.08%,IL6ST;ADCY7;IRF1;TRIM27;AHR
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),-0.4861849939749951,-1.4591591215576534,0.04025423728813559,0.36101084526731086,1.0,25/36,35.05%,CSF1;PARP9;GAS6;PARP14;CASP4;WNT5A;IRGM;HIF1A;NLRC5;MAVS;RIPK1;AGPAT2;TRIM6;ZBP1;PRKN;HSPA1B;IL7;LAPTM5;CXCR4;AGPAT1;EDN1;ADAM17;FADD;C1QTNF4;CD74
prerank,regulation of macrophage migration (GO:1905521),-0.6660648768903886,-1.4578313496273814,0.0564373897707231,0.3631661020609649,1.0,7/10,25.67%,CSF1;PTK2B;EMILIN1;CD200;CD81;P2RY12;CD200R1
prerank,atrioventricular valve development (GO:0003171),0.6687234797853384,1.457716987028719,0.13082039911308205,0.6278484313071133,1.0,4/14,1.81%,HEYL;NOTCH1;TBX20;SLIT3
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.621480240720259,1.4574413779003283,0.11496746203904555,0.626240696830669,1.0,6/20,11.85%,PTEN;HEXIM1;INCA1;NR2F2;LATS2;APC
prerank,regulation of dendrite development (GO:0050773),0.5591858307413645,1.4569975829548825,0.1036468330134357,0.6252090416909509,1.0,13/37,10.80%,NEDD4L;BMP5;SDC2;HECW2;MARK1;PTN;CHRNA3;CSMD3;BCL11A;ADGRB3;HECW1;SARM1;VLDLR
prerank,ceramide metabolic process (GO:0006672),-0.45450813797677486,-1.4567038407145394,0.04714640198511166,0.3648815664073268,1.0,18/49,24.03%,PLPP3;SGMS1;SGMS2;ST6GALNAC3;ACER2;ACER3;NSMAF;DEGS2;ST6GALNAC6;PLPP1;PLA2G15;SPTLC2;CLN8;ORMDL3;CLN6;SGPL1;SPTSSA;ORMDL2
prerank,regulation of nervous system development (GO:0051960),0.5639629553472628,1.4562472403703832,0.08270676691729323,0.6250263707165508,1.0,6/37,2.62%,HEY2;HEYL;PER2;PTN;GBX2;IL1B
prerank,neuronal action potential (GO:0019228),0.6151408793909238,1.456201696973089,0.10436432637571158,0.6228141623216545,1.0,7/22,8.85%,GPER1;CACNA1H;SCN2A;SCN5A;ANK3;SCN8A;SCN9A
prerank,cellular response to fatty acid (GO:0071398),0.6803077115399272,1.4559964180521017,0.12869198312236288,0.6210968976256268,1.0,3/12,7.19%,PID1;FFAR2;IRS1
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),-0.5185895325215649,-1.4553680606611141,0.05605381165919283,0.36705930760768185,1.0,10/26,16.55%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),-0.5126106647112423,-1.4537407369173474,0.047619047619047616,0.37012777815479914,1.0,10/26,18.75%,NOS3;ACER2;ACER3;CYP1B1;AKT1;GCH1;SPHK1;SPTLC2;NOS1;CYB5R3
prerank,embryonic heart tube development (GO:0035050),0.6693035310893068,1.4536819693120837,0.13771186440677965,0.6251244196762751,1.0,4/14,10.34%,TBX2;TBX20;RYR2;CITED2
prerank,activation of adenylate cyclase activity (GO:0007190),0.5733617953329103,1.4532209580253823,0.08007448789571694,0.6241321313874273,1.0,8/35,7.26%,EDNRA;CAP2;GIPR;ADCY8;ADCY3;ADCY6;ADCY9;CAP1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.5191158318974464,-1.4528443721984017,0.05855855855855856,0.37109022572685035,1.0,10/25,16.55%,SMAD3;KLF4;KLF2;DDAH1;P2RX4;NOS1AP;AKT1;PTGS2;HSP90AB1;TLR4
prerank,endocrine system development (GO:0035270),-0.5553104156530958,-1.4526472746568813,0.05916030534351145,0.37034819258121265,1.0,7/21,8.16%,WNT4;GLI2;DKK3;TGFBR1;SIX1;TBX1;STRA6
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),-0.4132768446404162,-1.45220811394469,0.022535211267605635,0.37020776064190447,1.0,15/76,10.43%,PTGIS;BMP7;ANXA4;KLF4;IRAK2;ARRB1;DAP;CYP1B1;MAP2K5;TMSB4X;CMKLR1;NLRC5;IRAK3;DAB2IP;ZC3H12A
prerank,positive regulation of Notch signaling pathway (GO:0045747),-0.4779239888012682,-1.4518233067491872,0.047505938242280284,0.3700022640015864,1.0,10/39,7.33%,TSPAN5;ROBO1;ZMIZ1;NOS3;IL6ST;KAT2B;CCN3;YAP1;BMP2K;STAT3
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.6530845009234079,1.4512065737518975,0.14644351464435146,0.6275870368167936,1.0,4/14,5.93%,DMD;FXYD2;ACTN4;ANK3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),-0.6291165369099356,-1.4504624753083222,0.05772811918063315,0.3722486967270023,1.0,5/12,18.06%,IGF1R;IRGM;UVRAG;BNIP3;ADRB2
prerank,rRNA metabolic process (GO:0016072),-0.3732867942695407,-1.449398501052148,0.003367003367003367,0.3738083604210686,1.0,64/160,24.46%,RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;XRN1;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RRP7A;DEDD2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36
prerank,positive regulation of response to wounding (GO:1903036),0.6004526217769137,1.4478995226369256,0.1,0.634653443975321,1.0,8/24,7.15%,VTN;PTK2;MYLK;SCARF1;PTN;ITGB1;ARFGEF1;HRAS
prerank,semaphorin-plexin signaling pathway (GO:0071526),-0.4732994866753081,-1.4477785741618336,0.03991596638655462,0.3768298068279127,1.0,12/35,11.70%,PLXNA2;NRP2;NRP1;SEMA3D;SEMA6A;SEMA3C;PLXNA4;SEMA7A;SEMA3E;PLXND1;ARHGDIA;SEMA3B
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.44797564994030825,-1.4465269520704387,0.04488778054862843,0.3788228775113069,1.0,13/57,10.32%,IGF1;IL31RA;IL15;IL6R;IL6ST;GHR;PARP9;CNOT7;PARP14;STAT3;KIT;TNFRSF1A;IL18
prerank,regulation of cholesterol transport (GO:0032374),0.6072822873200245,1.446519850288506,0.12090163934426229,0.6363371795023172,1.0,4/20,6.00%,NR1H3;ARV1;ABCA5;OSBPL6
prerank,synapse assembly (GO:0007416),0.5063540400794294,1.44513493163348,0.07226890756302522,0.6379732356596017,1.0,13/67,5.87%,PTEN;ADGRL3;CDH2;FARP1;PCDHB11;LRRTM3;PLXNB1;NRXN1;FGF13;DNER;RYK;GABRG2;GABRA2
prerank,NAD biosynthetic process (GO:0009435),-0.5546001554495986,-1.4432947139754604,0.07766990291262135,0.3858235521223519,1.0,11/20,24.30%,PTGIS;PARP9;NAMPT;PTGS2;NUDT12;NMNAT1;NNMT;PARP16;QPRT;NAPRT;KYNU
prerank,regulation of response to stress (GO:0080134),0.6850301892674546,1.4427304592361383,0.13389121338912133,0.642815217624824,1.0,4/10,14.18%,ADCY8;CORO2B;DYRK3;MLC1
prerank,positive regulation of insulin secretion (GO:0032024),0.5617058364883553,1.4424970215392618,0.08671586715867159,0.6411428345470415,1.0,3/36,3.74%,ANO1;GPER1;ADCY8
prerank,ribosomal small subunit assembly (GO:0000028),-0.5665299612337591,-1.442325792919529,0.058931860036832415,0.38717121689921985,1.0,9/16,22.27%,RPS14;RPS19;RPS5;RPS27;MRPS7;RPS15;RPSA;RRP7A;RPS27L
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),0.6140319070162131,1.4420878410603608,0.102,0.6401277289782362,1.0,7/25,6.29%,CACNB2;TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.7040233486318391,1.4413528718953041,0.14107883817427386,0.6400080011602804,1.0,3/10,1.22%,BMP5;NOTCH1;TBX20
prerank,regulation of cellular senescence (GO:2000772),0.5685233442809514,1.4407771295539844,0.1276595744680851,0.6393593893044524,1.0,7/28,11.35%,SLC30A10;CDK6;AKT3;NEK6;CGAS;NUAK1;RBL1
prerank,ribosome biogenesis (GO:0042254),-0.36204132996747346,-1.4406283712286774,0.0035087719298245615,0.3902656826461485,1.0,74/187,25.81%,GLUL;RPLP1;RPS14;SDAD1;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;NAF1;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;CUL4A;PAK1IP1;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RAN;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RBIS;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;ESF1;RPL36A;RRP12;RIOK2;RRP7A;URB2;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RRS1;RPL13A;FBL
prerank,urogenital system development (GO:0001655),-0.6428026230728843,-1.4405959553626806,0.05222437137330754,0.3890190319809331,1.0,4/11,16.39%,OSR1;ANXA1;EPHB2;EPHB3
prerank,Golgi localization (GO:0051645),0.6780210588096354,1.43986109802347,0.1425531914893617,0.6396699368435427,1.0,4/11,8.16%,ARHGAP21;PDCD10;YWHAZ;HOOK3
prerank,bile acid biosynthetic process (GO:0006699),0.6001561723985869,1.4397962168915894,0.10392156862745099,0.6376160100506995,1.0,5/24,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,response to zinc ion (GO:0010043),-0.5127147858127061,-1.4392830341628835,0.0533596837944664,0.39134057531745553,1.0,16/25,31.15%,PAM;P2RX4;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E;CRIP1;ATP13A2;HVCN1;KHK;MT2A
prerank,regulation of postsynapse organization (GO:0099175),-0.5040414150800347,-1.438336191466011,0.06732673267326733,0.392786793454086,1.0,10/28,15.96%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2;WNT5A;VPS35;ABHD17C;TANC2;HOMER1
prerank,regulation of response to cytokine stimulus (GO:0060759),-0.563425659211516,-1.4371851069072072,0.05555555555555555,0.3946162254111276,1.0,7/19,10.94%,ELF1;KLF4;PARP9;IRAK2;WNT5A;MAP2K5;MAVS
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.47843240503947054,-1.4371554862175513,0.06,0.39339780013858194,1.0,8/37,12.76%,ALCAM;HMCN1;CXADR;VCAM1;ADGRL1;ICAM1;CD164;FAT4
prerank,iron ion homeostasis (GO:0055072),-0.43763264364043425,-1.4369828049918594,0.031007751937984496,0.3925034092161775,1.0,17/58,18.23%,BMP6;CP;SCARA5;B2M;NEO1;ABCG2;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;BDH2;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1
prerank,organic acid transport (GO:0015849),-0.40307173788193734,-1.4364698352815606,0.030927835051546393,0.3925299815272017,1.0,20/94,11.28%,SLC7A11;ABCC4;SLC6A13;SLC13A3;PDPN;SLCO2B1;SLC6A6;SLC26A7;SLC6A12;SLCO1C1;ABCG2;SLC7A2;SLC16A1;SLC22A6;SLC7A7;SLC25A17;SLC7A14;SLC5A6;SLC38A5;SLC3A2
prerank,positive regulation of glial cell differentiation (GO:0045687),0.642385798181456,1.4364693734900345,0.11410788381742738,0.6447068728755393,1.0,5/17,8.39%,IL34;NOTCH1;PTN;BIN1;TENM4
prerank,heterotypic cell-cell adhesion (GO:0034113),0.5831978904616055,1.4362806523570912,0.11153846153846154,0.6429624665940451,1.0,5/25,5.53%,ITGA4;ITGA7;JAM3;CTNNA3;ITGB1
prerank,cellular response to purine-containing compound (GO:0071415),0.6869585825554464,1.4359543354685511,0.15434782608695652,0.6417070857274008,1.0,3/10,8.62%,CASQ2;RYR2;RYR3
prerank,positive regulation of phosphorylation (GO:0042327),-0.34317719522870155,-1.4355975717136056,0.004166666666666667,0.39353855402228854,1.0,72/240,14.80%,IGF1;DAB2;EPHA4;EPHA3;EGFR;FLT1;LEPR;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;LMO4;TEK;PECAM1;APP;ITGA6;FGFR2;THBS1;BMP4;EPHB4;IGF1R;ANGPT1;LRRK2;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;AR;FGF1;EFNA5;DDR1;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;TIE1;KIT;IRGM;HIF1A;EPHA8;FZD7;FLCN;KDR;P2RX7;MAVS;ITGB3;TGFB1;FGFR4;TMEM119;EPHB2;FLT4;CCN1;ENTPD5;KCTD20;CDK2AP1;MET;CCND1;RET;LIMCH1;PPIA;FXR2;MAPK3;RAD50
prerank,negative regulation of programmed cell death (GO:0043069),-0.3366859689695689,-1.4355855836694622,0.0,0.3922808217388744,1.0,75/355,14.19%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;MECOM;SMAD6;FHL2;CTSH;IL31RA;PDPN;TEK;FOXO1;SH3RF1;OSR1;ANXA4;NUPR1;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;IGF1R;ANGPT1;TXNDC5;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;RNF144B;WNT5A;CCND2;PTK2B;PLK2;CARD14;HSPA5;SH3RF2;TFRC;BIRC3;GOLPH3;ERC1;GPX4;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;PRDX2;IFIT3;CD38;GCLC;KDR;ARHGDIA;RAB7A;BNIP3L;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;SPHK1;MET;PIM3;BNIP3;SFRP1;RPL10;HYPK
prerank,regulation of interleukin-1 beta production (GO:0032651),-0.42657339593057797,-1.4354609610041598,0.03759398496240601,0.39131378650963317,1.0,15/66,16.55%,IGF1;FOXP1;APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;ZC3H12A;P2RX7;GBP5;GIT1;SIRPA;TLR4
prerank,regulation of exosomal secretion (GO:1903541),-0.5684294742309952,-1.4350869214855064,0.052104208416833664,0.3910660287242293,1.0,8/19,15.66%,SDCBP;SMPD3;PDCD6IP;SDC4;HGS;RAB7A;ATP9A;SDC1
prerank,cellular response to amino acid stimulus (GO:0071230),0.5522409060704205,1.4350368845777288,0.11434108527131782,0.6420413617377572,1.0,4/33,2.38%,SPAAR;UBR1;CPEB1;SESN3
prerank,nonribosomal peptide biosynthetic process (GO:0019184),0.6599266760989019,1.4342125531991494,0.1565217391304348,0.6419740406345027,1.0,2/12,2.70%,GGT1;CHAC1
prerank,regulation of epithelial cell proliferation (GO:0050678),-0.4056391171556344,-1.433934136938516,0.024657534246575342,0.3929372117260971,1.0,17/85,6.10%,BMP6;TGFBR3;MCC;IGF1;EGFR;MTSS1;TGFA;OSR1;NUPR1;FGFR2;BMP4;ANGPT1;B2M;TCF7L2;FGF1;YAP1;ACVRL1
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.5349192613513486,-1.4336231849282246,0.05313092979127135,0.39123755015777445,1.0,6/21,8.99%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.5349192613513486,-1.4336231849282246,0.05313092979127135,0.39123755015777445,1.0,6/21,8.99%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1
prerank,intestinal lipid absorption (GO:0098856),0.648836478554387,1.4334302261369933,0.13404255319148936,0.6419133529146288,1.0,2/11,3.38%,CEL;LDLR
prerank,negative regulation of protein localization to nucleus (GO:1900181),-0.5491782096436558,-1.433195226419164,0.06560636182902585,0.39113037765939707,1.0,6/18,9.92%,MDFIC;APOD;SUFU;MFHAS1;CTNNA1;FLCN
prerank,negative regulation of RNA metabolic process (GO:0051253),-0.5554153761624124,-1.432320744148436,0.06727272727272728,0.39243407843330647,1.0,9/18,22.56%,ESR1;KAT2B;RPS13;ZC3H12A;TGFB1;TMBIM6;PTBP3;RPS26;NUDT16
prerank,Golgi to plasma membrane transport (GO:0006893),-0.44972849884676475,-1.4322016010978875,0.05057471264367816,0.391470318909123,1.0,12/47,10.98%,VAMP5;STXBP6;MACF1;KIF13A;VPS35L;GGA2;EXOC4;GOLPH3;EXOC6;ARL3;EXOC5;OPTN
prerank,outflow tract septum morphogenesis (GO:0003148),-0.5303559316074001,-1.4318498056813092,0.060669456066945605,0.3911239437003696,1.0,11/24,4.79%,ROBO1;SMAD6;NRP2;NRP1;SEMA3C;TGFBR2;FGFR2;BMPR2;BMP4;ACVR1;ZFPM2
prerank,glycoprotein catabolic process (GO:0006516),-0.5651689327327194,-1.4313524579916714,0.0660377358490566,0.3910826329478738,1.0,11/17,33.53%,ADAMTS12;ADAMTS9;STT3B;EDEM2;MANBA;NGLY1;FBXO17;EDEM1;FBXO44;NEU2;FBXO2
prerank,negative regulation of blood pressure (GO:0045776),-0.5983512930933416,-1.431052572791719,0.06309751434034416,0.39059761861823517,1.0,5/13,15.93%,NOS3;BMPR2;PRCP;SCPEP1;NOS1
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.5350590902335397,-1.4307721366144521,0.05263157894736842,0.38997051402029037,1.0,5/21,5.90%,ERRFI1;ROCK2;BMP4;MAFG;SFRP4
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),-0.3276547707251038,-1.4284635926494773,0.0,0.3947754578776783,1.0,103/476,13.91%,NFIB;IGF1;ZMIZ1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;WNT4;HDAC4;GLI2;TBL1XR1;CREB5;IL31RA;BMP7;SP100;ELF2;FOXO1;APOE;FOXO3;MDFIC;ZIC2;KAT6B;HIVEP3;ESR1;ELF1;BMP4;ELF4;TGFBR1;KLF4;TCF4;FOXC2;LRP6;NFATC1;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;RGMB;CREB3L2;PARP9;QRICH1;NIBAN2;ARNT2;AR;BRD7;YAP1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;PRDM16;FOXC1;STAT1;STAT3;HINFP;SFR1;TBX1;FZD4;AKT1;DTX3L;RREB1;HIF1A;TRIM16;FOXK1;MMS19;FZD7;CD38;KARS1;ZKSCAN3;ESRRG;PML;BRCA2;KDM3A;GLI3;TGFB1;NSD1;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;GATA6;FBXW11;PRDM11;ATOH8;CLOCK;SPP1;RET;TAL1;SOX17;SFRP1
prerank,axoneme assembly (GO:0035082),0.5668112043720475,1.427135841386066,0.11428571428571428,0.657207463176238,1.0,8/30,8.56%,RSPH6A;SPEF1;TTLL3;JHY;GAS8;RSPH1;LRGUK;CFAP46
prerank,organic hydroxy compound transport (GO:0015850),-0.47778841510886044,-1.4265626387412185,0.06550218340611354,0.39871284558258985,1.0,7/36,8.16%,ABCC4;SLCO2B1;RBP4;SLCO1C1;SLC16A1;NPC2;STRA6
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.5547085465897088,-1.4265015048864573,0.084,0.3976523503778412,1.0,3/17,2.78%,BMP6;CD55;SASH1
prerank,negative regulation of bone mineralization (GO:0030502),-0.6113782788750053,-1.4260724811618735,0.07532956685499058,0.3975494581565961,1.0,4/13,9.39%,ENPP1;SRGN;PTK2B;ECM1
prerank,regulation of tumor necrosis factor production (GO:0032680),-0.38391428919427434,-1.4259738032395213,0.014749262536873156,0.3965340480537162,1.0,33/112,22.82%,IGF1;FOXP1;APP;LBP;THBS1;PTPRJ;ARHGEF2;CD34;GAS6;LGALS9;WNT5A;STAT3;CD47;IL33;OAS2;IRAK3;ZC3H12A;TRIM27;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;SIRPA;TLR4;RIPK1;SYK;DICER1;TYROBP;LPL;CCL19;RARA;PTPN6
prerank,Notch signaling involved in heart development (GO:0061314),0.6664739955018846,1.4257708795089796,0.14316239316239315,0.6587860313114277,1.0,3/11,1.19%,HEY2;HEYL;NOTCH1
prerank,small GTPase mediated signal transduction (GO:0007264),0.46793209957803716,1.4247679341355322,0.059282371294851796,0.6593524508869567,1.0,15/103,5.13%,RAPGEF5;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP32;RASGRP2;ARHGAP1;RASGRP3;NF1;RRAD;FGF2;RIN2;RIT2;SIAH2
prerank,positive regulation of autophagy (GO:0010508),-0.40763932265849584,-1.4244588019596813,0.04,0.39922877835378884,1.0,29/81,19.70%,DAPK1;DCN;FOXO1;FOXO3;LRRK2;TPCN1;PLK2;PIK3CB;IRGM;FLCN;ATF6;ZC3H12A;KDR;TRIM27;OPTN;BNIP3L;SH3GLB1;LARP1;TICAM1;BNIP3;PRKAA2;TRIM8;PARK7;TRIM14;SH3BP4;TMEM59;PIM2;ORMDL3;IKBKG
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),-0.5523914139078915,-1.4237487132379538,0.08637236084452975,0.3998909155866536,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,axon extension (GO:0048675),-0.5266191142105084,-1.4230694497202718,0.06387225548902195,0.4003694060239608,1.0,6/23,5.80%,AUTS2;ALCAM;NRP2;NRP1;SLIT2;MAP1B
prerank,negative regulation of cytokine production (GO:0001818),-0.3634748420256309,-1.4226131883847677,0.006968641114982578,0.4003871069810492,1.0,44/163,17.49%,FN1;LGR4;ANXA4;APOD;HDAC7;THBS1;EZR;KLF4;ANXA1;LEF1;PDCD4;HDAC9;CD34;GAS6;ARRB1;SRGN;LGALS9;APPL2;ADCY7;IKBKE;MAP2K5;TMSB4X;C1QTNF3;CMKLR1;PCBP2;NLRC5;RNF135;IRAK3;ZC3H12A;TRIM27;MAVS;RNF125;PPARA;TWSG1;SSC5D;SARS1;ZFPM1;CEACAM1;CD200;SIRPA;ASB1;TLR4;HOMER3;UBA7
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.5756894039467394,1.4221981726481832,0.11685823754789272,0.6645762548666094,1.0,10/26,12.17%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;LETM1;PKD2;CHERP;SLC8B1
prerank,substantia nigra development (GO:0021762),0.5563468264953912,1.422148738715463,0.0989010989010989,0.6624265511638593,1.0,2/37,0.70%,DYNLL1;GNB4
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.3680377017391897,-1.4220915849399145,0.006514657980456026,0.4005865891631901,1.0,38/152,16.28%,RNF220;SULF1;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;MACF1;RSPO3;FGFR2;SMURF2;USP47;RNF146;LRRK2;SKI;TNKS2;SULF2;LYPD6;SFRP4;RSPO2;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;WNT5B;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,arachidonate transport (GO:1903963),-0.6323586645264,-1.4219632521946612,0.09586466165413533,0.39851919331008656,1.0,3/10,6.54%,ANXA1;ACE;BDKRB2
prerank,arachidonic acid secretion (GO:0050482),-0.6323586645264,-1.4219632521946612,0.09586466165413533,0.39851919331008656,1.0,3/10,6.54%,ANXA1;ACE;BDKRB2
prerank,positive regulation of vasoconstriction (GO:0045907),0.664841622103489,1.4218654710880991,0.14316702819956617,0.6609531960254378,1.0,2/13,1.02%,TBXA2R;SMTNL2
prerank,muscle tissue morphogenesis (GO:0060415),0.6213835539637206,1.4216653144709155,0.1317365269461078,0.6592698974113651,1.0,4/16,1.47%,HEY2;NOTCH1;TBX20;MYLK
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.6591425465894585,1.4215249675195356,0.15317286652078774,0.6574688211439048,1.0,3/13,4.24%,ITGA4;AKT3;FGF2
prerank,cellular glucan metabolic process (GO:0006073),-0.6388914673300744,-1.4209781631899603,0.0842911877394636,0.399895737475347,1.0,2/11,1.80%,PRKAG2;PHKB
prerank,histone H4 deacetylation (GO:0070933),-0.6586964358652287,-1.420958772547301,0.07321772639691715,0.39873478648238114,1.0,6/10,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT2;SMARCAD1
prerank,endothelial cell proliferation (GO:0001935),-0.5558317938414348,-1.4203768877178078,0.076171875,0.3990038480884398,1.0,7/17,6.10%,TEK;DLG1;BMPR2;BMP4;CD34;BMPER;ACVRL1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5023001042903016,-1.420171560571993,0.05961538461538462,0.39835805640071137,1.0,7/26,9.13%,EYA2;EYA1;EYA4;MAP2K5;AKT1;MCL1;PPP2R1B
prerank,negative regulation of interleukin-1 production (GO:0032692),-0.5224089516644634,-1.4199146302852077,0.07627118644067797,0.3978337343012738,1.0,5/23,15.89%,IGF1;GAS6;ZC3H12A;GIT1;CEACAM1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),0.6608403541752489,1.4197845324171783,0.14925373134328357,0.6603109499543345,1.0,3/12,8.17%,IL1B;CARD9;IL12RB1
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),0.5653908706459828,1.4195349946961586,0.12825278810408922,0.6587658944115622,1.0,9/31,17.60%,PTEN;BTRC;MAGEC2;CDC14B;SKP1;BMI1;RAB1A;DCUN1D2;GORASP1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),-0.413400585166645,-1.4190744776095388,0.028132992327365727,0.3988601052136149,1.0,27/69,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;FZD5;CLU;SPHK2;CCR2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.5850301869806954,-1.4185021336605603,0.0900735294117647,0.39929924360217933,1.0,9/14,28.64%,LRRK2;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;BCL2L1;PRKN;SYVN1
prerank,cellular response to glucagon stimulus (GO:0071377),0.6173291895579924,1.4173889669810913,0.11479028697571744,0.6626101092422555,1.0,9/17,10.18%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,endoderm formation (GO:0001706),0.5523313794445512,1.4173775228272223,0.09426987060998152,0.6604367699282363,1.0,8/35,5.23%,ITGA4;ITGA7;VTN;TBX20;NODAL;MMP15;ITGB5;LAMB1
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.6515326517624268,1.4173762054564383,0.13882863340563992,0.6582571106215425,1.0,3/14,1.63%,ITGA4;RGCC;GPER1
prerank,protein export from nucleus (GO:0006611),-0.5074928461304512,-1.4173193314144579,0.06889352818371608,0.40117421748290116,1.0,12/27,20.51%,RANBP3L;SMURF1;CCHCR1;DUSP16;TGFB1;RAN;CALR;PKD1;STYX;TPR;CHP1;NUP214
prerank,regulation of response to biotic stimulus (GO:0002831),-0.502039295373415,-1.4169800348218975,0.05042016806722689,0.4008768328089232,1.0,11/28,13.27%,FOXP1;CD55;APPL2;IRF1;ERAP1;BIRC3;RNF135;CASP8;SAMHD1;GATA6;LRP8
prerank,regulation of DNA repair (GO:0006282),-0.4566595859980255,-1.4164706189261198,0.05301204819277108,0.40112405459389233,1.0,17/44,25.15%,EYA2;EYA1;EGFR;EYA4;PML;CEBPG;POLH;CDK9;SIRT7;NPAS2;BABAM2;RAD52;BABAM1;WRAP53;RNF8;BRCA1;RPS3
prerank,exit from mitosis (GO:0010458),0.6600407898841729,1.4163058916631008,0.16778523489932887,0.6590166345010761,1.0,2/12,5.26%,EPS8;CLASP2
prerank,regulation of interleukin-4 production (GO:0032673),-0.5346588755856424,-1.4153664556317387,0.09542743538767395,0.40281203899981816,1.0,8/21,22.36%,LEF1;LGALS9;PRKCZ;SLC7A5;ZFPM1;CEBPB;SYK;RARA
prerank,keratan sulfate catabolic process (GO:0042340),-0.6315673348170062,-1.4145702009843524,0.0948905109489051,0.403677323160266,1.0,8/11,13.98%,OGN;FMOD;HEXA;PRELP;HEXB;LUM;OMD;GALNS
prerank,negative regulation of potassium ion transport (GO:0043267),0.6489683225018394,1.4144745444870508,0.14410480349344978,0.6620236072927292,1.0,5/13,7.70%,CASQ2;NEDD4L;STK39;BIN1;KCNE5
prerank,lipoprotein biosynthetic process (GO:0042158),-0.6272785120763991,-1.414041599177945,0.08253358925143954,0.40398961856981536,1.0,4/11,13.66%,APOE;WIPI2;ATG10;UGCG
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),-0.6053660442220988,-1.4139766633228852,0.08484848484848485,0.40296865742000754,1.0,4/12,5.73%,IQGAP1;PODXL;MAGI2;PROM1
prerank,response to alcohol (GO:0097305),-0.508259876788324,-1.4130958118121135,0.04956896551724138,0.4041292633584069,1.0,4/27,3.45%,TGFBR3;SLIT2;TGFBR2;TGFBR1
prerank,negative regulation of nervous system development (GO:0051961),0.6126785357875132,1.4127926363832113,0.14705882352941177,0.6646250555162226,1.0,5/17,8.16%,NOTCH1;SLIT1;IL1B;ROBO2;HOOK3
prerank,metanephric mesenchyme development (GO:0072075),-0.6351294931845761,-1.411889700145313,0.07664233576642336,0.40612872169389225,1.0,4/10,7.09%,WNT4;OSR1;SIX1;STAT1
prerank,rRNA processing (GO:0006364),-0.36023941817102256,-1.411254347914403,0.010380622837370242,0.4065632489100277,1.0,70/172,25.91%,NSA2;RPLP1;RPS14;RPL9;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;RPL10;BYSL;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;NAT10;TFB1M;ESF1;RPL36A;RRP12;RIOK2;MRPL1;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;RPL13A;FBL;NHP2
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",-0.5218271584460942,-1.4109223859146929,0.07615230460921844,0.40629035952652115,1.0,7/22,13.00%,MAN1C1;RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,regulation of stress fiber assembly (GO:0051492),0.4811571230377199,1.4108565039736591,0.08745874587458746,0.6681302993795211,1.0,11/74,3.09%,DLC1;CARMIL1;ARHGAP6;PIK3R1;RGCC;PHLDB2;PPM1E;FERMT2;ROCK1;WAS;LIMK1
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.47913626625925654,1.4106277614647211,0.08808290155440414,0.6665680405268817,1.0,11/70,5.23%,ITGA4;LAMC3;MEF2C;PIK3R1;LAMC1;PEAK1;FERMT2;RILPL2;ABI2;NTNG2;LAMB1
prerank,regulation of plasminogen activation (GO:0010755),-0.5954666800875554,-1.4104965247972523,0.08396946564885496,0.4061770283104571,1.0,6/12,19.73%,THBS1;CLEC3B;ENO1;SERPINE1;PLGRKT;SERPINE2
prerank,sulfate transport (GO:0008272),-0.5777681242701372,-1.4102200418580866,0.1018867924528302,0.40578143500136266,1.0,3/14,2.95%,SLC13A4;SLC26A7;SLC26A2
prerank,peripheral nervous system development (GO:0007422),0.5920170075711065,1.40969611147089,0.11708253358925144,0.6669757305750543,1.0,4/23,6.50%,SERPINI1;NF1;ASIC2;SCN8A
prerank,dicarboxylic acid transport (GO:0006835),-0.4952558160508872,-1.4091911891728504,0.06666666666666667,0.4072858910521267,1.0,6/28,4.69%,SLC13A3;SLC1A3;PDPN;SLC26A7;GJA1;SLC22A6
prerank,glycogen biosynthetic process (GO:0005978),0.6586738326125428,1.4091129497813206,0.13186813186813187,0.6643115892533836,1.0,2/12,3.23%,PER2;UGP2
prerank,glucan biosynthetic process (GO:0009250),0.6586738326125428,1.4091129497813206,0.13186813186813187,0.6643115892533836,1.0,2/12,3.23%,PER2;UGP2
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.5691977782678472,-1.4088845363067368,0.07847082494969819,0.40700766260410304,1.0,8/15,28.31%,IGF1;AKT1;GPX1;PRELID1;PSMD10;BCL2L1;PRKN;CLU
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5439432946604313,1.4088285022188147,0.1303538175046555,0.6628905467021534,1.0,10/37,9.82%,PTEN;MEF2C;PRKG1;GPER1;LDLRAP1;FGF2;HTR1B;CDKN1A;PDGFB;EFEMP2
prerank,actin cytoskeleton reorganization (GO:0031532),-0.41861754743740553,-1.4084104750475392,0.04488778054862843,0.4071422001992327,1.0,16/63,8.93%,AUTS2;PHACTR1;NRP1;GSN;NEDD9;MCU;SIPA1L1;CXADR;NRK;EZR;PARVB;ANXA1;RHOA;DTNBP1;KIT;EFS
prerank,embryonic digestive tract development (GO:0048566),-0.5488765519776226,-1.407094373823917,0.07924528301886792,0.40949131260503946,1.0,9/18,14.90%,PDGFRA;GLI2;PCSK5;RARB;FGFR2;STRA6;GLI3;ID2;PKDCC
prerank,positive regulation of triglyceride metabolic process (GO:0090208),0.6130977693425493,1.4069053423348605,0.14081632653061224,0.666479891330523,1.0,3/16,3.38%,NR1H3;SCARB1;LDLR
prerank,positive regulation of lyase activity (GO:0051349),0.6478674591105875,1.4063993305015317,0.144,0.6657532501116087,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,response to interferon-beta (GO:0035456),-0.5130508499577127,-1.4061817089885982,0.07551020408163266,0.4106734583369774,1.0,11/22,25.16%,IFITM3;IRF1;IKBKE;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6;PLSCR1
prerank,regulation of cell migration (GO:0030334),-0.32459187187403765,-1.4060851103132752,0.0,0.40970931079127765,1.0,89/382,9.92%,PLXNA2;AFDN;SULF1;IGF1;ROBO1;DAB2;PHACTR1;PDGFD;LDLRAD4;EPHA4;DPYSL3;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;LMO4;CLIC4;PDPN;SEMA3D;IGFBP5;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;FOXO3;PODXL;RECK;PLXNA4;SLIT2;F3;CAV1;ITGA6;MACF1;CLDN5;PODN;SASH1;THBS1;PTPRJ;IGF1R;TGFBR1;MAGI2;SEMA7A;NKD1;ARSB;SRGAP3;SRGAP2;ANXA1;CSF1;ADAM9;SMAD7;CDH1;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;APPL2;SCAI;ACE;ACVRL1;SYNE2;RHOA;PTK2B;CYP1B1;RHOB;STAT3;HSPA5;SH3RF2;SEMA3E;TMSB4X;ACTG1;TBCCD1;TIAM1;MMP14;PLXND1;AKT1;KIT;ADAM15;ZMYND8;TWIST2;CDH13;FLCN
prerank,regulation of monooxygenase activity (GO:0032768),-0.49973195247807634,-1.4055682884904908,0.07630522088353414,0.4098977528403822,1.0,8/23,9.96%,EGFR;POR;CAV1;NOS3;DDAH1;NOS1AP;AKT1;LYPLA1
prerank,positive regulation of signaling (GO:0023056),0.5387102113212169,1.4052415053255782,0.13953488372093023,0.6669679281705299,1.0,11/37,12.33%,CLSTN1;ECE1;NMU;RIMS1;CLSTN3;RIMS2;SNCA;SYT1;KCTD13;WLS;GRIK2
prerank,positive regulation of ruffle assembly (GO:1900029),0.634984007439711,1.4050139303792042,0.15611814345991562,0.6654941906907411,1.0,3/13,7.15%,EPS8;EPS8L1;HRAS
prerank,negative regulation of secretion by cell (GO:1903531),0.5281595268185485,1.404669312678796,0.13043478260869565,0.6642865375903512,1.0,5/38,6.29%,GRM7;NOTCH1;RHBDF1;HTR1B;SNCA
prerank,regulation of protein import into nucleus (GO:0042306),-0.4728672991413976,-1.4039960262704951,0.05739514348785872,0.4129166906694985,1.0,12/36,13.01%,SMAD3;MDFIC;APOD;SUFU;BMP4;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,sphingosine metabolic process (GO:0006670),-0.555801176901698,-1.4027399470980964,0.07392996108949416,0.41514778201031655,1.0,7/17,14.17%,PLPP3;ACER2;NAAA;ACER3;PLPP1;SPHK1;SPTLC2
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.4065452740325614,-1.4017233341324258,0.0488997555012225,0.41682263777481576,1.0,21/79,10.24%,SULF1;ADAMTS12;SMAD6;SKIL;SLIT2;HTRA3;BMPR2;SMURF2;THBS1;SMAD9;SMAD7;SKI;NIBAN2;SULF2;BMPER;SMURF1;NBL1;VWC2;HGS;EMILIN1;DAB2IP
prerank,positive regulation of vasculature development (GO:1904018),-0.3882041685291754,-1.4012870817384373,0.020172910662824207,0.4168769748693471,1.0,32/94,13.40%,ANXA3;FLT1;CDH5;PTGIS;CTSH;TEK;F3;PLCG1;ITGB8;SASH1;NOS3;THBS1;RAMP2;CD34;VEGFD;VEGFC;FGF1;WNT5A;PRKCB;CYP1B1;RHOB;HK2;PIK3R6;TIE1;HIF1A;ECM1;ZC3H12A;KDR;GATA2;SMOC2;GATA6;SPHK1
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5892062840467486,-1.400774432959886,0.10261194029850747,0.41704599725084845,1.0,3/13,6.46%,SORBS1;IGF2;PRKCZ
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),-0.4899336890071857,-1.400489900733798,0.0636182902584493,0.41658805445222835,1.0,9/29,14.82%,IL31RA;IL15;GHR;SOCS2;STAT2;STAT1;STAT3;FER;PKD1
prerank,regulation of cartilage development (GO:0061035),0.6134997047398845,1.4002060594080081,0.1336116910229645,0.6746280315372531,1.0,3/18,1.50%,SOX5;MBOAT2;TRPS1
prerank,phospholipid homeostasis (GO:0055091),-0.6083534710377888,-1.39947761232357,0.11068702290076336,0.4183115084658662,1.0,3/11,8.29%,ABCA1;RCN3;TLCD2
prerank,negative regulation of immune response (GO:0050777),0.43357934941930065,1.3991990351911128,0.05113636363636364,0.6753425836713169,1.0,19/154,6.93%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;ADORA2A;MYH9;PRKAR1B;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;CD300A;NPSR1;PRKAR2B;CACTIN;GPR45;ADCY9
prerank,protein localization to cell-cell junction (GO:0150105),-0.5687553598480036,-1.3990230054096853,0.09433962264150944,0.4181638922981349,1.0,7/15,13.85%,CDH5;TJP2;LSR;ACTG1;F11R;ARHGEF18;ACTB
prerank,negative regulation of secretion (GO:0051048),0.653995595512385,1.398954570254182,0.12472647702407003,0.673970116674054,1.0,2/10,2.80%,NR1H3;NRG1
prerank,cell junction assembly (GO:0034329),0.45769586255504463,1.3988814438881003,0.06636500754147813,0.672071161179924,1.0,20/100,7.13%,GJC1;PTEN;LIMS1;ADGRL3;CDH2;FARP1;VASP;FERMT2;PCDHB11;NRXN1;SH3BP1;DNER;GJA4;RYK;CDH8;CDH22;FBLIM1;CDH19;CDH20;CDH7
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),-0.4021352003706174,-1.3983432656430463,0.03367875647668394,0.4187301646941111,1.0,28/73,28.70%,APP;LBP;THBS1;PTPRJ;ARHGEF2;LGALS9;WNT5A;STAT3;IL33;OAS2;MAVS;EPHB2;CYBA;PLCG2;ARFGEF2;TLR4;RIPK1;SYK;TYROBP;LPL;CCL19;SETD4;TWIST1;BCL10;FZD5;CLU;SPHK2;CCR2
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),0.6241942986938585,1.3983111959911931,0.12391304347826088,0.6715396697249427,1.0,7/16,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;AKAP6;FGF2
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.5870989660804001,-1.3976252184397084,0.09233791748526522,0.4193944854647738,1.0,8/13,12.24%,BMP7;NR3C1;ESR1;BMP4;NR3C2;AR;PGR;PLPP1
prerank,mitochondrial membrane organization (GO:0007006),-0.4764278902018504,-1.3973548612888398,0.09710743801652892,0.4190189160634572,1.0,15/32,29.59%,MICOS10;MTX2;SLC25A4;SPG7;BNIP3;APOOL;CHCHD6;MICOS13;MAIP1;RCC1L;HSPA9;BCL2L1;TIMM50;DNAJC11;MTX3
prerank,cardiac muscle cell contraction (GO:0086003),0.5996578794738378,1.3971135082363988,0.1328125,0.6729029763890858,1.0,6/19,7.38%,CACNA1C;FGF12;PIK3CA;CACNA2D1;SCN5A;CACNA1D
prerank,regulation of stem cell proliferation (GO:0072091),-0.5511009091324234,-1.3969757346007565,0.07462686567164178,0.418928902464706,1.0,4/17,5.89%,FBLN1;GJA1;YAP1;ACE
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6355809727798069,-1.3969515922036777,0.08097928436911488,0.4178482725279605,1.0,5/10,25.06%,BMP4;IRF1;GLI3;MDK;LAG3
prerank,positive regulation of ATPase activity (GO:0032781),0.5338641381536964,1.3956582127525954,0.12589928057553956,0.6750668003258822,1.0,7/41,9.11%,DYNLL1;FXYD2;ATP1B2;RYR2;MYL3;FGF10;MSH3
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.5677895691171488,-1.395512442505729,0.08712871287128712,0.4204239819395812,1.0,7/16,16.32%,APOD;PDCD4;APPL2;ADCY7;ZC3H12A;PPARA;SIRPA
prerank,regulation of RIG-I signaling pathway (GO:0039535),-0.5527887463148371,-1.3954828242613646,0.07706766917293233,0.4193602713280542,1.0,7/18,20.27%,DDX60;BIRC3;USP15;PUM1;RNF125;NPLOC4;SEC14L1
prerank,regulation of sprouting angiogenesis (GO:1903670),-0.4721530974016461,-1.3952727310356479,0.08333333333333333,0.41890240283114866,1.0,15/33,17.85%,GLUL;SEMA6A;ADAMTS9;THBS1;ITGA5;KLF4;KLF2;FGF1;BMPER;PIK3CB;PPP1R16B;RHOJ;CREB3L1;CEACAM1;PDPK1
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.38399890874226966,-1.3949750288698117,0.026525198938992044,0.41851616873930203,1.0,31/95,11.10%,UST;EXT1;CHST11;ST3GAL4;DCN;B4GALT1;ST3GAL6;CEMIP;OGN;FMOD;ST3GAL1;HS3ST3A1;ST3GAL2;ANGPT1;NDST1;CSGALNACT1;HSPG2;CHSY1;BGN;HEXA;SDC4;ST3GAL3;HS6ST1;PRELP;GLCE;HS3ST3B1;LUM;PXYLP1;OMD;CHST15;DSEL
prerank,lipid translocation (GO:0034204),-0.5169281074919182,-1.3949591250552644,0.08704453441295547,0.4174391331925388,1.0,8/21,17.16%,ABCA1;ATP10A;ABCA4;ATP9A;ATP8A1;TMEM30A;ATP11A;ATP11B
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.6099246504892278,-1.3945828857891565,0.09404990403071017,0.4172593026699804,1.0,3/11,10.02%,DAB2;EZR;RAB21
prerank,female gamete generation (GO:0007292),0.5624802720416966,1.3940629563775033,0.11984282907662082,0.6777154869680914,1.0,6/29,7.87%,DIAPH2;PTN;BCL2L10;FMN2;MEI4;NANOS1
prerank,membrane assembly (GO:0071709),0.5577308642159735,1.3933732329987105,0.12284069097888675,0.6775052178994573,1.0,10/34,11.13%,PTEN;CEL;RFTN1;NRXN1;SPTBN1;ANK3;EMP2;IL1RAPL1;UBXN2B;STX4
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),0.5878627406417848,1.392258409525497,0.1384928716904277,0.6784998696637977,1.0,6/19,4.24%,TBX2;MEF2C;NOTCH1;TBX20;ERBB4;FGF2
prerank,heart development (GO:0007507),0.4330536626837794,1.391588195620834,0.0693815987933635,0.67838667028105,1.0,15/150,3.07%,DLC1;ADAP2;CACNA1C;PTEN;PLCE1;TBX2;MEF2C;BMP5;NOTCH1;PTK2;NF1;FGF12;ERBB4;UTY;ECE1
prerank,"synaptic transmission, cholinergic (GO:0007271)",0.5858677485244694,1.391478940938484,0.13279678068410464,0.6765938762352268,1.0,7/19,9.04%,RAPSN;CHRNA3;CHRNA7;CHRFAM7A;ACHE;SLC5A7;COLQ
prerank,response to glucagon (GO:0033762),0.5967090687793056,1.3911206112865433,0.12391304347826088,0.6756359898018756,1.0,9/19,10.18%,CYSLTR2;PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,negative regulation of synaptic transmission (GO:0050805),0.5776981642746918,1.3911194313187163,0.13740458015267176,0.6735947934580632,1.0,5/23,8.09%,PTEN;IL1B;SLC24A2;ATAD1;ACHE
prerank,positive regulation of heart rate (GO:0010460),0.6159135204454507,1.3909191675073151,0.164,0.6720347079076602,1.0,3/17,6.59%,PDE4D;RYR2;ATP2A2
prerank,regulation of establishment of cell polarity (GO:2000114),-0.549149795442818,-1.3906331900472488,0.09293680297397769,0.42656482079792235,1.0,5/16,6.79%,CDH5;ROCK2;GSN;RAP1B;PTK2B
prerank,negative regulation of Wnt signaling pathway (GO:0030178),-0.34746353208310965,-1.3902940752871067,0.014234875444839857,0.42632299466795964,1.0,45/186,14.36%,NXN;MCC;DAB2;TRABD2B;IGFBP2;BICC1;WWOX;TMEM64;VGLL4;DKK3;APOE;CAV1;RNF213;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;NFATC1;MLLT3;RNF43;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;MDFI;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,response to cytokine (GO:0034097),-0.35939948026510593,-1.3900356537792857,0.013651877133105802,0.425821300584292,1.0,27/141,7.33%,TIMP3;DPYSL3;ALDH1A2;AFF3;COL3A1;SMAD3;NFAT5;PTPN14;PTPN13;HDAC4;SP100;APP;IL1R1;IL6R;IL6ST;TIMP2;ANXA1;ADAM9;LEF1;ADAM10;IRAK2;IFITM3;LGALS9;IKBKE;RHOA;STAT1;STAT3
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),0.5836263747223125,1.3899546207304785,0.1316793893129771,0.6727189478353934,1.0,7/25,8.91%,TRPC6;DMD;STK39;ATP1B2;ANK3;PDZK1;STAC
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5629299606025411,1.389912568992842,0.13663366336633664,0.6708253383416093,1.0,3/23,3.57%,CASQ2;ATP1A2;CACNA2D1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.5954763129949063,1.389817027945592,0.14591439688715954,0.6691379591210573,1.0,2/20,1.01%,PDE4D;RAPGEF2
prerank,regulation of peptidase activity (GO:0052547),-0.5297767837709536,-1.3896119851824134,0.10655737704918032,0.4258520602353865,1.0,6/19,12.12%,CTSH;CAV1;RCN3;CST3;ECM1;HDAC1
prerank,filopodium assembly (GO:0046847),-0.5624577751557525,-1.3890196610126704,0.09861932938856016,0.4262782206117601,1.0,6/16,10.58%,FGD5;FGD6;EZR;SRGAP2;DNM3;FGD4
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.5001263843645131,-1.3888962876259192,0.10526315789473684,0.4254891298219073,1.0,10/24,17.31%,EPHA4;APOE;CTSC;TMF1;PTK2B;PSME2;UBB;PKD1;PSME3;GPX1
prerank,regulation of monocyte differentiation (GO:0045655),0.6238495398749435,1.3882908524709985,0.17446808510638298,0.6714007691834953,1.0,2/14,1.10%,IL34;CDK6
prerank,sulfation (GO:0051923),-0.62398248426508,-1.3882741800924665,0.09506398537477148,0.4259140057092014,1.0,1/11,0.04%,UST
prerank,modification-dependent macromolecule catabolic process (GO:0043632),-0.6347915613940085,-1.388252001771773,0.08664259927797834,0.42486933830073376,1.0,5/10,14.35%,TUT4;TUT7;CHFR;UBB;NEDD8
prerank,regulation of osteoblast differentiation (GO:0045667),-0.39173004072004924,-1.3880781085951388,0.03926701570680628,0.424277059442507,1.0,25/82,9.61%,BMP6;RANBP3L;IGF1;SMOC1;SMAD6;WNT4;BMP7;TMEM64;IL6R;HDAC7;SUFU;FGFR2;BMPR2;BMP4;IL6ST;DDX5;ACVR1;ZHX3;SKI;YAP1;FBN2;NOCT;ATRAID;TWIST2;CCN4
prerank,protein O-linked glycosylation (GO:0006493),-0.3848082606358313,-1.388008641117068,0.03513513513513514,0.42334406930125035,1.0,17/96,11.41%,TMTC1;GXYLT2;ST3GAL4;LARGE1;TMTC4;ST3GAL1;ST3GAL2;EOGT;PLOD2;TMTC2;ST3GAL3;TET3;RXYLT1;ST6GALNAC2;GALNT12;POGLUT1;POGLUT2
prerank,negative regulation of blood coagulation (GO:0030195),-0.4638254350019266,-1.3865874608687048,0.06526315789473684,0.42570256481959384,1.0,7/38,4.57%,PDGFRA;SERPING1;APOE;F3;NOS3;THBD;CD34
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.6272648707660493,-1.3863300086017336,0.10505836575875487,0.425312722218155,1.0,2/10,1.96%,ABCA1;APOE
prerank,carnitine metabolic process (GO:0009437),-0.5922401178707443,-1.3860629662068706,0.10344827586206896,0.42494223995036357,1.0,5/12,17.19%,CPT1A;CPT2;TMLHE;ACADL;CPT1C
prerank,nucleoside catabolic process (GO:0009164),-0.6035286319136977,-1.3860505309761433,0.10311284046692606,0.423867212419319,1.0,6/11,18.32%,DPYD;UPP2;UPB1;NT5E;DERA;NT5C1A
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.6423514508910264,1.3857124706474806,0.17410714285714285,0.6764531547891499,1.0,2/11,4.97%,LIMD1;AJUBA
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.6462023269369733,1.3855332650924532,0.14743589743589744,0.6749467109704077,1.0,2/11,1.63%,MEF2C;GPER1
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),-0.4747610928370849,-1.3851077015862325,0.07276507276507277,0.4253142794723285,1.0,8/28,13.00%,NOD1;IRAK2;LACC1;MAP2K6;IRGM;CASP8;RELA;UBB
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.572411457677622,-1.3851054884862553,0.09363295880149813,0.42422946744284273,1.0,9/14,28.90%,SEMA7A;WNT5A;KIT;MAVS;PLCG2;TICAM1;NR4A3;BCL10;LAPTM5
prerank,regulation of osteoblast proliferation (GO:0033688),-0.5503479827479087,-1.3851005734453308,0.099609375,0.42317023388385333,1.0,8/17,13.91%,NPR3;FGFR2;MN1;RHOA;ATRAID;TMEM119;CCN1;SFRP1
prerank,negative regulation of biomineral tissue development (GO:0070168),0.5869485032481307,1.3849724717293768,0.15338645418326693,0.6744070030259721,1.0,4/21,2.15%,ASPN;HEY2;NOTCH1;ROCK1
prerank,endoderm development (GO:0007492),0.6290090197706872,1.3849097796062184,0.1522633744855967,0.6725628928194453,1.0,2/13,1.71%,TBX20;LAMC1
prerank,regulation of catabolic process (GO:0009894),0.5919683303922694,1.3845122615744805,0.14258188824662812,0.6716319876683845,1.0,4/18,9.18%,FAP;NEDD4L;ITGB1;ZDHHC2
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.5645218390679966,-1.3838096605969241,0.08823529411764706,0.42540143487973714,1.0,8/14,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;ERH;CAD;NT5C
prerank,mitochondrial outer membrane permeabilization (GO:0097345),-0.5884757757382674,-1.3833043107383842,0.1111111111111111,0.42561997792534345,1.0,3/13,13.81%,BCL2L11;BNIP3L;BNIP3
prerank,negative regulation of reproductive process (GO:2000242),-0.5492971347252571,-1.382582188030522,0.09221311475409837,0.42653026880496037,1.0,6/17,14.41%,SULF1;IGF1;GJA1;DUSP1;CALR;PAEP
prerank,regulation of smooth muscle cell proliferation (GO:0048660),-0.43940503224023064,-1.3820082239098994,0.059602649006622516,0.42701675692064717,1.0,16/46,10.32%,IGF1;FOXP1;ELN;IGFBP5;OGN;IL6R;APOD;THBS1;BMP4;TCF7L2;IGFBP3;STAT1;AKT1;CCN4;CDH13;IL18
prerank,cellular iron ion homeostasis (GO:0006879),-0.420087107271497,-1.381867110334224,0.05755395683453238,0.4263396154791165,1.0,23/55,28.79%,BMP6;CP;SCARA5;ABCG2;SLC39A14;TFRC;ATP6V1G1;ACO1;FTL;NEDD8;ATP6V0A2;HFE;CYB561A3;FRRS1;FTH1;NUBP1;CCDC115;TMEM199;SMAD4;ATP6AP1;ALAS2;ATP6V0D1;ATP13A2
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),0.4943085166578767,1.3816248547627883,0.11557788944723618,0.6776377446537085,1.0,11/57,9.85%,GRM7;ADCY8;ADCY3;ADCY6;HTR1B;OPRK1;ADCY9;GPR37;AKAP12;GRM4;NPY1R
prerank,ribonucleoprotein complex biogenesis (GO:0022613),-0.4187421996681535,-1.3814759300252493,0.06864988558352403,0.42626614507535593,1.0,23/57,22.78%,GLUL;SDAD1;RPS19;NAF1;RPL11;CUL4A;PAK1IP1;RPS16;RPS24;RPL14;RPL26;BYSL;RPL7;RPS15;RPS6;EBNA1BP2;RBIS;RPS25;RPS7;RPL38;RIOK2;URB2;RPL35A
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.3232123654493064,-1.380939567087866,0.0,0.4265950226134758,1.0,87/390,10.62%,FLRT2;SULF1;IGF1;SORBS1;PDGFD;EPHA4;PLCB1;EPHA3;EGFR;FLT1;EFNB2;COL1A1;NRP2;MTSS1;ROCK2;EPHA7;PDGFRA;NRP1;NTRK3;IL31RA;RHOQ;TEK;RBFOX2;NEDD9;FOXO1;ELMO1;SIPA1L1;FGFR2;VAV2;ANKS1A;CYFIP2;PTPRJ;EPHB4;IGF1R;MPZL1;SHB;ANGPT1;BAIAP2;YES1;FOXC2;GHR;CSF1;AP3S1;PXN;SOCS2;ATP6V0A4;COL4A6;ARHGEF28;VEGFD;SDCBP;VEGFC;IGF2;SLC39A14;AP2A2;FGF1;SULF2;PTPRG;EFNA5;DDR1;BDKRB2;RHOA;MAPK14;PTK2B;KL;FOXC1;STAT3;NAMPT;EFNB1;ACTG1;RAPGEF1;ARPC2;POLR2A;ATP6V1G1;PIK3CB;TIAM1;AKT1;TIE1;KIT;EFS;FRS2;EPHA8;GRB14;IDE;ATP6V0B;FGFBP1;ARPC1B;KDR
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.43651608003921893,-1.3807069007565318,0.05803571428571429,0.4261707809950991,1.0,23/50,27.32%,SH3RF1;USP47;THBS1;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;PARK7;LAMTOR5;MT3;PLAUR;RFFL;VEGFA;PIH1D1;RPS6KA3;YWHAE;CD44;CDKN2D;PAK2;SFN
prerank,B cell proliferation (GO:0042100),0.6112418606296921,1.3806910337595426,0.16872427983539096,0.6782022467983371,1.0,1/17,0.63%,MEF2C
prerank,regulation of fat cell differentiation (GO:0045598),-0.39933136052799223,-1.3806700432833354,0.05585106382978723,0.42521163947132323,1.0,28/74,19.25%,SMAD3;ZBTB16;MEDAG;TMEM64;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;SYAP1;NOCT;TRIO;WDFY2;AKT1;CMKLR1;CARM1;ANKRD26;ZC3H12A;GATA2;TGFB1;ID2;SFRP1;FTO;ZFPM1;SIRT2;CEBPB;ZFP36L2;E2F1
prerank,bile acid metabolic process (GO:0008206),0.5699088004240438,1.3804630709942185,0.1324376199616123,0.6769068189489219,1.0,5/27,6.00%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6
prerank,cardiac muscle cell development (GO:0055013),0.6049957031185854,1.3803282281365494,0.158004158004158,0.675310356423435,1.0,3/20,2.04%,PDGFRB;HEY2;MYH11
prerank,stem cell development (GO:0048864),0.598515478765143,1.3797167161740616,0.14502164502164502,0.6750209508559984,1.0,4/16,11.05%,CDH2;NRG1;KLHL12;SNAI2
prerank,regulation of cellular biosynthetic process (GO:0031326),-0.4815485469478392,-1.379707786023549,0.08704453441295547,0.4266957503844452,1.0,9/28,16.32%,PRKAG2;ADIPOR2;TNFRSF1B;CD47;NOS1AP;AVIL;FGFR4;PRKAA2;SIRPA
prerank,regulation of B cell receptor signaling pathway (GO:0050855),-0.5225806928870682,-1.3789693470028925,0.09561752988047809,0.4275351547186591,1.0,6/21,6.61%,FOXP1;PRKCH;ELF2;ELF1;SLC39A10;PRKCB
prerank,positive regulation of macroautophagy (GO:0016239),-0.43875717327515207,-1.3786390128477488,0.06378132118451026,0.42744870691350223,1.0,20/48,19.70%,DCN;HSPB8;RAB3GAP1;VPS13D;SLC25A4;BAG3;IRGM;KDR;PIP4K2B;OPTN;BNIP3L;SH3GLB1;UVRAG;LARP1;BNIP3;SPTLC2;PRKAA2;RAB3GAP2;ADRB2;IKBKG
prerank,positive regulation of brown fat cell differentiation (GO:0090336),-0.5860847225029845,-1.3785019405921501,0.10766423357664233,0.4267922129063742,1.0,6/13,11.61%,BMP7;SOX13;SIX1;RREB1;METRNL;PTGS2
prerank,cellular response to interferon-beta (GO:0035458),-0.562286607832406,-1.3778307665554401,0.1198501872659176,0.42746217644867573,1.0,8/14,23.98%,IRF1;STAT1;IRGM;UBE2G2;IFITM2;PNPT1;NDUFA13;TRIM6
prerank,positive regulation of lamellipodium organization (GO:1902745),0.5373242385380683,1.3777610155610869,0.14233576642335766,0.6782932462181676,1.0,5/32,3.65%,CARMIL1;PLCE1;PIK3R1;PIK3CA;ABI2
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.5430660554479888,-1.3776559253421408,0.09572301425661914,0.42683643972810803,1.0,11/18,13.39%,JCAD;HDAC7;FOXC2;ANXA1;HDAC9;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2
prerank,neuropeptide signaling pathway (GO:0007218),0.5024079048650535,1.3775979335153063,0.11519198664440734,0.6767990988129,1.0,9/58,11.05%,CYSLTR2;RAPGEF2;SORCS1;NMU;SORT1;OPRK1;GPR37;NXPH4;NTSR1
prerank,protein depolymerization (GO:0051261),-0.4886944063107354,-1.3775769253014496,0.09819639278557114,0.42601036079241644,1.0,3/27,1.88%,MICAL3;GSN;MICAL2
prerank,regulation of membrane repolarization (GO:0060306),0.6383445315912354,1.3774508013838929,0.16736401673640167,0.6752519996228887,1.0,5/13,7.70%,CASQ2;NEDD4L;CACNA2D1;AKAP6;KCNE5
prerank,receptor clustering (GO:0043113),0.5631649040378747,1.3770538502108562,0.14015151515151514,0.6743526834903356,1.0,4/27,3.96%,ITGA4;PTN;NRXN1;AGRN
prerank,cellular component assembly (GO:0022607),0.3999684225439452,1.3768662151457136,0.041720990873533245,0.6729487939528845,1.0,34/253,7.90%,MYO1B;LIN7A;EPS8;CALD1;LIMS1;AIF1L;LAMC1;VASP;FERMT2;WASF3;WAS;RSPH6A;LRRTM3;SPEF1;WIPF1;SH3BP1;TTLL3;SPTBN1;JHY;RAC3;WASL;RIMS1;PDCD10;GAS8;YTHDF3;ANK3;FBLIM1;YWHAZ;PLS3;RSPH1;LRGUK;DARS1;REC8;TEX12
prerank,ncRNA processing (GO:0034470),-0.34511273719259167,-1.3750728088190116,0.007352941176470588,0.43155010099008767,1.0,74/200,25.83%,SMAD3;RPLP1;RPS14;RPL9;TUT4;TUT7;RPL41;RPL18A;RPS19;UTP14A;RPL13;RPL18;RPS9;RPL34;RPL32;KRR1;UTP11;RPL27A;RPL12;RPL37;KARS1;NOP58;RPL11;SENP3;RPL39;RPS16;RPL24;UTP6;RPLP2;RPL28;RPS24;RPS27;RPL14;DDX49;RPL26;SARS1;RPL10;BYSL;INTS11;RPL7;RPL10A;RPL22;RPS15;RPS6;EXOSC5;RPL23;RPL17;EBNA1BP2;MPHOSPH6;WDR18;RPL31;RPS25;RPL15;RPS7;RPL38;RPLP0;RPL27;AGO1;ESF1;RPL36A;DICER1;RRP12;RRP7A;LYAR;RPL35A;PIH1D1;MRM2;EXOSC7;RPL8;RPL36;INTS5;RPL13A;FBL;POP1
prerank,lymphocyte migration (GO:0072676),-0.46973338705954515,-1.3746087237876123,0.0880503144654088,0.4316903525086308,1.0,26/32,52.42%,CCL15;CCL14;CCL25;S1PR1;RET;CCL13;CCL19;CKLF;CCL2;CX3CL1;MYO1G;CCL5;CCL11;ZAP70;ADAM8;CCL4;GATA3;CRTAM;CCL7;CCL8;MSMP;CCR6;CCL1;CCL3;TBX21;XCL1
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.4588261034234181,1.3734462374237868,0.10174880763116058,0.6803125647861511,1.0,15/100,4.24%,PDGFRB;PIP5K1B;PTEN;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PIP4K2A;PLXNB1;PIK3CA;NCF1;FGF2
prerank,primary miRNA processing (GO:0031053),-0.6376222574464404,-1.3734241579768898,0.10436432637571158,0.4337264121187317,1.0,1/10,0.62%,SMAD3
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.5908035666635336,-1.3725264644195414,0.10405643738977072,0.43495225870879967,1.0,5/12,22.25%,FOXP1;KLF4;MAP2K5;TLR4;LPL
prerank,embryonic limb morphogenesis (GO:0030326),0.5408667726563974,1.3722327410692863,0.13926499032882012,0.6815174189534275,1.0,5/34,3.07%,CACNA1C;TBX2;MAP3K20;TBX3;ECE1
prerank,positive regulation of cell junction assembly (GO:1901890),0.4860947647488296,1.3720961319364027,0.09424083769633508,0.6799838966413353,1.0,8/56,4.34%,ACE2;LIMS1;CLSTN1;FERMT2;ROCK1;NRXN1;CLSTN3;CNTNAP2
prerank,response to thyroid hormone (GO:0097066),-0.5737216457592381,-1.3719787857148074,0.10912698412698413,0.4354226712371259,1.0,5/13,11.79%,CTSH;THRB;LMO2;CTSB;CTSS
prerank,regulation of synapse assembly (GO:0051963),0.5001690814100042,1.3718591663107167,0.1012216404886562,0.6787286296242425,1.0,17/46,15.09%,MEF2C;CLSTN1;SLIT1;LRFN5;NRXN1;CLSTN3;SNCA;ROBO2;IL1RAPL1;SLITRK1;CUX2;IL1RAPL2;EPHB1;SLITRK2;NLGN3;CHRNB2;SYNDIG1
prerank,smooth muscle cell differentiation (GO:0051145),0.6404098066785721,1.3714355620370877,0.17473684210526316,0.6779955171825796,1.0,2/12,0.68%,MEF2C;HEY2
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),-0.44970634951610816,-1.3710989271375618,0.08533916849015317,0.436619511749219,1.0,14/37,16.55%,APOD;PDCD4;APPL2;ADCY7;MAPK14;STAT3;HIF1A;IL17RA;ZC3H12A;GBP5;PPARA;TICAM1;SIRPA;TLR4
prerank,regulation of protein autophosphorylation (GO:0031952),-0.45476840529055446,-1.370976319935533,0.07777777777777778,0.4358810561566206,1.0,14/36,19.04%,PDGFD;ERRFI1;EPHA7;ENPP1;RASSF2;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC;PPP2R5C;CHP1
prerank,retinol metabolic process (GO:0042572),-0.5788848628212608,-1.3708861437064535,0.11377245508982035,0.4350733703798085,1.0,4/14,13.44%,DHRS3;RBP4;CYP1B1;ADH1A
prerank,purine ribonucleotide transport (GO:0015868),-0.5560185337960913,-1.370317248041452,0.11397058823529412,0.4354986274476037,1.0,5/16,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,microtubule bundle formation (GO:0001578),0.511243727560411,1.3701394172261752,0.12835249042145594,0.6797120328757024,1.0,13/42,11.53%,MTCL1;RSPH6A;SPEF1;TTLL3;NCKAP5;JHY;GAS8;TPPP;RSPH1;LRGUK;CFAP46;CCDC66;KIF20A
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.6429283504123228,1.370105432175271,0.17607223476297967,0.6779083449081809,1.0,4/10,8.96%,NEDD4L;HECW2;STK39;HECW1
prerank,dendritic spine organization (GO:0097061),0.558020428334065,1.3696166427137089,0.15,0.677390454581993,1.0,4/26,6.61%,PTEN;DOCK10;WASL;CHRNA7
prerank,ketone body metabolic process (GO:1902224),-0.6229852125133518,-1.3695954581579537,0.10261194029850747,0.4362894103235685,1.0,4/10,14.75%,ACSS3;HMGCS2;BDH1;BDH2
prerank,regulation of granulocyte chemotaxis (GO:0071622),0.5759259406456122,1.3694596649398794,0.15074309978768577,0.6758914699886704,1.0,3/19,1.44%,IL34;PTK2;JAM3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.6425155516816098,1.368971147153846,0.16488222698072805,0.6752878758261082,1.0,3/10,6.03%,CACNB2;CACNA2D1;PDE4B
prerank,muscle organ development (GO:0007517),0.4965850424459329,1.3684109684111163,0.13,0.6750261500559033,1.0,6/54,1.67%,LAMA2;UTRN;MEF2C;DMD;ITGA7;CACNA1H
prerank,positive regulation of ion transport (GO:0043270),0.5117826612961467,1.3679724011265937,0.11544991511035653,0.674369123498222,1.0,9/48,7.38%,TRPC6;CACNB2;MYLK;STIM2;SCN5A;ANK3;RAB3B;PRSS8;CACNA1D
prerank,negative regulation of T cell proliferation (GO:0042130),0.5380663096102402,1.3678850719891202,0.13333333333333333,0.6727695805961743,1.0,2/28,1.05%,GLMN;TNFRSF21
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6412676226977485,1.367720197122699,0.1702127659574468,0.671333198826949,1.0,4/11,9.27%,HEY2;TBX20;SOX4;JAG1
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.5094065110006157,-1.367355895091457,0.11487758945386065,0.44100021812386103,1.0,11/21,28.64%,LRRK2;BCL2L11;CREB3L1;CREB3;TMBIM6;PARK7;XBP1;EIF2AK3;BCL2L1;PRKN;SYVN1
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.553019208517151,1.3673276028061219,0.14864864864864866,0.6705474492670098,1.0,10/29,13.89%,PTEN;BMP5;IL17RD;SPRED1;SPRY2;HPN;VASN;FUZ;SPRED2;SFRP2
prerank,cellular response to drug (GO:0035690),0.5657616675649747,1.3673135673732004,0.1579961464354528,0.6687569052425871,1.0,5/25,6.03%,MEF2C;PPM1E;IL1B;HTR1B;PDE4B
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.5594080576554691,1.3672338642257378,0.1294559099437148,0.6671948607884679,1.0,5/27,6.77%,MAP3K20;MAP3K5;BTRC;TNIP2;KAT7
prerank,import into cell (GO:0098657),-0.4515562686799073,-1.3670089459953494,0.06888888888888889,0.440978390583627,1.0,11/41,9.26%,SLC6A13;GLUL;SLC47A1;SLC1A3;SLC16A2;SLC6A6;SLC12A7;SLC39A14;SLC22A4;SLC7A5;SLC5A6
prerank,protein import into peroxisome matrix (GO:0016558),0.6151493504613444,1.3668579381795019,0.16780045351473924,0.6663927760358497,1.0,7/12,24.44%,PEX7;PEX5L;PEX1;PEX12;PEX2;PEX5;PEX6
prerank,fatty acid metabolic process (GO:0006631),0.4410660462459458,1.3668125926250354,0.0806697108066971,0.6647295188323865,1.0,15/115,7.27%,GGT5;CEL;GGT1;PER2;ACSF2;ABCD2;SLC27A2;PPARD;BAAT;ACOT12;SLC27A4;PON2;LIPH;LIPC;AOAH
prerank,DNA synthesis involved in DNA repair (GO:0000731),-0.4362088174575697,-1.3665917126208158,0.07051282051282051,0.4410525636114699,1.0,21/42,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;USP10;RPA3;POLA1;CDKN2D;POLD1;ISG15;DTL;WRN;PCNA;PARP10;RFC5
prerank,positive regulation of amyloid-beta formation (GO:1902004),-0.533562575369027,-1.365765215893004,0.109375,0.442210631177108,1.0,3/18,2.68%,EPHA4;ROCK2;SLC2A13
prerank,regulation of neuroinflammatory response (GO:0150077),-0.5240177218089124,-1.3653243646163085,0.09596928982725528,0.442276230331439,1.0,8/19,16.21%,IGF1;NUPR1;TNFRSF1B;IL33;IL18;PTGS2;SPHK1;CD200
prerank,positive regulation of glycolytic process (GO:0045821),-0.5156820311103059,-1.3652302868213568,0.10141987829614604,0.4404327788835371,1.0,6/20,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),-0.5156820311103059,-1.3652302868213568,0.10141987829614604,0.4404327788835371,1.0,6/20,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,atrioventricular valve morphogenesis (GO:0003181),0.5857733193206996,1.3645785371088164,0.16274089935760172,0.6689655544077797,1.0,4/19,1.81%,HEY2;HEYL;NOTCH1;SLIT3
prerank,cardiac atrium morphogenesis (GO:0003209),0.6132608221750756,1.3645443562035868,0.17419354838709677,0.667244207819537,1.0,3/16,1.22%,HEY2;NOTCH1;TBX20
prerank,mitochondrial calcium ion homeostasis (GO:0051560),-0.5100076725086049,-1.3643085100172625,0.10707456978967496,0.44189730007938266,1.0,10/21,19.68%,MCU;TGM2;SLC8A3;RAP1GDS1;MCUB;AFG3L2;MICU2;BCAP31;MICU1;MAIP1
prerank,glucose transmembrane transport (GO:1904659),0.5971885477291389,1.3642009043842198,0.16765285996055226,0.6664362031609077,1.0,7/18,12.50%,SLC5A1;SORT1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,regulation of macrophage cytokine production (GO:0010935),-0.5814567934835562,-1.363819071866011,0.12548262548262548,0.4422729194799116,1.0,5/13,13.39%,SEMA7A;WNT5A;IRAK3;TGFB1;PLCG2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6426499628286572,1.363235449132256,0.18161434977578475,0.6672110831832552,1.0,2/13,1.37%,HEY2;PER2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),-0.5053415889661904,-1.3627945228604863,0.11516314779270634,0.44392016098491055,1.0,13/21,34.04%,FOXP1;PRKCH;SLC39A10;PRKCB;RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;NFAM1;CARD11
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),0.5630282021786941,1.3622282320069812,0.1524390243902439,0.6680987143917744,1.0,2/21,3.42%,SLC30A10;ABCD2
prerank,negative regulation of cell population proliferation (GO:0008285),0.38815180784949455,1.3621247347972154,0.03132832080200501,0.6665692763924341,1.0,36/351,5.65%,DLC1;PTPRK;ITGA1;PTEN;GLMN;FAP;RERG;CBFA2T3;IGFBP7;RAPGEF2;CDK6;BMP5;NOTCH1;COL4A3;PER2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;NODAL;TNS2;NF1;ERBB4;IL1B;PLXNB1;ETS1;SH2B3;MYO16;RPS6KA2;GAS8;CD300A;FABP3;TNFRSF8;TFAP2B
prerank,positive regulation of macrophage chemotaxis (GO:0010759),0.5911935403610649,1.3616432617288747,0.15889830508474576,0.6660919536457305,1.0,2/14,1.34%,IL34;PTK2
prerank,regulation of neurogenesis (GO:0050767),0.4987259532825106,1.361598929488364,0.11921708185053381,0.6644623270256825,1.0,6/55,2.62%,HEY2;HEYL;NOTCH1;PER2;GPER1;IL1B
prerank,intracellular lipid transport (GO:0032365),-0.505530735554643,-1.3614867261473609,0.09274193548387097,0.44626287234818607,1.0,7/21,9.91%,PRKAG2;CERT1;CPT1A;SLC25A20;NPC2;CPT2;ACACA
prerank,positive regulation of macromolecule metabolic process (GO:0010604),-0.318122176289707,-1.3614474397253113,0.004830917874396135,0.4453243410967245,1.0,79/348,12.80%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;F3;WNT6;CLDN5;ITGB8;ANXA2;NOS3;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;MAGI2;KLF4;CSF1;LEF1;KLF2;RAMP2;CD34;HOXA5;SMO;MED26;GAS6;ARRB1;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;SCYL2;MAP2K5;TFRC;ACTG1;DTNBP1;PIK3CB;NOS1AP;AKT1;DTX3L;HGS;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;ID2;ATM;PRKAB1
prerank,positive regulation of interleukin-6 production (GO:0032755),-0.39866302467242515,-1.3610494543613563,0.06735751295336788,0.4452487844453282,1.0,28/68,30.22%,APP;IL6R;LBP;ARHGEF2;IL16;LGALS9;WNT5A;STAT3;IL33;IL17RA;MAVS;CYBA;PLCG2;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;RAB7B;IL17D;MYD88;SETD4;TWIST1;BCL10;SPHK2;F2R;AIF1
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),0.5839761312472872,1.3610107337146815,0.16632443531827515,0.6643730761318932,1.0,5/18,6.61%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7
prerank,regulation of cholesterol esterification (GO:0010872),-0.609737317745242,-1.3606979928066578,0.11376146788990826,0.44518396164369656,1.0,4/10,19.01%,APOE;STARD4;AGT;AGTR1
prerank,supramolecular fiber organization (GO:0097435),-0.3245911156153668,-1.3606170498716121,0.0049504950495049506,0.44434767828105604,1.0,84/333,13.07%,TSPAN5;COL1A2;COL3A1;SNCAIP;COL5A2;COL1A1;ADAMTS2;COL22A1;GSN;COL12A1;RHOBTB1;COL5A1;FIGN;LOXL1;SHROOM2;CD2AP;ELMO1;COL6A3;APP;DLG1;COL25A1;COL6A1;COL8A2;ITGA6;VIM;TLL1;COL4A5;SHROOM3;COL6A2;TGFBR1;PLEC;COL11A1;B2M;CLIP4;ARHGEF2;FBLN5;COL23A1;COL4A6;HSPG2;ADAM10;PLOD2;COL13A1;HDGFL3;ARHGAP17;IAPP;SERPINH1;PGM5;P4HB;SHROOM4;RHOA;COL18A1;CYP1B1;GGA2;FKBP1A;RHOB;H3-3A;FAT1;CST3;ITGB4;TGFBI;TRIOBP;COL14A1;DPT;GFAP;EMILIN1;COL15A1;SPAST;COL16A1;LUM;MAP7D3;MFAP4;ADAMTS14;AVIL;LAMA3;ADAMTS3;COL20A1;MDM2;EVL;ACTN1;COL9A2;TRPV4;CCDC88C;UBB;DNAJB6
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.43824826857541915,1.3605356222167513,0.09188361408882083,0.6639076551956832,1.0,33/118,13.34%,CHN1;MEF2C;PID1;NEDD4L;CDH2;SDC2;HECW2;PHLDB2;FERMT2;NF1;LRRC4C;CDX1;ETS1;CHRNA3;ABI2;FGF2;TSPAN12;CLASP2;EMP2;ADGRB3;MARK2;HECW1;ARHGAP35;ZMYM3;EPHA2;SARM1;BRSK1;PAK3;PAK1;PPFIA2;PHLDB1;RNH1;LZTS1
prerank,alcohol catabolic process (GO:0046164),0.6318644211517888,1.3601804131933894,0.17118997912317327,0.6630925043876471,1.0,2/10,2.20%,CEL;SCARF1
prerank,regulation of glucose transmembrane transport (GO:0010827),-0.5350577988852431,-1.360046377828721,0.11359026369168357,0.4447115662404639,1.0,5/18,9.65%,PRKAG2;OCLN;SLC2A1;PRKCB;C2CD5
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.5561500412633148,1.3599719459143556,0.15678776290630975,0.6619608120401026,1.0,8/24,10.52%,ITPR2;ITPR1;FGF2;HTR2C;RYR2;RYR3;PKD2;CHERP
prerank,regulation of cation channel activity (GO:2001257),0.45493989630860115,1.359946089035599,0.10664605873261206,0.6603001860690338,1.0,24/89,12.89%,PDE4D;MEF2C;DMD;CACNB2;KCNG1;FGF12;CACNG7;FGF13;MINK1;ITGB1;GRIA2;ANK3;KCNE5;STAC;NETO1;GRIN2B;HPCA;DLG2;GSG1L;FGF11;FGF14;PIRT;DLG3;JPH4
prerank,negative regulation of axonogenesis (GO:0050771),0.550410333843631,1.3594039334095114,0.15234375,0.6600878264908282,1.0,4/27,4.23%,PTEN;MAP2;LINGO1;FGF13
prerank,regulation of protein export from nucleus (GO:0046825),-0.5029377902862079,-1.359279435573727,0.1227364185110664,0.44567184228497614,1.0,13/23,25.85%,PTPN14;SP100;TCF7L2;GAS6;IFI27;ANP32B;BAG3;SIRT7;TPR;PARK7;YWHAE;XPO4;TP53
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.6115252537117383,1.3591637890076191,0.17872340425531916,0.6589983145830126,1.0,2/13,2.21%,PLA2R1;SPRED1
prerank,negative regulation of cellular protein catabolic process (GO:1903363),-0.6080839826483442,-1.3591541636053546,0.13163064833005894,0.4449713737792439,1.0,5/10,14.09%,EPHA4;ANXA2;ATRAID;DAB2IP;RGP1
prerank,prostanoid metabolic process (GO:0006692),-0.5787851453893132,-1.3583292816568413,0.10486891385767791,0.44609087563913297,1.0,6/13,24.76%,PTGS1;ACOX1;GSTM1;PTGR2;PTGES;PTGR1
prerank,amino acid transport (GO:0006865),0.5022686819942068,1.3580835104314968,0.1206581352833638,0.6599746235241314,1.0,3/49,2.19%,SLC38A11;SLC1A5;SLC1A4
prerank,regulation of vasculogenesis (GO:2001212),0.6012612468055581,1.357376703876012,0.18699186991869918,0.6601992983253074,1.0,5/14,6.90%,HEY2;RAPGEF2;RIN2;EMP2;RAP1A
prerank,regulation of cell adhesion (GO:0030155),-0.36315379551015803,-1.357326961712838,0.031055900621118012,0.44774288947484037,1.0,32/129,13.68%,PLXNA2;PKP4;EPHA4;ROCK2;EPHA7;FBLN1;PODXL;PLXNA4;TGM2;PTPRJ;ANGPT1;ADAM10;CXCL12;P4HB;ACVRL1;EFNA5;PTK2B;STX3;DUSP1;TGFBI;PLXND1;PPP1CB;CDH13;EPHA8;FLCN;IL18;ARHGDIA;CD164;EPHB2;ATM;CHRD;RET
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.527714460124511,1.3572846878825287,0.15163147792706333,0.6587421327770815,1.0,3/35,1.42%,GGT5;GGT1;GGTA1
prerank,regulation of wound healing (GO:0061041),0.5016829583084309,1.357068789792835,0.13250883392226148,0.6576971774108468,1.0,9/42,7.15%,VTN;AJAP1;PTK2;MYLK;CADM4;FGF2;ITGB1;ARFGEF1;HRAS
prerank,positive regulation of dendrite extension (GO:1903861),0.5901503034763382,1.3570196135367043,0.178714859437751,0.6561254563773474,1.0,5/17,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,adenine nucleotide transport (GO:0051503),-0.538085567503648,-1.3569928105626514,0.12701252236135957,0.4475380291693288,1.0,5/17,10.65%,ABCC4;ABCC6;SLC25A17;SLC25A4;SLC25A24
prerank,branching morphogenesis of an epithelial tube (GO:0048754),-0.4480279086560867,-1.3569266748876627,0.09210526315789473,0.4467020727635301,1.0,13/39,14.82%,NRP1;GLI2;SLIT2;TGFBR2;BMP4;LRP6;RASIP1;SIX1;SEMA3E;TIE1;KDR;MET;PKD1
prerank,negative regulation of gene expression (GO:0010629),-0.3207023343279628,-1.3566731179569547,0.004545454545454545,0.4463530317446294,1.0,87/302,19.18%,NOTCH2;IGF1;ROBO1;SLC24A3;DAPK1;LGR4;SAMD4A;ROCK2;FOXP1;WNT4;IGFBP5;OCLN;APOE;APP;CLDN5;ITGB8;XDH;ESR1;BMP4;DNMT3A;KLF4;KAT2B;TAF1;HDAC9;RBBP7;CD34;ADAM10;SMO;PARP9;CNOT7;WWP2;SRGN;LGALS9;PARP14;YAP1;MOV10;RNF139;ACVRL1;DDX6;SLC7A5;HINFP;RPS13;PGR;H3-3A;NOCT;IGF2BP2;HIF1A;FLOT2;FLCN;EMILIN1;JARID2;ZC3H12A;KDR;ANXA7;TRIM27;GATA2;ERN1;TGFB1;HDAC1;CPEB3;TWSG1;ID2;NUDT12;CALR;ATOH8;LARP1;CNOT8;SFRP1;CREB3L1;FXR2;TMBIM6;BMPR1A;PRKAA2;ASB1;PPHLN1;PNPT1;TNRC6A;PAIP2B;LSM5;PARK7;EIF4E2;TYMS;EZH2;PTBP3;ZFP36L2;PTRH2;AGO1
prerank,purine nucleotide metabolic process (GO:0006163),-0.4855600426233992,-1.356499837497026,0.09836065573770492,0.44583306122677163,1.0,12/24,25.02%,FHIT;XDH;PRPS2;NT5E;GDA;GPX1;PRPS1;PRPS1L1;NT5C1A;PNP;NT5C2;NT5C
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.48293327687306886,-1.3564362502943457,0.09492273730684327,0.4450167609592211,1.0,15/27,22.34%,SLC47A1;SLC1A3;SLC7A2;SLC6A9;SLC7A5;SLC25A38;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC22A2;SLC25A29;SLC1A1;SLC38A1
prerank,gland development (GO:0048732),-0.4126898226184839,-1.3564292631448405,0.057279236276849645,0.4440273614173688,1.0,14/59,8.16%,TGFBR3;WNT4;GLI2;DKK3;CAV1;FGFR2;EZR;TGFBR1;IGSF3;ANXA1;LSR;SIX1;TBX1;STRA6
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5148733642903053,1.3550631451521102,0.1349911190053286,0.6596429200561733,1.0,12/41,10.52%,ITPR2;TRPV2;CACNA2D1;ITPR1;FGF2;SLC24A2;HTR2C;RYR2;RYR3;PKD2;GRIN2B;CHERP
prerank,positive regulation of phospholipid transport (GO:2001140),-0.6135669257842135,-1.355010256472268,0.12727272727272726,0.4466583406359331,1.0,5/10,21.92%,APOE;ABCA3;TMEM30A;PRELID1;DBI
prerank,positive regulation of cell motility (GO:2000147),-0.3341229373718141,-1.3548381355839183,0.014814814814814815,0.4460945891909692,1.0,75/205,17.56%,IGF1;DAB2;PDGFD;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;ITGA6;THBS1;IGF1R;TGFBR1;SEMA7A;CSF1;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;SPOCK2;SYNE2;CAVIN1;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;TWIST2;CDH13;KDR;MYOC;TGFB1;SEMA3B;TRIP6;WNT5B;EPHB2;ATM;CCN1;SPHK1;FER;RET;MAZ;WASHC1;CLDN1;SNAI1;CXCL16;LAMC2;NTN1;RUFY3;SEMA3G;SEMA6B;CD151;WNT11;PDGFC;ROR2
prerank,retinoid metabolic process (GO:0001523),-0.3929702995934919,-1.3547429669819369,0.06459948320413436,0.44533519375040254,1.0,14/71,9.48%,ALDH1A1;ALDH1A2;RBP1;APOE;CYP26B1;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;CYP1B1;ABCA4;STRA6;SCPEP1
prerank,regulation of lipid biosynthetic process (GO:0046890),-0.4602782106459268,-1.354613389091423,0.09856262833675565,0.44466679737114795,1.0,9/32,15.89%,PRKAG2;SORBS1;APOE;ADIPOR2;AKT1;AVIL;PPARA;PRKAA2;CEACAM1
prerank,regulation of amyloid-beta formation (GO:1902003),-0.4566714093231726,-1.3533928718269035,0.10810810810810811,0.4467534183263026,1.0,5/34,2.68%,IGF1;EPHA4;ROCK2;APOE;SLC2A13
prerank,regulation of receptor internalization (GO:0002090),-0.4586827018632143,-1.3532735995425584,0.07692307692307693,0.4460723818540646,1.0,16/35,28.11%,RIN3;ANGPT1;MAGI2;SDCBP;ARRB1;SFRP4;SCYL2;ATXN2;ANKRD13D;VEGFA;NTF3;CD63;ANKRD13A;TBC1D5;PICK1;MKLN1
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3915866435907271,-1.3527029106541475,0.06493506493506493,0.44652062482360827,1.0,30/77,25.65%,IGF1;SH3RF1;ITGA6;THBS1;BMP4;TGFBR1;TCF7L2;ACVR1;CFLAR;AR;AKT1;MCL1;NR4A2;RELA;QARS1;MAZ;TMBIM6;PSME3;RIPK1;GPX1;PRELID1;PARK7;PLAUR;ZMYND11;NDUFA13;PIH1D1;TMEM14A;PSMD10;BCL2L1;PRKN
prerank,cellular potassium ion homeostasis (GO:0030007),0.6306576238527438,1.3522949419161465,0.15841584158415842,0.6649451680903822,1.0,4/13,4.90%,SLC12A2;ATP1A2;ATP1A4;ATP1B2
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.5342696011526445,1.352202918061782,0.15714285714285714,0.6634603235744012,1.0,9/31,12.56%,LIN7A;MTCL1;SH3BP1;CRB1;MARK2;CAMSAP3;DLG2;PARD3B;DLG3
prerank,negative regulation of myoblast differentiation (GO:0045662),0.6082924433574938,1.3520313969243563,0.18127490039840638,0.6622009703268882,1.0,3/13,4.38%,NOTCH1;TBX3;SOSTDC1
prerank,regulation of macroautophagy (GO:0016241),-0.36788780138607163,-1.3513814982444448,0.02702702702702703,0.449135008498716,1.0,33/105,21.26%,PRKAG2;DCN;SNX6;LRRK2;SNX32;EXOC4;CLEC16A;NRBP2;CAPNS1;ATP6V1G1;AKT1;CAPN1;ATP6V0B;KDR;VPS35;BNIP3L;ERN1;SH3GLB1;ATP6V0A1;PRKAG3;PRKAB1;LARP1;BNIP3;ATP6V0A2;PRKAA2;TBC1D25;QSOX1;RRAGB;LAMTOR5;ATG101;IKBKG;USP36;PRKAG1
prerank,pyroptosis (GO:0070269),-0.5540502493492221,-1.351305658883066,0.12815533980582525,0.44833688840232233,1.0,4/15,10.42%,GSDME;CASP4;CASP8;GSDMD
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5646167395276784,-1.349756943977307,0.11047619047619048,0.4512394986324039,1.0,2/13,0.60%,IGF1;PLCB1
prerank,oogenesis (GO:0048477),0.6027774277021248,1.3483791107480618,0.18105263157894738,0.6700268001921916,1.0,6/15,18.70%,PTN;FMN2;MEI4;NANOS1;TRIP13;KMT2D
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.5829478607699903,-1.3479703383683785,0.12476370510396975,0.4547577195366751,1.0,6/11,25.85%,HSPA5;ATF6;CREB3L1;CEBPB;ATF3;TP53
prerank,central nervous system neuron axonogenesis (GO:0021955),0.6405840621335301,1.3476731351697608,0.18840579710144928,0.6702006544750321,1.0,6/12,17.51%,PTEN;B4GALT6;ARHGAP35;EPHB1;CHRNB2;SPTBN4
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5843476763032316,-1.347454486359342,0.1224105461393597,0.4552016192081115,1.0,5/11,8.76%,IGF1;PLCB1;IGF1R;GHR;AKT1
prerank,negative regulation of epithelial cell migration (GO:0010633),-0.45689996672291794,-1.347396794039701,0.0767590618336887,0.45438983570758806,1.0,10/33,6.10%,MCC;DCN;SP100;APOE;ADAMTS9;SLIT2;PTPRM;THBS1;PTPRG;ACVRL1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.5162351687832859,1.3473100967801497,0.15225563909774437,0.6694948858146357,1.0,13/34,18.54%,MEF2C;MPP2;CHRNA3;GABRG2;GABRA2;GRIN2B;GABRA5;GABRA4;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),-0.4262964605056514,-1.3472730324665227,0.08144796380090498,0.4537554218789208,1.0,12/45,11.25%,SP100;B2M;VCAM1;IRF1;ICAM1;IRF2;STAT1;PRKCD;IRF9;OAS2;PML;CAMK2A
prerank,regulation of dendrite extension (GO:1903859),0.5848318981850876,1.347154020470507,0.1843687374749499,0.6681251454198301,1.0,5/18,11.38%,NEDD4L;RIMS1;RIMS2;SYT1;SYT2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),-0.33888968234322636,-1.3470776894309415,0.014336917562724014,0.4532923303487726,1.0,51/182,14.30%,NOTCH2;IGF1;ROBO1;SLC24A3;ROCK2;FOXP1;WNT4;OCLN;APOE;APP;CLDN5;ITGB8;XDH;RIN3;ESR1;BMP4;KLF4;TAF1;CD34;ADAM10;SMO;SDCBP;PARP9;CNOT7;WWP2;LGALS9;PARP14;YAP1;MOV10;ACVRL1;SLC7A5;HINFP;PGR;NOCT;HIF1A;ATXN2;FLOT2;FLCN;EMILIN1;ZC3H12A;KDR;ANXA7;OPTN;GATA2;TGFB1;HDAC1;ID2;ATOH8;SFRP1;CREB3L1;HSP90AB1
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.6173136009147114,-1.3468795831050004,0.12810707456978968,0.45281663188864973,1.0,4/10,10.91%,DCN;LRRK2;KDR;MYOC
prerank,regulation of mitochondrial fission (GO:0090140),-0.4854911789840125,-1.3468025062582298,0.1062992125984252,0.4520511423818909,1.0,13/24,25.65%,DCN;MCU;LRRK2;STAT2;KDR;VPS35;BNIP3;MYO19;CYRIB;DDHD1;INF2;RALBP1;PRKN
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.507513197492364,-1.3466302018614031,0.11666666666666667,0.451543796796151,1.0,4/22,12.33%,ALDH1A2;RBP1;CUBN;VKORC1L1
prerank,odontogenesis of dentin-containing tooth (GO:0042475),-0.5412665029190488,-1.3465531316576207,0.1422924901185771,0.4507771112550777,1.0,6/15,12.12%,GLI2;WNT6;LRP6;FOXC1;TBX1;HDAC1
prerank,ERBB2 signaling pathway (GO:0038128),0.5297369515264869,1.3455058032441898,0.15648854961832062,0.670833567604069,1.0,5/31,3.05%,GAB1;PIK3R1;ERBB4;NRG1;PIK3CA
prerank,inhibitory synapse assembly (GO:1904862),0.6234432027907502,1.344615918649604,0.2039045553145336,0.6714084364933832,1.0,4/11,5.87%,PLXNB1;FGF13;GABRG2;GABRA2
prerank,positive regulation of leukocyte activation (GO:0002696),-0.5164340245849397,-1.3442007113983971,0.12277227722772277,0.4558493476326535,1.0,6/18,16.55%,LBP;THBS1;WNT5A;IL33;KARS1;TLR4
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.5606099116150647,1.3441389035275932,0.1669902912621359,0.6708985380786189,1.0,5/23,9.56%,PTEN;INPP5J;MTMR12;MTMR7;INPP5B
prerank,regulation of cellular component size (GO:0032535),0.5338172173279155,1.3439520143371884,0.16194331983805668,0.6697124987517118,1.0,2/30,0.42%,EPS8;PTEN
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.4588390096312531,1.3433783746427332,0.11367380560131796,0.6694157667063144,1.0,19/75,12.82%,MEF2C;FARP1;BTBD3;SDC2;MAP2;MINK1;NTNG2;RYK;CNTN4;SLITRK5;ANK3;CCK;SLITRK1;CTNNA2;BRSK1;PAK3;RB1;ZDHHC17;SLITRK2
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),-0.5037890823017017,-1.3432799493228933,0.1154562383612663,0.45727328524221034,1.0,6/20,14.52%,ZMIZ1;TGFBR1;HIF1A;DNAJB2;HSP90AB1;WASHC1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.6183865570607193,1.3430280600715059,0.16210526315789472,0.6686356032164988,1.0,2/13,2.38%,SPAAR;SESN3
prerank,positive regulation of cyclase activity (GO:0031281),0.6204050569440693,1.3427858931555603,0.17525773195876287,0.6675677452938586,1.0,4/14,7.48%,CACNA1C;NF1;CACNA1D;STIM1
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5593197691030751,-1.342400472426338,0.136,0.4584456855144855,1.0,2/13,3.24%,GLI2;BMP4
prerank,acylglycerol homeostasis (GO:0055090),0.5714090079973939,1.3422759061519463,0.16363636363636364,0.6671727324953132,1.0,4/20,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,glycosphingolipid metabolic process (GO:0006687),-0.4371616682904165,-1.339938654413744,0.10504201680672269,0.46395138178022083,1.0,19/42,22.79%,LARGE1;ESYT2;ST6GALNAC3;A4GALT;SMPD3;HEXA;HEXB;B3GALNT1;PSAP;ST6GALNAC6;ESYT3;UGCG;SUMF2;ST3GAL5;NEU3;GLB1;ST8SIA5;CLN6;SUMF1
prerank,acute inflammatory response (GO:0002526),-0.48761572942062903,-1.3398710970930185,0.12551440329218108,0.463151961932515,1.0,4/23,6.62%,F3;IL6R;LBP;ANO6
prerank,negative regulation of B cell proliferation (GO:0030889),0.6257358498238421,1.3397165591788698,0.19469026548672566,0.6723665613708488,1.0,3/11,9.11%,TNFRSF21;CD300A;LYN
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),-0.4041212453967295,-1.339697790034311,0.08831168831168831,0.46259979812393814,1.0,26/55,27.22%,WWOX;CAV1;NUPR1;TGFBR1;GSDME;TNFSF10;BCL2L11;BECN1;DAB2IP;PML;TRIM39;BID;BCAP31;RIPK1;AGT;BBC3;TPD52L1;DEDD2;BCL2L1;RPS3;RACK1;TP53;FAS;CRADD;BCL10;PAK2
prerank,negative regulation of leukocyte activation (GO:0002695),0.5969000245646878,1.3391737150167544,0.19427402862985685,0.6721064247871485,1.0,5/15,6.03%,GPER1;NR1H3;LRFN5;CD300A;IL4
prerank,negative regulation of smooth muscle cell migration (GO:0014912),0.6148593938758563,1.3389516905743533,0.2,0.6709639762241114,1.0,2/14,0.65%,MEF2C;PRKG1
prerank,mitochondrion morphogenesis (GO:0070584),0.6286527518538352,1.3388607862925395,0.18979591836734694,0.6695238366572792,1.0,3/11,12.39%,PID1;SUPV3L1;MFF
prerank,"wound healing, spreading of cells (GO:0044319)",-0.4881359355517581,-1.3368992863358655,0.10706638115631692,0.46903708402516864,1.0,12/24,22.24%,COL5A1;PDPN;ITGA5;ACVRL1;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),0.6144736949986936,1.3364041809963951,0.175054704595186,0.674247872048194,1.0,4/12,7.30%,CACNA1C;CTNNA3;RYR2;BIN1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.42884261973327664,-1.3358290233013879,0.10212765957446808,0.4707885094939196,1.0,19/44,27.32%,SH3RF1;USP47;THBS1;CAST;KLF4;GAS6;FNIP1;MAP2K5;AKT1;DNAJB6;GPX1;LAMTOR5;MT3;VEGFA;RPS6KA3;YWHAE;CD44;CDKN2D;SFN
prerank,neuron projection development (GO:0031175),0.41067713838467584,1.3357756056233498,0.08873239436619719,0.6742028111546629,1.0,30/168,11.67%,GRM7;FRY;PTEN;DOCK10;RAPGEF2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;SVBP;MINK1;CNTNAP2;RYK;LAMB1;CNTN4;NYAP2;TAOK3;MARK2;BLOC1S1;MAP4K4;LYN;TMEM108;PLP1;NCKAP1;PRMT1;PAK3;PAK1;RB1
prerank,positive regulation of cell migration (GO:0030335),-0.32543829434369836,-1.3357717065596066,0.025423728813559324,0.46992435396893695,1.0,74/253,13.68%,IGF1;DAB2;DOCK5;PDGFD;FN1;EGFR;FLT1;COL1A1;CDH5;ROCK2;PDGFRA;NRP1;NTRK3;CTSH;PDPN;SEMA3D;CEMIP;SEMA6A;NEDD9;SEMA3C;PECAM1;PODXL;F3;CAV1;PLCG1;ITGA6;BMPR2;SMURF2;THBS1;IGF1R;TGFBR1;SEMA7A;RAB11A;CSF1;ARHGEF2;ADAM9;LEF1;ACVR1;ADAM10;SMO;SDCBP;CXCL12;FGF1;PRKCE;SYNE2;PTK2B;STAT3;HSPA5;SH3RF2;SEMA3E;ACTG1;TIAM1;MMP14;KIT;RREB1;HIF1A;TWIST2;CCN4;CDH13;DAB2IP;KDR;MYOC;TGFB1;SEMA3B;TRIP6;PFN1;WNT5B;EPHB2;ATM;CCN1;PLCG2;SPHK1;FER;RET
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.5008348185841581,1.3354506633842873,0.1582608695652174,0.6734128965523812,1.0,3/40,1.34%,PTEN;GLMN;PTK2
prerank,cellular amino acid catabolic process (GO:0009063),-0.3802520242408228,-1.3333788793316415,0.05263157894736842,0.4751674501942355,1.0,43/87,36.38%,GLUL;DDO;NOS3;ALDH7A1;IVD;ASPA;DDAH1;CARNMT1;ALDH4A1;PRODH;GLS;BCKDHB;AUH;PIPOX;CARNS1;NOS1;CBS;HOGA1;BCKDK;HNMT;BCKDHA;GCDH;ABAT;AMT;KYNU;HMGCL;AASS;ALDH6A1;MTRR;BLMH;FAH;HYKK;BCAT1;ALDH5A1;ACADSB;GLDC;SHMT1;HGD;IL4I1;HMGCLL1;HAAO;HSD17B10;NOS2
prerank,positive regulation of T cell migration (GO:2000406),-0.4970768655332055,-1.3333744324706878,0.11937377690802348,0.4741746944220113,1.0,6/20,6.89%,APP;ADAM10;CXCL12;WNT5A;RHOA;WNK1
prerank,positive regulation of transforming growth factor beta production (GO:0071636),-0.589698984210738,-1.3326537236066205,0.11776061776061776,0.47515699875574025,1.0,7/11,16.21%,THBS1;CD34;LGALS9;PTGS2;GATA6;BMPR1A;CD200
prerank,regulation of bicellular tight junction assembly (GO:2000810),-0.508947983117431,-1.3326145262637115,0.11605415860735009,0.4742744360200903,1.0,4/19,2.62%,ROCK2;PRKCH;OCLN;CLDN5
prerank,positive regulation of vascular permeability (GO:0043117),-0.5701505905617424,-1.3324090563711015,0.13409961685823754,0.47379280040456556,1.0,4/12,3.53%,BMP6;TJP2;OCLN;ANGPT1
prerank,regulation of chemokine production (GO:0032642),-0.4529729944244878,-1.3322442925760098,0.09808102345415778,0.47317714638236913,1.0,19/36,33.26%,FOXP1;APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL18;TLR4;CSF1R;SIGIRR;LPL;EGR1;IL7;AIF1;HMOX1;TREM2;TLR7;ADAM17
prerank,positive regulation of synapse assembly (GO:0051965),0.5321105057588293,1.332165867915539,0.148975791433892,0.6805283867638092,1.0,10/27,15.09%,CLSTN1;NRXN1;AGRN;CLSTN3;IL1RAPL1;CUX2;EPHB1;SLITRK2;NLGN3;SYNDIG1
prerank,negative regulation of inflammatory response (GO:0050728),0.40107051845466735,1.3317721317586355,0.08344733242134063,0.6798973186508341,1.0,24/182,7.27%,GGT5;CYSLTR2;PTH1R;GGT1;GNG2;RORA;ADORA2A;GPER1;NR1H3;MYH9;PRKAR1B;ADCYAP1R1;GIPR;LRFN5;ADCY8;ADCY3;ADCY6;PPARD;NPSR1;IL4;PRKAR2B;GPR45;ADCY9;AOAH
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5074439244945714,1.331560425519021,0.1622103386809269,0.6787897704672882,1.0,5/41,1.22%,MEF2C;HEY2;HEYL;NOTCH1;TBX20
prerank,thyroid hormone generation (GO:0006590),-0.6055165605490609,-1.3301162470220627,0.14487632508833923,0.4777858871128752,1.0,2/10,12.81%,CPQ;SLC5A5
prerank,regulation of T cell cytokine production (GO:0002724),-0.5320009554526246,-1.3296229860758928,0.14484126984126985,0.4782342119364523,1.0,4/15,6.32%,CD55;B2M;SMAD7;TNFRSF1B
prerank,regulation of interleukin-2 production (GO:0032663),0.5027490099196747,1.328862713944056,0.14673913043478262,0.6842602146201785,1.0,6/43,6.03%,PDE4D;GLMN;IL1B;SPTBN1;NAV3;PDE4B
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.4022832971796587,-1.3284836318164706,0.07932692307692307,0.4783819174757444,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,vesicle coating (GO:0006901),-0.4022832971796587,-1.3284836318164706,0.07932692307692307,0.4783819174757444,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,COPII vesicle coating (GO:0048208),-0.4022832971796587,-1.3284836318164706,0.07932692307692307,0.4783819174757444,1.0,32/61,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;SEC23IP;NAPA;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.5634056469314488,-1.3282965258144237,0.13924050632911392,0.47791960507705405,1.0,4/13,12.45%,NFIB;BMP4;RELA;PPARA
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),-0.30056650240899263,-1.3278157003862796,0.0,0.47810181613503244,1.0,143/572,16.89%,NFIB;BMP6;FOXP2;PRDM6;DAB2;AEBP1;SMAD3;SMARCA2;ZBTB16;FOXP1;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;LCOR;SP100;GLIS3;OSR1;SKIL;FOXO3;NR3C1;DLG1;HDAC8;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;BMP4;EZR;RPS14;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;SMAD7;KLF2;ETV6;TAF1;ID1;HDAC9;THRB;MXI1;SKI;SDCBP;ZFPM2;PARP9;IGF2;GATAD2A;GTF2IRD1;WWP2;AR;RARG;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;KMT5A;ATXN1;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;BAG3;RREB1;IL33;NR4A2;FLCN;BHLHE41;DAB2IP;PRDM5;ZKSCAN3;TGIF1;KLF12;TRIM27;MDFI;GLI3;NSD1;PTCH1;ZMYM5;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;UBB;CALR;ZGPAT;PPID;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SARS1;RPL10;ENO1;MAZ;ZBTB4;BEND3;NKX6-1;SNAI1;ZFPM1;YEATS2;RPL23;HHEX;SOX18;PHF21A;HCFC2;MNT;ZFP69;ZNF436;SIRT7;SIRT2
prerank,maintenance of blood-brain barrier (GO:0035633),0.5193290706052743,1.3277758117165552,0.1750465549348231,0.6854801268221397,1.0,8/30,5.53%,LAMA2;SLC12A2;DMD;JAM3;VCL;LAMC1;ESAM;ITGB1
prerank,microtubule anchoring (GO:0034453),0.6015295579838845,1.327706875558579,0.18,0.6840448158554295,1.0,5/12,18.98%,CLASP2;BICD2;CAMSAP3;GCC2;BCCIP
prerank,cytosolic calcium ion transport (GO:0060401),0.5421545819052243,1.3270288267526633,0.15748031496062992,0.6841774891883544,1.0,6/28,6.59%,CACNA1C;ATP2A3;CACNA2D1;ATP2B3;RYR2;ATP2A2
prerank,endodermal cell differentiation (GO:0035987),0.533930343391209,1.3257566356482462,0.1405940594059406,0.685849975541118,1.0,7/31,5.23%,ITGA4;ITGA7;VTN;NODAL;MMP15;ITGB5;LAMB1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.6166699662179269,1.3257100626700733,0.2,0.684322245495756,1.0,5/12,11.72%,GGT1;CTH;SEPHS2;PSAT1;SRR
prerank,response to hydroxyurea (GO:0072710),0.6031156422607977,1.325697206428464,0.19789473684210526,0.6827340682553805,1.0,6/11,19.55%,KAT7;TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,secretory granule organization (GO:0033363),-0.5943497471228627,-1.3248339915443692,0.13419117647058823,0.484912995223758,1.0,3/10,8.10%,ABCA1;SRGN;DTNBP1
prerank,protein N-linked glycosylation (GO:0006487),-0.391745222809623,-1.3248190023289688,0.07476635514018691,0.48397048094485023,1.0,20/66,19.41%,B4GALT1;MAN1C1;ST3GAL1;STT3A;STT3B;FUT8;MGAT1;SLC39A8;LMAN1;MGAT2;GFPT2;ENTPD5;ALG6;MCFD2;OST4;ASGR1;RPN2;OSTC;GFPT1;DOLPP1
prerank,defense response to symbiont (GO:0140546),0.4358608291076906,1.32449565583038,0.11198738170347003,0.6843706989679195,1.0,1/92,0.01%,ABCC9
prerank,endoplasmic reticulum mannose trimming (GO:1904380),-0.5157282330817771,-1.3240177237323654,0.14624505928853754,0.48514996478515265,1.0,6/18,13.00%,RNF139;RNF103;AMFR;RNF185;EDEM2;UBB
prerank,limb morphogenesis (GO:0035108),-0.5126382364244981,-1.3234789830546974,0.13529411764705881,0.4855772236105781,1.0,7/20,11.87%,PCSK5;CYP26B1;MBNL1;LRP6;SKI;GLI3;PTCH1
prerank,protein deacylation (GO:0035601),-0.49452658709634056,-1.3231778418410267,0.128,0.48539872347880314,1.0,12/23,21.43%,HDAC4;HDAC7;LYPLA1;NOTUM;HDAC1;ABHD17C;HDAC5;LYPLAL1;SIRT7;SIRT2;SIRT3;SIN3A
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),0.5314492610809523,1.3226992553760064,0.1670103092783505,0.687338249991651,1.0,2/26,1.22%,CASQ2;ATP1A2
prerank,positive regulation of BMP signaling pathway (GO:0030513),-0.47996777858119855,-1.3224098717155046,0.12551440329218108,0.4865018568708166,1.0,7/25,6.10%,SULF1;ZNF423;CDH5;BMPR2;BMP4;FOXD1;ACVRL1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.5271559106609328,1.3221791370024094,0.17509727626459143,0.6870854574506494,1.0,8/27,13.61%,PTEN;MARK1;NTNG2;IL1RAPL1;CTNNA2;BRSK1;PSEN1;ULK4
prerank,Ras protein signal transduction (GO:0007265),0.41597565460998714,1.3220959518535371,0.11594202898550725,0.6856942269335281,1.0,25/137,8.64%,EPS8;PLCE1;RERG;PLD1;RAPGEF2;ARHGAP6;RASGRP2;ARHGAP1;RASGRP3;ROCK1;NF1;WAS;LIMK1;CDC42EP1;ABI2;FGF2;RTKN;EPS8L1;RIT2;HACE1;RAP1A;HRAS;CDKN1A;ARHGDIB;GNA12
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.5709226335234304,-1.3219176925214946,0.13533834586466165,0.48674374218607763,1.0,3/12,13.16%,LPCAT3;P4HB;MFSD2A
prerank,nervous system development (GO:0007399),0.3687713561370159,1.32099682559223,0.03614457831325301,0.6868864660154912,1.0,94/429,13.51%,RAPGEF5;SERPINI1;PTEN;MEF2C;ADGRL3;CDH2;KALRN;DPF3;FARP1;BTBD3;SEMA5A;ST8SIA4;ADORA2A;DPYSL2;TBX3;MERTK;NF1;PCDHB11;LSAMP;GFRA2;ZEB2;PTN;FGF12;ERBB4;GBX2;CHAC1;NRG1;NAB1;LIMK1;NRXN1;TBX6;CHRNA3;GRIK1;AXL;FGF13;FGF2;DNER;ACAN;ROGDI;NAV3;SCN2A;RYK;SREBF2;MYLIP;FEZ2;CNTN4;MOG;RBFOX3;ASIC2;NINJ2;PCDH1;SCN8A;ANKLE2;LIG4;CNTN6;PPT1;IGSF8;NES;ACHE;ROBO2;ITM2B;ADAM23;SLITRK1;PKD2;JAG1;ACTL6B;MARCKS;NCKAP1;GDF11;BTBD6;APBA2;CHERP;TRAK1;SPOCK1;VLDLR;SOX6;AHI1;IL1RAPL2;FGF11;EP300;TRAK2;APC;MYT1L;EPHB1;GFRA1;ARHGAP26;PPP2R5D;ZC4H2;APC2;RPS6KA6;FEZ1;RITA1;NLGN3;DSCAM
prerank,endoplasmic reticulum membrane organization (GO:0090158),-0.5858336679761899,-1.3194391269660595,0.1497326203208556,0.49226935403356603,1.0,5/11,21.24%,LPCAT3;ATL2;BNIP1;STX18;MOSPD3
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5356447334117215,-1.319227137476723,0.12233009708737864,0.4918381758237819,1.0,5/16,6.98%,RBFOX2;ESR1;DDX5;AR;EGLN2
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),-0.480428040713787,-1.318213298781631,0.13814432989690723,0.4927213920078853,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),-0.480428040713787,-1.318213298781631,0.13814432989690723,0.4927213920078853,1.0,13/23,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5101675057723639,-1.317906569870104,0.14365671641791045,0.49258739829180803,1.0,5/18,6.79%,CDH5;ROCK2;TEK;RAP1B;PTK2B
prerank,plasma membrane tubulation (GO:0097320),-0.562951560628355,-1.3177539208188,0.13595706618962433,0.4920600022413349,1.0,6/13,17.70%,SNX9;CAVIN2;FNBP1L;CHMP4A;EHD2;MICALL1
prerank,positive regulation of dephosphorylation (GO:0035306),0.5295685638300388,1.3176518211214832,0.17131474103585656,0.6936633723848019,1.0,1/27,0.07%,DLC1
prerank,regulation of nitric-oxide synthase activity (GO:0050999),-0.4427866792496751,-1.3174457418147805,0.0988235294117647,0.49185373779362357,1.0,12/36,11.83%,EGFR;APOE;CAV1;NPR3;NOS3;DDAH1;PIK3CB;NOS1AP;AKT1;HIF1A;LYPLA1;GCH1
prerank,negative regulation of interleukin-1 beta production (GO:0032691),-0.5077682351833903,-1.3170567572316767,0.1359026369168357,0.4918635389803685,1.0,3/19,12.68%,IGF1;ZC3H12A;GIT1
prerank,negative regulation of cell differentiation (GO:0045596),-0.3290261630046152,-1.31590798546582,0.025,0.4940280981802496,1.0,49/181,13.48%,RANBP3L;LDLRAD4;ABCA1;SMAD3;ADAMTS12;EGFR;ZBTB16;COL5A2;SMAD6;EFEMP1;COL5A1;BMP7;TMEM64;FOXO1;OSR1;ENPP1;CAV1;HDAC7;XDH;SUFU;BMP4;TGFBR1;SMAD7;ADGRV1;WNT9A;PDCD4;SKI;ZFPM2;IGF2;YAP1;WNT5A;PTK2B;NOCT;TRIO;TBX1;ANP32B;TWIST2;DAB2IP;ANKRD26;GATA2;ITGB3;TGFB1;PTCH1;PPARA;ID2;CALR;CHRD;PTHLH;MEIS2
prerank,positive regulation of interleukin-4 production (GO:0032753),-0.5182044997539668,-1.3156630171195909,0.13282732447817835,0.4937476806184428,1.0,6/17,22.36%,LGALS9;PRKCZ;SLC7A5;CEBPB;SYK;RARA
prerank,axonogenesis (GO:0007409),0.38400053307934046,1.3152801950303523,0.07445442875481387,0.6981038103721418,1.0,34/237,7.59%,NOTCH3;PTEN;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PIK3CA;NRXN1;SPTBN1;NTNG2;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4;SLITRK5;ANK3;B4GALT6;DOK4;SPTA1;CNTN6;NRXN3;CCK
prerank,replicative senescence (GO:0090399),0.5948317854300338,1.3147758161965144,0.19162995594713655,0.6977584070185398,1.0,1/12,0.58%,PLA2R1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.43147875631565724,1.3146747583414318,0.12898330804248861,0.6963834205682257,1.0,12/110,3.95%,S1PR3;PTH1R;ADGRL3;TBXA2R;GNG2;RAPGEF2;UCN2;ADORA2A;GPER1;ADCY8;ADCY3;ADCY6
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),-0.4352943683040345,-1.3142741273099583,0.11607142857142858,0.4964860038788735,1.0,16/37,27.06%,CAV1;NUPR1;GSDME;BCL2L11;BECN1;EIF5A;UBB;BID;BCAP31;RPS7;BBC3;BCL2L1;RPS3;RACK1;TP53;MSX1
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.46532761912868037,-1.3141932772707883,0.14314928425357873,0.4956880147833835,1.0,6/26,10.10%,LGR4;APPL2;IRF1;BIRC3;FLOT2;IRAK3
prerank,dopamine metabolic process (GO:0042417),-0.5167308088290787,-1.313999019089108,0.1461864406779661,0.4952372658587053,1.0,5/18,11.83%,SNCAIP;MOXD1;MAOA;MAOB;GCH1
prerank,signal transduction by p53 class mediator (GO:0072331),-0.44639356899103133,-1.3138704364795928,0.12627291242362526,0.49458005131645094,1.0,4/30,5.04%,PPP1R13B;FHIT;DDX5;ACER2
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4815876180140213,-1.3136437513373962,0.12684989429175475,0.49427257014367393,1.0,7/24,7.64%,DPYSL3;NRP1;PALM;RHOQ;FNBP1L;ARAP1;DOCK11
prerank,chondroitin sulfate biosynthetic process (GO:0030206),0.5376198606375694,1.3130942043317244,0.19387755102040816,0.6988448985559087,1.0,3/21,2.02%,CSPG4;CHST3;CHST7
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.4758307270914672,1.312619197437863,0.140625,0.6984404031671829,1.0,15/54,11.54%,NEDD4L;GNG2;KCNJ12;KCNMB1;STK39;AKAP6;DPP10;KCNAB3;BIN1;CACNA1D;KCNE5;KCNJ3;KCNJ6;KCNIP1;KCNIP4
prerank,response to UV-A (GO:0070141),-0.5460508262977348,-1.3125122255734776,0.15485074626865672,0.4962568505493391,1.0,5/14,15.44%,EGFR;AKT1;PPID;CCND1;MMP2
prerank,regulation of trans-synaptic signaling (GO:0099177),0.509952528597409,1.3117002738348502,0.17938931297709923,0.699325053041883,1.0,10/33,13.46%,CEL;LRRC4C;EIF4EBP2;GRIK1;NRG3;GRID1;CACNA1A;GRIK5;GRIK2;NLGN3
prerank,lamellipodium organization (GO:0097581),0.5231233767883875,1.3116752230696866,0.1843137254901961,0.6978052141563827,1.0,5/29,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.5827599269103582,-1.3106713590818584,0.1475095785440613,0.5003123375738783,1.0,6/10,25.02%,DPYD;UPP2;UPB1;NT5E;NT5C1A;NT5C
prerank,cellular response to alkaloid (GO:0071312),0.5809279793322438,1.3105398490417943,0.20930232558139536,0.6991969606935651,1.0,4/17,8.62%,CASQ2;HTR1B;RYR2;RYR3
prerank,negative regulation of cell cycle (GO:0045786),0.44190345469199893,1.3105377380187353,0.12903225806451613,0.6976047051645247,1.0,17/73,11.85%,PTPRK;PTEN;CDK6;GPER1;SIPA1;RPS6KA2;HEXIM1;BRINP1;NUPR2;BRINP3;INCA1;HTRA2;NR2F2;TAF6;LATS2;RB1;APC
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.44150257675078164,1.3103437692593678,0.14465408805031446,0.6965392992487485,1.0,12/87,5.83%,DLC1;PDGFRB;EPS8;ROCK1;RND3;GRHL3;PIK3CA;SH3BP1;RAC3;CORO2B;ESAM;TESK1
prerank,regulation of ossification (GO:0030278),-0.4458475874314111,-1.3103123565465777,0.12694877505567928,0.5002283973044874,1.0,14/36,10.12%,ZBTB16;SMAD6;ENPP1;SGMS2;ANKH;BMPR2;BMP4;LRP6;ACVR1;CHSY1;BMP2K;WNT5A;ECM1;NOTUM
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.5571592854765633,-1.3095148680320077,0.143646408839779,0.5013315853237295,1.0,3/13,6.17%,GLUL;DDO;ASPA
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.5133694137214916,1.30939652662449,0.16353383458646617,0.6975056359245452,1.0,4/31,9.11%,GLMN;TNFRSF21;CD300A;LYN
prerank,negative regulation of transforming growth factor beta production (GO:0071635),-0.5967230342190275,-1.3093948389230519,0.1368421052631579,0.5006657824836582,1.0,5/10,23.39%,FN1;GATA6;HSP90AB1;TYROBP;CDH3
prerank,COPII-coated vesicle budding (GO:0090114),-0.38770492051697547,-1.3086995538111783,0.09158415841584158,0.5016414388145052,1.0,35/68,32.00%,TGFA;SEC23A;SEC24D;CTSC;SEC31A;TRAPPC10;SEC24A;USO1;SEC16B;LMAN1;TRAPPC4;TRAPPC3;F5;ANKRD28;MCFD2;VAPA;SEC23IP;NAPA;SAR1A;SAR1B;TMED2;BET1;TRAPPC6B;CNIH3;TRAPPC2;TBC1D20;SEC31B;TRAPPC5;TRAPPC2L;SEC16A;PREB;TMED10;CNIH2;GOLGA2;SCFD1
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.3621758543672905,-1.308301605315724,0.06571428571428571,0.5017147668118728,1.0,30/104,13.24%,LDLRAD4;SMAD3;SMAD6;SKIL;CAV1;HTRA3;TGFBR2;BMPR2;SMURF2;TGFBR1;SNX6;MAGI2;SMAD9;SMAD7;ACVR1;SKI;CCN3;BMPER;SMURF1;NBL1;PRDM16;VWC2;FKBP1A;EMILIN1;TGFB1;BCL9L;STRAP;PPARA;UBB;CHRD
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",-0.2827070085093813,-1.3079661793882067,0.0,0.501678977386445,1.0,185/807,14.51%,BMP6;FOXP2;PRDM6;DAB2;FOXN3;ZNF423;AEBP1;PLCB1;SMAD3;SMARCA2;ZBTB16;MECOM;FOXP1;WNT4;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;BMP7;LCOR;SP100;GLIS3;VGLL4;RBFOX2;DKK3;FOXO1;OSR1;SKIL;FOXO3;MDFIC;ZIC2;NR3C1;DLG1;HDAC8;KAT6B;CAV1;RARB;SUFU;ESR1;FGFR2;SMURF2;USP47;BMP4;EZR;RPS14;SNX6;FOXD1;DNMT3A;KLF4;DDX5;TCF7L2;FOXC2;TFDP2;SMAD7;LEF1;KLF2;ETV6;TAF1;ID1;PDCD4;HDAC9;SBNO2;THRB;MXI1;ZHX3;SKI;SDCBP;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;GAS6;GTF2IRD1;NIBAN2;WWP2;AR;BRD7;DAP;RARG;SCMH1;CREM;YAP1;FOXP4;GLIS2;SOX13;BHLHE40;PFDN5;KMT5A;ATXN1;IRF1;MIDEAS;WNT5A;ATN1;PRDM16;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;IFI27;KLF10;ZNF219;RTF1;ZBTB18;RREB1;TLE2;IL33;CBFA2T2;ZMYND15;RCOR3;TLE1;TWIST2;FOXK1;NR4A2;FLCN;BHLHE41;EHMT1;CD38;PHF10;IKZF1;GCLC;DAB2IP;JARID2;PRDM5;ZKSCAN3;TGIF1;PML;KLF12;TRIM27;MDFI;PATZ1;GLI3;TGFB1;NSD1;ELK3;PTCH1;ZMYM5;AHR;HDAC1;LRRFIP1;MDM2;RELA;CPEB3;PPARA;ID2;MEF2A;GATA6;CBX4;FBXW11;PRDM11;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;MEIS2;EZH1;CCND1;KCNIP3;HDAC5;ZNF568;SFRP1;QARS1;SARS1;RPL10;CREB3L1;ENO1;POU2F1;MAZ;ZBTB4
prerank,synapse organization (GO:0050808),0.41574455948847544,1.3078224070871514,0.10676691729323308,0.7000152508206805,1.0,22/125,8.63%,PTEN;CACNB2;ADGRL3;CDH2;APBB2;FARP1;PCDHB11;LRRC4C;DOK7;LRFN5;NRXN1;RAB39B;GRM5;AGRN;DNER;RYK;ANK3;SNCA;CHRNA7;PPFIBP2;ACHE;SLITRK1
prerank,acylglycerol metabolic process (GO:0006639),0.4968444946075406,1.3074066738959482,0.1761467889908257,0.699475786577311,1.0,3/37,1.88%,DGKB;DGKH;DGKG
prerank,negative regulation of actin filament polymerization (GO:0030837),-0.47616447155579783,-1.3068761888178715,0.1392931392931393,0.5036984320193144,1.0,10/22,19.61%,GSN;SLIT2;KANK3;TMSB4X;PRKCD;PFN1;TWF1;CYRIB;TMSB10;SSH3
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.43949456981820473,-1.306395943348039,0.12210526315789473,0.5039668221669834,1.0,9/36,11.17%,AFDN;VAMP5;MACF1;KIF13A;RILPL1;GGA2;GOLPH3;OPTN;RAB7A
prerank,protein autoubiquitination (GO:0051865),-0.3858054815823923,-1.3053507272873348,0.09738717339667459,0.5058636747740217,1.0,16/61,16.97%,RNF220;SH3RF1;RNF213;RNF146;WWP2;SH3RF3;SH3RF2;AMFR;RNF185;DTX3L;MDM2;RNF181;TRIM17;RNF115;RNF187;UBE3D
prerank,positive regulation of neuron differentiation (GO:0045666),0.49638633830149914,1.3051560398969018,0.1694290976058932,0.7037546246020997,1.0,6/40,8.37%,MEF2C;HEYL;ZEB1;BRINP1;BEND6;BRINP3
prerank,histone H3 acetylation (GO:0043966),-0.43032816373066457,-1.3044820208376617,0.11816192560175055,0.5073233966696399,1.0,23/40,32.81%,KAT6B;KAT2B;LEF1;KAT14;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;YEATS2;BRPF3;PHF14;BRPF1;BRD1;TAF5;SGF29;JADE1;ING4;TAF6L;JADE3;POLE3;NAA60;MAP3K7
prerank,sphingoid metabolic process (GO:0046519),-0.5520473571281046,-1.304104687451419,0.1446886446886447,0.5073913960660826,1.0,5/12,13.40%,PLPP3;NAAA;DEGS2;PLPP1;SPHK1
prerank,regulation of water loss via skin (GO:0033561),-0.5325942900743371,-1.3039551344646059,0.1423076923076923,0.5058795580375127,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,establishment of skin barrier (GO:0061436),-0.5325942900743371,-1.3039551344646059,0.1423076923076923,0.5058795580375127,1.0,9/15,36.35%,LSR;MET;UGCG;CLDN1;ALOX12;HRNR;SFN;ALOXE3;TMEM79
prerank,positive regulation of peptidase activity (GO:0010952),-0.49450644042289815,-1.3038545628630072,0.14717741935483872,0.5051762072641048,1.0,11/20,34.23%,CTSH;RCN3;PSME2;PSME3;PRELID1;VCP;NDUFA13;NCSTN;VSIR;APH1A;PINK1
prerank,regulation of cytokine production (GO:0001817),0.4168698928069733,1.3035667463838287,0.1184407796101949,0.7061425475831957,1.0,12/126,7.25%,ACE2;PLA2R1;GLMN;PIK3CD;AFAP1L2;RGCC;RPS6KA4;CARD9;MOG;SCAMP5;NLRP4;TRAF3
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5340786652860177,1.3034951654830984,0.19433962264150945,0.704724563514248,1.0,7/26,7.38%,CASQ2;NEDD4L;KCNG1;STK39;ATP1B2;ITGB1;CACNA1D
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),0.5562937040683568,1.3034915709735644,0.20634920634920634,0.7031524861923497,1.0,2/21,1.87%,PTEN;BTRC
prerank,maintenance of gastrointestinal epithelium (GO:0030277),-0.5570079149100494,-1.3033075998416859,0.1651031894934334,0.5057505006923508,1.0,3/12,16.55%,RBP4;STRAP;TLR4
prerank,cytoskeleton organization (GO:0007010),0.42051688312743807,1.3029632179146502,0.13230769230769232,0.7029442307200634,1.0,14/114,4.97%,MAST4;PLCE1;LIMD1;ARHGAP10;SH3KBP1;DPYSL2;MARK1;WASF3;SIPA1;RND3;ABI2;RAC3;FMNL3;AJUBA
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.6277947668061188,1.302694046766217,0.22851153039832284,0.7020859822973489,1.0,4/10,11.92%,GABRG2;GABRA2;GABRA5;GABRA4
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),0.5374238795551728,1.3025977087326694,0.18452380952380953,0.7007733396983616,1.0,10/22,18.34%,DMD;CACNB2;PDE4B;STAC;HPCA;CBARP;GPR35;FMR1;CACNB4;GNB5
prerank,erythrocyte differentiation (GO:0030218),-0.42352464141753515,-1.3019258208401314,0.09843400447427293,0.5084534349824489,1.0,22/44,27.93%,TGFBR3;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;CEBPG;ALAS1;ID2;TAL1;HIPK2;ZFPM1;PTPN2;CDK5RAP3;VEGFA;LYAR;HSPA9;ACIN1;NCKAP1L;ALAS2;HCLS1
prerank,regulation of metal ion transport (GO:0010959),0.5779492435404102,1.301652541061536,0.20496894409937888,0.7016193412983383,1.0,4/16,7.48%,SLC30A10;EPB41;CACNA2D1;STIM1
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),0.6247058841985784,1.3015994891775458,0.2222222222222222,0.7001826491207704,1.0,3/10,7.19%,PTH1R;SNCA;IRS1
prerank,regulation of mononuclear cell migration (GO:0071675),0.5306695835652453,1.30132786456084,0.18217821782178217,0.6993242523327501,1.0,3/23,1.34%,IL34;BMP5;PTK2
prerank,postreplication repair (GO:0006301),-0.41532552482754004,-1.3013237733437537,0.13023255813953488,0.5091088018066104,1.0,21/45,32.01%,REV1;POLH;UBB;RPA1;RFC3;VCP;UBE2L6;POLI;USP43;RFC1;BRCA1;USP10;RPA3;POLD1;WDR33;ISG15;DTL;UBE2V1;PCNA;PARP10;RFC5
prerank,positive regulation of protein transport (GO:0051222),-0.38360655286870193,-1.3010178134920944,0.08536585365853659,0.5089959622262724,1.0,19/67,19.90%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;GOLPH3;MYH10;TGFB1;PPID;PPIA;SYTL4;RUFY3;TPR;OAZ1;RAB29;CHP1;VPS28
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),-0.5318899119718278,-1.300809224693328,0.18627450980392157,0.5085523708760599,1.0,9/14,33.30%,ENTPD1;ENTPD5;ENTPD2;NUDT16;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),-0.4840708936423072,-1.3005018966136266,0.1413934426229508,0.5083689690126769,1.0,9/24,11.02%,CDH5;TEK;ANGPT1;RAMP2;GAS6;NDNF;ICAM1;KDR;GATA2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),-0.46389632468050884,-1.3003728242171815,0.15592515592515593,0.5078013446506073,1.0,6/26,14.71%,ST3GAL4;LARGE1;ST3GAL2;GOLPH3;ALG6;GCNT1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.5314474420038633,1.2993055621244771,0.18401486988847585,0.7029698880044861,1.0,7/27,9.15%,PDGFRB;RGCC;FGF2;TNKS;CDKN1A;PRKD2;PDGFB
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.40919829828597754,-1.2985870558526802,0.11778290993071594,0.5115126106003328,1.0,9/45,6.10%,BMP6;DAB2;BMP7;BMPR2;BMP4;TGFBR1;ACVR1;SDCBP;ACVRL1
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),-0.31115075047037166,-1.2984087429427236,0.03278688524590164,0.5110570865704489,1.0,62/248,16.28%,RNF220;MCC;DAB2;LRRK1;LGR4;EGFR;COL1A1;IGFBP2;BICC1;TBL1XR1;TMEM64;DKK3;APOE;CAV1;FGFR2;SMURF2;USP47;IGFBP6;NKD1;RNF146;TCF7L2;TLE4;LRRK2;LRP6;MLLT3;IGFBP4;TNKS2;LYPD6;SFRP4;SOX13;PFDN5;WNT5A;WNK1;USP8;CSNK1G2;SCYL2;AMFR;FZD4;TLE2;TLE1;USP34;FZD7;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;TGFB1;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;SOX7;GSKIP;PSME3;HHEX;PLEKHA4
prerank,regulation of cell division (GO:0051302),-0.37320278902707715,-1.2980430753865797,0.07936507936507936,0.5110680372004579,1.0,32/72,28.48%,FGFR2;RAB11A;KIF13A;MLLT3;FGF1;TXNIP;PLK2;CALM2;BECN1;FLCN;EFHC1;SH3GLB1;GIT1;UVRAG;TAL1;MYO19;CALM1;SIRT2;SMYD5;PLK4;CETN2;CCP110;BCL2L1;RACK1;PLK5;KLHL21;DLL1;FSD1;SFN;KIF18B;TLE6;KLHL9
prerank,regulation of cell-cell adhesion (GO:0022407),-0.4215920891263496,-1.2972064169559876,0.13846153846153847,0.5123719619287539,1.0,15/39,16.39%,AFDN;EPHA7;PODXL;DPP4;SMAD7;CDH1;PTPRG;EFNA5;CD47;FLOT2;MDGA1;TGFB1;MEGF10;CEACAM1;EPHB3
prerank,cAMP metabolic process (GO:0046058),0.5862417734304667,1.2970650153110115,0.211864406779661,0.707212229158797,1.0,6/13,9.84%,PDE4D;ADCY8;ADCY3;ADCY6;ADCY9;EPHA2
prerank,axon guidance (GO:0007411),0.3879906117678878,1.296714194659544,0.09333333333333334,0.7065897896151528,1.0,26/201,5.42%,NOTCH3;CHN1;LAMA2;PIK3CD;GAB1;SH3KBP1;NOTCH1;PTK2;PIK3R1;SEMA6D;SEMA5A;SLIT1;SLIT3;VASP;GFRA2;UNC5B;PLXNB1;PIK3CA;NRXN1;SPTBN1;RYK;SEMA6C;GRB10;SPTB;FEZ2;CNTN4
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5448197172258376,1.2965857360748285,0.19461697722567287,0.7053972737313908,1.0,4/20,1.88%,HEY2;HEYL;NOTCH1;TBX3
prerank,ion transport (GO:0006811),0.4204180057812581,1.2962804264750964,0.12954186413902052,0.7046366840618878,1.0,12/111,7.10%,ANO1;TRPC6;SLC12A2;ATP1A4;CHRNA3;SLC24A4;SLC24A2;SLC12A6;SLC26A1;SLC32A1;CHRNA7;SLC15A2
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.5225122003697079,-1.2959794312303148,0.18525519848771266,0.5146745654399116,1.0,7/16,22.85%,CLEC16A;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5117156834391333,-1.2959412055237391,0.18199233716475097,0.5138401203328704,1.0,4/16,12.45%,PRKAG2;APPL2;ACADL;PPARA
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.46802925208053525,1.2957976882005304,0.1690909090909091,0.7043344878853798,1.0,8/46,5.23%,ITGA4;LAMC3;PIK3R1;LAMC1;PEAK1;FERMT2;NTNG2;LAMB1
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.5861205151951572,-1.2956939318295149,0.16176470588235295,0.5135681858201948,1.0,5/10,10.24%,DCN;SEMA6A;XDH;PIK3CB;DAB2IP
prerank,peptidyl-amino acid modification (GO:0018193),0.6221575216169482,1.2956441790828568,0.24210526315789474,0.7032053496836244,1.0,2/10,3.70%,METAP2;ATP7A
prerank,inner mitochondrial membrane organization (GO:0007007),-0.4078412154856106,-1.2952202295870328,0.11086474501108648,0.5138785369522902,1.0,23/47,29.59%,MICOS10;MTX2;ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;TIMM13;AFG3L2;TIMM8B;MAIP1;TIMM9;HSPA9;ATP5MC2;NDUFA13;ATP5F1E;DNAJC11;TIMM10;MTX3
prerank,regulation of neurotransmitter secretion (GO:0046928),0.5093304532302089,1.2950230274811354,0.17454545454545456,0.7031914917067288,1.0,16/32,18.25%,MEF2C;GPER1;CHRNA3;RIMS1;RIMS2;SYN1;VPS18;BAIAP3;MCTP2;PNKD;RAB5A;PREPL;SYT11;FMR1;GSK3B;CPLX1
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.509424870852547,-1.2948075495440317,0.16344086021505377,0.5139818596328584,1.0,6/17,7.98%,ANXA4;KLF4;ANXA1;ARRB1;MAP2K5;TMSB4X
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.45065679745346265,1.2938759633657324,0.155,0.7046523897515556,1.0,12/72,4.24%,PDGFRB;PIK3CD;GAB1;ROR1;PTK2;PIK3R1;GPER1;UNC5B;PLXNB1;PIK3CA;NCF1;FGF2
prerank,negative regulation of autophagy (GO:0010507),-0.3935853408821125,-1.2935474846219022,0.11494252873563218,0.5163120084768567,1.0,20/54,20.95%,LEPR;NUPR1;LRRK2;DAP;RASIP1;STAT3;NRBP2;AKT1;MCL1;FOXK1;DAPL1;ZKSCAN3;EIF4G3;MET;WASHC1;SIRT2;QSOX1;MT3;USP36;TBC1D14
prerank,endoplasmic reticulum tubular network organization (GO:0071786),-0.5249723889429952,-1.2931682278026784,0.14177693761814744,0.5163565741934746,1.0,6/15,22.49%,ATL2;REEP1;RAB18;ZFYVE27;REEP2;TMEM33
prerank,regulation of actin filament-based process (GO:0032970),0.45280782420735066,1.2930417840259087,0.1518578352180937,0.7053015087863198,1.0,8/70,3.97%,DLC1;PDGFRB;ROCK1;RND3;GRHL3;SH3BP1;RAC3;CORO2B
prerank,regulation of mitochondrial fusion (GO:0010635),0.626251880613638,1.2920030548347294,0.2294736842105263,0.7064849219448304,1.0,2/11,2.73%,PID1;PLD6
prerank,positive regulation of kinase activity (GO:0033674),-0.3489122494894449,-1.291996056689002,0.0546448087431694,0.5185744547868301,1.0,31/107,13.68%,PRKAG2;EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;IQGAP1;FGFR2;EPHB4;IGF1R;SNX9;RASSF2;CSF1;GAS6;DDR1;PTK2B;ALS2;TIE1;KIT;EPHA8;KDR;FGFR4;EPHB2;FLT4;CCN1;MET;RET
prerank,ear morphogenesis (GO:0042471),-0.48444933863861256,-1.2910322958607452,0.16565656565656567,0.5201566358726867,1.0,6/20,12.29%,CHD7;OSR1;FGFR2;SIX1;TBX1;EPHB2
prerank,mesenchymal cell differentiation (GO:0048762),0.4654874801974075,1.2897951949973292,0.1824561403508772,0.7105395770174995,1.0,7/51,2.15%,LIMS1;MEF2C;HEY2;HEYL;NOTCH1;TBX20;ROCK1
prerank,regulation of developmental growth (GO:0048638),-0.4516095593260159,-1.2895247249967192,0.15466101694915255,0.5231629028966972,1.0,6/29,6.23%,IGF1;PLCB1;APOE;APP;GHR;SIX1
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5743449733350865,1.2884641117354712,0.20867768595041322,0.7123068292843354,1.0,1/15,0.40%,KCNJ8
prerank,neurotransmitter transport (GO:0006836),0.45122697855754557,1.2881853088373079,0.13926174496644295,0.7114155710018751,1.0,19/73,13.14%,LIN7A;ATP1A2;NRXN1;SNAP25;RIMS1;SYN2;GABRA2;SYN1;SLC32A1;SYT1;SLC5A7;SLC6A15;GRM4;STXBP2;GAD1;BRSK1;GLS2;PPFIA2;SLC29A2
prerank,receptor signaling pathway via STAT (GO:0097696),-0.4656822863985123,-1.2878430106982692,0.1511627906976744,0.5267730428396371,1.0,6/25,7.33%,IL31RA;GHR;SOCS2;STAT2;STAT1;STAT3
prerank,negative regulation of apoptotic process (GO:0043066),-0.29420324129673153,-1.287840376591139,0.005952380952380952,0.5258105924637346,1.0,120/444,19.22%,NOTCH2;IGF1;DAB2;FSTL1;EGFR;SMAD6;FHL2;CTSH;IL31RA;PDPN;PRKCH;TEK;FOXO1;SH3RF1;APOE;OSR1;CAV1;ANXA4;NUPR1;RNF213;ANXA5;MYO18A;USP47;THBS1;BMP4;IL6ST;ITGA5;IGF1R;SNX6;ANGPT1;TXNDC5;KLF4;ANXA1;LEF1;SOCS2;CFLAR;ADAM10;GAS6;NIBAN2;NAA35;ZFAND6;YAP1;RNF144B;NDNF;SIX1;WNT5A;CCND2;PTK2B;PLK2;CARD14;FNIP1;MAEA;HSPA5;SH3RF2;MAP2K5;NRBP2;TFRC;BIRC3;TBX1;GOLPH3;PRKCD;ERC1;TPT1;ERCC5;SON;AKT1;BAG3;MCL1;TLE1;PRDX2;IFIT3;NR4A2;CD38;GCLC;ZC3H12A;KDR;TRIM27;ARHGDIA;PRKCG;BNIP3L;FOXQ1;HDAC1;RELA;FLT4;GATA6;CBX4;UBB;DNAJB6;SPHK1;PIM3;BNIP3;SFRP1;QARS1;RPL10;HYPK;MAZ;MAPK3;DNAJC3;TMBIM6;RETREG1;PRKAA2;BNIP1;BID;TCIM;RIPK1;WNT11;GPX1;PSEN2;PRELID1;NFKBIA;ALOX12;PARK7;LAMTOR5;HSP90B1;HMGN5;BABAM2;MT3;PIM2;PTRH2;PPARGC1A
prerank,modulation by symbiont of host process (GO:0044003),-0.5870248805436226,-1.287322403415809,0.18233082706766918,0.5262388901273409,1.0,4/10,14.26%,B2M;HGS;UBB;ENO1
prerank,embryonic organ development (GO:0048568),-0.38870426556618143,-1.2869032717109934,0.0966183574879227,0.5263301881399354,1.0,25/61,16.16%,PBX1;GLI2;PBX3;PCSK5;RBP4;RARB;TGFBR2;FGFR2;COL13A1;TEAD4;TEAD1;STRA6;KIT;KDR;GLI3;TGFB1;FLT3LG;MFSD2A;TAL1;SOX17;RPL10;PKDCC;ZFPM1;BMPR1A;SOX18
prerank,negative regulation of ATP metabolic process (GO:1903579),0.5509856041739717,1.2868984669909909,0.2158859470468432,0.7132385045621528,1.0,2/17,0.85%,PID1;CBFA2T3
prerank,"phagocytosis, engulfment (GO:0006911)",-0.42697308549526897,-1.2867625696082314,0.13863636363636364,0.525753551426999,1.0,5/36,3.21%,GULP1;GSN;RHOBTB1;ELMO1;THBS1
prerank,carbohydrate derivative catabolic process (GO:1901136),-0.5051339407123056,-1.2862129018260606,0.1648148148148148,0.5262652033628753,1.0,9/18,22.83%,ADAMTS9;STT3B;FUCA1;SAMHD1;DERA;NAGA;MANBA;NGLY1;FBXO17
prerank,motor neuron axon guidance (GO:0008045),0.5684179404713193,1.286176198935317,0.222,0.7136124775235857,1.0,2/15,1.80%,CHN1;SLIT1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),-0.480407538539571,-1.2861665940570965,0.166,0.5254487153296054,1.0,3/22,2.68%,EPHA4;ROCK2;SLC2A13
prerank,positive regulation of viral life cycle (GO:1903902),0.5264964555797914,1.286120017229332,0.21747967479674796,0.7122473136012061,1.0,4/22,8.52%,TMPRSS4;AXL;CHMP2B;TMPRSS2
prerank,regulation of interleukin-6 production (GO:0032675),-0.35337329202761436,-1.2860926349078157,0.04843304843304843,0.5247103186821153,1.0,36/96,26.94%,APP;IL6R;LBP;ARHGEF2;IL16;GAS6;ARRB1;LGALS9;WNT5A;STAT3;CD47;C1QTNF3;IL33;IL17RA;IRAK3;ZC3H12A;MAVS;CYBA;PLCG2;CD200;SIRPA;TLR4;POU2F2;SYK;TYROBP;XBP1;LPL;PTPN6;RAB7B;IL17D;MYD88;CD200R1;NCKAP1L;SETD4;TWIST1;BCL10
prerank,striated muscle cell differentiation (GO:0051146),0.5615563002635277,1.2859493106560886,0.21074380165289255,0.7111106371422617,1.0,5/16,6.68%,MEF2C;NRG1;SORT1;POPDC3;SIK1
prerank,positive regulation of nuclear division (GO:0051785),0.5300799345109528,1.2856857756303426,0.19731800766283525,0.7102351782706894,1.0,3/25,2.62%,PDGFRB;RGCC;IL1B
prerank,regulation of filopodium assembly (GO:0051489),-0.4291914271058695,-1.2856384870526423,0.13926940639269406,0.5249251669131313,1.0,10/38,9.01%,DPYSL3;NRP1;PALM;RHOQ;CAPZB;FNBP1L;ARAP1;DOCK11;PRKCD;PPP1R16B
prerank,regulation of tube diameter (GO:0035296),0.575995266813617,1.2852833985525107,0.23922413793103448,0.7082608616625369,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,vascular process in circulatory system (GO:0003018),0.575995266813617,1.2852833985525107,0.23922413793103448,0.7082608616625369,1.0,3/13,3.95%,ACE2;ROCK1;ADCY6
prerank,response to growth factor (GO:0070848),-0.41713070293513305,-1.2849581915091015,0.12684989429175475,0.5257866415079787,1.0,13/41,15.93%,TGFBR2;BMPR2;TGFBR1;KLF4;ACVR1;ACVRL1;MAP2K5;AKT1;GATA6;SPHK1;SFRP1;BMPR1A;NOS1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),-0.5454536235580282,-1.284505100913653,0.19659735349716445,0.5260613752882579,1.0,7/11,27.84%,GSN;LGALS9;PARK7;PLAUR;PIH1D1;FAS;PRR7
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.36350475964833756,-1.2838842155030634,0.08533333333333333,0.5267866683215133,1.0,14/86,6.10%,BMP6;SULF1;DAB2;ZNF423;CDH5;BMP7;BMPR2;THBS1;BMP4;TGFBR1;FOXD1;ACVR1;SDCBP;ACVRL1
prerank,endoplasmic reticulum organization (GO:0007029),-0.3713672581822937,-1.2832748927636894,0.07653061224489796,0.5275697189690257,1.0,33/72,28.14%,APP;TRAM2;LRRK2;SEC31A;LPCAT3;STX1A;SEC16B;LMAN1;ATL2;ALDH3A2;DOP1B;CAV2;VAPA;REEP1;REEP5;BNIP1;RAB18;STX18;GET1;SEC61A1;MOSPD3;GAK;EIF2AK3;SEC61B;REEP2;TMEM33;WDR83OS;CCDC47;SEC31B;ATL3;TRAM1;SEC16A;TLE6
prerank,response to retinoic acid (GO:0032526),-0.3905460208186641,-1.2831874669297405,0.12183908045977011,0.5268595717004996,1.0,17/59,13.68%,EPHA3;CTSH;WNT6;RBP4;WNT9A;ACER2;RARG;WNT5A;PTK2B;TBX1;FZD4;TRIM16;FZD7;WNT5B;ATM;GATA6;RET
prerank,epithelial to mesenchymal transition (GO:0001837),0.46273509562074755,1.2831831432903762,0.17297297297297298,0.7120186398702149,1.0,6/47,2.15%,LIMS1;HEY2;HEYL;NOTCH1;TBX3;ROCK1
prerank,regulation of macrophage chemotaxis (GO:0010758),0.5322686095365763,1.283124858042921,0.1839323467230444,0.7106853747649072,1.0,2/21,1.34%,IL34;PTK2
prerank,regulation of cytoskeleton organization (GO:0051493),0.4191545431744723,1.282787493193836,0.13615023474178403,0.7100135672880579,1.0,23/108,11.50%,DLC1;PDGFRB;PTK2;PHLDB2;ROCK1;RND3;GRHL3;SPEF1;PLXNB1;SH3BP1;RAC3;CORO2B;SYDE1;TESK1;TPPP;MTOR;CORO1A;MARK2;ARHGAP35;BICD2;CAMSAP3;PAK3;PAK1
prerank,cellular response to oxygen-containing compound (GO:1901701),0.36771524094897745,1.2820655298713786,0.08311345646437995,0.7104903866905851,1.0,38/291,9.15%,GUCY1B1;PTPRK;MEF2C;PID1;RORB;SPAAR;GNG2;PDE3A;RAPGEF2;RORA;GPER1;CPEB1;NR1H3;IL1B;FFAR2;NCF1;AXL;NCOA3;ADCY6;AKAP6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;HCN2;CACTIN;RAP1A;FAM210B;IRS1;MTOR;BRINP3;RYR3;HCN3;HTRA2;PKD2;LYN;PDGFB
prerank,regulation of smooth muscle contraction (GO:0006940),0.5451945194632866,1.2819655684734639,0.224,0.7092585127649171,1.0,3/20,3.63%,PLCE1;CHRNA3;NMU
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.40019631454797344,1.2819466475079102,0.11773255813953488,0.7078263603513368,1.0,25/163,12.13%,PDE4D;MEF2C;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;BLNK;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,cellular defense response (GO:0006968),0.4885965235536208,1.2801132881453714,0.17785843920145192,0.7109212258129611,1.0,8/40,8.20%,NCF2;IL1RL2;ADORA2A;NCF1;ITGB1;CXCR2;KLRG1;CCR9
prerank,protein localization to organelle (GO:0033365),-0.34091285030287705,-1.2797692615271288,0.046511627906976744,0.5351384117827991,1.0,46/133,24.44%,ZNF423;COL1A1;LAMP2;BMP7;APP;BMP4;TRAM2;RAB11A;LRRK2;SIX1;EHD1;OBSL1;ARL3;TULP3;TOR1AIP1;STX1A;OPTN;VPS35;RPL11;GBP5;MDM2;ALDH3A2;CALR;SNX10;RPA1;SCG3;VAPA;TTC21B;TMEM30A;GBP2;HHEX;LAMP5;MICALL1;RAB6A;GET1;WDR35;FAM83H;CEP68;TULP1;GAK;SEC61B;CNTLN;RIPOR1;WDR83OS;CCDC47;YWHAE
prerank,positive regulation of interleukin-12 production (GO:0032735),-0.44045875861846306,-1.2794603070524655,0.15584415584415584,0.5349276277848729,1.0,9/31,22.31%,PLCB1;IL16;LGALS9;MAPK14;PLCG2;TLR4;SYK;MDK;CCL19
prerank,cell-cell junction assembly (GO:0007043),0.445207308454972,1.2790798629959668,0.16472545757071547,0.711994738308269,1.0,11/63,7.13%,GJD3;GJC1;CDH2;JAM3;VCL;GJA4;CDH8;CDH22;CDH19;CDH20;CDH7
prerank,regulation of Notch signaling pathway (GO:0008593),0.44111278529413767,1.278473521546122,0.1721311475409836,0.7120542142353696,1.0,8/76,5.07%,NOTCH3;NOTCH1;MAML2;CHAC1;TSPAN15;CD46;PDCD10;SREBF2
prerank,regulation of Rho protein signal transduction (GO:0035023),0.4386523536914312,1.2782835773753418,0.152317880794702,0.7109948315248831,1.0,9/72,4.91%,DLC1;STARD8;EPS8;TNFAIP1;CUL3;STARD13;PDCD10;EPS8L1;RIT2
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),-0.3455740461804506,-1.2781844035374172,0.06824925816023739,0.5372208981315987,1.0,24/121,7.33%,BMP6;IGF1;EPHA4;NRP1;IL31RA;NEDD9;PECAM1;IL15;IL6R;IL6ST;ITGA5;PTPRJ;ANGPT1;GHR;ARHGEF2;ACVR1;PARP9;IGF2;GAS6;PARP14;ACE;EFNA5;PTK2B;STAT3
prerank,endothelial cell migration (GO:0043542),-0.4204483982687133,-1.2779267961236345,0.13090128755364808,0.5369154163765796,1.0,14/37,9.71%,FSTL1;CDH5;NRP1;DPP4;NOS3;PXN;ID1;CCN3;RHOA;CYP1B1;STAT1;LGALS8;PLXND1;CDH13
prerank,positive regulation of cellular component organization (GO:0051130),-0.34657811252703785,-1.2778757255864306,0.06876790830945559,0.536093430221268,1.0,35/107,20.14%,DAB2;TRABD2B;ATP10A;CDH5;BMP7;APOE;FRMPD4;SHANK3;IGF1R;TGFBR1;ASAP1;ADGRL1;AR;FNIP1;TFRC;BCL2L11;DAB2IP;LMAN1;TGFB1;SH3GLB1;ADD1;TAL1;BNIP3;SURF4;TMEM30A;BID;CD151;GPX1;PARK7;VCP;LRP4;RHOC;NOX1;SYK;TMED9
prerank,protein prenylation (GO:0018342),0.6079496431711797,1.2778543419722652,0.23554603854389722,0.7105811451519641,1.0,2/10,3.16%,PTAR1;CHML
prerank,negative regulation of macrophage activation (GO:0043031),0.5558458529746934,1.2774091300632893,0.2059447983014862,0.7102853600170284,1.0,5/16,6.03%,NR1H3;LRFN5;LDLR;TAFA3;IL4
prerank,positive regulation of translational initiation (GO:0045948),0.5665780167219022,1.2773595362597177,0.20833333333333334,0.7089508671869471,1.0,10/18,19.09%,DAZL;RPS6KB2;BOLL;YTHDF3;DDX3X;MTOR;YTHDF2;RPS6KB1;HABP4;POLR2D
prerank,response to ketone (GO:1901654),-0.4691000078198134,-1.276998615584596,0.15560165975103735,0.5374304768325602,1.0,5/24,5.53%,TGFBR3;SLIT2;CAV1;THBS1;YAP1
prerank,positive regulation of proteolysis (GO:0045862),-0.3914442042164481,-1.276046196365749,0.0997624703087886,0.5390127254812085,1.0,14/55,12.85%,CTSH;CCBE1;APOE;CYFIP2;SNX9;ADAM9;CTSC;RCN3;TNFRSF1B;CASP8;ZC3H12A;TBC1D10A;FGFR4;FBXW11
prerank,cortical cytoskeleton organization (GO:0030865),-0.41043086842332294,-1.2756661503712594,0.1497584541062802,0.539084446825447,1.0,17/41,22.24%,FMNL2;ROCK2;RHOBTB1;RHOQ;DLG1;EZR;RHOA;RHOB;FHOD1;TRPV4;LLGL2;RHOH;RHOC;PPP2R3C;PLEK;RHOBTB2;LCP1
prerank,regulation of monocyte chemotaxis (GO:0090025),-0.46777809598223763,-1.2755282596587028,0.1656441717791411,0.5385214043669719,1.0,8/24,15.73%,SLIT2;CXCL12;CCN3;NBL1;ANO6;DUSP1;CREB3;SERPINE1
prerank,metanephros development (GO:0001656),-0.4532783067158203,-1.275519551143059,0.14845360824742268,0.5375893898017358,1.0,9/26,14.82%,CTSH;BMP7;OSR1;BMP4;FOXD1;SIX1;PTCH1;SOX17;PKD1
prerank,neurotrophin signaling pathway (GO:0038179),0.5388371911984023,1.2749955476591692,0.2046783625730994,0.7135712359663079,1.0,6/21,10.31%,RAPGEF2;BCAR1;SORT1;NTRK2;RAP1A;DDIT4
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.5424495353121488,-1.2736222858484736,0.1541501976284585,0.5417405331945258,1.0,5/13,11.16%,NUPR1;LRRK2;CHMP4B;CHMP4A;PHF23
prerank,cell part morphogenesis (GO:0032990),0.5944015896400856,1.273569767991622,0.23236514522821577,0.7156870777747177,1.0,3/13,12.39%,PID1;SUPV3L1;MFF
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),-0.5752842945081975,-1.2735562481905156,0.18568665377176016,0.5409418080587575,1.0,7/10,37.03%,INO80;SSBP1;DBF4;STOML2;WIZ;ATRX;E2F8
prerank,organophosphate ester transport (GO:0015748),0.5269201609384324,1.2734720452410204,0.2127659574468085,0.7144613118350961,1.0,3/24,3.38%,PITPNC1;SCARB1;LDLR
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),-0.4652889041463657,-1.2733427385938059,0.1557377049180328,0.5405816262830964,1.0,6/23,15.77%,IGF1;APP;HIF1A;P2RX7;ENTPD5;PRKAA2
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),0.6120101002110675,1.2733183274730981,0.21800947867298578,0.713371988619837,1.0,2/12,2.62%,GCNT2;IL1B
prerank,regulation of MAPK cascade (GO:0043408),-0.3252746272056868,-1.273201709053902,0.06430868167202572,0.5400189327543032,1.0,39/157,14.53%,TGFBR3;IGF1;FN1;EGFR;FLT1;ROCK2;EPHA7;NTRK3;LPAR1;TEK;IQGAP1;CAV1;JCAD;KSR1;FGFR2;NRK;PTPRJ;IGF1R;GSDME;IGF2;IAPP;DUSP1;TBX1;ADRA1B;TAOK2;KIT;EPHA8;DAB2IP;KDR;P2RX7;MYOC;PPEF2;FLT4;CCN1;PRDM11;PLCG2;RET;CAV2;MAPK3
prerank,negative regulation of T cell mediated immunity (GO:0002710),-0.5726458202441814,-1.2728056859994847,0.18548387096774194,0.5401369156247273,1.0,4/11,15.89%,SMAD7;AHR;HFE;CEACAM1
prerank,lamellipodium assembly (GO:0030032),0.5185234510941041,1.2727714934178649,0.20081967213114754,0.7132818228104627,1.0,5/26,5.53%,CARMIL1;ARHGEF6;VCL;SPEF1;ITGB1
prerank,regulation of gene expression (GO:0010468),-0.2709618530031057,-1.272484171809032,0.0,0.5400904750036998,1.0,185/903,13.91%,BMP6;AFDN;BNC2;PRDM6;NOTCH2;IGF1;ROBO1;SLC24A3;FOXN3;ZNF423;FN1;AFF3;SMAD3;SMARCA2;CDH5;EFEMP1;ROCK2;FOXP1;AHNAK;WNT4;NTRK3;GSN;HDAC4;DENND4A;CTSH;WWC2;CHD7;OCLN;BMP7;APOE;OSR1;APP;NFIA;NR3C1;F3;KAT6B;WNT6;CLDN5;ITGB8;XDH;SUFU;MBNL1;ESR1;NOS3;BMP4;GJA1;EZR;PRRX2;TGFBR1;FOXD1;ANGPT1;KLF4;CSF1;CDH1;LEF1;TAF1;RAMP2;SBNO2;CD34;HOXA5;ADAM10;SMO;PARP9;CNOT7;IGF2;MED26;SSBP2;GAS6;TAPBP;GTF2IRD1;ARNT2;RBM20;WWP2;AR;FGF1;RAB27A;CREM;LGALS9;PARP14;YAP1;MOV10;SFRP4;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;WNT5A;MAPK14;FOXC1;IRF2;SLC7A5;CHD3;STAT3;HINFP;AFF2;NR2C2;PGR;TFRC;NOCT;ZNF219;ACTG1;ERC1;AFF1;DTNBP1;IGF2BP2;POLR2A;ATRAID;TRRAP;GON4L;PIK3CB;NOVA2;NOS1AP;SON;VSX1;AKT1;HGS;RREB1;IL33;REXO4;HIF1A;PCBP2;TLE1;CCN4;CRABP2;CARM1;FLOT2;TULP3;FZD7;FLCN;CASP8;EMILIN1;SEC16B;ZC3H12A;PRDM5;SLC39A8;KDR;ESRRG;PML;ANXA7;TRIM27;P2RX7;GATA2;VPS35;BRCA2;PATZ1;CLK1;RPL11;NFYC;HINT1;PUM1;TGFB1;NSD1;AHR;HDAC1;FGFR4;EPHX2;TMEM119;EPHB2;MBNL2;RELA;GRSF1;ID2;NOVA1;YBX3;SRSF10;ZNF462;ATM;PRKAB1;PRDM11;CALR;GLRX2;ATOH8;TDG;CLOCK;PTHLH;WNT16;TRIM39;PLCG2;LARP1;HDAC5;TICAM1;SOX17;SFRP1
prerank,T cell receptor signaling pathway (GO:0050852),0.40434198298438245,1.2724418185576598,0.14285714285714285,0.7126447666881932,1.0,23/138,12.13%,PDE4D;PIK3CD;TNFRSF21;PIK3R1;BTRC;BCAR1;WAS;RFTN1;PTPN22;PIK3CA;PAG1;PSMB11;MOG;PDE4B;PSMF1;RIPK2;CSK;PRKD2;EIF2B3;PAK3;PAK1;TEC;PSME4
prerank,negative chemotaxis (GO:0050919),-0.4265073192290534,-1.2721945151994298,0.14669421487603307,0.5398960631949937,1.0,14/33,16.62%,ROBO1;EPHA7;SEMA3D;SEMA6A;SEMA3C;SLIT2;SEMA7A;RHOA;SEMA3E;ITGB3;SEMA3B;NTN1;SEMA3G;SEMA6B
prerank,regulation of protein phosphorylation (GO:0001932),-0.3038040924571113,-1.2711443247686303,0.03879310344827586,0.5417609085363242,1.0,67/256,14.83%,DAB2;FN1;EGFR;LEPR;CDH5;ROCK2;EPHA7;NTRK3;PTPN13;FBLN1;PLPP3;OCLN;BMP7;TEK;PECAM1;APP;SLIT2;XDH;BMP4;ANGPT1;LRRK2;LRP6;NIBAN1;VEGFD;IGFBP3;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;STAT2;BMPER;EFNA5;CCND2;CARD14;FNIP1;CCND3;TFRC;TBX1;WDFY2;AKT1;IRGM;FLCN;DAB2IP;ZC3H12A;KDR;PML;MAVS;ITGB3;TGFB1;NSD1;TMEM119;EPHB2;FLT4;CCDC88C;CCN1;TWF1;CDK2AP1;CCND1;FER;LIMCH1;NDUFS4;PPIA;FXR2;MAPK3;CORO1C
prerank,negative regulation of transport (GO:0051051),0.46733302535355553,1.2709897255575997,0.1746031746031746,0.7149877928991535,1.0,7/51,6.29%,PTEN;DYSF;NR1H3;NRG1;NDFIP2;SCAMP5;SNCA
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.42809164286505114,1.2703457439536527,0.18076285240464346,0.7150832236885418,1.0,21/75,11.85%,PTEN;SPRY4;PRKAR1B;NF1;IL1B;SH2B3;PKIA;SPRY2;HEXIM1;CD300A;TESK1;UCHL1;PRKAR2B;PRKAR2A;INCA1;NR2F2;LYN;PRKAR1A;LATS2;RB1;APC
prerank,cellular response to organic substance (GO:0071310),-0.3386394037001029,-1.2703438907160514,0.06402439024390244,0.5429880147521758,1.0,23/116,7.48%,DPYSL3;SMAD3;NFAT5;PTPN14;PTPN13;IGFBP5;SLIT2;TGFBR2;BMPR2;TGFBR1;CLEC3B;KLF4;LRRK2;GHR;LEF1;ACVR1;SOCS2;RAMP2;ACVRL1;RHOA;CYP1B1;STAT3;MAP2K5
prerank,sodium ion export across plasma membrane (GO:0036376),0.5852050353077103,1.2699012238503948,0.2229038854805726,0.7148005828933941,1.0,4/13,4.90%,ATP1A2;ATP1A4;FXYD2;ATP1B2
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),0.5118094577667636,1.268472427673905,0.2297551789077213,0.7170168831687629,1.0,8/27,7.19%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,secretion (GO:0046903),-0.5338010746387137,-1.2681288503112766,0.18250950570342206,0.5480054599958115,1.0,6/14,16.74%,FBLN5;SLC22A6;NPR1;SLC22A4;TPD52;SLC22A2
prerank,blood vessel morphogenesis (GO:0048514),-0.3863083132558714,-1.2679396257240332,0.11358024691358025,0.5475238404296111,1.0,17/54,8.16%,TGFBR3;FLT1;EFNB2;NRP1;LAMA1;CCBE1;CAV1;ITGB8;TGFBR2;TGFBR1;SMAD7;ID1;RAMP2;RASIP1;CYP1B1;TBX1;STRA6
prerank,positive regulation of phospholipase C activity (GO:0010863),0.469102553363462,1.2679072039275743,0.20555555555555555,0.716938470468396,1.0,6/40,7.15%,PDGFRB;EDNRA;ARHGAP6;FGF2;NTRK2;HRAS
prerank,neuron migration (GO:0001764),0.45545333540582084,1.2672464442766405,0.19107142857142856,0.717201655213643,1.0,14/48,10.61%,MEF2C;ADGRL3;RAPGEF2;MARK1;ASTN1;FGF13;DNER;ASTN2;NTRK2;TUBB2B;CCK;MARK2;DDIT4;SPOCK1
prerank,defense response to protozoan (GO:0042832),-0.5460470796595093,-1.2671502493253552,0.1968810916179337,0.5487017864583985,1.0,8/12,32.87%,GBP4;GBP6;GBP7;GBP2;MYD88;LYST;CD40;BATF2
prerank,hematopoietic stem cell differentiation (GO:0060218),-0.5829704369133065,-1.2671178767059426,0.17702448210922786,0.5478213333706063,1.0,6/10,25.85%,MLLT3;ACE;SFRP1;LMBR1L;SP7;TP53
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.4475582450972973,-1.2671171035390707,0.14516129032258066,0.5468803651444718,1.0,8/26,8.76%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;CCND3;UBE2E2;AKT1
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.4971901157948565,-1.2671158035211212,0.18426103646833014,0.5459426304861246,1.0,2/17,3.14%,PLA2G4A;LPGAT1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.6132157116752304,1.2669121040821258,0.25112107623318386,0.716605118107736,1.0,3/11,7.30%,CACNB2;CACNA2D1;BIN1
prerank,regulation of histone modification (GO:0031056),-0.5302509967088372,-1.266216944677781,0.1761252446183953,0.547441441701058,1.0,5/13,18.15%,IGF2;FLCN;NNMT;CDK9;PARK7
prerank,synaptic membrane adhesion (GO:0099560),0.5627166384028819,1.2659865073392151,0.23684210526315788,0.7175531187457049,1.0,4/14,12.82%,LRRC4C;LRFN5;SLITRK1;SLITRK2
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.4763769942613112,-1.264836034518456,0.15432098765432098,0.5502301623550384,1.0,4/20,2.33%,FMNL2;ROCK2;RHOQ;DLG1
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.39096188000774623,1.2646272980982363,0.1440329218106996,0.719473985966648,1.0,26/152,9.85%,S1PR3;PTH1R;ADGRL3;TBXA2R;UCN2;ADORA2A;GPER1;GNAZ;ADCYAP1R1;GIPR;ADCY8;ADCY3;ADCY6;HTR1B;CXCL10;OPRK1;ADCY9;WASF2;CACNA1D;GPR37;AKAP12;GRK5;ADGRB3;GNA12;ADGRE5;NPY1R
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),-0.5489326015582264,-1.2645031911341436,0.19172932330827067,0.5502171451260954,1.0,4/12,11.59%,ESR1;STAT3;ZC3H12A;TGFB1
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.5951341920815186,1.2644738422475692,0.23356009070294784,0.7183793340075811,1.0,3/13,6.40%,HEY2;NOTCH1;RYR2
prerank,circulatory system development (GO:0072359),0.40566760303311583,1.2641065543313206,0.1540880503144654,0.7179043501327943,1.0,13/118,3.07%,ADAP2;CACNA1C;PTEN;PLCE1;MEF2C;HEY2;NOTCH1;NF1;FGF12;ERBB4;UTY;PIK3CA;ECE1
prerank,negative regulation of interleukin-10 production (GO:0032693),0.5599988798062601,1.2639613271207704,0.23542116630669546,0.7168029576655064,1.0,2/16,5.34%,TNFRSF21;TRIB2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.3949954855620018,1.2632198882013734,0.1467065868263473,0.7171885267734416,1.0,8/138,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.4510010796513628,-1.263216465081264,0.16326530612244897,0.5527434146487273,1.0,14/29,27.00%,TCF7L2;TLE4;LEF1;TRRAP;TLE2;TLE1;BCL9L;HDAC1;PYGO2;SMARCA4;PYGO1;TCF7;CTNNB1;BCL9
prerank,regulation of apoptotic signaling pathway (GO:2001233),-0.4156631554781429,-1.2631652768533599,0.16666666666666666,0.5519294721997372,1.0,15/36,27.22%,SGMS1;TGFBR1;DEPTOR;NR4A2;DAB2IP;TRIM39;QARS1;PPIA;MAZ;TMBIM6;TPD52L1;RPS3;FAS;CRADD;DAPK2
prerank,monoacylglycerol metabolic process (GO:0046462),-0.53241077062389,-1.2629077458716036,0.19668737060041408,0.5517081386294789,1.0,4/13,20.52%,PLA2G4A;MGLL;ABHD16A;DGAT2
prerank,regulation of inflammatory response (GO:0050727),-0.3152289014907771,-1.2628554833475725,0.034013605442176874,0.5509196119610796,1.0,45/190,12.45%,ADAMTS12;CDH5;FOXP1;PTGIS;TEK;APOE;CASP12;APP;IL15;IL1R1;SNX6;SEMA7A;KLF4;ANXA1;PDCD4;SBNO2;IL16;LACC1;CCN3;LPCAT3;CASP4;WNT5A;TNFRSF1B;ENPP3;MFHAS1;PIK3AP1;CD47;BIRC3;TMSB4X;PRKCD;DAGLB;C1QTNF3;USP18;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;METRNL;VPS35;MGLL;PTGS2;RELA;PPARA
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),-0.5307138779731244,-1.2622518493633075,0.2099009900990099,0.5516450782766286,1.0,3/13,13.01%,RHOQ;LRRK2;RAN
prerank,fluid transport (GO:0042044),-0.5526466452081676,-1.261017830579809,0.20075046904315197,0.5540396548415775,1.0,2/12,15.56%,PDPN;AQP11
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.49850327730255184,-1.2605418657334777,0.1865079365079365,0.5544285651957207,1.0,4/16,12.43%,ST3GAL4;NFAT5;RHOA;RELA
prerank,excitatory postsynaptic potential (GO:0060079),0.5296463786189485,1.260045952719239,0.2332657200811359,0.7237352100971709,1.0,3/19,3.41%,MEF2C;MPP2;CHRNA3
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5244128865010986,-1.259542576822128,0.17794970986460348,0.5561934313498519,1.0,4/15,8.90%,PIEZO2;COL11A1;ADGRV1;KIT
prerank,regulation of stem cell population maintenance (GO:2000036),0.5428742168665321,1.2591234656755546,0.2399193548387097,0.7246172432298785,1.0,4/18,5.75%,NODAL;PTN;NCOA3;CNOT2
prerank,eye photoreceptor cell development (GO:0042462),0.5825037408820094,1.2586954995191535,0.2594142259414226,0.724250872143061,1.0,1/15,0.82%,RORB
prerank,negative regulation of fatty acid metabolic process (GO:0045922),-0.4966524230124561,-1.2582839788444462,0.19961977186311788,0.5587208197500424,1.0,8/16,31.51%,APPL2;ACADL;CEACAM1;ERLIN2;BRCA1;SIRT4;TRIB3;APOC1
prerank,positive regulation of cellular component biogenesis (GO:0044089),-0.35337941204573203,-1.2582369912258926,0.10109289617486339,0.5579134159841612,1.0,35/88,23.51%,TRABD2B;SMAD3;CDH5;BMP7;SDCBP;SMPD3;PDCD6IP;SYNPO2;SDC4;SYNPO;FNIP1;TFRC;HGS;BCL2L11;EMILIN1;DAB2IP;RAB7A;TGFB1;SH3GLB1;PFN1;TAL1;SDC1;BID;TPR;STX18;PARK7;VCP;RHOC;SYK;PLEK;VEGFA;PIH1D1;SLX4;ICE1;ERCC1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.41609065666293993,-1.2580170579624887,0.13555555555555557,0.557553611181901,1.0,13/37,16.89%,PRKAG2;CEMIP;BMP7;APP;SMAD7;CALM2;PARD3;IRGM;TGFB1;PPEF2;SPHK1;CALM1;SIRT2
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.47455630195249193,1.2578236316012206,0.2103386809269162,0.7250827338907565,1.0,10/40,10.93%,SGIP1;VTN;LDLRAP1;WASL;ATAD1;IL4;PPT1;HIP1;DGKD;AHI1
prerank,positive regulation of macrophage migration (GO:1905523),0.5254787437199961,1.2571082665422677,0.2292576419213974,0.7254535499333895,1.0,2/19,1.34%,IL34;PTK2
prerank,early endosome to Golgi transport (GO:0034498),-0.5513021067065242,-1.2565671983291855,0.19117647058823528,0.56048955083151,1.0,7/11,22.31%,TRAPPC10;LMAN1;SURF4;RAB6A;SNX8;TMED9;SNX2
prerank,receptor catabolic process (GO:0032801),-0.4597130874584712,-1.2564196178537619,0.19532908704883228,0.5599956789652136,1.0,10/24,13.03%,RNF43;AP2A2;SMURF1;CLTA;BECN1;ZNRF3;TGFB1;SH3GLB1;AP2A1;UVRAG
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.5388831121072838,1.2562451497802225,0.24324324324324326,0.7262010285534973,1.0,2/21,0.84%,MBOAT2;PLA1A
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.4714250903326308,1.2555693453715837,0.20216606498194944,0.7264860978331746,1.0,9/42,9.82%,UTRN;LIMS1;CDK6;FERMT2;ROCK1;RIN2;EMP2;MAP4K4;EFEMP2
prerank,regulation of anoikis (GO:2000209),0.5432954292449298,1.2551214230831564,0.23917525773195877,0.72609001167726,1.0,8/19,12.52%,NOTCH1;PTK2;PIK3CA;ITGB1;SIK1;SNAI2;ANKRD13C;SRC
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4842154461169573,1.2550726250536783,0.2159090909090909,0.724823571259408,1.0,5/35,3.58%,PIGU;NOTCH1;ERBB4;CRLF3;SH2B3
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),0.5595936075141551,1.2546284764812674,0.23780487804878048,0.7245243088543525,1.0,6/15,17.43%,BCAR1;SORT1;NTRK2;DDIT4;SOS1;HAP1
prerank,positive regulation of nervous system development (GO:0051962),0.4666921315682183,1.2546184296983818,0.17953321364452424,0.7231513961448761,1.0,13/42,15.28%,CLSTN1;GPER1;NRXN1;CLSTN3;LIG4;IL1RAPL1;CUX2;SPEN;EPHB1;SLITRK2;NLGN3;SYNDIG1;FAIM
prerank,regulation of cell communication (GO:0010646),0.49070440107982966,1.254516304397465,0.2124756335282651,0.7220467866992896,1.0,10/35,14.03%,CASQ2;IGFBP7;GRK3;RYR2;GRK5;NCLN;TBX18;PTPN1;GRK4;ANK2
prerank,amide transport (GO:0042886),-0.45177753226096606,-1.2539746615949086,0.17193675889328064,0.5655961205004191,1.0,7/26,10.88%,PDPN;PLTP;CERT1;ABCG2;SLC5A6;SLC38A5;DISP1
prerank,positive regulation of immune effector process (GO:0002699),-0.4489399273258736,-1.2530834510429172,0.15176715176715178,0.5669730931648038,1.0,7/27,7.41%,LBP;MYO18A;PTPRJ;DDX60;LGALS9;APPL2;RPS19
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.5102358733672412,1.252644463808781,0.2248062015503876,0.725443215791993,1.0,3/24,2.80%,MEF2C;CDH2;NRG1
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),-0.5412430816665391,-1.2516342803682015,0.21682242990654205,0.5699743433546564,1.0,4/12,8.87%,F3;APOD;PTPRJ;HGS
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",-0.2696610758432156,-1.251436858471266,0.0,0.5694735729450068,1.0,250/1082,18.15%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;ZNF423;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;COL1A1;DCN;NFAT5;WNT4;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CREB5;IL31RA;CDK8;BMP7;RHOQ;SP100;GLIS3;ELF2;FOXO1;APOE;OSR1;FOXO3;APP;MDFIC;ZIC2;NFIA;NR3C1;HDAC8;KAT6B;HIVEP3;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;TGFBR1;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;MLLT3;SBNO2;THRB;RGMB;HOXA5;CREB3L2;SKI;PCGF5;ZFPM2;PARP9;DCAF6;IGF2;SSBP2;ARRB1;QRICH1;NIBAN2;ARNT2;AR;FGF1;BRD7;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;PRDM16;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;SFR1;TBX1;SSBP3;FZD4;TFCP2;ZBTB18;FIZ1;AKT1;DTX3L;RREB1;IL33;HIF1A;TNFRSF1A;TRIM16;NLRC5;FOXK1;CDH13;NR4A2;MMS19;FZD7;FLCN;ATF6;FOSL2;CD38;PHF10;DAB2IP;IL18;KARS1;ZC3H12A;ZKSCAN3;ESRRG;FHOD1;EIF5A;PML;MAVS;GATA2;BRCA2;CEBPG;KDM3A;GLI3;TGFB1;NSD1;ELK3;BCL9L;AHR;HDAC1;ATXN7L3;ZIC3;RELA;PPARA;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;FBXW11;PRDM11;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;SPP1;MPND;HDAC5;RET;TAL1;SOX17;HSF2;SFRP1;SMARCC1;POU2F1;MAZ;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;DYRK1B;NKX6-1;SNAI1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;RNF187;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;MYRF;SIRT2;HNRNPAB;ATF1;MED21;RIPK1;WNT11;PTOV1;NFIL3;RAI1;SLC9A1;FZD1;HMGN1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,protein polymerization (GO:0051258),0.45650072437054323,1.251266473639523,0.21122112211221122,0.7275425160293173,1.0,9/55,6.38%,CASQ2;ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL;FGF13;TPPP
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.43170873820623273,1.251199565614939,0.18302828618968386,0.7262999367163953,1.0,7/67,3.88%,CARMIL1;UTRN;LIMS1;ECM2;CDK6;FERMT2;RAC3
prerank,potassium ion homeostasis (GO:0055075),0.524487559111127,1.2506567342560553,0.23473282442748092,0.7261918660042794,1.0,6/23,5.65%,SLC12A2;ATP1A2;ATP1A4;SLC12A6;ATP1B2;TFAP2B
prerank,defense response to virus (GO:0051607),0.40541779324754246,1.2500959269009093,0.16411042944785276,0.7262144459098461,1.0,1/100,0.01%,ABCC9
prerank,negative regulation of cell migration (GO:0030336),-0.3295420679181542,-1.2498587579802598,0.0847457627118644,0.5728132441585138,1.0,28/137,7.29%,AFDN;MCC;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;COL3A1;CLIC4;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;GJA1;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;IGFBP3;PTPRG;SCAI;ACVRL1;CYP1B1;RHOB
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),-0.4897071426983366,-1.2493629439977643,0.203125,0.5731837211025316,1.0,4/15,15.72%,SMAD7;IRAK3;TGFB1;HFE
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),-0.32671358658781613,-1.2491908778812573,0.061946902654867256,0.5727651944232246,1.0,40/138,14.23%,EPHA4;EPHA3;EGFR;FLT1;MTSS1;EPHA7;PDGFRA;NTRK3;IL31RA;TEK;NEDD9;FGFR2;BMPR2;IL6ST;EPHB4;IGF1R;MPZL1;YES1;CSF1;NPR1;PTPRG;DDR1;BDKRB2;PTK2B;TRIO;RAPGEF1;PIK3CB;TIE1;KIT;EFS;FRS2;EPHA8;KDR;FGFR4;EPHB2;FLT4;MET;FER;RET;STYK1
prerank,regulation of programmed cell death (GO:0043067),-0.32307926587757996,-1.2486227265063548,0.08118081180811808,0.5733062240678796,1.0,61/161,28.85%,DAPK1;MECOM;PPP1R13B;STEAP3;ACTN2;TGM2;GAS1;FBXO10;LRRK2;TRIM24;IGFBP3;ACER2;RARG;ACER3;STAT1;BIRC3;ANP32E;TPT1;ANP32B;AKT1;CTSB;BCL2L11;PRDX2;BNIP3L;NME1;ACTN1;ATM;CALR;LRP8;BNIP3;PLSCR3;CASP6;BID;RIPK1;PRELID1;ALK;AGT;VCP;LGALS1;SLK;USP36;LCMT1;OSGIN1;PTPN6;STK26;NTF3;PSMC5;RPS3;PLK5;PRKN;TP53;FAS;CRADD;APAF1;SRA1;DAPK2;ABL1;CLU;NUP62;FANK1;ANP32A
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.4868528574568503,1.2485448911447428,0.19348659003831417,0.7286759161185459,1.0,9/31,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,leukocyte tethering or rolling (GO:0050901),0.552860243743578,1.2484732323536585,0.22699386503067484,0.7274509017561658,1.0,3/17,5.53%,ITGA4;ROCK1;ITGB1
prerank,tetrahydrobiopterin metabolic process (GO:0046146),-0.5442044393644732,-1.2483598311593933,0.19183673469387755,0.5730953077293873,1.0,5/11,16.18%,NOS3;AKT1;GCH1;PTS;CALM1
prerank,positive regulation of DNA replication (GO:0045740),-0.4953770927415068,-1.248185949157063,0.1907514450867052,0.5726256280366007,1.0,2/16,1.10%,EGFR;GLI2
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.4877144134764403,-1.2475452055671026,0.19230769230769232,0.573483877108338,1.0,4/18,6.79%,CAMK1D;SLIT2;IL6R;PTK2B
prerank,myoblast differentiation (GO:0045445),-0.5156966732052347,-1.2475338119995212,0.19818181818181818,0.5725840895519337,1.0,5/14,7.36%,IGF1;MBNL1;DDX5;TCF7L2;HINFP
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),-0.3227556723288231,-1.2472286687708343,0.08433734939759036,0.5724599658865119,1.0,56/148,26.75%,PRKAG2;PPP1R13B;TAF1;RBBP7;BRD7;KMT5A;MAP2K6;RPS20;MAPK14;CHD3;AKT1;MEAF6;CCNG1;RPL37;EHMT1;PML;PIP4K2B;RPL11;PAK1IP1;HDAC1;PRKAG3;MDM2;ATM;PRKAB1;RPA1;RAD50;HIPK2;RPS15;TAF4B;RPL23;PRKAA2;TP53RK;PDPK1;PPP2R5C;RFC3;CHD5;TAF9B;CDK5RAP3;RFFL;TOP3A;PRKAG1;BRPF1;TAF5;USP2;RMI2;CHEK2;STK11;TTC5;BRCA1;RPA3;RRS1;L3MBTL1;TP53;HUS1;TAF11;TPX2
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.48781343384392695,-1.2471382937308984,0.2085889570552147,0.5717585699132732,1.0,4/18,4.15%,VGLL4;APOE;EZR;CTSC
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.41824098752212,-1.2465987803646763,0.16237623762376238,0.5722950635334539,1.0,11/33,13.57%,PLCB1;EGFR;ANXA1;ADAMTS1;CCND2;STXBP4;CCND3;UBE2E2;AKT1;PLCG2;CCND1
prerank,regulation of sequestering of calcium ion (GO:0051282),0.5735013466514737,1.2464874861549409,0.23210412147505424,0.7309059093001414,1.0,4/12,14.03%,CASQ2;RYR2;CASQ1;ANK2
prerank,positive regulation of gene expression (GO:0010628),-0.28206670223197344,-1.2462079770190182,0.011560693641618497,0.5724453380683268,1.0,93/442,13.39%,BMP6;AFDN;IGF1;ROBO1;SLC24A3;FN1;SMAD3;EGFR;SAMD4A;CDH5;ROCK2;NTRK3;GSN;CTSH;OCLN;BMP7;OSR1;APP;IL15;F3;WNT6;VIM;CLDN5;ITGB8;NOS3;THBS1;BMP4;GJA1;EZR;TGFBR1;FOXD1;ANGPT1;LARP4B;KLF4;DDX5;KAT2B;CSF1;LEF1;RAMP2;NIBAN1;CD34;HOXA5;SMO;MED26;GAS6;RBM20;AR;FGF1;RAB27A;LGALS9;YAP1;MOV10;SFRP4;WNT5A;MAPK14;STAT3;HINFP;RPS4X;BAZ1B;TFRC;ACTG1;DTNBP1;POLR2A;PIK3CB;C1QTNF3;NOS1AP;AKT1;HGS;UPF3A;IL33;HIF1A;TLE1;EMILIN1;SEC16B;ZC3H12A;P2RX7;GATA2;VPS35;RPL11;ERN1;TGFB1;FGFR4;EPHX2;TMEM119;EPHB2;CPEB3;ID2;POLR2F;ATM;PRKAB1;WNT16;RPL26;PLCG2
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.5524341013944839,1.2460268952401121,0.24329501915708812,0.7306489588609579,1.0,5/17,10.01%,WASF3;ABI2;WASF2;CTNNA2;NCKAP1
prerank,heart trabecula morphogenesis (GO:0061384),-0.474518613213998,-1.2458041553274661,0.1917808219178082,0.5726496992219368,1.0,7/18,7.22%,TGFBR3;BMP7;TEK;ADGRG6;RBP4;TGFBR1;FKBP1A
prerank,adherens junction organization (GO:0034332),0.4604124765305348,1.2456978607345623,0.21554770318021202,0.730085757707819,1.0,14/48,10.27%,CDH2;CDH4;JAM3;VCL;FERMT2;CADM2;CDH8;CDH22;CDH19;CDH20;CDH7;CSK;CDH10;CDH18
prerank,positive regulation of protein autophosphorylation (GO:0031954),-0.4562258887023801,-1.2451766683157612,0.19103313840155944,0.5735290321947814,1.0,10/22,17.39%,PDGFD;RASSF2;ACE;TOM1L1;CALM2;TAOK2;RAD50;CALM1;RAP2C;PDGFC
prerank,regulation of macrophage activation (GO:0043030),-0.4307845843882248,-1.2446398009676771,0.18052738336713997,0.5740754977908386,1.0,12/30,16.55%,IL31RA;LBP;MYO18A;THBS1;WNT5A;MFHAS1;IL33;KARS1;ZC3H12A;SPHK1;CD200;TLR4
prerank,regulation of intracellular signal transduction (GO:1902531),0.34595405663465306,1.2445744911587229,0.08292682926829269,0.7314594271159879,1.0,75/420,12.41%,DLC1;STARD8;CHN1;PIP5K1B;PTEN;ARHGEF17;ARHGAP21;ARHGAP10;KALRN;PLEKHG2;PRDM1;ARHGAP6;ARHGAP32;PHLPP1;ARHGEF6;LBH;ARHGAP1;PRKAR1B;SPRED1;IL1B;PTPN22;PIP4K2A;STARD13;ARAP2;RAC3;TRAF5;AKAP6;MINK1;RIT2;SYDE1;PEX5L;ROS1;PIP4K2C;NTRK2;PRKAR2B;ARHGEF12;TAOK3;ARHGEF26;SOS2;SLC15A2;TRAF3;PAK6;RAD1;STK3;ARHGDIB;MTOR;PRKAR2A;AKAP12;GNA12;ANKRD54;MAP4K4;PRKD2;ARHGEF9;LYN;ARHGAP35;PAK5;INPP5B;AKAP7;ATR;PRKAR1A;TBP;TAF6;DDIT4;KAT6A;ARHGEF7;PAK3;HIPK1;NUAK1;PAK1;EP300;ARHGEF4;WWC1;TTI1;ARHGAP9;ARHGAP26
prerank,DNA strand elongation (GO:0022616),0.5484350917536679,1.2435465534390824,0.2439516129032258,0.7326469700139168,1.0,5/18,10.98%,DCLRE1B;GINS1;GINS3;GINS4;MCM7
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.5993337016923909,1.242767343839343,0.26096997690531176,0.7331971168865791,1.0,2/10,1.19%,FAP;NOTCH1
prerank,clathrin-dependent endocytosis (GO:0072583),0.5004832030655223,1.2427306983099198,0.2403846153846154,0.7319005610625855,1.0,1/26,0.11%,SGIP1
prerank,regulation of protein-containing complex disassembly (GO:0043244),-0.5019028213153979,-1.2421517871152112,0.20997920997921,0.5800476129664343,1.0,5/16,16.11%,IGF1R;CLEC16A;IRAK3;BNIP3;TBC1D25
prerank,regulation of lipid kinase activity (GO:0043550),0.5801982056541763,1.2420716024335978,0.25675675675675674,0.7321154386444746,1.0,3/11,11.67%,PIK3R1;RBL1;RB1
prerank,cellular response to cadmium ion (GO:0071276),-0.45680678223476434,-1.241669713941936,0.17338709677419356,0.5803775434535553,1.0,12/24,20.00%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,negative regulation of cell development (GO:0010721),-0.43864789367879364,-1.2415381966802885,0.19230769230769232,0.5797861113696142,1.0,4/25,5.51%,IGF1;FBN1;B2M;APPL2
prerank,regulation of T cell mediated immunity (GO:0002709),0.5825500265511446,1.240902821856303,0.2531914893617021,0.7336838762090684,1.0,2/10,2.62%,WAS;IL1B
prerank,cellular response to cytokine stimulus (GO:0071345),-0.2873674786157719,-1.2408745831765227,0.02717391304347826,0.5806234517517411,1.0,100/416,15.90%,DAPK1;COL1A2;DPYSL3;FN1;SMAD3;ADAMTS12;LEPR;NFAT5;PTPN14;PTPN13;ST3GAL6;PTGIS;IL31RA;FOXO1;FOXO3;F3;IL1R1;IL6R;VIM;LBP;IL6ST;PTPRJ;LRCH1;GHR;ANXA1;CSF1;ARHGEF2;LEF1;SOCS2;VCAM1;GSDME;SBNO2;IL16;IRAK2;CXCL12;GAS6;ZFAND6;LGALS9;STAT2;MAOA;GREM2;IRF1;WNT5A;CCL15;TNFRSF1B;ICAM1;RHOA;FOXC1;WNK1;STAT1;STAT3;CCL14;CD47;STX3;GBP4;DUSP1;RAPGEF1;PIK3CB;AKT1;KIT;MCL1;IRGM;HIF1A;TNFRSF1A;BCL2L11;LAMA5;IFIT1;IRAK3;DAB2IP;IL18;STX1A;ZC3H12A;GBP6;GBP5;TGFB1;PTGS2;INPP5D;CCL25;GBP7;RELA;S1PR1;YBX3;FLT3LG;UBB;LRP8;CCND1;FER;OXSR1;UBE2G2;SFRP1;POU2F1;CDK9;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;CDKN1B
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.5541523054618123,-1.2405192242083967,0.20733944954128442,0.5806720660039026,1.0,5/10,18.15%,DIP2B;FLCN;PRKAA2;KLF15;PARK7
prerank,regulation of neuron projection arborization (GO:0150011),-0.49365389170963414,-1.2399912356416434,0.20883534136546184,0.5812018031450875,1.0,7/15,17.64%,MACF1;MOV10;WNT5A;MYO9A;FZD4;MFSD2A;MAP3K13
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.4632286151240914,1.2390823928756454,0.2202797202797203,0.7369483716829934,1.0,8/39,7.14%,PIK3CD;PIK3R1;PIP4K2A;PIK3CA;ITPKB;SOCS5;PIP4K2C;PIK3C2A
prerank,regulation of multicellular organismal development (GO:2000026),0.511085724927446,1.238848772946966,0.24425887265135698,0.7361109537812973,1.0,3/25,2.62%,SPAAR;PTN;GBX2
prerank,aminoglycan catabolic process (GO:0006026),0.5023173394212358,1.238758134356108,0.21721311475409835,0.7349729244788246,1.0,7/28,6.34%,SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,activation of phospholipase C activity (GO:0007202),0.48280020798771384,1.2379084550037653,0.22137404580152673,0.7356948034948533,1.0,2/29,1.07%,EDNRA;ARHGAP6
prerank,negative regulation of interleukin-6 production (GO:0032715),-0.42953497456334266,-1.237526786338701,0.16519823788546256,0.587060250298137,1.0,11/27,25.77%,GAS6;ARRB1;C1QTNF3;IRAK3;ZC3H12A;CD200;SIRPA;TLR4;PTPN6;CD200R1;NCKAP1L
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.4624275705656939,1.2374207110184496,0.21682242990654205,0.7355095034050878,1.0,10/39,10.61%,GCNT2;NOTCH1;AJAP1;SPRY4;CORO2B;ACTN4;AP1AR;MAP4K4;JAG1;SPOCK1
prerank,positive regulation of protein phosphorylation (GO:0001934),-0.2886458981303701,-1.23734596505356,0.027624309392265192,0.586615013322072,1.0,80/348,14.87%,PRKAG2;BMP6;IGF1;DAB2;PDGFD;EGFR;LEPR;ROCK2;NRP1;NTRK3;CEMIP;BMP7;TEK;IQGAP1;PECAM1;APP;IL15;CAV1;IL6R;BMPR2;BMP4;ITGA5;PTPRJ;SNX9;TGFBR1;RASSF2;ANGPT1;LRRK2;GHR;CSF1;ARHGEF2;ACVR1;NIBAN1;VEGFD;SDCBP;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACVRL1;TOM1L1;EFNA5;CCND2;PTK2B;CARD14;CALM2;FNIP1;CCND3;TFRC;ALS2;TBX1;WDFY2;TAOK2;AKT1;IRGM;FLCN;KDR;AKAP9;MAVS;ITGB3;TGFB1;TMEM119;TWSG1;FLT4;CCN1;CDK2AP1;LRP8;PLCG2;SPHK1;CCND1;TXN;LIMCH1;PPIA;HSP90AB1;FXR2;MAPK3;RAD50;CDK9
prerank,protein deacetylation (GO:0006476),-0.3970825035950638,-1.2368336706742182,0.14444444444444443,0.5870183367669726,1.0,14/41,21.43%,HDAC4;TBL1XR1;HDAC7;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SIRT3;MORF4L2;SIN3A
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.43584840963522087,1.2368217431107034,0.2,0.7356402131533457,1.0,15/59,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;LIPH;LIPC;SRR;GATM;OSBPL7;GAMT;HSD3B7;MLYCD;ACOX2
prerank,brain morphogenesis (GO:0048854),0.5667670535025805,1.236621973853952,0.2421259842519685,0.7347947499436533,1.0,1/12,0.42%,PTEN
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.4777035955123751,1.2365251146295533,0.23684210526315788,0.7337143146827644,1.0,11/39,17.43%,MYO1B;WASL;ACTN4;MYO6;TRAK1;TRAK2;PPFIA2;RAB1A;NDE1;HTT;HAP1
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.41829319909164897,-1.2363281479172967,0.17307692307692307,0.5875327884004793,1.0,16/34,13.40%,FLT1;NRP1;SEMA6A;GAS1;ANXA1;RAMP2;VEGFD;VEGFC;MAPK14;FOXC1;DAB2IP;KDR;ERN1;RELA;FLT4;SPHK1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.5857899717874578,1.2360335639067577,0.2627906976744186,0.7322193867905873,1.0,1/11,0.50%,CASQ2
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.5857899717874578,1.2360335639067577,0.2627906976744186,0.7322193867905873,1.0,1/11,0.50%,CASQ2
prerank,negative regulation of cell motility (GO:2000146),-0.3351814873253814,-1.235377587636278,0.09855072463768116,0.5892000260211613,1.0,28/108,9.92%,AFDN;SULF1;ROBO1;LDLRAD4;EPHA4;DPYSL3;CLIC4;FBLN1;IGFBP5;FOXO3;RECK;SLIT2;CLDN5;PODN;PTPRJ;MAGI2;SRGAP3;SRGAP2;SMAD7;CDH1;SCAI;ACVRL1;CYP1B1;RHOB;CCDC125;ADAM15;ZMYND8;FLCN
prerank,regulation of neuron projection development (GO:0010975),0.3813022072098991,1.235297196777018,0.16129032258064516,0.7326805219548077,1.0,36/163,11.73%,CHN1;SERPINI1;PTEN;CDH2;RAPGEF2;ROR1;RTN4RL1;PTPN9;MARK1;SCARF1;LRRC4C;PTN;ABI2;PLPPR5;ADCY6;NTNG2;ATP1B2;RIT2;MYLIP;NTRK2;CSMD3;RAP1A;FUT9;IL1RAPL1;MARK2;LYN;ARHGAP35;CTNNA2;TOX;ABL2;SPOCK1;BRSK1;PAK3;PAK1;EP300;PLXNB3
prerank,regulation of long-term synaptic potentiation (GO:1900271),-0.4425696469105786,-1.235094848891205,0.1936127744510978,0.5891028411810635,1.0,5/28,2.82%,EPHA4;APOE;APP;SHANK3;ADCY1
prerank,response to cadmium ion (GO:0046686),-0.4433939588253682,-1.2348079851734375,0.18533604887983707,0.5889189475542111,1.0,12/26,20.00%,EGFR;AKT1;MAPK3;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.3718573181961323,-1.2347241632782024,0.1401098901098901,0.588217906452261,1.0,21/67,11.22%,SULF1;FLT1;NRP2;ROCK2;NRP1;ELMO1;VAV2;CYFIP2;SHB;BAIAP2;PXN;VEGFD;VEGFC;CLEC14A;RHOA;MAPK14;PTK2B;PIK3CB;DAB2IP;KDR;ITGB3
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.5466492736301501,1.2347152892842137,0.25738396624472576,0.7327673852036894,1.0,3/14,3.05%,PIK3CD;GAB1;PIK3CA
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),0.49542568995219205,1.234419908240541,0.23732251521298176,0.7321691149873132,1.0,3/27,2.02%,CSPG4;CHST3;CHST7
prerank,glucan catabolic process (GO:0009251),-0.4927867746204615,-1.2336843549827414,0.2076923076923077,0.5901000990756798,1.0,7/15,26.97%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.4759118249884825,1.233668956847184,0.20567375886524822,0.7326883197810158,1.0,4/38,3.58%,PTEN;PHLPP1;GPER1;SH2B3
prerank,organic substance transport (GO:0071702),-0.32743043091583773,-1.2334289179960196,0.0764525993883792,0.58980238492411,1.0,27/121,13.16%,ABCA1;SLC47A1;SLCO2B1;PLTP;SLCO2A1;CALCRL;ABCG2;ABCA9;RAMP2;SLC22A6;RCN3;TXNIP;SLC22A4;ABCA3;ABCA4;TOM1;CUBN;SPNS2;SLC50A1;SLC22A5;ARRDC1;DISP1;RAB7A;SLC35F3;ATP8A1;SLC22A18;MFSD2A
prerank,regulation of apoptotic process (GO:0042981),-0.2729673090163866,-1.2331840493838706,0.02459016393442623,0.5895585497124396,1.0,135/676,14.32%,NOTCH2;IGF1;DAB2;DAPK1;UNC13B;PAWR;FSTL1;EGFR;SMAD6;FHL2;CTSH;AKAP13;PPP1R13B;IL31RA;TIAM2;PDPN;TEK;STEAP3;FOXO1;SH3RF1;OSR1;FOXO3;ACTN2;ARHGEF3;SLIT2;ANXA4;NUPR1;ITGA6;ANXA5;MYO18A;TGM2;VAV2;STK17B;USP47;THBS1;BMP4;IL6ST;GAS1;IGF1R;RASSF2;ANGPT1;TXNDC5;FBXO10;MCF2L;ANXA1;ARHGEF2;LEF1;SOCS2;CFLAR;TRIM24;HOXA5;ADAM10;IGFBP3;ACER2;GAS6;QRICH1;NIBAN2;TNFSF10;NAA35;IAPP;RARG;ZFAND6;RNF144B;SFRP4;WNT5A;CCND2;ANO6;PTK2B;PLK2;EGLN2;CYP1B1;PTPA;STAT1;CARD14;RHOB;HSPA5;SH3RF2;TFRC;BIRC3;ANP32E;TRIO;GOLPH3;ERC1;IFIT2;ADAMTSL4;ARHGEF1;TPT1;ERCC5;SON;ANP32B;AIFM1;TIAM1;AKT1;BAG3;MCL1;CTSB;UTP11;BCL2L11;PRDX2;EGLN3;IFIT3;FLCN;ATF6;CASP8;CD38;GCLC;DAB2IP;FGD4;KDR;ARHGDIA;BNIP3L;PLEKHG5;HDAC1;NME1;RELA;ACTN1;FLT4;ATM;GATA6;CBX4;TRIM35;UBB;CALR;PPID;ARHGEF18;LRP8;SPHK1;ARHGEF19;PIM3;BNIP3;SFRP1;RPL10;PPIA;HYPK;IP6K2
prerank,regulation of mitochondrial translation (GO:0070129),0.5195108866580138,1.2331046774027983,0.2438095238095238,0.7327681639322322,1.0,11/21,21.14%,FASTKD2;MRPS27;NSUN3;MALSU1;FASTKD3;MTG2;TRMT10C;RMND1;C1QBP;ALKBH1;TSFM
prerank,establishment of melanosome localization (GO:0032401),-0.47084794896844356,-1.2320434371682532,0.21772639691714837,0.5918208762631959,1.0,7/19,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.32555519848738146,-1.2315338172886514,0.09034267912772585,0.5923345696383594,1.0,31/129,16.28%,RNF220;LRRK1;LGR4;EGFR;COL1A1;TBL1XR1;CAV1;FGFR2;SMURF2;USP47;RNF146;LRRK2;TNKS2;LYPD6;SFRP4;WNK1;USP8;CSNK1G2;USP34;PSME2;TGFB1;PSMB4;SFRP1;PSMB1;PSMD11;PSMD8;PPM1B;GSKIP;PSME3;HHEX;PLEKHA4
prerank,positive regulation of interleukin-1 production (GO:0032732),-0.3816717768094731,-1.231390545652125,0.1720183486238532,0.5918016228115103,1.0,18/51,27.56%,APP;IL16;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.47413568327588107,1.2309751271649827,0.20566037735849058,0.7367451500222708,1.0,9/33,11.85%,PTEN;CDK6;MYO16;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,fatty acid elongation (GO:0030497),-0.5164661087862209,-1.2308338231894225,0.2270168855534709,0.5924189517758395,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,ribosomal small subunit biogenesis (GO:0042274),-0.4131894161865519,-1.230437475124751,0.16027088036117382,0.5925003389188968,1.0,15/39,22.27%,RPS14;RPS19;RPS5;RPS16;RPS24;RPS27;MRPS7;RPS15;RPS6;RPS25;RPSA;RPS7;RIOK2;RRP7A;RPS27L
prerank,positive regulation of DNA repair (GO:0045739),-0.3915846426385814,-1.2301460374713407,0.1912087912087912,0.5923594610454477,1.0,4/46,3.02%,EYA2;EYA1;EGFR;EYA4
prerank,regulation of lamellipodium organization (GO:1902743),0.551015594353048,1.2301066782890135,0.2701525054466231,0.7375183057740681,1.0,2/14,2.30%,CARMIL1;WAS
prerank,chondrocyte differentiation (GO:0002062),-0.4244329816697752,-1.230078411834078,0.19917864476386038,0.5916395537683308,1.0,9/32,5.48%,NFIB;SULF1;OSR1;BMPR2;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.49243937820035205,-1.2295632063086948,0.20309477756286268,0.5921347873465352,1.0,4/15,8.37%,DAB2;BMP2K;SCYL2;PIK3CB
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),-0.40986241631520737,-1.229352579243136,0.18494623655913978,0.5918507186244365,1.0,10/36,16.32%,MECOM;FOXO1;DLG1;EZR;SH3RF2;DUSP1;QARS1;PPIA;DUSP10;SIRPA
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5396299355490433,1.229191158466304,0.2669491525423729,0.7384104137037519,1.0,3/17,1.19%,HEY2;HEYL;NOTCH1
prerank,peroxisome organization (GO:0007031),0.48463734894015076,1.2291730353671795,0.24949698189134809,0.7371229493747498,1.0,9/25,15.58%,ABCD2;PEX7;PEX1;TMEM135;MFF;PEX3;PEX19;LONP2;PEX12
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.5570873134135587,-1.2290573599918477,0.23809523809523808,0.591696089176314,1.0,3/10,8.87%,APOD;PTPRJ;HGS
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4940212102036901,1.2284039065270196,0.2583170254403131,0.737658296676774,1.0,9/25,18.54%,MEF2C;MPP2;CHRNA3;GRIN2B;NLGN3;INSYN2A;GRIN2A;GSK3B;GRID2
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.48055375649507576,1.2281171825674604,0.2340823970037453,0.7370033244174657,1.0,4/34,2.79%,PDGFRB;RGCC;IL1B;CUL3
prerank,peptidyl-methionine modification (GO:0018206),0.5679973362570692,1.2273872097703584,0.26706827309236947,0.7373290427402832,1.0,4/12,18.38%,METAP2;NAA30;NAA15;METAP1
prerank,regulation of cholesterol storage (GO:0010885),0.5524210849561836,1.2273620186997753,0.2559652928416486,0.7360592210483803,1.0,5/15,5.46%,NR1H3;SCARB1;PPARD;SREBF2;MSR1
prerank,positive regulation of synaptic transmission (GO:0050806),0.41850105930552084,1.2266161650475245,0.18983050847457628,0.7365910276316097,1.0,19/72,11.13%,CLSTN1;GPER1;MPP2;NRXN1;CACNG7;NMU;ADCY8;RIMS1;CLSTN3;SLC24A2;RIMS2;CHRNA7;SYT1;KCTD13;NFATC4;ZDHHC2;GRIN2B;BAIAP3;STX4
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),-0.5486572929476519,-1.2257351996888837,0.24094202898550723,0.5999563107159688,1.0,4/10,16.55%,NAMPT;IL33;KDR;TLR4
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.3542440865611244,-1.2257016302636836,0.1509433962264151,0.5991418898063543,1.0,39/80,33.62%,PLPP3;ERGIC1;COPZ2;TAPBP;KLC1;COPA;RINT1;GOLPH3;ATP9A;UVRAG;ZW10;SURF4;SCYL1;NAPA;RER1;BNIP1;STX18;RAB6A;COPB1;TMED9;TMED2;CENPE;ARFGAP2;PICK1;TMEM115;KIF26A;ERGIC3;ARF4;USE1;KIF4A;ATP9B;TMED10;KIF1C;NBAS;SCFD1;KIF23;KIF18A;KLC2;DNAJC28
prerank,epithelium development (GO:0060429),-0.33441778067026234,-1.2256761839227637,0.12609970674486803,0.5982711935432318,1.0,27/107,16.16%,ALDH1A2;ERRFI1;WNT4;OSR1;ANXA4;FGFR2;MEOX2;CPT1A;CD34;SMO;RCN3;CNN3;SIX1;STAT1;TBX1;CTSB;KDR;ANXA7;TGFB1;PTCH1;GATA6;MFSD2A;SOX17;BDH2;PKD1;CASP6;SOX18
prerank,wound healing (GO:0042060),-0.3664826121883131,-1.2254383093023602,0.13942307692307693,0.5979712142771231,1.0,15/62,11.22%,IGF1;COL3A1;SMAD3;MYOF;PDGFRA;MACF1;TGFBR1;PLEC;CFLAR;FGF1;WNT5A;PRCP;FZD7;PPL;ITGB3
prerank,negative regulation of peptidase activity (GO:0010466),0.4474099511582078,1.2244429426668795,0.2029520295202952,0.7404377037583404,1.0,3/47,1.04%,SERPINI1;SERPINB8;VTN
prerank,regulation of cellular component movement (GO:0051270),-0.3820822497980058,-1.2235787618838083,0.14672686230248308,0.6022283574527602,1.0,12/49,7.41%,TGFBR3;EGFR;ROCK2;PDPN;SP100;DIAPH1;ARHGAP18;TGFBR1;CD9;ARAP1;RHOA;RPS19
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.41419099488840855,1.2233583371034904,0.20637329286798178,0.7416494670553205,1.0,17/93,11.50%,PDE4D;PTEN;DMD;NCK2;TNKS1BP1;FNIP2;PDCD10;SPRY2;INPP5J;SNCA;CAPRIN2;RIPK2;PRKD2;CNOT9;DDIT4;BRAF;PAK1
prerank,protein localization to plasma membrane (GO:0072659),-0.3231427386645316,-1.2228317584486543,0.11515151515151516,0.6034155123110608,1.0,28/129,12.08%,TSPAN5;AFDN;ROCK2;ATP1B3;TTC7B;ACTN2;DLG1;FYB1;BSG;EZR;FCHO2;RAB11A;LRP6;CDH1;EFR3B;RAMP2;GAS6;SMURF1;S100A10;EHD1;TNFRSF1A;KCNB1;C2CD5;FLOT2;SLMAP;RAB8A;PTCH1;F11R
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),-0.3563355458343319,-1.2225763350245735,0.1382716049382716,0.6032224393769576,1.0,22/67,14.90%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;IL15;FGFR2;IGF1R;GHR;DDR1;PTK2B;KIT;BMX;KDR;FGFR4;EPHB2;FLT4;FER;MAPK3;PKDCC
prerank,histone deubiquitination (GO:0016578),-0.46616501798655197,-1.222562528795787,0.21912350597609562,0.602326422595351,1.0,6/18,20.83%,USP15;TRRAP;ATXN7L3;USP49;USP22;USP36
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.541418893380413,1.222319213649313,0.2613390928725702,0.7427339061967884,1.0,4/14,4.18%,TBXA2R;NOTCH1;STARD13;PDCD10
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),-0.5209884307589252,-1.2222967588840672,0.2193158953722334,0.6021544552805965,1.0,8/12,39.19%,RAB27A;CYBA;PLCG2;TLR4;CD36;TLR6;ZNF205;SLC5A3
prerank,regulation of actin filament depolymerization (GO:0030834),0.561572800500138,1.2213877656772327,0.2723404255319149,0.7438112902272815,1.0,3/12,3.34%,SEMA5A;PIK3CA;SH3BP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.437780072153147,-1.220301743740706,0.20816326530612245,0.6067370329550562,1.0,8/26,19.04%,IGF1;FHL2;LMCD1;PLCG2;HOMER3;SLC9A1;EFHB;CHP1
prerank,peptide biosynthetic process (GO:0043043),-0.31176582576209205,-1.220072809321145,0.0851063829787234,0.6063965891449705,1.0,63/153,19.07%,PCSK5;RPLP1;RPS14;RPL9;RPS12;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;RPS11;RPL13;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;RPL37;RPL11;RPS18;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;MRPL52;RPL10A;MRPL24;HARS1;RPL22;RPS15;RPS6;CARNS1;RPL23;RPL17;RPL31;RPS25;RPL15;RPSA;RPS7;RPL38;RPLP0;RPL27;GGT7
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.5490471684626198,1.22007171052761,0.252465483234714,0.7456790843216764,1.0,3/14,11.11%,LIMS1;EMP2;LOXL3
prerank,regulation of cytokinesis (GO:0032465),-0.34648579804434587,-1.2200516437229807,0.15363881401617252,0.605537012288781,1.0,18/78,16.18%,PKP4;RAB11A;KIF13A;CDC14A;PRKCE;RHOA;PLK2;CALM2;ZFYVE19;BECN1;SVIL;FLCN;SPAST;SH3GLB1;GIT1;UVRAG;MYO19;CALM1
prerank,cristae formation (GO:0042407),-0.43538992317379,-1.2200133126418649,0.21235521235521235,0.6047311385883078,1.0,10/27,16.08%,ATP5PF;DMAC2L;SPG7;APOOL;CHCHD6;MICOS13;ATP5MF;ATP5MC3;ATP5MC1;AFG3L2
prerank,regulation of mitochondrial membrane potential (GO:0051881),0.46949401119585804,1.2196392398398448,0.2328519855595668,0.7453651150665437,1.0,3/40,1.57%,PID1;SLC25A33;CCN6
prerank,regulation of transcription by RNA polymerase II (GO:0006357),-0.2579332952801376,-1.2194082636488919,0.0,0.6054919855792111,1.0,373/1668,18.25%,NFIB;AUTS2;BMP6;TSHZ2;FOXP2;PRDM6;IGF1;DAB2;ZMIZ1;PBX1;PKNOX2;MAF;AEBP1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;DCN;NFAT5;KDM7A;FOXP1;ZKSCAN2;WWOX;HDAC4;GLI2;CUX1;FHL2;TBL1XR1;NFIX;WWC2;CREB5;ZFHX4;CDK8;RHOQ;LCOR;SP100;TGFA;GLIS3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;SKIL;FOXO3;APP;ZIC2;NFIA;NR3C1;DLG1;HDAC8;KAT6B;HIVEP3;CAV1;ANXA4;ERG;ITGA6;HOXB3;RARB;MLXIP;SUFU;ESR1;FGFR2;ZIC5;BMPR2;SMURF2;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;EZR;PRRX2;RPS14;FOXD1;DNMT3A;TBX15;KLF4;PLAGL1;DDX5;KAT2B;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;ETV6;TAF1;ID1;HDAC9;SBNO2;THRB;MXI1;HOXA5;ZHX3;CREB3L2;SKI;ZNF23;SP140;PCGF5;SDCBP;ZFPM2;PARP9;DCAF6;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;ARRB1;HOXA3;ZNF697;GTF2IRD1;TEAD4;ARNT2;WWP2;AR;FGF1;BRD7;RARG;CREM;YAP1;STAT2;FOXP4;TMF1;HIF3A;PRRX1;MOV10;GLIS2;SOX13;THRAP3;BHLHE40;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;ATN1;INO80;ZNF292;PRKCB;HLF;KDM5B;HOXC6;TET3;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;LMO2;CHD3;HIVEP1;STAT1;FNIP1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;IFRD1;PGR;IFI27;BAZ1B;KLF10;ZNF219;TBX1;RTF1;SSBP3;ZBTB8A;TFCP2;IRF9;ZBTB18;FIZ1;BAZ2B;BBS7;KIT;FOXL1;LHX6;RREB1;IL33;HIF1A;TADA1;TNFRSF1A;MKX;RCOR3;TWIST2;TADA2A;NLRC5;FOXK1;CDH13;NR4A2;FLCN;ATF6;BHLHE41;FOSL2;PHF10;IKZF1;DAB2IP;HOXB9;TFCP2L1;IL18;ZC3H12A;PRDM5;ZKSCAN7;ZKSCAN3;TGIF1;ESRRG;FHOD1;ZFHX2;EIF5A;KLF12;TRIM27;SIX5;MAVS;MDFI;GATA2;CEBPG;PATZ1;ZSCAN25;NFYC;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;PTCH1;ZMYM5;BCL9L;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;CPEB3;PPARA;CHD2;ID2;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;CBX4;SP110;UBB;CALR;ATOH8;ZGPAT;PPID;CLOCK;LPIN3;MET;MEIS2;ZNF585A;ZNF585B;EZH1;CCND1;MPND;KCNIP3;HDAC5;ZNF568;TAL1;SOX17;RFX2;HSF2;DACH2;SARS1;TOX4;RPL10;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;MAPK3;HOXC4;TTC21B;PKD1;HOXB5;CDK9;HOXB7;HIPK2;PCGF3;BEND3;NKX6-1;SNAI1;ZFPM1;CREB3;YEATS2;JUND;RPL23;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;PHF21A;HCFC2;MNT;TLR4;RNASEL;USF2;ZMIZ2;ZFP69;TNRC6A;ZNF436;SIRT7;JUNB;SIRT2;ATF1;TSHZ1;MED21;RIPK1;FBXL19;PTOV1;NFIL3;PSIP1;RAI1;TPR;SLC9A1;NFKBIA;NFYB;ZFP14;CSRNP3;NPAS2;MAFF;SOX12;NR6A1;CC2D1A;CEBPB;KLF15;PARK7;CIR1;ELP3
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),-0.4513720911912691,-1.2192773945275295,0.20739219712525667,0.6049364922977528,1.0,3/23,3.49%,ERRFI1;CAV1;SNX6
prerank,regulation of cellular protein metabolic process (GO:0032268),-0.3894085931575788,-1.2189158593554472,0.17463617463617465,0.6050047995914253,1.0,15/47,19.01%,APOE;FOXO3;APP;KLF4;CSF1;AKT1;ATXN2;VPS35;TGFB1;TCOF1;RPL10;GEMIN5;NFKBIA;AGT;AGTR1
prerank,glutathione derivative metabolic process (GO:1901685),-0.4550295678678601,-1.218674280691044,0.2126865671641791,0.6038851093816602,1.0,6/20,15.21%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.4550295678678601,-1.218674280691044,0.2126865671641791,0.6038851093816602,1.0,6/20,15.21%,GSTA4;GSTM1;MGST1;GSTT1;GSTM2;AKR1A1
prerank,positive regulation of cell division (GO:0051781),-0.40051757467663474,-1.2186534022080495,0.18464730290456433,0.6030451459398032,1.0,8/38,10.29%,PKP4;FGFR2;CDC14A;FGF1;PRKCE;RHOA;SVIL;SPAST
prerank,negative regulation of innate immune response (GO:0045824),-0.4139172872167127,-1.2178411019547943,0.2,0.6042919717872683,1.0,9/34,10.17%,SERPING1;CNOT7;STAT2;RPS19;USP15;USP18;NLRC5;IRAK3;SAMHD1
prerank,regulation of cell population proliferation (GO:0042127),0.32725127416719674,1.2175421563408615,0.08202247191011236,0.7492552319441267,1.0,63/691,7.19%,DLC1;PTPRK;ITGA1;PDGFRB;ACE2;PTEN;TBX2;IL34;S1PR3;LIMS1;GLMN;RERG;CBFA2T3;IGFBP7;RAPGEF2;GCNT2;CDK6;BMP5;NOTCH1;COL4A3;SLC25A33;PTK2;NCK2;RGCC;CCN6;GPER1;FRK;TBX3;TNS2;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;CADM4;TBX6;ETS1;MECP2;SH2B3;MYO16;PDCD10;FGF2;SPDYA;RPS6KA2;GAS8;TSPAN31;FABP3;TNFRSF8;TFAP2B;CXCR2;CXCL10;NTRK2;NUPR2;IL4;CXCL5;AGO3;SOX4;CHRNA7;EMP2;CDCA7;HRAS;IRS1
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.5001139812693165,-1.2174769204441043,0.2140077821011673,0.604328769153572,1.0,3/14,10.10%,THBS1;CMKLR1;IRAK3
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.5017084466649692,1.217197795067518,0.24217118997912318,0.7488062205526405,1.0,7/20,13.07%,LIMD1;AJUBA;AGO3;TNRC6C;EIF6;TNRC6B;CELF1
prerank,mitochondrial genome maintenance (GO:0000002),0.5517100407446001,1.2170032707777831,0.2629399585921325,0.7479494661853068,1.0,2/11,2.36%,SLC25A33;AKT3
prerank,cellular response to virus (GO:0098586),-0.428926644285877,-1.2163804810781744,0.19599109131403117,0.6065056114808245,1.0,8/30,10.79%,GSDME;LGALS9;MAPK14;LGALS8;IRGM;HIF1A;ZC3H12A;EIF5A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),-0.5142144309246088,-1.2159712620642313,0.23134328358208955,0.6067000055311943,1.0,7/13,34.64%,ENPP1;SULT1A1;TPST1;TPST2;SULT4A1;ABHD14B;SULT2B1
prerank,amino acid transmembrane transport (GO:0003333),0.46274551171935485,1.215916929594813,0.23201438848920863,0.7493612188584557,1.0,1/45,0.03%,SLC38A11
prerank,negative regulation of protein processing (GO:0010955),-0.5204082330852977,-1.2158120773441803,0.24954128440366974,0.6062339300924053,1.0,6/12,19.73%,THBS1;GAS1;LRRK2;SERPINE1;TMEM59;SERPINE2
prerank,cellular response to light stimulus (GO:0071482),0.42035079680791204,1.2155701843300208,0.22564102564102564,0.7488356494967479,1.0,15/66,17.97%,PTPRK;OPN1MW;OPN1MW3;CASP9;ERCC4;ATR;EP300;RRH;OPN3;PDE6A;DHX36;PARP1;FMR1;RHNO1;SAG
prerank,response to peptide hormone (GO:0043434),-0.3938878118650811,-1.2155177464741158,0.17050691244239632,0.606127128291846,1.0,10/43,9.53%,TGFBR3;ROCK2;IGFBP5;CAV1;ANXA1;STAT2;STAT1;STAT3;AKT1;TRIM16
prerank,regulation of protein kinase B signaling (GO:0051896),0.3660988933225063,1.215481826611814,0.15782122905027932,0.7477475469942994,1.0,20/193,5.97%,PDGFRB;PTEN;PIK3CD;GAB1;GCNT2;PHLPP1;PTK2;PIK3R1;SEMA5A;GPER1;FERMT2;ERBB4;NRG1;PIK3CA;SH2B3;AXL;FGF2;SPRY2;ITGB1;NTRK2
prerank,gene expression (GO:0010467),-0.2831903351356673,-1.2153601211507712,0.04522613065326633,0.6056649690054502,1.0,126/348,26.69%,CELF2;TSPAN5;RBMS2;RPLP1;RPS14;THRB;RPL9;RPS12;ATXN1;RPL41;RPS20;RPL18A;RPS13;RPS19;RPS23;SRBD1;RPS4X;GOLPH3;RPS11;POLR2A;RPL13;SMG6;RPL18;RPS9;EEF1A1;RPL34;RPL32;MRRF;RPL27A;RPS8;RPL12;NR4A2;MMS19;RPL37;NXF1;RPL11;RPS18;PWP1;RPL39;RPS5;RPS16;RPL24;RPS15A;RPLP2;POLR2F;NOVA1;MEF2A;RPL28;RPS24;RPS27;RPL14;RPL26;MRPS7;MRPS6;SARS1;RPL10;MRPS18A;RPL7;DTX1;MRPL52;DNAJB11;RPL10A;MRPL24;AGFG1;NUP98;HARS1;RPL22;RPS15;RPS6;RPL23;RPL17;HHEX;RPL31;RNASEL;SRSF2;SMG5;RPS25;POLR2E;SNRNP40;TPR;RPL15;RPSA;RPS7;SRSF6;RPL38;RPLP0;RPL27;E2F1;NUP88;THOC1;RRBP1;UPF2;RPL36A;MCM3AP;NUP214;THAP1;HNRNPL;DEDD2;RPS26;SRSF5;RPL35A;FIP1L1;NXT1;NUP37;THOC7;FARSB;RPS29;DHX8;RPL8;RPL36;POLR2G;MRPL35;ALKBH5;SRSF11;PPP5C;RPS3;RRAGC;HNRNPF;RPL13A;NUP155;EPC1;ABCF1;DDX54;ASMT;TSPAN33;MRPL34
prerank,alpha-amino acid catabolic process (GO:1901606),-0.42158235957606316,-1.2148931816234514,0.18292682926829268,0.6060411985413576,1.0,14/29,36.32%,DDO;ALDH4A1;PRODH;CBS;HOGA1;KYNU;MTRR;BLMH;FAH;ACADSB;HGD;IL4I1;HAAO;HSD17B10
prerank,glycoprotein biosynthetic process (GO:0009101),-0.3500218232179848,-1.2147079567873895,0.16539440203562342,0.6056371482488044,1.0,16/79,10.55%,IGF1;CHST11;ST3GAL4;LARGE1;ST3GAL6;BMPR2;ST3GAL2;CSGALNACT1;ST3GAL3;GOLPH3;MGAT1;ST6GALNAC2;FOXL1;B3GALNT1;SERP2;ST8SIA2
prerank,actin filament polymerization (GO:0030041),0.4961240213000013,1.2146339149022256,0.23486238532110093,0.748541753317903,1.0,6/29,3.93%,ARHGAP6;WASF3;WAS;CORO7;SPIRE1;WASL
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.5764616645730861,1.21425509747019,0.2631578947368421,0.7481143754497869,1.0,2/10,3.58%,PRKG1;SH2B3
prerank,glycoprotein metabolic process (GO:0009100),-0.3808342818842276,-1.2141729678712723,0.18763796909492272,0.6061918400614137,1.0,20/53,20.12%,ST3GAL4;LARGE1;MAN1C1;ADAMTS9;ST3GAL2;MAN2A1;ST6GALNAC3;STT3B;GOLPH3;FUT8;HIF1A;ST8SIA2;ST6GALNAC6;GCNT1;GANAB;MANBA;PARK7;GAL3ST2;NGLY1;ST8SIA5
prerank,Rac protein signal transduction (GO:0016601),0.5307187622160132,1.2141248290691151,0.2594059405940594,0.7471239437721563,1.0,4/18,10.01%,EPS8;ABI2;HACE1;NCKAP1
prerank,glycogen catabolic process (GO:0005980),-0.4834247284170208,-1.2140285016200745,0.2337917485265226,0.6056327316447354,1.0,9/15,34.05%,PHKB;PHKA2;PYGB;CALM1;GAA;PHKA1;PYGL;RB1CC1;STBD1
prerank,positive regulation of GTPase activity (GO:0043547),0.36823882352086923,1.213914185528225,0.16260162601626016,0.7463336697187967,1.0,35/188,10.04%,ARHGAP42;RGS6;TBC1D1;LIMS1;DOCK10;RAPGEF2;RASGRP2;FERMT2;SIPA1;NF1;PLXNB1;SH3BP1;GRTP1;GARNL3;AGRN;TBC1D30;SLC27A4;SYDE1;MAPRE2;ITGB1;TBC1D12;RIC1;ARHGEF26;RAP1A;RUNDC1;HRAS;RGS7;RALGAPA1;TBC1D2B;RAB11FIP2;MTSS2;MAP4K4;TBC1D10C;EPHA2;RGS10
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.36299566807946515,-1.213906542961942,0.14356435643564355,0.6050951695164579,1.0,10/59,5.06%,SDK1;ROBO1;HMCN1;PECAM1;BSG;PTPRM;MPZL2;CDH1;SDK2;PALLD
prerank,negative regulation of endopeptidase activity (GO:0010951),0.44368120765474095,1.2129786260198123,0.22735674676524953,0.7473009034883988,1.0,9/47,10.61%,SERPINI1;SERPINB8;VTN;SERPINA10;BIN1;PCID2;SPOCK3;SERPINA2;SPOCK1
prerank,positive regulation of interleukin-1 beta production (GO:0032731),-0.38968590548845267,-1.212928208446981,0.16968325791855204,0.6067868556574182,1.0,17/45,27.56%,APP;LGALS9;WNT5A;STAT3;TRIM16;CASP8;GSDMD;P2RX7;GBP5;TLR4;TYROBP;LPL;CCL19;EGR1;MYD88;PYDC1;FZD5
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3846900729734582,-1.2122956922654582,0.21479713603818615,0.60762246753649,1.0,14/43,22.82%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27;SIRPA;TLR4;DICER1;CD274;RARA;PTPN6
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.4928512737084548,-1.211438594785808,0.25096525096525096,0.6090051106452468,1.0,4/14,6.72%,SEC23A;SEC24D;SEC31A;SEC24A
prerank,calcium ion import across plasma membrane (GO:0098703),0.5569209065938252,1.2113254976715966,0.26170212765957446,0.7500880370338838,1.0,3/14,4.63%,TRPV2;CACNA2D1;SLC24A2
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),0.5724250847759055,1.2111892870547751,0.2727272727272727,0.7490901859616661,1.0,7/11,26.80%,MSH3;TIMELESS;BLM;FBXO5;TIPIN;FBH1;SMARCAL1
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.5124527435041143,-1.211020316629346,0.22939068100358423,0.6091693200953529,1.0,1/14,0.08%,AUTS2
prerank,negative regulation of cellular metabolic process (GO:0031324),-0.40026087188813697,-1.2107837468376388,0.18029350104821804,0.608949695107605,1.0,13/37,27.02%,APOE;RIN3;SDCBP;ATXN2;OPTN;ITGB3;SIRT2;MT3;ANKRD13D;BRCA1;ANKRD13A;PRKN;EDNRB
prerank,B cell activation (GO:0042113),0.4169821250441471,1.2107815669935207,0.23102866779089376,0.7487903252400294,1.0,3/68,0.77%,ITGA4;MEF2C;PIK3CD
prerank,regulation of cell-matrix adhesion (GO:0001952),0.4257796193944072,1.2104852999447375,0.2208904109589041,0.7482268605204339,1.0,9/64,4.29%,UTRN;CDK6;AJAP1;PTK2;VCL;PEAK1;ROCK1;NF1;MINK1
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.5295866816613651,1.2103070964206644,0.24390243902439024,0.7473949778720438,1.0,3/18,5.53%,ITGA4;ROCK1;ITGB1
prerank,protein localization to nucleus (GO:0034504),-0.32817924551285965,-1.2099050849448434,0.11634349030470914,0.6105641572547211,1.0,40/102,31.14%,COL1A1;BMP7;BMP4;APPL2;SIX1;STAT3;AKT1;PINX1;TOR1AIP1;PML;RPL11;IPO7;FAM53C;IPO13;MDM2;RAN;CALR;GBP2;HHEX;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;YWHAE;RRS1;NUP155;RANBP17;MSX1;EIF4ENIF1;MORC3;CSE1L;NUP62;PTTG1IP;TNPO2;WRN;PAF1;HEATR3
prerank,negative regulation of viral genome replication (GO:0045071),-0.39115857136456045,-1.2097874753881246,0.20430107526881722,0.6099920725891406,1.0,22/40,36.96%,IFITM3;OAS2;IFIT1;MAVS;IFITM2;RNASEL;RSAD2;SETDB1;MPHOSPH8;SRPK1;INPP5K;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;BST2;PARP10;OASL;FAM111A;ISG20;PROX1
prerank,regulation of ion transport (GO:0043269),0.41160716915625156,1.2087221796237333,0.19418960244648317,0.7499558841849463,1.0,15/76,11.38%,KCNJ8;NEDD4L;KCNJ12;CLDN10;CHRNA3;NKAIN2;ANK3;SNCA;SIK1;STC1;PDZK1;SYT1;KCNJ3;KCNJ6;SYT2
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),-0.5049012996981417,-1.2086323562350263,0.24022346368715083,0.6122833514135183,1.0,3/13,5.61%,ELOVL7;HACD4;HACD3
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5032847464929397,-1.2085463170120583,0.23443223443223443,0.6116057435901017,1.0,3/14,11.54%,DDX60;USP15;PUM1
prerank,cellular response to osmotic stress (GO:0071470),0.5250772010965559,1.2084183995975903,0.2642706131078224,0.7494071793803183,1.0,6/21,9.02%,MYLK;RCSD1;STK39;SCN2A;DDX3X;PKD2
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),-0.29604658809171636,-1.2082443155574545,0.07924528301886792,0.6115376928157397,1.0,69/234,19.22%,ANXA3;SMAD3;HDAC4;CAMK1D;PLPP3;PRKCH;APP;ZIC2;CAV1;ADCY1;ESR1;NOD1;LRP6;ARHGEF2;FZD2;CFLAR;TAF1;SMO;IRAK2;AR;LGALS9;WNT5A;IKBKE;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FZD4;AKT1;KIT;FLOT2;IRAK3;IL18;TRIM27;MAVS;CEBPG;CAMK2A;RELA;TNFRSF11A;UBB;LRP8;CLOCK;PLCG2;SPHK1;FER;HDAC5;TICAM1;PPIA;HIPK2;NKX6-1;CD200;TLR4;TRIM8;RIPK1;FZD1;MAP3K13;NFKBIA;EDA;PARK7;STK36;TRIM14;ALK;LAMTOR5;AGT;TRIM41;EDA2R;PPARGC1A
prerank,heterocycle biosynthetic process (GO:0018130),-0.5006285065709486,-1.2074682095662905,0.23123732251521298,0.6127712946692608,1.0,9/14,40.49%,GCH1;PYCR2;NOXRED1;GPHN;PYCR1;MOCS2;ALOX5;NFS1;PYCR3
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.49151250090633336,1.207358894157994,0.2490842490842491,0.7505525697040573,1.0,4/28,3.94%,ATP2A3;MAP3K5;CHAC1;ITPR1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),0.48733917188369935,1.2073331879114333,0.27204502814258913,0.7493265460501513,1.0,8/28,7.19%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;PIP4K2C;IRS1
prerank,selective autophagy (GO:0061912),0.42645026782072487,1.2073107963778713,0.2247787610619469,0.748106252818839,1.0,1/56,0.06%,DYNLL1
prerank,neural crest cell migration (GO:0001755),-0.3975171230374859,-1.2070910802843315,0.20824295010845986,0.6129053105597817,1.0,13/36,16.62%,FN1;NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;TBX1;SEMA3B;RADIL;CORO1C;SEMA3G;SEMA6B
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),-0.5270645839212753,-1.2066952206856214,0.24775583482944344,0.6131560199608298,1.0,6/11,25.65%,HIF1A;PARK7;NONO;NR4A3;RACK1;PRKN
prerank,response to estradiol (GO:0032355),0.4825384719018889,1.2066592378860639,0.2558139534883721,0.7484085210182541,1.0,4/31,3.87%,GGT5;GGT1;GPER1;NCOA3
prerank,negative regulation of cellular protein metabolic process (GO:0032269),-0.3392400694303158,-1.2063953132336722,0.1478494623655914,0.6131202138895766,1.0,24/88,20.56%,DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;CST3;IGF2BP2;ATRAID;AKT1;DAB2IP;CPEB3;CALR;LARP1;CNOT8;RGP1;FXR2;CLN8;PAIP2B;EIF4E2;TYMS;SERPINE2;CDK5RAP3
prerank,epidermal cell differentiation (GO:0009913),-0.3914823617436615,-1.2060447302093886,0.18793503480278423,0.613134776261399,1.0,15/41,25.94%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;HDAC1;GATA6;WNT16;UGCG;GLI1;DSP;ERCC2;USH2A;ERCC3;CTNNB1
prerank,metal ion export (GO:0070839),0.4682742465731768,1.205789629161396,0.22992700729927007,0.7491982323907338,1.0,7/31,7.70%,ATP1A2;ATP1A4;FXYD2;KCNE4;ATP7A;ATP1B2;KCNE5
prerank,protein peptidyl-prolyl isomerization (GO:0000413),-0.46366515253411855,-1.2056921675028758,0.21370967741935484,0.6132172984345048,1.0,6/20,14.14%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.43730179325039165,1.205008780406785,0.22942206654991243,0.7497993393336577,1.0,9/47,6.20%,CARMIL1;LIMS1;PTK2;SPRY4;FERMT2;RAC3;ACTN4;TESK1;AP1AR
prerank,histone modification (GO:0016570),-0.32491408672682276,-1.2045965704449573,0.13529411764705881,0.6153641773653239,1.0,28/109,21.43%,EYA2;EYA1;HDAC4;TBL1XR1;KAT6B;EYA4;HDAC9;MIDEAS;BAZ1B;PRKCD;TRRAP;RCOR3;CARM1;EHMT1;PRDM5;NSD1;HDAC1;ATXN7L3;HDAC5;SIRT7;SIRT2;PARK7;EZH2;MT3;USP22;MORF4L2;USP36;SIN3A
prerank,keratinocyte differentiation (GO:0030216),-0.413161469060645,-1.2043796639372721,0.21267893660531698,0.6150929149200925,1.0,7/29,13.66%,CLIC4;ANXA1;ADAM9;WNT5A;TXNIP;WNT16;UGCG
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.4893810416664255,1.2041453041249,0.2551984877126654,0.7506189889835845,1.0,4/24,3.65%,PLCE1;PIK3R1;PIK3CA;ABI2
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.43179465119059035,1.2039809256882488,0.23404255319148937,0.7497273080357416,1.0,17/60,15.03%,PTEN;HEY2;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;TNRC6C;MED20;TNRC6B;MED4;ATF7IP;DHX36;MED6
prerank,calcium ion transport into cytosol (GO:0060402),0.5190480348075841,1.2039239556418382,0.26899383983572894,0.7485991004488516,1.0,4/21,9.80%,CACNA1C;CACNA2D1;RYR2;GRIN2B
prerank,defense response to Gram-negative bacterium (GO:0050829),-0.3887245213767184,-1.2036795162496274,0.2219730941704036,0.6161427400826204,1.0,10/42,16.55%,IL6R;LBP;RPS19;IRGM;GSDMD;OPTN;SERPINE1;HMGB2;MR1;TLR4
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.5027147910624233,-1.203349910614755,0.2532347504621072,0.6161625073837471,1.0,5/12,17.23%,HSPA5;INSIG2;GPAA1;RER1;TAPT1
prerank,DNA conformation change (GO:0071103),-0.48280204442298724,-1.2028388528219665,0.2556818181818182,0.6166933909967784,1.0,10/17,31.61%,TOP2B;HHEX;HMGB2;TOP3A;TOP2A;HAT1;ERCC3;ABL1;TOP1;NAA10
prerank,cellular protein-containing complex assembly (GO:0034622),0.36895765916109635,1.20272229252843,0.19605077574047955,0.75032324834345,1.0,13/159,7.30%,SGIP1;CASQ2;DMD;HIGD1B;NCK2;IMMP2L;NRG1;CHRNA3;PSMG3;CENPW;SNCA;PIK3C2A;BIN1
prerank,cellular senescence (GO:0090398),0.48514664000763474,1.2026202016821552,0.26627218934911245,0.7492733962450939,1.0,5/27,10.83%,TBX2;TBX3;HRAS;CDKN1A;KAT6A
prerank,negative regulation of interleukin-2 production (GO:0032703),-0.4628692449262436,-1.2024810298852922,0.2550607287449393,0.616789359052328,1.0,5/18,17.12%,HDAC7;EZR;CD34;TRIM27;HOMER3
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.48440911902438044,-1.2019014385787734,0.23679060665362034,0.6174172005568559,1.0,3/15,6.23%,BMP4;SMO;SIX1
prerank,actin filament organization (GO:0007015),0.373320780850351,1.201792208143903,0.18686131386861313,0.749995005433194,1.0,26/151,10.80%,MYO1B;EPS8;CARMIL1;MPRIP;BCAR1;RND3;WAS;CORO7;SH3BP1;ABI2;RAC3;SPIRE1;WASL;TMOD1;TMOD3;EMP2;PLS3;SPTA1;MYO6;CORO1A;MARCKS;ERMN;HIP1;LMOD1;ARPC4;GAS2
prerank,chondroitin sulfate catabolic process (GO:0030207),0.5594356038305994,1.2014367366660215,0.28662420382165604,0.7495802233889237,1.0,1/13,0.21%,CSPG4
prerank,ether lipid metabolic process (GO:0046485),-0.495605967427498,-1.2011913537901182,0.21975806451612903,0.6185234147551221,1.0,4/14,11.23%,AGMO;NCEH1;PLA2G6;LIPE
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4294828077463275,-1.2010517854811675,0.2300194931773879,0.6180377808806482,1.0,13/27,30.68%,NFAT5;RHOA;CD47;RELA;SIRPA;CYRIB;MDK;NR4A3;ITGB2;CD44;HAS2;CCR2;CCL2
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),0.5850665633966745,1.2005372787641557,0.27293064876957496,0.7504266798221806,1.0,4/10,17.30%,CPEB1;NCBP2;DHX36;HSF1
prerank,regulation of protein dephosphorylation (GO:0035304),0.4606852802754252,1.200282878656219,0.2563600782778865,0.7497574172022777,1.0,1/37,0.07%,DLC1
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.44481838352422576,-1.2001964606165403,0.21551724137931033,0.6194591531225201,1.0,5/21,5.39%,BMP6;DAB2;BMP4;TGFBR1;CCN3
prerank,mucosal immune response (GO:0002385),0.542467053243131,1.1999666811669143,0.29124236252545826,0.7492372357129579,1.0,3/15,6.03%,FFAR2;CAMP;IL4
prerank,mitotic DNA replication (GO:1902969),0.5725661124700091,1.1998673047619963,0.2795031055900621,0.7482102042862223,1.0,4/10,10.98%,GINS1;GINS3;MCM6;MCM2
prerank,negative regulation of phosphorylation (GO:0042326),0.40101316401973497,1.1996855687901884,0.20224719101123595,0.7473732713548433,1.0,7/85,3.06%,DYNLL1;PTEN;PID1;CBFA2T3;ROCK1;PRR5L;CADM4
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.49395154914428235,-1.1994929776079872,0.24277456647398843,0.6204413893205432,1.0,5/15,9.53%,PRKCH;BMP4;SFRP4;FOXC1;TRIM16
prerank,positive regulation of protein modification process (GO:0031401),-0.29686120327358095,-1.1989990674232103,0.07692307692307693,0.6208510896443962,1.0,55/203,14.53%,DAB2;TRABD2B;EGFR;LEPR;CDH5;ROCK2;NTRK3;TEK;PECAM1;APP;BMP4;ANGPT1;LRRK2;NIBAN1;VEGFD;VEGFC;LIMK2;IGF2;GAS6;ARRB1;FGF1;ACE;EFNA5;RAB3GAP1;CCND2;PTPA;CARD14;CALM2;FNIP1;CCND3;TFRC;TBX1;PRKCD;WDFY2;NOS1AP;AKT1;PPP1R16B;IRGM;FLCN;KDR;MAVS;ITGB3;TGFB1;TMEM119;FLT4;CCN1;CDK2AP1;CCND1;ATG10;TXN;NNMT;LIMCH1;PPIA;FXR2;MAPK3
prerank,chromatin organization (GO:0006325),-0.318621688029008,-1.1989545521449887,0.1488095238095238,0.620080442612303,1.0,33/132,20.44%,SMARCA2;MECOM;HDAC4;HDAC8;ESR1;SETD7;KAT2B;BAZ1A;INO80;KDM5B;PRDM16;BPTF;BAZ1B;BAZ2B;TADA2A;EHMT1;JARID2;HDAC1;EZH1;MPND;HDAC5;SMARCC1;SNAI1;HMGB2;KDM6B;HCFC2;HMGN1;EZH2;SMARCAD1;SETDB1;HP1BP3;RSF1;MCM3AP
prerank,negative regulation of cellular process (GO:0048523),0.32790040253898706,1.198904446155189,0.1210710128055879,0.7479539598550496,1.0,49/521,6.56%,DLC1;PTPRK;ITGA1;PTEN;GLMN;RERG;CBFA2T3;APBB2;IGFBP7;RAPGEF2;TNFRSF21;CDK6;DYSF;BMP5;NOTCH1;COL4A3;NCK2;SEMA5A;RGCC;CCN6;GPER1;NR1H3;SLIT3;FRK;MYH9;TNS2;FERMT2;SIPA1;SPEF1;FOXM1;ERBB4;IL1B;PLXNB1;ETS1;CRLF3;SH2B3;MYO16;FGF2;RPS6KA2;BRINP1;GAS8;FABP3;TNFRSF8;TFAP2B;NUPR2;CBLL1;DDX3X;CAPRIN2;SOX4
prerank,long-chain fatty acid transport (GO:0015909),-0.4077886184851741,-1.198645188342435,0.2222222222222222,0.6199816712629642,1.0,10/30,18.87%,PRKAG2;APOE;CPT1A;SLC25A20;CPT2;ACACA;MFSD2A;PRKAA2;FABP5;ACACB
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),-0.4320118729796789,-1.1979914131264784,0.234251968503937,0.6209164002278712,1.0,7/25,20.49%,APP;RIN3;SDCBP;ATXN2;ITGB3;NEU3;ANKRD13D
prerank,regulation of myoblast fusion (GO:1901739),-0.5359582940681168,-1.1974489535027613,0.24452554744525548,0.6215414891767963,1.0,4/11,15.60%,CFLAR;MAPK14;EHD1;EHD2
prerank,limb development (GO:0060173),-0.4269511085069952,-1.1970222130023243,0.2069672131147541,0.621886694058615,1.0,9/28,11.87%,SMOC1;CHD7;PCSK5;KAT2B;RSPO2;INTU;ZNRF3;GLI3;PTCH1
prerank,cartilage development (GO:0051216),-0.3838869646279178,-1.1966526523599705,0.20892018779342722,0.6220463004832024,1.0,10/49,5.48%,NFIB;SULF1;ZBTB16;OSR1;ITGB8;BMP4;CREB3L2;SLC39A14;CCN3;SULF2
prerank,regulation of neuron migration (GO:2001222),-0.4242712676662221,-1.1965661621267172,0.21428571428571427,0.6214049680937607,1.0,5/26,4.01%,PHACTR1;COL3A1;SEMA6A;SRGAP2;ARHGEF2
prerank,regulation of B cell activation (GO:0050864),0.4928349718765741,1.1964556251081016,0.2720306513409962,0.7526257751639632,1.0,3/25,6.03%,SH3KBP1;TNIP2;IL4
prerank,positive regulation of mononuclear cell migration (GO:0071677),-0.41504583300559816,-1.1962473041354726,0.2109704641350211,0.6214389190952826,1.0,8/29,15.73%,JAM2;CXCL12;GAS6;LGALS9;ANO6;CALR;CREB3;SERPINE1
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.42686557830653155,-1.1957048874217275,0.22845691382765532,0.6220038876044078,1.0,6/27,6.76%,IGF1;FN1;PDGFRA;GAS6;WNT5A;S100A6
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.4820188840109852,1.1952301507607483,0.2589792060491493,0.754238920140929,1.0,2/29,1.77%,MBOAT2;NR1H3
prerank,positive regulation of metabolic process (GO:0009893),-0.32206561689265606,-1.1951165689765462,0.1495601173020528,0.6227367380399249,1.0,35/103,20.99%,LEPR;CAMK1D;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;ACACA;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;BEND3;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;ACACB;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,negative regulation of bone remodeling (GO:0046851),-0.5334862713977673,-1.1947086498900785,0.23984526112185686,0.6230334937483902,1.0,5/11,22.12%,P2RX7;TMEM119;SFRP1;GPR137;UBASH3B
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.46483326203596476,-1.1943779801614163,0.24489795918367346,0.6229914340547745,1.0,13/18,36.49%,AKT1;HIF1A;PPIA;PARK7;NONO;PRKN;BAG5;SOD2;HSPB1;PINK1;MAPK7;VNN1;NME5
prerank,engulfment of apoptotic cell (GO:0043652),-0.49503372619516856,-1.1943413915639043,0.2570281124497992,0.6222275884640247,1.0,5/15,22.19%,RHOBTB1;THBS1;MEGF10;RHOH;RHOBTB2
prerank,glycosaminoglycan catabolic process (GO:0006027),0.4237034004776691,1.1942949581505162,0.25,0.755153944238382,1.0,11/55,6.34%,CSPG4;SDC2;CEMIP2;SDC3;HYAL4;AGRN;FGF2;ACAN;GPC5;GPC3;GNS
prerank,negative regulation of signaling receptor activity (GO:2000272),0.49623927469666196,1.1936582029334726,0.2727272727272727,0.7554868703762636,1.0,3/25,5.24%,ACE2;CNRIP1;SOCS5
prerank,cellular response to ATP (GO:0071318),-0.48596150639901303,-1.1936327048796873,0.25736738703339884,0.6232415884070965,1.0,6/14,25.05%,TAF1;P2RX4;P2RX7;P2RY1;HSP90B1;P2RY12
prerank,glycine transport (GO:0015816),-0.5439202159148776,-1.1933745942509304,0.2682926829268293,0.6230467101532455,1.0,4/10,20.15%,SLC6A9;SLC25A38;SLC38A5;SLC36A1
prerank,organic anion transport (GO:0015711),-0.34548794008054395,-1.1930292683057795,0.17857142857142858,0.6231340175295104,1.0,16/76,10.70%,ABCC4;SLCO2B1;SLC16A2;SLC26A7;SLCO2A1;SLC4A10;SLCO1C1;ABCG2;SLC22A6;ABCC6;SLC25A17;SLC25A4;SLC39A8;MGST1;SLC25A24;SLC35A2
prerank,regulation of myotube differentiation (GO:0010830),-0.43641081888698063,-1.192491635001515,0.26810176125244617,0.6237323090818672,1.0,11/24,13.66%,HDAC4;HDAC9;CCN3;PIEZO1;MAPK14;MMP14;DMPK;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4378878779087725,-1.1917246058735678,0.22718446601941747,0.6249341139096842,1.0,4/23,2.83%,CAMK1D;MCU;SLIT2;DPP4
prerank,P-body assembly (GO:0033962),0.5530446282755404,1.1916632116689136,0.27524752475247527,0.7591794278224037,1.0,2/12,5.17%,LIMD1;LSM3
prerank,anion transmembrane transport (GO:0098656),-0.3505032241095908,-1.1914810543943473,0.16747572815533981,0.624693033387005,1.0,19/67,16.03%,SLC13A4;SLC6A13;SLC13A3;SLC1A3;SLC7A2;SFXN2;SLC6A9;SLC7A5;SLC25A4;SLC5A6;SLC25A38;SLC38A5;SLC39A8;SLC35A2;SLC3A2;SLC25A19;SLC25A22;SLC7A1;ARL6IP5
prerank,positive regulation of myoblast differentiation (GO:0045663),-0.48027244640321454,-1.1913063886866073,0.258252427184466,0.6243071610611723,1.0,5/16,6.70%,RANBP3L;PLCB1;BOC;IGFBP3;MAPK14
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.4723118902722128,1.1909648966917308,0.28125,0.7596227008630804,1.0,15/35,18.08%,PCDHB11;ATP2C1;CDH8;CDH22;CDH19;CDH20;CDH7;CDH10;CDH18;CDH12;PCDHB16;PCDHGB4;CDH6;PCDHGC3;DCHS1
prerank,negative regulation of tumor necrosis factor production (GO:0032720),-0.3803444184133723,-1.1909266562085417,0.22458628841607564,0.6245188387676841,1.0,8/41,10.89%,IGF1;LBP;CD34;GAS6;LGALS9;IRAK3;ZC3H12A;TRIM27
prerank,"regulation of transcription, DNA-templated (GO:0006355)",-0.2513792439954573,-1.1902450040706962,0.0,0.6254814534617591,1.0,386/1646,19.36%,NFIB;TSHZ2;BNC2;FOXP2;IGF1;ZMIZ1;PBX1;PKNOX2;FOXN3;ZNF423;MAF;PLCB1;SMAD3;FLI1;SMARCA2;EGFR;ZBTB16;MECOM;SMAD6;COL1A1;EFEMP1;NFAT5;KDM7A;FOXP1;ZKSCAN2;WNT4;HDAC4;DENND4A;GLI2;CUX1;TBL1XR1;NFIX;WWC2;CREB5;IL31RA;CHD7;ZFHX4;BMP7;LCOR;SP100;TGFA;GLIS3;VGLL4;RBFOX2;DKK3;HOXB6;IKZF2;ELF2;FOXO1;PBX3;APOE;OSR1;KLF3;FOXO3;MDFIC;ZIC2;NFIA;NR3C1;KAT6B;HIVEP3;ANXA4;ERG;HOXB3;MLXIP;SUFU;ESR1;ZIC5;SMURF2;USP47;VGLL3;ELF1;BMP4;MAFG;ELF4;MEOX2;ZBTB7C;PRRX2;TGFBR1;SNX6;FOXD1;TBX15;KLF4;PLAGL1;DDX5;NR3C2;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;LRP6;NFATC1;SMAD7;CDH1;LEF1;ACVR1;FZD2;KLF2;ETV6;ID1;MLLT3;PDCD4;HDAC9;SBNO2;MXI1;RGMB;HOXA5;ZHX3;CREB3L2;ZNF23;SP140;PCGF5;ZFPM2;PARP9;CNOT7;IGF2;GATAD2A;HDGFL3;MED26;SSBP2;GAS6;ARRB1;HOXA3;ZNF697;GTF2IRD1;TEAD4;QRICH1;NIBAN2;ARNT2;WWP2;AR;BRD7;DAP;SCMH1;CREM;YAP1;STAT2;FOXP4;HIF3A;PRRX1;GLIS2;SOX13;THRAP3;BHLHE40;PFDN5;KMT5A;ACVRL1;ATXN1;IRF1;TEAD1;MIDEAS;SIX1;WNT5A;BAZ1A;CDK17;ZNF292;PRKCB;HLF;KDM5B;HOXC6;PRDM16;MAPK14;ID3;FOXC1;IRF2;GLIS1;SFMBT1;CHD3;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;IFRD1;PGR;BAZ1B;KLF10;SFR1;ZNF219;TBX1;ERC1;POLR2A;FZD4;ZBTB8A;TRRAP;GON4L;TFCP2;IRF9;ZBTB18;VSX1;BAZ2B;AKT1;DTX3L;BBS7;KIT;FOXL1;LHX6;RREB1;TLE2;REXO4;HIF1A;CBFA2T2;TADA1;MKX;ZMYND15;RCOR3;TRIM16;TLE1;TWIST2;TADA2A;FOXK1;CRABP2;CARM1;NR4A2;MMS19;TULP3;FZD7;ATF6;BHLHE41;EHMT1;FOSL2;CD38;PHF10;IKZF1;GCLC;DAB2IP;HOXB9;TFCP2L1;JARID2;KARS1;PRDM5;ZKSCAN7;ZKSCAN3;SLC39A8;TGIF1;ESRRG;ZFHX2;PML;KLF12;SIX5;GATA2;BRCA2;CEBPG;PATZ1;ZSCAN25;NFYC;HINT1;BACH2;KDM3A;GLI3;FOXQ1;TGFB1;NSD1;ELK3;MED27;AHR;HDAC1;LRRFIP1;ZSCAN22;ATXN7L3;MDM2;ZIC3;RELA;PPARA;CHD2;ID2;MEF2A;SRSF10;USF1;GATA6;CBX4;FBXW11;PRDM11;SP110;CALR;GLRX2;ATOH8;ZGPAT;CLOCK;MEIS2;SPP1;ZNF585A;ZNF585B;HDAC5;RET;ZNF568;TAL1;SOX17;RFX2;HSF2;SFRP1;QARS1;DACH2;TOX4;CREB3L1;SMARCC1;ENO1;SLTM;POU2F1;MAZ;ZBTB4;HOXC4;TTC21B;HOXB5;HOXB7;HIPK2;DYRK1B;PCGF3;SOX7;WWP1;NKX6-1;SNAI1;CREB3;YEATS2;JUND;SREBF1;CDKN1B;NOS1;NKRF;L3MBTL2;RNF187;HHEX;MEIS1;HMGB2;SOX18;HCFC2;MNT;USF2;ZMIZ2;ZFP69;ZNF436;JUNB;MYRF;SIRT2;HNRNPAB;ASCC1;ATF1;TSHZ1;TCIM;MED21;FBXL19;WNT11;NFIL3;PSIP1;RAI1;ACTR8;FZD1;NFYB;ZFP14;CSRNP3;NFXL1;NPAS2;MAFF;SOX12;RRP8;NR6A1;CC2D1A;RHOH;CEBPB;KLF15;BASP1;CIR1;ELP3;PCGF6;POU5F2;TYMS;AGT;EZH2;PLAG1;YAF2;ZSCAN2;BRF2;SBNO1;ATF7;HMGN5;MT3;PIM2;SCML4;PPARGC1A;E2F1;ZFX;ETV4;IRF2BPL;THOC1;ZFP57
prerank,negative regulation of binding (GO:0051100),-0.3413454722476775,-1.189966075605047,0.165374677002584,0.6253565251863548,1.0,27/81,22.97%,DAB2;ARHGAP28;SP100;CAV1;LRRK2;LEF1;SMO;PRKCD;IFIT2;AKT1;IFIT1;MDFI;DNAJB2;ACTB;ZFPM1;TMBIM6;MITD1;STYX;NFKBIA;EFHB;PARK7;E2F1;CTNNBIP1;RSF1;BAG2;PLN;CFHR2
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.4505166119315758,-1.1892961501243795,0.23684210526315788,0.6263184172836843,1.0,2/19,0.11%,BMP6;AFDN
prerank,response to lipid (GO:0033993),-0.3265758689119314,-1.1886295928733333,0.15142857142857144,0.6273176237483938,1.0,32/105,16.84%,SMAD6;FOXP1;CTSH;FOXO1;FOXO3;LBP;RBP4;ESR1;NOS3;ANXA1;SOCS2;ACER2;RARG;LGALS9;ALPL;STAT3;NOCT;TRIM16;IRAK3;TGFB1;GCH1;FGFR4;PPARA;GATA6;TNFRSF11A;SPP1;FER;MAPKAPK3;NOS1;HMGB2;TLR4;PELI1
prerank,phosphorylation (GO:0016310),0.3329058445359248,1.188451532124383,0.14631197097944376,0.7645076373419555,1.0,74/384,11.79%,DGKB;LIMD1;PRKG1;MAP3K20;PIK3CD;CDK6;DGKH;MAP3K5;SNRK;PEAK1;PKN1;FRK;DGKG;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;PIK3CA;LIMK1;RPS6KA4;GRK3;CDK15;CDC42BPA;STK39;STK38L;JAK1;MINK1;RYK;TESK2;TRIB2;ROS1;NEK1;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK24;STK3;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;XYLB;PRKD2;LYN;PDGFB;GK;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;GNPTG;DGKD;DYRK3;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PAK1;TEC;NLK
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.45225818387708,-1.1882486720515641,0.23679060665362034,0.6275758997324354,1.0,6/20,18.53%,IGF1;NIBAN2;FOXC1;TGFB1;PARK7;LAMTOR5
prerank,triglyceride homeostasis (GO:0070328),0.485751947936757,1.1879757786867642,0.2829076620825147,0.7644978427491386,1.0,4/26,6.95%,RORA;NR1H3;SCARB1;LIPC
prerank,modified amino acid transport (GO:0072337),0.5365537942958802,1.1874526034065969,0.27385892116182575,0.7645027686555907,1.0,3/15,3.11%,SLC16A12;SLC1A4;SLC19A1
prerank,glucose import (GO:0046323),0.5512563462360384,1.1873560831717505,0.3028322440087146,0.763507576296644,1.0,4/13,8.28%,SLC5A1;SORT1;SLC27A4;SLC2A3
prerank,regulation of signal transduction (GO:0009966),0.36006882949799485,1.1871205465443064,0.19727891156462585,0.7628523673529345,1.0,18/190,5.31%,RGS5;RGS4;RGS6;PLCE1;IGFBP7;RORA;NCK2;SEMA5A;RGS3;TSPAN15;CD46;GRK3;RGS11;IFT81;TSPAN12;SREBF2;SOCS5;OGT
prerank,regulation of T cell proliferation (GO:0042129),0.42879355724376683,1.1868634665427666,0.2525083612040134,0.762216839212706,1.0,5/61,2.84%,GLMN;TNFRSF21;NCK2;IL1B;CD46
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),-0.49113778412488057,-1.1867656991689848,0.2725490196078431,0.6307515280427971,1.0,9/14,29.65%,SUFU;TMSB4X;MDFI;PKD1;NFKBIA;PSMD10;G3BP2;NFKBIE;KEAP1
prerank,metal ion homeostasis (GO:0055065),0.45399835900453395,1.1866094817957915,0.26102292768959434,0.7615906808175266,1.0,10/40,13.22%,SLC12A2;SLC12A6;TFAP2B;ANK3;SNCA;LETM1;COX11;SLC12A5;FAM20A;SLC12A4
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.4710847967986118,1.1863021233687876,0.2471042471042471,0.7610816549243946,1.0,4/31,1.19%,LIMD1;RORB;CDK6;NOTCH1
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4795112175951741,-1.1861796145404186,0.24094202898550723,0.6314298782702966,1.0,1/16,0.08%,AUTS2
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.3751415152865331,1.1861581150554945,0.22205882352941175,0.7601699325018676,1.0,16/124,9.76%,FRY;CARMIL1;RAPGEF2;MAP2;ROCK1;CNTNAP2;RYK;ATP1B2;LAMB1;CNTN4;BLOC1S1;FAM161A;PKD2;LYN;TMEM108;PLP1
prerank,acute-phase response (GO:0006953),-0.4987623227995657,-1.1859558668871228,0.2829827915869981,0.6311939160519497,1.0,5/12,25.16%,IL6R;LBP;CEBPB;SIGIRR;PLSCR1
prerank,camera-type eye development (GO:0043010),-0.42685264476213614,-1.1847759419034583,0.23503325942350334,0.6334571866852247,1.0,9/25,8.16%,FBN1;EFEMP1;LAMA1;SHROOM2;SKI;RAB3GAP1;FBN2;CYP1B1;STRA6
prerank,negative regulation of protein catabolic process (GO:0042177),-0.38002105857370827,-1.1847073738526104,0.2071269487750557,0.6327664053961,1.0,15/40,22.15%,TIMP3;EGFR;PTPN3;TIMP2;CST3;ATRAID;IRAK3;DAB2IP;PRKCG;RGP1;TIMP4;SIRT2;SNX3;CDK5RAP3;AZIN1
prerank,regulation of fatty acid biosynthetic process (GO:0042304),-0.43082830006098166,-1.1844605851350722,0.2390852390852391,0.6325387208967298,1.0,10/26,24.18%,PRKAG2;ADIPOR2;LPGAT1;ACADL;PRKAA2;CEACAM1;ERLIN2;ADIPOR1;SLC45A3;BRCA1
prerank,atrial septum development (GO:0003283),0.5450806639410227,1.1843464887108008,0.3083511777301927,0.7632792471981009,1.0,2/13,1.22%,HEY2;TBX20
prerank,interleukin-6-mediated signaling pathway (GO:0070102),-0.4645231821386932,-1.184224844124955,0.2591093117408907,0.6323663787241404,1.0,5/18,7.33%,IL6R;IL6ST;YAP1;STAT1;STAT3
prerank,cholesterol homeostasis (GO:0042632),0.41999147689637006,1.1840785848648185,0.2231833910034602,0.7626786228991712,1.0,9/64,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5601287230836592,1.1838734985171098,0.3111111111111111,0.7619323032295812,1.0,6/10,16.37%,MAPRE2;FGF10;MTOR;MAP4K4;IQSEC1;EPB41L4B
prerank,sterol homeostasis (GO:0055092),0.41746130538174214,1.1836198390510304,0.22184300341296928,0.7612953326413663,1.0,9/65,6.95%,CYP7B1;RORA;NR1H3;SCARB1;LDLRAP1;LDLR;FABP3;ABCA5;LIPC
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),-0.47560095565953975,-1.183408072820766,0.265748031496063,0.6337687096157073,1.0,7/16,11.83%,APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,regulation of B cell differentiation (GO:0045577),-0.46299990524455414,-1.1830140512685339,0.2593984962406015,0.6339878069256574,1.0,8/17,25.77%,MMP14;ID2;SFRP1;ZFP36L2;PPP2R3C;SYK;XBP1;NCKAP1L
prerank,negative regulation of receptor binding (GO:1900121),0.5589537406820798,1.1829808338384813,0.28699551569506726,0.7616054333517158,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,canonical Wnt signaling pathway (GO:0060070),-0.35041983841809626,-1.1825528816493158,0.18798955613577023,0.6343607321002852,1.0,21/68,13.91%,WNT4;PLPP3;WNT6;CAV1;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;SCYL2;FZD4;NR4A2;FZD7;BCL9L;WNT5B;WNT16;SFRP1
prerank,epithelial cell morphogenesis (GO:0003382),-0.46844273192863944,-1.1821849195420602,0.2571428571428571,0.6344726053613767,1.0,6/17,13.47%,COL22A1;RILPL1;COL18A1;COL15A1;CCDC88C;MET
prerank,error-prone translesion synthesis (GO:0042276),-0.4387113741922267,-1.181586135587344,0.25,0.635253037312712,1.0,13/21,36.71%,REV1;POLH;UBB;RPA1;RFC3;POLI;POLE2;RFC1;RPA3;PCNA;RFC5;MAD2L2;PRIMPOL
prerank,regulation of RNA metabolic process (GO:0051252),-0.3506284095119307,-1.181057047816579,0.16972477064220184,0.6358308271291429,1.0,15/59,12.60%,AHNAK;MBNL1;RBM20;TNFRSF1B;AFF2;IGF2BP2;RC3H2;NOVA2;SON;OAS2;PCBP2;CLK1;MBNL2;GRSF1;NOVA1
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.4776880956530946,-1.1807382413012988,0.24271844660194175,0.6357896921621641,1.0,6/14,19.93%,CD55;TGFBR2;LGALS9;IL18;CD81;SYK
prerank,positive regulation of protein binding (GO:0032092),-0.36409023530421836,-1.1803796244855356,0.20537897310513448,0.6359261109053117,1.0,20/56,15.72%,APOE;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;TIAM1;DTX3L;IDE;RPL11;ADD1;RAN;PKD1;HIPK2;HFE
prerank,ovarian follicle development (GO:0001541),-0.49021219635101015,-1.1803397927744637,0.26256983240223464,0.635171633445177,1.0,7/13,28.26%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;EIF2B4
prerank,proteolysis (GO:0006508),0.3394111782874344,1.180327602715306,0.176,0.7667299598967791,1.0,23/252,6.31%,ENPEP;GGT5;TMPRSS4;FAP;NAALAD2;GGT1;CPM;METAP2;TMPRSS7;USP25;ADAM19;ATG4A;ECE1;MMP15;ANPEP;TASP1;SVBP;CTSF;ACAN;PSMB11;OGT;DESI1;DESI2
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5145523372664098,1.1802398553079478,0.2910602910602911,0.7656799181201589,1.0,4/17,2.62%,S1PR3;VCL;ROCK1;IL1B
prerank,cellular response to peptide (GO:1901653),-0.35757826211789373,-1.1802382606372266,0.19154228855721392,0.6346336392222827,1.0,13/56,6.56%,IGF1;EPHA4;APP;CAV1;VIM;GJA1;IGF1R;SNX6;NOD1;ARHGEF2;VCAM1;CASP4;ICAM1
prerank,positive regulation of receptor internalization (GO:0002092),-0.4486487232728662,-1.1801800003449012,0.2439516129032258,0.6339278434839639,1.0,5/22,7.40%,ANGPT1;MAGI2;ARRB1;SFRP4;SCYL2
prerank,organelle transport along microtubule (GO:0072384),0.4665166522075113,1.1801583105691447,0.26356589147286824,0.7646533488256737,1.0,10/31,17.43%,ARHGAP21;BICD2;UXT;TRAK1;TRAK2;COPG2;RAB1A;NDE1;HTT;HAP1
prerank,positive regulation of innate immune response (GO:0045089),-0.4130918964354302,-1.179842711233302,0.25054466230936817,0.6340286289704866,1.0,7/30,11.55%,LBP;WNT5A;RPS19;IFI35;NLRC5;MAVS;GBP5
prerank,regulation of neuron differentiation (GO:0045664),0.4038410538783497,1.179536587249475,0.23624595469255663,0.7649818837215022,1.0,12/76,9.43%,MEF2C;HEYL;ZEB1;ZFHX3;ROCK1;MOSMO;BRINP1;CNTN4;BIN1;BEND6;BRINP3;MED1
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),-0.47011241417049465,-1.1792849248191664,0.2668024439918534,0.6347833933556576,1.0,4/17,5.67%,PODXL;FOXC2;ADAM9;PIEZO1
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.571059863813222,1.1791032045751257,0.30434782608695654,0.7648098676241672,1.0,4/10,10.38%,DGKH;GAP43;PRKD3;DGKD
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.47962510880116926,-1.1789371233171917,0.26750448833034113,0.6348812776224054,1.0,5/15,22.25%,OSBPL8;PPARA;PLIN2;OSBPL11;LPL
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.45058894837184826,-1.1788342812539856,0.2625482625482625,0.6343487416164534,1.0,6/19,14.16%,WNT4;VIM;BMP4;EMILIN1;TGFB1;CREB3L1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),0.48331864093393107,1.1787200606316144,0.2796116504854369,0.7645112250058397,1.0,3/24,5.46%,COX4I2;PID1;SLC25A13
prerank,regulation of oxidative stress-induced cell death (GO:1903201),-0.5090618487793068,-1.178243689416636,0.2640449438202247,0.6351804082216593,1.0,7/11,34.91%,P4HB;PARK7;STK26;PRKN;LANCL1;PINK1;MMP3
prerank,regulation of viral genome replication (GO:0045069),-0.3616220909205552,-1.1782141867638647,0.2116279069767442,0.6343948206482855,1.0,30/56,36.96%,CNOT7;IFITM3;HACD3;OAS2;IFIT1;MAVS;PPARA;PPID;LARP1;PPIA;DDB1;IFITM2;RNASEL;RSAD2;SRPK1;NR5A2;TRIM6;SRPK2;PLSCR1;ISG15;ADARB1;ILF3;BST2;PARP10;OASL;FAM111A;PPIE;RAD23A;ISG20;PROX1
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.5017049159511079,-1.177766943594727,0.2784313725490196,0.634725659413059,1.0,5/12,12.09%,GMDS;CSGALNACT1;FUT8;EXTL2;GFPT2
prerank,muscle tissue development (GO:0060537),-0.4987369569068615,-1.1774814301909824,0.27710843373493976,0.6346525595793673,1.0,7/13,11.87%,BMP4;SMO;PGM5;CSRP2;STRA6;POGLUT1;PTCH1
prerank,calcium ion import into cytosol (GO:1902656),0.538829245178432,1.17724862827133,0.2948717948717949,0.766857146812555,1.0,3/15,4.63%,TRPV2;CACNA2D1;SLC24A2
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3638323827844915,1.1771174714045773,0.21929824561403508,0.7659593741640178,1.0,21/151,7.63%,PDGFRB;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ERBB4;PTPN22;ACKR3;FGF2;SPRY2;CARD9;NTRK2;HTR2C;CHRNA7;RAP1A;HRAS;FGF10
prerank,post-translational protein modification (GO:0043687),-0.28174346735129074,-1.1770858711976893,0.09691629955947137,0.6348830298076964,1.0,98/332,21.65%,FBXL7;FBN1;FN1;FSTL1;ZBTB16;IGFBP5;APOE;APP;CP;BMP4;FBXO10;RAB11A;ITIH2;PTP4A2;CSF1;STT3A;ASB2;SOCS2;SPSB1;IGFBP4;RBBP7;ADAM10;IGFBP3;DCAF6;GAS6;HIF3A;VWA1;P4HB;SERPIND1;TNC;KLHL2;CALU;STT3B;CST3;MSLN;OBSL1;DCAF11;GOLM1;HIF1A;RAB2A;NOTUM;PRSS23;ASB7;MXRA8;KLHL5;PSME2;CUL4A;ASB5;RAB8A;CKAP4;COPS4;PSMB4;CCN1;FBXW11;COPS8;SPP1;ELOB;F5;LTBP1;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;SCG3;NEURL2;RCN1;UBA3;FBXL14;SUMF2;DNAJC3;PSME3;APLP2;PDIA6;ASB1;DCAF4;CCDC8;FBXL19;SPSB4;SPSB2;QSOX1;PSMD4;DCAF8;UBE2M;HSP90B1;PSMA2;FBXO41;ASB6;LGALS1;PSMD3;FAM20C;PSMB7;WSB2;CISH;FSTL3;GAN;ELOC;CUL5
prerank,regulation of chondrocyte differentiation (GO:0032330),0.48580630054938745,1.17703051699037,0.2695167286245353,0.7649464193658503,1.0,3/24,1.50%,SOX5;MBOAT2;TRPS1
prerank,renal absorption (GO:0070293),-0.5370914785187839,-1.1768935219546295,0.28867924528301886,0.6345749241423386,1.0,3/10,10.38%,GSN;WNK4;KCNQ1
prerank,regulation of cardiac muscle contraction (GO:0055117),0.46405402054458006,1.1768520106113798,0.2920517560073937,0.7641624399772333,1.0,6/34,7.08%,PDE4D;SCN5A;PDE4B;RYR2;ATP2A2;STC1
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.3910213818801864,-1.1766968745684132,0.22323462414578588,0.6342292559013653,1.0,17/38,26.22%,NDUFV3;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFA4;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,inositol phosphate-mediated signaling (GO:0048016),0.5122714525463109,1.1760313965688332,0.3,0.7648978010161648,1.0,5/19,8.96%,PLCE1;INPP5A;PPP3CA;GPR62;NFATC4
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.4792428790015421,1.175787683272499,0.300187617260788,0.7642862249749488,1.0,5/27,5.52%,UTRN;NEDD4L;FGF12;FXYD2;SCN5A
prerank,ceramide transport (GO:0035627),-0.49902678139564177,-1.1752778497446117,0.2751322751322751,0.6372025555127742,1.0,3/12,10.07%,PLTP;CERT1;PSAP
prerank,cardiac muscle tissue development (GO:0048738),0.431446275322812,1.1752689749629575,0.2664298401420959,0.7643068429988977,1.0,9/50,6.97%,TBX2;HEY2;BMP5;NOTCH1;TBX20;NRG1;SCN5A;SIK1;SGCZ
prerank,positive regulation of cell killing (GO:0031343),-0.4950688662949393,-1.1749228067219553,0.26326530612244897,0.6373931271456804,1.0,5/13,19.93%,WNT5A;FZD7;CYBA;NOX1;SYK
prerank,negative regulation of cell adhesion (GO:0007162),-0.3369115283249376,-1.1745278324895654,0.18434343434343434,0.6375861382591478,1.0,22/72,12.29%,PLXNA2;FBLN1;SEMA6A;PODXL;PLXNA4;ANGPT1;CDH1;ADAM10;ACER2;ACVRL1;RHOA;CYP1B1;DUSP1;FZD4;TGFBI;PLXND1;CDH13;FZD7;ARHGDIA;CD164;TGFB1;EPHB2
prerank,negative regulation of glucose transmembrane transport (GO:0010829),0.5728480673405886,1.173765039337492,0.3326133909287257,0.7667612226614765,1.0,3/10,5.21%,PID1;IL1B;GRB10
prerank,toll-like receptor 4 signaling pathway (GO:0034142),-0.4468758020493032,-1.1736126223849102,0.2839756592292089,0.6392762410313315,1.0,4/19,7.04%,LBP;LGALS9;PRKCE;PIK3AP1
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),-0.510477791411549,-1.1734997389805242,0.2695035460992908,0.6379219800457049,1.0,3/12,19.04%,FHL2;HOMER3;CHP1
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.510477791411549,-1.1734997389805242,0.2695035460992908,0.6379219800457049,1.0,3/12,19.04%,FHL2;HOMER3;CHP1
prerank,regulation of protein processing (GO:0070613),-0.4401265615685087,-1.1734582631945165,0.25680933852140075,0.6371977807894138,1.0,4/21,5.88%,CCBE1;GAS1;LRRK2;RNF139
prerank,cellular response to amyloid-beta (GO:1904646),-0.3979704432986915,-1.1734464627852943,0.23543123543123542,0.6363907595322076,1.0,9/35,6.56%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,sodium ion import across plasma membrane (GO:0098719),0.5265941181110352,1.1732323764336297,0.2920168067226891,0.766787738957353,1.0,4/17,8.33%,SLC12A2;SLC5A1;HCN2;SLC9A7
prerank,regulation of microglial cell activation (GO:1903978),0.5101780676423866,1.1724279935363155,0.2952586206896552,0.7675399140938892,1.0,3/15,6.28%,LDLR;TAFA3;TTBK1
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.5479310338465231,1.1723247230202032,0.3174946004319654,0.7665526465999787,1.0,1/11,0.83%,NEDD4L
prerank,cellular response to nutrient levels (GO:0031669),-0.3529454378059901,-1.1722563009463072,0.20763723150357996,0.6388036516734381,1.0,24/62,25.26%,LAMP2;FOXO1;BMPR2;LRRK2;WIPI2;FNIP1;CLEC16A;KLF10;KCNB1;FLCN;PPARA;MFSD2A;SFRP1;SREBF1;PRKAA2;RRAGB;ZFYVE1;FAM107A;XBP1;LPL;STK26;RIPOR1;ATG7;RRAGC
prerank,camera-type eye morphogenesis (GO:0048593),0.5806370328239052,1.172163896272916,0.31752577319587627,0.7657493407813041,1.0,2/10,2.17%,TBX2;NF1
prerank,O-glycan processing (GO:0016266),-0.3623584880482189,-1.172141273503943,0.22413793103448276,0.6382821666049983,1.0,7/54,9.97%,GXYLT2;ST3GAL4;ST3GAL1;ST3GAL2;ST3GAL3;ST6GALNAC2;GALNT12
prerank,striated muscle tissue development (GO:0014706),0.4686029073924741,1.1715580512894377,0.2734225621414914,0.7659592582508838,1.0,6/29,7.45%,TBX2;MEF2C;BMP5;POPDC3;SGCZ;IGSF8
prerank,cellular response to hydroxyurea (GO:0072711),0.5445336581216482,1.1715555949493413,0.3044397463002114,0.7647652422832636,1.0,5/10,19.55%,TIMELESS;BLM;FMR1;DDX11;RTF2
prerank,histone H3-K36 demethylation (GO:0070544),-0.5258546863466131,-1.1711695455067854,0.286527514231499,0.6401829392265104,1.0,1/10,0.92%,KDM7A
prerank,calcium import into the mitochondrion (GO:0036444),-0.5371527155516609,-1.1708730964181677,0.2797074954296161,0.640140500519251,1.0,6/10,19.68%,MCU;MCUB;AFG3L2;MICU2;MICU1;MAIP1
prerank,regulation of neutrophil migration (GO:1902622),0.5673507395857628,1.1708150777581896,0.3283898305084746,0.7652649098267149,1.0,1/10,1.44%,JAM3
prerank,detection of visible light (GO:0009584),-0.4672926035996714,-1.1707008869287192,0.2917505030181087,0.6398065018718362,1.0,5/16,26.06%,ABCA4;RP1;CACNA2D4;TULP1;GNAQ
prerank,regulation of cellular respiration (GO:0043457),0.5143867058121792,1.1706920590737953,0.3040816326530612,0.7644045215526658,1.0,3/17,6.03%,CBFA2T3;NOA1;IL4
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.3569762205526259,1.1706680547047719,0.21676300578034682,0.763282487981623,1.0,8/166,2.82%,NOTCH3;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2
prerank,neurogenesis (GO:0022008),0.4306862809225118,1.1704869227642782,0.2625,0.7625139683513354,1.0,12/43,14.08%,CDK6;BTBD3;CHAC1;ROGDI;RYK;BTBD6;TRAK1;SPOCK1;TRAK2;EPHB1;RITA1;SIX4
prerank,cellular response to interleukin-6 (GO:0071354),-0.41593741368424675,-1.1699343284100965,0.26229508196721313,0.6410877940251843,1.0,8/26,7.33%,ST3GAL6;PTGIS;IL6R;IL6ST;SBNO2;YAP1;STAT1;STAT3
prerank,cellular response to oxygen levels (GO:0071453),-0.5372757838800566,-1.169883523993625,0.2792452830188679,0.6403944936897382,1.0,7/10,27.55%,ATP6V1G1;ATP6V0A2;CCDC115;TMEM199;PICK1;ATP6AP1;ATP6V0D1
prerank,negative regulation of chemotaxis (GO:0050922),-0.399621646873012,-1.1693073962394136,0.25840336134453784,0.6410761815814094,1.0,7/31,3.63%,ROBO1;SEMA3D;SEMA6A;SEMA3C;SLIT2;THBS1;SEMA7A
prerank,regulation of double-strand break repair (GO:2000779),0.44743638853943024,1.1689882266351166,0.258364312267658,0.7648724090982482,1.0,12/39,17.60%,WAS;FOXM1;SPIRE1;FMN2;DEK;SLF2;TIMELESS;OTUB1;PPP4C;MRNIP;RPA2;DDX11
prerank,regulation of insulin secretion (GO:0050796),0.3827838435307848,1.1689547915703025,0.25688073394495414,0.7637534772202096,1.0,14/101,7.38%,CACNA1C;RAPGEF4;PER2;GPER1;ITPR2;IL1B;GIPR;SNAP25;ITPR1;TFAP2B;SOX4;RAP1A;IRS1;CACNA1D
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.5203629332464295,-1.168832078907237,0.2809611829944547,0.6414948177474948,1.0,7/11,25.35%,PDPN;RREB1;CORO1C;ENPP2;ARPIN;KANK1;CD44
prerank,regulation of axon regeneration (GO:0048679),0.5375251834627321,1.1686488871853404,0.2908704883227176,0.7633182261015549,1.0,4/12,8.00%,RTN4RL1;SCARF1;PTN;STK24
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.5590344072899414,1.1685079706916606,0.3178947368421053,0.7624688085271502,1.0,5/10,9.01%,VTN;IL1B;GRB10;ARNT;PRKD2
prerank,pancreas development (GO:0031016),-0.5046242782847543,-1.1684318551465926,0.2684310018903592,0.641778292685396,1.0,4/12,15.34%,TCF7L2;ZIC3;MET;NKX6-1
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.46839344293410345,-1.1681961778967103,0.2878787878787879,0.6416261913893451,1.0,4/16,6.23%,BMP4;FOXD1;FGF1;SIX1
prerank,ventricular septum morphogenesis (GO:0060412),-0.4194295305844089,-1.1681847730265889,0.26043737574552683,0.6408345539475698,1.0,10/27,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;BMP4;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,Rho protein signal transduction (GO:0007266),0.424997829242553,1.1681498597729068,0.2539404553415061,0.7620740923808793,1.0,9/53,4.60%,EPS8;ARHGAP6;ARHGAP1;ROCK1;WAS;LIMK1;CDC42EP1;RTKN;EPS8L1
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3847234959594737,1.1674961395477739,0.24,0.7624952915708393,1.0,9/98,6.29%,PDGFRB;ACE2;PID1;NR1H3;ECE1;PPARD;ATAD1;IL4;SNCA
prerank,protein-containing complex assembly (GO:0065003),-0.28836338868527345,-1.1674882581749602,0.1134453781512605,0.6418918925538629,1.0,66/259,16.08%,AFDN;FBXL7;FN1;OCLN;TGFA;CD2AP;MCU;SEC23A;SEC24D;SLC2A1;SNX9;TCF7L2;TLE4;LRRK2;LEF1;CTSC;SEC31A;ADAM10;CXCL12;TAPBP;REPS2;TRAPPC10;YAP1;TEAD1;ANO6;SEC24A;PTK2B;PLEKHA7;TRRAP;TIAM1;PARD3;TLE2;TNFRSF1A;TLE1;CARD10;CASP8;USO1;SEC16B;GSDMD;ZC3H12A;COL16A1;PML;P2RX7;LMAN1;GPAA1;BCL9L;HDAC1;TRAPPC4;MDM2;TRAPPC3;PPID;SKAP2;SPG7;ZW10;ELOB;F5;GEMIN5;ANKRD28;MCFD2;CLDN1;PYGO2;CAPZA2;HFE;SEC23IP;NAPA;AFG3L2
prerank,regulation of JNK cascade (GO:0046328),-0.3219326847068996,-1.1673516307186471,0.17231638418079095,0.6414648351791238,1.0,18/101,10.24%,TGFBR3;PLCB1;EGFR;MECOM;CCN2;SH3RF1;APP;IGF1R;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP
prerank,detection of mechanical stimulus (GO:0050982),0.49239824360800155,1.1672181012648508,0.3,0.7619904477299575,1.0,2/19,1.34%,CDH2;PTK2
prerank,dorsal/ventral pattern formation (GO:0009953),-0.43801603450640125,-1.166192449214963,0.26129666011787817,0.6437964622328692,1.0,8/20,15.76%,GLI2;ACVR1;ACVRL1;NBL1;MDFI;PTCH1;SFRP1;BMPR1A
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.4190955409895148,1.1661052135413128,0.26109215017064846,0.7635217727338397,1.0,9/60,11.66%,PDGFRB;RGCC;FGF2;TNKS;PARM1;PRKD2;PDGFB;ATR;HNRNPA1
prerank,positive regulation of cholesterol efflux (GO:0010875),-0.44011551191129866,-1.165458033006334,0.2638888888888889,0.6448788626519293,1.0,8/21,20.47%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,pulmonary valve development (GO:0003177),-0.46436918724620563,-1.165392790199985,0.2854251012145749,0.6442038635611732,1.0,11/18,9.40%,NOTCH2;ROBO1;SMAD6;SLIT2;NOS3;BMPR2;BMP4;NFATC1;TNFRSF1B;STRA6;TNFRSF1A
prerank,establishment of epithelial cell polarity (GO:0090162),-0.4521380157708364,-1.165385723066618,0.2589641434262948,0.6434035804568816,1.0,8/19,16.57%,MYO18A;EZR;RHOA;MYO9A;GOLPH3;PARD3;OPHN1;CYTH1
prerank,positive regulation of viral genome replication (GO:0045070),-0.4140125180529587,-1.1650342376760832,0.25840336134453784,0.6435146236322808,1.0,13/29,25.12%,CNOT7;HACD3;TOP2B;IFIT1;PPARA;PPID;LARP1;PPIA;DDB1;SRPK1;NR5A2;TOP2A;SRPK2
prerank,cellular component maintenance (GO:0043954),-0.4895821615449948,-1.164845009997969,0.286527514231499,0.6431983636495595,1.0,3/12,14.79%,IGF1R;ITGA3;CLDN1
prerank,neuron projection morphogenesis (GO:0048812),0.36741135124700797,1.1648034059938996,0.23476968796433878,0.765538817992408,1.0,30/137,12.15%,PTEN;DOCK10;FARP1;BTBD3;SDC2;MAP2;ROCK1;PLXNB1;ATP7A;MYO16;WASL;MINK1;CNTNAP2;NTNG2;RYK;CNTN4;SLITRK5;NYAP2;ANK3;TAOK3;CCK;SLITRK1;MAP4K4;CTNNA2;NCKAP1;BRSK1;PAK3;PAK1;ZDHHC17;EPHB1
prerank,transport along microtubule (GO:0010970),0.5344734597933986,1.1646483708522903,0.30721649484536084,0.7647020044401395,1.0,5/13,16.41%,ARHGAP21;DYNC1I2;CAMSAP3;COPG2;APBA1
prerank,neutrophil activation involved in immune response (GO:0002283),-0.26496254884212683,-1.1645036276651295,0.049079754601226995,0.643282375115574,1.0,119/428,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;SYK;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,triglyceride metabolic process (GO:0006641),-0.36202783806234634,-1.164163295024145,0.2132701421800948,0.6433249994641532,1.0,4/48,3.14%,APOE;AGMO;CAV1;LPGAT1
prerank,sodium ion transport (GO:0006814),0.3907655496905589,1.1637146138012522,0.26356589147286824,0.7658206664503168,1.0,17/85,9.02%,SLC12A2;NEDD4L;ATP1A2;ATP1A4;SLC5A1;FGF13;SLC24A4;SLC24A2;SCN2A;SCN5A;ASIC2;HCN2;SCN8A;HCN3;SLC6A15;SCN9A;PKD2
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.5686598602606315,1.1635650208760047,0.31567328918322296,0.7650105192538581,1.0,2/10,3.42%,NR1H3;ABCD2
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),-0.2979919742283662,-1.1632936716006188,0.1368421052631579,0.6448592410814751,1.0,37/161,14.36%,MCC;DAB2;IGFBP2;BICC1;TMEM64;DKK3;APOE;CAV1;IGFBP6;NKD1;TCF7L2;TLE4;LRP6;MLLT3;IGFBP4;SFRP4;SOX13;PFDN5;WNT5A;SCYL2;AMFR;FZD4;TLE2;TLE1;NOTUM;DAB2IP;ZNRF3;PSME2;GLI3;HDAC1;PSMB4;CCDC88C;SOX17;SFRP1;PSMB1;PSMD11;PSMD8
prerank,carbohydrate homeostasis (GO:0033500),-0.344790218980847,-1.1632710445633896,0.2048780487804878,0.6441024437477395,1.0,18/67,20.35%,LEPR;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;KCNB1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PTPN2;TENT4B;ADIPOR1
prerank,negative regulation of dephosphorylation (GO:0035305),-0.4498384667190836,-1.1632006399264683,0.2947976878612717,0.643483342769713,1.0,8/18,23.86%,MFHAS1;PTPA;SH3RF2;PPP1R16B;CHP1;ARPP19;SH2D4A;INPP5K
prerank,positive regulation of superoxide anion generation (GO:0032930),-0.49220768217806105,-1.1629910947465862,0.26425855513307983,0.643288178160249,1.0,6/13,27.52%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,positive regulation of developmental process (GO:0051094),-0.29461608263562344,-1.1629295143272393,0.16393442622950818,0.6426702545763676,1.0,50/164,22.59%,PLCB1;ZBTB16;DCN;BMP7;CCN2;SLC6A6;APOE;MCU;SHANK3;BMPR2;SMURF2;BMP4;GJA1;FOXD1;ACVR1;ADGRL1;NIBAN2;AR;WNT5A;NR2C2;TFRC;FZD4;RREB1;DAB2IP;KDR;VPS35;TMEM119;CPEB3;LRP8;SHLD1;BNIP3;HSP90AB1;KMT5C;CORO1C;EDN3;BMPR1A;TAPT1;MAP3K13;CEBPB;BASP1;ALK;ZDHHC15;TRPM4;NUMA1;ENPP2;MDK;XBP1;SRF;VEGFA;DDHD1
prerank,negative regulation of anoikis (GO:2000811),0.5275096618007435,1.1626109603770098,0.31769722814498935,0.7660776530739648,1.0,6/14,12.52%,NOTCH1;PTK2;PIK3CA;ITGB1;SNAI2;SRC
prerank,regulation of keratinocyte proliferation (GO:0010837),0.4792415326610678,1.161792678351216,0.3153846153846154,0.7668764501652114,1.0,1/22,0.16%,PTPRK
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),-0.3566546380744888,-1.1617788700027576,0.2111368909512761,0.6448565086829101,1.0,18/49,27.22%,SGMS1;CAV1;NUPR1;GSDME;P4HB;MCL1;BCL2L11;BECN1;BID;BCAP31;BBC3;PLAUR;EIF2AK3;NDUFA13;BCL2L1;RACK1;TP53;DAPK2
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.32979920177720856,-1.161312947954819,0.1928020565552699,0.6452612652811507,1.0,24/80,19.74%,EPHA4;SAMD4A;ROCK2;VIM;SLC2A13;THBS1;LARP4B;NIBAN1;SMPD3;NSMAF;RPS4X;PRKCD;PLA2G6;UPF3A;TNFRSF1A;RELA;CPEB3;RPL26;FXR2;ELAVL1;SIRT3;ZCCHC4;NAT10;METTL5
prerank,epidermis development (GO:0008544),-0.36102775316467656,-1.1605438730831392,0.22879177377892032,0.6465139390334279,1.0,20/56,23.46%,SVEP1;CCN2;FGFR2;EMP1;CRABP2;FLOT2;LAMA3;HDAC1;GATA6;ALDH3A2;PTHLH;UGCG;PLOD1;LAMC2;FABP5;EDA2R;KRTDAP;GLI1;EDAR;DSP
prerank,cellular response to mechanical stimulus (GO:0071260),-0.3566505675989476,-1.160065573942247,0.20046620046620048,0.6469563092854447,1.0,25/46,36.58%,PIEZO2;MAP3K14;MAP3K1;PIEZO1;IRF1;TNFRSF1A;CASP8;F11R;BNIP3;MAPK3;TLR4;SLC9A1;MYD88;FAS;CRADD;BCL10;CD40;LTBR;KCNK4;TLR7;FADD;CHEK1;TNFRSF10B;AQP1;TLR5
prerank,leukocyte cell-cell adhesion (GO:0007159),0.48380468607631405,1.1598349276644189,0.3089887640449438,0.7703536666684265,1.0,3/24,5.53%,ITGA4;ROCK1;ITGB1
prerank,regulation of innate immune response (GO:0045088),-0.35542017666338666,-1.1596894334764736,0.22871046228710462,0.6471325933169839,1.0,15/57,16.61%,PARP9;APPL2;IRF1;ERAP1;BIRC3;USP18;IFI35;RNF135;CASP8;IRAK3;SAMHD1;GBP5;LRP8;HSP90AB1;RNASEL
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.5122777785468303,1.1595865244485146,0.31568228105906315,0.7697516378189989,1.0,6/14,19.04%,WAS;FANCB;TIMELESS;PARP1;MRNIP;FUS
prerank,thymus development (GO:0048538),-0.49095834506455655,-1.159107409985143,0.28136200716845877,0.6478265259178844,1.0,4/13,16.39%,TGFBR1;SIX1;TBX1;EPHB3
prerank,negative regulation of TOR signaling (GO:0032007),0.44326800792626386,1.1590734779229643,0.2822429906542056,0.7697563476508914,1.0,9/36,14.30%,SPAAR;UBR1;SESN3;AKT1S1;NPRL3;DDIT4;UBR2;NPRL2;PRKAA1
prerank,neutrophil degranulation (GO:0043312),-0.2639603513488816,-1.1589577687973975,0.042682926829268296,0.6474237040730547,1.0,118/425,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,regulation of amyloid fibril formation (GO:1905906),-0.46332143132735076,-1.1587603336300545,0.2840690978886756,0.6471727366529753,1.0,4/15,5.98%,APOE;APP;IAPP;PFDN5
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.49580274931335366,-1.1575263497870272,0.28846153846153844,0.6496049896453202,1.0,6/13,28.72%,TGFBR2;GLI3;PNP;CBFB;NCKAP1L;SOCS1
prerank,positive regulation of viral process (GO:0048524),-0.3494647939162094,-1.1562678949330034,0.21513002364066194,0.6522234556689774,1.0,22/60,25.12%,MDFIC;CNOT7;HACD3;POLR2A;IFIT1;RAB7A;PPARA;POLR2F;PPID;LARP1;PPIA;DDB1;KPNA6;CDK9;POLR2E;RSF1;SRPK1;NR5A2;NELFCD;POLR2G;TBC1D20;SRPK2
prerank,positive regulation of reproductive process (GO:2000243),0.46750857186180433,1.155905627665493,0.31315240083507306,0.7761037539358728,1.0,5/31,5.01%,PDE3A;CACNA1H;TACR2;TACR1;SYDE1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.35445982779443247,-1.1558905860564896,0.23399014778325122,0.6524795396639158,1.0,8/55,7.76%,IGF1;IGFBP2;IL15;IL6ST;ANXA1;VCAM1;IGF2;TFRC
prerank,positive regulation of macrophage differentiation (GO:0045651),0.5591026407472013,1.1554150624835955,0.3282275711159737,0.776183868280428,1.0,1/11,0.50%,IL34
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.32713638044754884,-1.155321532700686,0.17897727272727273,0.6532019623066231,1.0,30/91,20.00%,BMP6;APP;CP;SCARA5;ABCG2;SLC39A14;ATOX1;SLC39A13;SLC39A10;TFRC;ATP6V1G1;ACO1;FTL;SLC39A8;NEDD8;ATP6V0A2;HFE;CYB561A3;SLC30A1;FRRS1;FTH1;MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.37254932099192434,1.1551710285626677,0.2593192868719611,0.7756117120521535,1.0,16/102,8.24%,CYSLTR2;SLC30A10;SLC25A33;PIK3R1;GPER1;CPEB1;PRKAR1B;RAB8B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;IRS1;GOT1;PRKAR2A
prerank,macromolecule catabolic process (GO:0009057),-0.4135609320110873,-1.1547143582001724,0.27104722792607805,0.6540322508049673,1.0,12/26,22.40%,TRIM24;SMURF1;BECN1;IDE;TGFB1;SH3GLB1;UVRAG;CLN8;TPP1;CLN6;CLN5;CLPX
prerank,positive regulation of cell projection organization (GO:0031346),-0.31200780239923587,-1.1545459374306637,0.17366946778711484,0.6536695967861507,1.0,24/115,9.29%,PLXNA2;ROBO1;DPYSL3;EPHA3;NTRK3;CUX1;CAMK1D;TIAM2;APOE;PLXNA4;SLIT2;ITGA6;MAGI2;ARSB;NDNF;WNT5A;RHOA;PTK2B;RAPGEF1;FZD4;OBSL1;TIAM1;PLXND1;CBFA2T2
prerank,regulation of endopeptidase activity (GO:0052548),0.41075303800763946,1.1544819719426178,0.26825127334465193,0.7760474428745161,1.0,3/59,1.04%,SERPINI1;SERPINB8;VTN
prerank,positive regulation of secretion by cell (GO:1903532),-0.33954862657611273,-1.1543519939043059,0.22139303482587064,0.6534033810013714,1.0,20/70,15.91%,BMP6;IGF1;UNC13B;CD2AP;MYO18A;EZR;ADAM9;RAB27A;P2RX4;GOLPH3;DTNBP1;MYH10;KCNB1;STX1A;TGFB1;GRK2;PPID;PPIA;EDN3;SYTL4
prerank,iron ion transmembrane transport (GO:0034755),-0.52328563675537,-1.1543259639516859,0.30111524163568776,0.6526648597632015,1.0,3/10,10.60%,SCARA5;SLC39A14;SLC39A8
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),-0.33920154339534336,-1.1541805757501877,0.2077922077922078,0.6522099323715875,1.0,30/72,30.77%,ELF1;CFLAR;IRAK2;GAS6;STAT1;BIRC3;USP18;TNFRSF1A;CASP8;IRAK3;SPHK1;HSP90AB1;VRK2;RNASEL;RIPK1;AGPAT2;PTPN2;IKBKG;SYK;SIGIRR;PTPN6;CBFB;ZBP1;RACK1;LIFR;TAX1BP1;IL7;SOCS1;TRADD;AGPAT1
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.5160833737790828,-1.1541776061787319,0.29411764705882354,0.6514209025337073,1.0,7/10,40.85%,ABCA3;MFSD2A;MTMR3;MTMR1;PHB2;MTMR4;GNB3
prerank,glucose homeostasis (GO:0042593),-0.32426175038900457,-1.1540977392294134,0.20987654320987653,0.6508446233603606,1.0,22/83,20.35%,LEPR;FOXO1;MCU;ADIPOR2;RBP4;IGF1R;TCF7L2;APPL2;STAT3;HK2;HIF1A;KCNB1;FOXK1;FGFR4;USF1;RPS6;PRKAA2;BACE2;PARK7;PPARGC1A;PTPN2;ADIPOR1
prerank,cardiac cell development (GO:0055006),0.5546803458840333,1.1540714420364226,0.3243801652892562,0.7758882051160018,1.0,3/11,9.27%,NOTCH1;MYH11;JAG1
prerank,mRNA splice site selection (GO:0006376),-0.3946213363567476,-1.153945442248152,0.2650862068965517,0.6504376497524411,1.0,10/30,27.11%,CELF2;LUC7L;SRSF10;PSIP1;SRSF6;SRSF5;SF3A3;CELF5;PUF60;SNRPC
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.5373217924493292,1.1537374331486183,0.3065843621399177,0.7754665875315212,1.0,3/12,5.93%,DMD;ATP1B2;ANK3
prerank,GTP metabolic process (GO:0046039),-0.4747278620719094,-1.1536884184252933,0.3101391650099404,0.6503642905080773,1.0,3/15,13.01%,RHOQ;LRRK2;RAN
prerank,triglyceride catabolic process (GO:0019433),0.49449714566583736,1.1535121736901461,0.31376518218623484,0.774823941504436,1.0,3/19,6.95%,FABP3;LIPH;LIPC
prerank,central nervous system neuron differentiation (GO:0021953),0.45747316648379555,1.153442810989154,0.30377358490566037,0.7738115030628365,1.0,10/33,12.91%,MAP2;ATP7A;CEND1;RYK;NTRK2;SOX4;MDGA2;TOX;SPOCK1;ZC4H2
prerank,glucosamine-containing compound metabolic process (GO:1901071),0.5228486462730025,1.153392829605123,0.3259423503325942,0.7727793900624396,1.0,4/13,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.39353725968381004,-1.1531890906996767,0.26348547717842324,0.6508045210421396,1.0,18/32,13.66%,JCAD;HDAC7;THBS1;MEOX2;KLF4;FOXC2;ANXA1;HDAC9;RHOA;MAP2K5;CARD10;FGFBP1;KDR;GATA2;PTGS2;RHOJ;SRPX2;HDAC5
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),0.5424257083592807,1.1531365218234915,0.3436123348017621,0.7721876147933553,1.0,1/12,0.88%,APOBEC1
prerank,epiboly involved in wound healing (GO:0090505),-0.4591063381019839,-1.15287726421911,0.28094302554027506,0.6508309801901888,1.0,10/16,25.35%,PDPN;DDR1;RHOA;CCN1;CEACAM1;CD151;RHOC;TMEFF2;LCP1;CD44
prerank,neutrophil mediated immunity (GO:0002446),-0.2624536987944704,-1.1525993850383127,0.04375,0.6508080764229286,1.0,119/432,21.45%,ANXA3;PTPRB;GSN;B4GALT1;CTSH;LAMP2;IQGAP1;PECAM1;CD55;SPTAN1;AMPD3;DIAPH1;ANXA2;PTPRJ;B2M;TIMP2;TXNDC5;ARSB;RAP1B;KCMF1;CTSC;VPS35L;ADAM10;SDCBP;CRISPLD2;CD93;AP2A2;PGRMC1;RAB27A;BRI3;SNAP23;ACE;FGL2;PYGB;TNFRSF1B;RHOA;ANO6;MAPK14;NPC2;HEXB;STOM;CD47;CST3;TOM1;PRKCD;FUCA1;NHLRC3;EEF1A1;CTSB;PGLYRP1;PRCP;STK10;CAPN1;PLEKHO2;FTL;PSAP;IQGAP2;GSDMD;MGST1;COTL1;TMC6;RAB7A;YPEL5;DERA;ATP6V0A1;CTSS;TCIRG1;DNASE1L1;CKAP4;ATP8A1;NBEAL2;CYBA;PSMB1;GALNS;PPIA;PSMD11;SURF4;HSP90AB1;VAPA;TMEM30A;DNAJC3;S100A11;NIT2;CEACAM1;SIRPA;UBR4;MANBA;ATP11A;RAP2C;RAB18;FABP5;ATP11B;VAT1;GAA;DYNC1H1;QSOX1;LRG1;ACTR10;FTH1;RAB6A;PSMA2;CANT1;CYB5R3;PNP;AGPAT2;VCP;APRT;PLAUR;ORMDL3;COPB1;GLB1;CREG1;PSMD3;CYBB;RAB24;PSMB7;TYROBP;DSN1;VAMP8
prerank,macrophage migration (GO:1905517),-0.4852496086347087,-1.152028662381678,0.28051001821493626,0.6514786620916826,1.0,8/13,38.70%,P2RX4;P2RY12;EDNRB;CCR2;CKLF;CCL2;CXCL17;CCL5
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),-0.402538383753054,-1.151328479476027,0.26899383983572894,0.6526161649350535,1.0,7/25,13.39%,CD55;B2M;LACC1;WNT5A;SLC7A5;KIT;PLCG2
prerank,cell projection assembly (GO:0030031),-0.4231905238492165,-1.1511149708857626,0.2851153039832285,0.6524001543000558,1.0,6/22,18.11%,GSN;RHOQ;PARVB;RHOJ;PARVA;RHOH
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.4640733213222195,1.1506283043573093,0.32038834951456313,0.7769181281251083,1.0,5/23,9.95%,SLC12A2;SLC12A6;TFAP2B;SLC9A7;SLC12A5
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.4462931092025973,1.1505565186620785,0.2943327239488117,0.7759644198255541,1.0,4/34,4.24%,PDGFRB;PTK2;PIK3R1;FGF2
prerank,ameboidal-type cell migration (GO:0001667),0.4182188345108891,1.1500853629985257,0.2741652021089631,0.7759200056301041,1.0,9/51,7.87%,ITGA4;SEMA6D;SEMA5A;PKN1;ERBB4;SEMA6C;GPC3;PDLIM1;NANOS1
prerank,I-kappaB phosphorylation (GO:0007252),-0.51472765722661,-1.1492081553656117,0.311787072243346,0.6567238937139026,1.0,7/10,43.73%,ERC1;DAB2IP;TLR4;TLR7;MAP3K7;TLR2;TLR3
prerank,transition metal ion homeostasis (GO:0055076),-0.40433316837084277,-1.1491801863256579,0.2549019607843137,0.656013428647485,1.0,8/28,19.09%,CP;B2M;NEO1;SLC39A14;FTL;BDH2;HFE;MT3
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.5040918004922388,-1.1486717602832415,0.31793960923623443,0.656496892203474,1.0,5/11,31.28%,LGALS9;TWSG1;CD274;CBFB;VSIR
prerank,cellular response to interleukin-12 (GO:0071349),-0.35427229894682116,-1.1485768791111097,0.22717149220489977,0.6559472849380961,1.0,8/48,7.61%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;CD47;TALDO1
prerank,positive regulation of cilium assembly (GO:0045724),0.49973345750785525,1.1484687144198447,0.319672131147541,0.7785698832054719,1.0,9/18,18.59%,ARHGAP35;FUZ;CEP120;KCTD17;CEP135;HTT;HAP1;MARK4;SEPTIN9
prerank,regulation of macrophage differentiation (GO:0045649),0.5225211067407098,1.1483508553133177,0.3297413793103448,0.7776841265984685,1.0,1/15,0.50%,IL34
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.48020158820990066,1.1480345251118986,0.3115079365079365,0.7772740117780705,1.0,4/27,4.24%,PDGFRB;PTK2;AGAP2;FGF2
prerank,mesenchymal to epithelial transition (GO:0060231),-0.5307509374109586,-1.1475545580238047,0.32821497120921306,0.6578793424190568,1.0,3/10,18.15%,BMP4;FZD7;BASP1
prerank,chromatin remodeling (GO:0006338),-0.31922928619691066,-1.1473999002584037,0.19008264462809918,0.6575014102149296,1.0,28/100,22.86%,SMARCA2;HDAC4;ESR1;KAT2B;BAZ1A;INO80;KDM5B;CHD3;BPTF;BAZ1B;BAZ2B;TADA2A;JARID2;HDAC1;EZH1;MPND;HDAC5;ACTB;SMARCC1;KDM6B;HCFC2;ACTR8;SMARCAD1;RSF1;CHRAC1;MBD2;PIH1D1;SMARCA4
prerank,regulation of cell aging (GO:0090342),0.5438637620778835,1.1471385161678764,0.30578512396694213,0.7782438277740051,1.0,5/11,20.78%,FOXM1;NEK6;NUAK1;RSL1D1;NEK4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),-0.44992618972362,-1.1471297112522678,0.30495049504950494,0.6574382495576732,1.0,5/17,15.34%,BMP4;SFRP4;TMEM100;ATOH8;NKX6-1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.4810528822421098,-1.1470339318648146,0.27755905511811024,0.6568942140962406,1.0,4/13,3.45%,BMP6;DAB2;BMP4;TGFBR1
prerank,negative regulation of cell death (GO:0060548),-0.32407214510408805,-1.146964360329934,0.21081081081081082,0.6562880613290903,1.0,30/88,19.70%,MECOM;BMP7;CCN2;BMP4;SRGAP2;LRRK2;CSF1;CD34;CCN3;TNFRSF1B;AKT1;CCN4;BECN1;CHMP4B;CHMP4A;VPS35;BNIP3L;CCN1;WNT16;BNIP3;PARP16;CD200;CCN5;WNT11;NPAS2;SRSF6;PARK7;MT3;PPARGC1A;IKBKG
prerank,positive regulation of protein processing (GO:0010954),-0.44176343510132915,-1.1466457521700701,0.2765957446808511,0.6563559935074434,1.0,4/19,5.46%,GSN;CCBE1;CLEC3B;LPCAT3
prerank,N-glycan processing (GO:0006491),0.4969773960239443,1.1458434668307083,0.3010752688172043,0.7801645899798649,1.0,3/18,2.99%,PRKCSH;ST8SIA4;ST8SIA1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.3943285936979676,-1.145566411279421,0.26609442060085836,0.6585213326250466,1.0,6/31,7.22%,TGFBR3;FGFR2;TGFBR1;SMAD7;ZFPM2;FKBP1A
prerank,positive regulation of phagocytosis (GO:0050766),-0.3571387792212797,-1.1451477690052443,0.2534562211981567,0.6587948464527333,1.0,13/47,13.32%,CAMK1D;IL15;MYO18A;PTPRJ;GAS6;RAB27A;APPL2;ANO6;CD47;GATA2;C4B;CALR;CYBA
prerank,positive regulation of endothelial cell proliferation (GO:0001938),-0.3337024121573236,-1.145130094374708,0.23116883116883116,0.6580536706196547,1.0,22/75,11.22%,NRP2;NRP1;TEK;F3;PLCG1;JCAD;BMPR2;BMP4;TGFBR1;VEGFD;VEGFC;IGF2;WNT5A;AKT1;PPP1R16B;HIF1A;ECM1;CDH13;FGFBP1;KDR;GATA2;ITGB3
prerank,cardiac muscle cell differentiation (GO:0055007),0.4902201715404358,1.1447132729899214,0.3142292490118577,0.7816863774048405,1.0,4/21,6.68%,MEF2C;MYH11;NRG1;SIK1
prerank,generation of neurons (GO:0048699),0.34375854511109366,1.1443879019515104,0.2563380281690141,0.7813095735302708,1.0,30/190,12.04%,MEF2C;HEY2;ADGRL3;HEYL;RAPGEF2;CDK6;PER2;MARK1;IL1B;ASTN1;FGF13;DNER;RYK;ASTN2;TAFA3;NTRK2;TUBB2B;CCK;FUT9;IL1RAPL1;MARK2;RNF112;LHX4;RUNX2;DDIT4;SPOCK1;BRSK1;WNT3;YTHDF2;MYT1L
prerank,Wnt signaling pathway (GO:0016055),-0.31911681077111986,-1.1435910769006157,0.25,0.6614634685896036,1.0,27/92,13.91%,NXN;WNT4;PLPP3;WNT6;CPE;TCF7L2;LRRK2;LRP6;LEF1;FZD2;WNT9A;RARG;SFRP4;WNT5A;CSNK1G2;FZD4;USP34;NR4A2;FZD7;VPS35;BCL9L;WNT5B;CCDC88C;UBB;WNT16;PLCG2;SFRP1
prerank,N-acetylglucosamine metabolic process (GO:0006044),0.5009144391780538,1.1433956245891899,0.3227176220806794,0.7825812595139446,1.0,4/15,9.94%,CHST3;CHST7;CHST2;CHST5
prerank,diterpenoid metabolic process (GO:0016101),-0.3488284895422047,-1.1429976055953803,0.24285714285714285,0.6622201900024598,1.0,10/55,8.16%,ALDH1A1;RBP1;APOE;DHRS3;RBP4;HSPG2;AKR1B1;SDC4;ABCA4;STRA6
prerank,neurotransmitter biosynthetic process (GO:0042136),-0.46846460013847036,-1.1428441443923367,0.30943396226415093,0.6618121441700504,1.0,4/14,16.74%,MOXD1;DAGLB;NOS1;SLC22A2
prerank,regulation of defense response (GO:0031347),-0.3298366249119958,-1.1428088171132034,0.22137404580152673,0.6611457591002403,1.0,26/76,13.27%,ADAMTS12;FOXP1;APOE;CASP12;IL1R1;SEMA7A;ANXA1;SBNO2;LACC1;APPL2;CASP4;IRF1;WNT5A;PIK3AP1;ERAP1;BIRC3;TMSB4X;DAGLB;USP18;RNF135;CASP8;SAMHD1;MGLL;PTGS2;RELA;LRP8
prerank,pharyngeal system development (GO:0060037),-0.4658106694345045,-1.142795825084108,0.32490272373540857,0.6604008598668897,1.0,7/15,15.76%,BMP7;BMPR2;BMP4;TGFBR1;TBX1;PTCH1;BMPR1A
prerank,positive regulation of cholesterol transport (GO:0032376),-0.404723614499232,-1.14251379980785,0.2828282828282828,0.6603191449192853,1.0,9/27,20.47%,PLTP;APOE;CAV1;LPCAT3;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.47172979625752165,1.1424716366646954,0.3143418467583497,0.7835231084197114,1.0,5/24,5.37%,LIMS1;PIK3R1;FERMT2;ROCK1;MAPRE2
prerank,regulation of cellular ketone metabolic process (GO:0010565),-0.3498971325488885,-1.1423934022689626,0.23218390804597702,0.6598740164854868,1.0,20/61,24.71%,PRKAG2;CAV1;PSME2;FGFR4;PPARA;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,protein catabolic process (GO:0030163),-0.34976914575700935,-1.1422904469220092,0.24880382775119617,0.6593780643791515,1.0,24/59,25.65%,LAMP2;APOE;ADAMTS9;TRIM24;DENND3;STT3B;IDE;DAB2IP;UBE2G2;DDB1;CEACAM1;MANBA;CLN8;RIPK1;VCP;NGLY1;TPP1;CLN6;CLN5;CLPX;FBXO17;CHEK2;CTSD;PRKN
prerank,cardiac myofibril assembly (GO:0055003),0.5041262081881352,1.1421336539114169,0.32096069868995636,0.7832263540901677,1.0,1/15,0.19%,PDGFRB
prerank,ceramide catabolic process (GO:0046514),-0.4792172755184445,-1.141981018128486,0.297951582867784,0.6593403747853435,1.0,5/14,11.64%,ACER2;HEXA;HEXB;ACER3;NAGA
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.4668342686867079,-1.1418087403333839,0.296078431372549,0.6589975283259442,1.0,6/15,28.70%,CD55;GLI3;PNP;SYK;HSPH1;CCR2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.4696382151411923,-1.1411923857734259,0.2803921568627451,0.6598220093558644,1.0,4/14,11.08%,ATP1B3;ACTN2;AKAP9;LRRC38
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),-0.3509436787683981,-1.140475200807293,0.24700239808153476,0.6611092687611465,1.0,23/54,35.93%,CFLAR;GAS6;CASP4;BIRC3;TNFRSF1A;CASP8;SPHK1;RIPK1;PTPN2;IKBKG;SYK;RFFL;RACK1;PRKN;PYDC1;TAX1BP1;HSPA1B;LAPTM5;TRADD;SPATA2;ADAM17;FADD;PELI3
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.436666330654761,-1.1404200713599724,0.2924901185770751,0.660453448619244,1.0,4/18,14.53%,DAB2;EZR;RAB21;MAPK3
prerank,response to tumor necrosis factor (GO:0034612),0.3744483509400932,1.1403137078047245,0.26697530864197533,0.7864615329011997,1.0,5/91,1.63%,GGT5;PID1;GGT1;TNFRSF21;GPER1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.46244725483137783,-1.140248031990444,0.306640625,0.6601399667167578,1.0,4/15,6.32%,APOE;SNX9;ADAM9;TNFRSF1B
prerank,regulation of B cell apoptotic process (GO:0002902),-0.4901288124641132,-1.1394738998814005,0.33271028037383177,0.6613470952342995,1.0,2/12,7.17%,FOXP1;FNIP1
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),0.5281514167628473,1.1391615105722623,0.32967032967032966,0.7880938353701911,1.0,3/10,9.21%,OGT;ZNF692;SDHAF3
prerank,positive regulation of intracellular signal transduction (GO:1902533),-0.25640226625647616,-1.1390710588985484,0.08633093525179857,0.6616223462283132,1.0,140/509,19.80%,IGF1;PDGFD;FN1;EGFR;FLT1;DCN;ROCK2;NFAT5;PDGFRA;NTRK3;AKAP13;LPAR1;OSBPL8;VWF;TEK;TGFA;IQGAP1;APP;F3;CAV1;NUPR1;JCAD;SASH1;KSR1;ESR1;TGM2;FGFR2;THBS1;PTPRJ;GJA1;IGF1R;TGFBR1;ANGPT1;MAP3K14;NR3C2;TCF7L2;NOD1;ADGRV1;CFLAR;PDCD4;GSDME;IGF2;DDX60;GAS6;TNFSF10;FGF1;IAPP;LGALS9;WNT5A;RPS20;IKBKE;RHOA;PRKCB;KL;PLK2;MFHAS1;PIK3AP1;FNIP1;FKBP1A;P2RX4;TFRC;BIRC3;EEF1D;TBX1;GOLPH3;USP15;PIK3CB;ADRA1B;NOS1AP;KIT;TNFRSF19;FRS2;ECM1;TNFRSF1A;BCL2L11;IFI35;CDH13;BECN1;EPHA8;FLCN;RPL37;CASP8;DAB2IP;IL18;KDR;TRIM27;MYOC;MAVS;PUM1;TGFB1;TNFAIP8L3;TRIP6;PLEKHG5;FGFR4;RELA;FLT4;FLT3LG;WNT16;PLCG2;SPHK1;MET;RET;TICAM1;TXN;HSP90AB1;CAV2;MAZ;VAPA;RPS15;RPL23;TLR4;PELI1;BID;TRIM8;BCAP31;TCIM;RIPK1;WNT11;PDGFC;TRAF3IP2;ROR2;MAP3K3;PDPK1;ADRB2;CC2D1A;RRAGB;PARK7;TRIM14;LAMTOR5;AGT;CANT1;MST1R;BBC3;PIK3R5;PIM2;EDA2R;LGALS1;CHD5;IKBKG;RHOC
prerank,melanosome localization (GO:0032400),-0.42761890241415024,-1.138932885980059,0.30677290836653387,0.6612335705503812,1.0,7/21,20.78%,SHROOM2;RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.4362012696292876,-1.1379217641129271,0.3151969981238274,0.663059632269066,1.0,3/19,6.17%,DDO;ALDH7A1;ASPA
prerank,regulation of activin receptor signaling pathway (GO:0032925),-0.4673694666870899,-1.1370945234131447,0.32170542635658916,0.6644769608055195,1.0,5/15,7.22%,MAGI2;SMAD7;ACVR1;SKI;FKBP1A
prerank,bile acid and bile salt transport (GO:0015721),-0.4187135701965302,-1.1369468420618158,0.3105590062111801,0.6640875174915303,1.0,3/24,3.90%,ABCC4;SLCO2B1;SLCO1C1
prerank,oxoacid metabolic process (GO:0043436),-0.4045266687419402,-1.1369241390904252,0.2907949790794979,0.6633649201027,1.0,9/27,25.87%,DDO;ENPP1;SULT1A1;TPST1;AGXT;TPST2;PPA1;SULT4A1;GRHPR
prerank,regulation of B cell proliferation (GO:0030888),0.42676569937168063,1.1368066574804392,0.30018083182640143,0.7926223893849214,1.0,4/44,6.03%,MEF2C;TNFRSF21;CD300A;IL4
prerank,regulation of cell death (GO:0010941),-0.31775450772917324,-1.1366301030313755,0.20270270270270271,0.6633349173566977,1.0,33/94,19.09%,BMP7;CCN2;RRAS2;BMP4;SRGAP2;LRRK2;RILPL1;ACER2;CCN3;TNFRSF1B;ACER3;PRODH;CCN4;BECN1;ZC3H12A;SLC25A24;CHMP4B;VPS35;BNIP3L;CCN1;UBB;WNT16;BNIP3;CDKN1B;PARP16;CCN5;WNT11;NPAS2;SRSF6;PARK7;RAB29;CHP1;MT3
prerank,positive regulation of tissue remodeling (GO:0034105),-0.5173482778755628,-1.1364176038122331,0.3269230769230769,0.663076259304463,1.0,3/10,10.32%,ROCK2;IL15;IL18
prerank,phosphate-containing compound metabolic process (GO:0006796),0.3421084487536456,1.1364133799255576,0.26153846153846155,0.7924454522131279,1.0,12/198,4.57%,INPP4B;PTEN;PLCE1;LIMD1;IMPA2;PIK3CD;INPP5A;PIP4K2A;PIK3CA;PLPPR5;PPP3CA;ITPKB
prerank,negative regulation of transposition (GO:0010529),-0.4561734888598225,-1.1363504245290212,0.30451127819548873,0.662460504127164,1.0,5/16,19.72%,TUT4;MOV10;TUT7;SIRT7;SMYD5
prerank,regulation of sensory perception of pain (GO:0051930),-0.5092852424996677,-1.1359302724910796,0.3191489361702128,0.6627641690860052,1.0,4/11,11.08%,CCN3;TMEM100;ZFHX2;MGLL
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.5495964340863915,1.1356194662359351,0.3524416135881104,0.7931609515607225,1.0,1/10,0.56%,SOX5
prerank,negative regulation of fat cell differentiation (GO:0045599),-0.37233028257497874,-1.1355086662066938,0.27253218884120173,0.6631075025939291,1.0,15/34,19.25%,SMAD3;FOXO1;ENPP1;ZFPM2;YAP1;WNT5A;TRIO;FLCN;ANKRD26;GATA2;TGFB1;ZFPM1;SIRT2;ZFP36L2;E2F1
prerank,stress-activated MAPK cascade (GO:0051403),0.4015454713092904,1.1346055482875412,0.27702702702702703,0.7943449720315886,1.0,7/61,7.58%,MAP3K20;MAP3K5;ARHGEF6;BTRC;MINK1;TNIP2;RIPK2
prerank,cytokine-mediated signaling pathway (GO:0019221),-0.2559831404100036,-1.1345788650246384,0.10256410256410256,0.6648615393672849,1.0,143/532,20.35%,COL1A2;FN1;PLCB1;LEPR;IL31RA;SP100;FOXO1;FOXO3;ADIPOR2;IL15;F3;IL1R1;IL6R;VIM;LBP;ANXA2;IL6ST;PTPRJ;B2M;MAP3K14;RAP1B;NOD1;GHR;ANXA1;CSF1;SOCS2;VCAM1;PDCD4;PITPNA;TNFRSF11B;IL16;IRAK2;CXCL12;IFITM3;APPL2;YAP1;STAT2;MAOA;GREM2;P4HB;IRF1;CCL15;TNFRSF1B;ICAM1;MAP3K8;PTK2B;FOXC1;IRF2;STAT1;CARD14;STAT3;CCL14;STX3;TALDO1;IFI27;BIRC3;TMSB4X;PRKCD;RAPGEF1;IFIT2;PIK3CB;IRF9;AKT1;KIT;MCL1;IL33;HIF1A;OAS2;TNFRSF1A;BCL2L11;IL17RA;IFI35;IFIT3;LAMA5;IFIT1;IRAK3;SAMHD1;IL18;STX1A;EIF5A;PML;PSME2;CAMK2A;TGFB1;PTGS2;INPP5D;CCL25;RELA;S1PR1;PSMB4;FBXW11;FLT3LG;TNFRSF11A;UBB;LRP8;CCND1;FER;UGCG;PSMB1;PPIA;PSMD11;IP6K2;PSMD8;POU2F1;MAPK3;CNTFR;IFITM2;GBP2;MMP2;SDC1;CCL13;IL10RB;PSME3;CEACAM1;CDKN1B;JAGN1;RNASEL;PELI1;JUNB;TRIM8;RIPK1;CSF3R;TRAF3IP2;RSAD2;NFKBIA;MAP3K3;EDA;PSMD4;RPLP0;HSP90B1;PSMA2;IL17RE;CSF2RA;MT3;EDA2R;IL20RB;NDN;CANX;IKBKG;SYK;PSMD3;CSF1R;ADIPOR1
prerank,organelle organization (GO:0006996),0.3140181827542626,1.1344628788165207,0.22738095238095238,0.7935242238082116,1.0,64/388,11.77%,MAST4;PLCE1;LIMD1;ARHGAP21;ARHGAP10;SH3KBP1;SYNE1;SLC25A33;DPYSL2;MARK1;WASF3;SIPA1;ABCD2;PTCD2;TMCC1;TOR1B;ABI2;SORT1;ATP7A;MREG;WASL;COG7;FMNL3;CENPW;FANCG;PEX7;AJUBA;ATP8B2;COG1;CLASP2;FAF2;YTHDF3;ESRRA;CHMP2B;ARFGEF1;HACE1;GABPA;LIG4;BIN1;PAK6;PIKFYVE;VPS18;BLZF1;PEX1;TFAM;RAB38;FAM161A;RNF112;MIA3;PKD2;ZMYM3;TMED7;PAK5;VPS11;UBXN2B;TMED4;KIF3A;DYRK3;TMEM135;ARHGEF7;STX4;KIF5C;PACSIN3;YTHDF2
prerank,sensory perception of chemical stimulus (GO:0007606),0.5199642985710173,1.1344596317127538,0.3201663201663202,0.7923826831350027,1.0,3/15,6.84%,ADCY3;SLC24A4;UBR3
prerank,positive regulation of mitochondrial translation (GO:0070131),0.515868497232821,1.1343742821441072,0.3097713097713098,0.791427729544751,1.0,6/14,16.51%,FASTKD2;MRPS27;FASTKD3;TRMT10C;RMND1;C1QBP
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.47506831588599774,-1.1339096819298264,0.3284671532846715,0.6658539443547624,1.0,1/13,0.32%,ZMIZ1
prerank,histone mRNA catabolic process (GO:0071044),-0.4618135996677376,-1.133748651788863,0.29111531190926276,0.6654994173469652,1.0,6/15,20.22%,TUT4;TUT7;MTPAP;ATM;XRN1;TENT4B
prerank,intracellular protein transport (GO:0006886),-0.2698517024636176,-1.1334469840836872,0.1267605633802817,0.6655709314533836,1.0,122/304,29.60%,RANBP3L;LAMP2;KIF13B;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;ARHGEF2;KIF13A;TLK1;SEC31A;COPZ2;RABGAP1L;APPL2;STX7;SMURF1;USP6NL;TBC1D8B;GGA2;STAT3;STX3;COPA;ARFIP2;CCHCR1;EHD1;TBC1D8;RASSF9;AP3B1;AKT1;BAG3;C2CD5;AP4M1;RAB21;STX1A;USO1;STX6;VPS35;LMAN1;RAB7A;RPL11;TBC1D10A;TGFB1;IPO7;FAM53C;IPO13;AP2A1;SCFD2;RAN;CALR;EVI5;ARL5A;SURF4;TBC1D2;PKD1;SEC23IP;NAPA;TBC1D25;RAB3GAP2;NXT2;IPO8;RAB18;HOMER3;TBC1D13;TPR;AP4E1;SAR1A;RAB29;RAB6A;STX2;RAB32;HPS4;CHP1;SAR1B;NUP88;SNX8;RABL3;MAIP1;YWHAH;VPS26C;ARFIP1;VPS28;SYK;TMED9;NUP214;TBC1D14;RAB24;AP3D1;TMED2;WDR11;ACD;NXT1;AP4B1;LTBP2;AKT2;XPO4;TBC1D22B;STX17;TBC1D5;SEC31B;NUP155;ARL4D;TBC1D4;PICK1;RANBP17;TBC1D17;EIF4ENIF1;TBC1D16;RAB19;STX19;SEC16A;CSE1L;PREB;EIF2D;NUP62;ARF4;PTTG1IP;LAPTM5;CTTN;RAB22A;TMED1;TNPO2
prerank,folic acid-containing compound metabolic process (GO:0006760),0.4770481824345943,1.1332148352006532,0.3313373253493014,0.7930405046088996,1.0,4/19,7.42%,SLC19A1;DHFR;GGH;MTHFD2
prerank,positive regulation of exocytosis (GO:0045921),-0.37444177826377195,-1.1327753602008532,0.28541666666666665,0.6666238145569182,1.0,16/35,30.45%,SDCBP;SMPD3;PDCD6IP;RAB27A;SDC4;HGS;RAB7A;SDC1;SYTL4;RAB2B;EXPH5;RAB3D;ATP6AP1;RAB3A;ATP13A2;CADPS2
prerank,cellular response to catecholamine stimulus (GO:0071870),0.4638621580577579,1.1324969491671415,0.3175542406311637,0.7935893730718042,1.0,6/23,6.89%,GNG2;ADCY6;PDE4B;SNCA;RYR2;GABPA
prerank,negative regulation of mononuclear cell migration (GO:0071676),-0.48712608397842005,-1.1319390325179586,0.31048387096774194,0.6679963207083333,1.0,6/12,8.76%,PLCB1;SLIT2;CCN3;NBL1;DUSP1;AKT1
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),0.5300913953227576,1.1319146839496355,0.3317972350230415,0.7938230684144006,1.0,2/12,0.65%,MEF2C;PRKG1
prerank,myeloid cell development (GO:0061515),-0.4425235791257023,-1.1317121998351052,0.33025830258302585,0.66783216003041,1.0,5/18,11.70%,FOXP1;APP;ANXA2;KIT;ALAS1
prerank,synaptonemal complex organization (GO:0070193),0.4967732377037237,1.131630136898266,0.3229166666666667,0.7922456650677765,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,synaptonemal complex assembly (GO:0007130),0.4967732377037237,1.131630136898266,0.3229166666666667,0.7922456650677765,1.0,5/15,17.01%,REC8;TEX12;TRIP13;STAG3;SYCP2
prerank,negative regulation of developmental growth (GO:0048640),0.4410825640511582,1.1315784317094906,0.32341269841269843,0.7912120840304547,1.0,10/30,16.80%,PTEN;MAP2;FGF13;CDKN1A;WWC1;FGFR3;MAG;TRIM46;RNF6;SLC6A4
prerank,oligosaccharide metabolic process (GO:0009311),-0.3637447677508361,-1.1315320551057941,0.2798165137614679,0.6675328839577689,1.0,15/46,20.12%,ST3GAL4;B4GALT1;ST3GAL6;ST3GAL2;ST6GALNAC3;ST3GAL3;FUT8;ST8SIA2;NAGA;ST6GALNAC6;MANBA;MAN2C1;MAN2B2;NEU3;ST8SIA5
prerank,positive regulation of interferon-gamma production (GO:0032729),0.4178700494630927,1.1313500957806657,0.31607142857142856,0.7906529956399166,1.0,5/48,8.17%,PDE4D;IL1B;PTPN22;PDE4B;IL12RB1
prerank,activation of protein kinase activity (GO:0032147),-0.3091774308738668,-1.130761354420784,0.22713864306784662,0.6688067959215357,1.0,27/106,14.14%,IGF1;NTRK3;ADCY5;OSBPL8;ADCY1;TGFBR2;NRK;ANGPT1;GHR;GAS6;FGF1;ADCY7;TOM1L1;WNT5A;PTK2B;CARD14;PRKCD;PRRC1;TAOK2;AKT1;CARD10;IL18;ITGB3;COPS8;PRKACB;TXN;PPIA
prerank,negative regulation of immune effector process (GO:0002698),-0.47802369765404323,-1.130710905431376,0.307843137254902,0.6681530383413953,1.0,5/13,13.59%,CD55;ENPP3;RPS19;CD47;FER
prerank,positive regulation of transferase activity (GO:0051347),-0.29441130854872233,-1.1306509764383794,0.21337579617834396,0.6675342188748272,1.0,39/142,18.97%,EPHA4;EPHA3;EGFR;FLT1;EPHA7;PDGFRA;NTRK3;LMO4;TEK;FGFR2;EPHB4;IGF1R;KLF4;IGF2;DDR1;TIE1;DTX3L;KIT;NAF1;EPHA8;KDR;TGFB1;FGFR4;EPHB2;FLT4;MET;RET;HSP90AB1;MAPK3;RAD50;SERINC1;CD200;MAP3K4;EPHB3;ROR2;ARRDC4;ALK;MST1R;RFC3
prerank,positive regulation of endopeptidase activity (GO:0010950),-0.405944085575039,-1.130576129978125,0.3041575492341357,0.6669707690826143,1.0,6/26,17.57%,EPHA4;ROCK2;STAT3;PSME2;PSME3;PRELID1
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.4620376226397361,1.130496928413081,0.3244274809160305,0.7915042748532904,1.0,7/25,11.14%,CACNA1C;CTNNA3;FGF13;RYR2;ATP2A2;TBX18;RANGRF
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.4929190430429864,-1.1302723080578716,0.3192660550458716,0.6669988010946984,1.0,1/11,0.32%,ZMIZ1
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),-0.442188744790447,-1.1298249766046153,0.3229571984435798,0.667444554499171,1.0,8/18,13.66%,HDAC4;CCN3;FRS2;FZD7;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.35060928112196305,1.1294569923457702,0.2665684830633284,0.7927570642075863,1.0,15/150,5.53%,PDGFRB;PIK3CD;GAB1;GCNT2;PTK2;PIK3R1;SEMA5A;FERMT2;ERBB4;NRG1;PIK3CA;AXL;FGF2;SPRY2;ITGB1
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4316769086563466,1.1284160843541196,0.29906542056074764,0.7941297153136926,1.0,5/34,5.83%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1
prerank,regulation of secretion (GO:0051046),0.5065296103469761,1.1282277689505789,0.3192389006342495,0.7934464086448131,1.0,4/13,8.18%,NRG1;OPRK1;FGF10;MYO6
prerank,cellular protein catabolic process (GO:0044257),-0.3434251216570269,-1.1277231957747358,0.2616822429906542,0.6723337417870652,1.0,19/59,13.89%,ADAMTS12;CTSH;CAPN2;CTSC;DENND3;AP2A2;CLTA;CTSB;CASP8;IDE;DAB2IP;RAB7A;BNIP3L;CTSS;TCIRG1;MDM2;AP2A1;BNIP3;UBE2G2
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.42837668239277976,-1.127420196946095,0.31477927063339733,0.6723644989296227,1.0,6/19,20.30%,ENPP1;SLC26A2;PAPSS2;SULT1A1;TPST1;TPST2
prerank,extracellular transport (GO:0006858),-0.4811613858089725,-1.1271936432144083,0.3143418467583497,0.6721933942409674,1.0,9/12,39.68%,WWP2;ARRDC1;SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,embryonic eye morphogenesis (GO:0048048),-0.49001916906759757,-1.1268145207531979,0.3230769230769231,0.6724679010809833,1.0,6/11,6.61%,FBN1;EFEMP1;MFAP5;LRP6;RARG;FBN2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),-0.38370830683870794,-1.126693200015261,0.28936170212765955,0.6720282010347961,1.0,13/31,29.31%,PPP1R13B;TFDP2;CASP8;PPP3CC;BID;BBC3;E2F1;YWHAH;YWHAE;TP53;SFN;TFDP1;NMT1
prerank,chondroitin sulfate metabolic process (GO:0030204),0.4447030691654947,1.1266216239471858,0.3035019455252918,0.7960868163448663,1.0,3/30,2.02%,CSPG4;CHST3;CHST7
prerank,cellular response to alcohol (GO:0097306),-0.364050048143601,-1.1265096705565147,0.2853982300884956,0.6717180545639476,1.0,15/42,13.91%,ADCY5;ADCY1;LRP6;CDH1;SMO;GRAMD1C;GRAMD1A;ADCY7;GOLPH3;ADAM15;CTNNA1;PTCH1;AHR;LARP1;SFRP1
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),-0.4854870475141002,-1.1264414514347874,0.3452830188679245,0.6711200149772127,1.0,7/12,31.51%,ACADL;CEACAM1;ERLIN2;BRCA1;PIBF1;TRIB3;APOC1
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),-0.3153457585112581,-1.126371884433722,0.24645892351274787,0.6705322224246191,1.0,36/93,23.64%,PLCB1;CCN2;SH3RF1;APP;SASH1;XDH;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;ZC3H12A;RELL1;FLT4;WNT16;SPHK1;MAPK8IP1;HIPK2;ARL6IP5;MAP3K4;RIPK1;GADD45G;EDA2R;TPD52L1;CCL19;VEGFA;EDAR;KLHDC10;SEMA4C;GADD45B;DUSP15
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),-0.47283208941838867,-1.1261841143842555,0.33653846153846156,0.6702501964727635,1.0,5/14,13.61%,ADAM10;WNT5A;PTK2B;WNK1;OXSR1
prerank,regulation of axonogenesis (GO:0050770),0.4146535649985924,1.1260910088866292,0.292894280762565,0.7961970978213214,1.0,16/51,11.73%,CHN1;PTEN;CDH2;LINGO1;LRRC4C;PLXNB1;METRN;NTRK2;ROBO2;SLITRK1;MARK2;ARHGAP35;BRSK1;PAK3;PAK1;PLXNB3
prerank,negative regulation of endothelial cell proliferation (GO:0001937),-0.3813170417270308,-1.1260180439942977,0.28507795100222716,0.6699105255928526,1.0,8/35,3.21%,SULF1;FLT1;APOE;SPARC;CAV1;XDH;PTPRM;THBS1
prerank,aortic valve morphogenesis (GO:0003180),0.45450783234714137,1.1252851701146591,0.3196078431372549,0.7969333574916563,1.0,6/30,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,peptide metabolic process (GO:0006518),0.38706779714021167,1.125149048097613,0.2744755244755245,0.7961665639560546,1.0,6/75,4.11%,ENPEP;DMD;GGT1;CPM;ANPEP;GSTT2
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.39304065526531956,1.124978371773706,0.2893835616438356,0.7954473533380839,1.0,12/65,10.90%,ITGA1;SH3KBP1;AFAP1L2;GPER1;RHBDF1;SPRY2;EPN1;MVB12A;CNOT9;HIP1;DGKD;ARHGEF7
prerank,response to amyloid-beta (GO:1904645),-0.36109205081646845,-1.1245490575886679,0.2867132867132867,0.6730444407316648,1.0,9/44,6.56%,IGF1;EPHA4;APP;GJA1;IGF1R;SNX6;VCAM1;CASP4;ICAM1
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3749566114387447,-1.1243833642841632,0.2626728110599078,0.6727036443054122,1.0,12/37,18.15%,FHIT;TAF1;SDCBP;PML;RPL11;TRIM39;HSP90AB1;HIPK2;RPL23;HFE;RPS7;PARK7
prerank,purine ribonucleotide catabolic process (GO:0009154),0.4793947384822061,1.123742816928047,0.32515337423312884,0.7971277328677852,1.0,2/21,2.42%,PDE4D;PDE9A
prerank,negative regulation of cell projection organization (GO:0031345),0.41464081715568296,1.1235172143754277,0.31494661921708184,0.7965136170033147,1.0,7/48,5.15%,PTEN;RAPGEF2;RTN4RL1;PTPN9;ADCY6;SPRY2;MYLIP
prerank,eosinophil migration (GO:0072677),-0.4619504430933281,-1.1229130792906992,0.3116883116883117,0.6750704530941807,1.0,11/14,52.25%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,eosinophil chemotaxis (GO:0048245),-0.4619504430933281,-1.1229130792906992,0.3116883116883117,0.6750704530941807,1.0,11/14,52.25%,CCL13;CCL2;CX3CL1;CCL5;CCL11;CCL4;CCL7;CCL8;CCL1;CCL3;LGALS3
prerank,positive regulation of muscle hypertrophy (GO:0014742),-0.4656272573876326,-1.1221185918435108,0.317907444668008,0.6763197841248987,1.0,3/15,3.30%,IGF1;ROCK2;IL6ST
prerank,regulation of protein localization to centrosome (GO:1904779),0.5383021723288095,1.1220083916205321,0.35990888382687924,0.7989390746656766,1.0,4/10,18.48%,UBXN2B;APC;GSK3B;MARK4
prerank,negative regulation of phagocytosis (GO:0050765),0.4890768040747683,1.1219417133667318,0.3305439330543933,0.7979916758080741,1.0,3/17,6.72%,DYSF;CD300A;APPL1
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.44468163936866856,-1.1218287628094137,0.34099616858237547,0.6763304713347554,1.0,5/16,14.16%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,negative regulation of neuron apoptotic process (GO:0043524),0.3866069436518981,1.121740965650161,0.2967409948542024,0.797358885003635,1.0,14/69,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;NTRK2;LIG4;PPT1;NFATC4;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,glycine metabolic process (GO:0006544),0.5315338212301827,1.1216001512291975,0.3383947939262473,0.7965589689556637,1.0,5/12,15.53%,BAAT;GCSH;GLYAT;GCAT;DLD
prerank,steroid biosynthetic process (GO:0006694),0.39638399584012896,1.121354182576154,0.3122866894197952,0.7960648742309017,1.0,17/56,15.83%,CYP7B1;OSBPL3;SLC27A2;BAAT;OSBPL6;SQLE;LSS;DHCR7;STAR;TM7SF2;PRLR;SRD5A1;CYP11B1;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,morphogenesis of a polarized epithelium (GO:0001738),-0.47017883741429956,-1.1213161197552772,0.3254437869822485,0.6769407578222665,1.0,7/12,24.86%,ACTG1;LAMA5;LAMA3;ACTB;VANGL2;ZDHHC7;SCRIB
prerank,positive regulation of locomotion (GO:0040017),0.4611132703807063,1.121308154638175,0.3413654618473896,0.795068132807023,1.0,1/27,0.19%,PDGFRB
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.40845335583127407,-1.1212311460218678,0.30145530145530147,0.6764434370426297,1.0,5/24,9.53%,ERRFI1;ROCK2;PRKCH;FOXC1;TRIM16
prerank,regulation of hydrolase activity (GO:0051336),-0.3277924534638471,-1.1208918847783578,0.26932668329177056,0.676573103752671,1.0,20/71,13.19%,PLXNA2;EPHA4;EPHA3;FGD5;FGD6;SIPA1L1;PLXNA4;CHN2;CAV1;VAV2;RASIP1;EFNA5;RAB3GAP1;PLXND1;DAB2IP;ADAP1;FGD4;CAMK2A;FBXW11;TDG
prerank,response to fatty acid (GO:0070542),0.490597685476936,1.12089005187444,0.3157894736842105,0.7949774082506452,1.0,3/17,7.19%,PID1;FFAR2;IRS1
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4914306481862658,1.1207932015767383,0.33468559837728196,0.7941068752531174,1.0,3/17,11.86%,COX4I2;COX4I1;COX5A
prerank,MAPK cascade (GO:0000165),0.3248701748175358,1.120311401675577,0.2607003891050584,0.7941519157123704,1.0,55/295,13.55%,PDGFRB;MEF2C;MAP3K20;RAPGEF2;MAP3K5;PTK2;PIK3R1;BTRC;RASGRP3;IL17RD;NF1;SPRED1;GFRA2;ERBB4;IL1B;CUL3;NRG1;PIK3CA;IL2RA;RBX1;SPTBN1;RASAL2;JAK1;FGF13;FGF2;MINK1;RIT2;PSMB11;SPTB;TNIP2;TAOK3;PSMF1;SPTA1;HRAS;IRS1;FGF10;PPP1CC;MAP4K4;PDGFB;GRIN2B;DLG2;RGL3;BRAF;KBTBD7;PAK1;RASGEF1A;PSME4;RGL1;GFRA1;DLG3;FGFR3;RASA3;NRG4;SYNGAP1;RASA1
prerank,heme catabolic process (GO:0042167),-0.46587816644950086,-1.1202818625072226,0.3239171374764595,0.6766050549447828,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.46587816644950086,-1.1202818625072226,0.3239171374764595,0.6766050549447828,1.0,2/14,3.98%,SLCO2B1;ABCG2
prerank,positive regulation of cytokinesis (GO:0032467),-0.3747194137824852,-1.1199811062646892,0.29141716566866266,0.676587850688963,1.0,6/32,10.29%,PKP4;CDC14A;PRKCE;RHOA;SVIL;SPAST
prerank,regulation of secretion by cell (GO:1903530),0.40959183505185215,1.1198816867134456,0.31462585034013607,0.7940268601235975,1.0,12/54,11.13%,MEF2C;RAB8B;RHBDF1;RIMS1;RIMS2;RAB3B;SYN1;RIC1;LGI3;SYT1;STXBP5L;STX4
prerank,superoxide anion generation (GO:0042554),0.5302766394093293,1.1197492173238826,0.35268817204301073,0.7932777218336737,1.0,3/13,9.84%,NCF2;NCF1;NOX3
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.5032045630389556,-1.1191645766799576,0.32536764705882354,0.6779491988545062,1.0,4/10,20.81%,PLA2G4A;PLA2G6;PLA2G15;ENPP2
prerank,regulation of neurotransmitter transport (GO:0051588),0.5126647080317113,1.1190474827338257,0.3553191489361702,0.793814903742926,1.0,3/16,6.12%,MEF2C;RIMS1;SYN1
prerank,T cell mediated immunity (GO:0002456),-0.46195706846140605,-1.1186212063751317,0.33980582524271846,0.6785803579560298,1.0,2/13,2.13%,CTSH;CD55
prerank,positive regulation of protein-containing complex assembly (GO:0031334),-0.2981270804779237,-1.1181255067331701,0.23582089552238805,0.6790718194509856,1.0,43/113,25.85%,UNC13B;TRABD2B;ABCA1;CDH5;ESR1;RAP1B;ASAP1;PIEZO1;RASIP1;FNIP1;TFRC;ERCC5;BCL2L11;DAB2IP;CUL4A;GBP5;TGFB1;SH3GLB1;ATM;TAL1;DDB1;RPA1;TLR4;BID;PARK7;VCP;RHOC;SYK;PLEK;LCP1;VEGFA;PIH1D1;ICE1;ERCC1;PSMC2;ERCC2;PSMC5;RPA3;MYD88;RPS3;RACK1;ERCC3;TP53
prerank,sensory perception of taste (GO:0050909),0.5404798050070485,1.1181136664799796,0.36511627906976746,0.7948497534821474,1.0,3/10,12.30%,TAS1R1;ASIC2;ASIC3
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.4535410785395505,1.1180153994036528,0.33127572016460904,0.7939680936714468,1.0,7/26,10.94%,PTEN;NRXN1;RIMS1;RIMS2;CHRNA7;TMEM108;CUX2
prerank,toxin transport (GO:1901998),-0.49925255200178464,-1.1176982001730935,0.3623445825932504,0.6793680475923546,1.0,4/10,18.30%,ANTXR2;ADAM10;SLC22A2;RAB29
prerank,response to interleukin-4 (GO:0070670),-0.5068385066707783,-1.117242187209155,0.34450651769087526,0.6797966296229084,1.0,4/10,24.39%,LEF1;XBP1;SHPK;TCF7
prerank,glycogen metabolic process (GO:0005977),-0.3997774995861735,-1.1172143952428406,0.2875536480686695,0.6791278173647968,1.0,4/27,6.29%,PRKAG2;PHKB;PHKA2;PYGB
prerank,negative regulation of developmental process (GO:0051093),0.3894184509655561,1.1171470450556633,0.3042016806722689,0.7948815980110108,1.0,6/69,2.56%,TBX2;HEY2;CDK6;NOTCH1;ROCK1;FOXM1
prerank,negative regulation of insulin secretion (GO:0046676),-0.4418014948669221,-1.1171333505657932,0.3488843813387424,0.6785683983454175,1.0,9/17,29.25%,CCN3;KCNB1;PIM3;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.42099163358028324,-1.1166125684818269,0.30919765166340507,0.6791475969534918,1.0,10/21,22.46%,IGF1;IGFBP5;GJA1;ADAMTS1;ERN1;MMP2;BMPR1A;P2RY6;DNMT1;NR4A3
prerank,renal filtration (GO:0097205),-0.49395341517014263,-1.1161014697940441,0.3333333333333333,0.6797156133169779,1.0,5/10,6.49%,SULF1;ITGA3;CD34;SULF2;TBC1D8B
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.49909146394693366,1.1160617826200647,0.3214990138067061,0.7963290548782479,1.0,2/19,2.35%,NDST3;EXTL3
prerank,organic cation transport (GO:0015695),-0.41810069581562503,-1.1158799187914603,0.34189723320158105,0.6795505224178128,1.0,9/20,20.27%,SLC47A1;SLC22A4;SLC22A5;SLC22A18;SLC25A19;SLC22A2;SLC25A26;SLC25A29;SEC14L1
prerank,cellular response to topologically incorrect protein (GO:0035967),-0.3811755147646483,-1.1156638271040256,0.3203463203463203,0.6793401056955792,1.0,13/31,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;DNAJB12;PRKN;ATXN3;HSPA1B
prerank,energy reserve metabolic process (GO:0006112),-0.44022966441346356,-1.11557311061986,0.3150684931506849,0.6788304099157269,1.0,3/19,1.80%,PRKAG2;LEPR;PHKB
prerank,cellular response to interleukin-1 (GO:0071347),-0.29256023355467253,-1.115507558455022,0.22018348623853212,0.6782589970634637,1.0,45/143,24.90%,PLCB1;ADAMTS12;PTGIS;IL1R1;NOD1;IRAK2;CCL15;MAP3K8;CCL14;CD47;HIF1A;IRAK3;DAB2IP;ZC3H12A;PSME2;CCL25;RELA;PSMB4;FBXW11;UBB;SFRP1;PSMB1;PSMD11;PSMD8;MAPK3;GBP2;CCL13;PSME3;SIRPA;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;CCL19;PSMC2;GBP3;USP10;PSMC5;EGR1;PSMD10;MYD88
prerank,cytoplasmic microtubule organization (GO:0031122),-0.34613023300572837,-1.1140052545294228,0.2789598108747045,0.6813123062373654,1.0,15/54,20.68%,FIGN;DLG1;EZR;CLIP4;RAB11A;LIMK2;RHOA;SPAST;TRPV4;CCDC88C;TUBGCP5;DYNC1H1;CHP1;SLK;NUMA1
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),-0.3400047219111594,-1.1134315657392508,0.2930648769574944,0.681956571380661,1.0,23/52,29.31%,PPP1R13B;NPEPPS;TFDP2;CASP8;SH3GLB1;TOMM7;SAE1;PPP3CC;LEPROT;BID;BBC3;HPS4;E2F1;YWHAH;USP36;BAP1;YWHAE;TP53;SFN;FZD5;TFDP1;RHOU;NMT1
prerank,regulation of lipid storage (GO:0010883),-0.4114946329788754,-1.1129231766038286,0.33675564681724846,0.6825429297691128,1.0,9/22,30.55%,IKBKE;ZC3H12A;ITGB3;FTO;NFKBIA;PTPN2;LPL;C3;HILPDA
prerank,positive regulation of response to stimulus (GO:0048584),-0.3624148983391767,-1.1129028355305373,0.3238512035010941,0.6818521845800706,1.0,9/40,17.63%,IL15;B2M;WNT5A;PRKCD;MAVS;YPEL3;FXR2;HOMER1;RSAD2
prerank,cellular response to unfolded protein (GO:0034620),-0.39989258418428264,-1.1125316404876722,0.33201581027667987,0.6820256370436373,1.0,11/26,28.08%,HSPB8;HSPA5;BAG3;DAB2IP;OPTN;ERN1;TMBIM6;HSPA13;HSPA9;PRKN;HSPA1B
prerank,regulation of protein metabolic process (GO:0051246),-0.35442807860805653,-1.112366827935498,0.29148936170212764,0.6816809311251565,1.0,14/44,14.35%,ROCK2;APOE;APP;KLF4;KLF2;LTBP4;ACE;FKBP1A;MAP2K5;HGS;VPS35;MDM2;HSP90AB1;NEDD8
prerank,nerve growth factor signaling pathway (GO:0038180),0.5400329319430368,1.112018645536471,0.3516483516483517,0.8046903164125627,1.0,2/10,6.90%,RAPGEF2;RAP1A
prerank,regulation of striated muscle contraction (GO:0006942),0.45571183439390217,1.1118006017537825,0.33586337760910817,0.8040822170384935,1.0,4/27,7.49%,DMD;ATP1A2;RYR2;MYL3
prerank,monocyte differentiation (GO:0030224),-0.494011153639517,-1.1114957072884775,0.35174953959484345,0.6832701079437233,1.0,3/10,4.16%,IL31RA;BMP4;PIR
prerank,negative regulation of viral life cycle (GO:1903901),-0.4536708347916101,-1.111367925460776,0.33879781420765026,0.6828686120880818,1.0,7/15,22.67%,GSN;LY6E;IFITM3;PPIA;IFITM2;SNX3;TRIM11
prerank,renal water homeostasis (GO:0003091),0.4620046237058759,1.11105253767293,0.3313253012048193,0.8047660974157617,1.0,10/23,10.18%,PRKAR1B;ADCY8;ADCY3;ADCY6;TFAP2B;PRKAR2B;ADCY9;PRKAR2A;RAB11FIP2;PRKAR1A
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.36576023343088565,-1.1107076891178163,0.2806236080178174,0.6838259174304979,1.0,12/41,20.20%,PLA2G4A;PTGS1;CYP1B1;DAGLB;GPX4;ACOX1;MGLL;GSTM2;ELOVL1;GPX1;ALOX12;EPHX1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),0.412105137293026,1.1105276984062888,0.3279569892473118,0.804869299984455,1.0,14/44,15.83%,CYP7B1;OSBPL3;PER2;SLC27A2;BAAT;OSBPL6;SQLE;PSAT1;DHCR7;TM7SF2;OSBPL7;HSD3B7;HMGCR;ACOX2
prerank,development of primary male sexual characteristics (GO:0046546),-0.37035363812206235,-1.1102348039519987,0.2865979381443299,0.6843021763160996,1.0,6/34,12.78%,WNT4;LHFPL2;AR;WNT5A;KIT;GATA6
prerank,lymphocyte proliferation (GO:0046651),0.46688302860682745,1.1101893820075994,0.3229571984435798,0.804598282104876,1.0,1/22,0.63%,MEF2C
prerank,ventricular septum development (GO:0003281),-0.3717898719583403,-1.1101702164951286,0.303347280334728,0.6837279967532982,1.0,9/37,4.79%,TGFBR3;ROBO1;SLIT2;TGFBR2;BMPR2;TGFBR1;SMAD7;ACVR1;ZFPM2
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.44279986408463073,-1.1100407487020405,0.35195530726256985,0.6833204523440635,1.0,2/17,2.01%,CAMK1D;MCU
prerank,aspartate family amino acid metabolic process (GO:0009066),0.47890081563781306,1.1092519191357866,0.3495762711864407,0.8057411736408687,1.0,4/18,8.11%,NAALAD2;SLC25A13;MSRA;GOT1
prerank,intermediate filament organization (GO:0045109),-0.43514247181343013,-1.109122369217129,0.290448343079922,0.6849655226274625,1.0,6/17,28.89%,VIM;GFAP;DNAJB6;BFSP1;DSP;BFSP2
prerank,protein glycosylation (GO:0006486),-0.2944007631851461,-1.1090098297768984,0.23076923076923078,0.6845077689009829,1.0,35/125,20.99%,ST3GAL4;LARGE1;B4GALT1;ST3GAL6;MAN1C1;ST3GAL1;ST3GAL2;EOGT;STT3A;PLOD2;ST3GAL3;TET3;STT3B;FUT8;MGAT1;ST6GALNAC2;B3GALNT1;SERP2;ST8SIA2;SLC39A8;POGLUT1;MGAT2;GFPT2;ENTPD5;ALG6;PLOD1;AQP11;ST3GAL5;RPN2;GFPT1;DOLPP1;ST8SIA5;PLOD3;B3GALNT2;MOGS
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.4646360002268768,-1.1088990061521156,0.3483992467043315,0.684075249613487,1.0,4/13,16.55%,NAMPT;IL33;KDR;TLR4
prerank,response to lipopolysaccharide (GO:0032496),0.34500757842898977,1.1088211335142606,0.30074074074074075,0.805654947483517,1.0,15/138,6.42%,GGT5;MEF2C;GGT1;NR1H3;SCARB1;IL1B;PTPN22;AXL;CXCL10;OTUD5;TNIP2;PDE4B;CXCL5;SNCA;CACTIN
prerank,plasma membrane repair (GO:0001778),0.5000309457745226,1.1087112495010631,0.3369098712446352,0.8048326507992636,1.0,2/13,1.97%,DYSF;MYH9
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4310681726507098,-1.1084247594947023,0.34210526315789475,0.6844767079247417,1.0,2/18,2.01%,CAMK1D;MCU
prerank,embryonic hemopoiesis (GO:0035162),-0.4819448979874438,-1.1083603357675684,0.34946236559139787,0.6838927595099591,1.0,6/12,15.41%,TGFBR2;KIT;KDR;FLT3LG;TAL1;ZFPM1
prerank,negative regulation of macroautophagy (GO:0016242),-0.3996955987637579,-1.1073076333696197,0.33402489626556015,0.6858666253199457,1.0,8/26,11.16%,NUPR1;LRRK2;CLEC16A;NRBP2;AKT1;CHMP4B;CHMP4A;PHF23
prerank,positive regulation of double-strand break repair (GO:2000781),0.4141956280170482,1.107272505064743,0.33460076045627374,0.8069890535944106,1.0,15/39,19.04%,WAS;FOXM1;SPIRE1;FMN2;FANCB;SLF2;TIMELESS;SETMAR;PRKDC;SHLD3;KMT5B;PARP1;MRNIP;DDX11;FUS
prerank,cellular response to copper ion (GO:0071280),-0.4391996000619751,-1.1068282958657891,0.3302752293577982,0.6863879555146704,1.0,9/16,20.00%,MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,import into nucleus (GO:0051170),-0.3233282506153951,-1.10666161489928,0.27648578811369506,0.6860799170358243,1.0,29/73,29.60%,APPL2;STAT3;GEMIN7;AKT1;BACH2;IPO7;FAM53C;IPO13;RAN;GEMIN5;SNRPF;NXT2;IPO8;SNRPD1;SNRPD2;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;SNRPB;EIF4ENIF1;SNRPE;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.37868728819768016,-1.1065787602049568,0.31453362255965295,0.6855220474781603,1.0,11/32,25.85%,PPP1R13B;FHIT;DDX5;PML;HINT1;HIPK2;RRP8;RPS27L;STK11;TMEM109;TP53
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.45424123155928786,1.106038536433328,0.35,0.8087584931270292,1.0,2/28,1.34%,PTEN;PTK2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),-0.475126929177626,-1.1060174377531264,0.3352059925093633,0.6862261261322214,1.0,4/12,9.84%,ROCK2;APOE;FKBP1A;FLOT2
prerank,positive regulation of T cell activation (GO:0050870),-0.3332844984444461,-1.1047063956212073,0.324455205811138,0.6888478265253121,1.0,19/62,22.31%,ZMIZ1;IL15;IL6ST;ANXA1;VCAM1;LGALS9;CD47;TFRC;FLOT2;SLC7A1;SIRPA;CYRIB;RHOH;PNP;CD81;MDK;CD274;XBP1;CCL19
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.4478854745838971,-1.1045698078348969,0.33460076045627374,0.6884796500395658,1.0,10/15,43.78%,MDM2;TAF9B;CD44;PRKN;PTTG1IP;KDM1A;CD74;MUC1;TAF9;MIF
prerank,endothelial tube morphogenesis (GO:0061154),-0.49868475066337115,-1.1045624197143287,0.3434704830053667,0.6877513228175424,1.0,4/10,7.29%,BMP4;ACVRL1;RHOA;RHOB
prerank,positive regulation of actin filament bundle assembly (GO:0032233),-0.35292479112439895,-1.1045198562206189,0.3349875930521092,0.6871503296672747,1.0,20/51,14.78%,ROCK2;NRP1;LPAR1;CCN2;TGFBR1;SORBS3;PXN;ARHGEF10L;SYNPO2;SYNPO;RHOA;CD47;S100A10;FHOD1;MYOC;PFN1;EVL;SFRP1;LIMCH1;ARHGEF15
prerank,negative regulation of MAPK cascade (GO:0043409),-0.30201453929773775,-1.1045091430191658,0.24860335195530725,0.68644173409298,1.0,28/87,16.55%,TIMP3;FBLN1;BMP7;SEMA6A;FOXO1;APOE;DLG1;CAV1;BMP4;PTPRJ;EZR;DUSP1;PRKCD;PIK3CB;FLCN;IRAK3;EMILIN1;DAB2IP;P2RX7;PPEF2;EPHB2;DUSP7;QARS1;PPIA;CNKSR3;DUSP10;SIRPA;TLR4
prerank,positive regulation of actin filament polymerization (GO:0030838),0.417201696994738,1.1044809652993948,0.35294117647058826,0.8112564494760734,1.0,9/44,10.58%,CARMIL1;NCK2;VASP;CDC42EP1;SPIRE1;BIN1;NCKAP1;LMOD1;ARPC4
prerank,glycerophospholipid metabolic process (GO:0006650),0.38157936176246965,1.1034713142601023,0.3106312292358804,0.8125674607473823,1.0,10/75,10.75%,PDGFRB;PLA1A;DGKH;GPCPD1;CPNE7;ABHD3;PLAAT1;GDPD1;PIGZ;PLA2G4E
prerank,maintenance of protein localization in organelle (GO:0072595),-0.4288783393944846,-1.103412186962044,0.34714003944773175,0.6885674963595092,1.0,9/19,34.51%,HSPA5;HK2;AKT1;PML;TAPT1;HK1;MORC3;PINK1;BCL3
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.4699607000468945,-1.1032352146390778,0.3560311284046693,0.688320985414039,1.0,8/14,24.02%,AKT1;NNMT;DDB1;PPARGC1A;PTPN2;ARPP19;AKT2;SLC45A3
prerank,response to acidic pH (GO:0010447),-0.4684982019669909,-1.1026741240009035,0.33935018050541516,0.6890936035584522,1.0,6/13,24.98%,CTSS;RAB11FIP5;SLC9A1;CHP1;GPR4;PKD1L3
prerank,regulation of actomyosin structure organization (GO:0110020),-0.46828250971512664,-1.102309006088654,0.3671586715867159,0.6892914771408138,1.0,5/13,10.75%,ROCK2;AKAP13;ASAP3;ACTG1;FHOD1
prerank,platelet aggregation (GO:0070527),-0.3748658492135737,-1.1021473129553219,0.32599118942731276,0.6889842822152868,1.0,10/33,14.14%,FN1;PDGFRA;ACTG1;CLIC1;PIK3CB;GNAS;ITGB3;ACTN1;ACTB;PPIA
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3742416180539715,1.1016660206893445,0.31166666666666665,0.81574374918658,1.0,11/74,5.26%,PTEN;GCNT2;BMP5;RGCC;PHLDB2;FERMT2;IL17RD;SPRED1;IL1B;SPRY2;CLASP2
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.45321878780648406,-1.1016320599893803,0.3541666666666667,0.6896146261326566,1.0,6/15,22.25%,PRKCH;CSF1;IL18;AGT;AGTR1;LPL
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),-0.3469419895387993,-1.1007301227386757,0.30528846153846156,0.6912246549172923,1.0,13/50,13.40%,EGFR;NFAT5;APP;SASH1;NR3C2;NOD1;PDCD4;LGALS9;RHOA;IFI35;TRIP6;RELA;SPHK1
prerank,nuclear migration (GO:0007097),-0.4700449253988298,-1.100529090624162,0.35648994515539306,0.6910136736862386,1.0,6/13,23.08%,CLMN;SYNE3;SYNE2;FBXW11;DYNC1H1;PAFAH1B1
prerank,regulation of extracellular matrix organization (GO:1903053),0.5032785908657915,1.1004967802207335,0.3504950495049505,0.8173916265449244,1.0,5/15,11.67%,FAP;NOTCH1;RIC1;EFEMP2;RB1
prerank,protein localization to membrane (GO:0072657),0.32825497347035404,1.1004682635064709,0.2912234042553192,0.8163382426539971,1.0,35/187,11.68%,LIN7A;ITGA4;CACNB2;RAPGEF2;FERMT2;ROCK1;RFTN1;PTN;RAB8B;TSPAN15;NRXN1;SPTBN1;AGRN;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;RAB38;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17;DLG2;ARL5C;NPC1;BRAF;NDC1;KCNIP4;PPIL2
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.4943668698450401,1.1004012545012252,0.3558282208588957,0.8153972518197208,1.0,2/16,1.99%,CLDN10;CLDN15
prerank,monocarboxylic acid transport (GO:0015718),-0.3504360171599689,-1.1001753623598822,0.28255528255528256,0.691241649804173,1.0,11/51,6.18%,ABCC4;SLC6A13;SLCO2B1;SLC16A2;SLC6A12;SLCO2A1;SLCO1C1;ABCG2;SLC16A1;SLC16A6;SLC16A11
prerank,regulation of fibrinolysis (GO:0051917),0.5104268492454982,1.1000715379211505,0.367170626349892,0.815033495254822,1.0,1/13,0.68%,FAP
prerank,protein auto-ADP-ribosylation (GO:0070213),0.5065967542994819,1.0996601069717704,0.35668789808917195,0.814856823298786,1.0,2/12,5.14%,PARP8;TNKS
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5017618826695143,-1.099556588619647,0.352165725047081,0.6921463393697347,1.0,4/10,28.72%,SH3RF1;CBFB;NCKAP1L;SOCS1
prerank,anterior/posterior axis specification (GO:0009948),0.4897602674909203,1.0992227839611206,0.3594080338266385,0.8147993346847299,1.0,4/15,15.63%,TBX3;CDX1;WLS;TASOR
prerank,positive regulation of heart contraction (GO:0045823),0.47586102045374046,1.0990762977670974,0.35450819672131145,0.8140714097447734,1.0,3/19,6.59%,ATP1A2;RYR2;ATP2A2
prerank,positive regulation of vasculogenesis (GO:2001214),0.5143923483570703,1.0989102277378682,0.35398230088495575,0.813382503459863,1.0,3/10,6.90%,RAPGEF2;RIN2;RAP1A
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.334437241212086,1.0986337570473794,0.30758620689655175,0.8128972708810399,1.0,15/190,3.94%,PDE4D;PTEN;LIMD1;PDE3A;PHLPP1;RORA;UBR1;GPER1;DGKG;NF1;SPRED1;SH3BP1;SH2B3;BCL2L10;ITPR1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.31625786650875753,1.098176875142839,0.2706964520367937,0.8128701335404147,1.0,25/259,6.90%,DYNLL1;CARMIL1;RAPGEF2;AIF1L;NOTCH1;ARHGEF6;MYLK;VCL;DZIP1L;IFT43;RILPL2;SPEF1;RAB8B;TTLL3;CYS1;MINK1;TTC36;IFT81;CCDC57;IFT20;ITGB1;NEK1;SCLT1;EMP2;RAP1A
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.46332086691666174,1.0978597108437658,0.3702928870292887,0.8125321901925924,1.0,3/22,3.49%,NOTCH1;ERBB4;CRLF3
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.3644045928649924,1.097725724788267,0.31789137380191695,0.8117478858868088,1.0,16/94,16.52%,DYNLL1;PRKAR2B;SCLT1;CSNK1E;DYNC1I2;CEP41;AHI1;NPHP4;CEP97;TUBB4A;TCTN3;DCTN1;DCTN3;CEP76;CEP135;NDE1
prerank,regulation of inclusion body assembly (GO:0090083),-0.48297928564844783,-1.0975353024701846,0.3619744058500914,0.696716537151807,1.0,4/11,15.71%,SNCAIP;DNAJB2;DNAJB6;DNAJA4
prerank,negative regulation of T-helper cell differentiation (GO:0045623),-0.48759721007619417,-1.097481537302749,0.3787313432835821,0.6961367739723543,1.0,4/11,10.43%,ANXA1;SMAD7;RC3H2;ZC3H12A
prerank,insulin receptor signaling pathway (GO:0008286),-0.32530232049512586,-1.0969008998783183,0.29528535980148884,0.6969685280293516,1.0,22/69,15.26%,SORBS1;RHOQ;FOXO1;IGF1R;BAIAP2;FOXC2;AP3S1;ATP6V0A4;IGF2;SLC39A14;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;ATP6V0A1;TCIRG1;FER;CAV2;ATP6V0A2
prerank,regulation of AMPA receptor activity (GO:2000311),0.4561819589867006,1.0962151094118415,0.36058700209643607,0.8142016156991996,1.0,3/25,4.29%,MEF2C;CACNG7;MINK1
prerank,interleukin-12-mediated signaling pathway (GO:0035722),-0.34262722743655416,-1.0961173705133356,0.3002257336343115,0.6982854226640998,1.0,7/46,7.61%,PLCB1;ANXA2;RAP1B;PDCD4;PITPNA;P4HB;TALDO1
prerank,regulation of receptor binding (GO:1900120),0.504479918869761,1.095772827264327,0.36086956521739133,0.8141717060575896,1.0,2/10,6.59%,ATP2A3;ATP2A2
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.37154988360381375,1.095734020191943,0.34539473684210525,0.8131750837245301,1.0,13/82,16.52%,DYNLL1;PRKAR2B;CSNK1E;DYNC1I2;CEP41;DYRK3;TUBB4A;DCTN1;DCTN3;CEP76;KCNH5;CEP135;NDE1
prerank,positive regulation of protein depolymerization (GO:1901881),0.5206017588246556,1.095312144061922,0.3630573248407643,0.8130602354965613,1.0,3/11,11.94%,SEMA5A;NES;CFL2
prerank,positive regulation of neuron projection development (GO:0010976),0.37245014885236516,1.0949355925297146,0.32576985413290116,0.8128795175264371,1.0,22/85,11.73%,SERPINI1;RAPGEF2;BMP5;ROR1;SCARF1;PTN;PLPPR5;ATP1B2;RIT2;NTRK2;CAPRIN2;RAP1A;FUT9;MARK2;LYN;ARHGAP35;TOX;ABL2;VLDLR;CUX2;EP300;PLXNB3
prerank,regulation of superoxide anion generation (GO:0032928),-0.4547485582609729,-1.0946686274926427,0.3602251407129456,0.7012895126475552,1.0,6/14,27.52%,PRKCD;TGFB1;SYK;TYROBP;ITGB2;ITGAM
prerank,establishment of endothelial intestinal barrier (GO:0090557),-0.4776021894856589,-1.0944768046994133,0.37524557956778,0.701037958918588,1.0,2/11,1.06%,AFDN;TJP2
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.33051540001502244,-1.093565334863257,0.3051948051948052,0.7026496316349624,1.0,11/56,8.76%,PLCB1;EGFR;RAB11A;ANXA1;ADAMTS1;CDC16;CCND2;CCND3;RAD51B;UBE2E2;AKT1
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),-0.39278128558079334,-1.0934704927771572,0.33620689655172414,0.7021576886250264,1.0,15/27,39.15%,MAP3K1;IRAK2;IRAK3;UBB;TLR4;MYD88;MAP3K7;CD36;LY96;TLR6;TLR1;TLR5;TAB2;CD14;TLR2
prerank,regulation of cytoplasmic translation (GO:2000765),0.5094991971164639,1.0934473168893555,0.3655913978494624,0.8151786767040197,1.0,6/14,16.87%,CPEB1;RBM24;CPEB4;DHX36;FMR1;PKM
prerank,protein insertion into membrane (GO:0051205),-0.370463664661179,-1.0933154421735245,0.32454361054766734,0.7018110239655642,1.0,12/32,24.11%,EGFR;APP;TRAM2;STX1A;ALDH3A2;VAPA;REEP1;GET1;MAIP1;SEC61B;WDR83OS;CCDC47
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.3591670462289675,1.093285357486361,0.3255131964809384,0.8145112597689522,1.0,13/108,6.87%,DLC1;ATP2A3;MAP3K5;COL4A3;GPER1;NODAL;GRAMD4;BCL2L10;CARD9;SNCA;DDX3X;BCL2L13;CASP9
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.49373254129793154,-1.0932265807306607,0.36015325670498083,0.701296387573402,1.0,1/10,2.26%,ST3GAL1
prerank,catecholamine metabolic process (GO:0006584),-0.4465482170183295,-1.092263724677487,0.35234215885947046,0.7030098832199213,1.0,1/14,0.58%,SNCAIP
prerank,positive regulation of cell population proliferation (GO:0008284),0.3052242011615831,1.0920336348798014,0.2625766871165644,0.8163208287744975,1.0,47/423,7.92%,PDGFRB;PTEN;TBX2;IL34;S1PR3;MEF2C;PID1;GCNT2;CDK6;BMP5;NOTCH1;TBX20;SLC25A33;RBPMS2;PTK2;GPER1;LAMC1;TBX3;NODAL;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;MECP2;PDCD10;FGF2;SPDYA;LAMB1;SCN5A;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;SOX4;CHRNA7;EMP2;LIG4;HRAS;IRS1;FGF10;CDKN1A;NES
prerank,negative regulation of protein binding (GO:0032091),0.3793853670650841,1.0917870993226175,0.33671742808798644,0.8158288074837807,1.0,11/71,9.33%,ITGA4;ATP2A3;MAP2;ROCK1;GNL3L;TTBK1;ATP2A2;CDKN1A;NES;PDGFB;CSNK1E
prerank,positive regulation of protein metabolic process (GO:0051247),-0.29105489348365443,-1.0915277141998905,0.2664835164835165,0.7041492947946791,1.0,34/110,19.90%,ROCK2;FOXO1;APOE;APP;SMURF2;NKD1;KLF4;CSF1;KLF2;WWP2;SMURF1;WNT5A;SLC6A9;PLK2;EGLN2;MAP2K5;AKT1;IDE;DAB2IP;IL18;RAB7A;ASB5;TGFB1;DDB1;PAEP;WWP1;CDKN1B;NFKBIA;OAZ1;FZR1;AGT;AGTR1;VCP;VPS28
prerank,cardiac muscle cell membrane repolarization (GO:0099622),-0.47815473804702574,-1.0913662244287106,0.3761814744801512,0.7038101735698445,1.0,5/11,26.44%,KCNJ2;KCNQ1;ATP1A1;YWHAE;KCNH2
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.47525596801764214,-1.0911200243570935,0.3761467889908257,0.7037529163629263,1.0,4/11,17.17%,ITM2A;NECAB1;ITM2C;BACE2
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.4116738696166175,1.0910525066865198,0.3460837887067395,0.8165378136972834,1.0,14/37,19.43%,PHLDB2;ROCK1;CLASP2;MAPRE2;TPPP;MARK2;BICD2;CAMSAP3;PHLDB1;PRKAA1;CDK2AP2;TRAF3IP1;GSK3B;STMN4
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.4283166890278637,-1.0910388159816702,0.375,0.7032284488704365,1.0,5/17,14.16%,WNT4;VIM;BMP4;TGFB1;CREB3L1
prerank,nuclear membrane organization (GO:0071763),0.4706543977547692,1.0901119602683527,0.36779324055666,0.81770335871414,1.0,6/19,16.33%,GPER1;TOR1B;UBXN2B;EMD;DCTN1;TOR1A
prerank,positive regulation of viral transcription (GO:0050434),-0.38993564730971103,-1.0900983867158123,0.34355828220858897,0.7050020349369799,1.0,10/25,30.31%,MDFIC;POLR2A;POLR2F;CDK9;POLR2E;RSF1;NELFCD;POLR2G;CTDP1;SUPT4H1
prerank,neuron development (GO:0048666),0.34368352023373744,1.0899717746237925,0.2875722543352601,0.816973779934009,1.0,20/141,9.76%,FRY;MEF2C;RAPGEF2;MAP2;ETV1;ROCK1;ATP7A;CNTNAP2;RYK;LAMB1;CNTN4;NTRK2;B4GALT6;PPT1;TENM4;BLOC1S1;LYN;TMEM108;ACTL6B;PLP1
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.41942469200649374,-1.0898841884502064,0.3438735177865613,0.7048157887194016,1.0,12/18,34.23%,DCN;MCU;KDR;VPS35;BNIP3;DDHD1;RALBP1;PRKN;RALA;DNM1L;MIEF2;PINK1
prerank,regulation of cell development (GO:0060284),0.4234652235714082,1.0893650470496823,0.3472727272727273,0.8172832834316028,1.0,4/36,2.62%,HEY2;HEYL;PER2;IL1B
prerank,estrogen metabolic process (GO:0008210),-0.4362228368949353,-1.089176384510235,0.3691148775894539,0.705801003385278,1.0,4/15,18.71%,CYP1B1;SULT1A1;HSD17B7;HSD17B8
prerank,gliogenesis (GO:0042063),0.4773193691973255,1.0889983566169006,0.36995515695067266,0.8170910012021935,1.0,3/15,4.28%,CDH2;CDK6;METRN
prerank,regulation of phosphorylation (GO:0042325),0.343781473844297,1.088943740805385,0.3251908396946565,0.8161481505436857,1.0,25/120,11.83%,DYNLL1;GLMN;PTK2;ROCK1;FNIP2;CADM4;GRM5;NUP43;OGT;SLC2A6;TESK1;IL4;ANKLE2;EMP2;CDKN1A;NUP35;LYN;GCK;PRKRIP1;MCM7;SEC13;EIF6;NDC1;EP300;BTBD10
prerank,defense response to bacterium (GO:0042742),-0.2949492452563349,-1.0882097779674949,0.28654970760233917,0.7075524744719959,1.0,23/105,16.55%,ANXA3;IL6R;LBP;NOD1;RPS19;GBP4;PRKCD;PLA2G6;IRGM;STAB1;OAS2;PGLYRP1;GSDMD;MAVS;GBP6;OPTN;RPL39;GBP7;GBP2;SERPINE1;HMGB2;MR1;TLR4
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.48843181928843776,-1.0874275392619477,0.38533834586466165,0.7088817822724153,1.0,5/10,27.30%,CSGALNACT1;PXYLP1;DSEL;XYLT1;B3GAT3
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.38308353606495615,-1.0871701284197983,0.34710743801652894,0.7088359042658654,1.0,9/27,19.01%,ABCA1;PRKCH;CSF1;IL18;ITGB3;PPARA;NFKBIA;AGT;AGTR1
prerank,negative regulation of GTPase activity (GO:0034260),-0.4017989359845156,-1.0871612940526785,0.3654223968565815,0.7081329598391659,1.0,10/22,24.09%,LRCH1;LRRK2;WNK1;CPEB2;DAB2IP;F11R;GMIP;SH3BP4;TMED2;RDX
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),-0.30156624359217704,-1.0870065414214876,0.30857142857142855,0.7078036285865233,1.0,31/90,20.99%,LEPR;ADIPOR2;CAV1;GJA1;IGF1R;APPL2;PRDM16;CPT2;GNAS;CMKLR1;EHMT1;IL18;ESRRG;ACADL;KDM3A;UCP2;PRKAB1;KDM6B;CNOT3;FABP5;MFAP2;PDGFC;DYNC1H1;ADRB2;CEBPB;GADD45G;PPARGC1A;SYK;ADIPOR1;ALMS1;DECR1
prerank,negative regulation of defense response (GO:0031348),-0.31055875836714497,-1.086803386706207,0.3064935064935065,0.7076377737163299,1.0,17/77,12.45%,CDH5;PTGIS;TEK;APOE;KLF4;CCN3;LPCAT3;ENPP3;MFHAS1;PRKCD;C1QTNF3;PCBP2;TNFRSF1A;IRAK3;METRNL;VPS35;PPARA
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.4253613358697785,1.0865148118103096,0.3427495291902072,0.8208054904521842,1.0,8/29,17.01%,MEI4;MEIOB;REC8;TEX12;FANCD2;TRIP13;STAG3;SYCP2
prerank,response to gamma radiation (GO:0010332),0.45044251076320985,1.0863775164921294,0.3543788187372709,0.8200614994598721,1.0,8/24,17.88%,MAP3K20;LIG4;HRAS;ATR;FANCD2;PRKAA1;HSF1;TLK2
prerank,zinc ion transport (GO:0006829),0.4480065841570932,1.086246581607896,0.36127744510978044,0.8192938832120693,1.0,1/21,0.46%,SLC30A10
prerank,regulation of insulin receptor signaling pathway (GO:0046626),0.4047732788436384,1.0861801822237014,0.3579136690647482,0.8183739506746884,1.0,9/43,7.19%,PID1;TNS2;IL1B;PIP4K2A;SLC27A4;GRB10;OGT;PIP4K2C;IRS1
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.5102459384378899,1.086083693606254,0.3577586206896552,0.8175641608540928,1.0,3/13,8.40%,CACNA1H;SCAMP5;SYT1
prerank,cellular polysaccharide biosynthetic process (GO:0033692),0.44370375717992827,1.0856363832499187,0.3405511811023622,0.8175827106108622,1.0,4/25,9.19%,NDST3;B3GALT1;FUT9;B3GNT8
prerank,negative regulation of transmembrane transport (GO:0034763),-0.49916595946873643,-1.0853870662642648,0.3797216699801193,0.7105518277673066,1.0,4/10,8.76%,THBS1;CTTNBP2NL;PRKCB;AKT1
prerank,actin crosslink formation (GO:0051764),0.5091044521969258,1.085105278921308,0.38235294117647056,0.8177618561159113,1.0,1/12,0.31%,EPS8
prerank,regulation of acrosome reaction (GO:0060046),0.49993823878909194,1.0844412836878354,0.37199124726477023,0.8182591036691929,1.0,2/10,5.05%,CACNA1H;SERPINA10
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.3880677479211354,-1.0840911114566065,0.3616600790513834,0.7132259814193654,1.0,11/29,29.08%,SMAD3;TUT4;TUT7;PUM1;SNIP1;AGO1;DICER1;ZC3H7B;ZC3H7A;SMAD2;AGO2
prerank,protein N-linked glycosylation via asparagine (GO:0018279),-0.3766656146055073,-1.0833644333671633,0.34004024144869216,0.7144178706764587,1.0,11/30,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,iron ion transport (GO:0006826),-0.34122553137336603,-1.0833275119418972,0.3442622950819672,0.7138055112642143,1.0,14/47,18.23%,STEAP3;CP;SCARA5;ATP6V0A4;SLC39A14;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;FTH1
prerank,regulation of actin filament bundle assembly (GO:0032231),-0.39058486619989785,-1.082982527384934,0.34808853118712274,0.7140685388565954,1.0,8/26,11.88%,ROCK2;ASAP3;SHANK3;SYNPO2;SYNPO;ACTG1;FHOD1;PFN1
prerank,positive regulation of growth (GO:0045927),-0.31694287769343604,-1.0826638737557361,0.30179028132992325,0.7141887392597422,1.0,14/64,13.91%,PLCB1;EGFR;USP47;TGFBR1;ADAM10;SDCBP;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1
prerank,triglyceride biosynthetic process (GO:0019432),-0.41798668384209126,-1.0826312935258635,0.37701612903225806,0.713553278148678,1.0,2/18,3.14%,AGMO;LPGAT1
prerank,regulation of cholesterol biosynthetic process (GO:0045540),-0.42151420012427204,-1.0824954387952088,0.35489833641404805,0.7131882239045896,1.0,6/17,18.27%,APOE;FGF1;LPCAT3;RAN;SREBF1;ERLIN2
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.4279219491198561,-1.0824899962062535,0.35670103092783506,0.712467000319723,1.0,5/16,10.45%,DPYSL3;DPYD;UPP2;UPB1;NT5E
prerank,regulation of protein ubiquitination (GO:0031396),-0.2926132819434144,-1.08234541420911,0.32577903682719545,0.7120729460232171,1.0,43/108,28.94%,NXN;HDAC8;CAV1;SASH1;TGFBR1;ANGPT1;LRRK2;SMAD7;ARRB1;FKBP1A;SH3RF2;BIRC3;AKT1;PINX1;IVNS1ABP;PRKCG;PHF23;DNAJB2;FANCI;UBB;SPHK1;HSP90AB1;WASHC1;SIRT7;PARK7;CHP1;VPS28;CDK5RAP3;UBXN1;FAM107A;BAG2;BRCA1;PSMD10;RPS3;CENPX;PRKN;BAG5;BCL10;PRR7;HSPA1B;PTTG1IP;LAPTM5;ISG15
prerank,receptor-mediated endocytosis (GO:0006898),0.3399625779399293,1.0823369016429154,0.31689088191330345,0.822162543372259,1.0,22/132,10.80%,SGIP1;COLEC12;IGF2R;SCARB1;SCARF1;LDLRAP1;LDLR;GRK3;ACKR3;LRP1B;AP1G1;MSR1;ITGB1;CXCR2;SNCA;PPT1;PIKFYVE;AP2S1;TMEM108;AP2B1;RABEPK;VLDLR
prerank,sterol transport (GO:0015918),0.4589621204478386,1.082254771746068,0.3545816733067729,0.8213001312350702,1.0,5/19,10.78%,LDLRAP1;ARV1;LDLR;MSR1;NPC1
prerank,negative regulation of endothelial cell migration (GO:0010596),0.41081087743929556,1.0819140434511785,0.35424354243542433,0.8209745782054557,1.0,6/36,4.24%,MEF2C;NOTCH1;RGCC;MECP2;SVBP;FGF2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),-0.4580267911963557,-1.0818191562641188,0.37084870848708484,0.7127402669532373,1.0,4/13,10.62%,NRP1;TGFBR2;SEMA3E;KDR
prerank,regulation of nucleic acid-templated transcription (GO:1903506),-0.2543063912699752,-1.0817308757252875,0.2037914691943128,0.7122714669267157,1.0,91/327,21.06%,BNC2;ZMIZ1;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;SRSF10;CALR;GLRX2;CLOCK;SOX17;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;NONO;HP1BP3;NAB2;NFATC2;NIF3L1;THAP1;TEAD2;LMX1B
prerank,regulation of fibroblast proliferation (GO:0048145),-0.34488949747784947,-1.0816257725984375,0.3377777777777778,0.711840079331578,1.0,15/45,19.25%,IGF1;FN1;PDGFRA;SKI;GAS6;WNT5A;S100A6;DAB2IP;SPHK1;SFRP1;NDUFS4;PDGFC;FTH1;AGT;E2F1
prerank,phospholipid dephosphorylation (GO:0046839),0.4167726880516538,1.0814666932175934,0.35359116022099446,0.8209874588539081,1.0,13/37,19.66%,PTEN;PLPPR5;INPP5J;MTMR12;MTMR7;INPP5B;SACM1L;MTMR11;PLPPR2;PIP4P1;PLPPR1;SGPP1;TPTE
prerank,skeletal muscle organ development (GO:0060538),-0.3836456349823938,-1.0806674883471679,0.3484251968503937,0.7134957844651633,1.0,9/26,10.88%,LARGE1;CAV1;CFLAR;MYL6;SIX1;STRA6;ZBTB18;SVIL;DISP1
prerank,positive regulation of protein localization to nucleus (GO:1900182),-0.3191933803963418,-1.0805724935735415,0.3284671532846715,0.7129707966167367,1.0,16/66,13.01%,SMAD3;CDH1;LIMK2;PARP9;YAP1;TFRC;PRKCD;AKT1;DTX3L;BAG3;PINX1;CARD10;ZC3H12A;MAVS;TGFB1;RAN
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.45207434819647363,1.0804392245512109,0.359026369168357,0.8224063076173204,1.0,5/20,11.99%,BMP5;GPER1;SIK1;PRMT3;ERLIN1
prerank,apoptotic cell clearance (GO:0043277),-0.3828740297095516,-1.0802205541559464,0.35135135135135137,0.7131476827432647,1.0,6/30,5.09%,RHOBTB1;TGM2;THBS1;TXNDC5;ANXA1;GAS6
prerank,phosphatidylserine metabolic process (GO:0006658),0.43496278135907285,1.0796227598874544,0.3893280632411067,0.8231652365810748,1.0,2/32,0.84%,MBOAT2;PLA1A
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.5068078017782804,1.0795014986501534,0.37142857142857144,0.822421445052798,1.0,2/11,8.17%,CARD9;IL12RB1
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.4330966489633916,-1.0794155943279702,0.37545126353790614,0.7144645629713333,1.0,5/16,11.02%,JCAD;THBS1;PPP1R16B;FGFBP1;GATA2
prerank,plasma membrane invagination (GO:0099024),-0.37673053793017885,-1.0794132566259442,0.35714285714285715,0.7137508898030525,1.0,5/29,6.59%,GULP1;GSN;ELMO1;SNX9;RHOA
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.4564314701090972,1.0789048857043082,0.4051383399209486,0.822801415618025,1.0,7/21,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,negative regulation of response to wounding (GO:1903035),0.4550416688557676,1.0785195248470139,0.36627906976744184,0.8226384567222594,1.0,3/19,4.24%,AJAP1;RTN4RL1;FGF2
prerank,regulation of microtubule nucleation (GO:0010968),0.5136711342649851,1.0783087055539,0.3881578947368421,0.822069106057017,1.0,5/10,13.85%,MECP2;ARHGEF7;RANGRF;PAK1;DCTN1
prerank,inner ear morphogenesis (GO:0042472),-0.4036954004429203,-1.0782933971475814,0.3642105263157895,0.715887735881957,1.0,6/22,12.29%,CHD7;FGFR2;SIX1;TTC39C;TBX1;EPHB2
prerank,regulation of neuroblast proliferation (GO:1902692),0.4831184390680078,1.0778535183863933,0.3760330578512397,0.8220554420221322,1.0,3/15,4.96%,NF1;PTN;TAFA3
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.38360945654975337,1.0778458182476915,0.35111876075731496,0.8210336312822546,1.0,8/54,4.24%,MEF2C;RGCC;NF1;AKT3;SH3BP1;ETS1;MECP2;FGF2
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),-0.3357183996012427,-1.0772537445632675,0.35172413793103446,0.7178765935600167,1.0,10/48,10.17%,ROBO1;SLIT2;CNOT7;GAS6;PARP14;STAT2;USP18;NLRC5;IRAK3;SAMHD1
prerank,cellular response to organonitrogen compound (GO:0071417),0.35353634750066604,1.0771666268335458,0.33011272141706927,0.8215911748429016,1.0,14/99,9.02%,MEF2C;SPAAR;PDE3A;RAPGEF2;CPEB1;AKAP6;GABRG2;HTR1B;HCN2;RAP1A;MTOR;RYR3;HCN3;PKD2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.3789808394699529,-1.0767594235209368,0.3298538622129436,0.718436383629736,1.0,13/29,25.23%,CNOT7;STAT2;WNT5A;USP18;NLRC5;SAMHD1;MAVS;HSP90AB1;RNASEL;PTPN2;PTPN6;TRIM6;ZBP1
prerank,photoreceptor cell development (GO:0042461),0.48734493769962045,1.0764490162946305,0.3755186721991701,0.8222595451995993,1.0,1/14,0.82%,RORB
prerank,translesion synthesis (GO:0019985),-0.343012346352708,-1.07641438201401,0.34598214285714285,0.7185626543483494,1.0,20/42,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;UBE2L6;POLI;USP43;POLE2;RFC1;USP10;RPA3;POLD1;ISG15;DTL;PCNA;PARP10;RFC5
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),-0.23456196787104044,-1.0760576898826928,0.15476190476190477,0.7188183693885389,1.0,191/834,18.15%,NFIB;AUTS2;BMP6;IGF1;DAB2;ZMIZ1;PBX1;SMAD3;SMARCA2;EGFR;DCN;NFAT5;WWOX;HDAC4;GLI2;TBL1XR1;NFIX;CDK8;RHOQ;GLIS3;FOXO1;MICAL2;OSR1;FOXO3;APP;NFIA;NR3C1;HDAC8;KAT6B;ERG;ITGA6;HOXB3;RARB;MLXIP;ESR1;FGFR2;BMPR2;ELF1;BMP4;ELF4;MEOX2;KLF4;PLAGL1;KAT2B;TCF4;TCF7L2;FOXC2;SMAD9;TFDP2;MRTFB;LRP6;ARHGEF2;NFATC1;SMAD7;LEF1;ACVR1;KLF2;SBNO2;THRB;HOXA5;SKI;PCGF5;ZFPM2;DCAF6;IGF2;SSBP2;ARRB1;ARNT2;AR;FGF1;RARG;YAP1;TMF1;GLIS2;THRAP3;ACVRL1;IRF1;TEAD1;SIX1;WNT5A;INO80;HLF;TET3;FOXC1;IRF2;GLIS1;LMO2;HIVEP1;STAT1;BPTF;STAT3;HINFP;NR2C2;MAP2K5;NAMPT;PGR;KLF10;TBX1;SSBP3;TFCP2;ZBTB18;FIZ1;PLXND1;RREB1;IL33;HIF1A;TNFRSF1A;NLRC5;CDH13;NR4A2;FLCN;ATF6;FOSL2;PHF10;DAB2IP;IL18;ZC3H12A;FHOD1;EIF5A;MAVS;GATA2;CEBPG;GLI3;TGFB1;ELK3;BCL9L;AHR;HDAC1;ZIC3;RELA;PPARA;MEF2A;USF1;ZNF462;ATM;GATA6;CCN1;UBB;ATOH8;CLOCK;LPIN3;MET;MEIS2;MPND;HDAC5;TAL1;SOX17;HSF2;POU2F1;MAPK3;HOXC4;PKD1;CDK9;HOXB7;HIPK2;NKX6-1;ZFPM1;CREB3;JUND;SREBF1;SERPINE1;BMPR1A;NOS1;NKRF;CEBPZ;HHEX;MEIS1;HMGB2;SOX18;KDM6B;TLR4;RNASEL;USF2;ZMIZ2;SIRT7;JUNB;SIRT2;ATF1;MED21;RIPK1;PTOV1;SLC9A1;NFKBIA;NFYB;CSRNP3;NPAS2;MAFF;SOX12;CEBPB;KLF15;PARK7
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.3454986213259753,1.0755324058403064,0.3409436834094368,0.8233859385575332,1.0,8/112,2.10%,PTPRK;SOX5;LIMS1;MEF2C;PDE3A;GCNT2;PTK2;FERMT2
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.36882753969435894,-1.0754993208893082,0.37362637362637363,0.7195512820321223,1.0,13/32,19.26%,IGF1;APP;NUPR1;TMSB4X;HIF1A;P2RX7;PPARA;ENTPD5;ENO1;BEND3;PRKAA2;PPARGC1A;VCP
prerank,regulation of NMDA receptor activity (GO:2000310),-0.3619155556164904,-1.074895373943904,0.354978354978355,0.7204042791075451,1.0,9/32,12.29%,DAPK1;ACTN2;APP;DLG1;SLC6A9;PTK2B;CAPN1;CAMK2A;EPHB2
prerank,zinc ion transmembrane transport (GO:0071577),0.44043661966434816,1.073998704159659,0.3715953307392996,0.8257964158464411,1.0,1/22,0.46%,SLC30A10
prerank,negative regulation of ossification (GO:0030279),0.43954521385633577,1.0736749353438393,0.3727810650887574,0.8255172476107244,1.0,2/23,1.19%,MEF2C;NOTCH1
prerank,regulation of fibroblast migration (GO:0010762),0.45957853712788627,1.0735221377972444,0.37524557956778,0.8247977278202602,1.0,7/20,10.90%,PTK2;PRR5L;FGF2;ITGB1;APPL1;GNA12;ARHGEF7
prerank,response to chemokine (GO:1990868),0.48597160247275656,1.0729772762699559,0.3799126637554585,0.824992565490737,1.0,3/13,3.66%,SLC12A2;SH2B3;STK39
prerank,aortic valve development (GO:0003176),0.4197765495329837,1.0724786639807091,0.3522727272727273,0.8250687689203737,1.0,6/34,2.15%,HEY2;HEYL;NOTCH1;TBX20;SLIT3;ROCK1
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3656820701443715,1.0724576272572708,0.36129032258064514,0.8240670871806428,1.0,10/80,4.60%,EPS8;PLCE1;PIK3R1;PIK3CA;CDC42EP1;ABI2;PLPPR5;WASL;AGRN;EPS8L1
prerank,cardiac conduction system development (GO:0003161),-0.38422067849911345,-1.0723235544691476,0.39293139293139295,0.7262333515435896,1.0,4/24,3.37%,NOTCH2;GJB6;BMP4;GJA1
prerank,regulation of lamellipodium assembly (GO:0010591),0.41666771677894743,1.0721146854049564,0.37335834896810505,0.8238198990666544,1.0,9/34,11.73%,PLCE1;PIK3R1;WAS;PIK3CA;ABI2;WASF2;EPHA2;NCKAP1;PLXNB3
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.4069138178455821,1.0721084247832293,0.3692022263450835,0.8228021156760069,1.0,4/39,5.98%,ITGA1;SH3KBP1;SPRY2;EPN1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.5103227384571268,1.0720828007660814,0.39655172413793105,0.8197762974828958,1.0,6/11,25.57%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.5103227384571268,1.0720828007660814,0.39655172413793105,0.8197762974828958,1.0,6/11,25.57%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,coenzyme A biosynthetic process (GO:0015937),0.5103227384571268,1.0720828007660814,0.39655172413793105,0.8197762974828958,1.0,6/11,25.57%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),-0.24913828687286124,-1.0720388210068816,0.21578947368421053,0.7262062560516029,1.0,98/366,21.06%,BNC2;FOXN3;ZNF423;SMARCA2;EFEMP1;DENND4A;WWC2;CHD7;FOXO3;APP;NFIA;NR3C1;KAT6B;SUFU;ESR1;PRRX2;TGFBR1;SBNO2;IGF2;SSBP2;GTF2IRD1;ARNT2;CREM;SOX13;BHLHE40;PFDN5;ACVRL1;ATXN1;TOM1L1;SIX1;FOXC1;IRF2;CHD3;STAT3;HINFP;NR2C2;ZNF219;ERC1;POLR2A;TRRAP;GON4L;VSX1;RREB1;REXO4;HIF1A;CRABP2;CARM1;ATXN2;TULP3;FZD7;SLC39A8;ESRRG;PML;BRCA2;PATZ1;NFYC;HINT1;NSD1;AHR;RELA;TCOF1;SRSF10;CALR;GLRX2;CLOCK;SOX17;RPL10;GEMIN5;ZBTB4;HOXB7;SOX7;SOX18;HCFC2;SMC3;ASCC1;NFIL3;ACTR8;NFYB;NFXL1;SOX12;RHOH;CEBPB;EZH2;PLAG1;YAF2;SBNO1;ATF7;HMGN5;PPARGC1A;E2F1;RABL3;NONO;HP1BP3;NAB2;NFATC2;THAP1;TEAD2;LMX1B
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),-0.3547738167448687,-1.0717096319609876,0.36009174311926606,0.7263082633674645,1.0,11/40,8.71%,DAB2;SMAD3;COL1A1;PDPN;TGFBR2;TGFBR1;TCF7L2;LEF1;SDCBP;FOXC1;TIAM1
prerank,regulation of lymphocyte differentiation (GO:0045619),0.46165770328859157,1.0716013994240772,0.3660531697341513,0.8199118771960399,1.0,1/18,1.07%,PRDM1
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.43166308479102455,1.0714934732677728,0.3480083857442348,0.819171537262675,1.0,2/27,2.21%,PLA2R1;SPRED1
prerank,somite development (GO:0061053),-0.4685056048186554,-1.071278834946603,0.394392523364486,0.7266791149139011,1.0,3/11,11.87%,MEOX2;SMO;PTCH1
prerank,negative regulation of viral entry into host cell (GO:0046597),-0.46116934413071864,-1.0710546690764087,0.37163375224416517,0.7265396631901443,1.0,3/12,5.43%,GSN;LY6E;IFITM3
prerank,regulation of smooth muscle cell migration (GO:0014910),0.4568912048937316,1.0710512430304053,0.36129032258064514,0.819132855833216,1.0,2/20,1.04%,PDGFRB;VTN
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),-0.34751977158510583,-1.0710060741645182,0.3511111111111111,0.725927240513571,1.0,16/46,12.98%,ALDH1A1;ZNF423;LGR4;IL15;ADAMTS5;NPR3;FOXC2;ID1;ACOT11;MAP2K6;LNPEP;NOVA2;FLCN;IP6K1;NOVA1;PGAM5
prerank,connective tissue development (GO:0061448),-0.35575907215121955,-1.070141198471131,0.3525641025641026,0.7274351557427352,1.0,7/35,7.50%,SULF1;ZBTB16;ITGB8;CREB3L2;SULF2;SLC39A13;NAMPT
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),-0.37233738909247605,-1.0697632413728893,0.3706896551724138,0.727643733997134,1.0,11/29,18.55%,WWOX;CAV1;THBS1;TNFSF10;PPP2R1B;PML;RET;SFRP1;BID;RIPK1;AGT
prerank,carboxylic acid transport (GO:0046942),-0.33272840376082535,-1.0697514599190394,0.3469387755102041,0.7269472683038641,1.0,18/55,15.94%,SLC6A13;SLC13A3;SLC16A2;SLC6A6;SLC6A12;SLC16A1;SLC16A6;SLC16A11;SLC6A9;SLC7A5;PSAP;SLC38A5;SLC3A2;SLC38A6;SLC16A13;LLGL2;SLC66A1;SLC7A1
prerank,C-terminal protein amino acid modification (GO:0018410),-0.4625772397245744,-1.0696257197899703,0.3808630393996248,0.7265541752218609,1.0,6/11,30.76%,FOLH1;LCMT1;ATG7;ATG12;AGBL1;ICMT
prerank,regulation of cilium movement (GO:0003352),-0.48607270189741897,-1.0691303033864903,0.3927272727272727,0.7270669186544245,1.0,6/10,39.28%,CFAP43;ODAD2;DRC1;CCDC65;CFAP206;CCDC40
prerank,positive regulation of stem cell proliferation (GO:2000648),0.4562202935899706,1.0689784247276835,0.374749498997996,0.82283236187812,1.0,5/17,15.97%,FERMT2;N4BP2L2;KAT7;HNRNPU;CCNE1
prerank,negative regulation of protein ubiquitination (GO:0031397),-0.3322285084607012,-1.0689756174795464,0.325,0.7267467760146998,1.0,12/50,10.98%,NXN;HDAC8;CAV1;SMAD7;TAF1;ARRB1;SH3RF2;AKT1;DTX3L;PINX1;IVNS1ABP;PRKCG
prerank,ether lipid biosynthetic process (GO:0008611),-0.48409990567156536,-1.068921030752178,0.41050583657587547,0.7261672912622167,1.0,1/10,1.12%,PLA2G4A
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.4505657392368313,1.0684945616026782,0.3671399594320487,0.8228968875559499,1.0,2/20,2.70%,GGT1;CHAC1
prerank,regulation of ERBB signaling pathway (GO:1901184),-0.44300379761886416,-1.0684363689183123,0.38943248532289626,0.7267310584755587,1.0,5/15,15.89%,EGFR;CDH13;RHBDF2;FER;CEACAM1
prerank,negative regulation of cell activation (GO:0050866),-0.44533519416148887,-1.0682760060410172,0.39454545454545453,0.7264354856691475,1.0,4/14,3.29%,PDGFRA;APOE;NOS3;THBD
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.40614197622392384,1.067450324982366,0.37568058076225047,0.8243268642331991,1.0,6/39,6.03%,ITGA4;SEMA5A;RGCC;GPER1;TNIP2;IL4
prerank,regulation of myoblast differentiation (GO:0045661),0.41340259933984225,1.067337747832164,0.3654916512059369,0.8235579645541125,1.0,5/32,4.38%,MEF2C;NOTCH1;TBX3;RBM24;SOSTDC1
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.4789878495390747,-1.0671367021829676,0.3981308411214953,0.7286527998992297,1.0,5/10,19.36%,DNMT3A;PCGF5;IGF2;PCGF3;ZFP57
prerank,neutrophil activation (GO:0042119),-0.456306960261158,-1.0670890731016458,0.39783001808318263,0.7280360974608777,1.0,4/12,21.20%,IL15;PRKCD;SYK;TYROBP
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.440636229829277,1.0668255477979518,0.38323353293413176,0.8236677938645025,1.0,6/25,13.05%,AFAP1L2;GPER1;CNOT9;HIP1;DGKD;BCAR3
prerank,positive regulation of macrophage activation (GO:0043032),-0.4216187740808852,-1.0667450810456816,0.39644970414201186,0.7281812168284024,1.0,5/17,10.34%,LBP;THBS1;WNT5A;IL33;KARS1
prerank,negative regulation of amyloid fibril formation (GO:1905907),-0.45400191278707575,-1.0666451954810316,0.38476190476190475,0.7277152964000376,1.0,3/12,5.98%,APOE;IAPP;PFDN5
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.4851543049775461,-1.0664475113343117,0.4,0.7275404752411899,1.0,3/10,10.03%,SETD7;KMT5A;EHMT1
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.40158956424114745,-1.0663065858132401,0.36885245901639346,0.7272061708451835,1.0,5/20,10.32%,CD55;IL1R1;B2M;PRKCZ;IL18
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.4237445090332572,-1.0661843110333793,0.3641732283464567,0.7267844305140163,1.0,4/16,8.37%,AUTS2;ARHGAP17;ALS2;PIK3CB
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.43618144943493337,-1.0661581010505279,0.39173228346456695,0.7261247995098945,1.0,4/15,5.81%,ITGA5;KLF4;FGF1;BMPER
prerank,regulation of ruffle assembly (GO:1900027),0.4472687436827504,1.065748772553594,0.3709677419354839,0.825135696397476,1.0,3/23,7.15%,EPS8;EPS8L1;HRAS
prerank,membrane protein intracellular domain proteolysis (GO:0031293),-0.4031423957141253,-1.0655244612348607,0.3766478342749529,0.7269479323129722,1.0,7/20,24.75%,ADAM9;ADAM10;TGFB1;RELA;PSEN2;MBTPS1;NCSTN
prerank,positive regulation of neuron apoptotic process (GO:0043525),-0.39167627184253617,-1.0647878717620989,0.40117416829745595,0.7282272877134387,1.0,3/24,2.53%,EPHA7;FOXO3;NUPR1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.379060197385247,1.0647669063208394,0.38153310104529614,0.8263418808478283,1.0,17/59,15.03%,PTEN;MECP2;MED10;MED13;AGO3;CDKN1A;CCNC;RUNX2;MED1;MITF;TNRC6C;MED20;BCLAF1;THRA;TNRC6B;MED4;MED6
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4303228308349142,1.0647420374301124,0.394990366088632,0.8253748931822503,1.0,8/32,11.07%,TRPC1;GPER1;AKAP6;NPSR1;CXCL10;SNCA;PKD2;CASQ1
prerank,dermatan sulfate metabolic process (GO:0030205),0.49261900299877026,1.064672347651146,0.37037037037037035,0.8245269129471084,1.0,1/13,0.21%,CSPG4
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),-0.30644594953753873,-1.0641997793005415,0.3333333333333333,0.7290050647074042,1.0,13/80,8.76%,DAPK1;EPHA7;UACA;SH3RF1;USP47;THBS1;KLF4;NOD1;GAS6;TNFSF10;FNIP1;MAP2K5;AKT1
prerank,innate immune response in mucosa (GO:0002227),0.5248168489229558,1.0641273516510696,0.40311804008908686,0.8248205944667674,1.0,2/10,6.03%,CAMP;IL4
prerank,central nervous system development (GO:0007417),0.31263102464128206,1.064065133413091,0.35117493472584854,0.8239600093069248,1.0,44/250,11.11%,SERPINI1;PTEN;ADGRL3;PCDH18;CDH2;ADORA2A;TBX3;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;TBX6;GRIK1;JHY;CNTNAP2;DNER;ACAN;ROGDI;CNTN4;MOG;ASIC2;TPPP;SOX4;ANKLE2;LIG4;CNTN6;PPT1;NCOA6;NES;ROBO2;ADAM23;PKD2;UFM1;MARCKS;GRIN2B;NCKAP1;DDIT4;SPOCK1;SOX6;AHI1;IL1RAPL2;LOXL3
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.39331950682890426,-1.0636674408453353,0.38911290322580644,0.7296640694089732,1.0,9/24,12.65%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4
prerank,negative regulation of cell-cell adhesion (GO:0022408),-0.33855804699908243,-1.0636560212958677,0.3522975929978118,0.7289807642839354,1.0,10/39,12.45%,BMP6;PODXL;KLF4;CDH1;FXYD5;WNK1;MAP2K5;AKT1;TGFB1;PPARA
prerank,response to glucocorticoid (GO:0051384),-0.38603856406593967,-1.0635172179574501,0.38839285714285715,0.7286214189206276,1.0,5/26,9.52%,NR3C1;SLIT2;ANXA1;ADAM9;BCL2L11
prerank,regulation of protein polymerization (GO:0032271),0.40978153895197134,1.063336693049726,0.3856332703213611,0.8245518389160977,1.0,9/35,13.98%,PLEKHG2;MAP2;ESAM;TTBK1;TPPP;CAMSAP3;PAK3;RASA1;ABITRAM
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.32276808853349437,-1.062730407777182,0.34953703703703703,0.729888522915278,1.0,5/53,3.83%,EYA2;EYA1;EGFR;EYA4;DDX5
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.38485066893515507,-1.0626118439507082,0.3708086785009862,0.7294820583233639,1.0,10/26,14.01%,SULF1;CCBE1;IL6ST;SULF2;CYP1B1;HIF1A;TGFB1;PTGS2;FLT4;SARS1
prerank,positive regulation of cell cycle (GO:0045787),-0.31824553859992244,-1.0624271342857676,0.35185185185185186,0.7292094200428818,1.0,19/62,15.90%,EGFR;APP;NUPR1;FGFR2;LRP6;CCND2;CCND3;AKT1;RPS15A;MDM2;SMOC2;CALR;SPHK1;MEIS2;CCND1;TAL1;PKD1;EIF4EBP1;CDKN1B
prerank,intestinal absorption (GO:0050892),-0.4416656930698543,-1.0617209947334014,0.38653846153846155,0.7303535076230939,1.0,4/13,13.66%,TJP2;KCNQ1;F11R;UGCG
prerank,brain development (GO:0007420),0.3366344820259222,1.0616811472145544,0.34642356241234223,0.8273593580011547,1.0,24/136,10.88%,PTEN;ADGRL3;PCDH18;CDH2;RAPGEF2;ZFHX3;NF1;HESX1;COL4A1;TMX2;UGP2;JHY;CNTNAP2;ROGDI;CNTN4;PPT1;NCOA6;NES;ROBO2;UFM1;GRIN2B;CTNNA2;DDIT4;SOX6
prerank,regulation of sodium ion transport (GO:0002028),-0.35415877786636635,-1.0616523803329252,0.35555555555555557,0.7298095601253334,1.0,15/34,21.00%,SNTA1;DLG1;WNK4;WNK1;GPD1L;P2RX4;AHCYL1;SLMAP;P2RX7;ATP1A1;CNKSR3;NOS1;YWHAH;NKAIN4;SCN3B
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.4355851466242547,1.0615155303041728,0.3838582677165354,0.8267437793902309,1.0,3/22,4.80%,PLA2R1;SPRED1;HEXIM1
prerank,protein localization to cilium (GO:0061512),-0.3669288466510698,-1.0613715617475423,0.3628691983122363,0.7297787709002734,1.0,13/32,29.53%,ZNF423;EHD1;ARL3;TULP3;SNX10;TTC21B;RAB29;WDR35;TULP1;TMEM107;BBS9;IFT122;ATP6V1D
prerank,regulation of protein secretion (GO:0050708),0.3385581392992017,1.0612610479860707,0.3493975903614458,0.8263110107818111,1.0,18/119,9.86%,CACNA1C;SLC12A2;RAPGEF4;PER2;ITPR2;IL1B;GIPR;RHBDF1;SNAP25;ITPR1;FRMD4A;TFAP2B;RAP1A;CACNA1D;ACHE;GCK;MYOM1;CACNA1A
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.41878944121787826,1.0612230404140548,0.38825757575757575,0.825402584272699,1.0,10/32,13.12%,MAP2;SPEF1;FGF13;NAV3;CLASP2;SNCA;CAMSAP3;APC;TUBB4A;APC2
prerank,serine family amino acid metabolic process (GO:0009069),0.47462476477943905,1.0611979313850024,0.40039840637450197,0.8244604156319787,1.0,6/16,12.63%,CTH;BAAT;SEPHS2;GLYAT;SRR;DAO
prerank,icosanoid biosynthetic process (GO:0046456),-0.4728199997425524,-1.0605925954839666,0.39344262295081966,0.7310482321414451,1.0,1/10,1.12%,PLA2G4A
prerank,negative regulation of receptor internalization (GO:0002091),-0.4553085527023744,-1.060078172243915,0.4141791044776119,0.7316977780569459,1.0,3/12,9.79%,RIN3;SDCBP;ATXN2
prerank,positive regulation of actin nucleation (GO:0051127),0.5117931871358781,1.0596784021074552,0.39959839357429716,0.8269615011943322,1.0,4/11,10.01%,WASF3;ABI2;WASF2;NCKAP1
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.38842350391837194,-1.059474014225525,0.4025157232704403,0.7325964928862417,1.0,10/24,21.88%,DNMT3A;RBBP7;H3-3A;JARID2;TRIM27;PPHLN1;EZH2;SMYD5;MPHOSPH8;DNMT1
prerank,regulation of cell cycle (GO:0051726),0.3053782300010015,1.0590423589997755,0.32085561497326204,0.8274403075108003,1.0,39/271,11.89%,PTPRK;FAP;MAP3K20;APBB2;CDK6;NOTCH1;AFAP1L2;PER2;RGCC;GPER1;TBX3;SIPA1;FOXM1;CRLF3;RPS6KA2;BRINP1;NUPR2;SIK1;HRAS;BIN1;FGF10;CDKN1A;GRK5;RNF112;HTRA2;PKD2;TTLL12;CDC14B;NEK6;TAF6;CITED2;ASAH2;WDR12;SETMAR;RPRD1B;EP300;RB1;APC;SND1
prerank,motile cilium assembly (GO:0044458),0.48397093260487356,1.0587051216070429,0.3824130879345603,0.827216665767579,1.0,1/12,2.33%,RSPH6A
prerank,histone acetylation (GO:0016573),-0.3098799900820467,-1.0586775811532498,0.34595959595959597,0.7340025027242196,1.0,26/69,25.98%,KAT6B;KAT2B;LEF1;KAT14;TRRAP;TADA1;MEAF6;TRIM16;TADA2A;BRCA2;BEND3;YEATS2;NAA40;BRPF3;CHD5;MORF4L2;BRPF1;BRD1;TAF5;HAT1;SGF29;BRD8;JADE1;ING4;ATF2;EPC1
prerank,inflammatory response (GO:0006954),0.31799487602268284,1.0586137165543397,0.3519781718963165,0.8263972198615452,1.0,20/195,9.30%,GGT5;PIK3CD;TBXA2R;AFAP1L2;ADORA2A;IL1B;CD96;CCRL2;IL2RA;ADCY8;TACR1;CXCR2;CXCL10;IL4;CXCL5;KLRG1;RIPK2;NFATC4;IL22;ADGRE5
prerank,regulation of oxidative phosphorylation (GO:0002082),0.4783806948048205,1.0575750777117583,0.39835728952772076,0.827742415973906,1.0,2/16,3.70%,SLC25A33;ATP7A
prerank,activation of protein kinase A activity (GO:0034199),0.4597192942437046,1.0574721422684175,0.36477987421383645,0.8269697451102621,1.0,8/16,10.18%,PRKAR1B;ADCY8;ADCY3;ADCY6;PRKAR2B;ADCY9;PRKAR2A;PRKAR1A
prerank,dermatan sulfate biosynthetic process (GO:0030208),0.49613227101395024,1.0574708360507354,0.3684210526315789,0.8259742303920864,1.0,1/12,0.21%,CSPG4
prerank,regulation of protein-containing complex assembly (GO:0043254),-0.282998747464831,-1.0571901010401872,0.3264705882352941,0.7371932665717937,1.0,39/110,28.77%,TRABD2B;ABCA1;CDH5;GSN;APOE;IAPP;PRKCZ;FNIP1;HSPA5;TFRC;IRGM;BCL2L11;GFAP;DAB2IP;TGFB1;SH3GLB1;TAL1;NAPA;BID;PARK7;SAR1A;SAR1B;VCP;RHOC;SYK;LCMT1;HJURP;VEGFA;PIH1D1;ICE1;HCK;RPS3;RACK1;AIDA;BIK;CLU;PREB;SLF1;MPP7
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),-0.2735132503605082,-1.0571733822656117,0.33980582524271846,0.736526402881802,1.0,41/149,19.70%,PRKCH;APP;CAV1;NOD1;ARHGEF2;CFLAR;IRAK2;AR;LGALS9;WNT5A;PRKCZ;PRKCB;CARD14;STAT3;TFRC;ERC1;FLOT2;IRAK3;IL18;TRIM27;CAMK2A;RELA;TNFRSF11A;UBB;CLOCK;SPHK1;FER;TICAM1;PPIA;TLR4;TRIM8;RIPK1;MAP3K13;NFKBIA;EDA;TRIM14;ALK;LAMTOR5;AGT;EDA2R;IKBKG
prerank,cellular response to estrogen stimulus (GO:0071391),-0.4397025498132442,-1.0571235319039096,0.4174757281553398,0.7359472199314776,1.0,8/14,29.33%,TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;SRA1;SERPINB9
prerank,sulfur compound biosynthetic process (GO:0044272),0.3384337779166242,1.0569932349964186,0.3448275862068966,0.8260633888642827,1.0,13/104,7.23%,CSPG4;GGT5;GGT1;CHST3;GGTA1;CHST7;CHAC1;CTH;ACAN;SLC26A1;B4GALT6;TPK1;CHST2
prerank,cell chemotaxis (GO:0060326),0.370824543961108,1.0567098245097404,0.3696027633851468,0.8256996840817183,1.0,12/60,12.15%,PDGFRB;SEMA5A;BCAR1;CCRL2;ACKR3;CXCR2;ACKR2;CCR9;PDGFB;EPHA2;PLXNB3;EPHB1
prerank,extracellular matrix assembly (GO:0085029),0.44185509747360974,1.056454063395028,0.4116504854368932,0.8252991793322741,1.0,6/23,5.23%,TNXB;MYH11;ATP7A;PXDN;NTNG2;LAMB1
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),-0.41033120163493547,-1.0562598635502742,0.38747553816046965,0.7374006767519989,1.0,6/20,17.00%,TGM2;RAP1GDS1;PML;TMCO1;SELENOK;BCAP31
prerank,negative regulation of cytoskeleton organization (GO:0051494),-0.3641377783590066,-1.0559924707228976,0.3877118644067797,0.7373477515641149,1.0,14/29,26.62%,LIMA1;SLIT2;SHANK3;KANK3;PRKCD;FKBP4;PFN1;TWF1;CYRIB;SSH3;ARPIN;KANK1;PRKN;SMAD4
prerank,catecholamine biosynthetic process (GO:0042423),-0.4551577837800596,-1.0559351264851387,0.42293233082706766,0.7367608360327289,1.0,3/11,17.95%,MOXD1;GCH1;DDC
prerank,positive regulation of cell cycle process (GO:0090068),0.3585029264015237,1.0556891359139309,0.3910891089108911,0.8260392895655649,1.0,12/91,10.17%,PDGFRB;MAP3K20;RGCC;IL1B;CUL3;OPN1MW;CSPP1;PCID2;PDGFB;CDC14B;UBXN2B;NUSAP1
prerank,icosanoid metabolic process (GO:0006690),0.40885297703637224,1.055655554510465,0.37781954887218044,0.8251249631711985,1.0,2/40,0.87%,GGT5;GGT1
prerank,contractile actin filament bundle assembly (GO:0030038),-0.42694006544881036,-1.0552467497934572,0.3869047619047619,0.7370724405131743,1.0,6/15,7.88%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,stress fiber assembly (GO:0043149),-0.42694006544881036,-1.0552467497934572,0.3869047619047619,0.7370724405131743,1.0,6/15,7.88%,SORBS1;PHACTR1;FAM171A1;ARRB1;RHOA;ZYX
prerank,cellular polysaccharide catabolic process (GO:0044247),-0.41810415869446826,-1.055202798211147,0.396078431372549,0.736503584451502,1.0,5/16,17.83%,PHKB;PHKA2;PYGB;CALM1;GAA
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),-0.41558399254955875,-1.0551144442125575,0.3941747572815534,0.7360162693880142,1.0,9/16,30.28%,CAV1;PARP14;HGS;LEPROT;PTPN2;ADIPOR1;PIBF1;SOCS1;INPP5F
prerank,AMP metabolic process (GO:0046033),-0.44444289830256367,-1.0548835024636771,0.37213740458015265,0.735911392341097,1.0,5/13,20.93%,AMPD3;XDH;NT5E;NT5C1A;ADSS1
prerank,cholesterol efflux (GO:0033344),-0.3930670351886073,-1.05457672681464,0.398406374501992,0.7359822970816151,1.0,3/20,6.78%,ABCA1;APOE;NPC2
prerank,positive regulation of cellular process (GO:0048522),0.28716689536675727,1.0544007554250698,0.3409873708381171,0.8269596692214295,1.0,52/565,7.78%,TRPC3;PDGFRB;PTEN;TBX2;IL34;S1PR3;IL15RA;GCNT2;COLEC12;BMP5;NOTCH1;SLC25A33;PTK2;GPER1;TBX3;ZFHX3;MERTK;PABIR1;PTN;FOXM1;ERBB4;IL1B;CUL3;NRG1;TBX6;ETS1;MECP2;AKAP6;PPP3CA;PDCD10;FGF2;CIDEB;SPDYA;ACTN4;TSPAN31;TFAP2B;CXCR2;NTRK2;IL4;CXCL5;DDX3X;TPPP;RYR2;SOX4;CHRNA7;SUPV3L1;EMP2;HRAS;IRS1;RIPK2;FGF10;NCMAP
prerank,regulation of hippo signaling (GO:0035330),0.45327685711828647,1.053981312495057,0.39173228346456695,0.8269120254840274,1.0,3/17,4.97%,LIMD1;SCHIP1;AJUBA
prerank,mitotic cell cycle phase transition (GO:0044772),0.31378658483360683,1.0535416557958275,0.3687845303867403,0.8269500956777599,1.0,35/203,16.52%,DYNLL1;EPS8;CDK6;BTRC;FOXM1;CUL3;CRLF3;PPP2R2A;SPDYA;CCDC57;AJUBA;CLASP2;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;TACC3;BRSK1;LATS2;RB1;TUBB4A;PPP1R12A;CDK14;DCTN1;EIF4E;ANAPC7;CCNH;SKP1;DCTN3;CEP76;CCNE1;CEP135;NDE1
prerank,peptidyl-asparagine modification (GO:0018196),-0.36508083468135144,-1.0534646046436367,0.38755020080321284,0.7381131018301659,1.0,11/31,18.79%,STT3A;STT3B;FUT8;MGAT1;LMAN1;MGAT2;MCFD2;OST4;ASGR1;RPN2;OSTC
prerank,positive regulation of response to external stimulus (GO:0032103),-0.280708557277758,-1.0532537874057681,0.32087227414330216,0.7379317226052617,1.0,33/128,19.01%,BMP6;APP;IL15;SASH1;THBS1;THBD;PDCD4;IL16;DDX60;WNT5A;CD47;STX3;USP15;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;PUM1;GBP5;TGFB1;USF1;CYBA;CD180;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;AGT;AGTR1
prerank,positive regulation of B cell activation (GO:0050871),0.38297583779674454,1.0531041776183976,0.37300177619893427,0.826977387693169,1.0,4/50,6.03%,MEF2C;SH3KBP1;TNIP2;IL4
prerank,cellular response to glucose starvation (GO:0042149),-0.341891297124486,-1.0530808815884483,0.3741794310722101,0.737662082748273,1.0,15/41,21.84%,PRKAG2;FOXO3;ITFG2;HSPA5;BECN1;ZC3H12A;SH3GLB1;PRKAG3;PRKAA2;MTMR3;RRP8;KPTN;PRKAG1;XBP1;EIF2AK3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.34810207167078194,1.0528647703487464,0.3890675241157556,0.8265242640127006,1.0,12/101,7.15%,PDGFRB;IL34;RAPGEF2;RGCC;FERMT2;IL1B;PDCD10;FGF2;SPDYA;SNCA;DDX3X;HRAS
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.31105125365997605,1.0523563949122718,0.3629032258064516,0.8267332479952265,1.0,25/214,7.15%,PDGFRB;PTEN;SLC30A10;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;SPRED1;ERBB4;IL1B;PTPN22;ACKR3;FGF2;SPRY2;CARD9;ROS1;NTRK2;HTR2C;CHRNA7;YWHAZ;RAP1A;HRAS
prerank,muscle cell development (GO:0055001),0.42759664988637436,1.0522671775531272,0.4128787878787879,0.8259268807408463,1.0,4/30,2.04%,DMD;HEY2;DYSF;MYH11
prerank,regulation of mitotic cell cycle (GO:0007346),-0.2700372336180678,-1.0521743572249307,0.32459016393442625,0.7393031190680507,1.0,62/171,27.74%,SMAD3;IQGAP1;PTPN3;APP;GAS1;SDCBP;CDC16;FOXC1;MAEA;OBSL1;BTG3;PSME2;ANAPC4;TGFB1;MDM2;SMOC2;PSMB4;TRIM35;SPHK1;MEIS2;PIM3;TAL1;PSMB1;PSMD11;CAV2;DDB1;PSMD8;CDK9;EIF4EBP1;PSME3;CDKN1B;RNF40;CCDC8;ANAPC16;PSMD4;FZR1;PSMA2;PIM2;USP22;PSMD3;CDC27;CDK5RAP3;THAP1;PSMB7;ANAPC5;CUL9;CDKN1C;USP2;PSMC2;ERCC2;TMEM8B;PSMC5;CDK11B;PSMD10;SCRIB;L3MBTL1;ERCC3;ANGEL2;SRA1;NEK7;PSMD7;MKI67
prerank,long-chain fatty acid metabolic process (GO:0001676),-0.31615805029526256,-1.0521641262075276,0.3788659793814433,0.7386299208838017,1.0,16/64,17.81%,PLA2G4A;CPT1A;CYP1B1;CPT2;DAGLB;GPX4;ACOX1;MGLL;ACADL;PTGS2;EPHX2;GSTM2;ELOVL1;GPX1;ACSL4;ALOX12
prerank,regulation of glycolytic process (GO:0006110),-0.30505557824332513,-1.0520349213830293,0.38095238095238093,0.7382347748716203,1.0,5/68,2.53%,PRKAG2;IGF1;HDAC4;APP;NUPR1
prerank,peptidyl-tyrosine modification (GO:0018212),-0.3177961556501696,-1.051999633212868,0.3722627737226277,0.7376244911339419,1.0,8/56,3.02%,EPHA4;EPHA3;EGFR;FLT1;EFEMP1;PDGFRA;TEK;FGFR2
prerank,regulation of potassium ion transport (GO:0043266),0.41379729587701036,1.0519208778406246,0.3956442831215971,0.8257297683753374,1.0,8/31,11.54%,CASQ2;DPP10;KCNAB3;ANK3;CACNA1D;KCNE5;KCNIP1;KCNIP4
prerank,calcium-mediated signaling (GO:0019722),0.3483167014713534,1.0519194235604898,0.38341158059467917,0.8247533411895563,1.0,11/93,8.20%,CACNA1C;PLCE1;CCRL2;ACKR3;GRM5;PPP3CA;CXCR2;RYR2;ATP2A2;ACKR2;CCR9
prerank,positive regulation of protein import (GO:1904591),-0.3735877997523079,-1.0518179275782145,0.40421052631578946,0.7373574858683517,1.0,10/30,17.87%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN;TPR;PDCD5
prerank,cellular response to estradiol stimulus (GO:0071392),-0.40275656175075536,-1.0509691773973873,0.40039447731755423,0.7388445429140802,1.0,3/18,2.97%,EGFR;LCOR;ESR1
prerank,lymphocyte differentiation (GO:0030098),0.35919044167982106,1.050734342808047,0.38578680203045684,0.8263885110058049,1.0,10/68,6.77%,ITGA4;PIK3CD;PTPN22;AXL;GPR89A;GPR89B;ITGB1;IL4;SOX4;KAT7
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.37640573503030506,1.0498245342325003,0.3812154696132597,0.827426285973347,1.0,10/48,10.94%,CARMIL1;LIMS1;FERMT2;RAC3;TESK1;CAPRIN2;IL1RAPL1;DOCK1;ARHGEF7;CUX2
prerank,cellular response to acid chemical (GO:0071229),0.417334386217628,1.0497568067400425,0.39918533604887985,0.8265931704742012,1.0,2/27,1.65%,SPAAR;CPEB1
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.33044320566564656,1.0491325849801432,0.375,0.8270689111415246,1.0,15/125,10.99%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;NUSAP1;TACC3;TUBG2;XPO1;SEC13
prerank,antibacterial humoral response (GO:0019731),0.46503691645438616,1.0489392681825485,0.3912087912087912,0.8265539596712095,1.0,8/16,24.35%,WFDC3;CAMP;RNASE6;DMBT1;SLPI;JCHAIN;ANG;RNASE7
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.3636978298350526,1.048809869846763,0.38724727838258166,0.8259189140522443,1.0,7/73,6.87%,DLC1;ATP2A3;COL4A3;BCL2L10;SNCA;BCL2L13;CASP9
prerank,non-canonical Wnt signaling pathway (GO:0035567),-0.27870848399698767,-1.0478977102044449,0.3261538461538461,0.7459747137699648,1.0,42/124,21.25%,PLCB1;WNT4;SMURF2;TCF7L2;NFATC1;LEF1;FZD2;AP2A2;MOV10;SFRP4;SMURF1;WNT5A;RHOA;PLCB3;FZD4;TIAM1;FZD7;PSME2;CAMK2A;PFN1;AP2A1;PSMB4;CCDC88C;ARHGEF19;SFRP1;PSMB1;PSMD11;PSMD8;FZD8;PSME3;CALM1;TNRC6A;WNT11;ROR2;FZD1;PSMD4;PSMA2;AGO1;PSMD3;PPP3CB;PSMB7;VANGL2
prerank,cellular response to interleukin-4 (GO:0071353),-0.4789893810664717,-1.0477212528244984,0.4417293233082707,0.7457334030183335,1.0,4/10,24.39%,LEF1;XBP1;SHPK;TCF7
prerank,digestive tract morphogenesis (GO:0048546),-0.4398135495306188,-1.0476673251566138,0.4337568058076225,0.7451898288243003,1.0,7/14,16.39%,PDGFRA;FGFR2;STRA6;BBS7;ID2;SOX17;EPHB3
prerank,activation of GTPase activity (GO:0090630),0.35226956540547033,1.0476493530369566,0.39184952978056425,0.8274758308650191,1.0,16/89,9.84%,ARHGAP42;TBC1D1;SIPA1;GRTP1;GARNL3;TBC1D30;SLC27A4;SYDE1;TBC1D12;ARHGEF26;RUNDC1;RALGAPA1;TBC1D2B;MTSS2;TBC1D10C;EPHA2
prerank,regulation of cell differentiation (GO:0045595),0.3276780792756203,1.0474843447726316,0.3645390070921986,0.8268738185685698,1.0,17/148,7.30%,MBOAT2;HEY2;CDK6;PTK2;TRPS1;PHLDB2;ZFHX3;ROCK1;NF1;NR1D2;HEMGN;MOSMO;CLASP2;TFAP2B;SIK1;EMP2;BIN1
prerank,negative regulation of cellular biosynthetic process (GO:0031327),-0.33404980274505175,-1.0474397969853164,0.37872340425531914,0.7450300831477333,1.0,12/47,16.32%,ROCK2;WNT4;PTGIS;CAV1;CD34;C1QTNF3;ZC3H12A;ACADL;PGP;SNAI1;CEACAM1;SIRPA
prerank,positive regulation of lipid kinase activity (GO:0090218),0.4304107290341439,1.047271377739901,0.42549019607843136,0.8263919998404109,1.0,5/29,9.15%,PDGFRB;PTK2;FGF2;IRS1;PDGFB
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.30652854049172557,-1.0471041382087178,0.3708791208791209,0.7452118766108957,1.0,14/78,8.76%,SORBS1;DAB2;EPHA3;EGFR;PRKCH;RHOQ;DLG1;ITGA3;AR;STX7;PRKCE;STX3;MMP14;AKT1
prerank,regulation of microtubule-based movement (GO:0060632),0.49410947638927327,1.0470767198022877,0.42557651991614254,0.8258640663945817,1.0,1/11,1.46%,MAP2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),-0.47396455331946363,-1.0464172511833705,0.42857142857142855,0.745483750960771,1.0,6/10,35.72%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,DNA dealkylation (GO:0035510),-0.47396455331946363,-1.0464172511833705,0.42857142857142855,0.745483750960771,1.0,6/10,35.72%,ASCC3;FTO;ASCC1;ALKBH5;ASCC2;MGMT
prerank,cellular response to ketone (GO:1901655),-0.3470505447314006,-1.0463993944210532,0.3936842105263158,0.7448239279932538,1.0,11/35,13.91%,ROCK2;ADCY5;NR3C1;ADCY1;AR;GOLPH3;ADAM15;AHR;SPP1;LARP1;SFRP1
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.4442367500077524,1.046203151923968,0.38571428571428573,0.8267939798821935,1.0,4/20,6.87%,BCL2L10;IL4;APPL1;CASP9
prerank,pulmonary valve morphogenesis (GO:0003184),0.46670994239094754,1.0461981264788043,0.43610547667342797,0.8258352640689618,1.0,4/17,1.22%,HEY2;HEYL;NOTCH1;TBX20
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),-0.4313297395076373,-1.0459553556321346,0.4280373831775701,0.7453399222739042,1.0,5/15,21.20%,ADAM9;MAPK14;EHD1;EHD2;TYROBP
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.37686629096019825,-1.045402618253156,0.41561181434599154,0.7460852247260481,1.0,8/28,13.01%,SMAD3;CDH1;PRKCD;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,positive regulation of signaling receptor activity (GO:2000273),-0.34938375794608617,-1.045337997507173,0.3956043956043956,0.7455327972400029,1.0,10/36,18.15%,NRP1;TGFA;SHANK3;TAF1;HIF1A;HDAC1;EPHB2;HFE;ADRB2;PARK7
prerank,regulation of phagocytosis (GO:0050764),0.37813779648631457,1.0446108428901197,0.4,0.8283867719648219,1.0,5/53,2.62%,IL15RA;DYSF;SCARB1;MERTK;IL1B
prerank,mitotic cytokinesis (GO:0000281),-0.3302988006646638,-1.0445342912185962,0.3686534216335541,0.7468411650625353,1.0,18/47,19.80%,ROCK2;SNX9;PDCD6IP;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2;MITD1;KLHDC8B;STAMBP;CIT;RHOC
prerank,myofibril assembly (GO:0030239),0.3942199011437928,1.04445003835464,0.37967914438502676,0.8277785102025977,1.0,3/42,5.35%,PDGFRB;TMOD1;TMOD3
prerank,heme biosynthetic process (GO:0006783),-0.39039963993228805,-1.0442586706580488,0.41472868217054265,0.7468647139712336,1.0,13/22,33.87%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.458189566605245,1.0442163639695254,0.4268041237113402,0.827334497639305,1.0,2/16,1.91%,PDGFRB;BCAR1
prerank,regulation of cell motility (GO:2000145),-0.2777313362644933,-1.0435315456135397,0.3382352941176471,0.7480740566016852,1.0,19/121,8.76%,PLXNA2;EGFR;ROCK2;LMO4;FBLN1;PLXNA4;MACF1;DIAPH1;ARHGAP18;FGF1;SPOCK2;CAVIN1;RHOA;RHOB;TMSB4X;TBCCD1;CCDC125;PLXND1;AKT1
prerank,regulation of cellular protein catabolic process (GO:1903362),-0.4040811483152701,-1.043356707688621,0.4288659793814433,0.7478180178679611,1.0,6/18,14.09%,VGLL4;EZR;ATRAID;DAB2IP;VPS35;RGP1
prerank,negative regulation of vascular permeability (GO:0043116),-0.45002183404162893,-1.0429921859267879,0.42911877394636017,0.7480904866488346,1.0,6/12,6.45%,SLIT2;CLDN5;PTPRJ;ANGPT1;RAMP2;DDAH1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.47697237130657155,1.042779531274902,0.40794979079497906,0.829611568253756,1.0,3/14,4.75%,ZEB1;SPRED1;SPRY2
prerank,reverse cholesterol transport (GO:0043691),-0.43862964476276767,-1.042540187272027,0.39399624765478425,0.74852122970457,1.0,2/13,1.96%,ABCA1;APOE
prerank,membrane lipid catabolic process (GO:0046466),-0.4844169703409653,-1.0423452742585162,0.4359925788497217,0.7483218475178293,1.0,6/10,24.73%,CYP1B1;FUCA1;NAGA;ENPP2;SGPL1;PDXDC1
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),-0.42747347049494233,-1.0422330334422474,0.40185185185185185,0.7479153439527768,1.0,12/14,42.35%,RELA;RAB29;IKBKG;CD81;RPS3;BCL10;KCNN4;CARD11;TRAT1;CD226;TESPA1;LCK
prerank,sodium ion transmembrane transport (GO:0035725),0.35498171783728905,1.041334991558934,0.3805031446540881,0.8318989574375607,1.0,18/84,9.02%,SLC12A2;ATP1A2;ATP1A4;SLC5A1;FXYD2;SLC24A4;SLC24A2;SCN2A;ATP1B2;SCN5A;ASIC2;HCN2;SCN8A;SLC9A7;HCN3;SLC6A15;SCN9A;PKD2
prerank,positive regulation of chemokine production (GO:0032722),-0.3361760469789227,-1.0409441918419329,0.3946784922394678,0.7504138782288089,1.0,9/44,10.94%,APP;IL6R;LGALS9;WNT5A;IL33;HIF1A;IL17RA;IL18;MAVS
prerank,regulation of glycogen metabolic process (GO:0070873),-0.4484247344413972,-1.0407282368393627,0.42602495543672014,0.7502216177629307,1.0,5/12,29.52%,AKT1;PPP1R3B;PPP1R3F;INPP5K;KHK
prerank,cellular response to organic cyclic compound (GO:0071407),0.3255058271172572,1.0406644748632496,0.3799126637554585,0.8324367141121394,1.0,22/141,9.43%,MEF2C;GNG2;PDE3A;RAPGEF2;ATP1A2;RORA;GPER1;IL1B;ADCY8;ADCY3;NCOA3;ADCY6;AKAP6;GABRG2;HCN2;RAP1A;FAM210B;RYR3;HCN3;PKD2;PDGFB;MED1
prerank,positive regulation of protein catabolic process (GO:0045732),-0.29657448015410964,-1.0405431802580758,0.3651226158038147,0.7499829249471847,1.0,19/84,11.46%,VGLL4;FOXO1;APOE;SMURF2;EZR;SNX9;NKD1;ADAM9;WWP2;SMURF1;WNT5A;TNFRSF1B;PLK2;EGLN2;IDE;DAB2IP;VPS35;RAB7A;ASB5
prerank,negative regulation of hippo signaling (GO:0035331),0.47293198888774,1.0403697508131085,0.37815126050420167,0.8321836341741635,1.0,2/12,4.97%,LIMD1;AJUBA
prerank,DNA biosynthetic process (GO:0071897),-0.4149324764993947,-1.040245740374051,0.4086629001883239,0.7500261917934223,1.0,8/16,30.13%,POLH;PPIA;TYMS;RFC3;POLA1;CDKN2D;POLD1;WRN
prerank,negative regulation of osteoclast differentiation (GO:0045671),-0.40756471338094374,-1.0401080198718522,0.4083969465648855,0.7496708469286346,1.0,5/18,21.45%,FBN1;TCTA;GPR137;TLR4;FSTL3
prerank,negative regulation of response to external stimulus (GO:0032102),0.339714320839751,1.0399920180672677,0.39755351681957185,0.832034913990907,1.0,12/105,7.27%,PTEN;AJAP1;RORA;RTN4RL1;GPER1;NR1H3;LRFN5;PPARD;FGF2;IL4;CACTIN;AOAH
prerank,negative regulation of DNA binding (GO:0043392),0.4144744770499746,1.039448147724001,0.426,0.832271088558536,1.0,3/28,5.14%,HEY2;PER2;TNKS
prerank,regulation of protein sumoylation (GO:0033233),-0.4079532102496874,-1.0392379880390534,0.4145873320537428,0.7512240207151714,1.0,2/17,1.09%,ZMIZ1;HDAC4
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.3750876859235646,-1.0391805126518636,0.41030927835051545,0.7507004056976102,1.0,7/25,13.57%,SLIT2;CAPZB;LIMK2;YAP1;PRKCD;EVL;TCHP
prerank,neural crest cell development (GO:0014032),0.3871377335383733,1.0390294295769749,0.3953068592057762,0.8322975810827702,1.0,6/44,4.82%,CDH2;SEMA6D;SEMA5A;ERBB4;NRG1;SEMA6C
prerank,ephrin receptor signaling pathway (GO:0048013),0.34530345132403106,1.0389880502867397,0.39867109634551495,0.8314191515999468,1.0,25/82,13.55%,CHN1;KALRN;PTK2;SDC2;NCK2;ROCK1;WASL;ARPC5;ANKS1B;HRAS;AP2S1;LYN;GRIN2B;EPHA2;AP2B1;ARPC4;ARHGEF7;PAK3;EPHA10;PAK1;EPHB1;SRC;PSEN1;ARPC1A;RASA1
prerank,peptidyl-proline modification (GO:0018208),-0.37523107881265555,-1.038923257686206,0.4171779141104294,0.7506569468740885,1.0,9/25,22.83%,FKBP5;FKBP1A;FKBP4;PPIC;PPID;PPIA;FKBP7;PPIL1;FKBP10
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.43136973694456504,-1.0387890137989992,0.412962962962963,0.750282686610628,1.0,10/13,28.17%,SEC16B;EDEM2;TMEM30A;TM9SF4;BCAP31;SAR1A;SAR1B;CD81;SEC16A;EDEM1
prerank,autonomic nervous system development (GO:0048483),-0.40508923493005367,-1.0386125112989213,0.4254473161033797,0.7500558107115274,1.0,2/17,1.02%,FN1;NRP1
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.3615553526513782,-1.0386098825013297,0.4130879345603272,0.7493690377956792,1.0,3/29,2.98%,NOTCH2;IGF1;TGM2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),-0.44332573464072755,-1.0385582452265996,0.441340782122905,0.7488082995509747,1.0,7/13,23.89%,IL6ST;STAT1;STAT3;OAS2;CANX;TYK2;CRLF1
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.3156975356662823,1.038321030536071,0.3678977272727273,0.8319392754719541,1.0,27/166,9.25%,PDGFRB;PTH1R;PLD1;RGCC;NR1H3;SCARB1;ZEB2;IL1B;LDLR;ATP7A;FGF2;FABP3;YTHDF3;SNCA;DDX3X;SOX4;APPL1;KAT7;IRS1;NMD3;MTOR;EIF3C;ARNT;PRKD2;PKD2;PDGFB;GCK
prerank,establishment of vesicle localization (GO:0051650),-0.4045524613670227,-1.0382244973303825,0.4095634095634096,0.7489872452517278,1.0,4/18,5.45%,RAB11A;LIMK2;RAB27A;CCDC186
prerank,cell proliferation in forebrain (GO:0021846),0.5053824769802484,1.0377225548436142,0.41956521739130437,0.8323333588530023,1.0,4/10,19.41%,HOOK3;AKNA;CEP120;DOCK7
prerank,positive regulation of hydrolase activity (GO:0051345),0.32790728624754417,1.0374914750281028,0.38394160583941606,0.8319484671425901,1.0,20/137,8.81%,RGS6;LIMS1;DOCK10;RAPGEF2;RASGRP2;MTCL1;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;RIC1;RAP1A;HRAS;RGS7;RAB11FIP2;MAP4K4
prerank,positive regulation of T cell chemotaxis (GO:0010820),-0.4659013802130022,-1.0374514296184814,0.41682242990654206,0.7502774509469186,1.0,4/10,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),-0.31061860737885527,-1.0373780874523508,0.37772397094430993,0.7497523862289805,1.0,14/59,17.71%,ROCK2;MAP3K14;IRAK2;BIRC3;ERC1;AKT1;TNFRSF1A;DAB2IP;RELA;UBB;TICAM1;TLR4;RIPK1;NFKBIA
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4915785283601899,1.0368373132432938,0.4116331096196868,0.8325001554057476,1.0,2/10,2.78%,NR1H3;PTPN22
prerank,cellular protein localization (GO:0034613),0.2993611326716623,1.0367046488012794,0.37516170763260026,0.8318280654545654,1.0,43/285,11.87%,PTPRK;TBC1D1;DMD;HEY2;PIGU;JAM3;VCL;FERMT2;STX16;GRTP1;COG7;CNTNAP2;COX18;TBC1D30;ESAM;GAS8;GGA3;ARL4C;DNAJC27;TBC1D12;RIC1;EMP2;RUNDC1;FGF10;RAB28;MYO6;TBC1D2B;RAB38;TBC1D10C;TMED7;TMED4;BICD2;STXBP2;ARL5C;AHI1;SEC13;STX4;ARFRP1;WLS;AXIN2;ERP29;COPB2;TBC1D9B
prerank,regulation of chromatin organization (GO:1902275),-0.43109058182444604,-1.0365827586274377,0.4148148148148148,0.7510395197916022,1.0,3/14,5.02%,TLK1;MLLT3;IGF2
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.43336834516666467,1.03619473550488,0.41200828157349895,0.832017120153734,1.0,1/23,0.56%,MBOAT2
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.31075063994024665,-1.036121213634097,0.42401960784313725,0.7515626905972846,1.0,21/65,24.71%,FBXL7;FHL1;USP47;CHFR;ZFYVE19;PINX1;PSME2;NABP1;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;CDK5RAP3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.37783394972243034,-1.0360395923889354,0.40357852882703776,0.7510830125795364,1.0,4/22,12.45%,SORBS1;APOE;AKT1;PPARA
prerank,atrial septum morphogenesis (GO:0060413),0.5093568647391276,1.0359165721922519,0.4228187919463087,0.8317000094670648,1.0,2/10,1.22%,HEY2;TBX20
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5065034683495473,1.0356026346878868,0.4279918864097363,0.8314297345172623,1.0,3/11,5.96%,COLEC12;RFTN1;TNIP2
prerank,histone H3-K9 demethylation (GO:0033169),-0.45841493307086606,-1.035574126089781,0.4327485380116959,0.7516103080514578,1.0,2/11,11.47%,KDM7A;KDM3A
prerank,positive regulation of cell-cell adhesion (GO:0022409),-0.3400525872245929,-1.035548223317698,0.43956043956043955,0.7509861131009616,1.0,7/41,7.45%,AFDN;PLPP3;BMP7;PODXL;SMAD7;PIEZO1;CD47
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.38564690690000386,-1.035288902674698,0.42084168336673344,0.7509756347754916,1.0,4/22,5.80%,AEBP1;AKAP13;APOE;MAP1B
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.43856141238112045,1.0350577195072335,0.42549019607843136,0.831708662078775,1.0,8/21,21.29%,MED13;MED1;MITF;BCLAF1;MED4;DHX36;MED30;MED16
prerank,regulation of immune response (GO:0050776),-0.2764310986678377,-1.03502573687857,0.3712574850299401,0.7509059152677728,1.0,20/135,10.17%,COL1A2;COL3A1;COL1A1;FOXP1;CXADR;IL15;CLEC2D;B2M;VCAM1;CD34;APPL2;ADCY7;IRF1;ICAM1;FKBP1A;ERAP1;BIRC3;RNF135;CASP8;SAMHD1
prerank,negative regulation of cellular amide metabolic process (GO:0034249),-0.293489291246966,-1.0349646979791454,0.3699731903485255,0.7503892137098301,1.0,15/84,14.50%,IGF1;DAPK1;SAMD4A;IGFBP5;APOE;CNOT7;RNF139;DDX6;IGF2BP2;CPEB3;CALR;SPHK1;LARP1;CNOT8;FXR2
prerank,postsynaptic membrane organization (GO:0001941),0.4507517002933526,1.0345050075325357,0.4163265306122449,0.8320033090193365,1.0,2/17,3.16%,CEL;NRXN1
prerank,axonal fasciculation (GO:0007413),-0.44059349118223334,-1.034047757925737,0.4199623352165725,0.7519886581236215,1.0,2/12,0.65%,EPHA4;EPHA3
prerank,neural tube development (GO:0021915),-0.42017592153508143,-1.0338143128142927,0.4338235294117647,0.7519100549941207,1.0,4/15,14.82%,ALDH1A2;TGFB1;PTCH1;PKD1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),-0.45770646868458215,-1.0337572805854676,0.44952380952380955,0.7506975427904394,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,calcineurin-mediated signaling (GO:0097720),-0.45770646868458215,-1.0337572805854676,0.44952380952380955,0.7506975427904394,1.0,5/10,20.58%,NFAT5;NFATC1;PPP3CC;PPP3CB;NFATC2
prerank,sterol metabolic process (GO:0016125),-0.31471802066052146,-1.033482930808416,0.4114713216957606,0.7506975547996226,1.0,11/60,12.16%,PRKAG2;ABCA1;APOE;CYP26B1;LBR;LIPA;CYP27A1;CYP1B1;OSBPL1A;INSIG2;STARD3
prerank,negative regulation of organelle assembly (GO:1902116),-0.34886763612248706,-1.0333740321948623,0.41201716738197425,0.7502752271333273,1.0,10/35,16.06%,NUPR1;KAT2B;LRRK2;LIMK2;YAP1;CHMP4B;CHMP4A;PHF23;TCHP;NBDY
prerank,myeloid cell activation involved in immune response (GO:0002275),-0.3996995190770261,-1.033001209645903,0.41353383458646614,0.7504926862909574,1.0,8/18,21.20%,LBP;SBNO2;ENPP3;IFI35;KARS1;PLCG2;SYK;TYROBP
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),0.483912144324378,1.0326628633528947,0.42669584245076586,0.835132991714806,1.0,1/11,0.63%,MEF2C
prerank,T cell homeostasis (GO:0043029),-0.46660808435852374,-1.0326599747557752,0.44090056285178236,0.7506682020864868,1.0,10/10,53.37%,AKT1;PPP2R3C;NCKAP1L;FAS;FADD;JAK3;ZC3H8;FOXP3;RIPK3;PMAIP1
prerank,hemidesmosome assembly (GO:0031581),-0.44708106550843235,-1.0325459942182948,0.44761904761904764,0.7502703346893318,1.0,6/11,17.17%,ITGA6;PLEC;ITGB4;LAMA3;LAMC2;CD151
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.44147968794152326,-1.0314782666112632,0.44165170556552963,0.7521542721513236,1.0,8/12,43.78%,RPL26;TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.42329597557348986,1.0314516265536442,0.42857142857142855,0.8369234477109481,1.0,7/24,9.01%,VTN;IL1B;CADM4;GRB10;TMEM204;ARNT;PRKD2
prerank,negative regulation of complement activation (GO:0045916),-0.4554636704677202,-1.0313067220895038,0.4158790170132325,0.751921528402322,1.0,2/10,2.13%,SERPING1;CD55
prerank,response to amino acid (GO:0043200),0.40003850138555697,1.031176157286476,0.4112903225806452,0.8365550316947542,1.0,2/31,1.65%,SPAAR;CPEB1
prerank,lipoprotein catabolic process (GO:0042159),-0.4536855641700087,-1.031034465150443,0.4365942028985507,0.7519386110090501,1.0,8/11,28.99%,APOE;LYPLA1;NOTUM;ABHD17C;LYPLAL1;LYPLA2;CTSD;ABHD17A
prerank,retinoic acid receptor signaling pathway (GO:0048384),-0.472232645815716,-1.0309429027072676,0.42696629213483145,0.751493618042286,1.0,3/10,8.00%,RARB;RARG;TBX1
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.43904492858194616,1.0309270030067956,0.44016227180527384,0.8361589595766249,1.0,7/23,14.91%,NOTCH1;ERBB4;CRLF3;IL4;PRLR;OCIAD1;JAK2
prerank,regulation of MAP kinase activity (GO:0043405),0.34134994820378023,1.0308702006934745,0.40494590417310666,0.835357187855618,1.0,12/92,6.00%,PDGFRB;IL34;SPRY4;NF1;IL1B;SH2B3;PDCD10;FGF2;SPRY2;TRIB2;CD300A;UCHL1
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.473988299343964,1.0308567016739996,0.4258474576271186,0.834433364109682,1.0,3/13,10.48%,RCL1;TBL3;NOP14
prerank,positive regulation of cell adhesion (GO:0045785),-0.30209660556951046,-1.0300900314271235,0.3871794871794872,0.7528405051654652,1.0,19/74,13.68%,AFDN;EPHA4;VIT;TGM2;PTPRJ;FOXC2;ADAM9;SMAD7;CXCL12;NDNF;P4HB;CD47;STX3;FBLN2;FLCN;ATM;CHRD;MEGF10;RET
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.3890772922999533,-1.0298219750327282,0.4228456913827655,0.7521686178565402,1.0,6/23,15.05%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.3890772922999533,-1.0298219750327282,0.4228456913827655,0.7521686178565402,1.0,6/23,15.05%,DAB2;THBS1;SDCBP;FLCN;HSP90AB1;HIPK2
prerank,cholesterol transport (GO:0030301),0.3826783068590859,1.0297615631733916,0.41155234657039713,0.8359517869998284,1.0,7/45,6.95%,CEL;SCARB1;LDLRAP1;LDLR;MSR1;ABCA5;LIPC
prerank,cellular response to insulin stimulus (GO:0032869),-0.2756065091426957,-1.0293408886977444,0.35674157303370785,0.7526839837649633,1.0,31/124,14.31%,SORBS1;RHOQ;FOXO1;ENPP1;IGF1R;BAIAP2;KAT2B;FOXC2;AP3S1;ATP6V0A4;HDAC9;IGF2;SLC39A14;SYAP1;CPEB2;NAMPT;ATP6V1G1;AKT1;C2CD5;GRB14;IDE;ATP6V0B;INSIG2;RAB8A;ATP6V0A1;TCIRG1;USF1;LPIN3;FER;HDAC5;CAV2
prerank,negative regulation of JNK cascade (GO:0046329),-0.3540014381146842,-1.029272603901637,0.4335511982570806,0.7521840779874607,1.0,11/31,27.71%,MECOM;PDCD4;SH3RF2;MAPK8IP1;DUSP10;SIRPA;ZMYND11;HIPK3;PRKN;AIDA;DACT1
prerank,melanosome transport (GO:0032402),-0.39529003528770273,-1.0290587793668555,0.418426103646833,0.7513283071015888,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,pigment granule transport (GO:0051904),-0.39529003528770273,-1.0290587793668555,0.418426103646833,0.7513283071015888,1.0,6/18,20.78%,RAB11A;RAB27A;BBS7;BLOC1S6;MLPH;BBS5
prerank,endothelial cell development (GO:0001885),0.4144833595019104,1.0286829956066994,0.4137254901960784,0.8373766095727422,1.0,2/25,1.01%,PDE4D;RAPGEF2
prerank,regulation of protein binding (GO:0043393),-0.2789609664744107,-1.028613800020931,0.3976945244956772,0.7517854882203019,1.0,34/114,18.15%,DAB2;HDAC4;APP;CAV1;CLDN5;BMP4;B2M;TCF7L2;LRRK2;TAF1;FKBP1A;AMFR;PRKCD;IFIT2;TIAM1;AKT1;DTX3L;IFIT1;IDE;RPL11;DNAJB2;ADD1;RAN;HDAC5;ACTB;PKD1;HIPK2;ZFPM1;TMBIM6;HFE;MITD1;STYX;EFHB;PARK7
prerank,cellular response to glucocorticoid stimulus (GO:0071385),-0.40458812109175224,-1.0284490520193754,0.43415637860082307,0.751500325236878,1.0,5/18,21.55%,NR3C1;ANXA1;BCL2L11;ZFP36L2;FAM107A
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),-0.46877095894108844,-1.0282218781447174,0.45794392523364486,0.7514316321614414,1.0,2/10,15.89%,LGALS9;CEACAM1
prerank,fibrinolysis (GO:0042730),-0.4317487867267266,-1.0280552968804906,0.42135922330097086,0.7511323104925076,1.0,9/13,52.37%,SERPINE1;PLAUR;HRG;PLAT;PLG;SERPINB2;CPB2;GP1BA;F2
prerank,phospholipid metabolic process (GO:0006644),-0.29770900343833345,-1.0280520384806104,0.43291139240506327,0.7504752293250956,1.0,28/71,34.98%,PLA2G4A;PLPP3;AGPAT4;SMPD3;GPX4;PIP4K2B;TNFAIP8L3;PLPP1;PLA2G15;PGP;PLCD1;CLN8;AGPAT2;ENPP2;LPL;PLPPR4;PLPP2;PLBD2;PLA2G4F;MBOAT1;SMPD1;AGPAT1;ANGPTL3;LGALS13;FITM2;FADS1;ABHD12;PLA2G5
prerank,dephosphorylation (GO:0016311),0.318556726834264,1.027763285908543,0.4098360655737705,0.8385543406960023,1.0,11/147,4.73%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;PTPN22;SSH2;PLPPR5;PPP3CA;PPP2R2A;PTPN4
prerank,regulation of neuron apoptotic process (GO:0043523),0.33215125104467125,1.0276605644997536,0.419773095623987,0.8378291880930946,1.0,19/96,14.08%,SLC30A10;MEF2C;NF1;AGAP2;UNC5B;TFAP2B;NTRK2;LIG4;AKT1S1;PPT1;NFATC4;GRM4;TRIM2;CPEB4;SET;KDM2B;RASA1;MAG;SIX4
prerank,protein homotetramerization (GO:0051289),-0.32213283052649866,-1.0273932584054921,0.40786240786240785,0.751361899012726,1.0,10/49,11.55%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.41847262704596616,1.026440626928687,0.43227091633466136,0.8395721634944245,1.0,2/25,1.37%,HEY2;PER2
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),-0.2891928832752233,-1.026429567926349,0.37110481586402266,0.7531137311481101,1.0,14/87,14.53%,FLRT2;RBFOX2;FGFR2;FGF1;NDNF;KL;TBX1;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;SFRP1;MAPK3
prerank,sister chromatid segregation (GO:0000819),-0.350465079175848,-1.0261476646371914,0.43286573146292584,0.7531195562243063,1.0,21/31,37.97%,INO80;TOP2B;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;TOP2A;SPAG5;KIF18B;KIFC1;NSL1;NDC80;CDCA8;SGO1;KIF18A;PLK1;KLHL22;ESPL1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.48408745669221226,1.0260260763503493,0.4364406779661017,0.8395312461728472,1.0,2/10,1.54%,NOTCH1;RGCC
prerank,negative regulation of DNA replication (GO:0008156),0.46306571127865714,1.025688312942772,0.40350877192982454,0.8392970113886058,1.0,5/13,17.26%,ATR;WAPL;CDAN1;RAD17;TERF1
prerank,regulation of axon extension involved in axon guidance (GO:0048841),-0.3765361309072709,-1.0249349643685348,0.44536082474226807,0.7554753355581071,1.0,6/24,7.65%,NRP1;SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E
prerank,phosphatidylcholine metabolic process (GO:0046470),0.35696633158983343,1.0246348392634557,0.413290113452188,0.8407144919560025,1.0,11/70,13.43%,MBOAT2;NR1H3;SLC44A2;LIPC;ABHD3;PLAAT1;ACHE;STARD7;PLA2G4E;CHKB;ABHD4
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.3154603441174377,-1.0243936757668848,0.4341801385681293,0.7561676179860267,1.0,9/52,14.50%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;MBNL2;NOVA1;FXR2
prerank,negative regulation of myotube differentiation (GO:0010832),-0.44836352926917067,-1.0241831800342063,0.4496268656716418,0.7560297517506516,1.0,6/12,13.66%,HDAC4;CCN3;BHLHE41;HDAC1;TMEM119;HDAC5
prerank,response to estrogen (GO:0043627),-0.3587568953940102,-1.0238719345039,0.4308390022675737,0.7561797631646898,1.0,13/31,30.35%,CAV1;ESR1;TRIM24;AR;SFR1;SFRP1;NCOA4;RARA;BRCA1;KRT19;SRA1;SERPINB9;RBBP5
prerank,membrane repolarization (GO:0086009),0.4523314791272897,1.0237814890411734,0.4350515463917526,0.8416373039950403,1.0,4/15,7.70%,ATP1A2;KCNE4;ATP1B2;KCNE5
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.40406469854939714,-1.0236826210619847,0.45318352059925093,0.7559747451101952,1.0,8/19,21.82%,ZMIZ1;GAS6;MMP14;RHOH;PPP2R3C;SYK;MDK;XBP1
prerank,positive regulation of dendrite development (GO:1900006),0.4866452093540241,1.0224254071573178,0.44,0.8437186108744856,1.0,2/10,2.51%,BMP5;PTN
prerank,DNA strand elongation involved in DNA replication (GO:0006271),0.44029973870765443,1.021474403747724,0.4189189189189189,0.8449949971661258,1.0,4/18,10.98%,GINS1;GINS3;GINS4;MCM7
prerank,negative regulation of signal transduction (GO:0009968),0.29902928013727015,1.0214223896555883,0.40939597315436244,0.8441639498467864,1.0,26/249,6.75%,NOTCH3;PTEN;PID1;BMP5;SPRY4;BTRC;TNS2;IL1B;CHAC1;TSPAN15;PIP4K2A;CADM4;FGF2;SOSTDC1;SPRY2;SLC27A4;MOSMO;SIAH2;GRB10;SOCS5;GPC3;PIP4K2C;SNCA;CACTIN;APPL1;KCTD6
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),0.45597863904268954,1.0212731417268324,0.4068522483940043,0.8435478854640832,1.0,1/15,0.21%,CSPG4
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4672890160503314,1.0212578254259805,0.44234800838574423,0.8426373566798568,1.0,2/12,5.19%,RMDN1;CHAMP1
prerank,regulation of interleukin-8 production (GO:0032677),-0.303500961172984,-1.0211721356261911,0.43243243243243246,0.7613858416815381,1.0,19/69,18.53%,F3;ANXA4;LBP;KLF4;NOD1;ANXA1;ARRB1;LGALS9;STAT3;MAP2K5;TMSB4X;MAVS;RELA;SSC5D;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5
prerank,cytoplasmic translational initiation (GO:0002183),-0.39868179922763225,-1.0210683950728419,0.43610547667342797,0.7609737955018198,1.0,10/17,37.98%,EIF4A1;EIF2S2;DENR;EIF4A2;EIF2D;EIF3D;DHX29;RBM4;EIF4B;EIF3I
prerank,beta-catenin destruction complex disassembly (GO:1904886),-0.38138433631094903,-1.0210030887486232,0.45109780439121755,0.7604784689365113,1.0,3/21,4.13%,CAV1;LRP6;FZD2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),-0.43537045561244614,-1.020694517643849,0.4450651769087523,0.760553782074033,1.0,5/13,14.54%,APP;SHANK3;ADCY1;EPHB2;SHISA7
prerank,negative regulation of type I interferon production (GO:0032480),-0.333132092077919,-1.0205961299776605,0.4131455399061033,0.7601188949317801,1.0,16/40,28.94%,IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;PPM1B;SIRPA;UBA7;NPLOC4;UBE2L6;RNF216;REL;PTPRS;TAX1BP1;ISG15
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.4949971207586741,1.0204889114801627,0.43231441048034935,0.8433871157587384,1.0,3/10,9.11%,RAPGEF2;AXL;LYN
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),-0.3559956582822098,-1.020423485728415,0.4449152542372881,0.7599065614646227,1.0,8/29,19.70%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,response to organic cyclic compound (GO:0014070),0.37690470544205124,1.0196868482570849,0.41519434628975266,0.8442877800364397,1.0,4/52,4.36%,GGT5;GGT1;IL1B;DHFR
prerank,regulation of protein kinase activity (GO:0045859),0.33461202245023175,1.0196344687669823,0.4416403785488959,0.8434691203453126,1.0,16/106,9.48%,PLCE1;RAPGEF2;PTK2;PPM1E;NF1;SPRED1;AGAP2;SPDYA;TRIB2;DBNDD2;SNCA;RAP1A;AKT1S1;CDKN1A;ANKRD54;TARBP2
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.4381369996560762,1.0196186501785627,0.41767068273092367,0.8425637254873851,1.0,3/19,2.15%,LIMS1;FERMT2;ROCK1
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.3711969793417481,-1.0195634675429872,0.43983402489626555,0.7614377931584978,1.0,4/26,3.49%,ERRFI1;TGFA;APP;SNX6
prerank,cellular glucose homeostasis (GO:0001678),-0.32811940745692797,-1.0195118370864757,0.4276595744680851,0.7608970053124688,1.0,10/41,11.52%,UNC13B;FOXO1;IGF1R;SLC39A14;GAS6;HK2;HIF1A;KCNB1;FOXK1;ERN1
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.31943351208844994,-1.0193601734303805,0.43427230046948356,0.7606088473752456,1.0,14/51,14.56%,BMP7;GAS7;NRK;SRGAP2;LRRK2;NBL1;ALS2;TRIO;DTNBP1;TAOK2;DAB2IP;DCLK1;UBB;ANKRD27
prerank,monocarboxylic acid catabolic process (GO:0072329),0.4328894898687295,1.0192806108134165,0.4305019305019305,0.8423888790446009,1.0,2/21,4.22%,CEL;PPARD
prerank,fatty acid oxidation (GO:0019395),-0.30946902060542725,-1.0192641908889664,0.4473684210526316,0.7601591225443538,1.0,17/57,20.99%,ADIPOR2;CPT2;SLC25A17;ACOX1;ECI2;ACADL;ALDH3A2;AUH;BDH2;ACAD10;ECHDC2;ACADS;ALOX12;ILVBL;PPARGC1A;ADIPOR1;DECR1
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.42849211363652984,-1.0191066900655015,0.4280442804428044,0.7598721174129572,1.0,2/13,3.49%,ERRFI1;SNX6
prerank,negative regulation of protein depolymerization (GO:1901880),0.4196459961192267,1.018885297827521,0.4453125,0.8423494425275737,1.0,8/24,13.12%,SPEF1;PIK3CA;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.46614861623530335,1.0188008033260556,0.4426229508196721,0.8416198655561525,1.0,5/13,11.20%,UBA2;DESI1;DESI2;UBA1;UBA6
prerank,regulation of neuronal synaptic plasticity (GO:0048168),-0.34953485157934855,-1.0186562196433109,0.43621399176954734,0.7603043497945521,1.0,8/29,16.20%,APOE;APP;SLC4A10;RAB3GAP1;CAMK2A;EPHB2;SHISA7;MCTP1
prerank,cell differentiation in hindbrain (GO:0021533),0.48346678547098976,1.0184430035216834,0.45278969957081544,0.8414525888987296,1.0,2/11,4.05%,ATP7A;CEND1
prerank,DNA integrity checkpoint signaling (GO:0031570),0.38760891585595936,1.0179413636605068,0.4256120527306968,0.8415864941852657,1.0,7/36,14.26%,MAP3K20;RAD1;TIMELESS;ATR;SETMAR;RAD17;ATRIP
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.3090623652298337,-1.0171934095924187,0.4066193853427896,0.7632810325369245,1.0,11/54,11.30%,NXN;HDAC8;CAV1;SMAD7;ARRB1;SH3RF2;AKT1;PINX1;IVNS1ABP;PRKCG;RPL11
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.45105976000723497,1.0170170293613399,0.4562899786780384,0.842637356679857,1.0,4/16,13.00%,NCBP2;CACTIN;PRPF39;DDX23
prerank,negative regulation of neuron death (GO:1901215),0.33249158867224243,1.0166752835583377,0.4025764895330113,0.842452726278031,1.0,19/93,14.08%,SLC30A10;MEF2C;AGAP2;UNC5B;INPP5A;NTRK2;SNCA;LIG4;PPT1;NFATC4;HTRA2;CPEB4;BTBD10;SET;KDM2B;RASA1;TRAF2;MAG;SIX4
prerank,regulation of GTPase activity (GO:0043087),0.31288487263856396,1.0164522137039644,0.42105263157894735,0.8420051769763106,1.0,22/177,7.64%,CHN1;RGS6;LIMS1;PRKG1;DOCK10;RAPGEF2;PTK2;RASGRP2;FERMT2;NF1;PLXNB1;SH3BP1;AGRN;TBC1D30;MAPRE2;ITGB1;NTRK2;ARFGEF1;RIC1;RAP1A;HRAS;RGS7
prerank,sphingoid biosynthetic process (GO:0046520),-0.4478367354933638,-1.0162699776502715,0.4614003590664273,0.7642380012826891,1.0,4/11,14.17%,ACER2;ACER3;SPHK1;SPTLC2
prerank,sphingosine biosynthetic process (GO:0046512),-0.4478367354933638,-1.0162699776502715,0.4614003590664273,0.7642380012826891,1.0,4/11,14.17%,ACER2;ACER3;SPHK1;SPTLC2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",-0.3670134707903615,-1.0162168431839786,0.45790554414784396,0.7636868209185875,1.0,5/24,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,axonal transport (GO:0098930),-0.33909629399351365,-1.0157990577980713,0.44206008583690987,0.7640035213753297,1.0,12/36,23.08%,AP3S1;KIF1B;DTNBP1;AP3B1;HIF1A;RAB21;SPAST;FBXW11;BLOC1S6;DYNC1H1;AP3D1;PAFAH1B1
prerank,positive regulation of protein polymerization (GO:0032273),0.35907812884813023,1.0147029798759317,0.42487046632124353,0.8449593637620963,1.0,11/65,11.50%,CARMIL1;NCK2;VASP;CDC42EP1;NAV3;TTBK1;TPPP;BIN1;NCKAP1;LMOD1;PAK1
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),-0.32894640467972724,-1.0146427725726046,0.43364928909952605,0.766261708690039,1.0,18/40,28.31%,IGF1;TNFSF10;AKT1;BCL2L11;BNIP3;PLSCR3;BID;GPX1;PRELID1;PDCD5;BBC3;PLAUR;PSMD10;BCL2L1;PRKN;TP53;BIK;CLU
prerank,regulation of actin filament polymerization (GO:0030833),0.3514014480551302,1.0134780564032932,0.4178321678321678,0.8467527367616005,1.0,12/69,10.90%,CARMIL1;PLEKHG2;NCK2;VASP;SSH2;CDC42EP1;ESAM;ARFGEF1;BIN1;NCKAP1;LMOD1;PAK3
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.2818621465280267,1.0133950028901688,0.43028846153846156,0.8460011431460598,1.0,25/417,3.39%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.43456592009246875,1.0132715090960716,0.41458333333333336,0.8453297523254533,1.0,6/17,13.98%,PDCD10;CARD9;TAOK3;LYN;SCIMP;STK25
prerank,establishment of protein localization to organelle (GO:0072594),-0.29477502133720357,-1.01319147867174,0.435,0.7692605251258375,1.0,35/72,37.22%,LAMP2;RAB11A;APPL2;STAT3;HK2;AKT1;IPO7;FAM53C;IPO13;RAN;NXT2;IPO8;TPR;LAMP5;NUP88;SYK;NUP214;ZDHHC15;NXT1;NUP155;RANBP17;EIF4ENIF1;HK1;CSE1L;NUP62;PTTG1IP;TNPO2;HEATR3;RALA;IPO4;PINK1;PHB2;FAM53B;SPRN;NUP153
prerank,lytic vacuole organization (GO:0080171),-0.3410673250104545,-1.0123720311842308,0.45085470085470086,0.7706854732021705,1.0,12/32,27.24%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;ACP3;MYO7A
prerank,hydrogen peroxide metabolic process (GO:0042743),-0.3898881863992014,-1.0123173325564374,0.46548323471400394,0.770150540063834,1.0,7/19,19.85%,MAOB;ACOX1;PRDX2;CYBA;GPX1;PARK7;NOX1
prerank,RNA interference (GO:0016246),0.4455301813333387,1.0119551137707967,0.46405228758169936,0.8473875297885847,1.0,5/17,13.07%,CLP1;AGO3;TARBP2;TSN;CELF1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.46681989481697733,-1.0117944112719202,0.46139705882352944,0.7708354483896784,1.0,4/10,31.90%,ALDH7A1;HNMT;SMOX;DMGDH
prerank,regulation of protein kinase A signaling (GO:0010738),0.4337591626631327,1.0116207442616636,0.42424242424242425,0.8471873550339231,1.0,7/20,10.18%,PRKAR1B;AKAP6;PRKAR2B;PRKAR2A;AKAP12;AKAP7;PRKAR1A
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.31742193431514987,-1.0111644548611367,0.44711538461538464,0.7717823561544755,1.0,17/55,24.71%,FBXL7;FHL1;USP47;PINX1;PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;PSMC5;PSMD10
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),-0.2949916691320509,-1.0110731117077978,0.4267352185089974,0.7713448968367,1.0,11/72,14.53%,FLRT2;RBFOX2;FGFR2;FGF1;KL;POLR2A;FRS2;FGFBP1;FGFR4;POLR2F;MAPK3
prerank,regulation of protein modification process (GO:0031399),-0.3158631793680219,-1.010956928207418,0.43509615384615385,0.7709343719697643,1.0,15/50,14.87%,FN1;CDH5;KAT2B;IGF2;STAT2;FNIP1;PPP1R16B;FLCN;PML;CCDC88C;FER;ATG10;NDUFS4;CORO1C;CDK9
prerank,positive regulation of organelle assembly (GO:1902117),-0.32154217214931685,-1.0107526202316828,0.4406392694063927,0.7707735017385421,1.0,17/44,22.51%,ASAP1;SDCBP;PDCD6IP;SDC4;RAB3GAP1;PIP4K2B;SH3GLB1;SDC1;G3BP1;RAB3GAP2;TAPT1;DYNC1H1;STX18;NUMA1;PLK4;LCP1;CCP110
prerank,positive regulation of monooxygenase activity (GO:0032770),-0.36442834874896035,-1.0105131645923737,0.4134419551934827,0.7707019487972981,1.0,8/26,11.83%,POR;APOE;NPR3;PIK3CB;NOS1AP;AKT1;HIF1A;GCH1
prerank,positive regulation of programmed cell death (GO:0043068),-0.2433190101960359,-1.01033454465413,0.41013824884792627,0.7704748360237861,1.0,64/272,17.87%,DAPK1;UNC13B;PAWR;AKAP13;TIAM2;FOXO1;FOXO3;ARHGEF3;SLIT2;ITGA6;TGM2;VAV2;STK17B;BMP4;RASSF2;MCF2L;LRRK2;ARHGEF2;HOXA5;IGFBP3;QRICH1;TNFSF10;IAPP;RARG;SFRP4;ANO6;CYP1B1;PTPA;RHOB;TRIO;IFIT2;ADAMTSL4;ARHGEF1;AIFM1;TIAM1;UTP11;BCL2L11;FLCN;ATF6;CASP8;DAB2IP;FGD4;BNIP3L;PLEKHG5;ATM;TRIM35;UBB;PPID;ARHGEF18;ARHGEF19;BNIP3;SFRP1;IP6K2;RASGRF2;RPS6;ARL6IP5;NET1;BID;GNA13;RIPK1;STPG1;PSEN2;CSRNP3;PDCD5
prerank,negative regulation of ion transport (GO:0043271),0.41496846613058735,1.0101578376102023,0.4577319587628866,0.8495322032721551,1.0,4/24,7.08%,CASQ2;HTR1B;SNCA;STC1
prerank,cellular response to gamma radiation (GO:0071480),0.45038145933931734,1.0096508081368754,0.4364406779661017,0.8497524526643521,1.0,3/17,10.12%,MAP3K20;HRAS;ATR
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3503034428932743,1.0092929176876737,0.42857142857142855,0.8496343349809389,1.0,12/76,9.72%,PTEN;CBFA2T3;PTK2;PABIR1;RBX1;SOCS5;TRIB2;RCHY1;ZER1;DET1;CSNK1E;NKD2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.3780142896317727,1.0091706458593541,0.4384057971014493,0.8489702034727609,1.0,5/43,5.98%,ITGA1;SH3KBP1;SPRY2;SOCS5;EPN1
prerank,negative regulation of cell growth (GO:0030308),-0.27255142611272404,-1.009135742210962,0.43352601156069365,0.7727040518677845,1.0,28/121,14.32%,SMAD3;SMARCA2;VGLL4;FHL1;ENPP1;SLIT2;BMPR2;PTPRJ;GJA1;RBBP7;CCN3;NPR1;ACVRL1;NDRG3;OSGIN2;DIP2B;ADAM15;FLCN;ULK2;PML;DNAJB2;TGFB1;PRDM11;TCHP;SOX17;SFRP1;ENO1;IP6K2
prerank,positive regulation of cell death (GO:0010942),-0.30351986671454867,-1.009044977906051,0.45365853658536587,0.7722584088747102,1.0,9/59,8.23%,EFNB2;SLC6A13;SLC6A6;BMP4;LRRK2;ACER2;RARG;WNT5A;PRODH
prerank,muscle cell migration (GO:0014812),-0.45579831915528557,-1.008529974514237,0.48282442748091603,0.772876388518742,1.0,5/10,13.37%,CCN3;SIX1;DDR1;ITGB3;MEGF10
prerank,positive regulation of smooth muscle cell migration (GO:0014911),0.43114312705876023,1.008508801712643,0.4148471615720524,0.8494534392626613,1.0,2/17,1.04%,PDGFRB;VTN
prerank,Golgi to plasma membrane protein transport (GO:0043001),-0.35372509070482905,-1.0082929379479015,0.44956140350877194,0.7728177871603772,1.0,6/30,10.98%,VAMP5;MACF1;KIF13A;GGA2;GOLPH3;OPTN
prerank,negative regulation of gene silencing by miRNA (GO:0060965),-0.43332446753362475,-1.0076549308109148,0.4794007490636704,0.773783724532037,1.0,4/12,16.27%,ESR1;ZC3H12A;TGFB1;ELAVL1
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.45442057698991883,1.0075807687082385,0.44166666666666665,0.8505303474518315,1.0,4/15,9.01%,NOTCH1;SEMA5A;FGF2;PRKD2
prerank,cellular response to starvation (GO:0009267),-0.26576550676003263,-1.0074299762302898,0.43788819875776397,0.7736984700602324,1.0,49/147,26.47%,PRKAG2;LAMP2;FOXO1;FOXO3;BMPR2;LRRK2;DAP;WIPI2;FNIP1;ITFG2;HSPA5;CLEC16A;KLF10;ATP6V1G1;BECN1;DAPL1;FLCN;ATP6V0B;ZC3H12A;SH3GLB1;TCIRG1;PRKAG3;PPARA;MFSD2A;SFRP1;MAPK3;SREBF1;PRKAA2;MTMR3;GABARAPL1;RRP8;RRAGB;CEBPB;LAMTOR5;ZFYVE1;KPTN;PRKAG1;XBP1;EIF2AK3;ATP6V1F;STK26;RIPOR1;ATG7;RRAGC;TP53;ATF2;FAS;EIF2AK4;PICK1
prerank,negative regulation of cation channel activity (GO:2001258),0.4118968531129166,1.0073521250621829,0.4311740890688259,0.8501425696358846,1.0,1/26,0.50%,CASQ2
prerank,GPI anchor metabolic process (GO:0006505),0.40008591310365754,1.0073357111092271,0.4453125,0.849253498639583,1.0,6/26,16.62%,PIGU;PIGO;PIGZ;DPM3;PIGH;PGAP1
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.3949444654741502,-1.0072746694157302,0.464354527938343,0.7733942168599358,1.0,2/19,2.01%,CAMK1D;MCU
prerank,defense response to Gram-positive bacterium (GO:0050830),-0.32532006361936455,-1.007033030985979,0.4407894736842105,0.7733516979692635,1.0,10/40,16.47%,LBP;GBP4;PGLYRP1;GSDMD;GBP6;RPL39;GBP7;GBP2;HMGB2;MR1
prerank,pentose-phosphate shunt (GO:0006098),-0.45185538818382076,-1.006555217029987,0.4689265536723164,0.7738379445368327,1.0,6/11,23.00%,TALDO1;DERA;PGD;RPIA;PGLS;SHPK
prerank,growth hormone receptor signaling pathway (GO:0060396),0.45694159452066685,1.0063852588654494,0.4378947368421053,0.850451304562356,1.0,6/14,14.91%,PTK2;PIK3R1;LYN;PRLR;PTPN1;JAK2
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),-0.35654015768116576,-1.0059193339931654,0.45691382765531063,0.7747557280322077,1.0,11/27,25.91%,RNASE4;NYNRIN;ZC3H12A;ERN1;XRN1;TOE1;DICER1;NUDT16;ZC3H12B;POP1;NHP2
prerank,ncRNA 3'-end processing (GO:0043628),0.44914147383199055,1.005812088374944,0.4192825112107623,0.8507733166936209,1.0,3/14,14.00%,INTS6L;SSB;INTS12
prerank,protein localization to vacuole (GO:0072665),-0.4213157190850409,-1.0057828961296729,0.4503968253968254,0.7744113810026292,1.0,5/13,19.80%,SH3GLB1;LAMTOR5;SH3BP4;CD81;KPTN
prerank,cellular response to lipid (GO:0071396),0.30037569838236505,1.005689509509421,0.44460028050490885,0.8501246009567501,1.0,27/191,9.44%,MEF2C;PID1;RORB;ATP1A2;RORA;GPER1;NR1H3;IL1B;FFAR2;ADCY8;ADCY3;AXL;NCOA3;ADCY6;BRINP1;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN;FAM210B;IRS1;BRINP3;HTRA2;LYN;MED1;MAP4K1
prerank,response to muramyl dipeptide (GO:0032495),-0.431270362284064,-1.0054541086932347,0.4600389863547758,0.7746064434755527,1.0,3/12,4.01%,VIM;NOD1;ARHGEF2
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.426949596377588,-1.0053306594970424,0.47338403041825095,0.7742542065594253,1.0,5/12,27.39%,SMO;SIX1;AGT;VEGFA;GDNF
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),-0.29155969673725146,-1.0051246487335,0.4348894348894349,0.7741318714627495,1.0,15/71,14.35%,ADAMTS12;CTSH;CAPN2;CTSC;PDCD6IP;CHFR;CTSB;CASP8;IDE;CHMP4B;CTSS;MDM2;UBB;NEDD8;DDB1
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),-0.34654022219006475,-1.0049143178023987,0.4605543710021322,0.773969651829182,1.0,8/30,19.70%,IKBKE;BIRC3;CASP8;UBB;TICAM1;TLR4;RIPK1;IKBKG
prerank,protein targeting to lysosome (GO:0006622),-0.3795546557071867,-1.004811848561607,0.45660377358490567,0.7735644927009214,1.0,9/20,30.52%,LAMP2;HGS;AP4M1;RAB7A;ZFYVE16;NCOA4;CLU;LAPTM5;NEDD4
prerank,modulation by host of viral genome replication (GO:0044827),-0.4225205113614042,-1.0036980483715345,0.4648148148148148,0.7756263260387282,1.0,7/13,26.14%,IFI27;ZC3H12A;VAPA;FBXL2;TBC1D20;PRKN;EIF2AK4
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.41375174844143037,-1.00340443167494,0.4499054820415879,0.7756879596690963,1.0,3/14,5.48%,SULF1;THBS1;SULF2
prerank,sympathetic nervous system development (GO:0048485),-0.420323990264311,-1.002722891971772,0.4725490196078431,0.7767474603271132,1.0,2/15,1.02%,NRP2;NRP1
prerank,steroid catabolic process (GO:0006706),-0.4520461963344213,-1.0026340956295297,0.4697855750487329,0.7763261092908086,1.0,10/10,54.83%,SPP1;YWHAH;HSD17B14;HSD17B11;HSD11B1;CYP27B1;CYP24A1;FGF23;CYP19A1;HSD17B6
prerank,regulation of translational initiation (GO:0006446),0.35388307903476374,1.0025368438425626,0.43657331136738053,0.8561721618030464,1.0,10/63,6.30%,NCK2;EIF4EBP2;EIF4EBP3;DAZL;RPS6KB2;MTIF2;BOLL;YTHDF3;NCBP2;DDX3X
prerank,transferrin transport (GO:0033572),-0.34005191381319566,-1.0022556419258204,0.4444444444444444,0.7765873871036859,1.0,16/33,29.53%,STEAP3;ATP6V0A4;TFRC;ATP6V1G1;ATP6V0B;ATP6V0A1;TCIRG1;ATP6V0A2;HFE;REP15;MCOLN1;ATP6V1F;ATP6AP1;ATP6V0D1;ATP6V0C;ATP6V1D
prerank,negative regulation of response to stimulus (GO:0048585),0.3582358186975933,1.0020994569236807,0.4463373083475298,0.8561961855334501,1.0,6/60,5.24%,SLC30A10;CDK6;NR1H3;AKT3;SH2B3;SOCS5
prerank,multivesicular body organization (GO:0036257),-0.35488930782018807,-1.0019676839136207,0.4915254237288136,0.7766622305001357,1.0,6/31,10.72%,RAB11A;PDCD6IP;RAB27A;HGS;CHMP4B;CHMP4A
prerank,regulation of intracellular transport (GO:0032386),-0.32755716830117937,-1.0017959719801204,0.4897959183673469,0.7764259602403607,1.0,14/38,22.24%,GAS1;LRRK2;RNF139;NDEL1;RINT1;ATP9A;TTC21B;REEP5;DYNC1H1;DYNLT2B;DNAJC30;NUP214;NUMA1;LCP1
prerank,protein kinase B signaling (GO:0043491),0.42617139785643454,1.0016824463232838,0.45691382765531063,0.8562288420879328,1.0,2/23,2.62%,PTEN;IL1B
prerank,negative regulation of protein kinase activity (GO:0006469),-0.28711531856185213,-1.0012195162904758,0.4322250639386189,0.7772274139057945,1.0,37/88,29.20%,PRKAG2;PTPRB;CAV1;DEPTOR;LRP6;SLC8A3;DTNBP1;AKT1;DAB2IP;TRIM27;CEP85;QARS1;PPIA;CORO1C;GSKIP;DUSP10;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;CDK5RAP3;UBASH3B;CDKN1C;INPP5K;SH3BP5;PYDC1;GNAQ;PAK2;SFN;TRIB3;ABL1;PPM1F;PTPRQ;ADARB1;DUSP26
prerank,regulation of cellular pH (GO:0030641),-0.35122226948126956,-1.0010608103374947,0.4685466377440347,0.7769674021125618,1.0,9/29,19.04%,SLC9A2;SLC4A10;LACC1;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4311313090798871,1.0009864451548416,0.4572025052192067,0.8568012245040181,1.0,7/18,12.33%,SLC1A4;GRIK1;GRID1;GRIA2;CDH8;GRIK5;GRIK2
prerank,protein polyglutamylation (GO:0018095),0.46594435066835177,1.0002673149216192,0.4519650655021834,0.8574648115551001,1.0,6/11,20.78%,TTLL11;CEP41;TPGS1;CFAP20;TTLL5;TTLL7
prerank,positive regulation of JNK cascade (GO:0046330),-0.29598576025163376,-1.0000103869558177,0.47570332480818417,0.7788517909878377,1.0,18/70,15.05%,PLCB1;CCN2;SH3RF1;APP;RASSF2;SDCBP;PTK2B;SH3RF3;MFHAS1;SH3RF2;TAOK2;TNFRSF19;FZD7;DAB2IP;FLT4;WNT16;MAPK8IP1;HIPK2
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.41674242533966255,0.9997159138379907,0.4684317718940937,0.8567978595780803,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.41674242533966255,0.9997159138379907,0.4684317718940937,0.8567978595780803,1.0,5/22,13.17%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC21;ZDHHC23
prerank,protein processing (GO:0016485),0.32187634575998764,0.9993509644289743,0.4659270998415214,0.8567039635471515,1.0,6/102,3.07%,TMPRSS4;GGT1;CPM;METAP2;ADAM19;ECE1
prerank,cellular response to reactive oxygen species (GO:0034614),0.3630185002181486,0.9990603755767887,0.44093178036605657,0.8564616615908088,1.0,3/59,3.21%,PTPRK;MAP3K5;NCF1
prerank,regulation of stress-activated MAPK cascade (GO:0032872),-0.31920561796311864,-0.998804402546564,0.4642857142857143,0.781142150317825,1.0,12/47,16.03%,TGFBR3;EGFR;FOXO1;IGF1R;LGALS9;TAOK2;DAB2IP;MAPK8IP1;QARS1;PPIA;MAPK3;ARL6IP5
prerank,establishment of apical/basal cell polarity (GO:0035089),-0.4125303367434105,-0.9987079493705842,0.5066666666666667,0.7807048291671882,1.0,5/14,14.73%,EZR;RHOA;MYO9A;PATJ;OPHN1
prerank,positive regulation of cellular respiration (GO:1901857),-0.44003550291989524,-0.9986121336502065,0.4682080924855491,0.7802654154873289,1.0,8/11,34.23%,NUPR1;IL10RB;PRELID1;PARK7;VCP;IFNAR1;IFNLR1;PINK1
prerank,synaptic vesicle transport along microtubule (GO:0099517),-0.4074942047902539,-0.9985536943013485,0.4717741935483871,0.7790940409595325,1.0,5/15,21.46%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,anterograde synaptic vesicle transport (GO:0048490),-0.4074942047902539,-0.9985536943013485,0.4717741935483871,0.7790940409595325,1.0,5/15,21.46%,AP3S1;DTNBP1;AP3B1;BLOC1S6;AP3D1
prerank,natural killer cell mediated immunity (GO:0002228),-0.40315944102980217,-0.9983809735500986,0.4844961240310077,0.7788848015218647,1.0,10/15,48.70%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST;PLEKHM2;KIF5B;SLAMF7;KLRD1;KLRK1
prerank,hexose transmembrane transport (GO:0008645),0.42039371663264613,0.9981898150295303,0.4442307692307692,0.8573873509176244,1.0,6/21,12.50%,SLC5A1;PPARD;SLC45A1;SLC2A6;SLC2A3;SLC2A9
prerank,positive regulation of histone methylation (GO:0031062),-0.3610040985583122,-0.998082570799865,0.46601941747572817,0.7789382192279717,1.0,1/24,0.08%,AUTS2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),-0.4532298418821444,-0.997896885940173,0.47104247104247104,0.778722886375276,1.0,3/10,10.43%,SMAD7;RC3H2;ZC3H12A
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),-0.36485787920691903,-0.997559482389581,0.4549019607843137,0.7788617615750916,1.0,14/24,33.87%,ABCG2;PGRMC1;SLC25A38;ALAS1;PPOX;SUCLA2;CPOX;COX10;ALAS2;UROS;TSPO;HMBS;ABCB6;COX15
prerank,positive regulation of T cell differentiation (GO:0045582),-0.328829643462846,-0.9973281105208675,0.4577319587628866,0.7787687676508078,1.0,10/36,21.82%,ZMIZ1;GLI2;LEF1;GLI3;DUSP10;SOX12;RHOH;PNP;MDK;XBP1
prerank,vasculature development (GO:0001944),0.43575764480497925,0.9973133717268016,0.46017699115044247,0.8584210812736831,1.0,2/16,3.05%,PDGFRB;PIK3CA
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),-0.32888061137845687,-0.9969398232951215,0.4715261958997722,0.779079782265891,1.0,12/38,17.31%,SP100;NOS3;THBS1;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SFRP1;SERPINE1;RIPK1;GPX1
prerank,negative regulation of leukocyte migration (GO:0002686),0.48178858208252245,0.9966524612504926,0.44755244755244755,0.8589508691176201,1.0,2/10,5.44%,BMP5;CD300A
prerank,regulation of cellular component biogenesis (GO:0044087),-0.32623997363597645,-0.9963806416352903,0.4593967517401392,0.7798115795292319,1.0,10/39,10.24%,SNCAIP;ROCK2;APOE;EZR;RAP1B;RAPGEF1;TIE1;IRGM;GFAP;DAB2IP
prerank,microvillus organization (GO:0032528),0.4488292067365739,0.9963061554955619,0.4381551362683438,0.8587797579651847,1.0,4/13,8.81%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,regulation of nervous system process (GO:0031644),-0.38707777679891936,-0.9962521383484148,0.4624277456647399,0.7794598414774911,1.0,4/18,4.79%,ROCK2;APP;NOS3;SLC8A3
prerank,negative regulation of lipid storage (GO:0010888),-0.37682872213699636,-0.9961476655835015,0.4834307992202729,0.7790563498859532,1.0,6/19,19.45%,ABCA1;OSBPL8;ITGB3;PPARA;NFKBIA;PTPN2
prerank,liver development (GO:0001889),-0.33778718622771553,-0.996107639225659,0.4608695652173913,0.7785125152987814,1.0,4/32,4.43%,TGFBR3;WNT4;ANXA1;LSR
prerank,protein dephosphorylation (GO:0006470),0.3120078737589384,0.9960947603348699,0.4537177541729894,0.8583009841560639,1.0,11/135,4.73%,PTPRK;PTEN;PTPN9;PPM1E;BTRC;TNS2;PTPN22;SSH2;PPP3CA;PPP2R2A;PTPN4
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),-0.4326940385635033,-0.9956516447328205,0.4692737430167598,0.778941884217068,1.0,7/11,33.33%,LRP6;WNT5A;NR4A2;FZD1;CTNNB1;LMX1A;WNT2
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),0.43691642718384616,0.9955277980043933,0.44339622641509435,0.8586367760439071,1.0,2/21,2.35%,NDST3;EXTL3
prerank,neuron differentiation (GO:0030182),-0.2531509367159656,-0.9943182223482725,0.4379310344827586,0.7815437948391506,1.0,26/165,13.66%,PBX1;WNT4;GLI2;PBX3;WNT6;DTNB;TGFBR1;LRP6;FZD2;WNT9A;WNT5A;HS6ST1;WNK1;NRBP2;FZD4;VSX1;LHX6;NR4A2;FZD7;WNT5B;ITM2C;ID2;ATOH8;WNT16;MET;UGCG
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.31344069452914874,-0.9942829060306696,0.4634146341463415,0.7809759587608441,1.0,14/45,21.13%,EGFR;BMP4;DDX5;RBM20;POLR2A;ERN1;TGFB1;RELA;GRSF1;PNPT1;SIRT7;RIPK1;ZC3H18;RIOK2
prerank,positive regulation of calcium-mediated signaling (GO:0050850),-0.43172231994150156,-0.9938523662459678,0.47368421052631576,0.7813500830755887,1.0,8/11,41.74%,P2RX4;CDH13;PLCG2;TREM2;P2RX3;TRAT1;CCL4;NEUROD2
prerank,gene silencing by miRNA (GO:0035195),0.3822982899435948,0.9930220654763261,0.4633663366336634,0.8632579340863435,1.0,7/32,12.88%,LIMD1;AJUBA;AGO3;TARBP2;TNRC6C;EIF6;TNRC6B
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.391753279763457,-0.9929298025220535,0.48044692737430167,0.7830088499843737,1.0,5/16,14.40%,PARP9;DTX3L;PARP3;SHLD1;KMT5C
prerank,cellular response to leucine starvation (GO:1990253),0.48060857945622526,0.9926889156269648,0.4481236203090508,0.8630991334662339,1.0,3/10,16.48%,SESN3;MTOR;IMPACT
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.44383010198361905,-0.9922698980497384,0.4724264705882353,0.7839019629092013,1.0,2/10,16.38%,ADGRV1;WHRN
prerank,regulation of myelination (GO:0031641),0.4024408003692663,0.9919829142383273,0.45708582834331335,0.8638029032233693,1.0,6/25,10.50%,TNFRSF21;PTN;TPPP;NCMAP;TENM4;NKX6-2
prerank,positive regulation of wound healing (GO:0090303),0.3791236724237469,0.9918353730172811,0.46455223880597013,0.8631781042618227,1.0,8/36,8.14%,VTN;PTK2;MYLK;FERMT2;ITGB1;ARFGEF1;HRAS;MTOR
prerank,glycerol metabolic process (GO:0006071),0.4778410039926754,0.9913565408929942,0.49344978165938863,0.8633174343096983,1.0,3/10,9.26%,COQ2;GOT1;GK
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.3949912191674063,-0.99111051839934,0.5077220077220077,0.7861417170310919,1.0,7/16,17.23%,LRRK2;HSPA5;SEC16B;BCAP29;VAPA;BCAP31;TAPT1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),-0.44281395585461203,-0.9907530774974536,0.48080438756855576,0.7863201406636231,1.0,5/10,20.68%,PRKCH;FOXC1;TRIM16;ETV4;NUMA1
prerank,positive regulation of potassium ion transport (GO:0043268),0.3847261823657782,0.990431935231898,0.4888888888888889,0.8643916919691956,1.0,7/38,10.26%,GNG2;KCNJ12;KCNMB1;AKAP6;KCNE5;KCNJ3;KCNJ6
prerank,negative regulation of neuron differentiation (GO:0045665),-0.3612532353778726,-0.9903998565490387,0.49,0.786513099388547,1.0,4/22,14.59%,BMP7;B2M;CALR;DTX1
prerank,positive regulation of MAP kinase activity (GO:0043406),0.3542265812122234,0.9903819387468527,0.45439469320066334,0.8635885916393865,1.0,7/66,7.15%,PDGFRB;IL34;MAP3K5;PDCD10;FGF2;TAOK3;HRAS
prerank,toll-like receptor signaling pathway (GO:0002224),-0.2844086353623697,-0.9897266956130694,0.4619883040935672,0.7875013048989858,1.0,21/84,19.70%,SCARA3;LBP;MAP3K1;IRAK2;LGALS9;PIK3AP1;BIRC3;CTSB;SFTPA2;SFTPA1;CASP8;IRAK3;CTSS;UBB;PLCG2;TICAM1;MAPKAPK3;TLR4;RIPK1;HSP90B1;IKBKG
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.4081392372185557,-0.9894350227020616,0.48316831683168315,0.7875217706800085,1.0,8/15,24.90%,STAT3;HIF1A;IL17RA;GBP5;TICAM1;TLR4;IL17D;MYD88
prerank,regulation of RNA splicing (GO:0043484),-0.28486563320408176,-0.9892034557740806,0.4748201438848921,0.7874497403203651,1.0,23/69,26.65%,AHNAK;MBNL1;RBM20;AFF2;RPS13;POLR2A;SON;CLK1;ERN1;MBNL2;GRSF1;SRSF10;TMBIM6;AHNAK2;PTBP3;HNRNPL;SRPK1;RPS26;ZNF326;SRPK2;HNRNPF;CLK3;CWC22
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.31179293086100707,0.9890370518263556,0.4591381872213967,0.8655755945049854,1.0,23/128,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,anterior/posterior pattern specification (GO:0009952),-0.30704870179549804,-0.9889216435310799,0.4885844748858447,0.7875247225986762,1.0,17/53,16.05%,HOXB6;PCSK5;HOXB3;BMPR2;TGFBR1;HOXA5;SKI;HOXA3;BHLHE40;HOXC6;TBX1;BHLHE41;HOXB9;HOXC4;HOXB5;HOXB7;HHEX
prerank,negative regulation of histone methylation (GO:0031061),-0.4464784347009297,-0.9887822632522019,0.5009276437847866,0.7872266498150419,1.0,6/10,38.25%,JARID2;DNMT1;BRCA1;AASS;KDM1A;PHF1
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.4674632988233858,0.9885947473387553,0.46331236897274636,0.8656363207876834,1.0,6/10,24.78%,DERL3;UBAC2;INSIG1;ERLEC1;OS9;YOD1
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),-0.2761023445530967,-0.9885504060348262,0.47802197802197804,0.787126448473011,1.0,34/104,28.18%,KSR1;LRP6;SLC8A3;CCND2;RHOA;CALM2;SYAP1;CCND3;AKT1;HGS;IRGM;CCNG1;DAB2IP;PPEF2;UVRAG;CCND1;ACTB;CDKN1B;PARP16;CALM1;ADRB2;EZH2;TRIB1;CSF1R;CDK5RAP3;PIH1D1;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;TRIB3;ABL1;RPTOR
prerank,cellular lipid catabolic process (GO:0044242),0.4008044642496577,0.9884166879534881,0.45368620037807184,0.8651002585690258,1.0,3/27,7.27%,CEL;PPARD;AOAH
prerank,T-helper cell differentiation (GO:0042093),-0.413535332748405,-0.9884017320440381,0.48722627737226276,0.7868614499968051,1.0,4/14,16.10%,FOXP1;LEF1;ZFPM1;TMEM98
prerank,positive regulation of vacuole organization (GO:0044090),-0.4458240497352345,-0.987746318752364,0.5027522935779817,0.7878197341633518,1.0,5/10,16.80%,ANXA2;RAB3GAP1;PIP4K2B;SH3GLB1;RAB3GAP2
prerank,retina homeostasis (GO:0001895),-0.3607390712878777,-0.9877440663393697,0.4596153846153846,0.7871746162750263,1.0,8/23,23.39%,B2M;ACTG1;POC1B;ACTB;POTEF;WHRN;TULP1;CDH3
prerank,double-strand break repair via break-induced replication (GO:0000727),0.45807922531421963,0.9869678723528644,0.48459958932238195,0.8673176201237452,1.0,4/12,10.98%,GINS4;MCM6;MCM7;MCM2
prerank,myeloid leukocyte differentiation (GO:0002573),-0.29555436066485863,-0.9867264220201554,0.4688279301745636,0.7890090044041358,1.0,14/65,10.80%,FOXP1;IL31RA;IL15;TGFBR2;BMP4;CSF1;LEF1;PIR;SBNO2;LGALS9;MAPK14;KIT;CASP8;PML
prerank,apoptotic process (GO:0006915),0.29796109566602796,0.9861181205030715,0.4891304347826087,0.8683075263092671,1.0,36/203,12.77%,DLC1;FAP;TNFRSF21;TNFAIP1;ARHGEF6;ADORA2A;FASTKD2;IL1B;PIK3CA;IL2RA;AKAP1;PRUNE2;BCL2L10;PPARD;CIDEB;SCN2A;OGT;BCL2L13;CASP9;LIG4;PAK6;CDIP1;STK3;MTOR;BNIP2;PAK5;NCKAP1;HIP1;DDIT4;MCM2;IFT57;EP300;BCLAF1;MRPS30;FAM162A;YARS1
prerank,rhodopsin mediated signaling pathway (GO:0016056),0.4673443592240127,0.9860954744241139,0.46443514644351463,0.8674480573648955,1.0,5/10,26.78%,PDE6A;SAG;CNGB1;PDE6B;GNB1
prerank,nitrogen compound transport (GO:0071705),-0.258058768967735,-0.9859870226782045,0.5159235668789809,0.7900660426918438,1.0,36/141,20.27%,SLC7A11;SLC6A13;PDPN;SLC6A6;CERT1;SLC6A12;CALCRL;ABCG2;SLC7A2;RAMP2;RCN3;TXNIP;SLC7A7;SLC22A4;SLC7A5;TOM1;CUBN;SLC7A14;SLC22A5;SLC38A5;ARRDC1;RAB7A;SLC3A2;SLC35F3;TMEM30A;SLC7A1;ARL6IP5;SLC22A2;SLC52A3;ATP11B;ARRDC4;HSP90B1;SLC43A1;SLC25A29;SLC36A1;SEC14L1
prerank,cholesterol metabolic process (GO:0008203),0.3419741878886443,0.9859492565755765,0.45454545454545453,0.8668729213727298,1.0,13/68,13.32%,CEL;SCARF1;LDLRAP1;ARV1;PPARD;ABCA5;IL4;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;CYP11B1
prerank,protein phosphorylation (GO:0006468),0.2706537094377803,0.9858563856885636,0.4855824682814302,0.8661611563526885,1.0,78/478,11.79%,PDGFRB;MAST4;PRKG1;MAP3K20;PIK3CD;CDK6;MAP3K5;PTK2;SNRK;PEAK1;PKN1;FRK;MARK1;PRKAR1B;HUNK;MERTK;NUAK2;ROCK1;AKT3;FNIP2;ERBB4;LIMK1;RPS6KA4;GRK3;CDK15;ABI2;CDC42BPA;STK39;STK38L;JAK1;RPS6KB2;MINK1;CSNK1G1;RYK;RPS6KA2;TESK2;TNKS;TRIB2;ROS1;NEK1;NTRK2;TTBK1;TAOK3;SIK1;YWHAZ;PAK6;LMTK3;STK24;STK3;MTOR;GRK5;ACVR2B;MARK2;CSK;MAP4K4;PRKD2;LYN;PDGFB;CSNK1E;MAP4K1;BIRC6;PAK5;COQ8A;MAPK10;NEK6;ATR;DYRK3;ABL2;BRSK1;PAK3;HIPK1;BRAF;NUAK1;LATS2;PRKX;PAK1;TEC;NLK
prerank,cellular protein modification process (GO:0006464),0.25889224599040445,0.9856514701389919,0.5102481121898598,0.8656906693626913,1.0,129/982,11.23%,ART3;PTPRK;PTEN;PRKG1;CEL;MAP3K20;PIK3CD;PIGU;PARP8;CDH2;PRKCSH;IGFBP7;GCNT2;CDK6;MAP3K5;SDC2;METAP2;ST8SIA4;SNRK;PTPN9;MFGE8;LAMC1;PEAK1;PPM1E;PKN1;FRK;WSB1;BTRC;MARK1;USP25;PRKAR1B;HUNK;MERTK;NUAK2;PTAR1;ROCK1;AKT3;FNIP2;PTPN22;CUL3;SSH2;CTH;ST8SIA1;LIMK1;RPS6KA4;MMP15;CHML;RBX1;GRK3;CDK15;CDC42BPA;STK39;STK38L;COG7;JAK1;PPP3CA;MINK1;PPP2R2A;PTPN4;RYK;EPAS1;PSMB11;TESK2;SERPINA10;TNKS;SPARCL1;LAMB1;SOCS5;GPC3;TRIB2;ROS1;NEK1;TTBK1;ATE1;ASB8;TAOK3;MSRA;SIK1;PSMF1;KCTD6;YWHAZ;B3GALT1;PAK6;LMTK3;UBE2E1;PTPRT;STK24;STK3;PPP1CC;MTOR;GRK5;STC2;FUT9;ACVR2B;HLCS;RAB38;MARK2;CSK;MAP4K4;MIA3;PRKD2;LYN;PDGFB;ANO8;B3GNT8;OARD1;CSNK1E;MTMR7;MAP4K1;BIRC6;CDC14B;PAK5;COQ8A;MAPK10;NEK6;CHST5;BTBD6;SOCS6;DYRK3;ABL2;GAD1;BRSK1;NPC1;PAK3;HIPK1;BRAF;NUAK1;LATS2;KBTBD7
prerank,nucleosome assembly (GO:0006334),-0.34327905474895104,-0.985286043178925,0.48466257668711654,0.7910800458639119,1.0,17/31,36.43%,KAT6B;UBN1;H3-3A;ANP32B;HMGB2;RSF1;NAP1L2;BRD2;HAT1;ASF1A;CHAF1A;NAA60;SPTY2D1;IPO4;ATRX;ASF1B;GRWD1
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.3784635515443892,0.9844592450650784,0.4397705544933078,0.867360153629056,1.0,4/38,3.81%,IL34;NCK2;DOK7;GRM5
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.39120631449540777,0.9841958913782224,0.4613899613899614,0.867031473262586,1.0,4/28,10.43%,MAP2;CLASP2;MAPRE2;CAMSAP3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.29739278943310665,-0.9839635397875794,0.48868778280542985,0.7936907948655049,1.0,14/56,12.53%,ROCK2;SNX9;PDCD6IP;RHOA;USP8;RHOB;MYH10;SON;ARL3;TTC19;SPAST;EFHC1;CHMP4B;EFHC2
prerank,membrane organization (GO:0061024),0.29102060893094445,0.9839533133565762,0.4967148488830486,0.8666820031388446,1.0,47/227,15.41%,SGIP1;DYSF;SH3KBP1;IGF2R;FNBP1;LDLRAP1;ATP2C1;LDLR;SPTBN1;TMCC1;TOR1B;WASL;RIMS1;COX18;SYNGR1;ARPC5;ANK3;EPN1;CHMP2B;HACE1;SGCZ;PIK3C2A;BIN1;PPT1;SYT1;AP2S1;AP2B1;UBXN2B;HIP1;CPTP;ARPC4;NPC1;SYP;SYT2;KIF20A;EMD;DVL2;SERP1;VTI1B;ARPC1A;FCHO1;ANK2;VPS33B;RAB5A;MYADM;CHMP3;PLEKHA3
prerank,hippo signaling (GO:0035329),-0.3495703830207648,-0.9831098613100988,0.4819532908704883,0.7951033374278397,1.0,4/26,6.20%,TJP2;TEAD4;YAP1;TEAD1
prerank,lysosome localization (GO:0032418),0.3772037030715106,0.9828833754035422,0.4537205081669691,0.8681045783184512,1.0,2/37,1.97%,PIK3CD;MYH9
prerank,Rap protein signal transduction (GO:0032486),0.45687534263635204,0.9827541823772494,0.46558704453441296,0.867483567220228,1.0,2/10,6.90%,RAPGEF2;RAP1A
prerank,regulation of dendritic spine morphogenesis (GO:0061001),-0.3356161802516305,-0.9827486942462205,0.5112016293279023,0.7953535746988946,1.0,5/31,3.94%,EPHA4;PDLIM5;SIPA1L1;SHANK3;LRRK2
prerank,positive regulation of MAPK cascade (GO:0043410),0.2870527642956485,0.9827084337918469,0.472630173564753,0.8666832691727161,1.0,27/245,7.15%,PDGFRB;SLC30A10;IL34;RAPGEF2;GCNT2;NOTCH1;ROR1;GPER1;NODAL;FERMT2;ROCK1;ERBB4;PTPN22;ACKR3;PDCD10;FGF2;PELI2;RYK;SPRY2;RIT2;CARD9;NTRK2;HTR2C;TAOK3;CHRNA7;RAP1A;HRAS
prerank,protein autophosphorylation (GO:0046777),-0.2525793392716307,-0.982532823401745,0.5060975609756098,0.7952365700540832,1.0,47/157,21.23%,DAPK1;EPHA4;EGFR;FLT1;PDGFRA;TEK;FGFR2;STK17B;EPHB4;IGF1R;LRRK2;TAF1;DDR1;PTK2B;TAOK2;AKT1;KIT;STK10;EPHA8;BMX;ULK2;KDR;CAMK2A;MKNK2;ERN1;FGFR4;FLT4;ATM;PIM3;FER;OXSR1;MAPK3;MAPKAPK3;VRK2;EPHB3;RIPK1;MAP3K13;MAP3K3;PDPK1;ALK;PIM2;FES;SLK;CSF1R;RIOK2;PASK;CAD
prerank,protein transport (GO:0015031),-0.23182444019894816,-0.9823888323330822,0.5049019607843137,0.7949533999711651,1.0,93/332,22.33%,ABCA1;VAMP5;LAMP2;STEAP3;APOE;MACF1;ARL4A;SGSM2;TBC1D22A;SNX9;SNX6;CALCRL;ARHGEF2;KIF13A;TLK1;ATP6V0A4;SEC31A;RAMP2;COPZ2;RABGAP1L;RCN3;STX7;USP6NL;TBC1D8B;TXNIP;PRKCB;GGA2;STX3;COPA;ARFIP2;TFRC;TOM1;GOLPH3;ATP6V1G1;EHD1;TBC1D8;AP3B1;AP4M1;RAB21;ATP6V0B;TMEM167A;STX1A;USO1;STX6;ARRDC1;OPTN;VPS35;RAB7A;TBC1D10A;RAB8A;ATP6V0A1;TCIRG1;AP2A1;UNC119B;SCFD2;EVI5;ARL5A;TBC1D2;ATP6V0A2;HFE;SEC23IP;NAPA;ARL6IP5;TBC1D25;RAB3GAP2;RAB18;TBC1D13;REP15;ARRDC4;SAR1A;RAB29;RAB6A;STX2;HSP90B1;RAB32;PPY;SAR1B;SNX8;RABL3;CANX;YWHAH;VPS26C;ARFIP1;TMED9;MCOLN1;TBC1D14;RAB24;AP3D1;ATP6V1F;TMED2;TANGO2;WDR11;ACD
prerank,positive regulation of defense response (GO:0031349),-0.2808910979976061,-0.9820609129564848,0.4971590909090909,0.7951109033916184,1.0,29/89,25.23%,APP;IL15;PDCD4;IL16;WNT5A;CD47;IL33;TNFRSF1A;IL17RA;IFI35;CCN4;IL18;OPTN;GBP5;CYBA;NINJ1;SERPINE1;TLR4;RIPK1;NFKBIA;NPAS2;AGT;AGTR1;MDK;LPL;POLR3D;GPR4;PLSCR1;ZBP1
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.4062413668380337,0.9817292761729761,0.48140900195694714,0.8679312434607644,1.0,5/24,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,lipid transport (GO:0006869),0.32301200626574467,0.9816240629824883,0.45987654320987653,0.8672417514561509,1.0,11/97,6.57%,PITPNC1;SLCO3A1;SCARB1;SLC51B;LDLR;ABCD2;PPARD;SLC27A4;FABP3;ABCA5;PRELID3A
prerank,sterol biosynthetic process (GO:0016126),-0.3332286426541614,-0.9812650971737668,0.4915254237288136,0.7963641299530777,1.0,2/33,3.11%,PRKAG2;LBR
prerank,establishment of protein localization to membrane (GO:0090150),-0.29136677171306913,-0.9812130138663276,0.5191815856777494,0.7958381911252183,1.0,16/66,17.70%,AFDN;EGFR;SYNE3;RAB11A;SDCBP;RAB3GAP1;NACA;TAOK2;PARD3;ZDHHC24;REEP1;AQP11;FRMPD1;RAB3GAP2;BID;MICALL1
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),-0.38071275890552686,-0.9810147538042697,0.5058139534883721,0.7956729815337589,1.0,8/20,19.68%,MCU;SLC8A3;MCUB;SPG7;AFG3L2;MICU2;MICU1;MAIP1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),-0.38582200695533975,-0.9805817171119654,0.5062761506276151,0.7961206920172035,1.0,5/17,16.55%,CD55;STAT3;IL18;BACH2;TLR4
prerank,cell cycle G2/M phase transition (GO:0044839),0.3082812058673898,0.9805066443153712,0.4785185185185185,0.8688122588448733,1.0,23/129,16.52%,DYNLL1;BTRC;FOXM1;PPP2R2A;CCDC57;AJUBA;PRKAR2B;CDKN1A;NES;CSNK1E;DYNC1I2;CEP41;BRSK1;TUBB4A;PPP1R12A;CDK14;DCTN1;CCNH;SKP1;DCTN3;CEP76;CEP135;NDE1
prerank,negative regulation of microtubule polymerization (GO:0031115),0.44160539917077896,0.9802179941820038,0.4598698481561822,0.8685394893462213,1.0,4/12,12.85%,MAP2;SNCA;ARHGEF7;TUBB4A
prerank,RNA metabolic process (GO:0016070),0.3083219320115631,0.9801988908171899,0.4727272727272727,0.8676774202883856,1.0,30/127,15.02%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;PCBP3;NCBP2;ADARB2;AGO3;DDX3X;HNRNPR;SUPV3L1;XRN2;PAPOLA;RBMS1;RNASE6;POLR2C;PCBP1;HNRNPA1;SND1;HNRNPUL1;LAGE3;PABPC4;FASTKD1;HNRNPU;RNASEH1;LSM8;HNRNPC;HNRNPH2;DHX36
prerank,protein import (GO:0017038),-0.27805503073428744,-0.9799953003009066,0.5,0.7968805729968826,1.0,32/84,29.60%,LAMP2;APOE;APPL2;STAT3;SLC25A17;AKT1;IPO7;PXMP2;FAM53C;IPO13;ALDH3A2;RAN;ACBD5;GDAP1;PXMP4;NXT2;IPO8;TPR;TOMM22;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;PEX26;CLU;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,regulation of DNA metabolic process (GO:0051052),-0.3146906049053241,-0.9796546934585852,0.47884187082405344,0.7970739148851524,1.0,12/44,20.59%,HDAC8;TOM1L1;SMG6;POLH;MPV17;CDK9;WDR18;SIRT7;SMG5;SMARCAD1;THOC1;MPHOSPH8
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.2703606323713667,-0.9796160331404661,0.5140449438202247,0.7965250154011023,1.0,30/101,19.74%,SAMD4A;VGLL4;VIM;THBS1;CYFIP2;EZR;LARP4B;KLF4;CSF1;NIBAN1;RPS4X;AKT1;UPF3A;CASP8;VPS35;TBC1D10A;TGFB1;FGFR4;CPEB3;FBXW11;RPL26;ATG10;FXR2;ELAVL1;NFKBIA;AGT;ZCCHC4;AGTR1;NAT10;METTL5
prerank,lipoxygenase pathway (GO:0019372),-0.4100478447818755,-0.9794868695515531,0.4877126654064272,0.7961739067475678,1.0,5/14,17.81%,GPX4;PTGS2;PON3;GPX1;ALOX12
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4013801174633769,0.9794370726068795,0.4637964774951076,0.8684035881056125,1.0,9/24,17.72%,TTLL3;TTLL11;NAA11;CEP41;TPGS1;CFAP20;PARP1;TTLL10;TTLL5
prerank,adipose tissue development (GO:0060612),-0.437984749166764,-0.9790823935672959,0.4915572232645403,0.7965296398547655,1.0,5/11,21.82%,NAMPT;SPTLC2;DYRK1B;DGAT2;XBP1
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.33043139347266925,0.9785811589060116,0.4854368932038835,0.8684621065731728,1.0,10/78,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.33043139347266925,0.9785811589060116,0.4854368932038835,0.8684621065731728,1.0,10/78,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.38540682366471263,-0.9785298971423896,0.5243664717348928,0.7972689010462032,1.0,10/17,35.05%,MDM2;SNAI1;RFFL;PSMD10;CD44;PRKN;TWIST1;PTTG1IP;KDM1A;CD74
prerank,cell-cell junction organization (GO:0045216),0.3303904997723821,0.9776499930674823,0.43618739903069464,0.8695974362676342,1.0,11/79,7.13%,GJC1;LIMS1;CDH2;CDH4;CADM2;GJA4;CDH8;CDH22;CDH19;CDH20;CDH7
prerank,regulation of macromolecule metabolic process (GO:0060255),-0.2498699849936955,-0.9773764079375119,0.5322033898305085,0.7994805878748101,1.0,35/170,16.99%,PRDM6;IGF1;AFF3;ROCK2;FOXP1;APOE;APP;CDH1;TAPBP;HINFP;AFF2;AFF1;IGF2BP2;ATRAID;NOVA2;HIF1A;PCBP2;ZC3H12A;PRDM5;TRIM27;AHR;NOVA1;YBX3;ZNF462;PRDM11;PTHLH;TRIM39;TRIM17;EDN3;RNF187;KDM6B;MTMR3;SIRPA;CAVIN4;HNRNPAB
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.3911578440624698,-0.97716569208956,0.4824399260628466,0.7993697111182196,1.0,5/15,10.17%,CNOT7;STAT2;USP18;NLRC5;SAMHD1
prerank,interleukin-35-mediated signaling pathway (GO:0070757),-0.4265976308646451,-0.9767684762795915,0.5176678445229682,0.7996810464336653,1.0,3/11,7.33%,IL6ST;STAT1;STAT3
prerank,protein acetylation (GO:0006473),-0.3397482393471682,-0.9766948757123189,0.50920245398773,0.7992089942940066,1.0,11/30,24.92%,FOXO1;KAT2B;NAA35;CLOCK;SPHK1;NAA40;NAT10;NAT9;NAA80;HAT1;ING4
prerank,microvillus assembly (GO:0030033),0.43503988455865045,0.9766053158602075,0.4423076923076923,0.8710427262573349,1.0,4/14,8.81%,RAPGEF2;MINK1;RAP1A;MAP4K4
prerank,response to molecule of bacterial origin (GO:0002237),0.33869035054430696,0.9763639961804789,0.48083067092651754,0.8707134888886994,1.0,6/69,6.29%,GGT5;GGT1;IL1B;PTPN22;OTUD5;SNCA
prerank,epithelial cell migration (GO:0010631),0.38251672840266604,0.9759691476033442,0.4669260700389105,0.8707048591831529,1.0,8/37,7.87%,FAP;PKN1;ROCK1;ZEB2;PIK3CA;STARD13;TESK1;NANOS1
prerank,macrophage activation (GO:0042116),-0.3281180848518032,-0.9759141937442962,0.4883227176220807,0.8003455187576666,1.0,5/34,4.91%,FOXP1;APP;LBP;SBNO2;CD93
prerank,gas transport (GO:0015669),0.4643384296824014,0.975634491346057,0.47157894736842104,0.8705538955340115,1.0,1/10,3.53%,MB
prerank,protein homooligomerization (GO:0051260),-0.2619246064611188,-0.9754636229800553,0.5187319884726225,0.8008193929062679,1.0,27/114,16.56%,ALDH1A2;RNF213;KCNJ2;SCARA5;B2M;CLYBL;PDCD6IP;APPL2;SSBP1;UPB1;ALS2;EHD1;GLRA3;GLS;RNF135;ACACA;SAMHD1;SPAST;GSDMD;DISP1;GBP5;ATL2;NINJ1;BEND3;AQP11;ELAVL1;PNPT1
prerank,response to prostaglandin E (GO:0034695),0.45529979882694094,0.9753082140241335,0.44468546637744033,0.8703683782303009,1.0,2/10,3.95%,GNG2;ADCY6
prerank,regulation of intracellular pH (GO:0051453),-0.3276653517598342,-0.9751712958919775,0.5022421524663677,0.8008772350290673,1.0,10/34,19.85%,SLC9A2;SLC4A10;LRRK2;SLC9A9;TM9SF4;SLC9B1;SLC9A1;SLC4A2;CHP1;NOX1
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.38497466538094943,0.975120911048971,0.46934865900383144,0.8698560449202141,1.0,7/33,13.05%,AFAP1L2;GPER1;NCF1;CNOT9;HIP1;DGKD;BCAR3
prerank,DNA damage checkpoint signaling (GO:0000077),0.3903382909293147,0.9750436230357599,0.4649805447470817,0.8691186126882751,1.0,5/28,14.26%,MAP3K20;RAD1;ATR;RAD17;ATRIP
prerank,cellular response to hexose stimulus (GO:0071331),-0.36121179438159257,-0.974522024449766,0.520242914979757,0.801812557805554,1.0,6/23,11.52%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1
prerank,regulation of dendritic spine development (GO:0060998),0.4109742618069025,0.9744996038894761,0.43863636363636366,0.8693997699593221,1.0,1/19,0.63%,MEF2C
prerank,entrainment of circadian clock by photoperiod (GO:0043153),0.3978536901930859,0.9743167034452711,0.4642857142857143,0.8689265442975274,1.0,4/27,8.10%,PER2;CRTC1;SIK1;PPP1CC
prerank,Golgi organization (GO:0007030),0.3092425394966345,0.9742745003921809,0.4622356495468278,0.8681229470822337,1.0,31/112,17.74%,ARHGAP21;SYNE1;STX16;COG7;PDCD10;ATP8B2;COG1;CLASP2;VTI1A;ARFGEF1;HACE1;YWHAZ;BLZF1;TMED7;UBXN2B;TMED4;ARHGEF7;VPS51;GCC2;TRIP11;VTI1B;STK25;TJAP1;VMP1;RAB1A;PRKD1;HTT;CSNK1A1;GORASP1;GOLGA8B;GOLGA5
prerank,regulation of phospholipase C activity (GO:1900274),0.4315323016359519,0.9736805837740302,0.45233265720081134,0.8685574493763142,1.0,3/15,7.15%,PDGFRB;FGF2;HRAS
prerank,regulation of interferon-gamma production (GO:0032649),0.3359737487922988,0.9734463376388492,0.47351524879614765,0.8681666877801176,1.0,6/71,8.17%,PDE4D;IL1B;PTPN22;AXL;PDE4B;IL12RB1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.37839241549232333,-0.972969357810039,0.48282828282828283,0.8048922309084818,1.0,8/18,29.25%,CCN3;KCNB1;SFRP1;MIDN;SIRT4;PRKN;ADRA2A;CHGA
prerank,phosphate ion homeostasis (GO:0055062),-0.4394209573758812,-0.9728625133387804,0.5088062622309197,0.8045144214073067,1.0,3/10,12.18%,ENPP1;SFRP4;FGFR4
prerank,modification-dependent protein catabolic process (GO:0019941),-0.24295113439114013,-0.9728611185439148,0.5463917525773195,0.8038696416100187,1.0,54/193,21.82%,FBXL7;RNF213;SMURF2;FBXO10;RNF146;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;RNF144B;TTC3;SMURF1;CDC16;AMFR;RC3H2;CHFR;RNF185;DTX3L;KCTD10;ZNRF3;ARRDC1;UBE4B;ANAPC4;RNF125;MDM2;WDR81;UBB;UBE2G2;PSMD11;NEDD8;DDB1;FBXL14;ANKIB1;RNF40;UBR4;SPSB4;SPSB2;ANAPC16;FZR1;NPLOC4;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RNF126;ANAPC5;ELOC;RBBP6;XBP1
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2603930557615554,-0.9728039108754178,0.4502923976608187,0.8033506051356736,1.0,41/132,27.77%,CELF2;RPS14;LUC7L;RPS19;GEMIN7;EIF2S2;DENR;NAF1;RPL11;RPS5;STRAP;RPL24;SRSF10;RPS27;MRPS7;RAMAC;RPL10;GEMIN5;HSP90AB1;RPS15;SNRPF;SNRPD1;SNRPD2;RPSA;SRSF6;RPL38;RPLP0;DICER1;SRPK1;RRP7A;RPS27L;SRSF5;WDR77;CELF5;RRS1;SRPK2;PUF60;PRPF19;SNRPC;SNRPB;SNRPE
prerank,cellular response to chemokine (GO:1990869),0.35999103274762356,0.9727525219269586,0.4810606060606061,0.86875222975785,1.0,6/46,6.10%,SLC12A2;SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),-0.41536273990812156,-0.972449056957437,0.5260115606936416,0.803591710151283,1.0,4/12,22.00%,AR;TGFB1;AP2A1;TMEFF2
prerank,cranial nerve development (GO:0021545),-0.43377174747724295,-0.9723498825893825,0.521415270018622,0.8031758430275076,1.0,1/11,1.45%,CHD7
prerank,regulation of lymphocyte migration (GO:2000401),-0.4303628515366843,-0.9723196479057109,0.5288461538461539,0.8026120654497308,1.0,3/10,9.47%,JAM2;AKT1;STK10
prerank,positive regulation of phospholipase activity (GO:0010518),-0.3629655490808458,-0.9722756376181414,0.5071283095723014,0.802084961984355,1.0,6/22,3.02%,FLT1;PDGFRA;NTRK3;PLCG1;ESR1;FGFR2
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.3783712107776573,0.9721202176736751,0.47808764940239046,0.8692738561577844,1.0,16/31,26.75%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;DNLZ;TIMM17B
prerank,positive regulation of ERAD pathway (GO:1904294),-0.40513196598662216,-0.9720183778177127,0.49907578558225507,0.8020698428378081,1.0,7/13,37.09%,CAV1;RNF185;BCAP31;ATXN3;USP13;RNFT1;HERPUD1
prerank,sulfur amino acid catabolic process (GO:0000098),0.47385551164128437,0.9717189975154992,0.4759725400457666,0.8692640687169455,1.0,2/10,5.21%,CTH;TXN2
prerank,cellular response to sterol (GO:0036315),-0.4012744429345704,-0.9715174904509551,0.5254545454545455,0.8026324491082765,1.0,6/13,11.87%,LRP6;SMO;GRAMD1C;GRAMD1A;INSIG2;PTCH1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.32721290200850445,0.9713707652611027,0.49434571890145396,0.869120032483832,1.0,10/79,11.88%,DYNLL1;CTSF;AP1G1;PIKFYVE;AP2S1;DYNC1I2;AP2B1;KIF3A;SEC13;KIF3C
prerank,negative regulation of multicellular organismal process (GO:0051241),0.29485418705683486,0.9712809455034486,0.5070621468926554,0.8684379450827702,1.0,14/199,3.11%,PLCL1;PTEN;MEF2C;HEY2;BMP5;NOTCH1;RGCC;NR1H3;NODAL;IL17RD;ROCK1;SPRED1;IL1B;RPS6KA4
prerank,negative regulation of lipid metabolic process (GO:0045833),0.4063470078931476,0.9711376931906052,0.46601941747572817,0.8678504929873306,1.0,2/22,2.62%,GPER1;IL1B
prerank,negative regulation of hydrolase activity (GO:0051346),-0.3047761461961793,-0.9708573394596479,0.5172413793103449,0.8035563832463315,1.0,18/49,24.09%,LRCH1;LRRK2;SLC39A14;WNK1;CPEB2;SH3RF2;CST3;ECM1;DAB2IP;CAMK2A;F11R;GMIP;NOS1;SH3BP4;CHP1;TMED2;SH2D4A;RDX
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.4360957419844007,0.9707425193548808,0.4967741935483871,0.8678096234548888,1.0,5/15,14.09%,HECW2;NEK6;TACC3;PTTG1;ANAPC7
prerank,regulation of gastrulation (GO:0010470),0.43806246090809287,0.9706259559667002,0.4852941176470588,0.8672059216989244,1.0,4/14,13.10%,PHLDB2;CLASP2;TENM4;PHLDB1
prerank,protein-containing complex subunit organization (GO:0043933),0.31151486167094267,0.9706013261555297,0.5106382978723404,0.8663732642763072,1.0,7/109,3.96%,LIN7A;LAMC1;WASF3;WAS;WIPF1;WASL;RIMS1
prerank,genitalia development (GO:0048806),-0.41353043575540227,-0.9703702844069203,0.5029126213592233,0.8040776837890286,1.0,4/12,14.82%,CHD7;WNT5A;STRA6;PKD1
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.45830274210397537,0.969643384411712,0.484304932735426,0.8676487347128568,1.0,3/11,9.11%,JAK1;ANK3;LYN
prerank,membrane lipid metabolic process (GO:0006643),-0.3649927370040021,-0.9696258489287634,0.47764227642276424,0.8051584419880834,1.0,5/22,16.00%,ST3GAL6;AGMO;CYP1B1;SPHK1;SERINC1
prerank,regulation of myeloid cell differentiation (GO:0045637),0.340909390919812,0.9694728777768764,0.49557522123893805,0.8671632253111954,1.0,15/62,12.88%,MEF2C;CDK6;MYL9;HOXA9;AGO3;LYN;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;CTR9;TNRC6B
prerank,myoblast fusion (GO:0007520),-0.41951946442550386,-0.9692015966591361,0.5087040618955513,0.8055334503385526,1.0,7/12,19.75%,JAM2;ADAMTS5;CD9;ADAMTS15;PTGFRN;NOS1;CD81
prerank,negative regulation of cellular component organization (GO:0051129),0.34106498491997655,0.9683663863110699,0.5008488964346349,0.8687287082737292,1.0,7/74,6.30%,CARMIL1;FAP;WASL;SACS;SPRY2;SCAMP5;DDX3X
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.47131851093692995,0.9683154185918806,0.4915254237288136,0.8679652938708454,1.0,3/10,7.70%,KCNE4;ANK3;KCNE5
prerank,muscle filament sliding (GO:0030049),0.3753866714492761,0.9683026737280623,0.4878048780487805,0.8662591310546451,1.0,3/38,7.49%,DMD;TMOD1;MYL3
prerank,actin-myosin filament sliding (GO:0033275),0.3753866714492761,0.9683026737280623,0.4878048780487805,0.8662591310546451,1.0,3/38,7.49%,DMD;TMOD1;MYL3
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.38849583044409386,0.9682838457082696,0.48295454545454547,0.865442225723683,1.0,1/33,0.50%,IL34
prerank,acylglycerol biosynthetic process (GO:0046463),0.4034231086212536,0.9680527952186913,0.4827586206896552,0.8650970486622862,1.0,1/23,0.48%,PLCE1
prerank,regulation of integrin activation (GO:0033623),0.4312792806228566,0.9674488252902358,0.4794238683127572,0.8655433171814504,1.0,3/15,6.84%,JAM3;FERMT2;FBLIM1
prerank,"transcription, DNA-templated (GO:0006351)",-0.23939806597618293,-0.9672779827302215,0.5454545454545454,0.8094812442381594,1.0,64/207,26.26%,MAF;NFIX;GLIS3;FOXO3;TSC22D1;DDX5;PIR;TAF1;MLLT3;TRIM24;THRB;NOCT;RTF1;POLR2A;IRF9;RREB1;PMF1;NR4A2;MMS19;IVNS1ABP;PWP1;POLR2F;MEF2A;POLR3GL;EAF1;ELOB;DTX1;CDK9;TAF4B;GTF3C2;MNT;GTF3C5;POLR2E;TBPL1;BRF2;E2F1;GTF3C1;TAF9B;TEFM;POLRMT;UBTF;TCEA1;RSF1;TTF1;THAP1;NFE2L3;MRPL12;ELOC;XBP1;NELFCD;CEBPD;TAF5;HSF2BP;HIPK3;CBFB;ERCC2;POLR2G;PPP5C;RRAGC;CDK7;ERCC3;TP53;EPC1;TAF11
prerank,positive regulation of chemotaxis (GO:0050921),0.36233525394599625,0.9670377164142949,0.4765217391304348,0.8655660090229402,1.0,4/43,4.24%,PDGFRB;SEMA5A;PTN;FGF2
prerank,cellular respiration (GO:0045333),0.3650959884927357,0.9662653249433121,0.4737762237762238,0.8663724760399132,1.0,11/41,18.71%,COX4I2;UQCRFS1;SLC25A13;BLOC1S1;UQCRC2;ETFB;ETFA;MTFR1;ETFDH;OXA1L;NDUFA5
prerank,nucleosome organization (GO:0034728),-0.29638157199857473,-0.9661134930825511,0.5069124423963134,0.811593951869384,1.0,26/55,36.78%,KAT6B;INO80;BPTF;H3-3A;ANP32E;ANP32B;SMARCC1;HMGB2;CTCF;RSF1;MCM3AP;NAP1L2;BRD2;SMARCA4;RNF8;ASF1A;CHAF1A;SMARCD2;POLE3;PAF1;NAA60;SPTY2D1;ZNHIT1;ATRX;GRWD1;SRCAP
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.3221302789081932,0.9660590932529878,0.4759535655058043,0.8659118083749565,1.0,16/78,15.97%,PTEN;RGCC;SPDYA;HEXIM1;CDKN1A;INCA1;PKD2;NR2F2;PDGFB;CCNYL1;LATS2;APC;CCNH;BLM;GTF2H1;CCNE1
prerank,histone deacetylation (GO:0016575),-0.30552709487750906,-0.9658618541381233,0.5377574370709383,0.8115545111970794,1.0,14/43,21.43%,HDAC4;TBL1XR1;HDAC8;HDAC9;MIDEAS;RCOR3;PRDM5;HDAC1;HDAC5;SIRT7;SIRT2;SMARCAD1;MORF4L2;SIN3A
prerank,positive regulation of hormone secretion (GO:0046887),-0.38098993172947015,-0.9656565298113379,0.50293542074364,0.8113838233965841,1.0,10/17,39.36%,C1QTNF3;SPP1;EDN3;HFE;VAMP8;GRP;SNX4;EDN1;NMB;SOX11
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),-0.2914992205561901,-0.965596346986821,0.5346534653465347,0.8108853920149621,1.0,36/62,37.09%,LRRK2;ARHGEF2;CXCL12;TPT1;AKT1;MCL1;MDM2;YBX3;PPIA;CREB3L1;ENO1;SNAI1;CREB3;TMBIM6;PARK7;PLAUR;XBP1;NDUFA13;BCL2L1;PRKN;BAG5;CDKN2D;SOD2;CLU;SYVN1;PTTG1IP;HSPB1;HYOU1;RTKN2;PINK1;MAPK7;EPO;VNN1;PPIF;NME5;HERPUD1
prerank,transepithelial transport (GO:0070633),0.4295616936379536,0.9655731512064489,0.491701244813278,0.8661033469652484,1.0,1/15,0.64%,SLC12A2
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),-0.4025052315755259,-0.9655319729145843,0.5164835164835165,0.8104028088997953,1.0,5/13,16.05%,NIBAN2;HGS;EMILIN1;DAB2IP;HHEX
prerank,glutamine family amino acid metabolic process (GO:0009064),-0.326774419686569,-0.9653368496169626,0.5095541401273885,0.8101732490855506,1.0,11/33,16.85%,GLUL;DDAH1;ALDH4A1;PRODH;GLS;DGLUCY;GCLC;SLC39A8;OAT;NIT2;FPGS
prerank,chromatin assembly (GO:0031497),-0.3176086429798119,-0.9652283206489792,0.5050301810865191,0.8097963537170713,1.0,16/38,32.00%,KAT6B;H3-3A;ANP32B;EZH1;HMGB2;CTCF;RSF1;NAP1L2;BRD2;ASF1A;CHAF1A;TP53;POLE3;PAF1;NAA60;SPTY2D1
prerank,regulation of cell size (GO:0008361),0.38989259496700057,0.9651498820514453,0.46502057613168724,0.866161884082175,1.0,3/23,8.14%,PTEN;AKT1S1;MTOR
prerank,ATP-dependent chromatin remodeling (GO:0043044),-0.3139687382408456,-0.9650672278634093,0.5232558139534884,0.8095119610068279,1.0,15/42,29.02%,SMARCA2;INO80;CHD3;ANP32E;HDAC1;ACTB;SMARCC1;ACTR8;SMARCAD1;MBD2;SMARCA4;RNF8;ACTR5;SMARCD2;SMARCA1
prerank,Golgi inheritance (GO:0048313),0.4511847063831079,0.9649512907814112,0.46336206896551724,0.8657472587326247,1.0,3/11,13.98%,PDCD10;YWHAZ;STK25
prerank,PERK-mediated unfolded protein response (GO:0036499),-0.43204125185208675,-0.9648883929959025,0.5306859205776173,0.8093074895627249,1.0,2/10,7.42%,QRICH1;HSPA5
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4525606364896242,0.9648366271855194,0.49036402569593146,0.8651238177443311,1.0,5/12,22.72%,KAT7;WRNIP1;BLM;METTL4;TIPIN
prerank,positive regulation of apoptotic process (GO:0043065),0.2770207943383335,0.9647569749939198,0.5229007633587787,0.8644128717295342,1.0,31/293,9.08%,DLC1;ARHGEF17;FAP;MAP3K20;KALRN;PLEKHG2;MAP3K5;ARHGEF6;GPER1;NF1;RYBP;RPS6KA2;SLC27A4;ITGB1;TNFRSF8;TFAP2B;SNCA;DDX3X;ARHGEF12;SOX4;ARHGEF26;SIK1;CASP9;SOS2;BIN1;RNPS1;STK3;TNFAIP8;HTRA2;ARHGEF9;CCAR2
prerank,peroxisomal membrane transport (GO:0015919),0.39456186699781937,0.9647340238561883,0.49156118143459915,0.8636084750774021,1.0,8/27,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;PEX12
prerank,nucleic acid-templated transcription (GO:0097659),-0.31884470223646943,-0.9647008177929113,0.5033860045146726,0.8091015759695016,1.0,15/42,25.98%,THRB;POLR2A;NR4A2;MMS19;PWP1;POLR2F;MEF2A;DTX1;POLR2E;E2F1;THAP1;POLR2G;PPP5C;RRAGC;EPC1
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),-0.4315046167446044,-0.9644215599872753,0.527001862197393,0.8090881831928506,1.0,2/10,2.81%,APP;SHANK3
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.35019983540207317,-0.9642001075134419,0.5101214574898786,0.8090210741582317,1.0,4/24,13.21%,PLA2G4A;LPGAT1;ABCA3;PLA2G15
prerank,positive regulation of B cell proliferation (GO:0030890),0.39283478260912047,0.9638606433571781,0.48295454545454547,0.8646133091837955,1.0,2/29,6.03%,MEF2C;IL4
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.3655030635803101,0.9636767838218704,0.4706994328922495,0.8641544876417153,1.0,9/41,13.16%,IL34;DOK7;NCF1;GRM5;NTRK2;PDGFB;SRC;DLG3;PTPN1
prerank,membrane protein proteolysis (GO:0033619),-0.3173101770112349,-0.9635907105360805,0.49557522123893805,0.8097947066461296,1.0,10/37,17.55%,CTSH;ADAM9;ADAM10;ERAP1;TGFB1;RELA;RET;AFG3L2;BACE2;PSEN2
prerank,sphingolipid catabolic process (GO:0030149),-0.4031389462994603,-0.9635267971283508,0.5133079847908745,0.8093040817208961,1.0,8/15,25.61%,ACER2;ACER3;SPHK1;SMPDL3A;ENPP2;SGPL1;PDXDC1;GLA
prerank,sensory perception of sound (GO:0007605),0.322764892633884,0.963377991237413,0.4755134281200632,0.8639617466225211,1.0,3/88,1.30%,GRM7;COL4A3;ROR1
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4565512282659279,0.9629000929118058,0.49471458773784355,0.86412171908538,1.0,3/12,16.08%,GNL3L;CCT7;CCT3
prerank,necroptotic process (GO:0070266),-0.38429294384115487,-0.9628822509892206,0.499009900990099,0.8102555647199451,1.0,5/16,17.18%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1
prerank,phagosome acidification (GO:0090383),-0.34228708554141635,-0.962606910597564,0.5,0.8103063035995969,1.0,16/26,39.23%,ATP6V0A4;ATP6V1G1;ATP6V0B;RAB7A;ATP6V0A1;TCIRG1;ATP6V0A2;ATP6V1F;ATP6V0D1;ATP6V0C;ATP6V1D;RAB20;ATP6V1E1;ATP6V0D2;ATP6V1G2;RAB39A
prerank,innate immune response (GO:0045087),0.28493140731198846,0.9625287963966735,0.5219178082191781,0.8640370151746664,1.0,26/217,9.50%,PIK3CD;COLEC12;NCF2;PTK2;FRK;NCF1;MID2;AKAP1;ANKHD1;WFDC3;CARD9;CAMP;TRIM43;TRIM62;CXCL10;IL4;SNCA;DDX3X;RIPK2;RNASE6;ALPK1;CORO1A;ZDHHC1;TIFA;LYN;CR2
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.37901744584963865,-0.9624145839679852,0.5218181818181818,0.8100945947304602,1.0,9/16,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,positive regulation of acute inflammatory response (GO:0002675),0.4347703316941687,0.9623790259106912,0.49705304518664045,0.8635356232743048,1.0,3/14,8.74%,IL1B;FFAR2;OSMR
prerank,regulation of mitotic nuclear division (GO:0007088),0.34802131180592194,0.9622940324037105,0.5042735042735043,0.8628600122852655,1.0,3/55,2.62%,PDGFRB;RGCC;IL1B
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.42001014632986833,-0.9616051493254887,0.52046783625731,0.8114868808604905,1.0,3/12,8.01%,DPYSL3;DPYD;CTPS1
prerank,L-amino acid transport (GO:0015807),-0.3308761590180418,-0.9613669961888701,0.5173160173160173,0.8114138807496322,1.0,10/28,22.10%,SLC1A3;SLC7A2;SLC7A5;SLC38A5;SLC3A2;SLC25A22;SLC7A1;ARL6IP5;SLC36A1;SLC1A1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.44701691103816643,0.961100882244261,0.4708333333333333,0.8645658378287602,1.0,2/12,4.99%,IL1B;CARD9
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),-0.41284817442946736,-0.9610940676685291,0.5308411214953271,0.8114399179789066,1.0,7/12,31.77%,HSPA5;CHMP4B;CHMP4A;SEC61A1;SEC61B;SEC63;GET3
prerank,response to ionizing radiation (GO:0010212),-0.2776657095967448,-0.9604955212824368,0.5300261096605744,0.8122785490619291,1.0,23/70,26.24%,EYA1;ANXA1;INO80;MAPK14;RHOB;EEF1D;NHEJ1;NABP1;ATM;CLOCK;XRCC4;INIP;NET1;BABAM2;IKBIP;BABAM1;RAD51;STK11;RNF8;BRAT1;BRCA1;TP53;HUS1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.3632771144013687,0.9604467525536885,0.49280575539568344,0.8650961224619997,1.0,8/44,10.26%,GNG2;KCNJ12;KCNMB1;AKAP6;ATP1B2;KCNE5;KCNJ3;KCNJ6
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.37030259088996625,-0.9602764245579677,0.5191256830601093,0.8121797538780429,1.0,4/18,13.81%,SLC25A4;CAMK2A;SPG7;BNIP3
prerank,neuron apoptotic process (GO:0051402),0.41218761344939564,0.9600080646752621,0.4921875,0.86517240059424,1.0,3/19,6.89%,TNFRSF21;SCN2A;LIG4
prerank,lysine metabolic process (GO:0006553),-0.41143962473940493,-0.9599890649394788,0.5057251908396947,0.8115942769635762,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,lysine catabolic process (GO:0006554),-0.41143962473940493,-0.9599890649394788,0.5057251908396947,0.8115942769635762,1.0,5/12,28.69%,ALDH7A1;PIPOX;GCDH;AASS;HYKK
prerank,steroid metabolic process (GO:0008202),0.3336538212415474,0.9594597037794015,0.4991652754590985,0.8655195159472592,1.0,10/72,13.32%,CYP7B1;RDH5;ARV1;BAAT;NPC1;LSS;STAR;PRLR;SRD5A1;CYP11B1
prerank,pattern recognition receptor signaling pathway (GO:0002221),-0.295245277761916,-0.9592596123951396,0.5345268542199488,0.8126568967863942,1.0,13/56,18.59%,LBP;NOD1;IRAK2;LACC1;CTSB;SFTPA2;SFTPA1;CTSS;UBB;PLCG2;MAPKAPK3;TLR4;HSP90B1
prerank,GPI anchor biosynthetic process (GO:0006506),0.3752447367285842,0.9591913584683011,0.5037037037037037,0.8652368965085883,1.0,7/30,16.62%,PIGU;PIGO;PIGZ;DPM3;PIGH;PIGX;PGAP1
prerank,regulation of blood coagulation (GO:0030193),0.37996263971986305,0.9589354856425106,0.48031496062992124,0.8649548301412258,1.0,2/27,1.04%,FAP;VTN
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.40773101002109957,0.958669531354695,0.4811715481171548,0.8646820593042681,1.0,4/21,2.15%,PTK2;VCL;PEAK1;ROCK1
prerank,regulation of neural precursor cell proliferation (GO:2000177),-0.3566496580910194,-0.9582864364737322,0.5122950819672131,0.8143365092032363,1.0,5/22,12.56%,SLC16A2;LRRK2;APPL2;GATA2;ID2
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),-0.43079287118092024,-0.9581056973683072,0.5299625468164794,0.8141337594087495,1.0,4/10,14.73%,EZR;RHOA;MYO9A;OPHN1
prerank,regulation of chromatin binding (GO:0035561),-0.4294389425140005,-0.9580433408881686,0.5174418604651163,0.813655541345124,1.0,2/10,8.84%,PARP9;DTX3L
prerank,protein deubiquitination (GO:0016579),-0.23381763383339815,-0.9580367028541168,0.5780590717299579,0.8130398471294265,1.0,79/242,27.57%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;MINDY1;ATXN7L3;MDM2;USP49;PSMB4;UBB;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;MINDY2;SMAD4;SENP8;INO80E;ATXN3;ENY2;PSMD7
prerank,regulation of alcohol biosynthetic process (GO:1902930),-0.4142271596859083,-0.9577727848932179,0.5311355311355311,0.8130427040882553,1.0,4/12,15.54%,CLCN2;LPCAT3;RAN;SREBF1
prerank,regulation of lysosomal lumen pH (GO:0035751),-0.4084654759493348,-0.9574864578886637,0.551789077212806,0.8130906902739092,1.0,8/12,35.85%,LRRK2;CLN6;CCDC115;CLN5;TMEM199;TMEM165;CLN3;ATP6AP2
prerank,melanosome organization (GO:0032438),-0.33575060060093287,-0.9572805000870694,0.52,0.8129044358791677,1.0,9/26,21.46%,SHROOM2;KIF13A;DTNBP1;AP3B1;BLOC1S6;RAB29;RAB32;HPS4;AP3D1
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.44862262183544577,0.9570875648097661,0.5010570824524313,0.8671798615480734,1.0,5/13,14.55%,KPNA4;NUP35;CBLB;KPNA1;RANBP2
prerank,positive regulation of protein localization to cell periphery (GO:1904377),0.35441651081920184,0.9567568754482438,0.5225694444444444,0.8670494480043928,1.0,14/52,11.14%,PIK3R1;EPB41L2;PTPN9;GPER1;EPB41;SPTBN1;DPP10;ITGB1;EFCAB7;STAC;NKD2;EPHA2;STX4;RANGRF
prerank,endochondral bone morphogenesis (GO:0060350),0.4516075673009553,0.9567271858485051,0.4933920704845815,0.8662767342318879,1.0,1/11,0.63%,MEF2C
prerank,regulation of platelet aggregation (GO:0090330),0.41615528752219577,0.956684442834327,0.49141630901287553,0.8655255583130776,1.0,2/17,3.58%,PRKG1;SH2B3
prerank,positive regulation of interleukin-13 production (GO:0032736),-0.4338942116072,-0.9563841372417701,0.5306513409961686,0.8144343585579663,1.0,3/10,10.32%,LGALS9;PRKCZ;IL18
prerank,organelle assembly (GO:0070925),0.26924118348336445,0.9561838613779702,0.5495049504950495,0.8657425861897995,1.0,47/384,11.81%,DYNLL1;LIMD1;STARD9;NOTCH1;DZIP1L;IFT43;RILPL2;CDS2;RAB8B;TTLL3;CYS1;TMOD1;TTC36;IFT81;CCDC57;CENPW;TNKS;LSM3;IFT20;TMOD3;MAPRE2;YTHDF3;NEK1;RBM14;ATG16L1;CHMP2B;DDX3X;SCLT1;ATP2A2;CORO1A;RAB38;FAM161A;EHD3;MVB12A;CDC14B;TP53INP2;NEK6;UBXN2B;KIF3A;CEP41;LMOD1;SQLE;POGZ;AHI1;CCDC66;YTHDF2;CFAP20
prerank,lysosome organization (GO:0007040),-0.3137776643789849,-0.9561230333790675,0.5359477124183006,0.814396294106083,1.0,13/36,27.24%,ABCA1;ARSB;LRRK2;ZKSCAN3;GAA;HPS4;TPP1;CLN6;CLN5;MBTPS1;TMEM165;ACP3;MYO7A
prerank,cellular response to fluid shear stress (GO:0071498),0.4295308971930963,0.9557177967312253,0.47058823529411764,0.8658653068164331,1.0,3/12,9.02%,MEF2C;SREBF2;PKD2
prerank,tetrahydrofolate metabolic process (GO:0046653),0.4468210778683553,0.9554334328549926,0.48582995951417,0.8656421398731172,1.0,2/10,7.42%,DHFR;MTHFD2
prerank,cellular response to calcium ion (GO:0071277),0.33353050385227223,0.9551244536373867,0.48760330578512395,0.8654601841322959,1.0,14/67,11.38%,MEF2C;RASGRP2;ADCY8;ITPKB;CPNE7;SCN5A;SYT1;RYR3;PKD2;HPCA;CPNE4;BRAF;CHP2;SYT2
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3537197162449203,0.9550148950930002,0.5168738898756661,0.8648573247488756,1.0,5/44,3.09%,CARMIL1;RGCC;PPM1E;FERMT2;LIMK1
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.4184022076811168,0.9547041208814708,0.5,0.8646375135866549,1.0,5/18,9.01%,CRTC1;RPS6KA4;ADCY8;CRTC3;PRKD2
prerank,dicarboxylic acid metabolic process (GO:0043648),0.33178504367955186,0.9546192737023595,0.49214659685863876,0.8639717329535183,1.0,6/52,9.21%,GGT1;SLC19A1;DHFR;MTHFD2;GOT1;SDHAF3
prerank,positive regulation of cellular component movement (GO:0051272),-0.35335143816377035,-0.9541717460937075,0.5505836575875487,0.8183852546671894,1.0,12/24,26.38%,PDPN;TGFBR1;SPOCK2;CAVIN1;RPS19;NTN1;CSF1R;CCL19;VEGFA;STK11;AKT2;TWIST1
prerank,rRNA transcription (GO:0009303),-0.3790833312212962,-0.9539831520524373,0.5466666666666666,0.8181859737804343,1.0,6/17,19.54%,CAVIN1;TCOF1;GTF3C2;GTF3C5;SIRT7;GTF3C1
prerank,protein destabilization (GO:0031648),-0.3277672269597721,-0.953973108213544,0.52,0.8175826797478261,1.0,9/32,14.46%,GSN;CTSH;RNF139;IRGM;MDM2;CCDC88C;FBXW11;SOX17;SERF2
prerank,regulation of osteoclast differentiation (GO:0045670),-0.32713649508535864,-0.9537743605531075,0.5475206611570248,0.8174378482158953,1.0,8/33,22.12%,FBN1;CSF1;TCTA;GPR137;TLR4;CEBPB;FSTL3;UBASH3B
prerank,synaptic vesicle cycle (GO:0099504),0.37865347724700044,0.9537338361767025,0.5076628352490421,0.864945894840642,1.0,10/30,18.25%,SNAP25;RIMS1;SNCA;SLC32A1;BRSK1;RAB5A;SYNDIG1;CDK5;VAMP2;CPLX1
prerank,regulation of protein acetylation (GO:1901983),0.4298961595513219,0.9536741802435725,0.49044585987261147,0.8642577890664488,1.0,8/12,29.89%,DDX3X;FAM161A;GSK3B;CAMK1;TERF2IP;RAPGEF3;CEP295;SIRT1
prerank,error-free translesion synthesis (GO:0070987),-0.36152203525903537,-0.953556333897226,0.5201612903225806,0.8172966904225998,1.0,12/22,32.01%,REV1;POLH;UBB;RPA1;NPLOC4;RFC3;VCP;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,positive regulation of phosphate metabolic process (GO:0045937),0.38948361191548336,0.9527405449211017,0.49604743083003955,0.8653281330573541,1.0,2/25,0.67%,PTH1R;GLMN
prerank,negative regulation of protein phosphorylation (GO:0001933),0.295508127235109,0.95260240299576,0.5324675324675324,0.8647917949937033,1.0,17/150,6.42%,PDE4D;PTEN;DMD;PID1;NCK2;PPM1E;NF1;SPRED1;PRR5L;CADM4;SPRY2;TRIB2;INPP5J;TESK1;DBNDD2;SNCA;CACTIN
prerank,UV-damage excision repair (GO:0070914),-0.4149287976757553,-0.9524128447770761,0.5267175572519084,0.8193717896822497,1.0,5/12,26.02%,INO80;DDB1;ERCC1;ACTR5;POLA1
prerank,regulation of muscle cell differentiation (GO:0051147),0.3759384000209254,0.951767698018968,0.4870848708487085,0.8657450593063896,1.0,2/31,0.93%,MEF2C;CDH2
prerank,stem cell differentiation (GO:0048863),-0.31040454377684146,-0.9516948719945898,0.5277777777777778,0.8204609812151505,1.0,10/39,14.15%,OSR1;FGFR2;LRP6;MLLT3;ACE;KIT;JARID2;PUM1;SFRP1;PSMD11
prerank,regulation of chemotaxis (GO:0050920),0.3851062237725858,0.9511140051529307,0.508411214953271,0.8662758942366433,1.0,1/30,0.19%,PDGFRB
prerank,positive regulation of peptide hormone secretion (GO:0090277),-0.31702051922513874,-0.9505996580613195,0.5158371040723982,0.8224822597420681,1.0,6/39,9.97%,MCU;MYRIP;RBP4;TCF7L2;NNAT;NLGN2
prerank,protein lipidation (GO:0006497),0.3279842396648718,0.9502449524537692,0.5238095238095238,0.8672164492868664,1.0,13/59,14.22%,PIGU;ZDHHC14;PIGO;ZDHHC1;ZDHHC2;PIGZ;ZDHHC16;DPM3;ZDHHC17;ZDHHC21;ZDHHC23;HHAT;PIGH
prerank,regulation of proteolysis (GO:0030162),-0.29778650887494906,-0.9501008381308523,0.554140127388535,0.8229937998975049,1.0,14/48,19.73%,CAV1;CYFIP2;LTBP4;RNF139;CST3;AKT1;CASP8;TBC1D10A;FGFR4;FBXW11;NEDD8;CLN8;PLAUR;SERPINE2
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),-0.38873991720111356,-0.9498615135846293,0.530938123752495,0.8229013335561735,1.0,9/15,27.91%,SMAD7;DTX3L;RPL11;RPL23;RPS7;PARK7;BAG2;BAG5;ABL1
prerank,positive regulation of axon extension (GO:0045773),-0.3493164892283369,-0.9498080772634719,0.546692607003891,0.8223968670760792,1.0,10/22,22.32%,NRP1;MACF1;SEMA7A;NTN1;RUFY3;MAP3K13;ZFYVE27;MEGF8;DBN1;VEGFA
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),-0.35480065629819607,-0.9497203805480062,0.5557768924302788,0.8219583801020656,1.0,8/23,20.56%,WEE1;PLK2;CHFR;ZFYVE19;NABP1;ZW10;PRCC;CDK5RAP3
prerank,protein localization to cell periphery (GO:1990778),0.29809698406761603,0.9496215795087187,0.5332369942196532,0.8676117913377401,1.0,21/133,10.43%,LIN7A;CACNB2;RAPGEF2;ROCK1;RAB8B;TSPAN15;SPTBN1;FGF13;MAP7;CLASP2;DPP10;ANK3;RAB3B;EMP2;RAP1A;PDZK1;EHD3;ZDHHC2;NKD2;EPHA2;TSPAN17
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.39987436859570746,0.9490814492952849,0.5019685039370079,0.8678974549044906,1.0,4/23,4.10%,MEF2C;NRG1;RBM24;AKAP6
prerank,programmed necrotic cell death (GO:0097300),-0.3658990137991492,-0.9484600460220439,0.5193482688391039,0.8242656826441662,1.0,10/18,38.60%,ITPK1;PGAM5;TICAM1;TLR4;RIPK1;DNM1L;LY96;PPIF;CD14;CYLD
prerank,regulation of cation transmembrane transport (GO:1904062),0.38161854499371217,0.9482102416386062,0.48854961832061067,0.8689391427814114,1.0,11/29,13.71%,FGF12;DPP10;KCNAB3;SCN5A;CACNA1D;PDZK1;KCNE5;KCNIP1;RANGRF;KCNIP4;SLC30A5
prerank,cellular response to exogenous dsRNA (GO:0071360),0.44323316680013763,0.9477582626662837,0.5173160173160173,0.8690843175104025,1.0,1/12,1.09%,COLEC12
prerank,negative regulation of viral process (GO:0048525),-0.2888387088236653,-0.9475388033556285,0.5555555555555556,0.8257933205945371,1.0,28/57,33.45%,IFITM3;STAT1;OAS2;IFIT1;PML;TRIM27;MAVS;TRIM35;PPIA;IFITM2;RNASEL;TRIM8;RSAD2;TRIM14;SRPK1;TRIM11;TRIM6;SRPK2;PLSCR1;ISG15;ILF3;ZFP36;BST2;TRIM21;PARP10;OASL;TRIM13;FAM111A
prerank,JNK cascade (GO:0007254),0.3613078668373687,0.9472281042272352,0.518796992481203,0.8694028164328804,1.0,5/40,9.85%,MAP3K5;ARHGEF6;MINK1;RIPK2;MAPK10
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.3376572853673676,0.9472265517393613,0.5115131578947368,0.8685750043431266,1.0,11/57,9.80%,MAP3K5;GPER1;NODAL;GRAMD4;CIDEB;CARD9;TTBK1;DDX3X;RIPK2;HTRA2;GRIN2B
prerank,response to copper ion (GO:0046688),-0.36352088334941973,-0.9471404876631694,0.5391969407265774,0.8260868347328285,1.0,9/20,20.00%,MT3;MT1X;MT1A;MT1H;MT1B;MT1G;MT1M;MT1F;MT1E
prerank,response to exogenous dsRNA (GO:0043330),0.4197119464958302,0.9471305617838386,0.5201612903225806,0.8679374064048895,1.0,2/18,2.48%,COLEC12;RFTN1
prerank,regulation of mRNA metabolic process (GO:1903311),0.4487918620595329,0.9463553710059801,0.5154867256637168,0.8687796673667454,1.0,2/11,4.16%,PTCD2;SRPK3
prerank,cytoplasmic sequestering of protein (GO:0051220),-0.4021922850185867,-0.9461424636955733,0.5293005671077504,0.8277826692912156,1.0,7/13,29.65%,SUFU;MDFI;PKD1;NFKBIA;DBN1;NFKBIE;KEAP1
prerank,homologous chromosome segregation (GO:0045143),0.4042314359851519,0.9460694514811171,0.5210084033613446,0.8685571237175524,1.0,5/20,12.97%,FMN2;MEI4;MEIOB;PTTG1;FANCD2
prerank,double-strand break repair (GO:0006302),-0.24372746384402805,-0.9456288432885003,0.5993031358885017,0.8283707939232591,1.0,49/158,26.31%,EYA1;PARP9;INO80;POLM;RAD51B;BAZ1B;SFR1;ERCC5;DCLRE1C;DTX3L;PARP3;NHEJ1;SAMHD1;BRCA2;NABP1;AP5Z1;ATM;XRCC4;RPA1;RAD50;PAXX;HMGB2;CYREN;ACTR8;BABAM2;VCP;SMARCAD1;PIAS4;RECQL;RAD52;UBXN1;BABAM1;RAD51C;MCM8;BAP1;SLX4;RAD51;ERCC1;CHEK2;RNF8;BRCA1;RPA3;ZSWIM7;PPP5C;RAD54B;ACTR5;POLA1;HUS1;APLF
prerank,response to insulin (GO:0032868),-0.2682179928726776,-0.9451522656672386,0.5769230769230769,0.8288179578964934,1.0,17/80,13.66%,SORBS1;RHOQ;FOXO1;ENPP1;KAT2B;HDAC9;SLC39A14;SYAP1;CPEB2;AKT1;C2CD5;INSIG2;RAB8A;USF1;LPIN3;FER;HDAC5
prerank,regulation of protein targeting to membrane (GO:0090313),0.3795585022012319,0.9447803726290841,0.5162523900573613,0.870418527538656,1.0,5/28,7.40%,MTCL1;SLC51B;ANK3;HRAS;PDZK1
prerank,negative regulation of neuron projection development (GO:0010977),0.3431932216608215,0.9446738769371259,0.5086206896551724,0.8698258173208344,1.0,6/56,5.15%,PTEN;RTN4RL1;PTPN9;LINGO1;ADCY6;MYLIP
prerank,hydrogen peroxide catabolic process (GO:0042744),0.43360057594105655,0.9445868981994368,0.5270833333333333,0.869180714598511,1.0,2/11,7.33%,PXDN;GPX3
prerank,protein localization to cell junction (GO:1902414),0.3995597686021505,0.9445455948206322,0.4990059642147117,0.8684409339856967,1.0,6/22,15.15%,JAM3;FERMT2;JAK1;KIF3A;NPHS1;CGNL1
prerank,regulation of intracellular protein transport (GO:0033157),-0.3202385881681809,-0.9445315742547261,0.5560165975103735,0.8296621193294792,1.0,16/32,28.79%,PTPN14;BMP4;NDEL1;IFI27;TGFB1;RUFY3;SIRT7;TPR;OAZ1;RAB29;LCP1;RIPOR1;ICE1;ZFAND1;B3GAT3;ATP13A2
prerank,regulation of translation (GO:0006417),-0.24142305104497772,-0.9441128983094624,0.5942028985507246,0.829991644861015,1.0,52/173,26.14%,DAPK1;SAMD4A;IGFBP5;FOXO3;APP;VIM;THBS1;LARP4B;NIBAN1;CNOT7;RNF139;CTIF;DDX6;RPS4X;IGF2BP2;UPF3A;ATXN2;EIF4G3;CPEB3;TCOF1;CALR;RPL26;LARP1;EIF4A2;CNOT8;RPL10;GEMIN5;FXR2;EIF5B;ELAVL1;EIF2B2;PAIP2B;EIF4E2;TYMS;ZCCHC4;EIF1B;NAT10;METTL5;PASK;EIF2AK3;RPS27L;MIF4GD;CSDE1;SAMD4B;MTRF1;RPS6KA3;EIF3B;RPS3;MTG1;RACK1;RPL13A;EIF2AK4
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4108361045442685,0.9440551503855298,0.5152129817444219,0.8686691455779209,1.0,4/15,9.33%,DAAM2;SPEF1;GPC3;CSNK1E
prerank,cellular response to retinoic acid (GO:0071300),-0.31344699346827226,-0.9439179166231021,0.551948051948052,0.8298025978146232,1.0,11/42,13.68%,EPHA3;WNT6;WNT9A;WNT5A;PTK2B;TBX1;FZD4;FZD7;WNT5B;ATM;RET
prerank,amyloid-beta metabolic process (GO:0050435),-0.3743727688064583,-0.9437988011503662,0.5342205323193916,0.8294350358191754,1.0,6/16,24.75%,ACE;IDE;BACE2;PSEN2;APEH;NCSTN
prerank,regulation of biomineral tissue development (GO:0070167),0.38339032270163526,0.9436571497025955,0.5239923224568138,0.8686749892451853,1.0,3/26,2.15%,HEY2;NOTCH1;ROCK1
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.3949862711207214,-0.9435568531153504,0.5308880308880309,0.8293462424606531,1.0,5/14,26.62%,ACOX1;ECI2;ACOX3;AMACR;CROT
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.4628735564143609,0.9431950045446004,0.5136842105263157,0.8688221508566135,1.0,1/10,2.01%,DCLRE1B
prerank,cellular response to dsRNA (GO:0071359),0.4189309910688339,0.9431170713394715,0.5063559322033898,0.8681810454689552,1.0,1/15,1.09%,COLEC12
prerank,protein modification process (GO:0036211),-0.2750772731567503,-0.9429190701293095,0.5757575757575758,0.8302616081330597,1.0,24/76,24.89%,ST3GAL6;ST3GAL1;CPE;YES1;PHKA2;PLOD2;WWP2;SEPHS1;DUSP12;ST8SIA2;NEDD8;UBA3;FBXL2;MANBA;UBA7;RPN2;UBE2M;UBE2L6;PHEX;LCMT1;BAP1;AKT2;LOX;UBL4A
prerank,endodermal cell fate commitment (GO:0001711),-0.4258966436218822,-0.9425317659244071,0.531021897810219,0.8304959822181492,1.0,2/10,13.79%,RTF1;SOX17
prerank,lipid homeostasis (GO:0055088),-0.28877062201494225,-0.9424534747807533,0.5642857142857143,0.8300407284844531,1.0,15/57,21.82%,ABCA1;RBP1;APOE;RCN3;TLCD2;ACOX1;USF1;ADCK1;ACOX3;PRKAA2;USF2;CLN8;ORMDL3;DGAT2;XBP1
prerank,cilium organization (GO:0044782),0.2791403229029551,0.9422599593645645,0.5572207084468664,0.8692001086205687,1.0,22/209,11.23%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RAB8B;TTLL3;CYS1;TTC36;IFT81;CCDC57;IFT20;NEK1;SCLT1;FAM161A;EHD3;PKD2;CDC14B;KIF3A;CEP41;AHI1;CCDC66
prerank,regulation of acute inflammatory response (GO:0002673),0.4121054848965455,0.9420215528853564,0.5248508946322068,0.8688712503495949,1.0,3/18,8.74%,FFAR2;IL4;OSMR
prerank,cell junction organization (GO:0034330),0.32690235969018144,0.9415826683880701,0.5434412265758092,0.8689822623606452,1.0,13/71,7.88%,LIMS1;APBB2;VASP;FERMT2;RAB8B;SH3BP1;RAB39B;GRM5;AGRN;SNCA;CHRNA7;FBLIM1;PPFIBP2
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.43761761861474735,0.9414735898640713,0.5095137420718816,0.868383851177713,1.0,2/11,3.80%,MERTK;AXL
prerank,histone H3 deacetylation (GO:0070932),-0.38221802726915044,-0.9413335182368814,0.5544747081712063,0.8320239314789568,1.0,7/15,19.29%,HDAC4;HDAC8;HDAC9;HDAC1;SIRT7;SIRT2;SMARCAD1
prerank,plasma membrane organization (GO:0007009),-0.28072507762101834,-0.9408701127583466,0.5639810426540285,0.8324776538859098,1.0,19/61,18.44%,MYOF;COL5A1;SNX9;CAVIN2;FNBP1L;PLSCR2;A4GALT;ANO6;TLCD2;PLSCR4;CHMP4A;P2RX7;UGCG;EHD2;AHNAK2;PLSCR3;SYTL4;MICALL1;STX2
prerank,cellular response to radiation (GO:0071478),0.3511037670095592,0.9406273788791434,0.5451263537906137,0.8693568136400873,1.0,10/40,14.31%,TNKS1BP1;OPN1MW;OPN1MW3;LIG4;CDKN1A;RAD1;RRH;OPN3;TANK;BLM
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.3684223208192554,0.9402727687050138,0.5038314176245211,0.8692602406952108,1.0,8/28,13.98%,PLEKHG2;WAS;SH3BP1;ESAM;ARHGAP35;PAK3;RASA1;ABITRAM
prerank,cardiac muscle tissue morphogenesis (GO:0055008),-0.32010679976473577,-0.9396790790706605,0.5448851774530271,0.8346406401943071,1.0,6/29,12.46%,TGFBR3;FGFR2;SMAD7;FKBP1A;TGFB1;S1PR1
prerank,response to glucose (GO:0009749),-0.29589276631949474,-0.9394473359930225,0.5756207674943566,0.8345644588137551,1.0,6/46,5.09%,UNC13B;THBS1;IGF1R;TCF7L2;SLC39A14;GAS6
prerank,positive regulation of multicellular organismal process (GO:0051240),0.26977157819722947,0.9393134067832364,0.576379974326059,0.8704044174480551,1.0,26/308,6.25%,SOX5;PLA2R1;GLMN;PIK3CD;TBXA2R;GCNT2;SMTNL2;PER2;RGCC;NODAL;FERMT2;TRPV2;ROCK1;PTN;IL1B;NCOA3;G0S2;PPARGC1B;FGF2;EPAS1;CARD9;SYDE1;GRB10;OGT;IL4;SCAMP5
prerank,regulation of steroid metabolic process (GO:0019218),0.3964825978824519,0.9393026093668829,0.5302713987473904,0.8696072031241818,1.0,6/23,17.83%,RORA;ARV1;STAR;ASAH1;RORC;FMO5
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.30321803283840165,-0.9392829206137454,0.5638051044083526,0.834298967160942,1.0,11/46,13.01%,SMAD3;TCF7L2;CDH1;GAS6;PRKCD;ANP32B;BAG3;ZC3H12A;MAVS;TGFB1;RAN
prerank,positive regulation of cation channel activity (GO:2001259),-0.3032604077618221,-0.9386283819399589,0.5282608695652173,0.8352616769020889,1.0,11/40,18.45%,ACTN2;SHANK3;CALM2;TMSB4X;LRRC38;CTSS;EPHB2;GSTM2;CALM1;ADRB2;P2RY6
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.4137830908846142,0.9386238646726838,0.5316455696202531,0.8701981140674272,1.0,2/18,9.11%,BCAR1;LYN
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.34091105393534016,0.9385231880910309,0.5211009174311927,0.8695994136119574,1.0,11/49,12.88%,MEF2C;MYL9;AGO3;KMT2B;CNOT4;PRMT1;TNRC6C;EIF6;EP300;RBM15;TNRC6B
prerank,melanocyte differentiation (GO:0030318),0.43215557255522674,0.9376023720465098,0.5,0.8706419251258765,1.0,2/11,3.79%,MEF2C;MREG
prerank,regulation of rRNA processing (GO:2000232),-0.3732193054838737,-0.9374041230329639,0.5526315789473685,0.8375283338761064,1.0,6/16,24.11%,KAT2B;SIRT7;USP36;RIOK2;NUDT16;TRMT112
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.3055139607597755,-0.9371334642373966,0.569327731092437,0.8375219221189991,1.0,9/36,8.24%,PLCB1;TCF7L2;NFATC1;LEF1;FZD2;MOV10;WNT5A;PLCB3;FZD4
prerank,cellular response to ionizing radiation (GO:0071479),0.3464291883190493,0.936882388596126,0.510752688172043,0.8713397282167434,1.0,13/47,17.88%,MAP3K20;TNKS1BP1;LIG4;HRAS;CDKN1A;RAD1;ATR;TANK;NIPBL;BLM;HSF1;RHNO1;TLK2
prerank,transcription by RNA polymerase II (GO:0006366),0.2671105515101608,0.9368579241362679,0.5912596401028277,0.8705854529182886,1.0,50/305,16.45%,NOTCH3;SOX5;RORB;NOTCH1;RORA;MAML2;NR1H3;NR2F1;NR1D2;PPARD;CLP1;ESRRA;NCBP2;LSM10;PAPOLA;NR2C1;DEK;POLR2C;PCID2;MED1;RNMT;PAX5;TBP;TAF6;MAML3;SYMPK;MED20;RPRD1B;DRAP1;THRA;CTR9;TRIP11;EAF2;PHAX;INTS1;GTF2H5;INTS12;TRIP13;CCNH;MED4;SNAPC2;RORC;MAML1;RXRB;GTF2H1;TAF5L;PARP1;GTF2E1;NFX1;HDAC10
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.3965681817738979,-0.9367462669797938,0.5888888888888889,0.8377861551947189,1.0,8/13,35.05%,MDM2;SNAI1;PSMD10;CD44;TWIST1;PTTG1IP;KDM1A;CD74
prerank,sensory perception of mechanical stimulus (GO:0050954),0.3170724425395477,0.936500766855492,0.5274193548387097,0.8704776068306423,1.0,3/85,1.30%,GRM7;COL4A3;ROR1
prerank,protein mono-ADP-ribosylation (GO:0140289),0.4387826078766613,0.9364861593779821,0.5043103448275862,0.8696921944329387,1.0,1/11,0.90%,PARP8
prerank,positive regulation of small molecule metabolic process (GO:0062013),0.4149279667863044,0.936434063404225,0.5042372881355932,0.8689798728179823,1.0,3/15,7.19%,LDLRAP1;PPARD;IRS1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),-0.26930762563292027,-0.9363927533614338,0.6106666666666667,0.8380154492496592,1.0,15/72,13.17%,CDH5;APOE;LIMA1;SLIT2;SHANK3;ARHGEF2;KANK3;HDGFL3;IAPP;PFDN5;PRKCD;EMILIN1;EML2;PFN1;TWF1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.40160342120290826,-0.9360870878354177,0.5553505535055351,0.8381374856489274,1.0,5/12,22.09%,WNK1;AKT1;PPARA;MDK;ASS1
prerank,cellular response to glucose stimulus (GO:0071333),-0.32683556762210286,-0.9360823134137608,0.5612244897959183,0.8375182426686077,1.0,8/30,15.77%,UNC13B;IGF1R;SLC39A14;GAS6;KCNB1;ERN1;RAB11FIP5;PRKAA2
prerank,protein localization to centrosome (GO:0071539),-0.37093965553002084,-0.9360384602084919,0.5623762376237624,0.8369999575923803,1.0,7/17,30.07%,GOLGB1;SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,regulation of transport (GO:0051049),-0.3108304309673907,-0.9360137583189846,0.5627615062761506,0.8364421338215611,1.0,8/36,16.03%,LEPR;NRP1;RAB11A;LRRK2;ACTG1;ACTB;REEP5;ARL6IP5
prerank,establishment of endothelial barrier (GO:0061028),0.3693033227674733,0.9359464905263086,0.5238095238095238,0.8691792060513253,1.0,2/29,1.01%,PDE4D;RAPGEF2
prerank,positive regulation of protein localization to membrane (GO:1905477),-0.254804367505107,-0.9358484837166474,0.5809248554913294,0.8361889755200836,1.0,15/98,10.09%,SORBS1;EPHA3;EGFR;PPP1R13B;PRKCH;CEMIP;DLG1;TFDP2;ITGA3;PRKCE;STX3;AKT1;KCNB1;C2CD5;CASP8
prerank,smoothened signaling pathway (GO:0007224),-0.3143812573452664,-0.9352915910623201,0.5901639344262295,0.836835257600965,1.0,9/32,22.44%,GLI2;SMO;GLI3;PTCH1;HIPK2;EVC2;STK36;GLI1;TMEM17
prerank,cellular response to UV (GO:0034644),0.31680292286784545,0.934657415042029,0.5294117647058824,0.8710441697542997,1.0,20/76,21.76%,PTPRK;CASP9;CDKN1A;ERCC4;ATR;EP300;OPN3;DHX36;PARP1;XPC;IMPACT;FMR1;RHNO1;MMP1;SDE2;DDB2;CREBBP;HYAL1;EIF2S1;CERS1
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.38280272709518215,-0.9340043000511264,0.572265625,0.8391935414377425,1.0,8/15,25.85%,TCF7L2;GAS6;ANP32B;BAG3;TPR;YWHAE;XPO4;TP53
prerank,regulation of membrane depolarization (GO:0003254),-0.37255404559598526,-0.9336885407875574,0.5703125,0.8393182437224519,1.0,5/18,7.02%,PTPN3;FHL1;LRRK2;SMAD7;GPD1L
prerank,glial cell differentiation (GO:0010001),-0.32645362323227345,-0.933548915807944,0.5543933054393305,0.8390318934627249,1.0,4/28,7.33%,NFIB;ADGRG6;SLC8A3;STAT3
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.3352221386118978,0.9333364305641269,0.5422297297297297,0.8729289260461581,1.0,6/63,7.63%,MEF2C;NCK2;IL1B;CD46;IL4;FGF10
prerank,positive regulation of interleukin-10 production (GO:0032733),-0.3258447640604454,-0.9325857886540265,0.5673913043478261,0.840659961839381,1.0,8/30,21.54%,CD34;LGALS9;PRKCZ;STAT3;PLCG2;TLR4;SYK;CD274
prerank,fat cell differentiation (GO:0045444),-0.28263460538405266,-0.9321500005278395,0.5789473684210527,0.8409704515219295,1.0,13/57,13.23%,SMAD6;OSBPL8;FOXO1;KLF4;TCF7L2;PRDM16;ERAP1;C1QTNF3;BBS7;NR4A2;METRNL;WNT5B;TMEM120B
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3502579245255273,-0.9319239427921893,0.5733590733590733,0.8408613475025695,1.0,3/20,5.48%,SULF1;THBS1;SULF2
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.414643470808387,-0.9317674170513934,0.5693693693693693,0.8405980610227672,1.0,4/10,27.51%,HK2;GFPT2;GFPT1;HK1
prerank,regulation of DNA damage checkpoint (GO:2000001),0.43322400070183686,0.9316505815007466,0.5142857142857142,0.8756847899693998,1.0,4/10,17.06%,CCAR2;ETAA1;CRY1;RPA2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),-0.35424840308305355,-0.9314656637291118,0.5780933062880325,0.8406436272612529,1.0,8/20,16.62%,SEMA3D;SEMA6A;SEMA3C;SEMA7A;SEMA3E;SEMA3B;SEMA3G;SEMA6B
prerank,positive regulation of cell development (GO:0010720),0.3708641948898186,0.9314120335327818,0.5480769230769231,0.8753830705018254,1.0,2/31,1.63%,PDE3A;GPER1
prerank,regulation of protein catabolic process (GO:0042176),-0.2557514954363718,-0.9314024241528984,0.5932203389830508,0.8401418079587348,1.0,29/99,20.02%,EGFR;FOXO1;SMURF2;NKD1;WWP2;SMURF1;WNT5A;PLK2;EGLN2;HGS;EEF1A1;IRAK3;GFAP;IDE;DAB2IP;PRKCG;RAB7A;ASB5;MDM2;DDB1;WWP1;CDKN1B;SIRT2;ODC1;OAZ1;FZR1;VCP;VPS28;SNX3
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),0.4416290102015173,0.9310646723573015,0.5269978401727862,0.8752599854126059,1.0,5/12,15.79%,HOOK3;BICD2;KIF3A;DCTN1;CEP19
prerank,regulation of cell cycle process (GO:0010564),-0.2571103740242826,-0.9301965650113769,0.5823529411764706,0.8423245090809842,1.0,34/104,28.48%,RAB11A;KIF13A;PLK2;CALM2;OBSL1;BECN1;FLCN;SH3GLB1;GIT1;UVRAG;CEP85;SFRP1;CAV2;DBF4;MYO19;CALM1;CCDC8;DYNC1H1;NUMA1;PLK4;CUL9;CETN2;CCP110;NUDT16;RMI2;BCL2L1;L3MBTL1;PLK5;KLHL21;CTNNB1;FSD1;SPAG5;MKI67;KLHL9
prerank,negative regulation of response to cytokine stimulus (GO:0060761),-0.4152954705085485,-0.9297473974895105,0.5700934579439252,0.8426856123916334,1.0,3/10,10.10%,KLF4;MAP2K5;IRAK3
prerank,T cell activation involved in immune response (GO:0002286),-0.4001439723494155,-0.9296368173327122,0.5621414913957935,0.8423296855217979,1.0,4/12,26.14%,ICAM1;MDK;LCP1;EIF2AK4
prerank,L-glutamate transmembrane transport (GO:0015813),-0.41292186468756703,-0.9296180650079289,0.5841209829867675,0.8417458770687912,1.0,4/10,22.10%,SLC1A3;SLC25A22;ARL6IP5;SLC1A1
prerank,response to unfolded protein (GO:0006986),-0.29651052844406073,-0.9295730703965214,0.5929203539823009,0.8412251822403316,1.0,18/48,28.08%,SERPINH1;HSPB8;STT3B;HSPA5;BAG3;DAB2IP;OPTN;ERN1;DNAJB2;HSP90AB1;TMBIM6;DNAJB5;HSPA13;HSPA9;HSPB2;PRKN;HSPH1;HSPA1B
prerank,positive regulation of intracellular protein transport (GO:0090316),-0.24083689204401287,-0.9294843316467729,0.6160990712074303,0.8408139043146743,1.0,57/144,28.13%,SMAD3;PPP1R13B;CEMIP;NPEPPS;TCF7L2;TFDP2;CDH1;GAS6;PRKCD;ANP32B;BAG3;KCNB1;C2CD5;CASP8;SEC16B;ZC3H12A;MAVS;TGFB1;SH3GLB1;TOMM7;SAE1;RAN;TMEM30A;PPP3CC;TM9SF4;RUFY3;LEPROT;BID;TPR;OAZ1;SAR1A;RAB29;BBC3;HPS4;CHP1;SAR1B;E2F1;CD81;YWHAH;USP36;BAP1;RIPOR1;ICE1;AKT2;ITGB2;YWHAE;XPO4;ZFAND1;AKAP5;TP53;B3GAT3;SFN;ITGAM;FZD5;HCLS1;SEC16A;TFDP1
prerank,regulation of cellular protein localization (GO:1903827),0.33839907642048683,0.9285205537692666,0.5274336283185841,0.8797785339703059,1.0,12/45,17.55%,MAP2;GPC5;GPC3;CSNK1E;CCDC66;PTPN1;PRKAA1;TRIM46;DVL3;PARP1;TOR1A;TRIM67
prerank,regulation of ATP biosynthetic process (GO:2001169),0.40860288587312665,0.928299825151747,0.5223577235772358,0.8793854076906252,1.0,2/16,6.03%,PID1;IL4
prerank,photoperiodism (GO:0009648),0.3783358697995979,0.9280109113255787,0.5149812734082397,0.8791912388711669,1.0,4/28,8.10%,PER2;CRTC1;SIK1;PPP1CC
prerank,diol biosynthetic process (GO:0034312),-0.37328986692354227,-0.927508799351027,0.5561797752808989,0.8447748195996256,1.0,5/15,14.17%,ACER2;ACER3;GCH1;SPHK1;SPTLC2
prerank,cellular response to interleukin-2 (GO:0071352),0.43688850787968864,0.9274559463760729,0.5505376344086022,0.8786827820141295,1.0,2/11,4.10%,IL2RA;JAK1
prerank,interleukin-2-mediated signaling pathway (GO:0038110),0.43688850787968864,0.9274559463760729,0.5505376344086022,0.8786827820141295,1.0,2/11,4.10%,IL2RA;JAK1
prerank,monocarboxylic acid metabolic process (GO:0032787),0.2985928272175528,0.9272401083609102,0.5378670788253478,0.878311881079533,1.0,17/117,11.97%,GGT5;GGT1;PER2;SLC16A3;ACSF2;PPARD;BAAT;ACOT12;SLC27A4;AOAH;HLCS;MCCC1;ACOT2;NPC1;PDHX;GLYAT;GATM
prerank,phospholipid transport (GO:0015914),0.3333073024627542,0.9269292765858208,0.5238907849829352,0.8781539772281881,1.0,5/52,6.57%,PITPNC1;SCARB1;LDLR;ATP8B2;PRELID3A
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.3987939043264345,-0.9267416433076221,0.5627376425855514,0.8452430641829468,1.0,1/12,0.24%,IGF1
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),-0.3987939043264345,-0.9267416433076221,0.5627376425855514,0.8452430641829468,1.0,1/12,0.24%,IGF1
prerank,smooth muscle tissue development (GO:0048745),0.4476295868326787,0.92641861595512,0.5161290322580645,0.8783893602540963,1.0,2/10,2.17%,MYLK;NF1
prerank,cilium assembly (GO:0060271),0.26640531605952367,0.9261980826368421,0.6119791666666666,0.8780476785914179,1.0,54/296,17.75%,DYNLL1;NOTCH1;DZIP1L;IFT43;RILPL2;RSPH6A;RAB8B;TTLL3;CYS1;JHY;TTC36;IFT81;CCDC57;GAS8;IFT20;NEK1;PRKAR2B;SCLT1;RSPH1;LRGUK;CFAP46;FAM161A;EHD3;CSNK1E;DYNC1I2;CDC14B;KIF3A;CEP41;AHI1;IFT57;NPHP4;CCDC66;CFAP20;KIF3C;CEP97;FUZ;TUBB4A;TRIP11;TCTN3;DCTN1;CEP126;IFT80;DCTN3;MAK;CEP76;CEP19;CEP135;RAB1A;NDE1;TNPO1;TRAF3IP1;CEP162;TTC8;PTPDC1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.37659509893702825,-0.926078939664918,0.5807692307692308,0.8461381863432524,1.0,8/14,39.05%,HSPA5;BCL2L11;DAB2IP;TMEM33;BFAR;FICD;BAX;UFL1
prerank,regulation of actin nucleation (GO:0051125),-0.40022298007291834,-0.9259014588631014,0.5812133072407045,0.8459007980074305,1.0,5/12,26.47%,GSN;ARFIP2;ARFIP1;ARPIN;PICK1
prerank,mitochondrion transport along microtubule (GO:0047497),-0.3969652474866974,-0.9258277447217297,0.579136690647482,0.8454441296541021,1.0,3/13,13.00%,HIF1A;SPAST;UBB
prerank,angiogenesis involved in wound healing (GO:0060055),-0.4093459535011028,-0.9256474661225523,0.571157495256167,0.845243081270181,1.0,7/11,11.22%,ADIPOR2;CD34;NDNF;PRCP;KDR;GATA2;ITGB3
prerank,regulation of vasculature development (GO:1901342),0.38146864993871127,0.9256081039449429,0.5173824130879345,0.8784944575441248,1.0,6/26,9.84%,NF1;ETS1;FGF2;TSPAN12;EMP2;EPHA2
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.41738643559488564,-0.9254751650924922,0.5590551181102362,0.8449829679855557,1.0,7/10,35.09%,AKT1;TICAM1;TLR4;MYD88;TREM2;CD36;TLR6
prerank,glial cell development (GO:0021782),0.3845533523860595,0.9249193664570367,0.5254582484725051,0.8791084985838282,1.0,4/25,6.56%,CDK6;NF1;TPPP;SOX4
prerank,negative regulation of gluconeogenesis (GO:0045721),0.4158476894085341,0.9248537920923222,0.511727078891258,0.8784320618263768,1.0,4/11,13.27%,SIK1;GCK;EP300;CRY1
prerank,positive regulation of transmembrane transport (GO:0034764),-0.3833061810387204,-0.9246591988377102,0.550098231827112,0.8461913459457058,1.0,5/13,22.46%,ANO6;C2CD5;P2RX7;AZIN1;NR4A3
prerank,regulation of cell junction assembly (GO:1901888),0.37505014449377194,0.924392693905251,0.540650406504065,0.8785654495214348,1.0,3/27,2.15%,MEF2C;RAPGEF2;ROCK1
prerank,folic acid metabolic process (GO:0046655),0.3944354041446331,0.9240368993632836,0.5121457489878543,0.878490907851714,1.0,3/18,7.42%,SLC19A1;DHFR;MTHFD2
prerank,protein targeting to peroxisome (GO:0006625),0.3694063020084369,0.9239662415853559,0.5346938775510204,0.8778258743959616,1.0,9/29,15.58%,RAB8B;ABCD2;ATAD1;PEX7;PEX1;PEX3;PEX19;LONP2;PEX12
prerank,heterochromatin assembly (GO:0031507),-0.3520514286701799,-0.9238904892012582,0.562874251497006,0.8473172672711311,1.0,7/20,22.14%,H3-3A;HDAC1;EZH1;BEND3;SIRT2;RRP8;MBD2
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.280883999238097,0.923169065349664,0.5957142857142858,0.8786238103453072,1.0,29/184,16.52%,DYNLL1;HECW2;RGCC;BTRC;CUL3;PSMB11;PRKAR2B;APPL1;PSMF1;UBE2E1;CSNK1E;DYNC1I2;CDC14B;NEK6;CEP41;PSME4;TUBB4A;ANAPC2;DCTN1;ANAPC7;SKP1;DCTN3;MAD2L1;CEP76;KCNH5;XPC;PSMB5;CEP135;NDE1
prerank,peptidyl-serine modification (GO:0018209),0.2847029017337731,0.9230725535739159,0.5971014492753624,0.8780226558001388,1.0,30/166,11.26%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;MBOAT4;GALNT13;GALNT1;MTOR;MARK2;PRKD2;NAA11;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX
prerank,positive regulation of bone resorption (GO:0045780),-0.40736839478511316,-0.9228923929198973,0.5523809523809524,0.8489581524059924,1.0,8/11,40.75%,TNFRSF11A;SPP1;SYK;ATP6AP1;PRKCA;DEF8;MC4R;ADAM8
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),-0.2279287787105021,-0.9224456989937527,0.6702898550724637,0.849360280798844,1.0,53/208,19.80%,AKAP13;LPAR1;ESR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;ZFAND6;LGALS9;WNT5A;IKBKE;RHOA;PRKCB;PLK2;STAT1;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM27;MAVS;OPTN;PLEKHG5;RELA;TRIM39;PLCG2;TICAM1;VAPA;PPM1B;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;PDPK1;CC2D1A;RHOH;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,regulation of cellular amide metabolic process (GO:0034248),-0.31374519466013806,-0.9223005947662452,0.5913978494623656,0.8490948137630796,1.0,7/32,14.12%,FOXO3;APP;PRKCD;ATXN2;TCOF1;RPL10;GEMIN5
prerank,regulation of cellular component organization (GO:0051128),0.29017504827809554,0.9222754487493584,0.5643994211287988,0.8788507316462852,1.0,28/135,14.56%,PLCE1;RAPGEF2;RASGRP2;BCAR1;ROCK1;STK38L;NRG3;RIT2;ROS1;RAP1A;MTOR;AP2S1;PAK5;ALKBH4;ERMN;HIP1;NCLN;CAMSAP3;ABL2;SPOCK1;PACSIN3;SLITRK2;PTPN1;HNRNPU;TRAF2;URI1;RAB5A;ANKRA2
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),0.43909819379870296,0.9218169961156786,0.5190156599552572,0.8781928798859111,1.0,1/10,0.85%,CBFA2T3
prerank,negative regulation of glycolytic process (GO:0045820),0.43909819379870296,0.9218169961156786,0.5190156599552572,0.8781928798859111,1.0,1/10,0.85%,CBFA2T3
prerank,positive regulation of lymphocyte activation (GO:0051251),0.3760540378700138,0.921735844304112,0.5338983050847458,0.8775577400289614,1.0,3/28,7.63%,SH3KBP1;TNIP2;FGF10
prerank,regulation of trophoblast cell migration (GO:1901163),0.408059783902643,0.921712113044417,0.49145299145299143,0.8768044294960919,1.0,4/14,8.05%,NODAL;SYDE1;YTHDF3;ARHGDIB
prerank,positive regulation of fatty acid metabolic process (GO:0045923),0.4098968861713919,0.9212695254113865,0.4959016393442623,0.8769234857356787,1.0,2/15,4.22%,NR1H3;PPARD
prerank,hyaluronan metabolic process (GO:0030212),0.38314564550327534,0.9208570891471847,0.52734375,0.876952388193085,1.0,4/23,4.24%,CEMIP2;IL1B;HYAL4;FGF2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.40984834227200423,-0.9206710494961291,0.5779816513761468,0.8522353681387687,1.0,7/11,43.78%,TAF9B;CD44;KDM1A;CD74;MUC1;TAF9;MIF
prerank,regulation of mRNA catabolic process (GO:0061013),-0.2512690581245057,-0.9203983741203406,0.6439169139465876,0.8522257347968999,1.0,37/121,24.71%,SAMD4A;VIM;CNOT7;MOV10;PRKCD;IGF2BP2;RC3H2;AKT1;ZC3H12A;PSME2;PUM1;PSMB4;UBB;CNOT8;PSMB1;PSMD11;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PNPT1;PSMD4;PSMA2;CSDC2;ZFP36L2;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),-0.3789988278983968,-0.9194026783498871,0.5774647887323944,0.853888159329772,1.0,4/14,25.84%,GAS6;PTPN2;RFFL;PYDC1
prerank,actomyosin structure organization (GO:0031032),0.3184620409518703,0.9193257249406078,0.5484375,0.8792851319671092,1.0,17/75,11.07%,TNFAIP1;EPB41L2;MYH9;ROCK1;CUL3;EPB41;ITGB5;CDC42BPA;TMOD1;PDCD10;TMOD3;ITGB1;PDLIM1;KCTD13;ALKBH4;LMOD1;CASQ1
prerank,regulation of epithelial cell differentiation (GO:0030856),-0.3584635537184139,-0.9191267739170281,0.5679012345679012,0.8538781491720023,1.0,3/17,3.26%,OSR1;CAV1;MAFG
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.3185344178461672,-0.9188672731742192,0.5968819599109132,0.8538272321532185,1.0,8/29,24.97%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;LSM7
prerank,negative regulation by host of viral process (GO:0044793),-0.4161405332578074,-0.9179523989160502,0.5821428571428572,0.8552509404206837,1.0,4/10,26.14%,ZC3H12A;VAPA;PRKN;EIF2AK4
prerank,negative regulation of cell division (GO:0051782),-0.4003123067714235,-0.9178413364281698,0.5916030534351145,0.8548803735758056,1.0,2/11,8.52%,TXNIP;ZFYVE19
prerank,ribosomal large subunit biogenesis (GO:0042273),-0.2836611318992377,-0.9177026729765948,0.6122931442080378,0.8545544461535244,1.0,20/54,31.36%,NSA2;SDAD1;RPL11;PAK1IP1;RPL24;RPL14;RPL26;RPL10;RPL7;RPL10A;EBNA1BP2;RPLP0;MRPL1;RPL35A;RRS1;NHP2;MAK16;RPF1;HEATR3;RPL23A
prerank,negative regulation of B cell activation (GO:0050869),0.3916201733125529,0.9176756890709896,0.5342741935483871,0.8818287949960821,1.0,3/21,9.11%,TNFRSF21;CD300A;LYN
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.3139554085212616,0.9175783280219836,0.5585738539898133,0.8812188629332842,1.0,10/74,12.13%,LIMD1;NOTCH1;RBX1;EPAS1;PSMB11;PSMF1;ARNT;CITED2;EP300;PSME4
prerank,positive regulation of DNA metabolic process (GO:0051054),0.32530290108173754,0.9170587324248137,0.5384615384615384,0.8814593409466298,1.0,9/61,10.14%,PDGFRB;RGCC;MECP2;FGF2;FGF10;EYA3;PRKD2;PDGFB;TOX
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.3422952037307527,0.9169762754589975,0.5271739130434783,0.8808298703910591,1.0,5/43,5.74%,PDGFRB;RBPMS2;LDLRAP1;FGF2;HTR1B
prerank,positive regulation of interleukin-17 production (GO:0032740),-0.3423603987429563,-0.9169484236296076,0.5853174603174603,0.855673389052792,1.0,5/22,13.40%,IL15;SLC7A5;IL18;TGFB1;SPHK1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.3086459606554792,0.9169272946686648,0.569620253164557,0.8801459287512665,1.0,14/86,11.94%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1;NAV3;BIN1;EFEMP2;NCKAP1;LMOD1;PAK1;RB1;CFL2
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.3706291186307663,-0.9168524788967761,0.5606060606060606,0.8552576595174344,1.0,5/16,19.90%,TMEM50A;CHMP4B;CHMP4A;LEPROT;VPS28
prerank,positive regulation of protein deacetylation (GO:0090312),-0.3825369184494978,-0.9166725047034793,0.5708812260536399,0.8550218033514049,1.0,4/14,23.38%,SAP30BP;FNTA;NNMT;CTBP1
prerank,regulation of p38MAPK cascade (GO:1900744),-0.3054832952738699,-0.9166486878304485,0.5816554809843401,0.8544467438520323,1.0,13/35,16.35%,DLG1;SASH1;XDH;EZR;LGALS9;MFHAS1;DUSP1;DAB2IP;ZC3H12A;RELL1;SPHK1;DUSP10;MAP3K4
prerank,negative regulation of platelet activation (GO:0010544),-0.3731409085652956,-0.9163911111026405,0.5992779783393501,0.8544396476454216,1.0,6/16,8.03%,PDGFRA;APOE;NOS3;THBD;CD9;PRKCD
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.40389039768360147,-0.9161818538240042,0.5906542056074766,0.8542910863507095,1.0,8/11,37.68%,PPHLN1;TPR;SETDB1;MPHOSPH8;DNMT1;SIRT6;SETDB2;TRIM28
prerank,regulation of axon guidance (GO:1902667),-0.4220504504336439,-0.9160427140639762,0.5778611632270169,0.8539583063832795,1.0,2/10,11.44%,NRP1;ZSWIM6
prerank,regulation of isotype switching (GO:0045191),-0.37438300458693147,-0.9159891953122649,0.5989010989010989,0.8534620062233054,1.0,4/14,14.40%,TFRC;PARP3;SHLD1;KMT5C
prerank,response to cAMP (GO:0051591),-0.29989243712170033,-0.9159166636715373,0.5890688259109311,0.8529980668797135,1.0,10/37,14.05%,IGFBP5;EZR;RAP1B;STAT1;RAPGEF1;KCNQ1;AKAP9;AHR;SLC5A5;NDUFS4
prerank,regulation of vacuole organization (GO:0044088),0.39552910278398284,0.9156594723014022,0.5357873210633947,0.8819479052212118,1.0,9/20,18.62%,IFT20;TBC1D12;PIKFYVE;NPRL3;NPRL2;UBQLN2;RAB5A;RAB1B;ENO2
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.4310695876723,0.9153838104046127,0.5333333333333333,0.8816913374087614,1.0,6/10,22.21%,CBARP;GPR35;FMR1;GNB5;CALM3;DRD2
prerank,regulation of transferase activity (GO:0051338),-0.36011082002765954,-0.9152555827727171,0.573076923076923,0.8538741098145896,1.0,5/17,19.15%,SMG6;PINX1;NLRC5;ATM;PPP1R3F
prerank,negative regulation of protein-containing complex assembly (GO:0031333),-0.28337942415089207,-0.9151808297099978,0.6202247191011236,0.8534064932842951,1.0,5/49,7.42%,LDLRAD4;SMAD6;IAPP;PRKCZ;HSPA5
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),0.4057075802343719,0.9151626386902918,0.508298755186722,0.8813572716137356,1.0,5/14,18.54%,ADK;ADSL;PPAT;IMPDH2;RFK
prerank,positive regulation of neuroinflammatory response (GO:0150078),0.4229698590820378,0.9150923235305886,0.5222929936305732,0.8806994017422951,1.0,3/12,6.28%,IL1B;TAFA3;TTBK1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.38133221345300705,0.9150739599164516,0.5448717948717948,0.879953661087621,1.0,2/22,2.62%,GCNT2;IL1B
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.251415490739304,0.914676309791459,0.6666666666666666,0.8799354528132874,1.0,81/497,14.20%,PTPRK;KCTD1;TBX2;LIMD1;LIMS1;HEY2;RORB;CBFA2T3;HEYL;ZEB1;DPF3;NOTCH1;TBX20;PER2;LBH;BTRC;TBX3;FOXM1;NRG1;NR1D2;NAB1;CBX5;PHC3;PHC2;MECP2;PPARD;DHFR;PHC1;HEXIM1;TFAP2B;IL4;ARID5A;DDX3X;SFPQ;CBX3;KAT7;CDKN1A;NANOS1;TRIM33;MYB;NR2F2;RUNX2;CCAR2;PDGFB;MTERF3;CNOT9;TIMELESS;PSPC1;ATR;EID1;RLIM;CITED2;NKX6-2;MALSU1;WAPL;KAT6A;SFMBT2;LOXL3;SAMD13;RB1;RBM15;SPEN;BCLAF1;RCOR1;FOXS1;THRA;SET;TRAF6;CRY1;CDAN1;TSC22D4;DMAP1;CNOT10;PAIP2;LSM14A;NIPBL;SFRP2;CIART;SIX4;PUS7;RAD17
prerank,protein modification by small protein removal (GO:0070646),-0.22232225670853978,-0.9141327139396497,0.72,0.8551512359464856,1.0,79/252,26.95%,SMAD3;ESR1;SMURF2;USP47;TGFBR1;KAT2B;SMAD7;USP46;AR;USP12;INO80;RHOA;USP8;BIRC3;USP15;TRRAP;USP18;HGS;IL33;HIF1A;FOXK1;BECN1;USP34;ZC3H12A;USP35;USP11;USP5;PSME2;SENP3;MDM2;COPS4;USP49;PSMB4;UBB;COPS8;INO80D;ACTB;PSMB1;PSMD11;NEDD8;PSMD8;PSME3;RIPK1;ACTR8;NFKBIA;ADRB2;PSMD4;STAMBP;PSMA2;BABAM2;VCP;TAF9B;IKBKG;USP22;SNX3;PSMD3;USP36;PSMB7;BABAM1;CCP110;BAP1;USP2;PSMC2;BRCA1;USP10;PSMC5;PSMD10;COPS7A;SUDS3;ACTR5;PRKN;ABRAXAS2;TP53;CDC25A;SMAD4;SENP8;INO80E;COPS2;ATXN3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.38947307375644746,-0.9140518681521038,0.5774378585086042,0.8546938887066846,1.0,7/13,24.28%,ABCA1;CD9;CDH13;CD81;SYK;LPL;ITGB2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.28124042809027117,0.9137604501636897,0.6054131054131054,0.8810184090072309,1.0,24/159,8.63%,ADGRL3;CDH2;CDH4;CLDN10;CLDN15;PCDHB11;LRRC4C;ATP2C1;LRFN5;IGSF11;CNTN4;ITGB1;CDH8;CDH22;CRB1;CDH19;CDH20;CDH7;CNTN6;PTPRT;ROBO2;TENM4;IL1RAPL1;SLITRK1
prerank,protein-containing complex disassembly (GO:0032984),-0.27900522937601907,-0.9137205399951007,0.6199095022624435,0.8548143836639915,1.0,11/54,21.45%,LAMP2;CAV1;LRP6;FZD2;WIPI2;UVRAG;RPL23;GABARAPL1;FZD1;VCP;VAMP8
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.37070073775260826,-0.9135590180938544,0.5746268656716418,0.8545752365174137,1.0,8/15,30.32%,CNOT7;CPEB3;TNRC6A;TENT4B;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.4263762862913007,0.9129223230267779,0.5291666666666667,0.8818889997830632,1.0,2/13,6.03%,PID1;IL4
prerank,Golgi to lysosome transport (GO:0090160),0.4324223476181536,0.9128349185801218,0.5274725274725275,0.8812807583932281,1.0,4/11,12.86%,SORT1;AP1G1;EHD3;ANKFY1
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),-0.2610873679128873,-0.9121143092530573,0.6216867469879518,0.8571842736987244,1.0,13/76,13.40%,HDAC4;CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;ZC3H12A;PHF23;FANCI;SAE1;UBB;SPHK1
prerank,mammary gland development (GO:0030879),-0.34775616850515634,-0.9120024319629091,0.59765625,0.8568009894711509,1.0,3/21,2.43%,WNT4;GLI2;CAV1
prerank,mitochondrion localization (GO:0051646),0.3909820501942204,0.9119492334188898,0.5339805825242718,0.8822589792036769,1.0,6/19,17.43%,MARK1;MARK2;TRAK1;TRAK2;MFN1;HAP1
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.3122334798417926,-0.911825274583954,0.6075156576200418,0.8565689884164297,1.0,7/31,22.38%,RBP4;TFRC;EPHB2;SHLD1;KMT5C;XBP1;CLCF1
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),0.364885010367914,0.9118184224588732,0.5467196819085487,0.8817376732357385,1.0,9/26,14.44%,HEYL;NODAL;CNOT2;VPS18;CNOT9;VPS11;KANK2;CRY1;STRN3
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),0.4330445386384991,0.9117563405645657,0.5409090909090909,0.8810706016941303,1.0,2/10,7.30%,ATP1A2;BIN1
prerank,fatty acid catabolic process (GO:0009062),0.3230206943915706,0.9117556901100541,0.5964052287581699,0.8802868295817463,1.0,8/67,8.23%,CEL;ABCD2;SLC27A2;PPARD;HADHB;SLC27A4;ABHD3;ECI1
prerank,phospholipid biosynthetic process (GO:0008654),-0.3067716496194525,-0.9117509144178193,0.5793991416309013,0.8561150124602341,1.0,3/36,2.90%,SGMS1;AGPAT4;SGMS2
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3123320696882121,-0.9116486054273901,0.6070640176600441,0.855733324717496,1.0,9/31,24.97%,CNOT7;EDC3;DDX6;CNOT8;EXOSC5;LSM5;EXOSC7;POLR2G;LSM7
prerank,cellular response to oxidative stress (GO:0034599),0.2884247834211623,0.9112670386822124,0.5922038980509745,0.8805175511091092,1.0,12/118,9.02%,PTPRK;PLA2R1;NCF2;PRR5L;NCF1;SOD3;SNCA;MSRA;GPX3;ARNT;HTRA2;PKD2
prerank,long-chain fatty acid import into cell (GO:0044539),0.428753466737602,0.9109644485879749,0.5392781316348195,0.8803256492670413,1.0,5/10,21.36%,SLC27A2;SLC27A4;SPX;RPS6KB1;ACSL1
prerank,organonitrogen compound catabolic process (GO:1901565),0.32442996150709114,0.9109427560185753,0.5754385964912281,0.8795803759518825,1.0,8/57,8.14%,ENPEP;CTH;ANPEP;TXN2;LIPC;PPT1;TRHDE;MTOR
prerank,positive regulation of JUN kinase activity (GO:0043507),0.3818928515875907,0.9104493214651191,0.5528942115768463,0.8797809488976526,1.0,7/23,15.58%,MAP3K5;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,peptidyl-serine phosphorylation (GO:0018105),0.2831639167884179,0.9103690659292025,0.6044444444444445,0.87917467125469,1.0,31/153,13.45%,MAST4;PKN1;MARK1;ROCK1;AKT3;RPS6KA4;STK39;STK38L;RPS6KB2;CSNK1G1;RPS6KA2;TNKS;TTBK1;PIKFYVE;MTOR;MARK2;PRKD2;PDGFB;CSNK1E;MAP4K1;NEK6;ATR;DYRK3;BRSK1;HIPK1;LATS2;PRKX;NLK;PRKDC;RPS6KA6;MKNK1
prerank,homeostasis of number of cells (GO:0048872),0.4232551579064384,0.910246468188667,0.5462012320328542,0.8786439448845851,1.0,2/12,4.99%,NOTCH1;CARD9
prerank,regulation of mRNA polyadenylation (GO:1900363),0.40607837411825165,0.9101169951602451,0.554639175257732,0.8781133662430229,1.0,6/17,18.89%,CPEB1;NCBP2;CPSF6;CTR9;HSF1;CPSF7
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.41184344839143694,-0.9097611770994596,0.5892857142857143,0.8592852573695647,1.0,6/10,35.16%,HDAC5;PIH1D1;BRCA1;SMAD4;SPHK2;CHEK1
prerank,cell projection organization (GO:0030030),-0.31304850742459944,-0.9094479317777998,0.6155555555555555,0.8593117435231343,1.0,3/30,3.44%,GSN;RHOQ;PARVB
prerank,negative regulation of metabolic process (GO:0009892),0.32501749478912306,0.9092893037189409,0.5377855887521968,0.8790049915583846,1.0,4/54,2.62%,PLCL1;NOTCH1;NR1H3;IL1B
prerank,protein alkylation (GO:0008213),0.37326248450830507,0.9087653245962478,0.542016806722689,0.8792691940077813,1.0,7/22,16.75%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;FAM98A;SNRPD3
prerank,positive chemotaxis (GO:0050918),-0.36271680089145913,-0.9080253152245215,0.5932835820895522,0.8619026634357817,1.0,3/17,3.53%,NRP1;PTPRJ;ANGPT1
prerank,response to nutrient levels (GO:0031667),0.39430954676138286,0.9077449077976715,0.5668789808917197,0.8805135066053308,1.0,4/17,17.36%,UCN2;MTOR;PRKAA1;RPS6KB1
prerank,long-chain fatty acid biosynthetic process (GO:0042759),-0.3397851605820787,-0.9075079814805559,0.6121593291404612,0.8623830983740892,1.0,6/23,17.81%,GPX4;GSTM1;PTGS2;EPHX2;GSTM2;ALOX12
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),0.38449226494595845,0.9068381385862891,0.5517928286852589,0.8815607866292786,1.0,9/22,17.43%,AKAP6;RYR2;STAC;PKD2;CASQ1;ANK2;VMP1;HTT;HAP1
prerank,neutrophil chemotaxis (GO:0030593),0.3250902108953894,0.9066212482077204,0.5662020905923345,0.8812143961915955,1.0,6/53,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,cellular zinc ion homeostasis (GO:0006882),0.3741577013941148,0.9064964605020515,0.5551020408163265,0.8807103423419443,1.0,1/26,0.46%,SLC30A10
prerank,response to reactive oxygen species (GO:0000302),0.3232328090614379,0.9064237237439924,0.5866900175131349,0.8800812972783898,1.0,3/54,4.18%,PTPRK;NCF1;PDCD10
prerank,regulation of cytokine production involved in immune response (GO:0002718),-0.32934079011205764,-0.90604048157891,0.6112266112266113,0.865054718326779,1.0,4/22,6.94%,LACC1;WNT5A;TNFRSF1B;SLC7A5
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.3898650817788008,0.9059861000280207,0.5611650485436893,0.8801938123614144,1.0,5/21,7.70%,KCNE4;CACNA2D1;SCN5A;CACNA1D;KCNE5
prerank,natural killer cell activation (GO:0030101),0.37292896173298057,0.9059555724842444,0.5383104125736738,0.8794705120236748,1.0,4/23,10.14%,PIK3CD;AXL;KAT7;TOX
prerank,myelination (GO:0042552),0.33249387529127306,0.9057986354440931,0.5660377358490566,0.8790395918002539,1.0,7/46,6.50%,TNFRSF21;NF1;ABCD2;SCN2A;B4GALT6;TPPP;SCN8A
prerank,negative regulation of establishment of protein localization (GO:1904950),0.44930450671712324,0.905482554609498,0.5616740088105727,0.8789057707937505,1.0,2/10,3.97%,NDFIP2;CORO2B
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.30469893025855643,-0.9053646435048991,0.6051502145922747,0.8658768212374371,1.0,10/32,24.18%,FOXN3;RINT1;TAOK2;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1;BRCA1
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.35252279783573764,-0.9049982046064633,0.5884615384615385,0.8660963053294568,1.0,4/19,10.62%,PTPRJ;VCAM1;ADGRL1;KDR
prerank,receptor internalization (GO:0031623),-0.2856686653481695,-0.9046653535883592,0.594847775175644,0.8662618565421666,1.0,8/44,7.76%,CAV1;CALCRL;RAMP2;CD9;DNM3;ARRB1;SCYL2;TFRC
prerank,regulation of TORC1 signaling (GO:1903432),0.34824148397403787,0.9046171235709063,0.5325884543761639,0.8798578268895995,1.0,2/33,2.38%,SPAAR;SESN3
prerank,male gonad development (GO:0008584),-0.3019828085174209,-0.9045895715379124,0.5958762886597938,0.8658009983239913,1.0,11/34,29.06%,WNT4;AR;WNT5A;KIT;GATA6;NCOA4;CSDE1;COL9A3;ADAM21;BIK;WNT2B
prerank,histone H2A ubiquitination (GO:0033522),0.39038416982950097,0.9042449065262238,0.5566801619433198,0.8798534368907537,1.0,8/17,21.95%,RYBP;UBR2;KDM2B;SKP1;TRIM37;UBE2B;DDB2;UBE2A
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),0.4203256112696188,0.90400757293845,0.5442764578833693,0.8795613070394699,1.0,2/12,2.06%,HEYL;NODAL
prerank,neuron remodeling (GO:0016322),-0.4037311040053807,-0.9038478588564556,0.6189624329159212,0.8668104142897444,1.0,3/10,9.74%,APP;ANKS1A;EPHA8
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.35167505718562836,0.9036680515665113,0.5595238095238095,0.8794743722670296,1.0,13/29,20.38%,CNOT2;KCTD6;VPS18;UFM1;CNOT9;VPS11;KANK2;PAK1;STRN3;CNOT1;DDRGK1;KMT2D;WBP2
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.30134182988335634,0.9036500462073287,0.5691318327974276,0.878742848291577,1.0,14/87,12.13%,PTEN;CDK6;RGCC;RBX1;MYO16;PSMB11;PSMF1;CDKN1A;PKD2;KANK2;RBL1;RB1;APC;PSME4
prerank,protein kinase A signaling (GO:0010737),-0.3879165422797178,-0.9033924504968569,0.5893186003683242,0.8671212392618545,1.0,8/12,41.91%,EZR;PRKACB;LCP1;RDX;PRKACA;RAB13;TCP11X2;TCP11
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.32912056408655416,-0.9024393425076856,0.6134122287968442,0.8686653266113483,1.0,14/23,27.43%,ENPP1;SUFU;GLIS2;TULP3;MGRN1;GLI3;PTCH1;VCP;MEGF8;RACK1;RFX4;GPR161;PTCH2;IFT122
prerank,glycosaminoglycan metabolic process (GO:0030203),0.324056355715369,0.9023359843877384,0.5917667238421955,0.8805768370632457,1.0,8/54,6.34%,GCNT2;SDC2;SDC3;HYAL4;AGRN;GPC5;GPC3;GNS
prerank,negative regulation of telomere maintenance (GO:0032205),-0.36657105953272806,-0.9022495144492657,0.5811623246492986,0.8684624364718689,1.0,7/15,23.51%,TNKS2;SMG6;PINX1;ATM;RAD50;SLX4;ERCC1
prerank,myotube differentiation (GO:0014902),0.4052365941915248,0.9021820319225696,0.5622489959839357,0.8801354888998919,1.0,3/17,3.69%,MEF2C;CACNA1H;SORT1
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),-0.36789489667103437,-0.9020827624224831,0.6112115732368897,0.8682152110881145,1.0,3/14,14.40%,TFRC;SHLD1;KMT5C
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.3928168146169645,0.9020562591347654,0.5635245901639344,0.8796232851260334,1.0,3/17,6.95%,NR1H3;SORT1;LIPC
prerank,protein ubiquitination (GO:0016567),-0.20620489343798848,-0.9020404736896771,0.8700564971751412,0.8676983937394952,1.0,113/471,21.99%,RNF220;FBXL7;PDZRN3;SH3RF1;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF38;RNF146;ZNRF1;ASB2;TAF1;RNF43;TRIM24;SPSB1;RNF19A;ARRB1;TNKS2;WWP2;RNF144B;HIF3A;RNF139;SMURF1;CDC16;KLHL2;SH3RF3;SH3RF2;RNF103;AMFR;UBE2E2;LNPEP;RTF1;RC3H2;NHLRC3;CHFR;MKRN2;RNF185;DTX3L;HIF1A;KCTD10;RNF135;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;PSME2;UBE4B;CUL4A;ASB5;RNF125;MDM2;TRIM63;PSMB4;UBE2Q2;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ELOB;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;DTX1;TRIM17;RNF115;WWP1;FBXL14;ANKIB1;FBXL2;PSME3;RNF187;ASB1;RNF40;PELI1;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;ARRDC4;PSMD4;LONRF1;TRIM14;TRIM47;PSMA2;TRIM41;FBXO41;VCP;USP22;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RMND5A;RNF126;PSMB7;GAN;ELOC;CUL5;RBBP6;RNF182;CUL9;DZIP3
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.3763551406509089,0.9019362311633145,0.5651340996168582,0.8790816362630947,1.0,7/23,18.38%,METAP2;GUCY2D;PDE6A;GRK4;GUCY2F;SAG;METAP1
prerank,mature B cell differentiation involved in immune response (GO:0002313),0.4136337820562015,0.9011480343947945,0.5463510848126233,0.8798970854039816,1.0,1/12,0.75%,DOCK10
prerank,positive regulation of protein kinase activity (GO:0045860),0.2770159154212485,0.9007610619424571,0.6212338593974175,0.87989114263821,1.0,29/148,13.16%,IL34;RAPGEF2;PTK2;AGAP2;DOK7;GRM5;PDCD10;MINK1;SPDYA;TTBK1;SNCA;DDX3X;TAOK3;EMP2;RAP1A;PAK6;CDKN1A;STK3;MARK2;MAP4K4;PDGFB;PAK5;PAK3;ETAA1;PAK1;SRC;DLG3;TRAF6;PTPN1
prerank,protein localization to lysosome (GO:0061462),-0.3180640235869567,-0.9006705638690505,0.605427974947808,0.8701304848933348,1.0,12/28,30.52%,HGS;AP4M1;RAB7A;ZFYVE16;LAMTOR5;SH3BP4;CD81;KPTN;NCOA4;ATP13A2;LAPTM5;NEDD4
prerank,positive regulation of cell growth (GO:0030307),-0.24596011575427734,-0.9005171216126361,0.6703296703296703,0.8698674930149021,1.0,20/96,16.43%,IGF1;EGFR;MACF1;USP47;TGFBR1;SEMA7A;ADAM10;SDCBP;SMURF1;INO80;H3-3A;MMP14;AKT1;MFSD2A;DDX49;SPHK1;SFRP1;CXCL16;NTN1;RUFY3
prerank,cellular amide metabolic process (GO:0043603),-0.2483042316227406,-0.9003164503067338,0.6606060606060606,0.8697026102586917,1.0,25/102,20.03%,AEBP1;PLPP3;PCCA;ST3GAL1;CPE;SMPD3;ACOT11;NAAA;NSMAF;PCCB;CPXM2;SLC5A6;CPXM1;ALDH1L1;PLPP1;PLA2G15;NNMT;ACOT6;ACOT9;FPGS;CLN8;NIT1;ORMDL3;GNE;CPD
prerank,negative regulation of lymphocyte activation (GO:0051250),0.38247455670675545,0.9000108324115864,0.5392354124748491,0.8806633567943064,1.0,2/21,3.86%,PTPN22;PAG1
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.316958380841422,0.899677181823083,0.542314335060449,0.8805753698933654,1.0,3/51,2.51%,IL34;PTK2;PTN
prerank,regulation of ATP metabolic process (GO:1903578),0.3240982246625254,0.8994539420159314,0.5971731448763251,0.8802513202480875,1.0,12/54,11.70%,SLC25A33;ATP7A;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300;ATP5IF1
prerank,regulation of microtubule depolymerization (GO:0031114),0.37484418835167344,0.8993766119334599,0.5711462450592886,0.8796484873541176,1.0,7/25,13.12%,SPEF1;FGF13;NAV3;CLASP2;CAMSAP3;APC;APC2
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.36206444777846314,0.8993472303757093,0.5359848484848485,0.8781887127649852,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.36206444777846314,0.8993472303757093,0.5359848484848485,0.8781887127649852,1.0,7/29,15.91%,ACSF2;BAAT;ACOT12;ACOT2;GLYAT;MLYCD;ACOT7
prerank,heart process (GO:0003015),-0.3719038941249414,-0.8982851317063953,0.6243194192377496,0.8734493733099444,1.0,2/14,5.89%,SGCD;ACE
prerank,regulation of microtubule-based process (GO:0032886),0.34698016749913335,0.8976378136610751,0.5695488721804511,0.8807312292561936,1.0,15/36,18.48%,PHLDB2;ROCK1;CLASP2;TPPP;MARK2;BICD2;CAMSAP3;APC;PHLDB1;PRKAA1;MAP10;CDK2AP2;TRAF3IP1;GSK3B;MARK4
prerank,female gonad development (GO:0008585),-0.3390161363713315,-0.897476313006931,0.5854126679462572,0.8745866502692836,1.0,8/19,28.26%,KIT;EIF2B2;CEBPB;VEGFA;EIF2B5;FOXL2;COL9A3;EIF2B4
prerank,T cell differentiation (GO:0030217),0.3353077385364711,0.8973271968614123,0.5692599620493358,0.8805989129748236,1.0,6/40,6.89%,PIK3CD;PTPN22;GPR89A;GPR89B;SOX4;LIG4
prerank,histone H2A acetylation (GO:0043968),-0.36070596955722356,-0.8972658652019322,0.6350806451612904,0.8744163948051037,1.0,7/16,28.35%,TRRAP;MEAF6;NAA40;MORF4L2;BRD8;EPC1;SPHK2
prerank,cellular response to hormone stimulus (GO:0032870),0.31385888877374485,0.8970451695564948,0.5852090032154341,0.8804144324449197,1.0,10/69,9.43%,MEF2C;ATP1A2;GPER1;CACNA1H;SLIT3;NCOA3;ARID5A;ROBO2;GCK;MED1
prerank,histone H4-K16 acetylation (GO:0043984),0.3765410845426844,0.8961156515103021,0.5634095634095634,0.8815081544187585,1.0,8/19,19.14%,OGT;KAT7;KANSL3;KANSL1;KMT2A;MSL2;MCRS1;WDR5
prerank,endomembrane system organization (GO:0010256),0.27048528658471216,0.8959675310806341,0.6324549237170597,0.8810601606086214,1.0,45/178,17.74%,ARHGAP21;DYSF;SYNE1;SPTBN1;TMCC1;TOR1B;COG7;SYNGR1;ATP8B2;COG1;CLASP2;ANK3;CHMP2B;ARFGEF1;HACE1;VPS18;BLZF1;HOOK3;RNF112;MIA3;TMED7;VPS11;UBXN2B;TMED4;AKTIP;ARHGEF7;SYP;VPS51;PLEKHJ1;WASHC5;TRIP11;USP50;SERP1;TJAP1;VPS33B;VMP1;RAB1A;TOR1A;PRKD1;HTT;CSNK1A1;DNM1;GORASP1;GOLGA8B;GOLGA5
prerank,negative regulation of cholesterol transport (GO:0032375),0.4201136029120418,0.8959288506024277,0.5317286652078774,0.8803762423875294,1.0,1/10,5.07%,SREBF2
prerank,regulation of viral entry into host cell (GO:0046596),0.3611718458665196,0.8958217416067997,0.572289156626506,0.8798201898761235,1.0,4/30,8.52%,TMPRSS4;MID2;TRIM62;TMPRSS2
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),-0.2564950551303905,-0.8957856305894171,0.6704225352112676,0.8770243491336905,1.0,13/73,14.30%,EGFR;NTRK3;APP;CAV1;GAS6;FNIP1;TFRC;AKT1;IRGM;AKAP9;TGFB1;TXN;HSP90AB1
prerank,T cell activation (GO:0042110),0.30821756411573964,0.8956051908631746,0.586490939044481,0.879515955527021,1.0,8/69,6.56%,PIK3CD;NCK2;PTPN22;PPP3CA;GPR89A;GPR89B;IL4;SOX4
prerank,positive regulation of cartilage development (GO:0061036),0.3956932388578683,0.8952041592586184,0.5610766045548654,0.8795870669343908,1.0,1/17,0.56%,SOX5
prerank,regulation of embryonic development (GO:0045995),-0.3028409781503908,-0.8951855670557484,0.6193548387096774,0.8777599965148921,1.0,7/34,13.79%,PLCB1;NIBAN2;NR2C2;EHMT1;POGLUT1;TDG;SOX17
prerank,vesicle organization (GO:0016050),-0.28138889912918935,-0.8951612227981172,0.6409090909090909,0.8771914536624099,1.0,14/46,19.11%,CAV1;FNBP1L;CD34;SRGN;USP8;ALS2;ALS2CL;CAV2;SNX10;PHETA1;ARFGEF2;ZFYVE16;SAR1A;SAR1B
prerank,ncRNA export from nucleus (GO:0097064),0.341042586647722,0.8949000459216029,0.5766423357664233,0.8794282998581204,1.0,11/36,17.70%,NUP43;NOL6;NCBP2;SSB;NUP35;SEC13;NDC1;PHAX;RANBP2;TSC1;NUP133
prerank,positive regulation of neuron death (GO:1901216),-0.2823932249396087,-0.894754063035933,0.6490066225165563,0.8774562868900877,1.0,5/46,6.26%,EFNB2;EPHA7;FOXO3;NUPR1;WNT5A
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.25270079482123403,-0.8943381130307223,0.6693333333333333,0.8777665723668883,1.0,12/84,15.04%,CELF2;RBFOX2;MBNL1;DDX5;THRAP3;NOVA2;SON;MBNL2;NOVA1;SRSF10;FXR2;NUP98
prerank,regulation of kinase activity (GO:0043549),0.30132243036266343,0.8937990002530394,0.5894909688013136,0.8809096292699813,1.0,19/89,13.28%,PDGFRB;PLCE1;ROR1;MERTK;ERBB4;AXL;RYK;ROS1;NTRK2;EMP2;ANKRD54;EPHA2;EPHA10;RBL1;RB1;EPHB1;FGFR3;NPRL2;HNRNPU
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.32659192481390975,0.8937901800415735,0.5834767641996558,0.8801727705349003,1.0,4/46,4.75%,PTEN;GPER1;SPRED1;SPRY2
prerank,negative regulation of protein polymerization (GO:0032272),-0.3136650666030981,-0.8936785328861562,0.6028513238289206,0.8785343595664704,1.0,7/27,13.17%,CDH5;SLIT2;KANK3;PRKCD;EML2;PFN1;TWF1
prerank,receptor metabolic process (GO:0043112),-0.27877979229059313,-0.8935327140233278,0.6269035532994924,0.8782461784062012,1.0,17/53,19.93%,CAV1;CALCRL;RAMP2;CD9;DNM3;SMURF1;TFRC;BECN1;TGFB1;SH3GLB1;GRK2;UVRAG;PHETA1;ARFGEF2;REP15;CD81;SYK
prerank,positive regulation of immune system process (GO:0002684),0.3989209167229037,0.8934447025290608,0.5472061657032755,0.8800964105484816,1.0,1/16,0.77%,PIK3CD
prerank,hepaticobiliary system development (GO:0061008),-0.3457750919666449,-0.893126804123031,0.6297786720321932,0.8785339633998586,1.0,3/20,4.43%,TGFBR3;WNT4;LSR
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2581632110452026,-0.8931207815405293,0.6532258064516129,0.877927095756476,1.0,29/80,22.31%,SGSM2;SNX6;TRAPPC10;SNX32;ERC1;VPS50;STX6;TRIM27;VPS35;LMAN1;RAB7A;TBC1D10A;EVI5;RGP1;SURF4;WASHC1;PHETA1;HEATR5A;RAB29;RAB6A;VPS52;SNX8;SNX3;SPAG9;TMED9;TBC1D14;RNF126;CLN5;SNX2
prerank,cell differentiation in spinal cord (GO:0021515),0.42804574240295057,0.8928630536792725,0.5555555555555556,0.880498733529872,1.0,4/10,12.91%,SOX4;MDGA2;SOX6;ZC4H2
prerank,positive regulation of integrin activation (GO:0033625),-0.394317630350451,-0.8928318171331993,0.6088560885608856,0.8779288999588488,1.0,3/11,6.16%,RAP1B;PIEZO1;RASIP1
prerank,spliceosomal complex assembly (GO:0000245),-0.2836511532161175,-0.8923313315600331,0.6294536817102138,0.8783862443227857,1.0,14/46,27.77%,CELF2;LUC7L;SRSF10;SNRPD1;SNRPD2;SRSF6;SRPK1;SRSF5;SF3A3;CELF5;SRPK2;PUF60;PRPF19;SNRPE
prerank,zinc ion homeostasis (GO:0055069),0.36230600102759236,0.8920716531882451,0.572289156626506,0.8813136949732816,1.0,1/28,0.46%,SLC30A10
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.39714977915706806,0.8911604888969582,0.5757575757575758,0.8823581363840255,1.0,3/15,6.95%,SCARB1;ABCA5;LIPC
prerank,regulation of presynapse organization (GO:0099174),0.387550126550631,0.890889995228166,0.5564681724845996,0.8813960645506684,1.0,6/18,12.82%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,regulation of presynapse assembly (GO:1905606),0.387550126550631,0.890889995228166,0.5564681724845996,0.8813960645506684,1.0,6/18,12.82%,LRFN5;SNCA;IL1RAPL1;SLITRK1;IL1RAPL2;SLITRK2
prerank,inositol phosphate biosynthetic process (GO:0032958),0.4189287401943702,0.890787987002651,0.5512820512820513,0.8808501347617622,1.0,4/11,15.47%,FGF2;ITPKB;IPMK;IPPK
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.3046329151707275,0.8907153516159464,0.5924092409240924,0.880230715117049,1.0,6/76,3.29%,CARMIL1;NCK2;SEMA5A;VASP;LIMK1;CDC42EP1
prerank,regulation of interleukin-13 production (GO:0032656),0.3992989054489192,0.8903322592754026,0.5562248995983936,0.8802382822543541,1.0,2/13,6.03%,TNFRSF21;IL4
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.37250463560874403,-0.8894323849698331,0.5951035781544256,0.8840320114708233,1.0,5/12,18.44%,SNAP23;STX3;STX1A;SNAP47;STX2
prerank,positive regulation of T cell mediated immunity (GO:0002711),-0.32956602682988995,-0.88928541308027,0.6338028169014085,0.8837364698268031,1.0,3/22,5.73%,CD55;B2M;STX7
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.3983610493638998,-0.8888492204601732,0.6148007590132827,0.8839579510083027,1.0,3/10,8.76%,APOD;LRCH1;AKT1
prerank,regulation of response to external stimulus (GO:0032101),0.28728746342418393,0.8886488483863756,0.6358118361153262,0.882770958948151,1.0,8/121,3.73%,ACE2;GGT1;SPAAR;IL1RL2;METAP2;PTPN22;NR1D2;GUCY2D
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.3370745926713973,-0.8885728270468791,0.586073500967118,0.8839406128810778,1.0,2/20,1.64%,DAB2;RHOQ
prerank,NADH dehydrogenase complex assembly (GO:0010257),-0.2719695486757312,-0.8883298140587428,0.6888888888888889,0.8832290921059557,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),-0.2719695486757312,-0.8883298140587428,0.6888888888888889,0.8832290921059557,1.0,18/56,26.22%,NDUFV3;DMAC2;NDUFAF5;NDUFB8;NDUFS4;NDUFC1;NDUFS5;NDUFA11;NDUFB5;NDUFA13;NDUFB4;NDUFA10;NDUFS7;NDUFB7;NDUFS8;NDUFS1;NDUFB10;NDUFA3
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.32235044739330093,0.8880290007731775,0.5864527629233511,0.8832580849470787,1.0,18/57,16.77%,MEF2C;BEGAIN;CACNG7;MINK1;GRIA2;NETO1;GRIN2B;DLG2;GSG1L;DLGAP2;DLG3;NPTXR;DLGAP1;SHISA8;GRIN2A;GRIA1;GRIA4;SHISA6
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),-0.2517346538797116,-0.8877728722590349,0.6840659340659341,0.8838096690836559,1.0,35/85,28.31%,DAB2;NUPR1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;RNF185;BBS7;DAB2IP;USP5;ECSCR;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMC2;PSMC5;PSMD10;RACK1;PRKN;ATXN3;CEBPA;TRIB3;HSPA1B;CLU
prerank,regulation of leukocyte migration (GO:0002685),-0.3521129772362519,-0.887496669958638,0.61,0.8837737061863327,1.0,8/16,38.16%,ANXA1;RHOH;CD81;VEGFA;NCKAP1L;HMOX1;BST1;RAC2
prerank,negative regulation of protein metabolic process (GO:0051248),-0.2761835389260963,-0.8874108514189998,0.6357615894039735,0.8833312436753445,1.0,10/48,14.67%,EGFR;APOE;IAPP;PFDN5;FLOT2;IRAK3;PRKCG;ITGB3;HSP90AB1;PFDN2
prerank,protein stabilization (GO:0050821),-0.2254797038237602,-0.8871897204426301,0.7640845070422535,0.8831675350639338,1.0,56/168,28.91%,IGF1;EPHA4;ATP1B3;LAMP2;PLPP3;RASSF2;SMAD7;TAF1;STXBP4;PRKCD;BAG3;IRGM;FLOT2;RAB21;RPL11;PFN1;WDR81;CALR;TRIM39;SOX17;HYPK;HSP90AB1;PARVA;RPL23;SUGT1;RPS7;PARK7;HPS4;CHP1;MT3;PIM2;PPARGC1A;RABL3;GET1;TAF9B;USP36;TYROBP;BAG2;TMEM88;IFT46;MCM8;USP2;CHEK2;ZSWIM7;CDK7;PRKN;GNAQ;BAG5;MSX1;CRTAP;SEC16A;HSPA1B;MORC3;CLU;SYVN1;BAG1
prerank,protein deneddylation (GO:0000338),-0.39239993002203233,-0.8871417151046816,0.621832358674464,0.882662092782713,1.0,4/10,26.75%,COPS4;COPS8;COPS7A;COPS2
prerank,polarized epithelial cell differentiation (GO:0030859),-0.3803893498767642,-0.8871095770737093,0.6478599221789884,0.8821191260797536,1.0,7/13,28.85%,EZR;RHOA;MYO9A;OPHN1;ZDHHC7;SCRIB;RAP2A
prerank,negative regulation of MAP kinase activity (GO:0043407),0.32687598201884804,0.8868641024039842,0.5883361921097771,0.8848409677011256,1.0,8/44,6.00%,SPRY4;NF1;IL1B;PTPN22;SH2B3;SPRY2;CD300A;UCHL1
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.2963706828704838,0.8865125030644584,0.6152647975077882,0.8848234401074357,1.0,17/100,10.67%,GLMN;CBFA2T3;PABIR1;RBX1;RYBP;SOCS5;OGT;TRIB2;DESI1;RCHY1;ZER1;GNA12;CCAR2;DET1;CSNK1E;NKD2;XPO1
prerank,vitamin transport (GO:0051180),-0.310736105940576,-0.8864650227379429,0.6125,0.8828734697132787,1.0,10/29,25.93%,PDPN;ABCG2;CUBN;SLC5A6;SLC35F3;SLC52A3;SLC19A2;SLC52A1;CD320;SLC25A32
prerank,positive regulation of lipid storage (GO:0010884),0.3724957908565516,0.8863028500145897,0.5745098039215686,0.8844788078831297,1.0,4/21,9.22%,SCARB1;SREBF2;MSR1;VSTM2A
prerank,regulation of protein localization (GO:0032880),-0.26855841260926344,-0.8855261706571718,0.6907730673316709,0.8842399179290195,1.0,11/58,14.66%,AFDN;DLG1;RABGAP1L;USP8;FKBP1A;STX6;TRIM27;ITGB3;DNAJB6;HSP90AB1;TRIM17
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.2532837351588121,-0.8853772925156936,0.6747311827956989,0.8839757120626002,1.0,31/85,24.71%,SMURF2;MAGI2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,release of cytochrome c from mitochondria (GO:0001836),-0.3462722955898648,-0.8853458892651596,0.6182902584493042,0.8834411224023363,1.0,10/17,39.33%,BID;BBC3;BCL2L1;SFN;TIMM50;SOD2;CLU;DNM1L;BAX;GGCT
prerank,mRNA polyadenylation (GO:0006378),-0.3235569326320992,-0.8852682256371465,0.6439232409381663,0.8823609625541643,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,RNA polyadenylation (GO:0043631),-0.3235569326320992,-0.8852682256371465,0.6439232409381663,0.8823609625541643,1.0,12/26,31.08%,APP;AHCYL1;MTPAP;GRSF1;PNPT1;PAPOLB;TENT4B;FIP1L1;CPSF2;WDR33;PAF1;CPSF1
prerank,eye photoreceptor cell differentiation (GO:0001754),0.4088168577279741,0.8842480564508789,0.5856832971800434,0.8878351240042555,1.0,1/12,0.82%,RORB
prerank,mitochondrial transport (GO:0006839),-0.27257123421866103,-0.8840519293603701,0.6456876456876457,0.884302220332684,1.0,19/53,24.76%,MTX2;SLC25A4;SLC25A24;TOMM7;STARD3;SPG7;BNIP3;GDAP1;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;MAIP1;TIMM9;TMEM14A;TIMM44;BCL2L1
prerank,response to steroid hormone (GO:0048545),-0.3072776588673921,-0.8839251595148719,0.6454918032786885,0.8839364734958891,1.0,8/31,13.64%,NR3C1;CAV1;THBS1;AR;YAP1;TGFB1;ATP1A1;ATP1A3
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),-0.22625502027431674,-0.8835362105360902,0.768976897689769,0.8841286922654169,1.0,40/158,19.80%,AKAP13;LPAR1;GJA1;MAP3K14;NOD1;CFLAR;TNFSF10;LGALS9;IKBKE;RHOA;PRKCB;PLK2;FKBP1A;TFRC;BIRC3;EEF1D;TNFRSF19;ECM1;TNFRSF1A;CASP8;TRIM27;MAVS;PLEKHG5;RELA;TICAM1;VAPA;PELI1;TRIM8;RIPK1;TRAF3IP2;MAP3K3;CC2D1A;TRIM14;LAMTOR5;CANT1;PIM2;EDA2R;LGALS1;IKBKG;RHOC
prerank,regulation of establishment of protein localization (GO:0070201),0.3985173945743524,0.8835338789274876,0.5536105032822757,0.8885520011029772,1.0,3/13,16.20%,CORO2B;CEP120;CEP135
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.4295375354003169,0.8833666201891399,0.564935064935065,0.888105623944723,1.0,4/10,14.36%,BEGAIN;DLGAP2;NPTXR;DLGAP1
prerank,positive regulation of mRNA metabolic process (GO:1903313),-0.3713548344193337,-0.8828937119261325,0.6214689265536724,0.8848304553601098,1.0,5/13,16.56%,CNOT7;MOV10;ZC3H12A;CNOT8;PNPT1
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),-0.2936888932175971,-0.8827753357935743,0.6482758620689655,0.8844534885203298,1.0,13/38,24.23%,ESR1;STAT1;TLE1;CASP8;DAB2IP;ZC3H12A;TRIM39;PPM1B;RIPK1;RHOH;ZMYND11;MAPKBP1;USP10
prerank,chromatin assembly or disassembly (GO:0006333),-0.38654717261109894,-0.8825412821606259,0.6176470588235294,0.8843269534864275,1.0,1/11,2.35%,HDAC8
prerank,C21-steroid hormone biosynthetic process (GO:0006700),0.40580888283623073,0.8825383024327061,0.5622317596566524,0.8889957537932998,1.0,3/12,13.32%,CACNA1H;STAR;CYP11B1
prerank,negative regulation of axon extension (GO:0030517),0.34971416621448326,0.8823884994884034,0.5854126679462572,0.8885407263135849,1.0,4/30,4.82%,SEMA6D;MAP2;SEMA5A;SEMA6C
prerank,positive regulation of type 2 immune response (GO:0002830),-0.3610884379298921,-0.8815811553157393,0.629277566539924,0.8856897413882208,1.0,5/14,22.36%,PRKCZ;IL18;RSAD2;CD81;RARA
prerank,regulation of dephosphorylation (GO:0035303),-0.359006243890452,-0.8815596135920899,0.6287878787878788,0.8851282993079239,1.0,6/15,23.86%,SMG6;PPP1R16B;MTMR3;SMG5;CDK5RAP3;INPP5K
prerank,regulation of primary metabolic process (GO:0080090),-0.23428895641332337,-0.8813761242856811,0.7417417417417418,0.8849073625679961,1.0,38/126,24.71%,ROCK2;TBL1XR1;APOE;CHD9;CARM1;ACACA;PSAP;PSME2;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2;PSMB4;PRKAB1;PSMB1;PSMD11;IDI1;PSMD8;SREBF1;PSME3;ZFP69;ODC1;NFYB;OAZ1;PSMD4;PSMA2;ACACB;PSMD3;ADIPOR1;PSMB7;SIN3A;AZIN1;PSMC2;HELZ2;PSMC5;PSMD10
prerank,granulocyte differentiation (GO:0030851),0.379565405848028,0.881310555382068,0.5637149028077754,0.8899619477202803,1.0,4/18,11.61%,CBFA2T3;CDKN1A;DEK;EP300
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.31154822137316196,-0.8802829633809174,0.666,0.886550101242366,1.0,5/26,13.00%,NOD1;IRAK2;MAP2K6;CASP8;UBB
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3628261623234062,-0.8802289034907963,0.6242774566473989,0.8860509110471844,1.0,6/15,25.83%,NYNRIN;ZC3H12A;DICER1;NUDT16;ZC3H12B;POP1
prerank,response to progesterone (GO:0032570),-0.3433368475024928,-0.8802045504222554,0.6324110671936759,0.8854846027456553,1.0,4/18,11.59%,CAV1;THBS1;YAP1;TGFB1
prerank,cognition (GO:0050890),-0.28677576110485586,-0.8801399906624569,0.6537585421412301,0.8850153225686329,1.0,6/42,8.16%,ST3GAL4;CHD7;APP;SOBP;SHROOM4;STRA6
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.40720914218610543,0.880083734408547,0.5442764578833693,0.8915467680890211,1.0,1/11,1.19%,NOTCH1
prerank,regulation of telomere capping (GO:1904353),-0.32403483191788035,-0.8800663358352542,0.6213991769547325,0.8845782357298485,1.0,6/23,16.35%,TNKS2;SMG6;ATM;MAPK3;RAD50;MAP3K4
prerank,determination of bilateral symmetry (GO:0009855),0.37261475771919883,0.8799065992744919,0.6242544731610338,0.8911320196696453,1.0,3/24,10.34%,NOTCH1;PKD2;CITED2
prerank,regulation of protein localization to Cajal body (GO:1904869),0.4215052413533361,0.8796567287810756,0.5565217391304348,0.8901615138430498,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.4215052413533361,0.8796567287810756,0.5565217391304348,0.8901615138430498,1.0,11/11,57.88%,CCT7;CCT3;LARP7;DKC1;TCP1;CCT6A;CCT4;MEPCE;CCT8;CCT2;CCT5
prerank,protein maturation (GO:0051604),0.2909556749882264,0.8792075411093199,0.6325878594249201,0.890260975322049,1.0,8/95,5.31%,TMPRSS4;CPM;METAP2;ADAM19;TSPAN15;ECE1;TASP1;OGT
prerank,positive regulation of dendritic spine development (GO:0060999),-0.3351642233759495,-0.8785443225128733,0.6485981308411215,0.8870806023548792,1.0,4/20,13.27%,APOE;SHANK3;CPEB3;LRP8
prerank,mononuclear cell differentiation (GO:1903131),-0.31531646616086445,-0.878410192082762,0.6507936507936508,0.8867410529640039,1.0,4/24,5.09%,IL31RA;BMP4;PIR;GAS6
prerank,regulation of exocytosis (GO:0017157),0.32338706124981126,0.8783152598986433,0.6068840579710145,0.8912570337424033,1.0,17/46,18.98%,RAB8B;CLASP2;RIMS2;RAB3B;SNCA;LGI3;SYT1;IL1RAPL1;STXBP5L;STX4;RAB5A;CHMP3;HAP1;VAMP2;CPLX1;STXBP5;CADPS
prerank,regulation of protein localization to membrane (GO:1905475),0.35347365627744937,0.8779416508482102,0.6142034548944337,0.891261253869515,1.0,9/28,13.36%,LDLRAP1;SPTBN1;GPC5;GPC3;APPL1;PDZK1;ZDHHC2;NECAB2;VTI1B
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.30205098456337104,-0.8779290130846577,0.6437768240343348,0.8871391297404341,1.0,12/30,28.90%,FHIT;SDCBP;RPL11;TRIM39;HSP90AB1;HFE;STYX;PARK7;UBXN1;BAG5;EIF3H;USP14
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26992460273084645,-0.8775490814706989,0.660377358490566,0.8873409866128209,1.0,17/52,24.97%,SAMD4A;CNOT7;TUT4;TUT7;EDC3;DDX6;RC3H2;CNOT8;EXOSC5;CNOT3;PNLDC1;LSM5;CNOT11;PAN3;EXOSC7;SAMD4B;LSM7
prerank,protein tetramerization (GO:0051262),-0.2558364890446678,-0.8771847652970388,0.6989795918367347,0.8874996247209958,1.0,18/67,20.76%,ALDH1A2;KCNJ2;B2M;APPL2;SSBP1;UPB1;GLS;ACACA;SAMHD1;GBP5;KCNC3;PKD1;HOMER1;HSD17B8;ACACB;TRPM4;FARSA;MCOLN1
prerank,basement membrane organization (GO:0071711),0.39026504284095076,0.8770594590991229,0.5717299578059072,0.8922436143034821,1.0,5/14,5.23%,NID1;COL4A1;PXDN;NTNG2;LAMB1
prerank,carbohydrate derivative transport (GO:1901264),-0.34073955843853077,-0.8769960466152058,0.6339468302658486,0.88731321175375,1.0,6/18,14.57%,PLTP;LBP;NPC2;MFSD2A;SLC25A19;SLC29A1
prerank,regulation of extracellular matrix disassembly (GO:0010715),0.3951046775669431,0.8769476554580709,0.5775510204081633,0.8916979083562074,1.0,2/15,5.26%,FAP;CLASP2
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.3018023246359844,0.8758751160922829,0.5915254237288136,0.8930002946593372,1.0,16/67,16.84%,TBC1D1;PLD1;WAS;IFT20;MYO10;TBC1D2B;GAP43;TBC1D10C;EPHA2;TBC1D9B;TBC1D19;ABITRAM;RAB5A;TBC1D10B;FSCN1;FMR1
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.3432590029085703,-0.8756921459884931,0.6472868217054264,0.8895024810396669,1.0,6/16,16.96%,TNKS2;SMG6;NAF1;PINX1;ATM;SMG5
prerank,ribosome assembly (GO:0042255),-0.2745930645871803,-0.8754913728713836,0.6711111111111111,0.889317248887452,1.0,14/47,22.27%,RPS14;RPS19;RPL11;RPS5;RPL24;RPS27;MRPS7;RPL10;RPS15;RPSA;RPLP0;MPV17L2;RRP7A;RPS27L
prerank,regulation of T cell chemotaxis (GO:0010819),-0.3831380628882386,-0.8753646292504591,0.6071428571428571,0.8889716775193462,1.0,4/11,13.61%,ADAM10;WNT5A;WNK1;OXSR1
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.314001688399978,-0.8752364725209627,0.6194174757281553,0.8886372770928708,1.0,2/24,1.64%,DAB2;RHOQ
prerank,positive regulation of leukocyte migration (GO:0002687),0.35914433176478655,0.8751875922032797,0.5973782771535581,0.8936063471286478,1.0,4/27,9.00%,JAM3;PTN;IL4;MIA3
prerank,regulation of cell projection organization (GO:0031344),-0.36759061666141835,-0.8746224178079065,0.6455696202531646,0.8893396495267718,1.0,4/13,13.16%,MACF1;MOV10;MYO9A;MFSD2A
prerank,signal peptide processing (GO:0006465),-0.38458252133199256,-0.8745647870851516,0.6321428571428571,0.888845953660787,1.0,4/11,24.36%,PCSK5;SPCS1;CLN5;SEC11C
prerank,positive regulation of TOR signaling (GO:0032008),-0.2826012542241391,-0.8743995262904866,0.6854166666666667,0.8885893494972755,1.0,19/40,37.49%,GAS6;FNIP1;CLEC16A;GOLPH3;FLCN;GPR137;SIK3;RRAGB;LAMTOR5;PIH1D1;RRAGC;NCKAP1L;RPTOR;TREM2;HTR6;SLC38A9;WDR59;RRAGD;KLHL22
prerank,lipid droplet formation (GO:0140042),0.41411062335315796,0.8742749112292925,0.5733634311512416,0.8947033024897356,1.0,2/10,10.56%,CDS2;SQLE
prerank,cell junction maintenance (GO:0034331),-0.3638910771995198,-0.874273594302259,0.618860510805501,0.8882317328052427,1.0,8/14,36.88%,NLGN2;CLDN1;CSF1R;CBLN2;F2R;PRTN3;CBLN1;PARD6A
prerank,positive regulation of oxidoreductase activity (GO:0051353),-0.33756941202818624,-0.8739720802840035,0.6446280991735537,0.8883018619673805,1.0,6/18,19.01%,POR;EDN3;PARK7;SIRT3;AGT;AGTR1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.37408139834930776,-0.873929203556604,0.6128440366972477,0.8877934716138595,1.0,5/13,21.20%,GPD1L;STX3;HSP90AB1;TM9SF4;TYROBP
prerank,regulation of cellular metabolic process (GO:0031323),0.3210035754064706,0.8731017550683903,0.6017391304347826,0.8962386299418754,1.0,2/45,2.56%,PID1;FOXM1
prerank,cochlea morphogenesis (GO:0090103),0.43206248606080844,0.87283160612285,0.5708245243128964,0.8960366038584126,1.0,5/10,20.13%,MYO3B;TBX18;HPN;PAX2;HOXA1
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),0.32062761877043766,0.8725048081318586,0.6113013698630136,0.8959410676826648,1.0,13/52,11.14%,PIK3R1;PTPN9;GPER1;ATP2C1;SPTBN1;DPP10;ITGB1;STAC;ZDHHC2;NKD2;EPHA2;STX4;RANGRF
prerank,positive regulation of establishment of protein localization (GO:1904951),0.3780752634445185,0.8723809875020018,0.5711422845691383,0.8954288408939,1.0,5/18,16.20%,CORO2B;CEP120;CCT7;CCT3;CEP135
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3582094566792718,-0.8719744199145222,0.6370510396975425,0.8912460445969119,1.0,3/14,7.97%,ENPP1;ENPP3;CMPK1
prerank,protein import into mitochondrial matrix (GO:0030150),0.3737743010007858,0.8716003708066631,0.5618448637316562,0.8962144049549199,1.0,10/18,26.75%,GRPEL2;TOMM40L;TIMM23;TOMM40;TOMM70;DNAJC19;PAM16;TIMM17A;DNLZ;TIMM17B
prerank,DNA alkylation (GO:0006305),-0.32949313758993615,-0.8715149241250385,0.6266666666666667,0.8909230705894225,1.0,4/19,15.23%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,DNA methylation or demethylation (GO:0044728),-0.32949313758993615,-0.8715149241250385,0.6266666666666667,0.8909230705894225,1.0,4/19,15.23%,DNMT3A;GATAD2A;EHMT1;BEND3
prerank,regulation of cholesterol efflux (GO:0010874),-0.3063239066556356,-0.8709464555387321,0.6454918032786885,0.8914427522877455,1.0,8/30,20.47%,PLTP;APOE;CAV1;ABCA3;PTCH1;EEPD1;NFKBIA;ZDHHC8
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.4061822943482519,0.8708759167166918,0.5944798301486199,0.8968142848434516,1.0,2/14,4.99%,IL1B;CARD9
prerank,alpha-linolenic acid metabolic process (GO:0036109),0.40934867367980277,0.8708079131688464,0.582441113490364,0.8962175201905098,1.0,6/12,25.77%,FADS2;ELOVL2;HSD17B4;ACSL1;ABCD1;ELOVL5
prerank,establishment of protein localization to mitochondrion (GO:0072655),-0.2780118208864535,-0.8707182597228932,0.6705336426914154,0.8912805923838857,1.0,18/46,29.72%,HK2;AIFM1;AKT1;TOMM7;GDAP1;DNAJC15;TIMM13;BCAP31;TOMM22;TIMM8B;TOMM34;TOMM5;TIMM9;TIMM44;HK1;TIMM50;TIMM10;TSPO
prerank,negative regulation of calcium ion transport (GO:0051926),0.3844878965934049,0.8705627319711038,0.5914221218961625,0.8959691999079469,1.0,4/15,15.50%,ATP1A2;STC1;PACSIN3;CBARP
prerank,negative regulation of growth (GO:0045926),0.27651184632084513,0.8704259982066903,0.6459627329192547,0.8955026458288825,1.0,7/121,3.49%,TMPRSS4;RERG;APBB2;NOTCH1;SLIT3;SIPA1;CRLF3
prerank,negative regulation of protein modification process (GO:0031400),0.29735204500766593,0.8703861982445176,0.6408094435075885,0.8948471821788768,1.0,5/79,3.06%,PTEN;DMD;PID1;PRR5L;CADM4
prerank,regulation of cellular localization (GO:0060341),-0.27237811795512384,-0.8698386687198361,0.6790697674418604,0.8924489255464282,1.0,6/46,7.03%,GSN;ADCY5;LRRK2;PARD6G;EFNA5;STXBP4
prerank,negative regulation of translational initiation (GO:0045947),0.39351881771739095,0.8697134857544798,0.5908141962421712,0.8953668099967022,1.0,2/13,2.94%,EIF4EBP2;EIF4EBP3
prerank,negative regulation of neuroinflammatory response (GO:0150079),-0.36528197529154804,-0.8689425708054777,0.6495238095238095,0.8937111188145673,1.0,2/14,6.32%,IGF1;TNFRSF1B
prerank,positive regulation of catalytic activity (GO:0043085),-0.28710080011466105,-0.8688221663872068,0.6474654377880185,0.8933622969259355,1.0,14/37,27.91%,CAV1;IGF2;MAPK14;SSBP1;NHEJ1;FGFR4;XRCC4;MAPK3;PSEN2;MT3;MSH6;NCSTN;B3GAT3;ABL1
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.3310098986708937,-0.8683475895415045,0.654,0.8937098834966017,1.0,7/21,21.41%,SMO;EVC;TTC23;SFRP1;STK36;TXNDC15;GLI1
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.3012730572752007,0.8680974080515703,0.6278260869565218,0.8977763041636246,1.0,14/66,11.85%,PTEN;CDK6;RGCC;MYO16;DDX3X;LSM10;APPL1;FGF10;CDKN1A;PKD2;KANK2;RBL1;RB1;APC
prerank,water transport (GO:0006833),-0.3723525575864698,-0.868082581912616,0.6240875912408759,0.8936676902860803,1.0,1/12,1.41%,PDPN
prerank,proteasome assembly (GO:0043248),-0.3824272009019589,-0.8678813617128572,0.6393129770992366,0.8934805112153459,1.0,4/11,24.71%,POMP;PSMD11;PSMD4;PSMD10
prerank,positive regulation of telomere maintenance (GO:0032206),-0.29237264505743044,-0.8660982248509723,0.6803455723542117,0.8965254046237551,1.0,10/31,23.51%,TNKS2;NAF1;PML;ATM;MAPK3;RAD50;MAP3K4;MAP2K7;SLX4;ERCC1
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.33608439641769544,-0.865454717082025,0.6332665330661322,0.8972380741420964,1.0,2/19,1.96%,IGF1;APOE
prerank,regulation of endocytosis (GO:0030100),0.30758575253400655,0.8652598548449587,0.6439522998296422,0.9025399768723377,1.0,15/61,14.52%,NEDD4L;ROCK1;RIT2;GPC3;CBLL1;SCAMP5;SNCA;AP2S1;HIP1;ABL2;PACSIN3;SRC;PTPN1;ABCA7;RAB5A
prerank,actin polymerization or depolymerization (GO:0008154),0.3249940688065035,0.8645089147544714,0.6365159128978225,0.9032454656662428,1.0,7/50,3.93%,ARHGAP6;WASF3;WAS;CORO7;ABI2;SPIRE1;WASL
prerank,response to hydrogen peroxide (GO:0042542),-0.27480345251881233,-0.8644033887224556,0.6818181818181818,0.8987753084017553,1.0,13/45,18.15%,ANXA1;ADAM9;CYP1B1;RHOB;PRKCD;RELA;GLRX2;SIRPA;NET1;RIPK1;GPX1;OSER1;PARK7
prerank,response to interleukin-6 (GO:0070741),-0.3912996099913789,-0.8639492628100925,0.6595365418894831,0.8990500397605163,1.0,3/10,4.49%,ST3GAL6;PTGIS;SBNO2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),-0.3629689923521032,-0.8638478209306297,0.6547619047619048,0.8986332486816802,1.0,6/13,25.47%,LRRK2;MET;TXN;PARK7;NR4A3;RACK1
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.40471653639543353,0.863283134372523,0.6017130620985011,0.904875920422295,1.0,3/13,11.13%,AP1G1;IL4;STX4
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),-0.20392345465073744,-0.8627072549801655,0.9019607843137255,0.9003470153417605,1.0,86/341,21.82%,FBXL7;TBL1XR1;RNF213;SMURF2;FBXO10;RNF146;ZNRF1;ASB2;TAF1;RNF43;SPSB1;RNF130;RNF19A;ARRB1;WWP2;RNF144B;TTC3;SMURF1;TOM1L1;CDC16;MAEA;AMFR;IFI27;RC3H2;NHLRC3;DCAF11;CHFR;RNF185;DTX3L;KCTD10;PCBP2;ZNRF3;ARRDC1;PML;PSME2;UBE4B;ANAPC4;CUL4A;RNF125;MDM2;WDR81;PSMB4;FBXW11;CLOCK;UBE2G2;PSMB1;PSMD11;NEDD8;DDB1;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;RNF40;UBR4;PELI1;SIRT2;UBE3D;FBXL19;SPSB4;SPSB2;ANAPC16;PSMD4;FZR1;PPP2R5C;PSMA2;NPLOC4;VCP;RNF217;VPS28;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;UBXN1;ANAPC5;ELOC;RBBP6;XBP1
prerank,cellular response to cAMP (GO:0071320),0.3438287457458646,0.8625949149311083,0.6050583657587548,0.9055372055935358,1.0,6/30,9.02%,RAPGEF2;AKAP6;HCN2;RAP1A;HCN3;PKD2
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.40781079715736257,0.8624946735355137,0.5903083700440529,0.904262417201792,1.0,3/12,6.20%,SPRY4;ACTN4;AP1AR
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.40781079715736257,0.8624946735355137,0.5903083700440529,0.904262417201792,1.0,3/12,6.20%,SPRY4;ACTN4;AP1AR
prerank,myelination in peripheral nervous system (GO:0022011),-0.3667032567890375,-0.862442919594085,0.6514851485148515,0.9002960772723149,1.0,6/13,20.39%,ADGRG6;SKI;PARD3;MYOC;SIRT2;DICER1
prerank,mitochondrial protein processing (GO:0034982),0.4093683674014762,0.8623989636003344,0.5730337078651685,0.9037218286700373,1.0,4/11,17.40%,IMMP2L;YME1L1;MIPEP;PMPCB
prerank,cellular copper ion homeostasis (GO:0006878),-0.35744604538385594,-0.862280959249511,0.6586270871985158,0.8999859840321618,1.0,2/14,5.22%,APP;ATOX1
prerank,peptidyl-threonine phosphorylation (GO:0018107),-0.26364486500869666,-0.8622599943037125,0.7245657568238213,0.8994352782529705,1.0,13/59,15.07%,ROCK2;TGFBR2;TGFBR1;LRRK2;ACVR1;TAF1;WNK1;PRKCD;AKT1;CAMK2A;OXSR1;HIPK2;DYRK1B
prerank,barbed-end actin filament capping (GO:0051016),0.3818005202185803,0.8618406458941622,0.5968688845401174,0.9032891423981407,1.0,1/18,0.31%,EPS8
prerank,actin filament capping (GO:0051693),0.3818005202185803,0.8618406458941622,0.5968688845401174,0.9032891423981407,1.0,1/18,0.31%,EPS8
prerank,calcium-ion regulated exocytosis (GO:0017156),0.3497034462263797,0.8614606365962739,0.6142322097378277,0.9032571298834086,1.0,13/27,24.87%,RIMS1;RIMS2;SYT1;SYT2;SYT12;SYT11;VAMP2;SYT13;SYT3;ARL8B;VAMP7;SYT6;SYT10
prerank,regulation of coagulation (GO:0050818),-0.37746843160921495,-0.861445578829735,0.6469500924214417,0.9005188554516719,1.0,5/11,31.68%,CAV1;EPHB2;PROCR;F2R;HRG
prerank,copper ion transport (GO:0006825),-0.38686304764139123,-0.8613507197937437,0.6641929499072357,0.9000997565677662,1.0,2/11,5.22%,STEAP3;ATOX1
prerank,regulation of lipid metabolic process (GO:0019216),-0.2446077484701189,-0.8610533216777431,0.7685714285714286,0.900090369481827,1.0,14/88,12.56%,PRKAG2;TBL1XR1;CHD9;CAV1;NPC2;CARM1;ACACA;PSAP;NFYC;TNFAIP8L3;FGFR4;PLPP1;PPARA;ID2
prerank,DNA methylation (GO:0006306),-0.3166262138386164,-0.8609722149888674,0.6600790513833992,0.8996459084119856,1.0,8/23,27.29%,DNMT3A;GATAD2A;EHMT1;BEND3;ZFP57;DNMT1;PICK1;MTRR
prerank,protein localization to Golgi apparatus (GO:0034067),-0.3094433387697034,-0.8608175109506576,0.6813819577735125,0.8993674288760192,1.0,11/27,23.22%,VPS13A;GOLPH3;VPS13D;OBSL1;OPTN;GBP5;ARL5A;RAB6A;ZDHHC15;GAK;RIPOR1
prerank,positive regulation of osteoclast differentiation (GO:0045672),-0.3575875112499454,-0.8606982178163335,0.6765799256505576,0.8990160316585023,1.0,11/14,51.18%,CSF1;TYROBP;ATP6AP1;POU4F1;CCR1;TNFSF11;OCSTAMP;IL23A;TNF;IL23R;IL12B
prerank,mesoderm development (GO:0007498),0.37913646134542045,0.8601769736060688,0.589247311827957,0.9050901514867389,1.0,3/18,3.37%,TBX3;TCF15;TBX6
prerank,negative regulation of RNA splicing (GO:0033119),-0.3323038833712934,-0.86011635591031,0.6602687140115163,0.8995514697531783,1.0,7/19,21.95%,RPS13;SRSF10;TMBIM6;SRSF6;PTBP3;PCBP4;RPS26
prerank,cellular response to nitrogen compound (GO:1901699),-0.32717849943292937,-0.8599316527970404,0.6666666666666666,0.8993206630465927,1.0,1/20,0.88%,ROCK2
prerank,mitotic sister chromatid cohesion (GO:0007064),0.37262803336731753,0.8591751838252818,0.5954356846473029,0.9062722763954584,1.0,5/16,13.84%,REC8;POGZ;MAU2;RB1;NIPBL
prerank,purine ribonucleotide metabolic process (GO:0009150),-0.2509337155784699,-0.8591308366745004,0.7487046632124352,0.9003447958360836,1.0,18/68,24.88%,RHOQ;ENPP1;AMPD3;LRRK2;ACOT11;SULT1A1;HINT1;RAN;PTHLH;ACOT6;ACOT9;TPST1;TPST2;ADSS1;DBI;NT5C2;OXSM;SULT4A1
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.28067489246663585,0.8583748136831905,0.6602870813397129,0.9070456758571366,1.0,5/88,4.79%,MYO1B;CORO7;SORCS1;SORT1;AP1G1
prerank,long-term synaptic potentiation (GO:0060291),-0.3128585936822209,-0.8579069781063053,0.6620278330019881,0.9021977082531267,1.0,5/21,8.84%,SLC8A3;PRKCZ;PTK2B;PLK2;GRIN2D
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.36075909673457873,-0.857808750191532,0.6709796672828097,0.901794911112647,1.0,7/13,30.32%,CNOT7;CPEB3;TNRC6A;POLR2G;EIF4ENIF1;AGO2;ZFP36
prerank,cellular response to lipopolysaccharide (GO:0071222),0.27814214577828444,0.8577049952657457,0.6862123613312203,0.9076364351305685,1.0,10/101,6.42%,MEF2C;NR1H3;IL1B;PTPN22;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,regulation of steroid biosynthetic process (GO:0050810),0.3955472527501812,0.8576003158214762,0.5906183368869936,0.9070980758333942,1.0,1/11,1.15%,BMP5
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.36379121806550724,0.8572520400784186,0.59958071278826,0.90703330546719,1.0,8/20,18.01%,CHRNA3;AGRN;CHRNA7;RGS10;CHRNB2;RGS8;CHRM3;CHRM2
prerank,peptidyl-lysine modification (GO:0018205),-0.2325366310366318,-0.8569460258259707,0.7795275590551181,0.9029196327913966,1.0,24/99,20.63%,EYA1;HDAC4;LOXL1;KAT2B;HDAC9;PLOD2;NNAT;STX1A;SENP3;SAE1;NUP98;PLOD1;P3H4;SIRT7;SIRT2;TPR;PARK7;SIRT3;NUP88;PIAS4;ETFBKMT;NUP214;PLOD3;TRPM4
prerank,monosaccharide transmembrane transport (GO:0015749),0.37557784542112355,0.8564272258673019,0.5838264299802761,0.9079038528267372,1.0,5/16,16.92%,SLC5A1;SLC2A6;SLC2A9;SLC23A2;SLC23A1
prerank,protein secretion (GO:0009306),-0.2588728884088279,-0.8560344918851266,0.7242990654205608,0.9041507920514349,1.0,8/56,11.76%,ABCA1;STEAP3;PCSK5;ANXA1;RCN3;GOLPH3;TMEM167A;RAB8A
prerank,regulation of RNA export from nucleus (GO:0046831),0.39602349639664325,0.855572158629148,0.5858369098712446,0.9088063862266086,1.0,2/11,7.48%,NCBP2;CPSF6
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.36248661501031576,0.8554717325498494,0.5967741935483871,0.9082398052802986,1.0,13/24,23.20%,GNL3L;TNKS;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PARP1;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,cellular response to steroid hormone stimulus (GO:0071383),0.3665398120231641,0.8546965476948116,0.6193415637860082,0.9089166113376159,1.0,2/17,1.63%,ATP1A2;GPER1
prerank,protein complex oligomerization (GO:0051259),-0.24203892486393402,-0.8542672046897908,0.7429378531073446,0.9070265183151108,1.0,22/85,17.51%,MCU;RNF213;PDCD6IP;UPB1;ALS2;EHD1;GLRA3;RNF135;SPAST;GSDMD;ZC3H12A;ATL2;TMEM120B;KCNC3;NINJ1;CLDN1;BEND3;AQP11;HOMER1;ELAVL1;PNPT1;SLC9A1
prerank,multivesicular body assembly (GO:0036258),-0.30419353635505614,-0.8542289365028825,0.7040169133192389,0.9065078453597306,1.0,5/30,10.72%,RAB11A;PDCD6IP;HGS;CHMP4B;CHMP4A
prerank,mitotic cytokinetic process (GO:1902410),-0.32404600370538433,-0.8538408886038115,0.669260700389105,0.9066406338107461,1.0,6/20,17.90%,PDCD6IP;RHOA;CHMP4B;CHMP4A;MITD1;KLHDC8B
prerank,positive regulation of neuron migration (GO:2001224),0.39941208720164845,0.853705928843161,0.5819327731092437,0.9100739856918462,1.0,1/11,1.01%,RAPGEF2
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.29699430478094474,0.8536890412598186,0.7009803921568627,0.909367352450157,1.0,17/71,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,cardiolipin metabolic process (GO:0032048),-0.35668938663119787,-0.8535056053807805,0.6551724137931034,0.9067509740889049,1.0,3/13,15.84%,PLA2G4A;PLA2G6;PLSCR3
prerank,negative regulation of viral transcription (GO:0032897),0.38757378945707965,0.8530288934322956,0.59958071278826,0.9098839618918793,1.0,3/13,5.49%,MID2;HEXIM1;TRIM62
prerank,membrane raft organization (GO:0031579),0.38026435687525695,0.8529898436197212,0.614,0.9092292023613111,1.0,6/15,14.92%,RFTN1;EMP2;PPT1;NPC1;ABCA7;MYADM
prerank,epithelial tube morphogenesis (GO:0060562),0.34268640417316965,0.8525984938033547,0.6238003838771593,0.9092527065900592,1.0,9/32,11.50%,MEF2C;TBX20;COL4A1;RYR2;FGF10;PRKD2;PKD2;PRKX;PAK1
prerank,regulation of androgen receptor signaling pathway (GO:0060765),0.3378176711653872,0.8525149955230893,0.6149193548387096,0.9086694867083572,1.0,3/30,2.06%,HEYL;PKN1;NODAL
prerank,inner dynein arm assembly (GO:0036159),-0.38840495482032444,-0.8518811677656751,0.656188605108055,0.9094734184424605,1.0,9/10,57.92%,CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3;CFAP73;ZMYND10;DNAAF5
prerank,intracellular cholesterol transport (GO:0032367),-0.3420872251316745,-0.8517993747594543,0.6716141001855288,0.9090464341855643,1.0,3/15,6.78%,ABCA1;LRP6;NPC2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.29707931546456307,0.8515419504029325,0.6852459016393443,0.909800561153952,1.0,17/70,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,protein modification by small protein conjugation (GO:0032446),-0.19786376841112718,-0.8514834098967339,0.95,0.9090579010640986,1.0,79/361,20.63%,RNF220;FBXL7;EYA1;PDZRN3;RNF213;SMURF2;FBXO10;RNF38;ASB2;RNF43;TRIM24;SPSB1;ARRB1;WWP2;HIF3A;RNF139;SMURF1;CDC16;KLHL2;RNF103;AMFR;RTF1;CHFR;MKRN2;DTX3L;HIF1A;KCTD10;RNF135;STX1A;MGRN1;ZNRF3;ARRDC1;TRIM27;USP5;CUL4A;ASB5;MDM2;TRIM63;UBE2Q2;SAE1;FBXW11;TRIM35;BRAP;UBB;RNF181;TRIM39;ATG10;ELOB;UBE2G2;NEDD8;DDB1;DTX1;TRIM17;NUP98;UBA3;WWP1;FBXL2;RNF187;ASB1;RNF40;SPSB4;TPR;UBA7;SPSB2;ANAPC16;ARRDC4;TRIM14;UBE2M;TRIM47;TRIM41;VCP;NUP88;PIAS4;CDC27;RNF144A;URM1;NUP214;CDK5RAP3;TRPM4
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.2753566538144514,-0.8511702460436664,0.684322033898305,0.9090715740632168,1.0,15/39,28.74%,ABCA1;STEAP3;RCN3;GOLPH3;TMEM167A;RAB8A;PPY;CANX;TANGO2;TVP23B;LTBP2;RAB3D;ARL4D;PREB;RAB3A
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2917781724075218,-0.8509158604068567,0.6931330472103004,0.9089609185334194,1.0,14/32,28.31%,HK2;IFIT2;VPS35;CAMK2A;BNIP3;BID;BBC3;BCL2L1;NDUFS1;BIK;SFN;TIMM50;SOD2;CLU
prerank,granulocyte chemotaxis (GO:0071621),0.3048129210955348,0.8505032043899214,0.6568457538994801,0.9110256041525818,1.0,6/55,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,positive regulation of cytokine production (GO:0001819),0.24640702329150946,0.8504292956047649,0.7544987146529563,0.9104459638038783,1.0,14/292,3.56%,PDE4D;PLA2R1;GLMN;PIK3CD;RORA;AFAP1L2;RGCC;NODAL;RFTN1;IL1B;PTPN22;CD46;FFAR2;SPTBN1
prerank,regulation of cilium assembly (GO:1902017),0.2949249716039468,0.8485196004073512,0.6643356643356644,0.9133755837906946,1.0,15/62,16.80%,TBC1D1;TBC1D30;IFT20;TESK1;TBC1D2B;ARHGAP35;TBC1D10C;TBC1D9B;CEP97;FUZ;TBC1D19;CEP120;TBC1D10B;KCTD17;HTT
prerank,regulation of axon extension (GO:0030516),-0.28013328658557685,-0.8483199223195736,0.7115789473684211,0.9133714313738489,1.0,16/37,28.95%,APOE;MACF1;SEMA7A;DIP2B;NTN1;RUFY3;SEMA3G;MAP3K13;MT3;ZFYVE27;DBN1;SIN3A;PTPRS;RTN4R;ABL1;CTTN
prerank,mitotic spindle organization (GO:0007052),0.26064394475306113,0.8483189573222,0.7155297532656023,0.9130349625662411,1.0,21/153,15.10%,DYNLL1;RMDN1;MECP2;NUP43;TNKS;CLASP2;CENPP;PPP1CC;DYNC1I2;NEK6;TUBG2;XPO1;TOGARAM2;SEC13;NUDC;MZT1;KIFC2;LSM14A;RANBP2;CEP126;MAD2L1
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.31713950748052155,-0.8476249223526164,0.6771653543307087,0.9141411459018749,1.0,10/22,23.23%,SASH1;XDH;MFHAS1;ZC3H12A;RELL1;SPHK1;MAP3K4;GADD45G;VEGFA;GADD45B
prerank,protein localization to mitochondrion (GO:0070585),-0.35889078470284663,-0.8468042495358936,0.654275092936803,0.9150907713854272,1.0,8/11,34.23%,LRRK2;HK2;AKT1;MAIP1;HK1;ISG15;RALA;PINK1
prerank,positive regulation of nervous system process (GO:0031646),-0.32661745650247903,-0.8465683189523179,0.6527777777777778,0.9149277299860334,1.0,4/18,9.97%,UNC13B;TNFRSF1B;PARD3;NLGN2
prerank,response to light stimulus (GO:0009416),0.30300669332449204,0.846533701337532,0.6493738819320215,0.9157237626562094,1.0,20/55,23.01%,OPN1MW;OPN1MW3;TYR;ERCC4;CCAR2;MAPK10;BRSK1;RRH;OPN3;USP1;CRY1;UVSSA;ERCC8;CPT1B;UBE2B;DDB2;COPS3;UBE2A;DRD2;CIRBP
prerank,tRNA aminoacylation for protein translation (GO:0006418),-0.2750961973046766,-0.8462911415414553,0.7184873949579832,0.9148570915735242,1.0,14/42,23.90%,LARS2;RARS2;KARS1;TARS2;CARS1;QARS1;SARS1;HARS1;MARS2;EARS2;VARS2;FARSA;PPA1;FARSB
prerank,early endosome to late endosome transport (GO:0045022),-0.3202946891951063,-0.8462603527981769,0.7003968253968254,0.9143111693372806,1.0,5/20,14.56%,EEA1;BECN1;RAB7A;WDR81;ANKRD27
prerank,SNARE complex assembly (GO:0035493),-0.38578860706276186,-0.846237724363232,0.6410714285714286,0.9137460794952693,1.0,3/10,21.45%,STXBP6;UVRAG;VAMP8
prerank,mRNA modification (GO:0016556),0.3536814080832586,0.8458862561397503,0.6247464503042597,0.9162060251158424,1.0,8/22,19.98%,TRMT61A;CBLL1;TRUB1;TRMT10C;PUS7;NSUN2;ZC3H13;WTAP
prerank,mRNA catabolic process (GO:0006402),-0.26928770173453936,-0.8457390706169128,0.7429193899782135,0.9141702465634374,1.0,14/44,23.10%,DDX5;TUT4;THRAP3;TUT7;ERN1;NUDT12;XRN1;NBDY;PNPT1;LSM5;ZFP36L2;AGO1;NUDT16;DHX34
prerank,nuclear export (GO:0051168),-0.23761511520161965,-0.8454844760434869,0.7810026385224275,0.9140340911083858,1.0,26/80,30.82%,RANBP3L;ATXN1;SMURF1;CCHCR1;NXF1;TGFB1;RAN;CALR;PKD1;SRSF2;TPR;SRSF6;CHP1;THOC1;NUP214;SRSF5;THOC7;XPO4;SRSF11;NUP155;RANBP17;CSE1L;NUP62;THOC5;XPO5;LSG1
prerank,B cell mediated immunity (GO:0019724),0.4069716364494508,0.8453870464495443,0.5986238532110092,0.9164552836983264,1.0,2/10,18.74%,CARD9;CD27
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),0.3606104076501827,0.8452823941386778,0.6043737574552683,0.9159192005075274,1.0,10/19,23.20%,GNL3L;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;CTC1;EXOSC10
prerank,neutral amino acid transport (GO:0015804),-0.3006440414289726,-0.8451191310593241,0.696969696969697,0.9141252547418494,1.0,11/28,22.34%,SLC6A6;SLC6A9;SLC7A5;SLC38A5;SLC3A2;SLC38A6;LLGL2;SLC43A1;SLC36A1;SLC1A1;SLC38A1
prerank,regulation of interleukin-10 production (GO:0032653),0.31925584268517354,0.8449965915994834,0.654054054054054,0.9157303329951695,1.0,4/44,6.03%,TNFRSF21;CD46;TRIB2;IL4
prerank,positive regulation of translation (GO:0045727),0.2759759679238111,0.8449893201396659,0.6914556962025317,0.9150162104165748,1.0,33/94,20.20%,PLD1;FASTKD2;DAZL;RPS6KB2;MRPS27;BOLL;YTHDF3;DDX3X;SOX4;MTOR;EIF3C;EIF6;YTHDF2;FASTKD3;PRKDC;TRMT10C;UPF3B;LARP6;DHX36;RMND1;C1QBP;FMR1;PKM;RPS6KB1;PRR16;NSUN5;HNRNPD;HABP4;POLR2D;EEF2;EIF3E;RBM3;POLDIP3
prerank,regulation of lipid catabolic process (GO:0050994),0.36524833607723395,0.8447461204009014,0.6148007590132827,0.9147726369977758,1.0,7/19,23.38%,IL1B;RARRES2;PRKAA1;LONP2;PDE3B;TYSND1;ABCD1
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.37375972277970226,-0.8443912644709853,0.6544117647058824,0.9149126983305843,1.0,5/11,27.52%,MAVS;TICAM1;TYROBP;ITGB2;ITGAM
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.38884444307870225,0.8441981901948625,0.6267748478701826,0.9143358755550027,1.0,2/13,4.10%,IL15RA;JAK1
prerank,cellular response to interleukin-15 (GO:0071350),0.38884444307870225,0.8441981901948625,0.6267748478701826,0.9143358755550027,1.0,2/13,4.10%,IL15RA;JAK1
prerank,DNA double-strand break processing (GO:0000729),-0.32659801261686894,-0.8441460432416967,0.6936416184971098,0.9147829307761075,1.0,6/18,24.18%,ATM;RAD50;SMARCAD1;RAD52;SLX4;BRCA1
prerank,regulation of hormone secretion (GO:0046883),-0.3379886280596016,-0.8440285226195015,0.6833013435700576,0.9143950937474552,1.0,2/15,3.96%,SNX6;ANXA1
prerank,regulation of histone methylation (GO:0031060),-0.35217144295073366,-0.8437987607549802,0.681214421252372,0.9142401750462985,1.0,7/13,31.34%,JARID2;NSD1;NNMT;PIH1D1;AASS;PAF1;TET1
prerank,proteoglycan biosynthetic process (GO:0030166),0.3395651720706359,0.8437982639867726,0.6332703213610587,0.9143464578915624,1.0,2/31,2.35%,NDST3;EXTL3
prerank,regulation of complement activation (GO:0030449),0.31859105247261643,0.8437325471724013,0.6376811594202898,0.9137580656634932,1.0,6/40,9.50%,VTN;IL1B;CD46;C7;SUSD4;CR2
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.3498074685368235,0.8435477495461607,0.6070686070686071,0.9133727126706997,1.0,4/21,7.01%,SPRY4;SH3BP1;SPRY2;LZTR1
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.4017435801062326,0.843204813303005,0.6084070796460177,0.9133022629523141,1.0,4/11,22.69%,IL4;JAK2;HDAC2;TAF7
prerank,sodium-independent organic anion transport (GO:0043252),0.4124785084747459,0.8431058766329215,0.6105263157894737,0.9127494956547523,1.0,2/10,4.43%,SLCO3A1;SLCO5A1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.3723131677652521,0.842627478372903,0.6094069529652352,0.9129536877128777,1.0,9/18,18.00%,RIMS1;RIMS2;SYN1;RAP1A;VPS18;RAB5A;PREPL;FMR1;GSK3B
prerank,autophagy of nucleus (GO:0044804),-0.34181163621659527,-0.8422632929670045,0.7142857142857143,0.91656336446534,1.0,5/16,24.93%,WIPI2;ULK2;ATG2A;ATG7;ATG12
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.3542949697385593,-0.8421146931045829,0.678373382624769,0.9162637192886219,1.0,4/12,17.71%,ABCA1;ITGB3;PPARA;NFKBIA
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),-0.3023780490638175,-0.8418844882875067,0.7057692307692308,0.9161005652641809,1.0,10/26,22.36%,FBN1;TCTA;C1QC;ZFPM1;GPR137;CEACAM1;TLR4;PTPN2;FSTL3;RARA
prerank,cellular response to hypoxia (GO:0071456),0.2686687844347446,0.8418254123922985,0.6916030534351145,0.9137371137414223,1.0,10/126,4.92%,LIMD1;RORA;RGCC;CPEB1;RBX1;KCND2;FMN2;SCN2A;EPAS1;PSMB11
prerank,positive regulation of lipid catabolic process (GO:0050996),0.36612302701924626,0.8412714961528048,0.6486486486486487,0.9140961380379948,1.0,3/19,7.19%,IL1B;ABCD2;IRS1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3646836590581273,0.8411389143361763,0.6047904191616766,0.9136542715437403,1.0,7/17,13.82%,ROCK1;GGA3;NTRK2;CHRNA7;BIN1;RTN1;ABCA7
prerank,cellular response to arsenic-containing substance (GO:0071243),-0.34405842090729827,-0.840845476344144,0.6974459724950884,0.9174673741990087,1.0,7/15,25.44%,CPEB2;ZC3H12A;MKNK2;VCP;GSTO2;ATF3;ZFAND1
prerank,regulation of urine volume (GO:0035809),-0.3839552057025184,-0.8404846432257604,0.6806569343065694,0.9175557594158872,1.0,2/10,5.58%,NPR3;NPR1
prerank,regulation of cell growth (GO:0001558),0.24970042334384776,0.8404661405451324,0.7645429362880887,0.9142045771493003,1.0,19/204,8.14%,PLCE1;RERG;APBB2;SLC25A33;RASGRP2;SLIT3;BCAR1;SIPA1;PABIR1;CRLF3;NRG3;AKAP6;ROS1;DDX3X;CAPRIN2;SUPV3L1;PPT1;CDKN1A;MTOR
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.29160912204863854,0.8403890847411131,0.7214983713355049,0.9136452328207069,1.0,17/73,13.39%,PTK2;PIK3R1;WAS;WIPF1;PIK3CA;LIMK1;WASL;ARPC5;WASF2;MYO10;LYN;NCKAP1;DOCK1;ARPC4;PAK1;SRC;ARPC1A
prerank,presynaptic endocytosis (GO:0140238),0.35142523022092087,0.8401284040397533,0.6419213973799127,0.9134421775841979,1.0,7/24,17.69%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;VAMP2
prerank,macrophage chemotaxis (GO:0048246),-0.37912784309811964,-0.8399910462890721,0.7142857142857143,0.9179405242594372,1.0,5/10,38.70%,EDNRB;CKLF;CCL2;CXCL17;CCL5
prerank,positive regulation of developmental growth (GO:0048639),0.3097843190071325,0.839788433673363,0.6527777777777778,0.9133601712369837,1.0,5/49,5.27%,NEDD4L;LIMK1;AGRN;RIMS1;RIMS2
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),0.34883891145933604,0.8393581667765272,0.6342412451361867,0.913448309376396,1.0,2/23,4.24%,PIK3CD;FGF2
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.3284375166501761,-0.8388164408376969,0.6962264150943396,0.9195129127691563,1.0,4/18,11.59%,SMAD3;PDPN;EMILIN1;TGFB1
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),-0.2869368279475496,-0.8386989979457975,0.722707423580786,0.9191322903983368,1.0,14/30,25.95%,NOS3;ARHGEF2;CFLAR;TNFSF10;ICAM1;CASP8;SERPINE1;RIPK1;GPX1;PARK7;RFFL;BRCA1;BCL2L1;FAS
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.3165695713598896,-0.8386889936488284,0.6589595375722543,0.918550270835659,1.0,2/20,1.64%,DAB2;RHOQ
prerank,positive regulation of isotype switching (GO:0045830),-0.3351735646638308,-0.8385422063734894,0.6938775510204082,0.918231954833027,1.0,6/15,22.41%,TFRC;TGFB1;SHLD1;KMT5C;CLCF1;TNFSF13
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.28316319874317347,-0.8384568571499148,0.7206477732793523,0.9177917645573197,1.0,7/33,13.04%,ESR1;DDX5;AR;KLK2;H3-3A;CARM1;CALR
prerank,relaxation of muscle (GO:0090075),0.3784825947475003,0.8383212974763395,0.6260162601626016,0.9146563964428683,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.3815409356793026,-0.8378380443725885,0.6715867158671587,0.9183894680431306,1.0,3/10,20.27%,RNF125;NPLOC4;SEC14L1
prerank,mitochondrial gene expression (GO:0140053),0.31316797400366225,0.8376625773403182,0.6641509433962264,0.9151504871507498,1.0,16/42,20.03%,SLC25A33;FASTKD2;NOA1;TFAM;GATB;GFM2;PTCD3;IARS2;GATC;MRPS34;MRPS12;MRPS18B;TFB2M;MRPS17;MRPL47;MRPL2
prerank,ganglioside biosynthetic process (GO:0001574),-0.3459049185810144,-0.8370963449942102,0.7051039697542533,0.9192248382089808,1.0,5/15,11.77%,ST3GAL1;ST3GAL2;ST6GALNAC3;ST8SIA2;ST6GALNAC6
prerank,protein palmitoylation (GO:0018345),0.3320457543119856,0.8370366496769248,0.6593186372745491,0.9156438003752199,1.0,8/30,13.52%,ZDHHC14;ZDHHC1;ZDHHC2;ZDHHC16;ZDHHC17;ZDHHC21;ZDHHC23;HHAT
prerank,nucleoside diphosphate metabolic process (GO:0009132),-0.3319191222549017,-0.8368069814855161,0.7019607843137254,0.919169173716571,1.0,4/15,19.02%,ENTPD1;CMPK1;ENTPD5;ENTPD2
prerank,transcription by RNA polymerase I (GO:0006360),-0.2807418218001656,-0.8367678580367309,0.7200854700854701,0.9186402176276821,1.0,14/34,30.61%,TAF1;CAVIN1;TCOF1;POLR2F;MAPK3;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.3511902346554694,-0.8366046229649704,0.6705202312138728,0.9183354161821146,1.0,1/12,0.40%,UNC13B
prerank,positive regulation of lipid localization (GO:1905954),-0.36961421339580913,-0.8363619435681446,0.6831501831501832,0.9182180797082855,1.0,5/11,30.55%,IKBKE;ZC3H12A;LPL;C3;HILPDA
prerank,regulation of nuclear division (GO:0051783),-0.31553317988695617,-0.8361836493737131,0.68762278978389,0.9179342354987482,1.0,7/20,32.09%,OBSL1;CAV2;CCDC8;CUL9;L3MBTL1;MKI67;CUL7
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),-0.24444457792414204,-0.8357141617589322,0.7934508816120907,0.9182612074827307,1.0,27/72,30.73%,POLR2A;ERCC5;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;COPS2;PRPF19;POLD1;MNAT1;GTF2H3;PCNA
prerank,snRNA processing (GO:0016180),0.370530886175892,0.8355558417024348,0.5970464135021097,0.9176940114275844,1.0,3/16,14.00%,INTS6L;INTS1;INTS12
prerank,regulation of organelle organization (GO:0033043),-0.23660017118815618,-0.8353388692824607,0.7921348314606742,0.9183692081032766,1.0,26/80,24.09%,CLIC4;DIAPH1;EZR;CAPN2;ARMH3;USP6NL;CLEC16A;GOLPH3;AKAP9;MAVS;VPS35;LMAN1;F11R;SURF4;MAPK3;TBC1D25;SIRT7;STX18;SAR1A;SAR1B;TMED9;TMEM33;STMN3;NEXN;CAPN6;RDX
prerank,Golgi ribbon formation (GO:0090161),-0.35485811833261427,-0.835159998035825,0.68,0.9181169143434164,1.0,4/13,10.98%,MYO18A;GOLPH3;STX6;OPTN
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.3258638756192703,-0.8351376207779531,0.6978021978021978,0.9175606750533422,1.0,9/17,34.56%,ATP5PF;DMAC2L;ATP5MF;ATP5MC3;ATP5MC1;ATP5MC2;ATP5F1E;STOML2;ATP5MG
prerank,mitochondrion distribution (GO:0048311),-0.3581110323169502,-0.8350173433815155,0.6764705882352942,0.9171835542869804,1.0,3/12,15.88%,LRRK2;MEF2A;MSTO1
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.37363653573037076,0.8343816256772503,0.6502057613168725,0.9191697175585257,1.0,3/15,9.01%,SEMA5A;FGF2;PRKD2
prerank,regulation of cytoplasmic transport (GO:1903649),-0.36492137804369085,-0.8343543362167594,0.6787658802177858,0.9178701353164632,1.0,3/11,14.53%,LRRK2;ATP9A;MAPK3
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4023106466283602,0.8343202893529206,0.6344086021505376,0.9185486395122711,1.0,3/11,8.00%,MAP3K5;PDCD10;STK24
prerank,response to axon injury (GO:0048678),-0.32655326301204235,-0.8343010180184868,0.7236842105263158,0.9173822153930143,1.0,3/18,7.43%,DPYSL3;APOD;P2RX4
prerank,regulation of TOR signaling (GO:0032006),0.28325194670048415,0.8338954598360093,0.676818950930626,0.9186413449599803,1.0,15/67,16.23%,UBR1;PIK3CA;ROS1;AKT1S1;GNA12;NPRL3;DDIT4;DYRK3;SEC13;UBR2;TTI1;NPRL2;PRKAA1;MIOS;TSC1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.3163891526713588,-0.8335818304254186,0.7318548387096774,0.9181506839774426,1.0,9/21,20.84%,SAMD4A;CNOT7;TUT4;TUT7;CNOT8;CNOT3;PNLDC1;CNOT11;PAN3
prerank,regulation of regulated secretory pathway (GO:1903305),0.3257157016465098,0.8335234849138419,0.6625222024866785,0.9185719662287132,1.0,12/34,18.00%,RIMS1;RIMS2;SYN1;VPS18;SYT1;SYT2;RAB5A;PREPL;SYT12;SYT11;SYT13;GSK3B
prerank,extrinsic apoptotic signaling pathway (GO:0097191),-0.24316420368753763,-0.8331526061141759,0.7906403940886699,0.9183612873405657,1.0,15/70,18.05%,SMAD3;IL6R;TNFRSF1B;IFI27;BAG3;MCL1;TNFRSF1A;CASP8;DAB2IP;P2RX7;TGFB1;BID;RIPK1;PDPK1;DEDD
prerank,negative regulation of DNA metabolic process (GO:0051053),-0.29861293447250403,-0.8331026318270252,0.6973684210526315,0.9178783129587288,1.0,3/24,6.10%,BMPR2;NIBAN2;ACVRL1
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),0.35560214258048417,0.8328776891925516,0.6570841889117043,0.9190623837601809,1.0,5/18,20.20%,COX18;FASTKD3;COX20;OXA1L;SURF1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.29090038308660043,0.8324559960491349,0.6860670194003528,0.9191439705436533,1.0,8/62,11.46%,LIMD1;NUP43;AJUBA;DND1;POLR2C;NUP35;SEC13;NDC1
prerank,negative regulation of catabolic process (GO:0009895),0.3051621182153267,0.8324160052864322,0.6573426573426573,0.9184910705133381,1.0,4/47,4.05%,CBFA2T3;AGAP2;IL1B;FMN2
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),-0.378338230405601,-0.83221793654712,0.7124542124542125,0.9189306141536379,1.0,4/10,25.85%,ESR1;PSMC2;PSMC5;TP53
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.2709599381526524,0.8320951070923769,0.7104430379746836,0.9183884815117581,1.0,9/95,6.42%,MEF2C;NR1H3;IL1B;AXL;CXCL10;TNIP2;PDE4B;CXCL5;CACTIN
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.3453631873693591,0.8317214251439331,0.6423076923076924,0.9183768313948796,1.0,4/22,9.23%,RAPGEF2;NTRK2;RAP1A;TMEM108
prerank,hyaluronan catabolic process (GO:0030214),0.3595464155955364,0.8317074188003808,0.6447105788423154,0.9176841924176258,1.0,3/18,4.24%,CEMIP2;HYAL4;FGF2
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),-0.3683389145095599,-0.8308897916828072,0.6959847036328872,0.9208853700005811,1.0,5/10,22.98%,LRRK2;TXN;RIPK1;PARK7;STK26
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),0.35833355185207993,0.8308211263787869,0.612,0.9186234056288857,1.0,1/16,1.29%,RORA
prerank,sarcomere organization (GO:0045214),-0.29451735350982416,-0.8302664121632755,0.7212765957446808,0.9214831340837907,1.0,13/27,40.62%,ACTN2;CSRP2;MYOM2;KRT19;CAPN3;MYPN;MYLK3;FHOD3;TNNT3;TCAP;OBSCN;MYH6;CSRP1
prerank,cellular response to metal ion (GO:0071248),0.2636532067656768,0.8297152511714876,0.7399702823179792,0.9200244389588218,1.0,20/123,11.38%,MEF2C;SLC12A2;RASGRP2;CACNA1H;NCF1;ADCY8;ITPKB;CPNE7;SCN5A;ANK3;SNCA;SYT1;RYR3;PKD2;HPCA;DLG2;CPNE4;BRAF;CHP2;SYT2
prerank,RNA processing (GO:0006396),0.25267167490801085,0.8296125901042146,0.7854014598540145,0.9194992046401118,1.0,45/176,20.42%,RBPMS;APOBEC1;FASTKD2;ELAVL4;CLP1;DHX15;LSM3;NCBP2;ADARB2;SFPQ;HNRNPR;SRRM1;XRN2;RNPS1;CPSF6;TCERG1;RBMS1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;HNRNPUL1;PABPC4;DDX23;CELF1;HNRNPU;HNRNPC;KIN;LSM1;SF3B3;SNRPD3;KHSRP;USB1;HNRNPD;LIN28B;FUS;SNRNP48;HNRNPA2B1;RBM3;RNGTT;PPP2R1A;LUC7L3;SRRM4;LSM6
prerank,lymphocyte mediated immunity (GO:0002449),0.3725234411350613,0.8295666377290802,0.6162790697674418,0.9188516690145995,1.0,2/12,9.27%,CD46;JAG1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.27933991381167006,0.8294991271729669,0.7036474164133738,0.9182621331320387,1.0,15/94,9.84%,ATP2A3;MAP3K5;FNIP2;CHAC1;CUL3;BCL2L10;ITPR1;CIDEB;SCN2A;DDX3X;CASP9;CDKN1A;STK24;HTRA2;EPHA2
prerank,N-terminal protein amino acid modification (GO:0031365),0.37498369708953044,0.8292838398498342,0.6359918200408998,0.9179374237066171,1.0,5/14,21.24%,METAP2;NAA11;NAA15;METAP1;NTMT1
prerank,neuron projection fasciculation (GO:0106030),0.4015522784895209,0.829222201459596,0.6261061946902655,0.9173460419897962,1.0,3/10,9.18%,SEMA5A;CNTN4;ARHGAP35
prerank,sensory perception (GO:0007600),0.3079347739415295,0.8288569930094921,0.6869244935543278,0.9172909019840888,1.0,11/45,17.78%,ADORA2A;TRPV2;OPRK1;CHRNA7;SCN9A;TMEM150C;ASIC3;CHRNB2;NIPSNAP1;TTC8;GNAL
prerank,cellular response to hydrogen peroxide (GO:0070301),-0.2783723505549879,-0.82834559009564,0.7272727272727273,0.9243191549844287,1.0,10/33,18.15%,ANXA1;CYP1B1;RHOB;PRKCD;RELA;SIRPA;NET1;RIPK1;OSER1;PARK7
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),-0.30124247213043437,-0.8283257448372173,0.6884920634920635,0.9237564033439195,1.0,3/22,7.22%,ROCK2;PTPA;FKBP1A
prerank,negative regulation of catalytic activity (GO:0043086),0.3404840708618546,0.8280694447211296,0.6326129666011788,0.9180991868898577,1.0,5/24,13.42%,NOTCH1;NES;CCAR2;ATP5IF1;PPP1R12A
prerank,actin nucleation (GO:0045010),0.3466989647920822,0.8278043802822714,0.6334661354581673,0.917894001161191,1.0,6/21,13.39%,SPIRE1;ARPC5;ARPC5L;LMOD1;ARPC4;ARPC1A
prerank,respiratory chain complex IV assembly (GO:0008535),0.3359602446208482,0.8276605555405637,0.6408730158730159,0.9174539150039892,1.0,6/21,20.20%,COX18;FASTKD3;COA6;COX20;OXA1L;SURF1
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3109923272645974,-0.8276159037458583,0.6907407407407408,0.9244365213750736,1.0,3/20,13.54%,WNT4;C1QTNF3;PGP
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.3783694766543159,0.8273804179773322,0.6092436974789915,0.9172564578983615,1.0,4/12,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,copper ion homeostasis (GO:0055070),-0.32353539475388404,-0.8268618298328739,0.6937618147448015,0.925232592759032,1.0,2/17,5.22%,APP;ATOX1
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.34172327550398124,0.8266829230257248,0.6347826086956522,0.9178184384995585,1.0,4/20,11.61%,NOTCH1;CHD6;RUNX2;EP300
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.24335427761228537,-0.8261558679075413,0.7651515151515151,0.9259352476468198,1.0,28/70,28.39%,B2M;TAPBP;SNAP23;LNPEP;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1;MFSD6
prerank,protein insertion into ER membrane (GO:0045048),-0.27082216797333497,-0.8260989250213429,0.7091295116772823,0.925456650715404,1.0,16/37,32.57%,APP;TRAM2;EMC2;STX1A;ALDH3A2;VAPA;GET1;SEC61B;EMC6;WDR83OS;CCDC47;UBL4A;TRAM1;HMOX1;GET3;MMGT1
prerank,negative regulation of translation (GO:0017148),-0.23844254481766564,-0.825938358380761,0.8011204481792717,0.9251710926434608,1.0,21/87,18.49%,DAPK1;SAMD4A;ROCK2;IGFBP5;CNOT7;RNF139;DDX6;CPEB2;IGF2BP2;PUM1;CPEB3;CALR;LARP1;CNOT8;FTO;FXR2;EIF4EBP1;TPR;PAIP2B;EIF4E2;TYMS
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),-0.29976422887018994,-0.8252109715045846,0.7155172413793104,0.9258624315054607,1.0,7/26,20.68%,OCLN;AKAP9;TRPV4;MET;TOGARAM1;FES;NUMA1
prerank,regulation of mRNA stability (GO:0043488),-0.21777751949575624,-0.8251360729031366,0.8507936507936508,0.9254112317543985,1.0,40/145,24.71%,SAMD4A;ROCK2;VIM;THRAP3;NOCT;PRKCD;IGF2BP2;RC3H2;AKT1;PSME2;PUM1;TENT5A;PSMB4;UBB;LARP1;PSMB1;PSMD11;FTO;PSMD8;FXR2;EXOSC5;PSME3;XRN1;ELAVL1;PSMD4;PSMA2;CSDC2;ZFP36L2;E2F1;TENT5C;PSMD3;NUP214;PSMB7;PCBP4;TNFSF13;PSMC2;EXOSC7;SAMD4B;PSMC5;PSMD10
prerank,regulation of erythrocyte differentiation (GO:0045646),0.3181256420161475,0.8249898045488012,0.6793587174348698,0.9202362319546254,1.0,10/35,14.57%,CDK6;ETS1;FAM210B;ANKRD54;ARNT;LYN;MED1;PRMT1;PRKDC;ABCB10
prerank,mesoderm formation (GO:0001707),0.36090653825776653,0.8249729442880546,0.6459227467811158,0.9195646531881074,1.0,3/17,6.96%,TBX20;ITGB1;ITGA8
prerank,RNA destabilization (GO:0050779),0.353077381470883,0.8248295633180059,0.6492693110647182,0.9191194619637745,1.0,5/18,13.07%,ROCK1;RBM24;YTHDF3;YTHDF2;CELF1
prerank,cellular macromolecule catabolic process (GO:0044265),-0.2610476810509284,-0.8248195498921976,0.7629796839729119,0.9254039844379768,1.0,16/49,23.74%,ADAMTS9;DENND3;STT3B;SIDT2;IDE;DAB2IP;DNASE1L1;UBE2G2;PNPT1;MANBA;RIPK1;NGLY1;DFFB;FBXO17;CHEK2;EXOSC7
prerank,positive regulation of transport (GO:0051050),0.2762688763028818,0.8246733753559985,0.7052117263843648,0.9186956148249352,1.0,8/85,6.29%,NEDD4L;IL15RA;NR1H3;MERTK;IL1B;GPC3;CBLL1;SNCA
prerank,peptidyl-lysine methylation (GO:0018022),-0.29287059400535864,-0.8246175314903733,0.7350096711798839,0.9251969617251451,1.0,4/26,10.03%,SMYD3;SETD7;KMT5A;EHMT1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.36427142474057816,0.8243885141125614,0.6265060240963856,0.918516004295825,1.0,2/17,6.93%,RAPGEF2;ADCY9
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.35023147153020373,-0.8243672905294224,0.6984732824427481,0.9250479609105466,1.0,3/13,12.43%,NFAT5;RHOA;RELA
prerank,superoxide metabolic process (GO:0006801),0.3303884560191433,0.8241378719250343,0.6628571428571428,0.9182651633243001,1.0,4/29,5.97%,NCF2;NCF1;ATP7A;SOD3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.3414356809762156,-0.8237199277734485,0.7134615384615385,0.9256459627070424,1.0,5/14,22.33%,TNKS2;PINX1;BRCA2;TPP1;ACD
prerank,myeloid dendritic cell activation (GO:0001773),-0.351901556146798,-0.8236375921154442,0.6990291262135923,0.9252070190841473,1.0,1/12,3.00%,TGFBR2
prerank,cilium-dependent cell motility (GO:0060285),-0.3061587269820766,-0.8234752989082812,0.7242718446601941,0.9249116858165449,1.0,11/22,35.79%,EFHC1;EFHC2;DNAH3;DNAH8;DRC1;CCDC65;DNAH2;DNAAF2;TEKT2;CFAP44;DNAH17
prerank,regulation of vesicle-mediated transport (GO:0060627),0.26814111432476023,0.8234193664090382,0.7133655394524959,0.9189257159945575,1.0,25/91,18.92%,PLD1;SCARB1;RAB8B;RIT2;RIMS2;RAB3B;LGI3;SYT1;AP2S1;HIP1;ABL2;STXBP5L;STX4;DENND10;PACSIN3;SRC;PTPN1;RAB5A;CHMP3;MAPK1;HAP1;VAMP2;CPLX1;STXBP5;RAB33B
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.36432232486169586,-0.8231913511200779,0.687382297551789,0.9242574625766639,1.0,2/10,21.34%,CACNA2D4;TULP1
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.36432232486169586,-0.8231913511200779,0.687382297551789,0.9242574625766639,1.0,2/10,21.34%,CACNA2D4;TULP1
prerank,protein-DNA complex assembly (GO:0065004),-0.21722526651345714,-0.823135977153132,0.8770949720670391,0.9237715014868212,1.0,35/116,25.66%,KAT6B;TCF4;H3-3A;ERCC5;ANP32B;PSME2;CUL4A;PSMB4;UBB;PSMB1;PSMD11;DDB1;PSMD8;RPA1;PSME3;HMGB2;PSMD4;PSMA2;PSMD3;RSF1;PSMB7;NAP1L2;CETN2;MCM8;BRD2;RAD51;PSMC2;ERCC2;ASF1A;CHAF1A;PSMC5;RPA3;PSMD10;CDK7;ERCC3
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.23627739476472062,-0.8222173689889559,0.8210526315789474,0.924813140515641,1.0,31/78,28.31%,DAB2;CAV1;LRRK2;SMAD7;TAF1;RNF19A;RNF144B;SH3RF2;BBS7;USP5;DNAJB2;MDM2;ELOB;ANKIB1;SIRT2;BCAP31;FZR1;TRIB1;VCP;RNF217;RNF144A;BAG2;DDA1;RNF19B;PSMD10;RACK1;PRKN;CEBPA;TRIB3;HSPA1B;CLU
prerank,TOR signaling (GO:0031929),0.3330586443947998,0.8220867437363442,0.655241935483871,0.9205957940519277,1.0,5/26,8.92%,EIF4EBP2;PRR5L;RPS6KB2;MTOR;NPRL3
prerank,cAMP biosynthetic process (GO:0006171),0.38989414744557416,0.8215542606740199,0.6518046709129511,0.9208886043118244,1.0,4/10,6.93%,ADCY8;ADCY3;ADCY6;ADCY9
prerank,myeloid cell differentiation (GO:0030099),-0.26219885006963517,-0.8215508613597138,0.7645739910313901,0.9254398523585686,1.0,18/47,27.93%,ZBTB16;RPS14;MFHAS1;RPS19;KIT;SLC25A38;IKZF1;TAL1;HIPK2;ZFPM1;PTPN2;HSPA9;ACIN1;TET2;RASGRP4;ALAS2;CEBPA;HCLS1
prerank,positive regulation of myeloid cell differentiation (GO:0045639),-0.28286545570320976,-0.8213206539444338,0.7505112474437627,0.9252603516588588,1.0,15/33,29.82%,FOXO3;HOXA5;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2;FES;BRD1;RAB7B;NCKAP1L;MTURN;HSPA1B;ACVR2A
prerank,aminoglycan biosynthetic process (GO:0006023),0.30032235636019483,0.8210894374563688,0.6914893617021277,0.9210945984216277,1.0,8/49,9.19%,GCNT2;SDC2;SDC3;AGRN;GPC5;GPC3;B3GALT1;B3GNT8
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3015071961790186,-0.8201193978009144,0.7296747967479674,0.9268347294378305,1.0,2/21,7.81%,EPHA7;BIRC3
prerank,positive regulation of immune response (GO:0050778),-0.24481222360344104,-0.8198689085647732,0.7860696517412935,0.926666610777418,1.0,16/64,28.35%,IL15;IL6ST;LGALS9;IFI35;KARS1;GBP5;CYBA;RSAD2;CD81;XBP1;POLR3D;ITGB2;PLSCR1;EIF2AK4;ITGAM;SPHK2
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.38055255103425134,0.8196014588495744,0.6526315789473685,0.9231208228591626,1.0,3/14,5.49%,ELAVL4;DAZL;BOLL
prerank,snRNA 3'-end processing (GO:0034472),0.3513951605325257,0.819582002413662,0.6239669421487604,0.9224542286031429,1.0,4/19,17.93%,INTS6L;INTS1;INTS12;USB1
prerank,response to X-ray (GO:0010165),-0.3409722084090877,-0.8193157855363163,0.7080867850098619,0.927054209711361,1.0,4/14,20.30%,ANXA1;ATM;XRCC4;IKBIP
prerank,mRNA destabilization (GO:0061157),-0.27401699284872116,-0.8181425468048495,0.7648305084745762,0.9285650630363187,1.0,9/38,14.26%,ROCK2;TUT4;MOV10;TUT7;RC3H2;ZC3H12A;PUM1;CPEB3;FTO
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.2971922466099899,0.818086880153333,0.6818181818181818,0.9245029868181498,1.0,11/48,12.69%,FNIP2;BCL2L10;CIDEB;CASP9;CDIP1;HTRA2;EPHA2;DDIT4;HIPK1;EP300;PRKDC
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.36597668710309006,0.8180730177987013,0.6626262626262627,0.9238179044020125,1.0,4/17,7.70%,KCNE4;CACNA2D1;SCN5A;KCNE5
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),-0.36215231173930285,-0.8178394126420158,0.7083333333333334,0.9285382277705094,1.0,4/11,12.60%,IGF2BP2;NOVA2;PCBP2;NOVA1
prerank,negative regulation of protein dephosphorylation (GO:0035308),-0.30403166702050477,-0.817825876060676,0.7269076305220884,0.9279788691491169,1.0,4/21,9.01%,MFHAS1;PTPA;FKBP1A;PPP1R16B
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3253452841933115,0.8176304807945046,0.6827852998065764,0.9238829426286119,1.0,14/30,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,piRNA metabolic process (GO:0034587),0.3507178008645665,0.817511409512282,0.656441717791411,0.9233897451444906,1.0,3/19,14.98%,PLD6;TDRKH;EXD1
prerank,dendritic cell differentiation (GO:0097028),-0.30086722564918167,-0.8161275471456491,0.7402061855670103,0.9304321368099844,1.0,3/22,5.51%,TGFBR2;GAS6;LGALS9
prerank,regulation of receptor recycling (GO:0001919),0.3546256524016958,0.8160202611010015,0.6404040404040404,0.925392681591086,1.0,3/16,6.29%,ECE1;AP1AR;SNCA
prerank,negative regulation of cellular protein localization (GO:1903828),-0.2739922736943772,-0.8159674445686045,0.7667386609071274,0.930116364271512,1.0,5/34,9.92%,ROCK2;ACTN2;MFHAS1;CTNNA1;FLCN
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.2537268808444868,-0.8158668417971785,0.7893462469733656,0.9297213276023587,1.0,22/52,32.09%,SEC31A;HSPA5;ERN1;ADD1;EXTL2;DNAJB11;DNAJC3;PARP16;PDIA6;PDIA5;GFPT1;TPP1;XBP1;SHC1;ATP6V0D1;EDEM1;PREB;SYVN1;YIF1A;ZBTB17;HYOU1;CUL7
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",-0.3670399552525411,-0.815676524354753,0.7022058823529411,0.929473330745874,1.0,2/10,6.62%,APPL2;ANO6
prerank,erythrocyte development (GO:0048821),0.38108367946066424,0.8150226856041691,0.6216216216216216,0.9265668568106883,1.0,3/10,14.57%,SH2B3;MED1;ABCB10
prerank,neuron fate commitment (GO:0048663),-0.34061099729015254,-0.8147988518290548,0.7153846153846154,0.9304817369513918,1.0,8/14,44.37%,TGFBR1;ID2;DLL1;SHH;POU4F1;PAX6;ASCL1;ISL1
prerank,protein neddylation (GO:0045116),0.3624857398275291,0.8146925638736044,0.628099173553719,0.9264131231178386,1.0,6/13,23.42%,RBX1;DCUN1D2;UBE2F;RNF7;DCUN1D4;DCUN1D1
prerank,toll-like receptor 9 signaling pathway (GO:0034162),-0.3446922603699936,-0.814692059592869,0.6859344894026975,0.9300780684680899,1.0,2/13,7.04%,IRAK2;PIK3AP1
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),-0.27776605413712324,-0.814430301618299,0.7563352826510721,0.9299758777743311,1.0,14/30,28.89%,CXCL12;TPT1;MDM2;SNAI1;THOC1;PSMD10;BCL2L1;RPS3;CD44;TWIST1;CDKN2D;CLU;PTTG1IP;THOC5
prerank,negative regulation of hemostasis (GO:1900047),-0.35038945175628183,-0.8142555212997539,0.7224199288256228,0.92969109784999,1.0,3/12,4.57%,APOE;THBD;CD34
prerank,hexose metabolic process (GO:0019318),-0.2681858803112711,-0.8132463535698651,0.7835294117647059,0.9308984007800415,1.0,18/39,33.43%,APOD;SORD;FUCA1;SLC35A2;CHST15;AKR1A1;GAA;FPGT;ALDOA;BRAT1;GALT;FUCA2;HK1;GDPGP1;KHK;IRS2;DCXR;CHST1
prerank,intracellular sterol transport (GO:0032366),-0.3448249371093953,-0.8131237003696531,0.7265917602996255,0.9305284721508595,1.0,3/13,13.55%,ABCA1;NPC2;STARD4
prerank,membrane depolarization (GO:0051899),0.3256302337712739,0.8124131789389378,0.651031894934334,0.9298982428112458,1.0,9/32,14.68%,CACNA1H;SCN2A;SCN5A;SCN8A;SCN9A;CACNA1A;ATP5IF1;SCN1A;CHRNB2
prerank,integrated stress response signaling (GO:0140467),-0.33389841040629875,-0.8120571281743413,0.7235621521335807,0.9317281247159878,1.0,5/14,30.68%,QRICH1;HSPA5;EIF2AK3;EIF2AK4;CCL2
prerank,histone methylation (GO:0016571),-0.2938661683188214,-0.8119517068610843,0.7403100775193798,0.9313441198045963,1.0,9/26,25.81%,SMYD3;CARM1;EHMT1;NSD1;SIRT7;EZH2;SETD6;TRMT112;FBL
prerank,dendrite self-avoidance (GO:0070593),-0.3194075370895535,-0.8118300486993423,0.7211155378486056,0.9309865165133184,1.0,3/16,10.19%,BSG;PALLD;ROBO4
prerank,regulation of interleukin-17 production (GO:0032660),-0.28036775618819487,-0.8117899065133253,0.7655601659751037,0.9304858358999892,1.0,6/31,16.55%,IL15;SLC7A5;IL18;TGFB1;SPHK1;TLR4
prerank,DNA replication-independent nucleosome organization (GO:0034724),-0.3604314015248707,-0.8115471134516552,0.7191650853889943,0.9302992397564237,1.0,7/11,35.34%,UBN1;H3-3A;HAT1;ASF1A;IPO4;ATRX;ASF1B
prerank,relaxation of cardiac muscle (GO:0055119),0.3723985295800766,0.8110526739695366,0.6583333333333333,0.9317344883718547,1.0,2/13,3.05%,ATP1A2;PIK3CA
prerank,mRNA methylation (GO:0080009),0.3647199417418229,0.8104588291187084,0.6666666666666666,0.9321422837470658,1.0,6/15,19.98%,TRMT61A;CBLL1;TRMT10C;NSUN2;ZC3H13;WTAP
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3504528843587428,0.8104104486096108,0.6646586345381527,0.9315246314621846,1.0,1/18,1.34%,PIK3R1
prerank,positive regulation of protein maturation (GO:1903319),-0.357332476019555,-0.8100724621459267,0.7179962894248608,0.9322511718646209,1.0,1/11,1.79%,CCBE1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),0.35764361849782283,0.8099112254079395,0.6582809224318659,0.9317305481251466,1.0,6/14,15.63%,AK8;NMNAT3;AK7;AK5;AK4;AK3
prerank,amide biosynthetic process (GO:0043604),-0.25367960681354035,-0.8091248890881418,0.7764705882352941,0.9333306477721096,1.0,4/47,2.90%,PAM;PCSK5;SGMS1;SGMS2
prerank,regulation of glucose metabolic process (GO:0010906),0.3098400911604395,0.8085515751746198,0.7073643410852714,0.9335422218719552,1.0,5/34,9.21%,RORA;OGT;IRS1;ZNF692;SDHAF3
prerank,protein import into nucleus (GO:0006606),-0.23901508165133767,-0.8082719340067606,0.8387096774193549,0.9341727258523626,1.0,24/66,29.60%,APPL2;STAT3;AKT1;IPO7;FAM53C;IPO13;RAN;RGPD1;KPNA6;RPL23;NXT2;IPO8;TPR;NUP88;SYK;NUP214;NXT1;NUP155;RANBP17;EIF4ENIF1;CSE1L;NUP62;PTTG1IP;TNPO2
prerank,regulation of mast cell activation (GO:0033003),0.38273450790206764,0.8082667175739103,0.6550218340611353,0.9333779280696479,1.0,4/10,23.84%,LYN;CD84;TSLP;MILR1
prerank,regulation of cell cycle phase transition (GO:1901987),-0.22578336410789443,-0.8081819633417873,0.8328981723237598,0.9337595594224515,1.0,29/91,25.85%,TAF1;MN1;CDC16;PSME2;ANAPC4;PSMB4;TRIM39;PSMB1;PSMD11;DDB1;PSMD8;DBF4;PSME3;CDKN1B;TCIM;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;PSMC2;ERCC2;PSMC5;PSMD10;ERCC3;TP53
prerank,T cell proliferation (GO:0042098),-0.3381954046447034,-0.8081522643475821,0.7339805825242719,0.9332339127600321,1.0,7/13,42.31%,CTPS1;LMBR1L;PPP3CB;DOCK8;PIK3CG;TNFRSF4;CRTAM
prerank,neutrophil migration (GO:1990266),0.29050715564685625,0.8073140573494773,0.7132743362831858,0.9344074776580621,1.0,6/58,7.50%,PIK3CD;CXCR2;CXCL10;PDE4B;CXCL5;PIKFYVE
prerank,chromosome organization (GO:0051276),-0.22157977911029086,-0.8054494544172454,0.8913043478260869,0.9371297257582524,1.0,36/99,31.24%,HDAC8;SETD7;TCF7L2;TOP2B;H3-3A;EHMT1;CUL4A;HDAC1;COPS4;UBB;COPS8;EZH1;HDAC5;DDB1;CENPT;HHEX;HMGB2;HMGN1;EZH2;CETN2;TOP2A;SMARCA4;MSH6;SATB1;BRWD1;COPS7A;L3MBTL1;NUP155;COPS2;CENPH;ABL1;NDC80;POLE3;SUPT4H1;DOT1L;CDCA8
prerank,DNA repair (GO:0006281),-0.191182217616665,-0.8054035813454391,0.9695652173913043,0.9366151746243168,1.0,90/284,31.01%,EYA1;USP47;ASCC3;PARP9;PDS5B;INO80;HINFP;RAD51B;BAZ1B;TRRAP;ERCC5;DCLRE1C;DTX3L;PARP3;REXO4;MMS19;BRCA2;NABP1;POLH;APEX2;FANCI;ATM;UBB;UVRAG;TDG;XRCC4;FTO;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;ASCC1;ACTR8;PARK7;RFC3;BABAM2;VCP;PIAS4;SMC1A;RECQL;RAD52;POLI;UBXN1;POLE2;BABAM1;CETN2;RAD51C;NEIL3;BAP1;SLX4;EXO5;RMI2;RAD51;ERCC1;CHEK2;ERCC2;MSH6;RNF8;ASF1A;BRCA1;RPA3;ALKBH5;PPP5C;CENPX;ACTR5;NUDT1;ERCC3;TP53;POLA1;NEIL1;HUS1;APLF;CDKN2D;ATXN3;POLD1;FANCM;FANCA;ABL1;WDR33;MNAT1;EID3;WRN;GTF2H3;UBE2V1;DOT1L;PCNA;EXO1;HERC2
prerank,retinal metabolic process (GO:0042574),-0.3434103054781353,-0.805365782703331,0.7329317269076305,0.9360880360706706,1.0,2/12,7.96%,CYP1B1;ABCA4
prerank,histone H4-K8 acetylation (GO:0043982),0.3504482774839539,0.8045011774560695,0.6818181818181818,0.9381462292392441,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,histone H4-K5 acetylation (GO:0043981),0.3504482774839539,0.8045011774560695,0.6818181818181818,0.9381462292392441,1.0,6/15,19.14%,OGT;KAT7;KANSL3;KANSL1;MCRS1;WDR5
prerank,positive regulation of cellular senescence (GO:2000774),-0.35992071910110396,-0.804101136618475,0.7320143884892086,0.9375994558897796,1.0,2/10,13.90%,B2M;YPEL3
prerank,protein polyubiquitination (GO:0000209),-0.19342493060138455,-0.8036084098211732,0.967741935483871,0.9378316666394488,1.0,86/297,25.94%,FBXL7;RNF213;SASH1;HERC6;NPEPPS;SMURF2;FBXO10;RNF146;ZNRF1;TAF1;SPSB1;RNF19A;TNKS2;WWP2;RNF144B;TTC3;SMURF1;CDC16;AMFR;IFI27;UBE2E2;LNPEP;RC3H2;NHLRC3;CHFR;DTX3L;RNF135;TRIM27;PSME2;UBE4B;ANAPC4;RNF125;MDM2;PSMB4;UBE2Q2;FBXW11;UBB;UBE2G2;PSMB1;PSMD11;PSMD8;RNF115;WWP1;FBXL14;ANKIB1;PSME3;RNF187;PELI1;UBE3D;FBXL19;TRAF3IP2;PSMD4;LONRF1;TRIM14;FZR1;PSMA2;FBXO41;RNF217;PSMD3;CDC27;RNF144A;UBE2L6;RFFL;RMND5A;RNF126;PSMB7;ANAPC5;RBBP6;DZIP3;FBXO17;CCNF;DDA1;RNF19B;PSMC2;CBFB;RNF8;TRIM6;RNF216;BRCA1;PSMC5;PSMD10;BFAR;DCAF15;PRKN;UBE2H;CTNNB1
prerank,protein import into peroxisome membrane (GO:0045046),0.34142707824654983,0.8033432727103049,0.6595289079229122,0.9395094289046291,1.0,6/22,15.58%,RAB8B;ABCD2;ATAD1;PEX3;PEX19;PEX12
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.25854818147108555,0.8029187162579176,0.8024316109422492,0.939532840831028,1.0,17/122,9.25%,PDGFRB;PLD1;RGCC;IL1B;FGF2;YTHDF3;IL4;DDX3X;SOX4;KAT7;IRS1;NMD3;MTOR;EIF3C;PRKD2;PDGFB;GCK
prerank,protein oxidation (GO:0018158),-0.3562405973591149,-0.8028439746769193,0.7324478178368121,0.9385576650306456,1.0,1/11,1.62%,LOXL1
prerank,mitochondrion organization (GO:0007005),0.25005851973324655,0.8022186104666377,0.7881844380403458,0.940144025303578,1.0,16/165,8.56%,PID1;HIGD1B;SLC25A33;IMMP2L;AKT3;PLD6;PTCD2;ATP7A;FANCG;ESRRA;SUPV3L1;GABPA;TIMM22;MTFP1;TFAM;RAB38
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.3290184733377757,0.8021939460304566,0.6802443991853361,0.9394892986576164,1.0,4/22,9.11%,NR1H3;PTPN22;APPL1;LYN
prerank,anterograde axonal transport (GO:0008089),-0.2603815747295481,-0.8019834122459889,0.788546255506608,0.9394765197380649,1.0,6/37,10.29%,AP3S1;KIF1B;DTNBP1;AP3B1;RAB21;SPAST
prerank,organelle fusion (GO:0048284),0.34050423921494904,0.8016819085263501,0.6745562130177515,0.9397455575644088,1.0,7/22,15.80%,PLD6;VPS18;VPS11;STX4;MFF;MFN1;MIEF1
prerank,gonad development (GO:0008406),-0.25872815391918835,-0.8016182316058683,0.7804347826086957,0.9395287653818953,1.0,11/41,26.77%,WNT4;AR;WNT5A;KIT;GATA6;BASP1;NCOA4;CSDE1;COL9A3;ADAM21;BIK
prerank,interleukin-1-mediated signaling pathway (GO:0070498),-0.22505625689740935,-0.801365325455891,0.8610354223433242,0.9393707822165631,1.0,29/94,24.90%,PLCB1;IL1R1;NOD1;IRAK2;MAP3K8;IRAK3;PSME2;RELA;PSMB4;FBXW11;UBB;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;PELI1;NFKBIA;MAP3K3;PSMD4;PSMA2;IKBKG;PSMD3;PSMB7;PSMC2;PSMC5;EGR1;PSMD10;MYD88
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.3778969819456751,0.8012102572258439,0.6778523489932886,0.9399543511464654,1.0,2/11,9.66%,UQCRFS1;UQCRC2
prerank,cholesterol biosynthetic process (GO:0006695),0.31696390650792633,0.8010832416336149,0.6928982725527831,0.9394645546954078,1.0,14/31,24.88%,ARV1;HMGCS1;SQLE;LSS;DHCR7;TM7SF2;HMGCR;INSIG1;NSDHL;MVK;FDFT1;ACAA2;CYP51A1;FDPS
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.32990400814552145,-0.8009207500033041,0.7181467181467182,0.9394881876379394,1.0,5/14,29.56%,ETNK2;LPIN3;ETNK1;ETNPPL;CHKA
prerank,positive regulation of cell aging (GO:0090343),-0.34973599646130954,-0.8005921970885963,0.7324723247232472,0.9394620480648662,1.0,2/11,13.90%,B2M;YPEL3
prerank,positive regulation of cellular protein localization (GO:1903829),-0.2351499414878131,-0.7995930959977346,0.8320987654320988,0.9405997358249316,1.0,21/69,21.84%,LIMK2;PARP9;YAP1;GPD1L;STX3;TFRC;AKT1;DTX3L;CARD10;TGFB1;HSP90AB1;PRKAA2;TM9SF4;PARK7;LAMTOR5;ORMDL3;VPS28;CDK5RAP3;NUMA1;TYROBP;EIF2AK3
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),0.3817508991750189,0.7993951110035515,0.6946902654867256,0.9418967847916546,1.0,4/12,9.65%,PTPN22;CD300A;LYN;PAX5
prerank,glucose 6-phosphate metabolic process (GO:0051156),-0.29966369928170133,-0.79912730002913,0.762396694214876,0.9407424554093333,1.0,7/21,23.00%,TALDO1;HK2;DERA;PGD;RPIA;PGLS;SHPK
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),-0.27045595688805546,-0.7989048619494473,0.7905982905982906,0.9404929366566027,1.0,8/34,15.74%,PTPRB;PTPN13;PTPRJ;DUSP1;DUSP16;PGP;DUSP7;DUSP10
prerank,macrophage activation involved in immune response (GO:0002281),0.3653178890949793,0.7986436187603536,0.6792035398230089,0.9426383273782898,1.0,1/13,1.12%,DYSF
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.2382943634587968,-0.7986199427101223,0.8306878306878307,0.9403681133671609,1.0,21/73,20.59%,HDAC4;DNMT3A;KAT2B;RBBP7;IGF2;BAZ1B;H3-3A;JARID2;TRIM27;POLR2F;TDG;HDAC5;ACTB;PPHLN1;POLR2E;GPX1;EZH2;ZFP57;SMYD5;CTCF;MPHOSPH8
prerank,mitotic spindle assembly (GO:0090307),-0.2579890415750372,-0.7982778062609952,0.7893569844789357,0.940325627195599,1.0,18/42,33.68%,RAB11A;RHOA;SMC3;TOGARAM1;SMC1A;CEP192;CHEK2;ABRAXAS2;MISP;ARHGEF10;PIBF1;TPX2;KIFC1;STAG2;KIF4A;GOLGA2;KIF23;PRC1
prerank,positive regulation of monocyte chemotaxis (GO:0090026),-0.3138642642656917,-0.7982098146340562,0.7159309021113244,0.9398497556747826,1.0,4/17,15.73%,CXCL12;ANO6;CREB3;SERPINE1
prerank,maintenance of protein location in nucleus (GO:0051457),0.3363393985538457,0.7978113400903026,0.6875,0.9434893996726973,1.0,1/20,1.25%,SYNE1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.32410198010608293,-0.7970891433709372,0.7112403100775194,0.941156815969011,1.0,5/14,22.36%,ANXA1;PRKCZ;IL18;CCL19;RARA
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.36809645260872764,-0.7970484750464879,0.743879472693032,0.9406396585055464,1.0,1/10,1.69%,TGFA
prerank,positive regulation of mitotic cell cycle (GO:0045931),-0.28446668946930465,-0.7970293075703216,0.7723577235772358,0.9400886923078485,1.0,7/26,14.99%,APP;MDM2;SMOC2;SPHK1;MEIS2;TAL1;EIF4EBP1
prerank,apical protein localization (GO:0045176),-0.3634680650278329,-0.7969188034869883,0.7262569832402235,0.9397050184652975,1.0,2/10,3.09%,SHROOM2;SHROOM3
prerank,fatty-acyl-CoA metabolic process (GO:0035337),-0.30532206223578334,-0.7964908297748776,0.75,0.939826168324927,1.0,6/20,21.78%,ACACA;FAR2;ACSL4;HSD17B8;DGAT2;GCDH
prerank,protein localization to chromosome (GO:0034502),-0.2714461584530775,-0.7963096420753787,0.779835390946502,0.939526332186142,1.0,10/34,22.53%,ESR1;TNKS2;PARP3;PINX1;XRCC4;RPA1;TPP1;CTCF;ACD;MCM8
prerank,polyamine metabolic process (GO:0006595),0.36491030026604754,0.7961417762097986,0.6798245614035088,0.9458809867197772,1.0,4/13,16.45%,OAZ2;DHPS;AOC1;HDAC10
prerank,amyloid precursor protein metabolic process (GO:0042982),0.34616075929875023,0.795616046404645,0.6519114688128773,0.9461250928003776,1.0,3/18,8.09%,LDLRAP1;ADAM19;ACHE
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),-0.23977616709910382,-0.795181704796901,0.8542713567839196,0.9408294611878089,1.0,23/62,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,regulation of pseudopodium assembly (GO:0031272),0.3749991115535465,0.7950470274075744,0.6757369614512472,0.9457150166297909,1.0,3/10,15.91%,CDC42EP1;APC;CDC42EP4
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.3749991115535465,0.7950470274075744,0.6757369614512472,0.9457150166297909,1.0,3/10,15.91%,CDC42EP1;APC;CDC42EP4
prerank,base-excision repair (GO:0006284),-0.24961623662292115,-0.7946746389333562,0.8068181818181818,0.941049970181704,1.0,16/48,32.01%,USP47;ERCC5;APEX2;TDG;RPA1;ADPRS;RFC3;RFC1;NEIL3;RPA3;NEIL1;NTHL1;POLD1;WRN;PCNA;RFC5
prerank,oligodendrocyte development (GO:0014003),0.3489247129099349,0.7942684410751969,0.6815415821501014,0.9464303433299691,1.0,4/15,10.86%,B4GALT6;TPPP;PLP1;EIF2B3
prerank,response to interferon-alpha (GO:0035455),-0.3134730408400872,-0.7934073495504066,0.7384615384615385,0.9425063730109309,1.0,4/16,17.49%,GAS6;IFITM3;IFITM2;TPR
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),-0.29696481442848494,-0.7933245599109601,0.7749003984063745,0.9420492309929067,1.0,6/23,14.30%,PARP9;PARP14;STAT1;IRGM;NLRC5;HSP90AB1
prerank,regulation of telomere maintenance (GO:0032204),-0.29030676967665026,-0.7932545033014523,0.7885835095137421,0.9415851083071038,1.0,5/26,16.96%,HDAC8;SMG6;PML;RAD50;SMG5
prerank,B cell differentiation (GO:0030183),0.28979985773531647,0.7931662890433678,0.710431654676259,0.9477120214558808,1.0,3/46,6.03%,ITGA4;ITGB1;IL4
prerank,water-soluble vitamin metabolic process (GO:0006767),-0.2350781531236018,-0.7930549337322906,0.825065274151436,0.9413168120337364,1.0,21/68,27.29%,AOX1;PCCA;ENPP1;SLC2A1;PCCB;CUBN;SLC5A6;ALDH1L1;SLC25A19;NNMT;FPGS;SLC52A3;CYB5R3;SLC19A2;SLC52A1;GSTO2;CD320;SLC25A32;PDXK;PNPO;MTRR
prerank,nucleotide-excision repair (GO:0006289),-0.21770758817910088,-0.7930211893637032,0.8774373259052924,0.9407934523794659,1.0,32/101,27.15%,POLR2A;ERCC5;MMS19;BRCA2;CUL4A;COPS4;POLR2F;UBB;COPS8;DDB1;RPA1;POLR2E;HMGN1;RFC3;TCEA1;RFC1;CETN2;SLX4;ERCC1;ERCC2;RPA3;POLR2G;COPS7A;CDK7;ERCC3;TP53;POLA1;HUS1;COPS2;ATXN3;PRPF19;POLD1
prerank,regulation of calcium-mediated signaling (GO:0050848),-0.28081913244540785,-0.7927049695456604,0.772256728778468,0.9407634128411253,1.0,5/25,13.39%,LRRK2;P2RX4;CMKLR1;CDH13;PLCG2
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.31094636029867895,0.7926948830838277,0.6727605118829981,0.9478337822174769,1.0,6/33,11.05%,PTK2;JAM3;RAC3;LYN;EPHA2;SNAI2
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.3202727775080718,0.7926863720207286,0.6733870967741935,0.9471428285408612,1.0,2/24,1.93%,NR1H3;USP25
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.33511794042211024,0.7925705774890887,0.6950959488272921,0.946643397187859,1.0,6/20,9.97%,RGCC;SPDYA;TTBK1;PKD2;PDGFB;CCNYL1
prerank,endosome organization (GO:0007032),-0.259862370613813,-0.7924599399349855,0.7712418300653595,0.9405740707845917,1.0,10/41,16.20%,EEA1;RAB27A;USP8;ALS2;ALS2CL;CLCN3;SNX10;CORO1C;PHETA1;ARFGEF2
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),-0.2719890865112587,-0.7924370364467959,0.7672413793103449,0.9400295703964541,1.0,13/30,30.28%,CAV1;PARP14;PRKCZ;PRKCD;SFRP1;PTPN2;SAMSN1;PTPN6;NTF3;SH3BP5;PIBF1;SOCS1;INPP5F
prerank,regulation of lymphocyte activation (GO:0051249),0.37001542452044395,0.7921885469395045,0.6645161290322581,0.9466578597240843,1.0,1/12,3.86%,PAG1
prerank,negative regulation of kinase activity (GO:0033673),-0.2422778367242729,-0.7920696182350496,0.8170731707317073,0.9400307883245286,1.0,25/62,27.98%,PRKAG2;DEPTOR;LRP6;DTNBP1;AKT1;TRIM27;CEP85;QARS1;PPIA;GSKIP;CEACAM1;CDKN1B;PDPK1;PARK7;CHP1;TRIB1;UBASH3B;CDKN1C;INPP5K;PYDC1;GNAQ;PAK2;SFN;TRIB3;PPM1F
prerank,mitochondrial transcription (GO:0006390),0.3776825456939672,0.7916815536276781,0.683982683982684,0.9468352429660523,1.0,2/10,8.22%,SLC25A33;TFAM
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.36445648657103435,0.7916719896899361,0.6942148760330579,0.9461550594141028,1.0,1/12,1.34%,PIK3R1
prerank,NIK/NF-kappaB signaling (GO:0038061),-0.2315140154140355,-0.7915047498330124,0.8578811369509044,0.9403657999216165,1.0,23/72,25.28%,MAP3K14;CARD14;BIRC3;AKT1;CARD10;PSME2;RELA;PSMB4;FBXW11;COPS8;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;DICER1;PSMB7;PSMC2;PSMC5;PSMD10;REL
prerank,regulation of lipase activity (GO:0060191),-0.33535459669243506,-0.7902022222283539,0.7446808510638298,0.9418949202059373,1.0,2/13,6.59%,PCSK5;RHOA
prerank,entry into host (GO:0044409),-0.33651321794546374,-0.7901609953192101,0.7485493230174082,0.9413911669215969,1.0,7/13,32.51%,CDH1;MET;PPIA;CTNNB1;CXCR4;GRB2;CTNND1
prerank,regulation of protein localization to cell periphery (GO:1904375),0.3443522192308046,0.7898916180829265,0.6823770491803278,0.9486023874520045,1.0,6/18,15.84%,LDLRAP1;SPTBN1;APPL1;ZDHHC2;VTI1B;CDK5
prerank,T cell differentiation in thymus (GO:0033077),-0.32280612677413323,-0.7898885363150407,0.7417582417582418,0.9412600500703654,1.0,7/14,34.86%,GLI3;MR1;ZFP36L2;RABL3;ADAM17;FADD;SHH
prerank,peptidyl-lysine acetylation (GO:0018394),0.3764353721292531,0.7895223968634834,0.6946902654867256,0.9485337322305889,1.0,3/10,11.61%,KAT7;BLOC1S1;EP300
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.346489701096491,0.7894373618514913,0.6919831223628692,0.9479937159678401,1.0,5/17,13.73%,SPRED1;CADM4;SPRY2;DDIT4;SPRED2
prerank,macroautophagy (GO:0016236),0.2534466894357669,0.7891839562702304,0.802710843373494,0.9477341198947258,1.0,36/118,22.98%,DYNLL1;PIP4K2A;ATG16L1;CHMP2B;MTMR14;MVB12A;MTERF3;SRC;VTI1B;UBXN6;PRKAA1;PLEKHM1;VPS33B;MFN1;TOMM40;CHMP3;HDAC10;EI24;PIK3C3;ULK3;SNF8;LIX1L;VTA1;GABARAP;NBR1;PRKAB2;CSNK2A2;TOMM70;VPS37B;GABARAPL2;ATG13;ARL8B;VPS16;VAMP7;VPS36;VDAC1
prerank,sulfur amino acid metabolic process (GO:0000096),0.32424147585984336,0.7890302756713322,0.6952965235173824,0.9473080547479193,1.0,3/24,6.61%,CTH;TXN2;MSRA
prerank,positive regulation of interleukin-8 production (GO:0032757),-0.2473576097453446,-0.7887183152567179,0.8004750593824228,0.9425182223037597,1.0,13/49,19.93%,F3;LBP;NOD1;LGALS9;STAT3;MAVS;RELA;SERPINE1;TLR4;RIPK1;PARK7;LAMTOR5;SYK
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),0.37290591024659836,0.788325371930917,0.6887417218543046,0.9478949089393403,1.0,3/11,11.50%,BCAR1;HPN;PAK1
prerank,neuromuscular junction development (GO:0007528),0.33587738562673114,0.7880779276108579,0.6857707509881423,0.9476121605334236,1.0,5/24,7.88%,CACNB2;DOK7;AGRN;ANK3;PPFIBP2
prerank,response to sterol (GO:0036314),0.3699134088224308,0.7880375561520839,0.6807095343680709,0.9469862920120069,1.0,1/11,1.29%,RORA
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),-0.22860056910740287,-0.7879913132356134,0.8378378378378378,0.9431276783415508,1.0,21/72,25.66%,ENPP1;EDC3;RNASE4;ERCC5;REXO4;ZC3H12A;CUL4A;DNASE1L1;UBB;DDB1;RPA1;RAD50;SPO11;RFC3;PNRC2;DICER1;RFC1;ERCC1;ERCC2;RPA3;ERCC3
prerank,regulation of gluconeogenesis (GO:0006111),0.31060041161971547,0.7879817502826738,0.7267080745341615,0.9463844529511695,1.0,7/27,13.27%,OGT;SIK1;ZNF692;SDHAF3;GCK;EP300;CRY1
prerank,mitotic recombination (GO:0006312),-0.3171907865557031,-0.7876850097250591,0.7430683918669131,0.9430447134697464,1.0,7/15,25.37%,TEP1;RAD50;TPRKB;RAD52;RAD51;ERCC1;RAD54B
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),0.32608379813372307,0.7873185695234906,0.7282377919320594,0.9469181427956614,1.0,5/23,13.27%,CBFA2T3;SIK1;GCK;EP300;CRY1
prerank,telomere capping (GO:0016233),0.3529190639034298,0.7867258160079199,0.6963562753036437,0.947234832071694,1.0,5/16,22.11%,DCLRE1B;PRKDC;TERF1;TINF2;CTC1
prerank,regulation of cellular catabolic process (GO:0031329),-0.23558658759659085,-0.7863932917894617,0.8423645320197044,0.9445007009157083,1.0,12/62,16.25%,DAPK1;NUPR1;LRRK2;WDR41;ACER2;PSAP;PIP4K2B;RAB8A;ATM;FBXL2;GPR137;MTMR3
prerank,regulation of neuron death (GO:1901214),0.2633177443504783,0.7862501254677084,0.7677100494233937,0.9473679353418972,1.0,14/82,12.15%,MEF2C;MAP3K5;INPP5A;SNCA;CHRNA7;AKT1S1;HTRA2;GRM4;GRIN2B;SARM1;DDIT4;TRIM2;BTBD10;EPHB1
prerank,nucleoside salvage (GO:0043174),0.37186431429601174,0.7859109290272926,0.6733870967741935,0.9472559852966662,1.0,3/10,8.19%,TK1;TK2;DCK
prerank,mitotic spindle checkpoint signaling (GO:0071174),-0.297087816233494,-0.7858384044125972,0.7754318618042226,0.943679998878906,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),-0.297087816233494,-0.7858384044125972,0.7754318618042226,0.943679998878906,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,spindle assembly checkpoint signaling (GO:0071173),-0.297087816233494,-0.7858384044125972,0.7754318618042226,0.943679998878906,1.0,12/20,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),-0.34777711684817925,-0.7851603782393151,0.7555555555555555,0.9441610940680345,1.0,2/10,7.33%,GHR;STAT3
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3206983053128352,0.7850270578645766,0.705765407554672,0.9481432992225559,1.0,6/26,15.88%,HECW2;CUL3;NEK6;RB1;ANAPC7;NSMCE2
prerank,microtubule anchoring at centrosome (GO:0034454),0.38743481474556307,0.7846612810936966,0.6746724890829694,0.9481407050116567,1.0,5/10,21.21%,HOOK3;KIF3A;DCTN1;CEP19;CCDC68
prerank,regulation of spindle organization (GO:0090224),-0.3015659209985708,-0.7841660952330982,0.7683168316831683,0.9452074410974414,1.0,7/18,28.52%,PARP3;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;NUP62
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),-0.31325402164148874,-0.7839872730406349,0.7546125461254612,0.9449237841949752,1.0,2/17,3.38%,PTPRJ;EZR
prerank,negative regulation of endocytosis (GO:0045806),0.32908317638262075,0.7835370782395409,0.7068273092369478,0.949445741848395,1.0,11/24,23.37%,NR1H3;CD300A;SCAMP5;PACSIN3;ABCA7;SYT11;PRKD1;SNX33;LILRB1;PICALM;ARF6
prerank,regulation of response to oxidative stress (GO:1902882),-0.34391941386265007,-0.7834939773856386,0.7424812030075187,0.9451264318273359,1.0,7/11,41.04%,MCTP1;GGT7;PRKN;PINK1;ALOX5;HEBP2;AIFM2
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),-0.35659735811255067,-0.7828405593762325,0.7324723247232472,0.9456027833709684,1.0,4/10,21.78%,IVD;ACADL;ACADS;GCDH
prerank,positive regulation of catabolic process (GO:0009896),0.27081167721730454,0.782367849149352,0.7466887417218543,0.9508151487471329,1.0,6/65,6.86%,NEDD4L;HECW2;IL1B;OAZ2;GPC3;HACE1
prerank,regulation of cholesterol metabolic process (GO:0090181),0.33058068203120544,0.7823351211026034,0.702258726899384,0.9501751253208977,1.0,3/20,5.07%,LDLRAP1;ARV1;SREBF2
prerank,spinal cord development (GO:0021510),-0.3398794530531074,-0.782317168213641,0.7431372549019608,0.9458588565166068,1.0,2/12,2.85%,GLI2;VIT
prerank,neuromuscular synaptic transmission (GO:0007274),0.343128170181601,0.7822369580574952,0.6993736951983298,0.9496277852463264,1.0,4/18,8.50%,CHRNA3;ERC2;RIMBP2;SLC5A7
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.37169564674672995,0.7819225828770482,0.687089715536105,0.9487900561731603,1.0,4/10,10.80%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.37169564674672995,0.7819225828770482,0.687089715536105,0.9487900561731603,1.0,4/10,10.80%,MYLIP;AP2S1;AP2B1;VLDLR
prerank,regulation of DNA replication (GO:0006275),-0.24097847234752615,-0.7812344519886704,0.821078431372549,0.9470239783092601,1.0,3/49,6.10%,EGFR;GLI2;ACVRL1
prerank,regulation of autophagosome assembly (GO:2000785),0.30921301129674084,0.7808440656262783,0.7203703703703703,0.9499234606982224,1.0,11/33,14.52%,PIP4K2A;IFT20;FEZ2;PIP4K2C;TBC1D12;PIKFYVE;NPRL3;NPRL2;FEZ1;UBQLN2;RAB5A
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),-0.30333971194327525,-0.780801359365646,0.7898686679174484,0.9471283167535071,1.0,1/18,0.60%,PLCB1
prerank,skeletal muscle tissue development (GO:0007519),0.30914551070030083,0.7806556944308639,0.7153419593345656,0.9495464837007488,1.0,3/32,7.45%,MEF2C;POPDC3;IGSF8
prerank,regulation of T cell differentiation (GO:0045580),0.3102330152306004,0.7806082238479242,0.7196078431372549,0.9489310832155246,1.0,3/33,6.03%,PRDM1;IL2RA;IL4
prerank,Golgi to endosome transport (GO:0006895),0.349185667675063,0.7800123335426528,0.6886993603411514,0.9492508998756264,1.0,3/16,6.20%,CORO7;SORT1;AP1AR
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.3288011431905073,-0.7794722875652608,0.75,0.9485591571883766,1.0,3/13,10.94%,GAS6;WNT5A;MAVS
prerank,gluconeogenesis (GO:0006094),0.300343656389315,0.7789811737027319,0.7472324723247232,0.9503291575338739,1.0,7/39,15.44%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,negative regulation of coagulation (GO:0050819),-0.3239537346292366,-0.7788253246159728,0.7513513513513513,0.9489881693153739,1.0,3/14,4.57%,APOE;THBD;CD34
prerank,regulation of phosphatase activity (GO:0010921),-0.28196641229551506,-0.7787996041197488,0.7925311203319502,0.9484589499490066,1.0,7/24,23.32%,PTPA;SH3RF2;HSP90B1;TIPRL;CHP1;CDK5RAP3;SH2D4A
prerank,non-motile cilium assembly (GO:1905515),-0.26525312310373633,-0.7777632687422885,0.7836134453781513,0.949470140872666,1.0,11/30,29.19%,TOGARAM1;TMEM216;VANGL2;TBC1D32;TMEM17;C2CD3;TMEM107;PIBF1;IFT122;DISC1;CCDC13
prerank,glutamate metabolic process (GO:0006536),0.3317367655341532,0.7771433056986231,0.6904761904761905,0.9527811763877329,1.0,4/19,11.93%,GGT1;GOT1;GAD1;GLS2
prerank,regulation of astrocyte differentiation (GO:0048710),0.36078385640249344,0.7770961548918487,0.6849015317286652,0.9521574008482223,1.0,2/12,7.30%,NOTCH1;BIN1
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.23313568477219637,-0.7767423080105881,0.8827751196172249,0.9504350131567715,1.0,17/57,26.24%,FOXN3;RINT1;TAOK2;ATM;TRIM39;CCND1;FZR1;BABAM2;CDK5RAP3;BABAM1;RPS27L;CHEK2;BRCA1;STK33;TP53;ATF2;HUS1
prerank,cellular response to pH (GO:0071467),-0.30577173995599205,-0.7765241691384441,0.7973484848484849,0.9501870906638796,1.0,7/17,31.93%,RAB11FIP5;SLC9A1;CHP1;MCOLN1;PKD1L3;HVCN1;KCNK4
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3445175051632239,0.7762274638718326,0.6977687626774848,0.9530100018522879,1.0,2/17,6.25%,CACNA1H;SCAMP5
prerank,tRNA methylation (GO:0030488),0.3008631583968187,0.7759345862499039,0.7351247600767754,0.9528264253671185,1.0,13/34,24.31%,TRMT61A;TRMT5;TRMT1;THUMPD2;TRMT10C;MTO1;NSUN2;METTL6;TRMT1L;DALRD3;GTPBP3;TRMT10A;TRDMT1
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.2603775061002857,0.7758172169369915,0.8071895424836601,0.9523501392700168,1.0,15/83,15.97%,CDK6;CUL3;CDK15;CRLF3;DHFR;SPDYA;CDKN1A;NPAT;LATS2;RB1;CDK14;EIF4E;CCNH;CDK5;CCNE1
prerank,skeletal muscle contraction (GO:0003009),0.3401546073626645,0.775814575702795,0.7025948103792415,0.9516635728673595,1.0,2/19,8.91%,RCSD1;STAC
prerank,protein K48-linked ubiquitination (GO:0070936),0.2772969895185452,0.7757050527018093,0.7700348432055749,0.9511479544258182,1.0,9/54,11.86%,NEDD4L;CUL3;RBX1;UBE2E3;HACE1;UBE2E1;UBE2G1;KBTBD7;UBE3A
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),-0.2704387275727035,-0.7755565791173269,0.7834394904458599,0.9510461578023977,1.0,14/26,36.49%,LRRK2;AKT1;TXN;PPIA;PARK7;PRKN;BAG5;SOD2;HSPB1;PINK1;PYCR1;MAPK7;VNN1;NME5
prerank,cell-cell junction maintenance (GO:0045217),0.3719794340829988,0.7753513735570021,0.6957494407158836,0.9511075675069648,1.0,1/11,2.10%,FERMT2
prerank,protein localization to chromatin (GO:0071168),-0.3060594458965081,-0.7751761655369142,0.7622641509433963,0.9510575381197796,1.0,5/18,23.55%,ESR1;PPHLN1;MCM8;PIH1D1;SGF29
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),-0.20808701464448154,-0.7751653516207623,0.9093484419263456,0.9505054785120367,1.0,35/114,25.85%,FOXO3;MAP3K14;TNFRSF11B;TNFRSF1B;PTK2B;STAT1;CARD14;BIRC3;TMSB4X;TNFRSF1A;EIF5A;PSME2;RELA;PSMB4;TNFRSF11A;PSMB1;PSMD11;PSMD8;PSME3;RIPK1;NFKBIA;EDA;PSMD4;PSMA2;EDA2R;PSMD3;PSMB7;EDAR;TNFSF13;PSMC2;PSMC5;PSMD10;TNFSF8;PYDC1;TP53
prerank,peptidyl-threonine modification (GO:0018210),0.2713951263061907,0.775014156642063,0.7545008183306056,0.9510218977566511,1.0,15/66,12.69%,GALNTL6;ROCK1;CDC42BPA;STK39;TNKS;TTBK1;GALNT13;GALNT1;MARK2;PRKD2;DYRK3;HIPK1;NLK;GALNT4;PRKDC
prerank,neuromuscular process controlling balance (GO:0050885),0.3431581064555138,0.7745576878195277,0.6963123644251626,0.9511143497128526,1.0,1/12,3.16%,NRXN1
prerank,positive regulation of DNA recombination (GO:0045911),0.31008578467845704,0.7745194361194949,0.7007722007722008,0.950493898286191,1.0,8/27,19.04%,WAS;FANCB;TIMELESS;SHLD3;KMT5B;PARP1;MRNIP;FUS
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),-0.2969500783915808,-0.7743588472583358,0.7865853658536586,0.9511453585834461,1.0,8/20,19.22%,ARRB1;BRD7;DIP2B;TADA2A;MAPK3;PRKAA2;NOS1;PPARGC1A
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.21819515274401233,-0.7742920924251278,0.8981233243967829,0.9506690311251235,1.0,34/88,33.53%,FBXL7;PSME2;DMAC2;CUL4A;PSMB4;FBXW11;PSMB1;PSMD11;PSMD8;FBXL14;FBXL2;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;CUL5;FBXO17;CCNF;PSMC2;PSMC5;PSMD10;FBXL12;FBXL6;PSMD7;FBXL13;FBXL22;KIF14;FBXO44;FBXO38;PSMD12;PSMB9;FBXL20;FBXO2
prerank,regulation of mRNA 3'-end processing (GO:0031440),0.3697526711924356,0.7739555319804273,0.743801652892562,0.9507591680159229,1.0,3/11,15.02%,NCBP2;PAPOLA;DHX36
prerank,negative regulation of interferon-gamma production (GO:0032689),-0.283840244342696,-0.7735851920993113,0.7956777996070727,0.9511679457945424,1.0,6/23,22.36%,GAS6;LGALS9;ZC3H12A;TLR4;CD274;RARA
prerank,ganglioside metabolic process (GO:0001573),-0.29910212536823566,-0.7735831770657745,0.7922077922077922,0.9505983841503541,1.0,8/20,21.68%,ST6GALNAC3;HEXA;HEXB;ST8SIA2;ST6GALNAC6;ST3GAL5;NEU3;CLN6
prerank,regulation of establishment of planar polarity (GO:0090175),-0.21993414983721568,-0.7735417682305564,0.9098360655737705,0.9500823975200599,1.0,30/88,24.71%,SMURF2;FZD2;AP2A2;SMURF1;WNT5A;RHOA;FZD4;TIAM1;FZD7;PSME2;PFN1;AP2A1;PSMB4;ARHGEF19;PSMB1;PSMD11;PSMD8;PSME3;WNT11;ROR2;FZD1;PSMD4;PSMA2;PSMD3;PSMB7;VANGL2;AP2M1;PSMC2;PSMC5;PSMD10
prerank,positive regulation of gene silencing by miRNA (GO:2000637),0.30944626687266386,0.7734157290426706,0.710172744721689,0.9509930532872924,1.0,2/27,4.97%,LIMD1;AJUBA
prerank,cytosolic transport (GO:0016482),0.2497836659170275,0.7730867786740794,0.7947530864197531,0.9508709876150572,1.0,26/108,15.95%,DENND2A;STX16;CORO7;SORT1;AP1G1;VTI1A;RIC1;EMP2;PIKFYVE;HOOK3;EHD3;TBC1D10C;BAIAP3;AKTIP;ARFRP1;VPS51;PLEKHJ1;GCC2;ANKFY1;VTI1B;DCTN1;RAB5A;PREPL;RHOBTB3;TMEM87B;TBC1D10B
prerank,ion homeostasis (GO:0050801),0.308476471218999,0.7729022555740511,0.7406679764243614,0.9505136980917896,1.0,2/30,3.50%,NEDD4L;UNC80
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.3183007891722329,-0.772496211680586,0.7565543071161048,0.9510531772875789,1.0,5/15,14.52%,ARPC2;IQGAP2;ARPC1B;TRIM27;WASHC1
prerank,myelin assembly (GO:0032288),0.3712563211254864,0.7721268459643561,0.6766743648960739,0.951133290125966,1.0,3/10,8.39%,TPPP;NCMAP;TENM4
prerank,negative regulation of locomotion (GO:0040013),-0.32691103687920386,-0.7721266537889248,0.7556818181818182,0.951014343850623,1.0,4/12,19.45%,FBLN1;CCDC125;FRMD5;PTPN2
prerank,glycosphingolipid biosynthetic process (GO:0006688),-0.3135087980683851,-0.7716929782549115,0.7717601547388782,0.9510931838954398,1.0,5/16,11.77%,LARGE1;ST6GALNAC3;A4GALT;ST8SIA2;ST6GALNAC6
prerank,ceramide biosynthetic process (GO:0046513),-0.250779626170897,-0.7712058747510597,0.8022727272727272,0.9512868149167211,1.0,9/40,16.94%,SGMS1;SGMS2;ST6GALNAC3;ST8SIA2;DEGS2;ST6GALNAC6;SPTLC2;ST3GAL5;CLN8
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.2899686034825831,-0.770931526281365,0.7841584158415842,0.9511217468731091,1.0,6/20,16.55%,LBP;PRKCE;IL18;TGFB1;TICAM1;TLR4
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),0.29299568542841464,0.7707123316210317,0.7468354430379747,0.9528641823544153,1.0,10/42,19.04%,WAS;FANCB;TIMELESS;CGAS;SHLD3;PPP4C;PARP1;MRNIP;RPA2;FUS
prerank,signal transduction in response to DNA damage (GO:0042770),0.27820400675260787,0.7703009025415348,0.7724137931034483,0.952853097634947,1.0,7/49,14.26%,MAP3K20;CASP9;RAD1;MYO6;ATR;RAD17;ATRIP
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.3233011952216892,0.7699711414628156,0.7267080745341615,0.9526716135663806,1.0,3/22,2.42%,NOTCH1;ROCK1;PDE9A
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.33932455823197777,0.7699583682157257,0.6825726141078838,0.9520032884037418,1.0,1/16,1.63%,GPER1
prerank,coenzyme A metabolic process (GO:0015936),0.34875768976908006,0.7694193495381222,0.7010309278350515,0.9521983346131492,1.0,6/14,25.57%,COASY;ACOT7;SLC25A16;PANK3;PANK1;PPCDC
prerank,protein targeting (GO:0006605),-0.20628387249917318,-0.7686853228091606,0.9380281690140845,0.9539096378754546,1.0,42/118,29.95%,LAMP2;KIF13B;SDCBP;ZFAND6;NACA;RASSF9;TAOK2;PARD3;AP4M1;RPL11;TOMM7;ZDHHC24;GDAP1;AQP11;TIMM13;BCAP31;HOMER3;TOMM22;MICALL1;SPCS1;AP4E1;HPS4;TIMM8B;TOMM34;TOMM5;SEC61A1;ZDHHC15;TIMM9;VPS37D;AP4B1;LTBP2;TIMM44;ZDHHC7;YIF1B;RABGEF1;RAB3IP;EDEM1;ZDHHC12;TIMM10;SRP14;TSPO;SEC63
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.2565386969880021,-0.7680189742844411,0.8321678321678322,0.9543386046012226,1.0,14/38,27.17%,RBBP7;UBN1;CENPC;H3-3A;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;HAT1;ASF1A;CENPX;CENPH
prerank,ncRNA transcription (GO:0098781),-0.3276277140685788,-0.767965012836991,0.7753222836095764,0.9538515017195933,1.0,3/13,19.54%,CAVIN1;SIRT7;GTF3C1
prerank,amino sugar biosynthetic process (GO:0046349),-0.3328708290844929,-0.7679259613233961,0.7722007722007722,0.9533456662071047,1.0,3/12,19.18%,GFPT2;UAP1;GFPT1
prerank,histone mRNA metabolic process (GO:0008334),-0.2750037722731776,-0.7676665182457787,0.8268041237113402,0.95317587105166,1.0,10/27,27.77%,TUT4;TUT7;MTPAP;ATM;SNRPF;XRN1;TENT4B;SNRPB;CPSF2;SNRPE
prerank,response to organonitrogen compound (GO:0010243),-0.25055415424432864,-0.7673071594078521,0.843400447427293,0.9531619245187707,1.0,14/38,30.30%,RCN3;RNF139;GLRA3;RNF185;IRAK3;VCP;DNAJB12;CCDC47;KYNU;RRAGC;PRKN;TRPM2;SYVN1;MEAK7
prerank,mitochondrion disassembly (GO:0061726),-0.2606207933774918,-0.7670624457041081,0.8048245614035088,0.9529266289042302,1.0,9/34,25.65%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.29929389121044386,-0.7667911637768862,0.7752380952380953,0.952743433362238,1.0,3/18,10.03%,SETD7;SETD1B;EHMT1
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.3035249597469062,0.7664421721963722,0.7420560747663552,0.9565884872164395,1.0,8/31,17.73%,CACNA1H;SCAMP5;SYT1;SYT2;CBARP;SYT12;SYT11;SYT13
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.34843853990959117,-0.765650028076086,0.7763401109057301,0.9538724653029099,1.0,2/10,6.26%,LRP6;WNT5A
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),0.37017775805946995,0.7655791073636835,0.7072072072072072,0.9573679772095567,1.0,1/10,2.89%,EMC7
prerank,interstrand cross-link repair (GO:0036297),0.273185742076585,0.7655534964747113,0.7692307692307693,0.9567270376586077,1.0,12/53,17.06%,DCLRE1B;FANCF;FANCG;FANCB;ERCC4;ATR;USP1;FANCE;FANCD2;ATRIP;XRCC3;RPA2
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.33702236884051107,-0.7653847027616756,0.75,0.9536743273451311,1.0,3/11,19.18%,GFPT2;UAP1;GFPT1
prerank,vacuolar acidification (GO:0007035),-0.28512330578037487,-0.7651816549125148,0.772635814889336,0.953407452992169,1.0,9/21,27.55%,ATP6V0A4;ATP6V0A1;TCIRG1;ATP6V0A2;CLN6;CCDC115;CLN5;TMEM199;ATP6V0D1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.33161271979461016,0.7648358597639393,0.7066115702479339,0.9572415029136864,1.0,6/19,12.56%,MTCL1;CRB1;MARK2;DLG2;PARD3B;DLG3
prerank,nucleocytoplasmic transport (GO:0006913),-0.2515604200347127,-0.7644736701105834,0.8442105263157895,0.9539183506147992,1.0,9/40,16.93%,ATXN1;GEMIN7;BACH2;GEMIN5;NUP98;SNRPF;NXT2;SNRPD1;SNRPD2
prerank,cellular response to decreased oxygen levels (GO:0036294),0.2701106957966591,0.7642000110413081,0.7704347826086957,0.9575927085978151,1.0,7/65,4.85%,RORA;RGCC;CPEB1;KCND2;FMN2;SCN2A;EPAS1
prerank,termination of RNA polymerase II transcription (GO:0006369),0.2971921597441178,0.7635574313584663,0.7562862669245648,0.9579907277420322,1.0,8/33,19.25%,CLP1;NCBP2;LSM10;PAPOLA;SYMPK;SNRPD3;CPSF7;MED18
prerank,microtubule polymerization or depolymerization (GO:0031109),0.31017980393495986,0.762613065758087,0.728952772073922,0.9588961375675452,1.0,3/24,6.38%,NCKAP5;FGF13;TPPP
prerank,neurotransmitter uptake (GO:0001504),0.34887784505571845,0.7624323178135919,0.6842105263157895,0.9585181741244009,1.0,2/12,3.78%,ATP1A2;SNAP25
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.29859003842555054,0.761954607981478,0.7321100917431193,0.9586352238975548,1.0,1/33,0.42%,PTEN
prerank,protein homotrimerization (GO:0070207),-0.317547411062458,-0.761722635691761,0.7882797731568998,0.9567330364585821,1.0,4/14,16.56%,SCARA5;CLYBL;DISP1;PNPT1
prerank,protein trimerization (GO:0070206),-0.317547411062458,-0.761722635691761,0.7882797731568998,0.9567330364585821,1.0,4/14,16.56%,SCARA5;CLYBL;DISP1;PNPT1
prerank,neuron projection organization (GO:0106027),0.34272991340468933,0.7613884546054218,0.7070063694267515,0.9588745214554147,1.0,7/15,23.38%,ABCD2;CHRNA7;PSEN1;DCTN1;GSK3B;LGMN;ABCD1
prerank,regulation of phosphate metabolic process (GO:0019220),0.3407072111676981,0.7601451198980476,0.7157464212678937,0.9602494669121814,1.0,5/16,14.20%,IL4;MCM7;SMG7;PSEN1;RAD17
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.2274958604442322,-0.760095911471313,0.8753180661577609,0.958453143014875,1.0,26/67,28.09%,B2M;TAPBP;SNAP23;PSME2;PSMB4;CALR;CYBA;PSMB1;PSMD11;PSMD8;PDIA3;PSME3;PSMD4;PSMA2;IKBKG;PSMD3;CYBB;PSMB7;VAMP8;PSMC2;PSMC5;TAP2;PSMD10;FCGR1A;PSMD7;TAP1
prerank,proteasomal protein catabolic process (GO:0010498),0.22537856435062112,0.7598249796600525,0.8885906040268456,0.9600976336770689,1.0,27/201,12.49%,NEDD4L;TNFAIP1;HECW2;BTRC;TRIM9;CUL3;RBX1;PSMB11;SIAH2;UCHL1;SPOPL;FBXO45;ATE1;PSMF1;HACE1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;SOCS6;KBTBD7;TRIM2;SPOP;KCTD5;PSME4;APPBP2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.29812666881432526,0.7596755318968271,0.7495621716287215,0.9596851679219229,1.0,7/32,16.24%,SLC44A2;ABHD3;ACHE;STARD7;CHKB;LPCAT1;LPIN2
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.33534726102240436,0.759367857614963,0.7139830508474576,0.9595301369956512,1.0,3/18,9.00%,PTPN22;PAG1;MIA3
prerank,cellular response to chemical stress (GO:0062197),-0.21324503016561677,-0.7589084201595442,0.9224376731301939,0.9595238763289473,1.0,41/96,30.89%,FOXO1;FOXO3;CAV1;LRRK2;CPEB2;PRDX2;ZC3H12A;SLC25A24;VKORC1L1;TRPV4;ATM;CYBA;PPIA;VRK2;PRKAA2;PNPT1;SIRT2;GPX1;PARK7;STX2;BRF2;MT3;PPARGC1A;NOX1;RAD52;CYBB;TXNRD2;PYCR2;ATG7;ZFAND1;FAS;PRDX1;SOD2;ABL1;HSPA1B;ATP13A2;GSR;NUDT2;KEAP1;AIF1;CHCHD2
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.24284410506018145,-0.758808408865962,0.8310185185185185,0.9591064655578938,1.0,11/43,21.72%,FOXN3;RINT1;CHFR;TAOK2;NABP1;ATM;TRIM39;FZR1;BABAM2;CDK5RAP3;BABAM1
prerank,protein exit from endoplasmic reticulum (GO:0032527),-0.2827207594003105,-0.7583202404092055,0.8174757281553398,0.9592245081224712,1.0,11/23,31.02%,LMAN1;SURF4;HSP90B1;NPLOC4;VCP;TMED9;SEC61B;SEC16A;PREB;SYVN1;AUP1
prerank,regulation of hemopoiesis (GO:1903706),0.3634025723881106,0.7581100505880098,0.7052845528455285,0.9609839366110964,1.0,1/10,2.51%,PTN
prerank,DNA metabolic process (GO:0006259),-0.18209490060067784,-0.7578945778108671,0.9956896551724138,0.9592711254152698,1.0,109/270,37.68%,SP100;TCF7L2;PDS5B;INO80;HINFP;RAD51B;TOP2B;TRRAP;ERCC5;PARP3;REXO4;MMS19;SAMHD1;NT5E;NABP1;POLH;DNASE1L1;ATM;UBB;RAN;UVRAG;GLRX2;TDG;DDB1;INIP;RPA1;KMT5C;ADPRS;RAD50;DBF4;CBS;HMGB2;SIRT7;PARK7;TYMS;RFC3;VCP;SMARCAD1;SMC1A;RECQL;RAD52;POLI;TOP3A;DFFB;POLE2;RFC1;DNMT1;TOP2A;RAD51C;ACD;NEIL3;MCM8;SLX4;RMI2;RAD51;CDC45;ERCC1;MSH6;ASF1A;BRCA1;RPA3;SRPK2;NUDT1;ERCC3;POLA1;NEIL1;HUS1;NTHL1;POLD1;PRIM2;FANCA;TOP1;MCM3;MNAT1;EID3;POLE3;WRN;MCM5;GTF2H3;MCM10;DOT1L;PCNA;EXO1;DMC1;RAD54L;RFC5;FANCL;RAD51AP1;HUS1B;RECQL5;UHRF2;LONP1;CDC34;CHEK1;UHRF1;RAD51D;MGMT;FANCC;TOPBP1;ENDOG;PRIMPOL;CDK1;CDC6;ZRANB3;FEN1;DCTPP1;DNASE2;TICRR;TRIM28
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.24868630481130907,-0.7575274620710637,0.8312236286919831,0.959187073814259,1.0,14/38,29.11%,NPEPPS;LRRK2;LMAN1;SH3GLB1;TOMM7;SAE1;SREBF1;LEPROT;HPS4;USP36;BAP1;PRKN;FZD5;RHOU
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.3443081424752141,0.757209057260311,0.7020833333333333,0.9618230315394515,1.0,4/13,17.68%,HEXIM1;TCERG1;HNRNPU;LARP7
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),-0.2310079280591164,-0.7568774352858411,0.8942307692307693,0.9594953914089666,1.0,18/58,26.98%,POLM;DCLRE1C;NHEJ1;ATM;UVRAG;XRCC4;RAD50;PAXX;HMGB2;CYREN;BABAM2;PIAS4;BABAM1;ERCC1;RNF8;BRCA1;POLA1;PRPF19
prerank,regulation of ERAD pathway (GO:1904292),0.3624168532272997,0.7566476320876994,0.7320261437908496,0.9620449231971276,1.0,1/11,1.93%,USP25
prerank,tryptophan metabolic process (GO:0006568),0.350920313386063,0.7564493448751041,0.7146118721461188,0.9616680408087591,1.0,1/11,3.70%,ATP7A
prerank,positive regulation of chromosome organization (GO:2001252),0.3359812533551995,0.7559887450740633,0.7082494969818913,0.9617408525287503,1.0,5/15,17.60%,LIG4;SHCBP1L;PPP1R10;DHX36;DDX11
prerank,positive regulation of intracellular transport (GO:0032388),-0.2517268989076227,-0.7550961897082752,0.8385744234800838,0.9614248723519894,1.0,17/38,27.30%,ACTN2;EHD1;EHD2;RUFY3;TPR;DYNC1H1;STX18;OAZ1;RAB29;NUMA1;RIPOR1;ICE1;STK11;TBC1D20;ZFAND1;SPAG5;B3GAT3
prerank,negative regulation of hormone secretion (GO:0046888),-0.34069823526417264,-0.7550237148202134,0.7884972170686456,0.9609571121587154,1.0,3/10,14.97%,GJA1;RAB11FIP1;RAB11FIP5
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.27799170268857754,0.7547375245976445,0.7757009345794392,0.9631714835523553,1.0,14/44,18.07%,ROCK1;PRR5L;RBM24;YTHDF3;NANOS1;TNRC6C;YTHDF2;TNRC6B;CELF1;DHX36;CNOT1;RC3H1;KHSRP;ZC3HAV1
prerank,nucleic acid metabolic process (GO:0090304),-0.22218668685913617,-0.7547265969895647,0.9035532994923858,0.9607834211644642,1.0,12/69,14.80%,RBFOX2;ENPP1;POLR2A;PCBP2;ATXN2;MMS19;NT5E;DNASE1L1;POLR2F;RAN;DDX24;RAD50
prerank,regulation of JUN kinase activity (GO:0043506),0.2976415105206399,0.7540504234386955,0.7467411545623837,0.9636226988267801,1.0,8/33,15.58%,MAP3K5;PTPN22;TAOK3;PAK1;TRAF6;DVL2;TRAF2;DVL3
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2948835577436385,0.7538548790778159,0.7442748091603053,0.9632792717647229,1.0,2/33,2.01%,TNKS1BP1;DCLRE1B
prerank,membrane fusion (GO:0061025),0.2990770357277696,0.7536560112739974,0.7485265225933202,0.9629432787199541,1.0,9/33,17.69%,DYSF;RIMS1;HACE1;UBXN2B;VTI1B;VPS33B;GCA;DNM1;VAMP2
prerank,histone lysine methylation (GO:0034968),-0.25925728991918584,-0.7531582794678019,0.8170974155069582,0.9623890864990245,1.0,18/33,40.85%,SMYD3;SETD1B;PRDM5;EZH2;SETDB1;SETD6;WDR5B;TRMT112;RBBP5;DOT1L;WDR82;ASH2L;KDM6A;DYDC2;SETDB2;DPY30;N6AMT1;SMYD2
prerank,negative regulation of cell cycle process (GO:0010948),-0.22353645560573376,-0.7526045131912269,0.9029850746268657,0.9625500020504448,1.0,9/61,10.24%,BMP7;TOM1L2;BMP4;TFDP2;RBBP7;TOM1L1;ZFYVE19;EHMT1;DAB2IP
prerank,interleukin-7-mediated signaling pathway (GO:0038111),-0.2991322070427263,-0.75231121134263,0.8078512396694215,0.9618476751027168,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,cellular response to interleukin-7 (GO:0098761),-0.2991322070427263,-0.75231121134263,0.8078512396694215,0.9618476751027168,1.0,10/17,33.01%,SOCS2;STAT3;CISH;SMARCA4;BRWD1;IL7;SOCS1;IRS2;STAT5B;IL2RG
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.28545091755624497,0.7520596887582435,0.7761194029850746,0.9648715191728489,1.0,5/36,6.46%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,rRNA methylation (GO:0031167),0.3157499516433456,0.7520165937242433,0.7345309381237525,0.9642598344795495,1.0,3/22,5.31%,MRM3;FBLL1;NSUN3
prerank,membrane protein ectodomain proteolysis (GO:0006509),0.31270001751462007,0.7514954378896485,0.734251968503937,0.9644313224801587,1.0,2/21,2.53%,MYH9;ADAM19
prerank,regulation of pH (GO:0006885),-0.3359130575437315,-0.751155932440346,0.811787072243346,0.9627921089441964,1.0,4/11,17.51%,ATP6V0A4;LACC1;CLCN3;SLC9A1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.21395952177558233,0.7506062439679095,0.9466327827191868,0.965225582872714,1.0,55/314,16.30%,NEDD4L;TNFAIP1;UBR1;HECW2;BTRC;TRIM9;FAM8A1;CUL3;RBX1;DERL3;PSMB11;SIAH2;FAF2;FOXRED2;UCHL1;SPOPL;FBXO45;PSMF1;UBR3;HACE1;SGTB;UBE2J2;UBE2E1;SIAH3;KCTD13;HECW1;UBE2G1;UBXN2B;PTTG1;KBTBD7;TRIM2;RB1;ERLIN1;UBR2;SPOP;KCTD5;PSME4;RNF121;APPBP2;ANAPC2;RMND5B;ANAPC7;UBQLN2;DNAJC18;SKP1;AMN1;ARMC8;FAF1;MAD2L1;RNF103-CHMP3;ZFAND2A;KCTD17;PSMB5;ERCC8;TMUB2
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.2944159670638199,-0.7504268375334902,0.7921810699588477,0.9632127633748462,1.0,10/17,36.49%,P4HB;AKT1;PPIA;BAG5;SOD2;HSPB1;TREM2;MAPK7;VNN1;NME5
prerank,striated muscle cell development (GO:0055002),0.3331037371322355,0.7495495412244109,0.7106382978723405,0.9662566763724273,1.0,3/14,10.32%,TMOD1;TMOD3;LMOD1
prerank,positive regulation of lipid biosynthetic process (GO:0046889),0.30002151904030766,0.7492624570710645,0.7699805068226121,0.9660225435456817,1.0,5/29,8.14%,NR1H3;SCARB1;LDLR;FABP3;MTOR
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),0.3403499504588622,0.7488199755867286,0.7186813186813187,0.9660584157263451,1.0,2/13,7.48%,NCBP2;CPSF6
prerank,positive regulation of erythrocyte differentiation (GO:0045648),-0.2745336402783905,-0.7486135741500004,0.8403846153846154,0.9650427233450221,1.0,7/25,16.15%,FOXO3;MAPK14;STAT1;STAT3;HIF1A;TAL1;HMGB2
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.24426606864301062,-0.7485846549024201,0.852017937219731,0.9645170119374351,1.0,9/40,17.83%,KMT5A;PRKCD;IER3;MCL1;POLH;FXR2;CDK9;SIRT7;NPAS2
prerank,regulation of mast cell degranulation (GO:0043304),0.34571921259135874,0.7477592011992112,0.7104722792607803,0.9670572279555257,1.0,4/14,10.09%,CD300A;IL4;LYN;STXBP2
prerank,synaptic vesicle recycling (GO:0036465),0.29898610153415844,0.746719087798412,0.7453798767967146,0.9680270180921573,1.0,7/31,15.84%,CEL;SNCA;SYT1;SYT2;NLGN3;RAB5A;CDK5
prerank,cellular biogenic amine metabolic process (GO:0006576),0.35009895003192004,0.7463067952271171,0.7319819819819819,0.9680005617445457,1.0,2/12,3.70%,OAZ2;ATP7A
prerank,nucleotide biosynthetic process (GO:0009165),-0.29396309089018285,-0.7459532051149401,0.8171206225680934,0.9674242369217262,1.0,7/18,22.56%,ME1;PRPS2;NMNAT1;PRPS1;PRPS1L1;PNP;RRM2B
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",-0.23797892414596877,-0.745458219049386,0.8710407239819005,0.9675271510838431,1.0,7/48,17.27%,ZMIZ1;KAT2B;BAZ1B;POLR2F;ACTB;ZMIZ2;POLR2E
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.26836504545335566,0.7454427656051332,0.8035087719298246,0.968683740275624,1.0,7/53,10.67%,GLMN;RHBDF1;ALAD;DESI1;PSMF1;GNA12;XPO1
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.3193280533052665,0.7453400747641079,0.746268656716418,0.968172016496384,1.0,5/17,9.97%,RGCC;SPDYA;PKD2;PDGFB;CCNYL1
prerank,protein hydroxylation (GO:0018126),-0.30532379414081984,-0.7443930150162934,0.7807971014492754,0.9683171760884053,1.0,5/15,20.62%,PLOD2;EGLN3;PLOD1;P3H4;PLOD3
prerank,nuclear membrane reassembly (GO:0031468),0.2661944009408513,0.7443009290117352,0.7785234899328859,0.9691639769268409,1.0,15/54,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;UBXN2B;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),0.33872485489448423,0.7441788665565796,0.7366167023554604,0.968698922834971,1.0,1/13,1.15%,BMP5
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),0.3389032321501528,0.7435230972225015,0.7336065573770492,0.969052775882559,1.0,2/12,8.17%,IL1B;IL12RB1
prerank,histone lysine demethylation (GO:0070076),-0.27120545666186824,-0.7431618322635677,0.8176352705410822,0.9693925116747735,1.0,4/25,16.16%,KDM7A;KDM5B;KDM3A;KDM6B
prerank,cellular response to corticosteroid stimulus (GO:0071384),-0.3027623156378324,-0.7428285575537554,0.7967479674796748,0.9692563610217687,1.0,3/15,9.52%,NR3C1;ANXA1;BCL2L11
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),0.2859033650870699,0.742210494070117,0.7769516728624535,0.9704818068982917,1.0,6/36,9.08%,USP25;RYBP;OGT;ALAD;PSMF1;CCAR2
prerank,apoptotic DNA fragmentation (GO:0006309),-0.2988283225917381,-0.7420176179815382,0.8074866310160428,0.9697319853201058,1.0,7/16,37.23%,HMGB2;DICER1;DFFB;FOXL2;EXOG;ENDOG;DNASE2
prerank,microtubule nucleation (GO:0007020),0.3140599396487078,0.7419634665510294,0.7204081632653061,0.9702109418453171,1.0,4/19,10.49%,CCDC57;CLASP2;TPPP;TUBG2
prerank,negative regulation of interleukin-17 production (GO:0032700),-0.33886865800316346,-0.7417860798086574,0.815018315018315,0.9694483625893897,1.0,6/10,51.18%,TLR4;NCKAP1L;VSIR;IL12A;FOXP3;IL12B
prerank,linoleic acid metabolic process (GO:0043651),0.3293461798036544,0.7408298443172834,0.735966735966736,0.9713177900121669,1.0,1/17,2.03%,FADS2
prerank,covalent chromatin modification (GO:0016569),-0.30515932889361497,-0.7405972135150751,0.8105646630236795,0.9704286034898985,1.0,5/14,22.14%,HDAC1;SIRT7;PARK7;MT3;MBD2
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.26447400374398894,-0.7405816659562731,0.8438177874186551,0.9698881757484862,1.0,6/27,18.14%,NAAA;ETNK2;PLA2G6;PLA2G15;LPIN3;ETNK1
prerank,"DNA-templated transcription, elongation (GO:0006354)",-0.22273836416479506,-0.7403100699846186,0.9196891191709845,0.969686359726774,1.0,23/64,31.82%,MLLT3;RTF1;POLR2A;POLR2F;EAF1;ELOB;CDK9;POLR2E;TCEA1;ELOC;NELFCD;ELOF1;ERCC2;POLR2G;CDK7;ERCC3;ELP2;CTDP1;MNAT1;SUPT4H1;GTF2H3;PAF1;SSRP1
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.31849428551950415,-0.7397278817142776,0.7940074906367042,0.9698954585610753,1.0,4/11,20.35%,CAV1;HGS;LEPROT;ADIPOR1
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.3363307343769772,-0.7394919085875199,0.8059149722735675,0.9696203708118998,1.0,5/10,34.58%,JARID2;DNMT1;BRCA1;KDM1A;ATRX
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),-0.2280391884088117,-0.7394694850894371,0.8883826879271071,0.9690836190295826,1.0,17/50,31.13%,CCND2;CCND3;CCNG1;CCND1;ACTB;HSP90AB1;CDKN1B;CDK5RAP3;CDKN1C;CCNF;SERTAD1;CDK7;CDC25A;CDKN2D;MNAT1;CDKN3;CDKN2B
prerank,secondary alcohol metabolic process (GO:1902652),-0.23867380987817255,-0.7393048678700619,0.87117903930131,0.9687540972073425,1.0,9/42,21.68%,ABCA1;APOE;CYP27A1;OSBPL1A;STARD3;IDH3G;CLN8;EBP;CLN6
prerank,peptidyl-threonine dephosphorylation (GO:0035970),-0.27657688048073154,-0.7386383681279456,0.8230616302186878,0.9690742869521854,1.0,12/22,31.44%,DUSP1;DUSP16;DUSP7;PPM1B;DUSP10;PPM1G;PPP5C;PPM1F;PPP1CA;DUSP8;DUSP4;DUSP18
prerank,rRNA catabolic process (GO:0016075),0.32596794174556937,0.7381782850789208,0.7595959595959596,0.9747681703138349,1.0,2/16,10.41%,PELO;TRIR
prerank,response to hexose (GO:0009746),-0.2643767200024007,-0.7377725198838629,0.852760736196319,0.9696497925039702,1.0,2/25,3.88%,THBS1;TCF7L2
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.3520720218837197,0.737752810382212,0.7282608695652174,0.9747652354064504,1.0,1/10,1.44%,JAM3
prerank,protein acylation (GO:0043543),-0.24074644842150691,-0.7368655603440295,0.8850806451612904,0.9702363051749738,1.0,13/38,24.92%,GLUL;FOXO1;KAT2B;SELENOK;CLOCK;SPHK1;NAT10;ZDHHC8;ZDHHC15;NAT9;NAA80;ZDHHC7;ING4
prerank,RNA catabolic process (GO:0006401),0.2694458099930867,0.7363555874639073,0.8018518518518518,0.9762376081217646,1.0,14/46,20.42%,AGO3;SUPV3L1;XRN2;RNASE6;YTHDF2;SND1;PABPC4;RNASEH1;RNH1;CNOT10;DIS3L2;LSM2;HNRNPD;LSM6
prerank,cell cycle G1/S phase transition (GO:0044843),0.2608331259207595,0.735909970253941,0.8333333333333334,0.9762523171758646,1.0,9/61,14.27%,CDK6;CUL3;CRLF3;SPDYA;CDKN1A;LATS2;RB1;EIF4E;CCNH
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),-0.3128649016469242,-0.7357829874930424,0.8208092485549133,0.9710178947628736,1.0,3/13,17.91%,STX7;MR1;CYRIB
prerank,carbohydrate transport (GO:0008643),0.34261853996923797,0.7355173734015737,0.7441860465116279,0.976158842902075,1.0,3/11,16.92%,SLC5A1;SLC23A2;SLC23A1
prerank,modulation by symbiont of entry into host (GO:0052372),-0.290816518042753,-0.7344334944160901,0.8181818181818182,0.9721283221967039,1.0,6/16,31.21%,CAV1;TRIM27;TRIM14;TRIM6;FUCA2;TRIM21
prerank,protein localization to phagophore assembly site (GO:0034497),-0.3308374151179764,-0.7336149086039618,0.8060836501901141,0.9725887192895154,1.0,1/11,5.85%,WIPI2
prerank,regulation of stem cell differentiation (GO:2000736),0.24677269321047188,0.7334151008998127,0.8512,0.9787316634799619,1.0,23/89,19.85%,NOTCH1;TCF15;PTN;RBM24;PSMB11;PSMF1;MYB;JAG1;TCF12;YTHDF2;PSME4;PRKDC;OCIAD1;HNRNPU;PUS7;KMT2A;PSMB5;NSUN2;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,organelle fission (GO:0048285),0.2951227344806782,0.7332251415296172,0.7629482071713147,0.9783404944157367,1.0,8/24,17.53%,TMCC1;MTFP1;WASHC5;MFF;PEX19;MTFR1;MIEF1;DNM1
prerank,positive regulation of protein sumoylation (GO:0033235),-0.3277171094498359,-0.7330515975070019,0.8083182640144665,0.9727185751866821,1.0,4/10,24.62%,HDAC4;SAE1;PIAS4;PIAS3
prerank,homocysteine metabolic process (GO:0050667),0.34352641890470015,0.7330327465195859,0.7538126361655774,0.9779709591938721,1.0,1/11,2.95%,CTH
prerank,immunoglobulin mediated immune response (GO:0016064),0.34654884380336565,0.7328640351810343,0.7260579064587973,0.9775715609197444,1.0,1/10,4.99%,CARD9
prerank,positive regulation of mRNA processing (GO:0050685),0.30424124758382987,0.7324462891111009,0.7854406130268199,0.9775970550591134,1.0,9/21,27.15%,NCBP2;TRA2A;DAZAP1;DHX36;RBMX;RBM3;CIRBP;LEO1;SNW1
prerank,branched-chain amino acid metabolic process (GO:0009081),-0.27777231913640976,-0.7322254986275769,0.8259187620889749,0.9725855157013206,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,branched-chain amino acid catabolic process (GO:0009083),-0.27777231913640976,-0.7322254986275769,0.8259187620889749,0.9725855157013206,1.0,9/20,36.32%,IVD;BCKDHB;AUH;BCKDK;BCKDHA;ALDH6A1;BCAT1;ACADSB;HSD17B10
prerank,proton transmembrane transport (GO:1902600),0.2839582645187164,0.7316792690806696,0.7944444444444444,0.9780849402493139,1.0,3/36,6.14%,ATP1A2;ATP1A4;ATP6V0E2
prerank,regulation of G0 to G1 transition (GO:0070316),0.2730661332179406,0.731534623673968,0.8021778584392014,0.97763989553829,1.0,5/38,6.46%,CBX5;PHC3;RYBP;PHC1;CBX3
prerank,negative regulation of JUN kinase activity (GO:0043508),-0.32893612932744953,-0.7312485027192498,0.7950664136622391,0.9732467694545707,1.0,5/10,26.73%,PDCD4;MAPK8IP1;DUSP10;HIPK3;AIDA
prerank,autophagosome maturation (GO:0097352),-0.2517564318843617,-0.7312077994130697,0.890295358649789,0.9727310092719872,1.0,7/32,21.45%,LAMP2;WIPI2;UVRAG;CALM1;GABARAPL1;VCP;VAMP8
prerank,global genome nucleotide-excision repair (GO:0070911),0.2928917886947959,0.7309939681059673,0.786692759295499,0.9778050003113893,1.0,9/26,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,polyol biosynthetic process (GO:0046173),-0.2922175066622239,-0.730113683402333,0.8096153846153846,0.973537879077051,1.0,5/16,14.32%,CYP27A1;ACER3;IP6K1;ISYNA1;IP6K2
prerank,carboxylic acid catabolic process (GO:0046395),-0.31924232446768946,-0.729943920419943,0.7965779467680608,0.9731992312650883,1.0,8/12,53.15%,PON3;BCKDK;IL4I1;AMDHD2;GNPDA1;PON1;ACOT4;RENBP
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2921884331634426,0.7290797919506066,0.751434034416826,0.9800665615272128,1.0,7/27,11.61%,PHF20L1;KAT7;MRGBP;TAF6;KAT6A;RUVBL1;EP300
prerank,regulation of T cell receptor signaling pathway (GO:0050856),-0.250342389038237,-0.7290365125822227,0.8613445378151261,0.9737342258190531,1.0,13/33,29.29%,PTPRJ;EZR;RELA;CEACAM1;RAB29;PTPN2;IKBKG;CD81;DGKZ;RPS3;BCL10;LAPTM5;KCNN4
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),-0.272392671001118,-0.7269088312039717,0.8427184466019417,0.975769991123325,1.0,12/21,38.65%,ATM;ZW10;IK;TPR;TTK;CENPF;KNTC1;MAD2L2;PLK1;KLHL22;CDC20;BUB1
prerank,mitotic sister chromatid segregation (GO:0000070),-0.20394568548250763,-0.7266480634203704,0.9554317548746518,0.9755169027046722,1.0,37/98,33.68%,RAB11A;PDCD6IP;KMT5A;PDS5B;INO80;PINX1;BECN1;CHMP4B;CHMP4A;NCAPG2;RAN;ZW10;SMC4;CENPK;SMC1A;DSN1;CENPE;RRS1;PIBF1;SPAG5;KIF18B;KIFC1;CHMP5;NUP62;NSL1;NDC80;DCTN2;KIF14;CDCA8;CEP55;SGO1;EML3;KIF23;KIF18A;CSNK2B;CHMP6;PRC1
prerank,membrane repolarization during action potential (GO:0086011),-0.3053247806194208,-0.7264106429985836,0.8185328185328186,0.9752390145225726,1.0,3/13,13.64%,KCNJ2;KCNQ1;ATP1A1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.22551436653461573,0.7261740768756288,0.9151785714285714,0.9838004336135058,1.0,6/145,6.74%,DYNLL1;RBX1;MECP2;PSMB11;PRKAR2B;PSMF1
prerank,negative regulation of response to biotic stimulus (GO:0002832),-0.25966543329504954,-0.7258826387629738,0.8520971302428256,0.9753060857388042,1.0,11/26,33.55%,PCBP2;IRAK3;PPM1B;SIRT2;TRIB1;SIGIRR;LYAR;MAPKBP1;TRIM21;RNF26;ITCH
prerank,autophagy of peroxisome (GO:0030242),-0.3085696448579547,-0.7258681751715074,0.8189806678383128,0.9747619523464562,1.0,2/12,13.31%,ATM;ACBD5
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),-0.2825795490160189,-0.7258132158619721,0.8622641509433963,0.9742537672526379,1.0,13/18,44.84%,RAB11A;RAD51B;CCND1;RAD51C;CDC25A;DTL;CDC25B;CDK1;RCC2;CCNB1;BRD4;CDC25C;VPS4B
prerank,response to ethanol (GO:0045471),0.3220992453849966,0.7256422129625518,0.7505070993914807,0.9839665003334932,1.0,5/14,22.35%,GRIN2B;CHRNB2;GRIN2A;GRIN1;SOD1
prerank,regulation of endocytic recycling (GO:2001135),-0.3233159650927615,-0.7253301459004505,0.8113553113553114,0.9742641611130622,1.0,4/11,15.60%,ACTN2;EHD1;ATP9A;EHD2
prerank,positive regulation of natural killer cell activation (GO:0032816),0.33315010337137085,0.7247816658325247,0.7463002114164905,0.9845681929279212,1.0,2/13,4.79%,AXL;AP1G1
prerank,zymogen activation (GO:0031638),0.27366231007776604,0.7245453094253557,0.8198529411764706,0.9842572875706742,1.0,3/39,7.58%,GGT1;CIDEB;RIPK2
prerank,regulation of synapse organization (GO:0050807),0.29518390825277213,0.7229426041768408,0.7857142857142857,0.9860313545420092,1.0,4/26,9.91%,MEF2C;YWHAZ;IL1RAPL1;CTNNA2
prerank,regulation of response to interferon-gamma (GO:0060330),-0.29748069454702236,-0.7221773326678179,0.8220973782771536,0.977548811693136,1.0,4/14,19.45%,PARP9;STAT1;HSP90AB1;PTPN2
prerank,tRNA export from nucleus (GO:0006409),0.28299536878011383,0.7219723852673658,0.7954971857410882,0.9861053717914993,1.0,7/32,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.28299536878011383,0.7219723852673658,0.7954971857410882,0.9861053717914993,1.0,7/32,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.29033993077424947,0.7212223304127424,0.784,0.9865843417795448,1.0,3/26,6.30%,NR1H3;PTPN22;DDX3X
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",0.3191167013813586,0.7211964964191926,0.7473460721868365,0.9859348352834103,1.0,9/14,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,chemical homeostasis (GO:0048878),0.25219673354408234,0.7207849466828805,0.8429054054054054,0.9858911554176575,1.0,3/61,2.82%,NEDD4L;NR1H3;NR1D2
prerank,ncRNA catabolic process (GO:0034661),-0.25429207599890064,-0.7203761022680475,0.8678038379530917,0.9790601438183475,1.0,8/28,25.83%,TUT4;EXOSC5;XRN1;TENT4B;DEDD2;NUDT16;EXOSC7;POP1
prerank,electron transport chain (GO:0022900),-0.2920772625223835,-0.7201117426515904,0.8413001912045889,0.9788018452031021,1.0,4/15,19.22%,POR;PDIA5;CYB561;PPARGC1A
prerank,alanine transport (GO:0032328),0.346694459441308,0.7189754789966218,0.7711864406779662,0.9878854948351521,1.0,1/10,2.19%,SLC1A4
prerank,histone monoubiquitination (GO:0010390),0.29921138079744636,0.7189028401414629,0.780952380952381,0.9873234329510555,1.0,6/24,16.09%,RYBP;UBE2E1;CTR9;KDM2B;SKP1;TRIM37
prerank,regulation of lymphocyte proliferation (GO:0050670),0.3186359727295759,0.7182133844370182,0.7833333333333333,0.9877344176576498,1.0,2/16,7.63%,PTPN22;FGF10
prerank,tRNA aminoacylation (GO:0043039),-0.23873706238537967,-0.718016483395968,0.8817635270541082,0.9806635950665894,1.0,11/37,23.90%,LARS2;RARS2;KARS1;CARS1;QARS1;SARS1;HARS1;MARS2;FARSA;PPA1;FARSB
prerank,negative regulation of myeloid cell differentiation (GO:0045638),0.30450757446613186,0.7178622985813965,0.74373795761079,0.987575211111346,1.0,2/20,4.19%,CDK6;HOXA9
prerank,negative regulation of immune system process (GO:0002683),0.3164821551461465,0.7174631285466583,0.7535641547861507,0.9874590221844388,1.0,2/16,9.11%,GPER1;LYN
prerank,positive regulation of secretion (GO:0051047),-0.3155183401830023,-0.7171002454557251,0.8238434163701067,0.9812143282241295,1.0,4/11,37.94%,NPR1;XBP1;AQP1;SCIN
prerank,regulation of amyloid-beta clearance (GO:1900221),0.31453550497140265,0.7169657374403633,0.757700205338809,0.9874731372387939,1.0,4/16,14.71%,ROCK1;IL4;ABCA7;HMGCR
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",-0.2653944621351996,-0.7167656009561021,0.8604651162790697,0.9810569495375768,1.0,8/23,26.75%,CUL4A;COPS4;UBB;COPS8;DDB1;CETN2;COPS7A;COPS2
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.21897459053183033,0.7164909105326345,0.9304964539007092,0.9875177626987718,1.0,25/173,14.03%,DYNLL1;CUL3;SPTBN1;COG7;COG1;SPTB;ANK3;VTI1A;SPTA1;GOLT1A;MIA3;DYNC1I2;TMED7;KLHL12;TMED4;COL7A1;SEC13;RANGRF;COPB2;PROC;TRIP11;VTI1B;COG6;DCTN1;ANK2
prerank,telomere maintenance via recombination (GO:0000722),-0.31229093418610354,-0.7162888662218185,0.8068592057761733,0.9810614963572768,1.0,5/11,23.51%,TEP1;RAD50;TPRKB;RAD51;ERCC1
prerank,Fc receptor signaling pathway (GO:0038093),-0.19534541974971623,-0.7162340440699044,0.943502824858757,0.9805580761222317,1.0,39/110,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;KIT;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23666177635655,-0.7159755046673385,0.8760683760683761,0.9803010842691783,1.0,16/37,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,regulation of viral release from host cell (GO:1902186),0.30205005208760244,0.715923447982364,0.7852882703777336,0.9876477520586466,1.0,3/21,6.20%,MID2;TRIM62;CHMP2B
prerank,fatty acid beta-oxidation (GO:0006635),-0.22383181333868352,-0.715622352378507,0.9383886255924171,0.980135012398886,1.0,14/51,21.78%,IVD;CPT2;SLC25A17;ACOX1;ECI2;ACADL;AUH;BDH2;ACAD10;ACOX3;ECHDC2;ACADS;DECR1;GCDH
prerank,mRNA stabilization (GO:0048255),0.27514126194805194,0.7154061454931748,0.796875,0.9877129295273605,1.0,9/40,14.25%,RBM24;ELAVL4;DAZL;BOLL;DND1;AXIN2;HNRNPU;TENT5D;HNRNPC
prerank,regulation of tau-protein kinase activity (GO:1902947),-0.32046467290150255,-0.714975333762374,0.8339285714285715,0.9802842292247409,1.0,4/10,28.31%,HSP90AB1;NAB2;EGR1;CLU
prerank,regulation of immune effector process (GO:0002697),0.26873677778662175,0.7146258343670541,0.8202846975088968,0.988171655520334,1.0,5/41,9.50%,VTN;CD46;C7;SUSD4;CR2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),-0.2367236389988223,-0.7145589544608688,0.9128630705394191,0.9801776427330948,1.0,4/34,6.94%,RBP4;LACC1;WNT5A;SLC7A5
prerank,regulation of smoothened signaling pathway (GO:0008589),0.2599536773791571,0.7143358722382225,0.8202443280977313,0.9879118274445087,1.0,7/50,6.75%,RORA;BTRC;IFT81;MOSMO;GAS8;GPC3;KCTD6
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.3232415720640354,0.7141315276646392,0.7604395604395604,0.987541602844555,1.0,4/12,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,negative regulation of mRNA processing (GO:0050686),0.3158036176494584,0.7140432270762169,0.7784946236559139,0.9869882345084696,1.0,9/15,26.81%,RNPS1;C1QBP;RBMX;SRSF9;PTBP1;SAP18;SRSF12;SRSF4;SFSWAP
prerank,midbody abscission (GO:0061952),-0.2835545723579559,-0.7139188034220478,0.842911877394636,0.98035151326139,1.0,4/17,16.82%,PDCD6IP;CHMP4B;CHMP4A;MITD1
prerank,mammary gland epithelium development (GO:0061180),-0.295909036579386,-0.7139135310322564,0.8342644320297952,0.9797967280915955,1.0,6/14,24.86%,WNT4;AKT1;ID2;CSF1R;AKT2;SCRIB
prerank,histone H4 acetylation (GO:0043967),-0.21979673237200306,-0.7132510610508341,0.9090909090909091,0.9799986191597019,1.0,16/47,25.98%,LEF1;TRRAP;MEAF6;TRIM16;BRCA2;KANSL2;BEND3;NAA40;CHD5;MORF4L2;HAT1;BRD8;JADE1;ING4;ATF2;EPC1
prerank,regulation of cellular amino acid metabolic process (GO:0006521),-0.22213850421833478,-0.713148423614788,0.916289592760181,0.97955978860957,1.0,17/53,24.71%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;BCKDK;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2992922162895316,0.7130429025072139,0.7894736842105263,0.9877986664073275,1.0,2/22,3.27%,CD46;IL2RA
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",0.2930877133102645,0.7130011641925121,0.7710843373493976,0.9865196631070319,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",0.2930877133102645,0.7130011641925121,0.7710843373493976,0.9865196631070319,1.0,9/21,20.33%,RBX1;ERCC4;GTF2H5;GTF2H1;PARP1;CHD1L;RPA2;GTF2H4;DDB2
prerank,regulation of dopamine secretion (GO:0014059),0.2867983335734772,0.7128167681169065,0.8011049723756906,0.9861116113892483,1.0,11/25,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,protein O-linked glycosylation via serine (GO:0018242),0.34725890690436306,0.7123132315096901,0.7740585774058577,0.9862028859866218,1.0,3/10,12.29%,GALNT13;GALNT1;GALNT4
prerank,regulation of telomerase activity (GO:0051972),-0.22655112436279518,-0.7123036547685017,0.9324618736383442,0.9799255899082717,1.0,14/45,26.85%,KLF4;SMG6;NAF1;PINX1;ATM;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;TP53;CTNNB1;NEK7
prerank,endocytic recycling (GO:0032456),0.2576555216388863,0.7121821241768292,0.8488964346349746,0.9857253478910948,1.0,1/50,0.58%,ANKRD50
prerank,regulation of small molecule metabolic process (GO:0062012),0.28307905660779253,0.7121165335441242,0.7894736842105263,0.9851510150992191,1.0,2/28,3.04%,RORA;ARV1
prerank,regulation of viral transcription (GO:0046782),-0.2323617501366618,-0.7113637601140734,0.90625,0.9803958031349489,1.0,16/39,31.21%,MDFIC;IFITM3;POLR2A;TRIM27;POLR2F;CDK9;POLR2E;TRIM14;RSF1;NELFCD;TRIM11;POLR2G;CTDP1;SUPT4H1;ZFP36;TRIM21
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.24193906592697983,-0.7107207991037295,0.8810020876826722,0.9806076901499644,1.0,12/32,30.61%,TAF1;CAVIN1;POLR2F;MAPK3;POLR2E;UBTF;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",-0.2572055051062147,-0.7104498902061731,0.8670756646216768,0.9803586195880172,1.0,8/24,32.01%,UBB;RPA1;RFC3;RFC1;RPA3;POLD1;PCNA;RFC5
prerank,bicarbonate transport (GO:0015701),-0.2546962166627543,-0.7100404262268419,0.8571428571428571,0.9802753672639297,1.0,2/25,3.27%,SLC26A7;SLC4A10
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.3290165898633085,0.7089144025119779,0.7767857142857143,0.9890893692836901,1.0,6/13,18.43%,CIDEB;RIPK2;PERP;GRIN2A;ASPH;NLRC4
prerank,dopaminergic neuron differentiation (GO:0071542),-0.26976418251424744,-0.7088599868017142,0.8774703557312253,0.9810200534389577,1.0,8/19,34.86%,LRP6;NR4A2;LMX1B;VEGFA;CTNNB1;LMX1A;WNT2;SHH
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.29687456537964,0.7083887804769006,0.774,0.9891445385110963,1.0,5/20,15.11%,GRK3;SNCA;CRY1;APLP1;YWHAB
prerank,DNA geometric change (GO:0032392),-0.2560635403374423,-0.7083113701954835,0.8744939271255061,0.9810581564468032,1.0,5/24,20.33%,ASCC3;ANXA1;RAD50;HMGB2;RECQL
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),-0.26213967666273547,-0.7080099428633937,0.8850102669404517,0.9808454849075939,1.0,7/23,29.01%,ELOVL7;FAR2;ELOVL1;ACSL4;DGAT2;ACSBG1;ACSF3
prerank,epithelial cell development (GO:0002064),0.2950972114851583,0.7067926800658219,0.7934990439770554,0.9906909017120026,1.0,2/20,5.43%,RILPL2;ROS1
prerank,respiratory electron transport chain (GO:0022904),0.32248073423695667,0.7066753114933982,0.7866379310344828,0.9901884064064638,1.0,6/14,18.71%,UQCRFS1;SLC25A13;ETFB;ETFA;ETFDH;NDUFA5
prerank,magnesium ion transport (GO:0015693),-0.305057621919518,-0.7061010125884816,0.8370786516853933,0.9823403538200212,1.0,1/12,4.08%,SLC41A1
prerank,regulation of synapse maturation (GO:0090128),0.3286949943619191,0.7056588797338337,0.7783018867924528,0.9909960977473962,1.0,3/10,13.11%,NRXN1;YWHAZ;ANAPC2
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.26897275512488267,-0.7045567853624111,0.8555555555555555,0.9834464767417609,1.0,5/19,22.61%,CUX1;OBSL1;LRP8;DBN1;SS18L1
prerank,regulation of protein localization to cell surface (GO:2000008),0.26841659174415106,0.7044331701297651,0.8414414414414414,0.9920630997592643,1.0,1/33,0.83%,NEDD4L
prerank,'de novo' posttranslational protein folding (GO:0051084),-0.24280827081008036,-0.7042438904855657,0.8723849372384938,0.9832416655472593,1.0,11/30,31.24%,HSPA5;ENTPD5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,positive regulation of telomerase activity (GO:0051973),-0.23754904740196064,-0.7038129297353213,0.871578947368421,0.9831173153683802,1.0,10/33,26.85%,KLF4;NAF1;HSP90AB1;MAPK3;MAP3K4;ACD;MAP2K7;WRAP53;CTNNB1;NEK7
prerank,axonemal dynein complex assembly (GO:0070286),-0.2506015100044978,-0.7037841795434544,0.8731808731808732,0.9825915519417481,1.0,19/27,48.81%,DNAH8;ODAD2;DRC1;ODAD3;DNAL1;CCDC65;DNAAF2;DNAI4;TTC12;CFAP100;DNAH17;CCDC40;DNAAF4;ODAD1;DNAH1;DNAAF3;DNAAF1;DNAI3;CFAP73
prerank,regulation of histone acetylation (GO:0035065),-0.23550719288051705,-0.7035865261378073,0.888421052631579,0.9822399113989986,1.0,11/33,24.18%,ARRB1;BRD7;TADA2A;FLCN;HDAC5;MAPK3;NOS1;PARK7;PPARGC1A;CTBP1;BRCA1
prerank,protein heterooligomerization (GO:0051291),0.31020836799302753,0.7031794102565627,0.7940552016985138,0.99319733491422,1.0,7/17,21.35%,CPSF6;MAT2A;PKD2;GRIN2B;KCNC2;CPSF7;GRIN1
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.315879988522621,0.7030507668228001,0.7639484978540773,0.9927240017909685,1.0,2/13,8.95%,YAE1;ISCA1
prerank,RNA methylation (GO:0001510),0.24972791045522547,0.7027683475436286,0.8664323374340949,0.9924594450017594,1.0,19/60,24.31%,FBLL1;NSUN3;TRMT61A;TRMT5;CBLL1;THUMPD2;RBM15;TRMT10C;MTO1;TFB2M;NSUN2;NSUN5;ZC3H13;WTAP;METTL6;DIMT1;GTPBP3;TRMT10A;TRDMT1
prerank,regulation of mRNA processing (GO:0050684),0.27790161391951856,0.7024733499080127,0.8133333333333334,0.9922349200671979,1.0,8/32,17.68%,PTCD2;SRPK3;PAPOLA;KHDRBS2;YTHDC1;SAFB2;QKI;LARP7
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),-0.19244558602059783,-0.7023606413845628,0.9596541786743515,0.9829210606177418,1.0,39/109,28.98%,PLCG1;VAV2;MAP3K1;NFATC1;PIK3CB;PSME2;RELA;PSMB4;FBXW11;PLCG2;FER;PSMB1;PSMD11;PSMD8;MAPK3;PSME3;CALM1;PDPK1;PSMD4;PSMA2;IKBKG;SYK;PSMD3;PPP3CB;NFATC2;PSMB7;LCP2;NR4A3;MAP2K7;PSMC2;SHC1;PSMC5;PSMD10;BCL10;PAK2;PSMD7;MAPK9;VAV3;JUN
prerank,spliceosomal snRNP assembly (GO:0000387),-0.22997374482920024,-0.702186810979502,0.9088888888888889,0.9825381153274363,1.0,13/38,27.77%,GEMIN7;STRAP;SRSF10;GEMIN5;PRPF3;SNRPF;SNRPD1;SNRPD2;WDR77;PRPF19;SNRPC;SNRPB;SNRPE
prerank,tRNA transport (GO:0051031),0.2691946446411903,0.7021086280430168,0.8214936247723132,0.9920923989607696,1.0,7/35,14.55%,NUP43;NOL6;SSB;NUP35;SEC13;NDC1;RANBP2
prerank,fatty acid transport (GO:0015908),0.3001855892315982,0.7018533521008907,0.7872763419483101,0.9917717656091045,1.0,3/17,5.57%,PPARD;SLC27A4;FABP3
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.24271665135993187,-0.7014437966515635,0.8932806324110671,0.9827798832866479,1.0,9/30,22.76%,NPEPPS;SH3GLB1;TOMM7;SAE1;LEPROT;PDCD5;HPS4;USP36;BAP1
prerank,alpha-amino acid metabolic process (GO:1901605),0.26253855010463834,0.7011439470762765,0.8517179023508138,0.9920971042457899,1.0,6/45,11.93%,NAALAD2;ATP7A;SLC25A13;GOT1;SRR;GLS2
prerank,phagosome-lysosome fusion (GO:0090385),-0.31453840208798345,-0.7008812038979961,0.8512241054613936,0.9828117233148503,1.0,7/10,39.23%,RAB7A;RAB7B;SYT7;RAB20;CLN3;PLA2G5;RAB39A
prerank,mitotic nuclear membrane organization (GO:0101024),0.2532798794137937,0.7007113945631627,0.8422818791946308,0.9913588604451287,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2532798794137937,0.7007113945631627,0.8422818791946308,0.9913588604451287,1.0,14/51,20.10%,NUP43;PPP2R2A;CHMP2B;ANKLE2;NUP35;SEC13;NDC1;EMD;CHMP3;SUMO1;NUP133;UBE2I;RANGAP1;PPP2R1A
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.2669839083599567,0.7007048678717145,0.83203125,0.9907000902278933,1.0,14/45,19.76%,GCNT2;GRM5;NANOS1;ZC3H10;YTHDC1;METTL18;EIF4E;PUM3;TSC1;MATR3;RC3H1;METAP1;DDX25;RBM3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.21261512772350266,0.700266565585347,0.9688826025459689,0.9906315669906256,1.0,12/175,7.96%,LIMS1;PID1;TNFRSF21;GPER1;TRAF5;PSMB11;ACTN4;TNFRSF8;CACTIN;PSMF1;TRAF3;CDIP1
prerank,gastrulation (GO:0007369),0.31579580001517477,0.6999370846589906,0.8056155507559395,0.9904094645677537,1.0,3/15,15.63%,GPC3;LMBRD1;TASOR
prerank,positive regulation of protein acetylation (GO:1901985),0.3272173881356707,0.6997714645335198,0.7659574468085106,0.9899827021721572,1.0,3/12,14.30%,DDX3X;FAM161A;PRKAA1
prerank,embryonic axis specification (GO:0000578),-0.28404217073221616,-0.6996464336523105,0.8582375478927203,0.9835319193279286,1.0,1/15,0.78%,SMAD6
prerank,regulation of protein transport (GO:0051223),-0.24669136802102953,-0.6993740013227656,0.9035087719298246,0.9832501139815699,1.0,9/27,22.24%,WWP2;NDEL1;DISP1;RHBDF2;LLGL2;CHP1;ARFIP1;SNX3;LCP1
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.3230003700777221,0.6993234173833534,0.7647058823529411,0.9886396346425008,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.3230003700777221,0.6993234173833534,0.7647058823529411,0.9886396346425008,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.3230003700777221,0.6993234173833534,0.7647058823529411,0.9886396346425008,1.0,4/12,15.88%,CUL3;RB1;ANAPC7;NSMCE2
prerank,positive regulation of rRNA processing (GO:2000234),-0.3145470672807854,-0.6991042993749168,0.8354898336414048,0.9829943952442767,1.0,3/10,24.11%,SIRT7;RIOK2;TRMT112
prerank,regulation of oxidoreductase activity (GO:0051341),0.31888337618230517,0.6979183310463739,0.7832618025751072,0.9898868256381916,1.0,2/13,10.51%,ATP7A;ABL2
prerank,response to UV (GO:0009411),0.22761573009369393,0.6978989673940841,0.9105960264900662,0.9892563663237669,1.0,1/95,0.16%,PTPRK
prerank,protein K11-linked ubiquitination (GO:0070979),-0.24714087458852857,-0.6977092277623929,0.8870636550308009,0.98389356408955,1.0,8/27,25.78%,CDC16;UBE2E2;ANAPC4;FZR1;CDC27;ANAPC5;PRKN;UBE2H
prerank,protein heterotetramerization (GO:0051290),0.3155853070434879,0.6976127687644631,0.805439330543933,0.988989195955559,1.0,3/13,9.80%,CPSF6;PKD2;GRIN2B
prerank,positive regulation of mitochondrion organization (GO:0010822),-0.21328876113919468,-0.6951099372249,0.9375,0.9859525823979193,1.0,30/57,37.12%,DCN;MCU;TNFSF10;BCL2L11;KDR;VPS35;BNIP3;ADCK1;BID;PDCD5;PARK7;BBC3;PPARGC1A;PLAUR;DDHD1;RALBP1;PRKN;TP53;BIK;TREM2;RALA;DNM1L;MIEF2;HRK;PINK1;PPIF;ZNF205;AURKA;HIP1R;BAX
prerank,intraciliary retrograde transport (GO:0035721),0.31911554857798874,0.6949246654892971,0.7820224719101123,0.9919828568161003,1.0,1/12,2.29%,IFT43
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.31893551580700474,0.6946276436989078,0.8108651911468813,0.9916958045516463,1.0,1/13,1.77%,NR1H3
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3188980333933876,0.6945543245575534,0.8046511627906977,0.9904788126108451,1.0,4/11,18.12%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,miRNA mediated inhibition of translation (GO:0035278),0.3188980333933876,0.6945543245575534,0.8046511627906977,0.9904788126108451,1.0,4/11,18.12%,AGO3;TNRC6C;EIF6;NOTCH4
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.32289186977105433,0.694475492694904,0.8044806517311609,0.9899352943146853,1.0,3/12,8.19%,TK1;TK2;DCK
prerank,regulation of Golgi organization (GO:1903358),-0.2705809435341158,-0.6944125653664084,0.8517034068136272,0.986094854498075,1.0,5/17,17.97%,ARMH3;USP6NL;AKAP9;MAPK3;STX18
prerank,cobalamin metabolic process (GO:0009235),0.3014144158159142,0.6943669703332828,0.7868852459016393,0.98942391423549,1.0,3/17,13.83%,MMADHC;MMAB;LMBRD1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.3148435118274654,-0.6940971105038783,0.8597122302158273,0.9858600639692785,1.0,5/10,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,regulation of centriole replication (GO:0046599),-0.2728961554827186,-0.6937371209799885,0.8611111111111112,0.9856794391905611,1.0,6/17,28.52%,KAT2B;PLK2;ALMS1;PLK4;BRCA1;NUP62
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.2764886776242512,-0.6936872877839276,0.844488188976378,0.9851858044769822,1.0,2/16,5.34%,KAT2B;NAA35
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.28024031016714196,-0.6935710142303091,0.8605577689243028,0.9847565817701435,1.0,6/16,29.45%,AMPD3;ATIC;LHPP;ADSS1;PAICS;NUDT2
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.30550028315107414,0.6934710798518836,0.7789046653144016,0.9899510910445358,1.0,4/15,16.08%,RUVBL1;NOP10;CCT7;CCT3
prerank,tryptophan catabolic process (GO:0006569),-0.30630178389238766,-0.6932877085230216,0.8491228070175438,0.9844855215521169,1.0,10/11,57.20%,AFMID;KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,translational termination (GO:0006415),-0.18961188913691152,-0.6932814223020729,0.9836956521739131,0.9839421013242234,1.0,29/95,29.24%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;APEH;MTRF1;TRMT112;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",-0.25387688679046105,-0.6928335307249175,0.8833333333333333,0.9838430557169043,1.0,6/23,24.53%,REXO4;DNASE1L1;HMGB2;DICER1;DFFB;FOXL2
prerank,morphogenesis of an epithelium (GO:0002009),0.292735337853962,0.6927431478500188,0.8014842300556586,0.9902798404133107,1.0,6/25,12.92%,VCL;TIMELESS;TBX18;AHI1;PRKX;KDM2B
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.3148520448012557,0.6926560092721071,0.777027027027027,0.9897384832050273,1.0,4/12,13.28%,RLIM;YTHDC1;RBM15;HNRNPU
prerank,positive regulation of sodium ion transport (GO:0010765),0.33393700848188673,0.692479468396178,0.7942386831275721,0.989321998307828,1.0,3/12,7.25%,SCN5A;ANK3;PRSS8
prerank,regulation of humoral immune response (GO:0002920),0.2570071238260966,0.692449222987755,0.8599290780141844,0.9886957274347041,1.0,5/44,9.50%,VTN;CD46;C7;SUSD4;CR2
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.2245821675536802,-0.6922235341543149,0.9017467248908297,0.9839009142870344,1.0,1/41,0.05%,PRKAG2
prerank,negative regulation of histone modification (GO:0031057),-0.2817955308152984,-0.6918836713934091,0.8301526717557252,0.983687126037275,1.0,6/14,28.35%,JARID2;CTBP1;BRCA1;AASS;TWIST1;SPHK2
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.2853041830697457,0.6905565006061982,0.8251028806584362,0.9905678525823218,1.0,8/22,20.33%,RBX1;GTF2H5;GTF2H1;PARP1;XPC;CHD1L;GTF2H4;DDB2
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),-0.24253704197976528,-0.6900088693762171,0.907258064516129,0.9850229156150839,1.0,8/29,29.01%,ELOVL7;ACACA;ELOVL1;ACSL4;HSD17B8;GCDH;ACSBG1;ACSF3
prerank,V(D)J recombination (GO:0033151),0.32924417497829783,0.6897158762333433,0.788546255506608,0.9910620956888386,1.0,2/11,12.69%,LIG4;PRKDC
prerank,glycolipid biosynthetic process (GO:0009247),0.25939791151018365,0.6886107981186875,0.8428030303030303,0.9918746951277296,1.0,6/38,11.03%,PIGU;ST8SIA1;PIGO;B4GALT6;PIGZ;DPM3
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.28700713029382546,0.6885085889369172,0.804,0.9913468018178392,1.0,8/25,19.21%,SORT1;CHMP2B;MVB12A;DENND10;UBXN6;CHMP3;LEPROTL1;VTA1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.3079813586766854,0.6875242696454805,0.7933194154488518,0.9919932555283927,1.0,5/13,26.80%,ALG12;ALG1;ALG11;DPAGT1;MPDU1
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),-0.23985401689587332,-0.6871234845648279,0.9047619047619048,0.9872334175517513,1.0,10/29,25.91%,PINX1;PPIA;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,cilium movement (GO:0003341),0.2539426650981987,0.6858760304468846,0.8785211267605634,0.9934898291538585,1.0,8/47,17.56%,RSPH6A;SPEF1;GAS8;CAMSAP3;CCDC63;ODAD4;CFAP61;DNAH9
prerank,positive regulation of RNA splicing (GO:0033120),0.2697045562363555,0.6857933377912698,0.8504854368932039,0.9929348619777653,1.0,6/29,19.76%,PIK3R1;TRA2A;DAZAP1;HABP4;RBMX;RBM3
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.2693249366832506,0.6857024039156374,0.8320610687022901,0.9924047208419583,1.0,10/30,21.36%,ABCD2;SLC27A2;SLC27A4;ACOT2;TECR;ACOX2;ELOVL6;PEX2;ELOVL2;ACSL1
prerank,protein targeting to membrane (GO:0006612),0.23084995849662016,0.6855773941545454,0.9130434782608695,0.9919146276955769,1.0,17/83,18.15%,ZDHHC14;RAB8B;NCF1;ABCD2;ATAD1;SGTB;PIKFYVE;ZDHHC1;ZDHHC2;ZDHHC21;PEX3;ZDHHC23;PEX19;PEX12;ZDHHC9;CHM;NACAD
prerank,synaptic vesicle endocytosis (GO:0048488),0.26778184959547047,0.6854874393835946,0.8476953907815631,0.9913864386831563,1.0,10/33,20.16%,CEL;SNCA;SYT1;SYT2;NLGN3;CDK5;DNM1;VAMP2;SNAP91;AMPH
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.28512557098293484,-0.6844499130168876,0.8470588235294118,0.9892607043018223,1.0,3/14,13.18%,CARD14;CARD10;COPS8
prerank,chemokine-mediated signaling pathway (GO:0070098),0.25504431269653965,0.6844232626745868,0.8387096774193549,0.9920889799934234,1.0,5/42,6.10%,SH2B3;STK39;ACKR3;CXCL10;CXCL5
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.2742521801010823,0.6842306280713997,0.8520710059171598,0.9916873989203312,1.0,4/32,7.89%,CAMP;CXCL10;CXCL5;RNASE6
prerank,regulation of defense response to virus by host (GO:0050691),0.2763382255107667,0.6832806707974702,0.8313725490196079,0.9922400292990097,1.0,6/30,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;TARBP2;CGAS
prerank,regulation of store-operated calcium entry (GO:2001256),0.3338666697957099,0.6830422910611098,0.7913978494623656,0.9918950751785255,1.0,4/10,16.16%,STIM1;CASQ1;SLC8B1;CD84
prerank,regulation of organelle assembly (GO:1902115),0.23823516014343663,0.6827721787867541,0.8888888888888888,0.9916038105162169,1.0,15/72,15.95%,TBC1D1;IFT20;TBC1D12;PIKFYVE;TBC1D2B;NPRL3;TBC1D10C;VPS11;TBC1D9B;NPRL2;TBC1D19;UBQLN2;RAB5A;CEP76;TBC1D10B
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),-0.23648005862757912,-0.6826060257643268,0.9029535864978903,0.9905114234023137,1.0,7/29,19.88%,COPZ2;TRAPPC10;COPA;TRAPPC3;NAPA;RAB6A;COPB1
prerank,response to endoplasmic reticulum stress (GO:0034976),0.22131593087782966,0.6825457748345244,0.9412650602409639,0.99124101424112,1.0,7/107,6.59%,ATP2A3;MAP3K5;PIK3R1;CHAC1;ITPR1;SCAMP5;ATP2A2
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),-0.2553370465497482,-0.6824193806086176,0.9013282732447818,0.9901432620270276,1.0,2/22,3.38%,PTPRJ;EZR
prerank,mitochondrial fusion (GO:0008053),0.29789516610006517,0.682381646899566,0.8187250996015937,0.9908132535048961,1.0,4/18,15.80%,PLD6;MFF;MFN1;MIEF1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.2431495463779714,0.682024110842485,0.891566265060241,0.990592748264653,1.0,9/54,11.61%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.28821401387646567,-0.6811309381918564,0.8667917448405253,0.9907742111472848,1.0,6/13,19.75%,SEC16B;TMEM30A;TM9SF4;SAR1A;SAR1B;CD81
prerank,aromatic amino acid family catabolic process (GO:0009074),-0.27797364884094716,-0.6806609760420723,0.8862385321100917,0.9906948735322622,1.0,12/15,58.60%,KYNU;FAH;HGD;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD;GSTZ1
prerank,apoptotic nuclear changes (GO:0030262),0.2812704070009859,0.6800912814030325,0.8368200836820083,0.9923278697766302,1.0,1/24,1.63%,GPER1
prerank,protein localization to microtubule organizing center (GO:1905508),-0.2783668077605561,-0.6797981576275374,0.8568665377176016,0.9909313725952069,1.0,6/15,30.07%,SNX10;CEP192;C2CD3;PIBF1;SPAG5;DCTN2
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.24295854508779613,0.6790959033875411,0.8814159292035398,0.9929265436712114,1.0,10/48,11.61%,NOA1;NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,glycerophospholipid catabolic process (GO:0046475),-0.23826669635980957,-0.6790043383195764,0.8947368421052632,0.9911297153942435,1.0,4/27,13.21%,PLA2G4A;PLA2G6;ABHD16A;PLA2G15
prerank,nuclear transport (GO:0051169),-0.2691319410802767,-0.6788446972005703,0.8837209302325582,0.9907181512119915,1.0,6/16,32.42%,NUP98;NXT2;PSIP1;NXT1;ANP32A;RBM15B
prerank,recombinational repair (GO:0000725),-0.19518877470570892,-0.67858371733982,0.967741935483871,0.9904181162876081,1.0,32/77,35.56%,INO80;RAD51B;SFR1;ERCC5;SAMHD1;BRCA2;NABP1;AP5Z1;RPA1;RAD50;RECQL;RAD52;RAD51C;MCM8;SLX4;RAD51;BRCA1;RPA3;ZSWIM7;RAD54B;HUS1;AP5S1;WRN;HELQ;RMI1;RAD51AP1;ZFYVE26;MORF4L1;HUS1B;RECQL5;RAD51D;NSMCE1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.22174647756981297,-0.6782968819659597,0.9311827956989247,0.9901122122556774,1.0,16/39,32.01%,ERCC5;CUL4A;UBB;DDB1;RPA1;RFC3;RFC1;ERCC1;ERCC2;RPA3;ERCC3;NTHL1;POLD1;GTF2H3;PCNA;RFC5
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),-0.30192035119331667,-0.6780351584691738,0.8596153846153847,0.9898066471755825,1.0,3/11,18.06%,ARRB1;GRK2;ADRB2
prerank,microtubule polymerization (GO:0046785),0.2735391979233991,0.6778599055295835,0.836852207293666,0.993867093859291,1.0,5/28,10.49%,FGF13;CCDC57;CLASP2;TPPP;TUBG2
prerank,ribosomal subunit export from nucleus (GO:0000054),-0.28336966885037723,-0.67750203892684,0.8475499092558983,0.9897417815400608,1.0,5/13,25.05%,SDAD1;RAN;RPS15;NUP88;RRS1
prerank,carbohydrate catabolic process (GO:0016052),-0.2236642364841992,-0.6767758731463416,0.9222222222222223,0.9898775904938458,1.0,12/38,28.40%,HK2;DERA;NAGA;ENO1;MANBA;MAN2C1;MAN2B2;NEU3;ALDOA;LDHA;HK1;ENO3
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),-0.26589146305210987,-0.6765563619501539,0.8757396449704142,0.9895138760156814,1.0,5/18,29.01%,ELOVL7;ELOVL1;ACSL4;ACSBG1;ACSF3
prerank,mitotic nuclear division (GO:0140014),0.2311417974759071,0.6763069333594163,0.9187817258883249,0.9950859567123096,1.0,1/71,0.31%,EPS8
prerank,rRNA pseudouridine synthesis (GO:0031118),-0.30019139014690027,-0.6759218514181782,0.8943533697632058,0.989571734856324,1.0,5/10,33.73%,NAF1;NHP2;RPUSD4;RPUSD2;RPUSD3
prerank,regulation of mitotic spindle organization (GO:0060236),-0.22881047824047454,-0.6757702057363743,0.9113082039911308,0.9891653229779073,1.0,14/35,32.16%,PDCD6IP;PARP3;CHMP4B;TPR;DYNC1H1;NUMA1;GNAI1;TPX2;FSD1;CHMP5;HSPA1B;NUP62;CCSAP;EML3
prerank,positive regulation of myelination (GO:0031643),0.31651044518551474,0.6755759078090092,0.8116883116883117,0.995360408833696,1.0,3/11,8.39%,TPPP;NCMAP;TENM4
prerank,negative regulation of protein secretion (GO:0050709),0.26100200737313956,0.6745415270389945,0.8514285714285714,0.9959503194577844,1.0,4/38,7.19%,NR1H3;IL1B;RHBDF1;IRS1
prerank,translational elongation (GO:0006414),-0.18489660037086086,-0.67445131424068,0.985632183908046,0.9897768384983989,1.0,33/101,31.99%,MRPL33;EEF1D;EEF1A1;EEF1B2;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;EEFSEC;MRPL46;MRPL39;MRPL17;MRPL12;MRPL1;MRPS26;MRPL35;GTPBP2;MRPL4;RACK1;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49;EEF1A2;MRPL43;MRPL48
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),-0.2700521032616912,-0.6741783305920183,0.8891050583657587,0.989464612274537,1.0,3/16,17.91%,STX7;CEACAM1;CYRIB
prerank,protein K48-linked deubiquitination (GO:0071108),0.2808641917253941,0.6734830485197733,0.8240917782026769,0.9965836372682001,1.0,6/23,17.22%,USP25;OTUD5;OTUB1;USP50;USP33;OTUD7B
prerank,autophagy of mitochondrion (GO:0000422),-0.22357995747952897,-0.671588701244421,0.9179954441913439,0.9912070411159295,1.0,13/38,35.29%,WIPI2;BECN1;ULK2;BNIP3;ATG2A;GABARAPL1;ATG7;ATG12;PRKN;ATG14;RB1CC1;PINK1;PHB2
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),0.3095387914810812,0.6714514789498601,0.8305439330543933,0.9984086316182449,1.0,1/11,6.44%,LPO
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.27531985139724674,0.6707253050359107,0.8598484848484849,0.9986244890906139,1.0,5/25,16.33%,CUL3;UGGT2;ZER1;YME1L1;TOR1A
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.24706293480748132,-0.670583884349403,0.922920892494929,0.9915542988034907,1.0,7/23,22.72%,BCL2L11;TIMM13;TOMM22;TIMM8B;MAIP1;TIMM9;NDUFA13
prerank,embryo development ending in birth or egg hatching (GO:0009792),-0.270672998031952,-0.6703158900279232,0.8809980806142035,0.9912570197245475,1.0,1/15,1.42%,STOX2
prerank,negative regulation of signaling (GO:0023057),0.2743572802883752,0.6699916557985245,0.8430232558139535,0.9988708120739181,1.0,3/25,6.20%,IL1B;SOCS5;AP1AR
prerank,pseudouridine synthesis (GO:0001522),0.29882224742304336,0.6698152946274004,0.81419624217119,0.9984280995443064,1.0,5/13,24.16%,TRUB1;NOP10;PUS7;GAR1;DKC1
prerank,neuron maturation (GO:0042551),0.29449361080795783,0.6696966318127149,0.8211382113821138,0.9979297633325885,1.0,4/18,9.39%,SCARF1;B4GALT6;ADGRB3;ACTL6B
prerank,pre-miRNA processing (GO:0031054),-0.28629375481406405,-0.6693095454929339,0.8776290630975143,0.9915995549165749,1.0,4/14,20.39%,TUT4;TUT7;AGO1;DICER1
prerank,phasic smooth muscle contraction (GO:0014821),-0.30041590286800246,-0.6692203492940786,0.8943396226415095,0.9911184728107187,1.0,6/10,43.11%,EDN3;EDNRB;GDNF;EDN1;TIFAB;HTR1D
prerank,regulation of type I interferon production (GO:0032479),-0.19100712331021463,-0.6679929080965036,0.988950276243094,0.9916582502173652,1.0,30/84,33.81%,IRF1;IKBKE;PCBP2;NLRC5;RNF135;MAVS;RNF125;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;POLR2E;UBA7;NPLOC4;UBE2L6;POLR3D;RNF216;MYD88;ZBP1;CTNNB1;POLA1;TAX1BP1;POLR1C;ISG15;TRIM21;RNF26;PQBP1;ITCH;POLR3A
prerank,regulation of leukocyte activation (GO:0002694),0.29968587283858267,0.6679251149848894,0.8288288288288288,0.9993866986161908,1.0,2/14,9.11%,GPER1;LYN
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.23199495561946432,0.6677385174830591,0.9373970345963756,0.9989647625633508,1.0,7/69,12.01%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A;COA6
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.23399321003267715,-0.6672483496039802,0.9212253829321663,0.9911844672909794,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,CENP-A containing chromatin organization (GO:0061641),-0.23399321003267715,-0.6672483496039802,0.9212253829321663,0.9911844672909794,1.0,10/29,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,regulation of posttranscriptional gene silencing (GO:0060147),-0.20600353989128994,-0.6668414834108625,0.9623059866962306,0.9904532106343054,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,regulation of gene silencing by RNA (GO:0060966),-0.20600353989128994,-0.6668414834108625,0.9623059866962306,0.9904532106343054,1.0,17/50,29.08%,H3-3A;POLR2A;PUM1;POLR2F;NUP98;TNRC6A;IPO8;POLR2E;TPR;AGO1;NUP88;NUP214;NUP37;POLR2G;NUP155;NUP62;AGO2
prerank,protein autoprocessing (GO:0016540),-0.2589677089287791,-0.6657925072444901,0.8717948717948718,0.9908396723341529,1.0,3/17,16.86%,CASP4;AFG3L2;MYRF
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.21580094959324908,0.6655281274898309,0.9540581929555896,1.0,1.0,24/105,21.19%,BTRC;CLEC10A;FFAR2;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,cellular response to superoxide (GO:0071451),-0.299390561509064,-0.665437122753156,0.8778195488721805,0.9906025224037249,1.0,6/10,27.64%,NOS3;PRDX2;ADPRS;MT3;PRDX1;SOD2
prerank,tRNA metabolic process (GO:0006399),0.2852678831934803,0.6653557689581439,0.8416988416988417,1.0,1.0,9/17,26.60%,SSB;DARS2;ADAT1;AARS1;POP7;POP5;DTD1;RPP30;FARS2
prerank,amyloid precursor protein catabolic process (GO:0042987),0.29903651591268926,0.6647335553366837,0.823045267489712,1.0,1.0,3/14,13.82%,ADAM19;PSEN1;ABCA7
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.22576343087017497,0.664602336651473,0.9345335515548282,1.0,1.0,13/72,13.62%,RGCC;TNKS1BP1;FOXM1;CNOT2;SOX4;CDKN1A;MYO6;CNOT9;CNOT4;PRMT1;EP300;RPS6KA6;CNOT10
prerank,response to peptide (GO:1901652),-0.22304474109390637,-0.6638771998360438,0.9252136752136753,0.9913697882813239,1.0,9/33,24.44%,ANXA1;STAT2;STAT1;STAT3;MMP2;EIF2B2;ERBIN;GNAI1;EIF2B5
prerank,ESCRT complex disassembly (GO:1904896),0.31545292687277016,0.663208928284499,0.8101545253863135,1.0,1.0,1/10,6.20%,CHMP2B
prerank,ESCRT III complex disassembly (GO:1904903),0.31545292687277016,0.663208928284499,0.8101545253863135,1.0,1.0,1/10,6.20%,CHMP2B
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.2780546735144245,-0.662916231637831,0.8659003831417624,0.9916362488880085,1.0,3/13,19.18%,GFPT2;UAP1;GFPT1
prerank,positive regulation of defense response to virus by host (GO:0002230),0.27385455352056876,0.662702192704214,0.8428290766208252,1.0,1.0,5/24,10.05%,PTPN22;IL4;IL12RB1;ZDHHC1;CGAS
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),0.3092061165735873,0.6626955800004309,0.8025751072961373,0.9996462490937,1.0,2/10,12.84%,SNCA;SET
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.30434542758253236,0.6626031164544329,0.8322981366459627,0.9991144137315665,1.0,2/14,4.39%,PPP3CA;PPP2R2A
prerank,mRNA metabolic process (GO:0016071),0.2195006460359171,0.662591515515895,0.9477848101265823,0.9984826572643639,1.0,20/90,17.30%,DHX15;LSM3;PCBP3;NCBP2;AGO3;LSM10;SFPQ;HNRNPR;CPSF6;TCERG1;SSB;YTHDF2;CELF1;RNH1;CNOT10;DIS3L2;KIN;SNRPD3;LSM2;HSF1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),-0.2373211832181758,-0.662155907825473,0.9101796407185628,0.9917505508576647,1.0,10/25,31.24%,HSPA5;ST13;DNAJB5;HSPA13;GAK;HSPA9;DNAJB12;HSPA1B;BAG1;SDF2L1
prerank,regulation of transposition (GO:0010528),-0.2791087675635783,-0.6619223861332534,0.8781362007168458,0.9914075400746897,1.0,7/13,42.84%,SIRT7;SMYD5;TDRD9;DDX4;MYBL1;PIWIL4;SPOCD1
prerank,nucleobase-containing compound catabolic process (GO:0034655),-0.21959342815212357,-0.6606164945926604,0.9338842975206612,0.9919225036987978,1.0,14/37,33.30%,ENTPD1;SIDT2;DNASE1L1;ENTPD5;PNPT1;ENTPD2;DFFB;NUDT16;EXOSC7;NUDT1;NUDT18;ENTPD3;NUDT5;NUDT9
prerank,establishment of mitotic spindle localization (GO:0040001),0.26460880212526106,0.6602991467398978,0.8473895582329317,1.0,1.0,10/28,18.52%,CLASP2;ITGB1;UBXN2B;NUSAP1;DCTN1;MAD2L1;NDE1;HTT;CENPA;INSC
prerank,regulation of protein kinase C signaling (GO:0090036),-0.27199133223960126,-0.658558187263862,0.8930581613508443,0.9930672196031087,1.0,5/14,17.25%,ADGRV1;WNT5A;GPD1L;FLT4;WNT11
prerank,positive regulation of fatty acid oxidation (GO:0046321),0.3042156797594513,0.658421517160241,0.819838056680162,1.0,1.0,2/12,7.19%,ABCD2;IRS1
prerank,positive regulation of microtubule polymerization (GO:0031116),-0.23309211928258247,-0.6584011200166285,0.9048672566371682,0.9926513392839333,1.0,7/28,20.68%,OCLN;AKAP9;GIT1;MET;TOGARAM1;FES;NUMA1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.2916161232894683,-0.6579823524448003,0.9005524861878453,0.9924502670705869,1.0,5/11,25.85%,SP100;HIPK2;RPS27L;ING4;TP53
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.19060507456304673,-0.6578030724006677,0.9854721549636803,0.9920486050715821,1.0,19/73,24.71%,YAP1;FOXC1;LMO2;GATA2;PSME2;PSMB4;TAL1;PSMB1;PSMD11;PSMD8;PSME3;PSMD4;PSMA2;PSMD3;PSMB7;PSMC2;CBFB;PSMC5;PSMD10
prerank,regulation of cellular amine metabolic process (GO:0033238),-0.20848224261508042,-0.6577623230681748,0.9662921348314607,0.9915412359680831,1.0,16/50,24.71%,PSME2;PSMB4;PSMB1;PSMD11;PSMD8;PSME3;ODC1;OAZ1;PSMD4;PSMA2;PSMD3;PSMB7;AZIN1;PSMC2;PSMC5;PSMD10
prerank,peptidyl-proline hydroxylation (GO:0019511),0.30571106648180274,0.657428719831792,0.8285714285714286,1.0,1.0,3/11,10.02%,P4HA1;P3H2;P4HTM
prerank,histone H3-K4 trimethylation (GO:0080182),-0.28275838478654025,-0.6564028573158989,0.8888888888888888,0.9920830986874088,1.0,3/11,15.23%,SETD1B;TET3;BEND3
prerank,negative regulation of cilium assembly (GO:1902018),-0.28207467627002014,-0.6555302094300892,0.8660550458715597,0.9922240183922848,1.0,3/12,13.57%,LIMK2;YAP1;TCHP
prerank,acetyl-CoA metabolic process (GO:0006084),-0.2631337724968589,-0.6553757451031276,0.8869731800766284,0.9917965566988167,1.0,3/15,18.87%,HMGCS2;ACACA;ACACB
prerank,RNA stabilization (GO:0043489),-0.22197222229879415,-0.6547728546454671,0.9309576837416481,0.9917305203357871,1.0,9/33,19.79%,THRAP3;NOCT;NAF1;TENT5A;LARP1;ZCCHC17;ELAVL1;E2F1;TENT5C
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),0.2940885502407624,0.6544605383705361,0.8373101952277657,1.0,1.0,4/13,18.05%,B3GALT1;B3GNT8;B3GALT5;B3GNT2
prerank,mitochondrial translational termination (GO:0070126),-0.1823992800124122,-0.6543160014746093,0.9917582417582418,0.9915434899920202,1.0,27/88,29.24%,MRPL33;MRRF;MRPS7;MRPS6;MRPS18A;MRPS24;MRPL52;CHCHD1;MRPL24;MRPL15;MRPL46;MRPL39;MTRF1L;MRPL17;MRPL12;MRPL1;MRPS26;MTRF1;MRPL35;MRPL4;MRPL21;MRPL54;MRPL34;MRPS2;MRPL50;MRPS23;MRPL49
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.25455766071242303,-0.6537049044891087,0.9122807017543859,0.9914588136973891,1.0,5/18,29.84%,SIRT7;UBTF;EIF2AK3;LYAR;RASL11A
prerank,production of siRNA involved in RNA interference (GO:0030422),0.31027117831953144,0.653698515176707,0.8053691275167785,1.0,1.0,2/10,11.89%,TARBP2;TSN
prerank,retrograde axonal transport (GO:0008090),0.2818938817570328,0.653437982765348,0.834,1.0,1.0,7/16,22.35%,TMEM108;DLG2;HAP1;DST;KIF1A;NEFL;SOD1
prerank,miRNA metabolic process (GO:0010586),-0.25542461990689147,-0.6530470345094145,0.898854961832061,0.9913954992398654,1.0,5/20,20.39%,TUT4;TUT7;RAN;TENT4B;DICER1
prerank,vitamin D metabolic process (GO:0042359),-0.27646408203649325,-0.6525981198337546,0.8830935251798561,0.9911998446845517,1.0,8/13,50.28%,CUBN;PIAS4;CYP2R1;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.26082419718912064,0.6517951204336891,0.8821218074656189,1.0,1.0,12/28,24.50%,WAS;AUNIP;SETMAR;PRKDC;SHLD3;KMT5B;MRNIP;HSF1;HMGA2;PNKP;NUDT16L1;KDM4D
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.27074914726270133,0.6514538091834389,0.865530303030303,1.0,1.0,4/25,12.67%,GPER1;CIDEB;MFF;FAM162A
prerank,aromatic amino acid family metabolic process (GO:0009072),0.31354751823740645,0.6511359995161452,0.8244111349036403,1.0,1.0,1/10,3.70%,ATP7A
prerank,nuclear pore complex assembly (GO:0051292),-0.29574082246113104,-0.6509653299676019,0.9013539651837524,0.991936224897711,1.0,9/10,49.98%,NUP98;TPR;NUP153;NUP107;RTN4;NUP93;AHCTF1;NUP205;TMEM170A
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.18865017204881565,0.6507973166823944,0.9923273657289002,1.0,1.0,82/264,25.52%,SRPK3;CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;CLNS1A;SYMPK;PPIH;SCNM1;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;PRMT7;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;COIL;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;CDK13;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;DDX1;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5
prerank,cardiocyte differentiation (GO:0035051),-0.29732430382713826,-0.6499401395683403,0.9059040590405905,0.9922082713982531,1.0,3/10,16.16%,AKAP13;GATA6;KDM6B
prerank,positive regulation of histone acetylation (GO:0035066),0.2720834325113593,0.6496531077126882,0.8862745098039215,1.0,1.0,4/23,11.17%,IL1B;RPS6KA4;KAT7;GLYR1
prerank,response to UV-B (GO:0010224),-0.276885932179168,-0.6493987231707963,0.8956043956043956,0.9920755592635885,1.0,4/12,23.81%,MFAP4;RELA;CRIP1;STK11
prerank,potassium ion export across plasma membrane (GO:0097623),0.2938816300386198,0.6492707898803147,0.8528784648187633,1.0,1.0,2/13,7.70%,KCNE4;KCNE5
prerank,regulation of cellular response to heat (GO:1900034),-0.18792253996727923,-0.6491869105606353,0.9739952718676123,0.9917054138578429,1.0,26/77,28.91%,CD34;HSPB8;BAG3;FKBP4;CAMK2A;ATM;DNAJB6;HSP90AB1;RPA1;MAPK3;NUP98;TPR;NUP88;NUP214;BAG2;NUP37;YWHAE;RPA3;DNAJC2;NUP155;BAG5;HSPH1;HSPA1B;RPTOR;NUP62;BAG1
prerank,regulation of spindle assembly (GO:0090169),-0.23678256234237505,-0.6487149190196375,0.9138276553106213,0.9915179957291574,1.0,10/25,32.16%,PDCD6IP;CHMP4B;TPR;DYNC1H1;NUMA1;SPAG5;CHMP5;HSPA1B;CCSAP;EML3
prerank,spindle assembly (GO:0051225),0.22463664889739415,0.6486048494848025,0.9447322970639033,1.0,1.0,9/67,13.80%,STARD9;TNKS;CLASP2;MAPRE2;NEK6;TOGARAM2;MZT1;KIFC2;LSM14A
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),-0.1900194070400259,-0.6485293222378015,0.9814385150812065,0.9911146497774733,1.0,25/69,31.02%,STT3B;HSPA5;RNF103;AMFR;RNF185;UBXN4;UBE4B;DNAJB2;EDEM2;UBE2G2;ERLIN2;DNAJC10;HSP90B1;NPLOC4;VCP;SEC61B;FBXO17;DNAJB12;EDEM1;SYVN1;TMUB1;ANKZF1;UBE2J1;FBXO44;AUP1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),0.3062885289500923,0.647569004804623,0.8333333333333334,1.0,1.0,6/13,23.59%,SART3;PRPF6;PRPF31;LSM2;AAR2;SRSF12
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.2817629528486551,0.6474016332154773,0.8586278586278586,1.0,1.0,2/18,5.44%,NF1;CD300A
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.3098727272568099,0.6473826723789726,0.8369565217391305,1.0,1.0,4/11,24.16%,CCT7;CCT3;TERF1;DKC1
prerank,defense response to fungus (GO:0050832),0.2775645572477075,0.6473707266410247,0.8795918367346939,1.0,1.0,3/17,15.54%,CARD9;RARRES2;FAM3A
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.22369842823361252,0.6467512625461036,0.9338842975206612,1.0,1.0,11/63,13.62%,RGCC;TNKS1BP1;CNOT2;SOX4;CDKN1A;CNOT9;CNOT4;PRMT1;EP300;PRKDC;CNOT10
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",0.27866537644256195,0.64553073896713,0.8408602150537634,1.0,1.0,2/18,3.35%,NRXN1;CACNG7
prerank,regulation of carbohydrate catabolic process (GO:0043470),0.23799152656090186,0.6451706854156403,0.9023941068139963,1.0,1.0,9/41,11.61%,NUP43;OGT;SLC2A6;NUP35;GCK;SEC13;EIF6;NDC1;EP300
prerank,glucose metabolic process (GO:0006006),0.23360507011268541,0.644844937866116,0.9206081081081081,1.0,1.0,8/58,13.27%,PER2;PPARD;SLC25A13;TFAP2B;GOT1;ALDOC;GPI;CRY1
prerank,cellular response to amino acid starvation (GO:0034198),0.219509640375788,0.6448051914066353,0.9398373983739837,1.0,1.0,13/71,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,tetrapyrrole metabolic process (GO:0033013),0.27876549414384055,0.644801158286596,0.8565573770491803,1.0,1.0,3/18,13.83%,MMADHC;MMAB;LMBRD1
prerank,cellular response to misfolded protein (GO:0071218),0.2814700997485383,0.6441621727775247,0.8812877263581489,1.0,1.0,6/20,22.19%,CUL3;UGGT2;DNAJC18;TOR1A;STUB1;POMT2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.27342752385288527,-0.64403709154121,0.9015748031496063,0.9939791752258319,1.0,5/13,26.83%,UPP2;TDG;NT5C;NEIL1;NTHL1
prerank,negative regulation of histone acetylation (GO:0035067),0.2984430394297138,0.643422318193736,0.8539823008849557,1.0,1.0,2/11,12.84%,SNCA;SET
prerank,mitochondrial RNA metabolic process (GO:0000959),0.2916309245283728,0.6432565775297016,0.8624454148471615,1.0,1.0,3/14,13.05%,SLC25A33;TFAM;FASTKD1
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.21533187982543997,0.6432214689758357,0.9626168224299065,1.0,1.0,16/87,20.20%,SLC25A33;IMMP2L;COX18;UQCRFS1;NDUFB2;SDHAF3;ACAD9;FASTKD3;NDUFAF3;NDUFS6;COX20;OXA1L;NDUFA5;NDUFC2;NDUFAF2;SURF1
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.27193306400757356,-0.6425372715644749,0.9122807017543859,0.9945546356365473,1.0,1/13,5.19%,ADHFE1
prerank,nucleotide metabolic process (GO:0009117),0.26621483184374517,0.6422093617018599,0.8674948240165632,1.0,1.0,8/23,15.62%,AK8;REXO2;DCK;NMNAT3;DCTD;AK7;AK5;AK4
prerank,intracellular pH reduction (GO:0051452),0.25288148303198166,0.6418431702760202,0.8703007518796992,1.0,1.0,6/33,10.28%,GPR89A;GPR89B;DMXL1;ATP6V0E2;RAB38;ATP6V1B2
prerank,axonal transport of mitochondrion (GO:0019896),-0.286343920364601,-0.640714936297528,0.9059674502712477,0.9952775588273041,1.0,3/11,18.05%,HIF1A;SPAST;ACTR10
prerank,negative regulation of double-strand break repair (GO:2000780),0.25730442463347747,0.6405943330075925,0.9054820415879017,1.0,1.0,9/30,23.49%,FANCB;AUNIP;CGAS;OTUB1;SHLD3;HSF1;HMGA2;NUDT16L1;FBH1
prerank,negative regulation of inclusion body assembly (GO:0090084),-0.28810042997266755,-0.6405178262811609,0.9092495636998255,0.9948869483412767,1.0,3/10,15.71%,DNAJB2;DNAJB6;DNAJA4
prerank,organophosphate biosynthetic process (GO:0090407),0.24609343042202925,0.6398800588609772,0.911487758945386,1.0,1.0,8/37,17.82%,FGF2;ITPKB;TPK1;GK;IPMK;LPCAT1;IPPK;PIP5K1A
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2815478609992918,0.6396710482705691,0.857707509881423,1.0,1.0,3/16,13.02%,FANCB;CGAS;SHLD3
prerank,presynapse organization (GO:0099172),0.31041522510198394,0.6392752451423364,0.8538135593220338,1.0,1.0,1/10,2.44%,LRRTM3
prerank,ureteric bud morphogenesis (GO:0060675),-0.26073502095003254,-0.6388061172716443,0.8990291262135922,0.9955871760422342,1.0,2/16,6.23%,BMP4;SIX1
prerank,negative regulation of activated T cell proliferation (GO:0046007),-0.28501812914370084,-0.6384616653952337,0.9050279329608939,0.9952927682787535,1.0,3/10,24.86%,LGALS9;CD274;SCRIB
prerank,regulation of centrosome duplication (GO:0010824),-0.22328787068563355,-0.6377828199700277,0.9414141414141414,0.9952308804615295,1.0,8/29,27.68%,PDCD6IP;PLK2;CHMP4B;NAT10;ALMS1;CCNF;CENATAC;CHMP5
prerank,maturation of 5.8S rRNA (GO:0000460),-0.255797630956718,-0.6376448101489902,0.9204545454545454,0.9947886934903133,1.0,1/17,1.20%,NSA2
prerank,vasodilation (GO:0042311),0.29868639003230296,0.6374355585335242,0.8493449781659389,1.0,1.0,1/13,1.63%,GPER1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2717714997811554,0.637380303990267,0.8401639344262295,1.0,1.0,4/19,11.61%,CDIP1;DDIT4;HIPK1;EP300
prerank,megakaryocyte differentiation (GO:0030219),0.2910560228100555,0.637220704171169,0.8447488584474886,1.0,1.0,2/11,9.43%,SH2B3;MED1
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.26126880223008786,-0.6369185420620206,0.91015625,0.9947705218914237,1.0,9/16,36.07%,PIGN;PIGL;PIGW;PIGB;PIGC;PIGG;PIGA;DPM2;PIGV
prerank,establishment of spindle localization (GO:0051293),0.28323721302031435,0.6338924796449897,0.8477801268498943,1.0,1.0,2/14,10.17%,CLASP2;NUSAP1
prerank,mRNA processing (GO:0006397),0.18119259702543244,0.6332580328918901,0.99875,1.0,1.0,89/287,25.17%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;CPSF6;TCERG1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;RNMT;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;RPRD1B;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;CELF1;HNRNPU;LSM8;UPF3B;GTF2H5;HNRNPC;CCNH;HNRNPH2;ELAVL2;KIN;GTF2H1;PRPF31;SF3B3;ZC3H11A;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;GTF2H4;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;RNGTT;POLDIP3;SRRM4;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;AKAP8L;SMNDC1;THOC2;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40
prerank,acylglycerol catabolic process (GO:0046464),0.25313950108072153,0.6331106877228827,0.9135338345864662,1.0,1.0,3/30,6.95%,FABP3;LIPH;LIPC
prerank,maturation of SSU-rRNA (GO:0030490),-0.20899311587405617,-0.6320873677729637,0.9620253164556962,0.9976836341833774,1.0,5/34,12.39%,RPS14;RPS19;RPS8;RPS16;UTP6
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.25722192237047786,0.6318934049272888,0.884393063583815,1.0,1.0,14/30,23.20%,GNL3L;CDKN1A;ERCC4;HNRNPA1;SRC;HNRNPU;HNRNPC;PIF1;TERF1;TINF2;DACH1;CERS1;CTC1;EXOSC10
prerank,negative regulation of ATPase activity (GO:0032780),-0.2531366770795584,-0.6312050070679571,0.9377431906614786,0.9977235056222294,1.0,7/16,38.18%,PXK;IFIT1;PLN;TP53;TNNI3;PPIF;VCPKMT
prerank,aerobic electron transport chain (GO:0019646),0.21965926772998112,0.6308273402765799,0.9540229885057471,1.0,1.0,6/68,11.86%,COX4I2;UQCRFS1;NDUFB2;UQCRC2;COX4I1;COX5A
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.23518874218076835,-0.6306589693791465,0.9383429672447013,0.9975522069362868,1.0,6/22,22.86%,PWP1;UBTF;EIF2AK3;LYAR;PIH1D1;SMARCA4
prerank,spermatid development (GO:0007286),0.254301752665758,0.6301910307133466,0.8967495219885278,1.0,1.0,6/32,16.21%,PLD6;RSPH1;YTHDC2;SOX30;CCDC63;ACRBP
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),-0.22254516504120167,-0.6299085644903553,0.9406952965235174,0.9975127505289054,1.0,7/28,21.58%,BAG3;TNFRSF1A;CASP8;DAB2IP;BID;DEDD;DEDD2
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.286682570909143,0.629356584476463,0.8736842105263158,1.0,1.0,3/12,13.96%,ADSL;PPAT;IMPDH2
prerank,isotype switching (GO:0045190),0.29788900343479474,0.628745574797498,0.8548057259713702,1.0,1.0,1/10,6.89%,LIG4
prerank,histone ubiquitination (GO:0016574),0.2704500978726162,0.6278587998244337,0.8676171079429735,1.0,1.0,7/21,21.95%,PHC1;UBE2E1;UBR2;CTR9;UBE2B;HUWE1;UBE2A
prerank,autophagosome assembly (GO:0000045),-0.1963215855939222,-0.6276444616989618,0.983451536643026,0.9984797704051446,1.0,15/52,28.60%,WIPI2;SMURF1;IRGM;BECN1;ULK2;RAB7A;ATG2A;GABARAPL1;ATG101;EMC6;ATG7;ATG12;STX17;RAB19;ATG14
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),-0.2663006953377976,-0.6266309191527865,0.9087301587301587,0.9986026030582414,1.0,3/13,14.54%,SLC4A10;RAB3GAP1;SHISA7
prerank,negative regulation of centrosome duplication (GO:0010826),-0.2727206404131915,-0.626551618245378,0.9040590405904059,0.9981094870550112,1.0,4/11,27.46%,KAT2B;CCNF;BRCA1;CENATAC
prerank,glycerolipid catabolic process (GO:0046503),-0.24392215596074987,-0.626017519777345,0.9122448979591836,0.9979180444100649,1.0,1/19,1.12%,PLA2G4A
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),-0.2887378156116802,-0.6260143235101773,0.9222423146473779,0.9973856527335032,1.0,5/10,33.28%,BAG3;SIRT2;JUN;HIF1AN;NCK1
prerank,nuclear body organization (GO:0030575),0.2873391609059526,0.6255903371276518,0.880085653104925,1.0,1.0,3/12,13.00%,ETS1;DYRK3;USP50
prerank,positive regulation of interferon-beta production (GO:0032728),-0.21197401166404434,-0.6243469000480276,0.9530916844349681,0.997872551126733,1.0,4/33,10.94%,IRF1;OAS2;RNF135;MAVS
prerank,positive regulation of type I interferon production (GO:0032481),-0.18068244557200908,-0.6240757028678784,0.9920844327176781,0.9975258219868127,1.0,12/73,17.27%,IRF1;STAT1;OAS2;RNF135;MAVS;LRRFIP1;RELA;POLR2F;POLR3GL;G3BP1;TLR4;POLR2E
prerank,peptide hormone secretion (GO:0030072),-0.2219494066297148,-0.6239651723919525,0.9501084598698482,0.9970645315910783,1.0,2/26,4.34%,ANXA1;LTBP4
prerank,acyl-CoA metabolic process (GO:0006637),0.2429153029002131,0.6237139193339937,0.908273381294964,1.0,1.0,8/35,15.91%,ACSF2;BAAT;ACOT12;HMGCS1;ACOT2;GLYAT;MLYCD;ACOT7
prerank,serine family amino acid catabolic process (GO:0009071),0.3015094460167616,0.6235683593431987,0.8514644351464435,1.0,1.0,3/10,15.53%,GCSH;DAO;DLD
prerank,establishment of spindle orientation (GO:0051294),-0.21527015210704467,-0.6234704008129962,0.9428571428571428,0.9968550144868393,1.0,9/28,28.82%,GJA1;NDEL1;FBXW11;ZW10;LLGL2;NUMA1;PAFAH1B1;MISP;NDC80
prerank,methylguanosine-cap decapping (GO:0110156),-0.28384540680900316,-0.6231944458470776,0.89272030651341,0.9965034054881243,1.0,2/10,20.18%,EDC3;PNRC2
prerank,positive regulation of histone modification (GO:0031058),-0.21190443615170668,-0.6227794967196587,0.9568034557235421,0.9962388308622894,1.0,10/33,24.18%,ARRB1;BRD7;SAP30BP;TADA2A;MAPK3;CDK9;NOS1;PPARGC1A;CTBP1;BRCA1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.18239641069389143,0.6227355399637288,1.0,1.0,1.0,76/241,25.71%,CLP1;DHX15;LSM3;RBM14;NCBP2;SFPQ;CACTIN;HNRNPR;SART3;SRRM1;PAPOLA;RNPS1;POLR2C;SNRNP25;CRNKL1;TRA2A;PRPF6;PSPC1;CHERP;PCBP1;YTHDC1;SYMPK;PPIH;HNRNPA1;RBM15;SPEN;HNRNPUL1;DDX46;DDX23;HNRNPU;LSM8;UPF3B;HNRNPC;HNRNPH2;ELAVL2;PRPF31;SF3B3;SNRPD3;LSM2;RBM19;HNRNPD;CPSF7;FUS;POLR2D;SNRNP48;HNRNPA2B1;CWC27;PNN;RBMX;LSM6;SRSF9;PTBP1;PPIL3;PABPC1;DDX42;CWF19L2;SMNDC1;SRSF12;HNRNPK;DHX16;EIF4A3;GTF2F2;POLR2L;DHX35;POLR2H;EFTUD2;SRSF4;CTNNBL1;CASC3;POLR2J;SF3B2;SF3B1;CDC40;RSRC1;RBM5;ZCRB1
prerank,determination of left/right symmetry (GO:0007368),0.24065038902134261,0.6223968226509958,0.9073426573426573,1.0,1.0,3/36,10.34%,NOTCH1;PKD2;CITED2
prerank,nucleus organization (GO:0006997),0.22894473638424945,0.6223730767021747,0.9453262786596119,1.0,1.0,9/47,17.70%,SYNE1;CHMP2B;BIN1;NUP35;NDC1;CHMP3;TOR1A;WDR73;NUP133
prerank,response to amino acid starvation (GO:1990928),0.21156587838142332,0.6222375785277953,0.9547657512116317,1.0,1.0,13/72,16.73%,MAP3K5;SESN3;ATP6V0E2;CDKN1A;MTOR;NPRL3;ATP6V1B2;SEC13;NPRL2;MIOS;MAPK1;IMPACT;PRKD1
prerank,DNA duplex unwinding (GO:0032508),-0.1924174981073975,-0.6210989144649386,0.9827160493827161,0.9967397149902619,1.0,13/50,23.71%,ASCC3;ANXA1;SSBP1;CUL4A;UBB;DDB1;RPA1;RAD50;MCMDC2;RECQL;CETN2;RAD51;ERCC2
prerank,"DNA-templated transcription, termination (GO:0006353)",0.2136239706676853,0.6200031742496054,0.948073701842546,1.0,1.0,16/68,19.25%,CLP1;NCBP2;LSM10;PAPOLA;TBP;POLR1E;SYMPK;POLR1A;GTF2H5;CCNH;GTF2H1;SNRPD3;POLR1B;CPSF7;GTF2H4;MED18
prerank,organophosphate catabolic process (GO:0046434),-0.26970073591582866,-0.6199585183045033,0.9148148148148149,0.9968794714042184,1.0,7/11,47.98%,ENPP2;PLBD2;ANGPTL3;ABHD12;PLBD1;PDXP;PON1
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),0.2823172600222261,0.6195315795455366,0.8838268792710706,1.0,1.0,2/14,7.48%,NCBP2;CPSF6
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",0.25695847183024034,0.6191164882189975,0.8776290630975143,1.0,1.0,9/25,25.07%,SRRM1;PRPF6;DDX23;LSM1;SF3B3;KHSRP;SMNDC1;SRSF4;SF3B1
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.29286038760816296,0.618654950939002,0.8628230616302187,1.0,1.0,3/11,9.60%,TPK1;DCK;DCTD
prerank,insulin secretion (GO:0030073),0.2623647858838186,0.6179947016088996,0.9031007751937985,1.0,1.0,3/19,8.59%,RIMS2;MAFA;RAB11FIP2
prerank,negative regulation of phosphatase activity (GO:0010923),-0.2205641014846257,-0.6178494770096006,0.9370932754880694,0.9976408298560644,1.0,3/25,7.47%,PTPA;FKBP1A;SH3RF2
prerank,regulation of viral life cycle (GO:1903900),0.25469688781020877,0.6171773926883678,0.896551724137931,1.0,1.0,2/21,5.49%,AXL;TRIM62
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.2781956151871797,0.6170735889580373,0.8869565217391304,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.2781956151871797,0.6170735889580373,0.8869565217391304,1.0,1.0,7/15,22.32%,NANOS1;TNRC6C;TNRC6B;DHX36;CNOT1;ZFP36L1;PABPC1
prerank,negative regulation of transferase activity (GO:0051348),-0.2188950142510141,-0.6168800899641285,0.9522821576763485,0.9976887120122284,1.0,13/28,31.53%,SMAD7;DTX3L;PINX1;EIF4A2;CDKN1B;PARK7;CDKN1C;INPP5K;TP53;BAG5;ABL1;ZFP36;IRS2
prerank,telomere maintenance (GO:0000723),0.22301447187371057,0.6166489020254351,0.9438405797101449,1.0,1.0,13/50,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;XRCC3;NSMCE2;PARP1;PTGES3;SMC6;RPA2;TERF1;APEX1
prerank,regulation of sister chromatid cohesion (GO:0007063),-0.2669550445115363,-0.6162358295031432,0.9124767225325885,0.997545805761374,1.0,1/12,2.35%,HDAC8
prerank,hexose biosynthetic process (GO:0019319),0.23145561377297272,0.6161008403475328,0.9279279279279279,1.0,1.0,7/42,15.44%,PER2;SLC25A13;GOT1;ALDOC;GPI;CRY1;PCK2
prerank,regulation of microtubule polymerization (GO:0031113),0.2284128651130066,0.6160811562942501,0.9202772963604853,1.0,1.0,7/40,13.85%,MAP2;NAV3;SNCA;CAMSAP3;PAK1;TUBB4A;DCTN1
prerank,positive regulation of protein ubiquitination (GO:0031398),-0.17666850040073628,-0.6156269830146827,0.9897435897435898,0.99737147764216,1.0,23/80,28.90%,CAV1;ANGPT1;LRRK2;SMAD7;FKBP1A;BIRC3;PHF23;FANCI;UBB;SPHK1;SPSB4;ARRDC4;CDK5RAP3;FAM107A;BRCA1;PSMD10;CENPX;BCL10;FANCM;TRIB3;PTTG1IP;RPS2;LAPTM5
prerank,regulation of chromosome organization (GO:0033044),0.2605571265565091,0.6152634185045748,0.893574297188755,1.0,1.0,7/22,18.74%,LIG4;WAPL;SETMAR;RB1;SHCBP1L;PIF1;HNRNPD
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.2356737377812908,-0.6151481841703718,0.9227642276422764,0.9971383885072893,1.0,11/18,48.24%,SPEF2;ROPN1L;SPAG17;SPA17;DNAAF2;CCDC40;DNAAF4;NPHP3;OFD1;DNAAF1;ADCY10
prerank,histone exchange (GO:0043486),-0.2013988917841184,-0.6148527911349634,0.9735099337748344,0.9967948581473078,1.0,12/37,27.17%,RBBP7;CENPC;ANP32E;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;RNF8;CENPX;CENPH
prerank,regulation of defense response to virus (GO:0050688),-0.25474109317880983,-0.6132342333762112,0.9215686274509803,0.9972183732467846,1.0,7/14,33.55%,PCBP2;PPM1B;ELMOD2;RNF216;RNF26;IFNLR1;ITCH
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.29095593760322447,0.6116969691993095,0.8622881355932204,1.0,1.0,2/11,12.28%,AKAP6;RNF207
prerank,response to histamine (GO:0034776),0.290136817800724,0.6108252149638923,0.875268817204301,1.0,1.0,5/10,22.21%,GABRG2;AOC1;GABRB3;GABRB2;DRD2
prerank,negative regulation of cell communication (GO:0010648),0.25466980709114184,0.6106680538045661,0.8785578747628083,1.0,1.0,2/21,5.24%,IL1B;SOCS5
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.2294875203647188,-0.6105838773697345,0.9530332681017613,0.9982026186826058,1.0,6/20,26.43%,AMPD3;ATIC;LHPP;ADSS1;NT5C2;PAICS
prerank,lipid droplet organization (GO:0034389),0.2529151578082648,0.6101782845798083,0.9012605042016807,1.0,1.0,3/22,10.56%,CDS2;FAF2;SQLE
prerank,positive regulation of neuroblast proliferation (GO:0002052),-0.27757582805706604,-0.6093762948384347,0.9186691312384473,0.9983617256425569,1.0,6/10,39.62%,VEGFA;CTNNB1;DISC1;KDM1A;CX3CL1;CX3CR1
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.247903772900756,0.608750646048363,0.9293893129770993,1.0,1.0,6/25,19.13%,HEXIM1;TCERG1;HNRNPU;EAF2;LARP7;CDK13
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.24797700677445128,0.6087265728872832,0.8993963782696177,1.0,1.0,1/24,1.19%,NOTCH1
prerank,indolalkylamine catabolic process (GO:0046218),-0.27662745094454544,-0.6086367490220742,0.9211908931698775,0.9982528419964547,1.0,9/10,57.20%,KYNU;IL4I1;HAAO;KYAT1;AADAT;IDO2;TDO2;IDO1;ACMSD
prerank,regulation of telomere maintenance via telomerase (GO:0032210),-0.18927733781401224,-0.607318479033074,0.9722222222222222,0.9984711059651113,1.0,13/51,22.48%,TNKS2;SMG6;NAF1;PINX1;ATM;MAPK3;XRN1;MAP3K4;SMG5;NAT10;TENT4B;ACD;MAP2K7
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),-0.22679571711081875,-0.6068347216232484,0.9502982107355865,0.998187876059707,1.0,4/23,14.04%,CCDC186;KIF1B;CCDC88C;TUBA1B
prerank,oligodendrocyte differentiation (GO:0048709),-0.2285906525994891,-0.6065211590626427,0.9332023575638507,0.9978249054397512,1.0,7/19,28.49%,SLC8A3;SOX13;MYRF;EIF2B2;EIF2B5;EIF2B4;SOX10
prerank,regulation of phospholipase activity (GO:0010517),-0.2744606713768154,-0.6061916799243735,0.9057301293900185,0.9974777264431469,1.0,1/10,3.02%,FGFR2
prerank,snRNA metabolic process (GO:0016073),0.2702493407352414,0.6060732237847317,0.8924731182795699,1.0,1.0,3/17,14.00%,RBM7;INTS1;INTS12
prerank,chromatin remodeling at centromere (GO:0031055),-0.2081136123331592,-0.6059213275292635,0.9689578713968958,0.9970941944189268,1.0,10/31,27.17%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPU;CENPX;CENPH
prerank,phospholipid catabolic process (GO:0009395),-0.22378129551073717,-0.6056237029526758,0.9649890590809628,0.9967270510199353,1.0,12/24,41.11%,PLA2G4A;SMPDL3A;ENPP2;GDPD3;PLBD2;PLA2G4F;SMPD1;ANGPTL3;ABHD12;GDE1;PLBD1;PNPLA6
prerank,divalent inorganic cation homeostasis (GO:0072507),0.24817059021701565,0.6055952553009967,0.9043321299638989,1.0,1.0,3/25,6.29%,TFAP2B;ANK3;SNCA
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.26240815610607077,0.6046712258613676,0.8868312757201646,1.0,1.0,6/18,24.16%,RUVBL1;NOP10;CCT7;CCT3;EXOSC10;DKC1
prerank,synaptic vesicle membrane organization (GO:0048499),0.265468058183395,0.6045922966579554,0.8891129032258065,1.0,1.0,4/17,11.28%,SNAP25;SYNGR1;STX4;SYP
prerank,natural killer cell mediated cytotoxicity (GO:0042267),-0.23598942226883235,-0.6022539940829885,0.9426386233269598,0.9980310913885295,1.0,5/16,26.88%,CEBPG;ULBP1;RAET1E;TUBB4B;LYST
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",-0.24929783651928317,-0.6016098165845858,0.9459459459459459,0.9978371002241341,1.0,2/15,9.97%,USP46;NLGN2
prerank,kinetochore organization (GO:0051383),-0.24992539805860658,-0.6012964245520429,0.908745247148289,0.9974813755309715,1.0,8/13,36.29%,CENPC;CENPT;CENPE;CENPH;NDC80;CENPF;DLGAP5;NUF2
prerank,ribosomal large subunit assembly (GO:0000027),0.2424834293972069,0.6007438887334333,0.9171597633136095,1.0,1.0,5/24,16.43%,FASTKD2;RSL24D1;BRIX1;RPF2;MRPL20
prerank,RNA splicing (GO:0008380),0.19795536382336257,0.6007017453016834,0.9808,1.0,1.0,33/95,25.97%,DHX15;NCBP2;SFPQ;SRRM1;RNPS1;TCERG1;SNRNP25;PRPF6;CCAR2;DDX47;SCNM1;DDX23;HNRNPC;LSM1;SF3B3;SNRPD3;KHSRP;USB1;FUS;SNRNP48;PPP2R1A;LUC7L3;LSM6;PTBP1;NOL3;SMNDC1;DHX16;SRSF4;SF3B2;SF3B1;RSRC1;ZCRB1;TARDBP
prerank,purine-containing compound salvage (GO:0043101),0.28221901953991085,0.5999182801786339,0.8602620087336245,1.0,1.0,2/12,8.19%,ADK;DCK
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.24971290893337053,0.5997859316745671,0.9174852652259332,1.0,1.0,7/22,19.85%,PSMB11;PSME4;PSMB5;PSMA1;PSMB8;PSMA5;PSMB2
prerank,protein localization to synapse (GO:0035418),0.2849215446300661,0.5995815781400287,0.8285077951002228,1.0,1.0,2/12,12.65%,NRXN1;NPHS1
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.28180546563177594,0.5993560427977898,0.8884120171673819,1.0,1.0,4/11,17.60%,MTOR;IPPK;NOL11;DDX11
prerank,telomere maintenance via telomerase (GO:0007004),-0.21041313009325374,-0.5992172496277627,0.9670103092783505,0.9980575671873348,1.0,9/28,25.91%,PINX1;ANKRD28;HSP90AB1;RPA1;RAD50;RFC1;ACD;WRAP53;NHP2
prerank,cellular response to DNA damage stimulus (GO:0006974),0.16997475188233216,0.5991191295621681,1.0,1.0,1.0,70/336,17.60%,FNIP2;CBX5;RBM24;BCL2L10;FMN2;CIDEB;SPDYA;FANCF;FANCG;NUPR2;FBXO45;CBX3;TAOK3;CASP9;NCOA6;CDKN1A;ERCC4;RAD1;UBA1;SLF2;HTRA2;CBX1;LYN;MSH3;OARD1;CSNK1E;MBD4;TIMELESS;EPHA2;CGAS;ATR;SUSD6;ZDHHC16;BRSK1;AKTIP;MCM7;ETAA1;UBA6;OTUB1;PAK1;APC;PSME4;PRKDC;PARP4;CRY1;PSEN1;TANK;MUTYH;NIPBL;RAD17;ATRIP;KMT5B;BLM;PWWP3A;SUV39H1;TDP1;XRCC3;KIN;GTF2H1;PARP1;XPC;ERCC8;SMC6;MRNIP;CHD1L;FMR1;SUMO1;MASTL;APEX1;DDX11
prerank,maturation of LSU-rRNA (GO:0000470),-0.21864201482074974,-0.598393106968036,0.9616858237547893,0.9979335354889521,1.0,9/26,31.88%,NSA2;RPL7;RPL10A;MRPL1;FTSJ3;NHP2;MAK16;RPF1;URB1
prerank,body fluid secretion (GO:0007589),-0.2381715478054227,-0.5980874652113337,0.9258589511754068,0.9975877640882992,1.0,2/15,6.82%,NPR1;SLC22A4
prerank,regulation of protein neddylation (GO:2000434),0.28509250175042766,0.5962078711281844,0.8727678571428571,1.0,1.0,5/10,24.23%,EPAS1;DCUN1D2;DCUN1D4;DCUN1D1;RPL5
prerank,phagosome maturation (GO:0090382),0.22711564906836507,0.5960195335277063,0.9327272727272727,1.0,1.0,6/35,10.28%,MREG;ATP6V0E2;PIKFYVE;CORO1A;RAB38;ATP6V1B2
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),-0.20559186425092407,-0.5958409255521158,0.9719222462203023,0.9982284529344192,1.0,9/32,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,mismatch repair (GO:0006298),-0.21200565805727686,-0.595449087956807,0.9672131147540983,0.9979082372591469,1.0,9/27,30.97%,TDG;RPA1;ERCC1;MSH6;RPA3;POLD1;ABL1;PCNA;EXO1
prerank,fatty acid biosynthetic process (GO:0006633),-0.17750209183090576,-0.595432134204161,0.9855421686746988,0.997390404760234,1.0,13/63,23.82%,ELOVL7;HACD4;HACD3;GPX4;ACACA;PTGS2;EPHX2;ELOVL1;ALOX12;HSD17B8;XBP1;LPL;OXSM
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.20024078170218232,0.5954257132371116,0.9773462783171522,1.0,1.0,5/86,6.74%,LIMD1;RBX1;EPAS1;PSMB11;PSMF1
prerank,negative regulation of protein transport (GO:0051224),0.245080773889479,0.5953626557818642,0.8996212121212122,1.0,1.0,5/25,14.71%,RHBDF1;NDFIP2;CSK;ERP29;HMGCR
prerank,chromosome condensation (GO:0030261),0.22877310137559909,0.594915264402865,0.9376114081996435,1.0,1.0,13/36,26.86%,GPER1;NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;BANF2;BANF1;CSNK2A1;NCAPD2
prerank,resolution of meiotic recombination intermediates (GO:0000712),0.267712127124752,0.5944914477688463,0.9045553145336226,1.0,1.0,3/16,9.38%,MEIOB;ERCC4;HFM1
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2644559370192099,-0.5937450747600044,0.9214953271028037,0.9977145681937531,1.0,5/11,29.36%,TIMM13;TIMM8B;TIMM9;NDUFA13;TIMM10
prerank,quinone biosynthetic process (GO:1901663),0.276567449188233,0.5923724765538284,0.8928571428571429,1.0,1.0,4/14,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,histone H2A monoubiquitination (GO:0035518),0.2593391776394486,0.5914193962728213,0.9049586776859504,1.0,1.0,5/17,16.09%,RYBP;KDM2B;SKP1;BMI1;TRIM37
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.19168823088219392,0.5911634349425349,0.9907692307692307,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,cellular response to lectin (GO:1990858),0.19168823088219392,0.5911634349425349,0.9907692307692307,1.0,1.0,23/104,21.19%,BTRC;CLEC10A;PSMB11;CARD9;PSMF1;HRAS;LYN;PAK3;PAK1;EP300;PSME4;SRC;TRAF6;SKP1;PSMB5;RELB;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;CREBBP;TAB3
prerank,regulation of DNA recombination at telomere (GO:0072695),-0.22635195682832132,-0.5909506034715813,0.9497991967871486,0.9980054112877187,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,negative regulation of DNA recombination at telomere (GO:0048239),-0.22635195682832132,-0.5909506034715813,0.9497991967871486,0.9980054112877187,1.0,5/19,24.60%,POLR2A;POLR2F;POLR2E;ACD;POLR2G
prerank,lipoprotein localization (GO:0044872),-0.2641565420173259,-0.5906930795849303,0.93,0.9976091378656252,1.0,2/11,12.72%,PRKCB;UNC119B
prerank,regulation of mitochondrion organization (GO:0010821),0.21898133811225423,0.5905556085434018,0.9522935779816514,1.0,1.0,5/47,12.39%,PID1;SREBF2;HTRA2;EP300;MFF
prerank,termination of RNA polymerase I transcription (GO:0006363),-0.20380849885945254,-0.5901202358242698,0.9749478079331941,0.997368407594406,1.0,11/30,30.61%,CAVIN1;POLR2F;POLR2E;UBTF;TTF1;ERCC2;CDK7;ERCC3;POLR1C;MNAT1;GTF2H3
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2639771096849122,0.5900889582127308,0.8966942148760331,1.0,1.0,5/16,17.80%,RBM24;DND1;DHX36;RC3H1;KHSRP
prerank,tyrosine metabolic process (GO:0006570),0.2794449299105608,0.5897040055079437,0.8814968814968815,1.0,1.0,2/11,19.04%,TYR;THAP4
prerank,protein K63-linked deubiquitination (GO:0070536),0.23743540729421703,0.5892466729991527,0.9418386491557224,1.0,1.0,5/31,17.22%,USP25;OTUD5;USP50;USP33;OTUD7B
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.2144202068902049,-0.5881988640522249,0.9588477366255144,0.9977428262808481,1.0,2/23,8.51%,LGALS9;PIK3R6
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.26212781927465284,-0.5878065104406153,0.9343629343629344,0.9974148176613327,1.0,2/11,13.32%,MFHAS1;CYBA
prerank,sensory perception of pain (GO:0019233),-0.2195166030904899,-0.5877336451318645,0.9605263157894737,0.9969293368000168,1.0,11/21,38.55%,P2RX4;P2RX7;RETREG1;PTGES;TRPA1;CCR2;CCL2;KCNK4;OPRL1;ALOXE3;PROK2
prerank,transcription preinitiation complex assembly (GO:0070897),0.2769267370223795,0.5867476899014422,0.8921161825726142,1.0,1.0,5/12,22.69%,TBP;POLR1E;TAF7L;DR1;TAF7
prerank,negative regulation of interferon-beta production (GO:0032688),-0.26148979839362274,-0.5864618249169048,0.9325842696629213,0.9970178347020454,1.0,4/10,26.08%,PPM1B;SIRPA;REL;PTPRS
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),-0.26231780728652576,-0.5859168487999417,0.9315589353612167,0.996749327610074,1.0,5/10,30.28%,PARP14;PTPN2;PIBF1;SOCS1;INPP5F
prerank,positive regulation by host of viral transcription (GO:0043923),-0.2331330136645985,-0.5858342861967204,0.9523809523809523,0.9962778443405576,1.0,5/15,28.98%,LEF1;SMARCA4;TAF11;CTDP1;JUN
prerank,DNA modification (GO:0006304),-0.21522457001546402,-0.5856368897471649,0.9705263157894737,0.9958525195731247,1.0,7/22,26.83%,PARP3;TDG;EXOSC5;ACD;NEIL3;NEIL1;NTHL1
prerank,intracellular protein transmembrane transport (GO:0065002),0.21751634406667053,0.5844226368367377,0.9488636363636364,1.0,1.0,20/42,28.05%,PEX7;PEX1;GRPEL2;TOMM40L;TIMM23;TOMM40;PEX12;PEX2;SEC61A2;TOMM70;DNAJC19;PEX5;PAM16;PEX6;TIMM17A;ZFAND2B;DNLZ;TIMM17B;SEC62;CHCHD4
prerank,DNA-dependent DNA replication (GO:0006261),-0.15279412686228683,-0.583907989698967,1.0,0.9961339076671811,1.0,51/128,36.85%,BAZ1A;SSBP1;PSME2;PSMB4;UBB;CDK2AP1;PSMB1;PSMD11;PSMD8;RPA1;DBF4;PSME3;SIRT7;PSMD4;PSMA2;MCMDC2;RFC3;TEFM;PSMD3;RECQL;PSMB7;POLE2;RFC1;MCM8;RAD51;CDC45;PSMC2;PSMC5;RPA3;PSMD10;SRPK2;POLA1;POLD1;PSMD7;PRIM2;MCM3;POLE3;WRN;MCM5;MCM10;RFC5;PSMD12;PSMB9;PSMA8;RECQL5;CDC34;TWNK;TOPBP1;PRIMPOL;CDC6;GINS2
prerank,positive regulation of chromatin organization (GO:1905269),-0.24822525287866987,-0.5837380315043261,0.9467889908256881,0.9956740125636382,1.0,4/12,22.33%,H3-3A;TAL1;SIN3A;ACD
prerank,purine nucleotide biosynthetic process (GO:0006164),-0.24441272256040047,-0.5834509668437462,0.9348230912476723,0.9952870799702969,1.0,3/12,18.29%,PRPS2;PRPS1;PRPS1L1
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.24713495855756037,0.5834193420853119,0.9334719334719335,1.0,1.0,4/20,19.88%,PSMG3;PTGES3;PSMG2;HOPX
prerank,mitochondrial fission (GO:0000266),0.258517011612618,0.5828858881045828,0.9134199134199135,1.0,1.0,5/16,17.53%,MTFP1;MFF;MTFR1;MIEF1;DNM1
prerank,regulation of chromosome segregation (GO:0051983),-0.23370863800242314,-0.5824985952374613,0.9520295202952029,0.9952025966491103,1.0,11/16,50.85%,PUM1;NUMA1;RMI2;MKI67;CDC6;BUB1;IHO1;KIF2C;AURKB;PUM2;HORMAD1
prerank,stress granule assembly (GO:0034063),0.24669397031673335,0.5818835063823478,0.9141716566866267,1.0,1.0,6/20,17.42%,YTHDF3;DDX3X;YTHDF2;LSM14A;PRRC2C;OGFOD1
prerank,regulation of immunoglobulin production (GO:0002637),-0.21292843056582134,-0.5818303740044993,0.9639278557114228,0.9949996654090274,1.0,4/23,22.38%,RBP4;EPHB2;XBP1;CLCF1
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.2743685138295548,0.5814894545306035,0.8769230769230769,1.0,1.0,4/11,24.16%,FBLL1;LARP7;EXOSC10;DKC1
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),-0.23530360758354607,-0.579794294588091,0.9456521739130435,0.995369474264499,1.0,7/15,32.07%,RAB3GAP1;RAB3GAP2;SPCS1;SEC61A1;EDEM1;SRP14;SPCS2
prerank,rRNA modification (GO:0000154),0.24762559305960874,0.5797709533030899,0.8983402489626556,1.0,1.0,9/21,24.16%,FBLL1;NSUN3;NOP10;TFB2M;GAR1;DIMT1;TSR3;THUMPD1;DKC1
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.23052943825761707,0.5792245053737922,0.9473684210526315,1.0,1.0,6/29,11.00%,WDR46;RRP36;TBL3;NOP14;TSR2;UTP4
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),-0.2486552350408928,-0.5790316150693441,0.9453551912568307,0.9951958332664321,1.0,4/12,25.85%,CCND1;RPS27L;PLK5;TP53
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.21011947571455777,-0.5789549012262662,0.9607072691552063,0.9947127955384001,1.0,8/23,28.82%,GJA1;NDEL1;FBXW11;ZW10;NUMA1;PAFAH1B1;MISP;NDC80
prerank,lipoprotein transport (GO:0042953),-0.2647072853407737,-0.5781108781164179,0.9319066147859922,0.9945577412977823,1.0,2/10,12.72%,PRKCB;UNC119B
prerank,regulation of exit from mitosis (GO:0007096),0.2186221279269936,0.5772921200019482,0.9708029197080292,1.0,1.0,6/38,15.10%,RGCC;UBE2E1;CDC14B;ANAPC2;ANAPC7;MAD2L1
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),-0.2373432378783316,-0.5772467385089224,0.9539594843462247,0.9944022660860528,1.0,6/15,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,centromere complex assembly (GO:0034508),-0.18941352948838275,-0.5758119529814981,0.9782135076252724,0.994490269977734,1.0,12/36,28.92%,RBBP7;CENPC;CENPT;CENPK;RSF1;HJURP;CENPL;CENPE;CENPU;CENPX;CENPH;CENPF
prerank,protein monoubiquitination (GO:0006513),0.2247786045717426,0.5750934995208388,0.9309701492537313,1.0,1.0,6/36,15.58%,CUL3;RBX1;UBE2E1;KLHL12;CTR9;PEX12
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.2459693880645741,0.5739744634195396,0.9258474576271186,1.0,1.0,4/16,13.89%,ACKR3;CCAR2;SNAI2;SFRP2
prerank,double-strand break repair via homologous recombination (GO:0000724),0.18965173538006355,0.5724906091026739,0.9924242424242424,1.0,1.0,21/95,17.06%,FANCB;GINS4;SFPQ;MCM6;MEIOB;REC8;ERCC4;PALB2;AUNIP;MCM7;MCM2;REV3L;NIPBL;SEM1;BLM;XRCC3;NSMCE2;PARP1;RNF138;SMC6;RPA2
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.23917857071934268,0.5712408076974795,0.9075975359342916,1.0,1.0,3/17,13.54%,ALG12;ALG1;DHDDS
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.25777715575449833,0.5705370322217955,0.9111570247933884,1.0,1.0,3/15,13.00%,DDX3X;CPTP;USP50
prerank,7-methylguanosine RNA capping (GO:0009452),0.22517013172126207,0.5671375241022983,0.95,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,7-methylguanosine mRNA capping (GO:0006370),0.22517013172126207,0.5671375241022983,0.95,1.0,1.0,13/31,24.91%,NCBP2;POLR2C;RNMT;GTF2H5;CCNH;GTF2H1;POLR2D;GTF2H4;RNGTT;GTF2F2;POLR2L;POLR2H;POLR2J
prerank,acyl-CoA biosynthetic process (GO:0071616),0.24620010354986455,0.5645131428271463,0.9518828451882845,1.0,1.0,3/16,15.35%,PPT1;PPT2;MLYCD
prerank,protein sumoylation (GO:0016925),-0.17750467168397446,-0.5640439216877127,0.9952267303102625,0.9986844995316669,1.0,12/49,25.93%,EYA1;STX1A;SAE1;NUP98;TPR;NUP88;PIAS4;NUP214;TRPM4;NUP37;PIAS3;NUP155
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),-0.1986080435869546,-0.5635320771921138,0.9757085020242915,0.9983619776334782,1.0,20/29,49.42%,STX7;CYRIB;TYROBP;RAET1E;ITGAM;PVR;FADD;NOS2;SLAMF6;CD226;IL12A;CRTAM;STAP1;IL23A;KLRD1;CD160;SPI1;LAMP1;KLRK1;IL23R
prerank,purine-containing compound biosynthetic process (GO:0072522),0.23237984747664922,0.5624288057664779,0.9236947791164659,1.0,1.0,4/25,10.64%,ADK;ADSL;DCK;PPAT
prerank,tricarboxylic acid metabolic process (GO:0072350),-0.23453102646968116,-0.5620490586493313,0.9425925925925925,0.9984071039655371,1.0,5/12,30.18%,ACO1;IDH3G;ASS1;SIRT4;IDH3B
prerank,phagolysosome assembly (GO:0001845),0.25699388078515173,0.5619923211495528,0.94375,1.0,1.0,2/12,8.41%,PIKFYVE;CORO1A
prerank,ubiquinone biosynthetic process (GO:0006744),0.2567101696536438,0.5602332113486095,0.919661733615222,1.0,1.0,4/15,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,negative regulation by host of viral transcription (GO:0043922),-0.2402438256044006,-0.5598525425895399,0.953307392996109,0.998678149616423,1.0,8/12,52.82%,HDAC1;INPP5K;JUN;CCL5;CCL4;CCL3;POU2F3;REST
prerank,protein methylation (GO:0006479),0.20872701640070784,0.5597889575865231,0.9671179883945842,1.0,1.0,12/40,21.24%,METTL21A;EEF1AKMT1;PRMT1;METTL22;PRMT3;PRMT7;SETD3;FAM98A;SNRPD3;NSD3;ATPSCKMT;NTMT1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2282232176514694,0.5597428401856609,0.933579335793358,1.0,1.0,6/27,15.62%,AK8;RRM1;DCTD;AK7;AK5;AK4
prerank,regulation of fatty acid beta-oxidation (GO:0031998),0.2550148197825215,0.5593207482895943,0.9215686274509803,1.0,1.0,2/14,7.19%,ABCD2;IRS1
prerank,ubiquinone metabolic process (GO:0006743),0.2552811040637504,0.5588985149483318,0.9287211740041929,1.0,1.0,4/15,20.48%,COQ2;COQ8A;PDSS1;FDXR
prerank,protein K63-linked ubiquitination (GO:0070534),-0.180831342214585,-0.5585443836192345,0.9913419913419913,0.9986168173474619,1.0,17/41,33.55%,WWP2;UBE2E2;RNF135;TRIM27;RNF115;PELI1;TRAF3IP2;RNF126;RNF8;BFAR;PRKN;PRPF19;NEDD4;UBE2V1;TRIM21;RNF152;ITCH
prerank,receptor recycling (GO:0001881),-0.2501562381550104,-0.5578551751653995,0.9402173913043478,0.9983466452597348,1.0,3/10,17.96%,PHETA1;ARFGEF2;REP15
prerank,microtubule depolymerization (GO:0007019),0.23988392298565667,0.5566145272851565,0.9294871794871795,1.0,1.0,1/17,3.36%,NCKAP5
prerank,microtubule-based transport (GO:0099111),-0.24468984593214968,-0.5564997164967562,0.9556451612903226,0.9983191876512756,1.0,8/12,39.68%,SPEF2;ROPN1L;SPAG17;DYNC1I1;SPA17;DNAAF2;CCDC40;DNAAF4
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.248053741838272,0.5561437256361449,0.9202453987730062,1.0,1.0,14/14,75.22%,CLP1;TSEN15;DDX1;FAM98B;CPSF4;RTRAF;CSTF2;RTCB;TSEN54;TRPT1;ZBTB8OS;CPSF1;TSEN34;TSEN2
prerank,L-serine metabolic process (GO:0006563),-0.253030520385627,-0.5550362136939874,0.9523809523809523,0.9983334958885367,1.0,3/10,19.56%,CBS;SERINC3;SERINC5
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.1941917842965999,-0.5550272720720938,0.9800884955752213,0.9978205482251585,1.0,10/29,27.39%,THRAP3;NOCT;TENT5A;LARP1;ELAVL1;E2F1;TENT5C;DHX34;EIF4ENIF1;GDNF
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.20940846603842334,-0.5549941798026066,0.9565217391304348,0.9973162387663024,1.0,2/20,12.16%,AKR1B1;STARD3
prerank,reticulophagy (GO:0061709),-0.2386513274179678,-0.5539056728179985,0.9480286738351255,0.9971973440099297,1.0,3/12,16.45%,ULK2;RETREG1;ATG2A
prerank,histone H2B ubiquitination (GO:0033523),-0.24665707842409534,-0.5537207069787353,0.9675675675675676,0.99674247122015,1.0,4/10,30.79%,DTX3L;RNF40;RNF8;PAF1
prerank,protein localization to kinetochore (GO:0034501),-0.22545938743564675,-0.5533196571569607,0.9636015325670498,0.9963672803537409,1.0,3/14,15.46%,ZW10;IK;CENPT
prerank,synaptic vesicle exocytosis (GO:0016079),0.21115555927745944,0.5529458169172059,0.9568345323741008,1.0,1.0,7/40,11.38%,SNAP25;RIMS1;RIMS2;SNCA;SYT1;STX4;SYT2
prerank,RNA modification (GO:0009451),0.19926358302747246,0.5522866272595439,0.9786856127886323,1.0,1.0,12/54,17.95%,NSUN3;TRMT61A;TRUB1;SSB;TRMT1;RBM15;NOP10;PUS7;ELP5;NSUN2;NSUN5;AARS1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.2396361912798217,0.5519304754097708,0.9345991561181435,1.0,1.0,1/16,4.79%,AP1G1
prerank,telomere organization (GO:0032200),0.20475227362449386,0.5515358706656998,0.9596330275229358,1.0,1.0,10/43,17.43%,DCLRE1B;ERCC4;ATR;PRKDC;BLM;PARP1;PTGES3;RPA2;TERF1;APEX1
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.1566192440543053,-0.5513542220790291,0.9974937343358395,0.9965258690489107,1.0,21/84,24.71%,CDC16;PSME2;ANAPC4;PSMB4;UBB;PSMB1;PSMD11;PSMD8;PSME3;ANAPC16;PSMD4;FZR1;PSMA2;PSMD3;CDC27;PSMB7;ANAPC5;ECRG4;PSMC2;PSMC5;PSMD10
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",0.2160300334038705,0.5491707487191995,0.9617590822179732,1.0,1.0,10/29,20.33%,RBX1;GTF2H5;CCNH;GTF2H1;PARP1;XPC;CHD1L;RPA2;GTF2H4;DDB2
prerank,mitochondrial translation (GO:0032543),0.17623572089428216,0.549106756958414,0.9969604863221885,1.0,1.0,28/104,21.58%,FASTKD2;NOA1;MRPS27;MTIF2;MRPL55;MRPL58;GATB;GFM2;MRPS30;PTCD3;IARS2;GFM1;GATC;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL37;MRPL2;MRPL11;TSFM;MRPS15
prerank,regulation of cellular response to stress (GO:0080135),0.17721239284586013,0.54907468081549,1.0,1.0,1.0,26/115,18.00%,ADCY8;CORO2B;NUP43;AJUBA;CASP9;AKT1S1;MTOR;NUP35;CCAR2;NEK6;ATR;DYRK3;DNAJC7;SEC13;NUAK1;NDC1;EP300;RANBP2;RSL1D1;CAMK2G;PTGES3;MAPK1;RPA2;HSF1;NUP133;GSK3B
prerank,mitotic metaphase plate congression (GO:0007080),0.1994221936014421,0.5486266546547768,0.9877408056042032,1.0,1.0,4/51,6.20%,RMDN1;CUL3;CHAMP1;CHMP2B
prerank,B cell activation involved in immune response (GO:0002312),-0.23369435474476008,-0.5484480764128841,0.9662027833001988,0.9969459427716835,1.0,3/13,23.82%,CD180;MSH6;RNF8
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.218793324255631,0.5476784543399855,0.9663551401869159,1.0,1.0,7/32,15.97%,CDK15;DHFR;NPAT;RB1;CDK14;CDK5;CCNE1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.25903282981243764,0.5476749974690458,0.9317697228144989,1.0,1.0,4/10,23.88%,LYN;MAPK1;NBR1;GREM1
prerank,ERAD pathway (GO:0036503),0.18670789915321734,0.5465868225598541,0.9965986394557823,1.0,1.0,16/83,16.33%,FAM8A1;DERL3;FAF2;FOXRED2;UGGT2;SGTB;UBE2J2;ERLIN1;GET4;RNF121;UBXN6;UBQLN2;DNAJC18;RNF103-CHMP3;TMUB2;TOR1A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.21488022642381954,0.5462181749806821,0.9737335834896811,1.0,1.0,7/34,15.15%,GRAMD4;CD300A;CACTIN;LYN;SARM1;LRRC14;NFKBIL1
prerank,RNA biosynthetic process (GO:0032774),-0.18828288278404726,-0.5454179643353942,0.9810126582278481,0.9974192712381577,1.0,9/31,27.72%,POLR2A;TBPL1;BRF2;RSF1;TTF1;TAF5;POLA1;NAT14;PRIM2
prerank,tRNA modification (GO:0006400),0.19038037144133882,0.5449418933682744,0.9915397631133672,1.0,1.0,18/62,24.31%,TRMT61A;TRMT5;TRUB1;SSB;TRMT1;THUMPD2;PUS7;ELP5;MTO1;NSUN2;AARS1;ALKBH1;METTL6;THUMPD1;GTPBP3;TRMT10A;TRMT9B;TRDMT1
prerank,glycolytic process (GO:0006096),0.2133191245578191,0.5443670903565105,0.949814126394052,1.0,1.0,9/28,24.37%,GCK;ALDOC;GPI;PFKM;PKM;ENO2;PGM1;PFKFB2;PGK1
prerank,organelle disassembly (GO:1903008),0.20986377595959824,0.5428097933403125,0.9651376146788991,1.0,1.0,6/33,14.04%,PELO;MTIF2;UFM1;DYRK3;GFM2;ATG2B
prerank,tRNA wobble base modification (GO:0002097),-0.22158978693003473,-0.5425707919150918,0.9682539682539683,0.9978176790851457,1.0,6/14,36.29%,ELP3;URM1;KTI12;ADAT2;CTU2;CTU1
prerank,long-term memory (GO:0007616),-0.2101801709926212,-0.5414910423125763,0.9772296015180265,0.9976407083650335,1.0,1/19,1.96%,APOE
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.22839151165325072,0.539802907405929,0.9573643410852714,1.0,1.0,8/21,25.65%,NES;TOX;SMARCD3;NAP1L1;FZD9;DRD2;FZD3;DISP3
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.20067013718849613,-0.5396012004976107,0.9823874755381604,0.9976835287063709,1.0,5/22,22.50%,TOM1L1;RNF115;VPS28;RNF126;VPS37D
prerank,"base-excision repair, AP site formation (GO:0006285)",-0.2140125359691398,-0.5392838153024002,0.9777327935222672,0.9972706066769788,1.0,6/17,26.83%,ERCC5;TDG;ACD;NEIL3;NEIL1;NTHL1
prerank,positive regulation of histone deacetylation (GO:0031065),0.24349256285930054,0.5378041120738966,0.9521739130434783,1.0,1.0,5/12,22.91%,PRKD2;NIPBL;PRKD1;AKAP8;AKAP8L
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.23037355951967153,0.5368121796629914,0.9560669456066946,1.0,1.0,1/17,4.79%,AP1G1
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.2251222375470508,-0.5363113257873567,0.9596153846153846,0.9976538756580442,1.0,1/12,6.61%,PRKCB
prerank,snRNA transcription by RNA polymerase II (GO:0042795),-0.15852793721020356,-0.5350404376195773,1.0,0.9975199411731708,1.0,16/69,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2120101306331511,0.5342296430590738,0.9671179883945842,1.0,1.0,6/24,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,canonical glycolysis (GO:0061621),0.2120101306331511,0.5342296430590738,0.9671179883945842,1.0,1.0,6/24,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.23551202360771023,0.5321371759484673,0.9375,1.0,1.0,15/15,76.47%,FANCD2;RAD17;MDC1;MUS81;TIPIN;RAD9A;MRE11;EME2;RAD9B;EME1;NEK11;HUS1B;HUS1;ATF2;CHEK2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.23298601731903518,0.5306145280835953,0.9414225941422594,1.0,1.0,1/17,2.89%,EMC7
prerank,snRNA transcription (GO:0009301),-0.1574191162399336,-0.530097394357352,1.0,0.9983617097576915,1.0,16/70,26.26%,POLR2A;NABP1;POLR2F;INTS11;POU2F1;CDK9;RPRD2;POLR2E;POU2F2;TAF5;ICE1;INTS5;POLR2G;CDK7;SNAPC4;TAF11
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),-0.2041192517535217,-0.5298937737696175,0.9655831739961759,0.9979142178793238,1.0,11/18,52.86%,BID;TMEM14A;ZNF205;HIP1R;BAX;SLC25A5;GSK3A;BOK;MPV17L;TMEM102;MUL1
prerank,DNA catabolic process (GO:0006308),-0.23059028881420687,-0.5293232700435324,0.9646840148698885,0.9975533793557185,1.0,3/11,21.23%,REXO4;DNASE1L1;DFFB
prerank,DNA replication checkpoint signaling (GO:0000076),0.23433379379630814,0.5275232662563631,0.9550102249488752,1.0,1.0,16/16,76.59%,TIMELESS;RAD17;TIPIN;DNA2;RAD9A;NAE1;CLSPN;ORC1;RAD9B;CDT1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;CDC45
prerank,meiosis I (GO:0007127),0.2226804544689297,0.5264677675317427,0.9577464788732394,1.0,1.0,4/23,15.65%,MEIOB;BRDT;PTTG1;SLC25A31
prerank,positive regulation of telomere capping (GO:1904355),-0.20867336319717317,-0.5256509507645383,0.9759519038076152,0.9980113309284812,1.0,5/17,26.85%,TNKS2;MAPK3;MAP3K4;MAP2K7;NEK7
prerank,regulation of T cell activation (GO:0050863),0.2007331169070834,0.5254347252989229,0.9796672828096118,1.0,1.0,2/42,3.86%,PTPN22;PAG1
prerank,dendritic cell chemotaxis (GO:0002407),-0.21608772231344567,-0.5238025459373166,0.9764243614931237,0.9979607916951149,1.0,8/14,42.45%,TRPM4;CCL19;TRPM2;CCR2;CXCR4;PIK3CG;CCL5;CCR1
prerank,negative regulation of DNA recombination (GO:0045910),-0.17014888531109984,-0.5233472687921645,0.9952941176470588,0.9975603225882812,1.0,11/43,24.60%,POLR2A;PARP3;POLR2F;SHLD1;POLR2E;ACD;RMI2;KLHL15;MSH6;PARPBP;POLR2G
prerank,peptidyl-lysine trimethylation (GO:0018023),0.2040351910406731,0.5220449773060986,0.9664031620553359,1.0,1.0,9/26,19.72%,OGT;CTR9;SETD3;KMT5B;SUV39H1;KMT2A;KMT2D;SETD5;ATPSCKMT
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.2268963152428901,0.5208879726446335,0.9707112970711297,1.0,1.0,2/15,10.41%,CUL3;DYRK3
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.19392318907298328,-0.5204324676463363,0.96900826446281,0.9977830268322867,1.0,9/22,34.32%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.2050439364770896,0.5176182123960109,0.9785992217898832,1.0,1.0,6/25,18.62%,GCK;ALDOC;GPI;PFKM;PKM;ENO2
prerank,regulation of interferon-beta production (GO:0032648),-0.16645209133537187,-0.517522099963304,1.0,0.9979470413247016,1.0,11/46,26.08%,IRF1;OAS2;RNF135;MAVS;PPM1B;SIRPA;TLR4;POLR3D;RNF216;REL;PTPRS
prerank,synaptic vesicle transport (GO:0048489),-0.22298935335171038,-0.5172171887711025,0.9723865877712031,0.997516832881672,1.0,2/11,16.11%,RAB27A;SYNJ1
prerank,"phototransduction, visible light (GO:0007603)",-0.21316236831435292,-0.5171798193129075,0.9782608695652174,0.9970126311933247,1.0,3/14,26.06%,ABCA4;RP1;GNAQ
prerank,transcription by RNA polymerase III (GO:0006383),-0.18415956240814346,-0.5162022753167916,0.9897540983606558,0.9967258368319529,1.0,7/27,26.26%,IVNS1ABP;POLR3GL;GTF3C2;GTF3C5;GTF3C1;ICE1;SNAPC4
prerank,pyruvate metabolic process (GO:0006090),0.18237054456800408,0.5154035982936417,0.9894736842105263,1.0,1.0,10/52,16.87%,SLC16A3;GCK;ALDOC;PDHX;SRR;GPI;PFKM;PCK2;DLD;PKM
prerank,negative regulation of lipid catabolic process (GO:0050995),0.2235260171401511,0.5130019282260018,0.9614604462474645,1.0,1.0,1/17,2.62%,IL1B
prerank,low-density lipoprotein particle remodeling (GO:0034374),0.2393270997743436,0.5123146554505228,0.9698275862068966,1.0,1.0,1/11,6.95%,LIPC
prerank,chromatin disassembly (GO:0031498),0.22881988119154406,0.5120512150375203,0.9696356275303644,1.0,1.0,4/14,19.37%,SET;SMARCD3;NFE2;SMARCD1
prerank,nucleosome disassembly (GO:0006337),0.22881988119154406,0.5120512150375203,0.9696356275303644,1.0,1.0,4/14,19.37%,SET;SMARCD3;NFE2;SMARCD1
prerank,"base-excision repair, gap-filling (GO:0006287)",-0.17203412012494904,-0.5116533061063907,0.9956331877729258,0.9972481162361991,1.0,11/35,32.01%,TDG;RPA1;ADPRS;RFC3;RFC1;RPA3;NEIL1;NTHL1;POLD1;PCNA;RFC5
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),-0.19114760997844438,-0.5112893336345321,0.9848197343453511,0.9968174291916884,1.0,3/21,13.57%,RAB11A;RAD51B;CCND1
prerank,phosphate ion transmembrane transport (GO:0035435),-0.2152519067199599,-0.5112729739820802,0.9813780260707635,0.9963111863626489,1.0,4/12,27.90%,SLC20A2;SLC37A1;SLC37A2;SLC25A11
prerank,iron-sulfur cluster assembly (GO:0016226),-0.18533568745670173,-0.5104186716493289,0.9838383838383838,0.9960156268785139,1.0,11/24,39.44%,MMS19;ISCA2;CIAPIN1;NUBP1;HSPA9;CIAO2B;IBA57;NUBP2;CIAO2A;GLRX3;NFS1
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.17588088381233402,0.5091918508184472,0.9966329966329966,1.0,1.0,17/70,19.85%,TCF15;PSMB11;N4BP2L2;PSMF1;MYB;TCF12;YTHDF2;PSME4;PRKDC;PUS7;KMT2A;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.2445599602723449,0.508505362321829,0.951048951048951,1.0,1.0,3/10,14.23%,VPS9D1;ATP5F1A;ATP5PO
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),-0.18213304063858615,-0.5077760073834312,0.9897330595482546,0.996102813868809,1.0,1/27,1.24%,LPAR1
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.23546767106089161,0.5075781688349943,0.9437229437229437,1.0,1.0,12/12,76.47%,SETMAR;RAD17;NAE1;CLSPN;ORC1;TICRR;CDC6;TOPBP1;HUS1B;HUS1;STK33;CHEK2
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),-0.1835703756436214,-0.5070865989623231,0.9961013645224172,0.9957426225524494,1.0,8/24,28.31%,CXCL12;TPT1;SNAI1;TAF9B;BCL2L1;CD44;CDKN2D;CLU
prerank,histone H3-K4 methylation (GO:0051568),0.2001702479569012,0.5050800034585479,0.9738955823293173,1.0,1.0,7/26,19.14%,OGT;KMT2B;SETMAR;CTR9;KMT2A;KMT2D;WDR5
prerank,outer dynein arm assembly (GO:0036158),0.23298593671521856,0.504771813906239,0.9584199584199584,1.0,1.0,14/14,76.72%,CCDC63;ODAD4;DNAH5;LRRC49;DNAAF5;ZMYND10;DNAAF1;ODAD1;DNAAF4;DNAH17;DNAL1;ODAD3;ODAD2;DNAH8
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.21820447653611763,0.503300668307287,0.9655913978494624,1.0,1.0,6/17,23.94%,CHAMP1;RB1;CENPA;SPDL1;MTBP;ZWILCH
prerank,steroid hormone biosynthetic process (GO:0120178),0.1997629148643112,0.5031182866250549,0.968503937007874,1.0,1.0,5/29,13.32%,MED1;DHCR7;STAR;SRD5A1;CYP11B1
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",-0.20146997419247664,-0.5024613919943502,0.9812734082397003,0.9961235289787088,1.0,6/17,31.02%,HSP90B1;NPLOC4;VCP;SEC61B;SYVN1;AUP1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),-0.16922141603040325,-0.5009088963618825,0.9955555555555555,0.9959170081920872,1.0,9/35,26.85%,TNKS2;NAF1;ATM;MAPK3;MAP3K4;ACD;MAP2K7;CTNNB1;NEK7
prerank,microglial cell activation (GO:0001774),-0.19471083269993242,-0.5006566963665117,0.9897750511247444,0.995457772798334,1.0,1/21,2.11%,APP
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",0.21540780224021527,0.4992014397666035,0.9636363636363636,1.0,1.0,5/16,23.01%,TRA2A;DAZAP1;RBMX;RBM3;CIRBP
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),0.2125857932733155,0.4990965683768093,0.9631901840490797,1.0,1.0,2/19,8.19%,ADK;DCK
prerank,male meiosis I (GO:0007141),0.22428732889614456,0.49847023402135743,0.9570815450643777,1.0,1.0,16/16,77.59%,BRDT;SLC25A31;FOXJ3;ING2;FOXJ2;ZSCAN21;BTBD18;MEIOC;DNMT3L;CCNA1;MOV10L1;MYBL1;DDX4;TDRD9;SYCP3;HSF2BP
prerank,replication fork processing (GO:0031297),-0.16437504736274172,-0.49611449883584247,0.9957805907172996,0.9958086358877895,1.0,21/38,47.06%,SAMHD1;BRCA2;CDK9;THOC1;RAD51;CENPX;FANCM;WRN;PCNA;FAM111A;ATRX;PRIMPOL;ZRANB3;ALYREF;NUCKS1;EME1;GEN1;TONSL;RTEL1;CENPS;MMS22L
prerank,mRNA transport (GO:0051028),0.160326413070819,0.4957520917524456,0.9984871406959153,1.0,1.0,29/101,25.17%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;KIF5C;UPF3B;EIF4E;RANBP2;ZC3H11A;FMR1;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;ZFP36L1;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.21891659199903807,0.49542191585047385,0.9621513944223108,1.0,1.0,4/16,14.31%,MCM6;MCM7;MCM2;BLM
prerank,regulation of DNA recombination (GO:0000018),0.19498698453101976,0.4935805183224711,0.9835164835164835,1.0,1.0,6/32,17.06%,IL4;MSH3;KPNA1;PPP4C;BLM;RPA2
prerank,rRNA 3'-end processing (GO:0031125),-0.22261673706525492,-0.49344732717350276,0.9851301115241635,0.9958034725440286,1.0,4/10,39.17%,ERI3;EXOSC7;RPS21;ERI1
prerank,DNA replication (GO:0006260),0.1599218117153208,0.4925911397265779,1.0,1.0,1.0,20/105,17.51%,KAT7;MCM6;RBMS1;RAD1;WRNIP1;TIMELESS;ATR;MCM7;MCM2;SET;REV3L;RAD17;ATRIP;BLM;ORC4;KIN;PIF1;NAP1L1;RPA2;RHNO1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.20728286553036493,0.49141633898712644,0.9734693877551021,1.0,1.0,11/22,28.56%,MED13;MED1;MED4;DHX36;MED30;MED16;MED14;PSMC3;SUB1;PSMC4;MED17
prerank,modulation by host of symbiont process (GO:0051851),-0.1688361697934751,-0.4903356506691636,0.997872340425532,0.9958654307137842,1.0,14/31,41.46%,LEF1;SAP30BP;HDAC1;SMARCA4;INPP5K;TAF11;CTDP1;JUN;AQP1;CCL5;CX3CR1;NUCKS1;SAP30;CCL4
prerank,nuclear envelope organization (GO:0006998),0.21046484887690353,0.48971590183391756,0.9769673704414588,1.0,1.0,5/20,22.75%,TOR1B;EMD;TOR1A;LEMD3;SUN2
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.19957793474640678,0.4884821772641694,0.977319587628866,1.0,1.0,2/22,7.63%,KAT7;TCERG1
prerank,synaptic vesicle localization (GO:0097479),0.22648961923416044,0.48575040948640313,0.9753086419753086,1.0,1.0,4/13,16.33%,KIF5C;SYNDIG1;CDK5;TOR1A
prerank,nucleotide-sugar biosynthetic process (GO:0009226),0.20613779696178802,0.48393704712564345,0.9713114754098361,1.0,1.0,1/19,3.23%,UGP2
prerank,vesicle transport along microtubule (GO:0047496),0.20594195214350472,0.4827819377561942,0.9782178217821782,1.0,1.0,8/23,19.15%,KIF3A;TRAK1;TRAK2;RAB1A;NDE1;HTT;HAP1;KIF1A
prerank,autophagosome organization (GO:1905037),0.1788162605518519,0.4812745765228874,0.9930434782608696,1.0,1.0,18/50,24.88%,ATG16L1;ATP2A2;TP53INP2;UBXN2B;ATG2B;UBQLN2;VMP1;RAB1A;PIK3C3;ULK3;RAB1B;GABARAP;GABARAPL2;ATG13;ATG9A;TMEM41B;ATG16L2;UBXN2A
prerank,t-circle formation (GO:0090656),0.23100457563091015,0.478487471206481,0.9504310344827587,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,formation of extrachromosomal circular DNA (GO:0001325),0.23100457563091015,0.478487471206481,0.9504310344827587,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,telomere maintenance via telomere trimming (GO:0090737),0.23100457563091015,0.478487471206481,0.9504310344827587,1.0,1.0,3/10,17.26%,BLM;XRCC3;TERF1
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.208397091484485,0.4779506962256422,0.978021978021978,1.0,1.0,6/18,22.96%,PCID2;ZC3H11A;NUP133;DDX25;POLDIP3;THOC2
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),0.23176291624287915,0.4775997453180663,0.9757174392935982,1.0,1.0,3/10,20.84%,LYN;CD24;LILRB1
prerank,protein targeting to mitochondrion (GO:0006626),0.1735333801425336,0.4762217332291468,0.9946996466431095,1.0,1.0,18/52,26.75%,IMMP2L;TIMM22;GRPEL2;TOMM40L;MFF;TIMM23;TOMM40;MIPEP;PMPCB;TOMM70;PITRM1;AGK;DNAJC19;PAM16;TIMM17A;DNLZ;HSP90AA1;TIMM17B
prerank,mRNA export from nucleus (GO:0006406),0.15462672097901614,0.47562640212905366,1.0,1.0,1.0,21/102,20.86%,NUP43;NCBP2;SRRM1;RNPS1;PCID2;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;POLR2D;HNRNPA2B1;DDX25;POLDIP3;SRSF9
prerank,positive regulation of interferon-alpha production (GO:0032727),0.21218329267273703,0.47545899556116344,0.9743589743589743,1.0,1.0,2/19,7.58%,DDX3X;RIPK2
prerank,DNA packaging (GO:0006323),-0.1931389622548724,-0.4753048241766572,0.9767441860465116,0.9977322908096615,1.0,10/16,49.59%,AIFM1;HAT1;CHAF1A;TP53;NAA10;RBBP4;CHAF1B;NOC2L;M1AP;H1-0
prerank,negative regulation of defense response to virus (GO:0050687),0.22712095835096555,0.4752091380622859,0.9824561403508771,1.0,1.0,3/10,16.99%,TARBP2;C1QBP;TRAF3IP1
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.20422385771519588,0.4733355598765157,0.9859154929577465,1.0,1.0,6/19,22.98%,SREBF2;HTRA2;CAMKK2;HTT;CSNK2A2;VDAC1
prerank,RNA 3'-end processing (GO:0031123),0.1633306757403169,0.4733236936217894,1.0,1.0,1.0,8/69,11.42%,CLP1;NCBP2;SUPV3L1;SRRM1;PAPOLA;RNPS1;SYMPK;RPRD1B
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.22688537018582944,0.4726653778509767,0.9790356394129979,1.0,1.0,6/11,28.68%,UGGT2;TOR1A;POMT2;DERL1;BAG6;UGGT1
prerank,neuromuscular process (GO:0050905),0.20740928404605302,0.47225574152684935,0.9648351648351648,1.0,1.0,1/16,3.16%,NRXN1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.23169727387782418,0.4721453798988489,0.9563318777292577,1.0,1.0,3/10,24.16%,CCT7;CCT3;DKC1
prerank,nuclear pore organization (GO:0006999),0.21099183069019695,0.46941439991944844,0.9789029535864979,1.0,1.0,3/14,17.70%,NUP35;NDC1;NUP133
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.2111183766174845,0.46703569676821627,0.981404958677686,1.0,1.0,1/13,3.68%,DERL3
prerank,mitotic chromosome condensation (GO:0007076),0.1913814123131289,0.4668154073002996,0.9805825242718447,1.0,1.0,10/26,26.86%,NUSAP1;RB1;SET;NCAPD3;SMC2;CSNK2A2;AKAP8L;NCAPH;CSNK2A1;NCAPD2
prerank,negative regulation of viral release from host cell (GO:1902187),0.2136967847873647,0.4661953654290377,0.9713114754098361,1.0,1.0,1/13,3.31%,MID2
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),0.17903880658509644,0.4647100276809314,0.9904214559386973,1.0,1.0,6/40,14.31%,MSH3;TIMELESS;ATR;ETAA1;SETMAR;BLM
prerank,tRNA wobble uridine modification (GO:0002098),-0.19217352359114703,-0.463979095863968,0.9819277108433735,0.9987426756004105,1.0,6/14,36.29%,ELP1;ELP3;URM1;KTI12;CTU2;CTU1
prerank,cellular response to UV-A (GO:0071492),-0.20349121102400505,-0.46259419357106096,0.9856115107913669,0.9983969876900292,1.0,2/11,15.44%,PPID;MMP2
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.18655133913759597,0.4592587318564846,0.990791896869245,1.0,1.0,2/29,5.68%,LIMK1;MAGEC2
prerank,phosphate ion transport (GO:0006817),-0.18284364980943307,-0.4575520176798536,0.9939759036144579,0.9984501251242959,1.0,1/16,4.14%,SLC20A2
prerank,regulation of histone deacetylation (GO:0031063),-0.19483750543407374,-0.4564223401673898,0.9925650557620818,0.9980652223798607,1.0,3/13,28.35%,SAP30BP;CTBP1;SPHK2
prerank,aminoglycan metabolic process (GO:0006022),0.21685915139342193,0.455169334940078,0.9759825327510917,1.0,1.0,10/10,78.33%,B3GALT6;CHST9;B3GAT1;B3GAT2;B4GALT7;XYLT2;GAL3ST3;B3GAT3;XYLT1;CLN6
prerank,protein-DNA complex disassembly (GO:0032986),-0.18044937151149182,-0.4528815141626186,0.9939148073022313,0.9979324809813293,1.0,6/16,36.43%,SMARCC1;RPL23;SMARCA4;SMARCD2;MYC;GRWD1
prerank,RNA export from nucleus (GO:0006405),0.14591764562165324,0.4509054856146523,1.0,1.0,1.0,14/100,14.55%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;HNRNPA1;UPF3B;EIF4E;RANBP2
prerank,protein localization to condensed chromosome (GO:1903083),0.20431494054303817,0.44849686334384914,0.9721030042918455,1.0,1.0,1/12,5.19%,CHAMP1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.19834395209021552,0.44809911268929387,0.98125,1.0,1.0,6/19,19.23%,MTOR;MAF1;DHX36;CHD8;POLR3F;TENM1
prerank,DNA recombination (GO:0006310),0.17474821361578882,0.44782838860622853,0.9943714821763602,1.0,1.0,8/37,17.51%,SUPV3L1;LIG4;MSH3;TSN;BLM;XRCC3;HDAC10;RHNO1
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.19880737863478926,0.4474271101680969,0.9832285115303984,1.0,1.0,1/15,4.80%,CLP1
prerank,DNA replication initiation (GO:0006270),0.16891284870976225,0.4473255330587663,0.9964028776978417,1.0,1.0,7/37,17.07%,MCM6;MCM7;MCM2;PRIM1;ORC4;RPA2;POLE4
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",0.17655943610654665,0.4468701238610837,0.9942196531791907,1.0,1.0,9/25,26.09%,KAT7;CCAR2;EAF2;SETD5;CCNK;TSFM;CCNT2;WDR43;LDB1
prerank,aerobic respiration (GO:0009060),0.19149232548655704,0.4452770513717258,0.9794661190965093,1.0,1.0,5/20,20.20%,BLOC1S1;UQCRC2;MTFR1;OXA1L;SURF1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.1769071402593651,-0.44334882552571125,0.9919028340080972,0.9983700395995941,1.0,6/16,34.14%,DDX5;SRSF6;PUF60;HNRNPM;PQBP1;CELF4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",-0.16175967344581568,-0.4423936840945343,0.9962335216572504,0.9979540393009905,1.0,11/22,43.08%,ERI3;FTSJ3;EXOSC7;RRS1;ABT1;URB1;RPS21;RPP40;ERI1;KRI1;UTP20
prerank,regulation of catecholamine secretion (GO:0050433),0.17319281540924303,0.441484033335583,0.9907063197026023,1.0,1.0,11/29,24.87%,SNCA;SYT1;SYT2;CHRNB2;SYT12;SYT11;SYT13;SYT3;DRD2;SYT6;SYT10
prerank,negative regulation of oxidoreductase activity (GO:0051354),0.20715866480728856,0.4392600726826611,0.9787685774946921,1.0,1.0,1/10,6.29%,SNCA
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.14296014816673772,0.43804006860022443,1.0,1.0,1.0,26/96,25.17%,NUP43;NCBP2;SRRM1;RNPS1;NUP35;YTHDC1;SEC13;SYMPK;SMG7;NDC1;UPF3B;EIF4E;RANBP2;ZC3H11A;NUP133;HNRNPA2B1;DDX25;POLDIP3;SRSF9;THOC2;SEH1L;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,mitochondrial translational elongation (GO:0070125),0.1424714896192573,0.4323658485097488,1.0,1.0,1.0,29/88,25.61%,MRPS27;MRPL55;MRPL58;GFM2;MRPS30;PTCD3;GFM1;MRPL20;MRPS18C;MRPS33;MRPS34;MRPS12;MRPS18B;OXA1L;MRPS17;MRPL47;MRPL40;MRPL37;MRPL2;MRPL11;TSFM;MRPS15;MRPL42;DAP3;MRPS11;MRPL32;MRPL14;MRPS16;MRPL41
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.1735922431137325,0.43100173861604696,1.0,1.0,1.0,4/31,12.82%,LSS;STAR;PRLR;SRD5A1
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.1853028875836264,0.4308637891537169,0.9956043956043956,1.0,1.0,3/20,11.89%,AGO3;TARBP2;TSN
prerank,tRNA processing (GO:0008033),0.15302663104149675,0.43070768140082033,1.0,1.0,1.0,18/61,24.31%,CLP1;TRMT61A;TRUB1;SSB;TRMT1;ADAT1;TRMT10C;ELP5;NSUN2;AARS1;POP7;POP5;TSEN15;DDX1;THUMPD1;TRMT10A;TRMT9B;TRDMT1
prerank,tRNA 5'-leader removal (GO:0001682),-0.17969744055679018,-0.4299806125988887,0.9962406015037594,0.9984477632649476,1.0,6/13,37.74%,PRORP;RPP38;POP1;RPP25L;RPP21;RPP40
prerank,nuclear membrane disassembly (GO:0051081),0.1930635020413694,0.424968821096568,0.9813664596273292,1.0,1.0,5/14,26.40%,NEK6;DCTN1;NEK9;AKAP8L;VRK1
prerank,pre-replicative complex assembly (GO:0036388),0.1469407609796402,0.418800968592232,1.0,1.0,1.0,14/64,19.94%,PSMB11;PSMF1;MCM6;MCM7;MCM2;PSME4;ORC4;PSMB5;PSMA1;PSMB8;PSMA5;PSMD13;PSMB2;ORC6
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.18541117765022488,-0.4172073632413726,0.9980879541108987,0.9987893252479769,1.0,2/10,22.85%,NAF1;PIH1D1
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",-0.1270056168769569,-0.41662663911167147,1.0,0.9983132227040237,1.0,2/53,3.96%,CALCRL;ANXA1
prerank,regulation of mitotic spindle assembly (GO:1901673),0.17955525621502239,0.41590148237376234,0.997920997920998,1.0,1.0,5/19,19.22%,CHMP2B;CEP97;HNRNPU;CHMP3;DRG1
prerank,lipid biosynthetic process (GO:0008610),0.1406395594611336,0.4137133931367805,1.0,1.0,1.0,12/77,15.35%,LIPH;LIPC;LSS;STAR;PRLR;SRD5A1;PRKAA1;OLAH;HMGCR;PDSS1;LPCAT1;MLYCD
prerank,regulation of interferon-alpha production (GO:0032647),0.17804151167860663,0.41290921290212473,0.98635477582846,1.0,1.0,2/23,7.58%,DDX3X;RIPK2
prerank,regulation of centrosome cycle (GO:0046605),-0.15555037812026978,-0.4121532199131887,1.0,0.9980490358528529,1.0,2/21,10.71%,PDCD6IP;CHMP4B
prerank,C4-dicarboxylate transport (GO:0015740),0.18990353959285142,0.4100431464313953,0.9894957983193278,1.0,1.0,1/14,5.46%,SLC25A13
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.1909021916534044,0.4072131000340958,0.9891540130151844,1.0,1.0,5/13,22.99%,PCID2;MAD2L1;XRCC3;DYNC1LI1;CDK5RAP2
prerank,mRNA 3'-end processing (GO:0031124),0.13879501549834405,0.40445373905530335,1.0,0.9999357107157831,1.0,25/78,26.68%,CLP1;NCBP2;SRRM1;PAPOLA;RNPS1;CPSF6;SYMPK;RPRD1B;UPF3B;ZC3H11A;CPSF7;POLR2D;POLDIP3;SRSF9;PABPC1;THOC2;EIF4A3;TUT1;SRSF4;CASC3;CDC40;LEO1;PAPOLG;TENT2;SRSF3
prerank,RNA transport (GO:0050658),0.1326611836455168,0.38348653116881787,1.0,1.0,1.0,20/71,25.17%,RFTN1;NCBP2;SRRM1;RNPS1;KIF5C;HNRNPA1;UPF3B;EIF4E;ZC3H11A;FMR1;HNRNPA2B1;POLDIP3;SRSF9;ZFP36L1;THOC2;EIF4A3;RAE1;SRSF4;CASC3;CDC40
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.17236486076944862,0.3799686475071559,0.9913978494623656,1.0,1.0,4/13,19.42%,PTPN1;ABCA7;DDRGK1;PPP1R15A
prerank,androgen metabolic process (GO:0008209),0.15959162125314735,0.3662274939936642,0.9940828402366864,1.0,1.0,3/18,19.51%,MED1;SRD5A1;HSD17B4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.1689053477278433,0.354044184978811,1.0,1.0,1.0,10/10,83.12%,APC;KNSTRN;CDC42;RACGAP1;ECT2;NEK2;CCNB1;RCC2;SPAG5;SIRT2
prerank,ncRNA metabolic process (GO:0034660),0.1304508785265549,0.3391477030318882,1.0,1.0,1.0,5/37,17.80%,PLD6;TARBP2;TDRKH;EXD1;KHSRP
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.14283023606228012,0.3343391576090761,1.0,1.0,1.0,14/14,85.73%,WDR12;RPF2;DDX18;NOL9;PES1;ZNHIT6;ZNHIT3;BOP1;NIFK;RPL35;RPL7L1;URB1;FTSJ3;RPL7
prerank,tRNA 5'-end processing (GO:0099116),0.1486882368625248,0.3291293907213183,1.0,0.9996747201865741,1.0,4/15,21.95%,SSB;TRMT10C;POP7;POP5
